Citrus Sinensis ID: 005236
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 706 | 2.2.26 [Sep-21-2011] | |||||||
| O81905 | 850 | Receptor-like serine/thre | yes | no | 0.983 | 0.816 | 0.510 | 0.0 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.915 | 0.825 | 0.500 | 0.0 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.957 | 0.829 | 0.516 | 0.0 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.974 | 0.816 | 0.497 | 0.0 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.981 | 0.818 | 0.482 | 0.0 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.975 | 0.803 | 0.463 | 0.0 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.971 | 0.811 | 0.459 | 1e-174 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.980 | 0.811 | 0.482 | 1e-174 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.953 | 0.807 | 0.454 | 1e-174 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.968 | 0.812 | 0.434 | 1e-164 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 699 bits (1805), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/717 (51%), Positives = 471/717 (65%), Gaps = 23/717 (3%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
+GN VLR ++ + LWQSFD+P+DTLLP MKLGWD KTG R I SWKSPDDPS G+
Sbjct: 135 NGNFVLRDSKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGD 194
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAATLRQN-PVFNFSFVSSEDELYYTF 130
F++ +E + PE+ +W + YRSGPWNG+RFS Q F+F +S++E+ Y+F
Sbjct: 195 FSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSF 254
Query: 131 DLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISDL 190
+ V+SR+ ++ + L QRFTW + QNW P+D CD Y CG YG C +
Sbjct: 255 RITKSDVYSRLSISSSGLL-QRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTS 313
Query: 191 PVCQCLKGFKPKSR---GYVDWSQGCVRDKSLNYSREDGFIKFTAMKLPDATPSWVSKSM 247
PVC C+KGFKP++ G D S GCVR L+ DGF++ MKLPD T + V + +
Sbjct: 314 PVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGI 373
Query: 248 NLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYIRMSASELG 307
+KEC +KCL + +C A+ N+DIRG GSGC W GEL D+R++ GGQDLY+R++A++L
Sbjct: 374 GVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLE 433
Query: 308 AKGEPTTKIVLIVISTAALLAVVIAAGYLI-HKSRRNIVVN--IARYFRENRNNRGTEQ- 363
K + KI+ I + LL + +L K +R+I++ I + +R+ E
Sbjct: 434 DKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVV 493
Query: 364 -------KNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAV 416
E+ DL+LPL E +A AT+NFS KLG+GGFG VYKG L D QE+AV
Sbjct: 494 ISSRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAV 553
Query: 417 KRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFD 476
KRLSK S QG E KNE+ L ++LQH NLV+LL CC+ EK+LIYE++ N SLDS +FD
Sbjct: 554 KRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFD 613
Query: 477 QERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 536
+ R L+W RF II G ARGLLYLHQDSR RIIHRDLKASN+LLD+ M PKISDFG+A
Sbjct: 614 KSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMA 673
Query: 537 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHS 596
R FG DETE NT +VVGTYGYM+PEYA DG FS+KSDVFSFG+LLLEI+S K+N+GFY+S
Sbjct: 674 RIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNS 733
Query: 597 DNKLNLIRHAWKLWNEGMPSQLIDACFKDS---FNLAEVIRCIHIGLLCVQQYPEDRPCM 653
D LNL+ W+ W EG ++ID DS F E++RCI IGLLCVQ+ EDRP M
Sbjct: 734 DRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTM 793
Query: 654 PSVILMLGSE-IVLPQPKQPGYLADRKSTRLDSSLSMP---ESSSTNTITISELEGR 706
VILMLGSE +PQPK PGY +R DSS S ES + N IT+S L+ R
Sbjct: 794 SLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 678 bits (1750), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/701 (50%), Positives = 470/701 (67%), Gaps = 55/701 (7%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
+GNLV+R G + Y+WQS DYP D LPGMK G + TGL R +TSW++ DDPS GN
Sbjct: 132 TGNLVVRNS--GDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGN 189
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSA-ATLRQNPVFNFSFVSSEDELYYTF 130
+T ++ P+ + K S +R+GPWNGLRF+ L+ NP++ + +V +E+E+YYT+
Sbjct: 190 YTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTY 249
Query: 131 DLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISDL 190
L + +V +R+ +N L QR+TW Q+W L+ D CD Y LCG YG C I++
Sbjct: 250 KLENPSVLTRMQLNPNGAL-QRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINES 308
Query: 191 PVCQCLKGFKPKS-RGYV--DWSQGCVRDKSLNYSR-EDGFIKFTAMKLPDATPSWVSKS 246
P C+CLKGF K+ + +V DWS+GCVR L+ + EDGF+K + +KLPD SW K+
Sbjct: 309 PACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKN 368
Query: 247 MNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYIRMSASEL 306
M+L EC++ CL N +C AY+ DIR GG GC +WFG+LID+R++ + GQDLY+R+++SE+
Sbjct: 369 MDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLASSEI 428
Query: 307 GAKGEPTTKIVLIVISTAALLAVVIAAGYLIHKSRRNIVVNIARYFRENRNNRGTEQKNE 366
++++ + +K E
Sbjct: 429 ETLQRESSRV--------------------------------------------SSRKQE 444
Query: 367 DQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQG 426
++ DL+LP +L T++ AT FS KLG+GGFGPVYKGTLA QE+AVKRLS+ S QG
Sbjct: 445 EE--DLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQG 502
Query: 427 LKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWS 486
++E KNEI L +KLQHRNLVK+LG C+ EE++LIYE+ PNKSLDSFIFD+ER + LDW
Sbjct: 503 VEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWP 562
Query: 487 KRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546
KR II G ARG+LYLH+DSRLRIIHRDLKASNVLLD DMN KISDFGLAR GGDETE
Sbjct: 563 KRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEA 622
Query: 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHA 606
NT RVVGTYGYM+PEY DG FS+KSDVFSFG+L+LEIVSG++NRGF + ++KLNL+ HA
Sbjct: 623 NTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHA 682
Query: 607 WKLWNEGMPSQLIDACFKDS-FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665
W+ + E ++ID +S +++EV+R IHIGLLCVQQ P+DRP M V+LML SE++
Sbjct: 683 WRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEML 742
Query: 666 LPQPKQPGYLADRKSTRLDSSLSMPESSSTNTITISELEGR 706
L P+QPG+ +R D+ E S N T+S ++ R
Sbjct: 743 LLDPRQPGFFNERNLLFSDTVSINLEIPSNNFQTMSVIDPR 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 676 bits (1743), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/713 (51%), Positives = 478/713 (67%), Gaps = 37/713 (5%)
Query: 6 FLFVCYSGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPD 65
L + SGNL+ G E LWQSFDYP +T+L GMKLG + KT +E ++SWK+
Sbjct: 128 LLKISCSGNLI----SSDGEEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLK 183
Query: 66 DPSPGNFTWAVERQDNPELIMWKG--SRKFYRSGPWNGLRFSAATL--RQNPVFNFSFVS 121
DPSPG+FT +++ + P+LI+ K S YR G WNGL F+ A R+N +F++ F S
Sbjct: 184 DPSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTS 243
Query: 122 SEDELYYTFDLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGD 181
S E+ Y++ + V SR+V+N T L RF K Q W L P D CD Y++CG
Sbjct: 244 SAQEVNYSWTPRHRIV-SRLVLNNTGKL-HRFIQSKQNQ-WILANTAPEDECDYYSICGA 300
Query: 182 YGICIIS--DLPVCQCLKGFKPKSRGYVDWSQG---CVRDKSLNYSREDGFIKFTAMKLP 236
Y +C I+ + P C CL+GFKPKS + S+G CV + N ++D F+KF +KLP
Sbjct: 301 YAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLP 360
Query: 237 DATPSW--VSKSMNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGG 294
D + SW M L++C+ KC N SC AY N+DIR GG GC +WFG+L+DMR++ G
Sbjct: 361 DTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFG 420
Query: 295 QDLYIRMSASELGAKGEPTTKIVLIVISTAALLAVVIAAGYLIHKSRRNIVVNIARYFRE 354
QD+YIRM +++ KG +V+ + A++ VV+ A + R+ I + RY E
Sbjct: 421 QDVYIRMGFAKIEFKGREVVGMVVGSVVAIAVVLVVVFACF-----RKKI---MKRYRGE 472
Query: 355 NRNNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEI 414
N +G E++ DLDLP+F+ TI+ ATD+FS LG GGFGPVYKG L D QEI
Sbjct: 473 NFR-KGIEEE------DLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEI 525
Query: 415 AVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI 474
AVKRLS S QG++E KNE+ L +KLQHRNLV+LLGCCI GEE +LIYE+MPNKSLD FI
Sbjct: 526 AVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFI 585
Query: 475 FDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 534
FD+ R LDW KR +II G ARG+LYLHQDSRLRIIHRDLKA NVLLD DMNPKISDFG
Sbjct: 586 FDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFG 645
Query: 535 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 594
LA++FGGD++E +TNRVVGTYGYM PEYA DG FSVKSDVFSFG+L+LEI++GK NRGF
Sbjct: 646 LAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFR 705
Query: 595 HSDNKLNLIRHAWKLWNEGMP-SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCM 653
H+D+ LNL+ H WK+W E + +++ + EV+RCIH+ LLCVQQ PEDRP M
Sbjct: 706 HADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTM 765
Query: 654 PSVILMLGSEIVLPQPKQPGYLADRKSTRLDSSLSMPESSSTNTITISELEGR 706
SV+LM GS+ LP P QPG+ +R + SSLS+ S N ++I+ L+GR
Sbjct: 766 ASVVLMFGSDSSLPHPTQPGFFTNRNVPDISSSLSL---RSQNEVSITMLQGR 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 664 bits (1712), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/718 (49%), Positives = 475/718 (66%), Gaps = 30/718 (4%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
+GN +LR + LWQSFD+P+DTLL MKLGWD KTG R + SWK+ DDPS G
Sbjct: 133 NGNFLLRDSNN----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGE 188
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAAT-LRQNPVFNFSFVSSEDELYYTF 130
F+ +E + PE + YRSGPWNG+RFS+ Q ++F +S++E+ Y++
Sbjct: 189 FSTKLETSEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSY 248
Query: 131 DLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISDL 190
+ ++SR+ +N L QR TW + TQ+W+ P+DLCD Y +CG++G C + L
Sbjct: 249 RINKTNLYSRLYLNSAGLL-QRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSL 307
Query: 191 PVCQCLKGFKP---KSRGYVDWSQGCVRDKSLNYSREDGFIKFTAMKLPDATPSWVSKSM 247
P C C+KGFKP ++ D S GC+R L+ DGF + MKLPD T + V + +
Sbjct: 308 PNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREI 367
Query: 248 NLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYIRMSASELG 307
LK C+E+CLE+ +C A+ N+DIR GGSGC +W E++DMR++ GGQDLY+R++A+EL
Sbjct: 368 GLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELE 427
Query: 308 AKGEPTTKIV--LIVISTAALLAVVIAAGYLIHKSRRNIVV---NIARYFRENR------ 356
K KI+ I +S LL+ VI + K +R+I + N+ + ++
Sbjct: 428 DKRIKNEKIIGSSIGVSILLLLSFVIFH-FWKRKQKRSITIQTPNVDQVRSQDSLINDVV 486
Query: 357 -NNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIA 415
+ RG K E ++ L+LPL EL +A AT+NFS + KLG+GGFG VYKG L D +EIA
Sbjct: 487 VSRRGYTSK-EKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIA 545
Query: 416 VKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIF 475
VKRLSK+S QG E NE+ L +KLQH NLV+LLGCC+ EK+LIYE++ N SLDS +F
Sbjct: 546 VKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLF 605
Query: 476 DQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 535
DQ R L+W KRF II G ARGLLYLHQDSR RIIHRDLKASNVLLD++M PKISDFG+
Sbjct: 606 DQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGM 665
Query: 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 595
AR FG +ETE NT RVVGTYGYM+PEYA DG FS+KSDVFSFG+LLLEI+SGK+N+GFY+
Sbjct: 666 ARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYN 725
Query: 596 SDNKLNLIRHAWKLWNEGMPSQLIDACFKDS----FNLAEVIRCIHIGLLCVQQYPEDRP 651
S+ LNL+ W+ W EG +++D DS F E++RCI IGLLCVQ+ EDRP
Sbjct: 726 SNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRP 785
Query: 652 CMPSVILMLGSEIV-LPQPKQPGYLADRKSTRLDSSLSMP--ESSSTNTITISELEGR 706
M SV++MLGSE +PQPK+PG+ R DSS S + + N IT+S ++ R
Sbjct: 786 VMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 654 bits (1687), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/715 (48%), Positives = 465/715 (65%), Gaps = 22/715 (3%)
Query: 13 GNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTG-LERRITSWKSPDDPSPGN 71
GN VLR ++ +LWQSFD+P+DTLL MK+GWD K+G R + SWK+ DDPS G+
Sbjct: 134 GNFVLRDSKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGD 193
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAAT-LRQNPVFNFSFVSSEDELYYTF 130
F+ + PE ++ YRSGPW G RFS+ ++ + SF + ++ Y++
Sbjct: 194 FSTKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSY 253
Query: 131 DLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISDL 190
+ ++S + ++ T L QR TW +A Q+W+ P+DLCD Y CG+YG C +
Sbjct: 254 RVNKTNIYSILSLSSTGLL-QRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTS 312
Query: 191 PVCQCLKGFKP--KSRGYVDWSQGCVRDKSLNYSREDGFIKFTAMKLPDATPSWVSKSMN 248
P+C C+KGF+P + D S GCVR L+ DGF++ M+LPD T + V K +
Sbjct: 313 PICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIG 372
Query: 249 LKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYIRMSASELGA 308
LKEC E+CL+ +C A+ N+DIR GGSGC +W G L D+R++ GGQDLY+R++A +L
Sbjct: 373 LKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLED 432
Query: 309 KGEPTTKIVLIVISTAALLAV-VIAAGYLIHKSRRNI-----VVNIAR----YFRENRNN 358
K + KI+ I + LL + I + K +R+I +V++ R E
Sbjct: 433 KRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKA 492
Query: 359 RGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKR 418
+ E++ L+LPL E +A AT+NFS + KLG+GGFG VYKG L D +EIAVKR
Sbjct: 493 SRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKR 552
Query: 419 LSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQE 478
LSK+S QG E NE+ L +KLQH NLV+LLGCC+ EK+LIYE++ N SLDS +FDQ
Sbjct: 553 LSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQT 612
Query: 479 RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538
R L+W KRF II G ARGLLYLHQDSR RIIHRDLKASNVLLD++M PKISDFG+AR
Sbjct: 613 RSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI 672
Query: 539 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 598
FG +ETE NT RVVGTYGYM+PEYA DG FS+KSDVFSFG+LLLEI+SGK+N+GFY+S+
Sbjct: 673 FGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNR 732
Query: 599 KLNLIRHAWKLWNEGMPSQLIDACFKDS----FNLAEVIRCIHIGLLCVQQYPEDRPCMP 654
LNL+ W+ W EG +++D D+ F E++RCI IGLLCVQ+ EDRP M
Sbjct: 733 DLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMS 792
Query: 655 SVILMLGSEIV-LPQPKQPGYLADRKSTRLDSSLSMP--ESSSTNTITISELEGR 706
SV++MLGSE +PQPK+PG+ R S +DSS S + + N +T+S ++ R
Sbjct: 793 SVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 651 bits (1679), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 337/727 (46%), Positives = 466/727 (64%), Gaps = 38/727 (5%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
+GN V+R + + YLWQSFDYP+DTLLP MKLG++LKTGL R +TSW+S DDPS GN
Sbjct: 137 NGNFVMRDSSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDDPSSGN 196
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAATLRQNPVFN-FSFVSSEDELYYTF 130
F++ +E Q PE + + + +RSGPWNG+RFS Q + ++F+ + +E+ YTF
Sbjct: 197 FSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIENNEEVAYTF 256
Query: 131 DLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRD-LCDTYALCGDYGICIISD 189
+ + + +SR+ + Y QR TW + + W + P D CDTY +CG Y C ++
Sbjct: 257 RMTNNSFYSRLTLISEGYF-QRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAYCDVNT 315
Query: 190 LPVCQCLKGFKPKSRGYVD---WSQGCVRDKSLNYSREDGFIKFTAMKLPDATPSWVSKS 246
PVC C++GF P++ D W+ GC+R L+ S DGF + MKLP+ T + V +S
Sbjct: 316 SPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSCS-GDGFTRMKKMKLPETTMATVDRS 374
Query: 247 MNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDG---GQDLYIRMSA 303
+ +KEC+++C+ + +C A+ N+DIR GGSGC +W L D+R++ GQDLY+R++A
Sbjct: 375 IGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDAIDGQDLYVRLAA 434
Query: 304 SELGAKGEPTTKIVLIVISTAALLAVVI------------AAGYLIHKSRRNIVVNIARY 351
+++ K + KI+ + + + LL +++ A+ I ++RN + +
Sbjct: 435 ADIAKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAISIANTQRNQNLPMNEM 494
Query: 352 FRENRNNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADE 411
++ E K E+ L+LPL E+ T+ AT+NFS KLG+GGFG VYKG L D
Sbjct: 495 VLSSKREFSGEYKFEE----LELPLIEMETVVKATENFSSCNKLGQGGFGIVYKGRLLDG 550
Query: 412 QEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLD 471
+EIAVKRLSK S QG E NE+ L ++LQH NLV++LGCCI G+EK+LIYE++ N SLD
Sbjct: 551 KEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLD 610
Query: 472 SFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 531
S++F + R L+W++RF I G ARGLLYLHQDSR RIIHRDLK SN+LLD++M PKIS
Sbjct: 611 SYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKIS 670
Query: 532 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNR 591
DFG+AR F DETE NT +VVGTYGYM+PEYA G FS KSDVFSFG+++LEIVSGKKNR
Sbjct: 671 DFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSFGVIVLEIVSGKKNR 730
Query: 592 GFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDS-------FNLAEVIRCIHIGLLCVQ 644
GFY+ D + +L+ + W W EG +++D DS F EV++CI IGLLCVQ
Sbjct: 731 GFYNLDYENDLLSYVWSRWKEGRALEIVDPVIVDSLSSQPSIFQPQEVLKCIQIGLLCVQ 790
Query: 645 QYPEDRPCMPSVILMLGSEIV-LPQPKQPGYLADRKSTRLDSSLSMP----ESSSTNTIT 699
+ E RP M SV+ M GSE +PQPK PGY R LD S S ES + N T
Sbjct: 791 ELAEHRPAMSSVVWMFGSEATEIPQPKPPGYCVRRSPYELDPSSSWQCDENESWTVNQYT 850
Query: 700 ISELEGR 706
S ++ R
Sbjct: 851 CSVIDAR 857
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 613 bits (1581), Expect = e-174, Method: Compositional matrix adjust.
Identities = 333/724 (45%), Positives = 475/724 (65%), Gaps = 38/724 (5%)
Query: 13 GNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNF 72
GNLVL G S W+SF++P++TLLP MK G+ ++G++R +TSW+SP DP GN
Sbjct: 130 GNLVLLDPVTGKS---FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNI 186
Query: 73 TWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAATLRQNP-VFNFSFVSSEDELYYTFD 131
T+ +ER+ P+++M+KG ++R+G W G R+S N +FN SFV++ DE+ T+
Sbjct: 187 TYRIERRGFPQMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYG 246
Query: 132 LIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGIC--IISD 189
++D +V +R+V+N+T L QRF W + W + P D CD Y CG G C ++
Sbjct: 247 VLDASVTTRMVLNETGTL-QRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTE 305
Query: 190 LPVCQCLKGFKPKS-RGYV--DWSQGCVRDKSLNYSR-EDGFIKFTAMKLPDATPSWVSK 245
C CL G++PK+ R + D S GC R K+ + ++GF K +K+P+ + V
Sbjct: 306 KFECSCLPGYEPKTPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDM 365
Query: 246 SMNLKECREKCLENSSCMAYTNS--DIRGGGSGCAMWFGELIDMRDFPDGGQDLYIRMSA 303
++ LKEC ++CL+N SC+AY ++ + + G GC W G ++D R + GQD Y+R+
Sbjct: 366 NITLKECEQRCLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDK 425
Query: 304 SEL------GAKGEPTTKIVLIVISTAALLAVVIAAGYLIHKSRR-----NIVVNIARYF 352
SEL GA G+ ++VLI+IS A++ +++ + + + RR N + F
Sbjct: 426 SELARWNGNGASGK--KRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSF 483
Query: 353 RENR---NNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLA 409
+ + ++ ED++ +LPLFEL+TIA AT+NF+ KLG GGFGPVYKG L
Sbjct: 484 APSSFDLEDSFILEELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQ 543
Query: 410 DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKS 469
+ EIAVKRLSK S QG++E KNE+ L SKLQHRNLV++LGCC+ EEK+L+YE++PNKS
Sbjct: 544 NGMEIAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKS 603
Query: 470 LDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 529
LD FIF +E+ LDW KR II G RG+LYLHQDSRLRIIHRDLKASNVLLD +M PK
Sbjct: 604 LDYFIFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPK 663
Query: 530 ISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 589
I+DFGLAR FGG++ EG+TNRVVGTYGYM+PEYA DGQFS+KSDV+SFG+L+LEI++GK+
Sbjct: 664 IADFGLARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKR 723
Query: 590 NRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF-KDSFNLAEVIRCIHIGLLCVQQYPE 648
N FY + LNL++H W W G ++ID +++++ EV++C+HIGLLCVQ+
Sbjct: 724 NSAFY--EESLNLVKHIWDRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQENSS 781
Query: 649 DRPCMPSVILMLGSEIV-LPQPKQPGYLADRKST-----RLDSSLSMPESSSTNTITISE 702
DRP M SV+ MLG + LP PK P + A R+ D+ S SS+ N +T+++
Sbjct: 782 DRPDMSSVVFMLGHNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSSTINDVTLTD 841
Query: 703 LEGR 706
++GR
Sbjct: 842 VQGR 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 613 bits (1580), Expect = e-174, Method: Compositional matrix adjust.
Identities = 348/721 (48%), Positives = 459/721 (63%), Gaps = 29/721 (4%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
+GN VLRG + S+ +LWQSFD+P+DTLLP MKLG D K GL R +TSWKS DPS G+
Sbjct: 136 NGNFVLRGSKINESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGS 195
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAA-TLRQNPVFNFSFVSSEDELYYTF 130
F + +E PE + + YRSGPW+GLRFS ++Q ++F + +E+ YTF
Sbjct: 196 FMFKLETLGLPEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYNFTENREEVAYTF 255
Query: 131 DLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISDL 190
+ D +SR+ +N L + F W+ Q W + +P+D CD Y +CG Y C +S
Sbjct: 256 RVTDHNSYSRLTINTVGRL-EGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTS 314
Query: 191 PVCQCLKGFKPKSRGYVDWSQGCV----RDKSLNYSREDGFIKFTAMKLPDATPSWVSKS 246
P C C+KGF+P S DW+ G V R K+ ED F + MK+P T + V K
Sbjct: 315 PTCNCIKGFQPLSPQ--DWASGDVTGRCRRKTQLTCGEDRFFRLMNMKIPATTAAIVDKR 372
Query: 247 MNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYIRMSASEL 306
+ LKEC EKC + +C AY NSDIR GGSGC +W GE D+R++ GQDL++R++A+E
Sbjct: 373 IGLKECEEKCKTHCNCTAYANSDIRNGGSGCIIWIGEFRDIRNYAADGQDLFVRLAAAEF 432
Query: 307 GAKGEPTTKIVLIVISTAALLAV-VIAAGYLIHKSRRNIVVNIARYFRE--------NRN 357
G + KI+ ++I + +L + I + K +R +R+ N
Sbjct: 433 GERRTIRGKIIGLIIGISLMLVLSFIIYCFWKKKQKRARATAAPIGYRDRIQELIITNGV 492
Query: 358 NRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVK 417
+ ++ + DL+LPL E T+ AT+NFS + LG GGFG VYKG L D QEIAVK
Sbjct: 493 VMSSGRRLLGEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQEIAVK 552
Query: 418 RLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQ 477
RLS++S QG E KNE+ L ++LQH NLV+LL CCI+ +EK+LIYE++ N SLDS +F+
Sbjct: 553 RLSEMSSQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSHLFET 612
Query: 478 -ERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 536
+ L+W RF II G ARGLLYLHQDSR +IIHRDLKASNVLLD++M PKISDFG+A
Sbjct: 613 TQSSNKLNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISDFGMA 672
Query: 537 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHS 596
R F DETE NT +VVGTYGYM+PEYA +G FSVKSDVFSFG+L+LEIVSGK+NRGF++S
Sbjct: 673 RIFERDETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVSGKRNRGFHNS 732
Query: 597 DNKLNLIRHAWKLWNEGMPSQLIDACFKDS------FNLAEVIRCIHIGLLCVQQYPEDR 650
NL+ + W+ W EG +++D+ DS F EV+RCI IGLLCVQ+ EDR
Sbjct: 733 GQDNNLLGYTWENWKEGKGLEIVDSIIVDSSSSMSLFQPHEVLRCIQIGLLCVQERAEDR 792
Query: 651 PCMPSVILMLGSEI-VLPQPKQPGYLADRKS-TRLDSSLSM---PESSSTNTITISELEG 705
P M SV+LMLGSE +PQPK+PGY R S DSS S ES + N IT+S +
Sbjct: 793 PKMSSVVLMLGSEKGEIPQPKRPGYCVGRSSLDTADSSSSTKRDSESLTVNQITVSVINA 852
Query: 706 R 706
R
Sbjct: 853 R 853
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 612 bits (1579), Expect = e-174, Method: Compositional matrix adjust.
Identities = 331/728 (45%), Positives = 461/728 (63%), Gaps = 55/728 (7%)
Query: 13 GNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNF 72
GNLVL G S W+SFD+P+DT LP M+LG+ K GL+R +TSWKS DP G+
Sbjct: 127 GNLVLFDPVTGRS---FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDL 183
Query: 73 TWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAA-TLRQNPVFNFSFVSSEDELYYTFD 131
+ER+ P+LI++KG ++R G W G R+S + +FN SFV++EDE+ +T+
Sbjct: 184 ILRMERRGFPQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYG 243
Query: 132 LIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISDLP 191
+ D +V +R ++N+T + RFTW + W +VP++ CD YA CG G C D P
Sbjct: 244 VTDASVITRTMVNETGTM-HRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYC---DSP 299
Query: 192 V-----CQCLKGFKPK-SRGYV--DWSQGCVRDKSLNY-SREDGFIKFTAMKLPDATPSW 242
C CL GF+PK R + D S GC + K + S +DGF+K MK+PD + +
Sbjct: 300 SSKTFECTCLPGFEPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDAS 359
Query: 243 VSKSMNLKECREKCLENSSCMAYTNS--DIRGGGSGCAMWFGELIDMRDFPDGGQDLYIR 300
V ++ LKEC+++CL+N SC+AY ++ + + G GC W G ++D R + + GQD YIR
Sbjct: 360 VDMNITLKECKQRCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIR 419
Query: 301 MSASEL------GAKGEPTTKIVLIVISTAALLAVVIAAGYLIHKSRRNIVVNIARYFRE 354
+ EL G G+ ++LI + A +L VI + + + RR +
Sbjct: 420 VDKEELARWNRNGLSGKRRVLLILISLIAAVMLLTVIL--FCVVRERR----------KS 467
Query: 355 NRNNRGTE-------------QKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFG 401
NR+ + + +D+ + +LPLF+L TI AT+NFS KLG GGFG
Sbjct: 468 NRHRSSSANFAPVPFDFDESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFG 527
Query: 402 PVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461
PVYKG L + EIAVKRLS+ S QG++E KNE+ L SKLQHRNLV++LGCC+ EEK+L+
Sbjct: 528 PVYKGVLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLV 587
Query: 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 521
YE++PNKSLD FIF +E+ LDW KR I+ G ARG+LYLHQDSRLRIIHRDLKASN+L
Sbjct: 588 YEYLPNKSLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNIL 647
Query: 522 LDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 581
LD +M PKISDFG+AR FGG++ EG T+RVVGT+GYMAPEYA +GQFS+KSDV+SFG+L+
Sbjct: 648 LDSEMIPKISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLM 707
Query: 582 LEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF-KDSFNLAEVIRCIHIGL 640
LEI++GKKN F+ + NL+ H W LW G +++ID +++++ EV++CI IGL
Sbjct: 708 LEIITGKKNSAFHEESS--NLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGL 765
Query: 641 LCVQQYPEDRPCMPSVILMLGSEIV-LPQPKQPGYL-ADRKSTRLDSSLSMPESSSTNTI 698
LCVQ+ DR M SV++MLG LP PK P + A R+ + L S N +
Sbjct: 766 LCVQENASDRVDMSSVVIMLGHNATNLPNPKHPAFTSARRRGGENGACLKGQTGISVNDV 825
Query: 699 TISELEGR 706
T S+++GR
Sbjct: 826 TFSDIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 578 bits (1490), Expect = e-164, Method: Compositional matrix adjust.
Identities = 311/715 (43%), Positives = 433/715 (60%), Gaps = 31/715 (4%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
SGNL+L+ R+ G LW+SF +P D+ +P M LG D +TG ++TSW S DDPS GN
Sbjct: 139 SGNLMLQDNRNNGE--ILWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGN 196
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAATLRQNPVFNFSF-VSSEDELYYTF 130
+T + PEL++WK + +RSGPWNG F + +F F ++S+++ +
Sbjct: 197 YTAGIAPFTFPELLIWKNNVPTWRSGPWNGQVFIGLPNMDSLLFLDGFNLNSDNQGTISM 256
Query: 131 DLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISDL 190
+ + ++ + Q+ W + + W + + P CD Y CG +G C +
Sbjct: 257 SYANDSFMYHFNLDPEGIIYQK-DWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAGEN 315
Query: 191 PVCQCLKGFKPKSRGYVD---WSQGCVRDKSLNYSRE------------DGFIKFTAMKL 235
P C+C+KGF PK+ + WS GC+R L R+ DGF+K MK+
Sbjct: 316 PPCKCVKGFVPKNNTEWNGGNWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKMKV 375
Query: 236 P-DATPSWVSKSMNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGG 294
P A S S+ + C + CL+N SC AY G GC +W G+L+DM+ F G
Sbjct: 376 PISAERSEASEQV----CPKVCLDNCSCTAYAYDR----GIGCMLWSGDLVDMQSFLGSG 427
Query: 295 QDLYIRMSASELGAKGEPTTKIVLIVISTAALLAVVIAAGYLIHKSRRNIVVNIARYFRE 354
DL+IR++ SEL I VI + AV + +K R + +
Sbjct: 428 IDLFIRVAHSELKTHSNLAVMIAAPVIGVMLIAAVCVLLACRKYKKRPAPAKDRSAELMF 487
Query: 355 NRNNRGTEQKNEDQN-IDL-DLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQ 412
R T N I L +LPLFE +A +TD+FS+ KLG+GGFGPVYKG L + Q
Sbjct: 488 KRMEALTSDNESASNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQ 547
Query: 413 EIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDS 472
EIAVKRLS+ S QGL+EL NE+++ SKLQHRNLVKLLGCCI GEE++L+YE+MP KSLD+
Sbjct: 548 EIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDA 607
Query: 473 FIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 532
++FD + K+LDW RF+I+ G RGLLYLH+DSRL+IIHRDLKASN+LLD+++NPKISD
Sbjct: 608 YLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISD 667
Query: 533 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRG 592
FGLAR F +E E NT RVVGTYGYM+PEYA +G FS KSDVFS G++ LEI+SG++N
Sbjct: 668 FGLARIFRANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSS 727
Query: 593 FYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPC 652
+ +N LNL+ +AWKLWN+G + L D D E+ +C+HIGLLCVQ+ DRP
Sbjct: 728 SHKEENNLNLLAYAWKLWNDGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQEVANDRPN 787
Query: 653 MPSVILMLGSE-IVLPQPKQPGYLADRKSTRLDSSLSMPESSSTNTITISELEGR 706
+ +VI ML +E + L PKQP ++ R ++ +SS + S N ++++ + GR
Sbjct: 788 VSNVIWMLTTENMSLADPKQPAFIVRRGASEAESSDQSSQKVSINDVSLTAVTGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 706 | ||||||
| 224124250 | 820 | predicted protein [Populus trichocarpa] | 0.961 | 0.828 | 0.627 | 0.0 | |
| 224113157 | 786 | predicted protein [Populus trichocarpa] | 0.915 | 0.821 | 0.629 | 0.0 | |
| 224113149 | 820 | predicted protein [Populus trichocarpa] | 0.927 | 0.798 | 0.633 | 0.0 | |
| 224113153 | 785 | predicted protein [Populus trichocarpa] | 0.913 | 0.821 | 0.625 | 0.0 | |
| 224126243 | 836 | predicted protein [Populus trichocarpa] | 0.974 | 0.822 | 0.606 | 0.0 | |
| 449458261 | 814 | PREDICTED: receptor-like serine/threonin | 0.964 | 0.836 | 0.585 | 0.0 | |
| 449476944 | 1267 | PREDICTED: receptor-like serine/threonin | 0.964 | 0.537 | 0.583 | 0.0 | |
| 224115136 | 843 | predicted protein [Populus trichocarpa] | 0.977 | 0.818 | 0.581 | 0.0 | |
| 356546914 | 788 | PREDICTED: G-type lectin S-receptor-like | 0.917 | 0.822 | 0.574 | 0.0 | |
| 356545297 | 824 | PREDICTED: G-type lectin S-receptor-like | 0.971 | 0.832 | 0.579 | 0.0 |
| >gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2318), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/706 (62%), Positives = 531/706 (75%), Gaps = 27/706 (3%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
SGNLVLR E+D S YLWQSFDYPSDTLLPGMKLGWDL+ GL+RR+++WKSPDDPS G+
Sbjct: 131 SGNLVLRDEKDDNSGIYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGD 190
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAA-TLRQNPVFNFSFVSSEDELYYTF 130
FTW + Q NPEL+MWKGS+K+YRSGPWNG+ FS LR NPVF F FV +E+YYT+
Sbjct: 191 FTWGTQLQSNPELVMWKGSKKYYRSGPWNGIGFSGGLALRINPVFYFDFVDDGEEVYYTY 250
Query: 131 DLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISDL 190
+L +K++ +RIVMNQT Y RQR+TW + Q W L VPRD CDTY LCG YG CI+S
Sbjct: 251 NLKNKSLITRIVMNQTTYFRQRYTWNEINQTWVLYATVPRDYCDTYNLCGAYGNCIMSQS 310
Query: 191 PVCQCLKGFKPKSR---GYVDWSQGCVRDKSLNYSREDGFIKFTAMKLPDATPSWVSKSM 247
PVCQCL+ F P+S +DWS+GCVR+K L+ + DGF+K+ +KLPDAT SWV+K+M
Sbjct: 311 PVCQCLEKFTPRSPESWNSMDWSKGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTM 370
Query: 248 NLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYIRMSASELG 307
NLKECR KCL+N SCMAYT ++I+ SGCA+WFG+LID+R F GQ++YIR++ASE
Sbjct: 371 NLKECRSKCLQNCSCMAYTATNIKER-SGCAVWFGDLIDIRQFSAAGQEIYIRLNASESR 429
Query: 308 AKGEPTTKIVLIVISTAALLAVVIAAGYLIHKSRRNIVVNIARY-FRENRNNRGTEQKNE 366
AK K+ + + L++ +A G L+ +A Y F+ + G ++
Sbjct: 430 AKAASKIKMTV-----GSALSIFVACGILL----------VAYYIFKRKAKHIGGNREEN 474
Query: 367 DQ-----NIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSK 421
DQ DL+LPLF+ TIA AT+ FS N KLGEGGFGPVYKGTL D QEIA K LS+
Sbjct: 475 DQIDSGPKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAKTLSR 534
Query: 422 ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCK 481
S QGL E KNE+IL +KLQHRNLVKLLGCCI GEEK+L+YE+MPNKSLDSFIFDQ R K
Sbjct: 535 SSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQTRGK 594
Query: 482 LLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541
LLDWSKRF IICG ARGLLYLHQDSRLRI+HRDLKASNVLLD+DMNPKISDFGLAR FGG
Sbjct: 595 LLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARMFGG 654
Query: 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLN 601
D+TEGNT RVVGTYGYMAPEYA+DG FSVKSDVFSFGIL+LEI+SGKK+RGF H D+ L+
Sbjct: 655 DQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRGFCHPDHSLS 714
Query: 602 LIRHAWKLWNEGMPSQLIDACFKDSFNLAEVI-RCIHIGLLCVQQYPEDRPCMPSVILML 660
LI HAW+LW +G P LI+A +S NL+EVI RCI+I LLCVQQ+P+DRP M +V+ ML
Sbjct: 715 LIGHAWRLWKDGKPLGLIEAFPGESCNLSEVIMRCINISLLCVQQHPDDRPSMATVVWML 774
Query: 661 GSEIVLPQPKQPGYLADRKSTRLDSSLSMPESSSTNTITISELEGR 706
G E LPQPK+PG+ R SS E S N IT S L R
Sbjct: 775 GGENTLPQPKEPGFFKGSGPFRPSSSSKNTELFSNNEITSSLLYPR 820
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113157|ref|XP_002332644.1| predicted protein [Populus trichocarpa] gi|222832839|gb|EEE71316.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 889 bits (2298), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/699 (62%), Positives = 534/699 (76%), Gaps = 53/699 (7%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
SGNLVLR E+ S YLWQSFD+PSDTL+PGMKLGWDL+TGLERR++SW+S DDPSPG+
Sbjct: 137 SGNLVLRDEK-SDSGRYLWQSFDHPSDTLIPGMKLGWDLRTGLERRLSSWRSSDDPSPGD 195
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAAT-LRQNPVFNFSFVSSEDELYYTF 130
TW ++ Q+NPE I+W+GS++++RSGPW G+ F+ A L QNPVF +FVSSEDE+Y ++
Sbjct: 196 LTWGIKLQNNPETIIWRGSQQYFRSGPWTGIAFTGAPELVQNPVFKLNFVSSEDEVYLSY 255
Query: 131 DLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISDL 190
+L + + FSRIV+NQT R+ +TW +ATQ W L +VPRD CD YA CG G CII+DL
Sbjct: 256 NLKNISAFSRIVVNQTTNYREAYTWNEATQTWVLYASVPRDSCDNYASCGANGNCIINDL 315
Query: 191 PVCQCLKGFKPKSR---GYVDWSQGCVRDKSLNYSREDGFIKFTAMKLPDATPSWVSKSM 247
P+C+CLK FKPKS +DWS GCVR+K LN + DGF+K+ +K PDAT SW++KSM
Sbjct: 316 PICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGDGFVKYLGLKWPDATHSWLNKSM 375
Query: 248 NLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYIRMSASELG 307
NL ECR KCL+N SCMAY+NSD+RGGGSGC +W+G+LID+R FP GGQ+LYIRM+ SE
Sbjct: 376 NLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGDLIDIRQFPAGGQELYIRMNPSE-- 433
Query: 308 AKGEPTTKIVLIVISTAALLAVVIAAGYLIHKSRRNIVVNIARYFRENRNNRGTEQKNED 367
+A + + +N++ T+ +NED
Sbjct: 434 ---------------SAEM---------------------------DQQNDQITDGENED 451
Query: 368 QNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGL 427
L+LP FE A I NAT+NFSI KLG+GGFGPVYKGTL D QEIAVKRLS S QG
Sbjct: 452 ----LELPQFEFAKIVNATNNFSIKNKLGQGGFGPVYKGTLEDGQEIAVKRLSMSSRQGS 507
Query: 428 KELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSK 487
KE KNE+IL +KLQHRNLVKLLGC I EE+LL+YE+MPNKSLDSF+FDQ + KLLDWSK
Sbjct: 508 KEFKNEVILINKLQHRNLVKLLGCSIQREERLLVYEYMPNKSLDSFLFDQTKSKLLDWSK 567
Query: 488 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547
RF+IICG ARGLLYLHQDSRLRIIHRDLK+SNVLLD+DMNPKISDFGLAR FGGD+TEGN
Sbjct: 568 RFNIICGIARGLLYLHQDSRLRIIHRDLKSSNVLLDKDMNPKISDFGLARTFGGDQTEGN 627
Query: 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAW 607
T+RVVGTYGYMAPEYA+DG FSVKSDVFSFGI+LLEIV+GKK+RGFYH DN L+LI +AW
Sbjct: 628 TSRVVGTYGYMAPEYATDGLFSVKSDVFSFGIMLLEIVTGKKSRGFYHPDNSLSLIGYAW 687
Query: 608 KLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLP 667
+LW EG P +L+D ++S+NL+EV++CIHI LLCVQQYPEDRP M SV+LMLG E LP
Sbjct: 688 RLWKEGKPLELVDGLAEESWNLSEVMKCIHISLLCVQQYPEDRPSMASVVLMLGGERTLP 747
Query: 668 QPKQPGYLADRKSTRLDSSLSMPESSSTNTITISELEGR 706
+PK+PG+ DR SS S ESSSTN I+ S LE R
Sbjct: 748 KPKEPGFFKDRGPVEAYSSSSKVESSSTNEISTSVLEPR 786
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113149|ref|XP_002332642.1| predicted protein [Populus trichocarpa] gi|222832837|gb|EEE71314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 887 bits (2291), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/674 (63%), Positives = 519/674 (77%), Gaps = 19/674 (2%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
SGNLVLR E+D S YLWQSFDYPSDTLLPGMKLGWDL+ GL+RR+++WKSPDDPS G+
Sbjct: 125 SGNLVLRDEKDANSGIYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGD 184
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAA-TLRQNPVFNFSFVSSEDELYYTF 130
FTW + Q NPEL+MWKGS+++YRSGPWNG+ FS LR NPVF F FV +E+YYT+
Sbjct: 185 FTWGTQLQSNPELVMWKGSKEYYRSGPWNGIGFSGGPELRINPVFYFDFVDDGEEVYYTY 244
Query: 131 DLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISDL 190
+L +K++ +RIVMNQ+ Y RQR+TW + Q W L NVPRD CDTY+LCG YG CIIS
Sbjct: 245 NLKNKSLITRIVMNQSTYFRQRYTWNEINQTWVLYANVPRDYCDTYSLCGAYGNCIISQS 304
Query: 191 PVCQCLKGFKPKSR---GYVDWSQGCVRDKSLNYSREDGFIKFTAMKLPDATPSWVSKSM 247
PVC+CL+ F PKS +DWSQGCVR+K L+ + DGF+K+ +KLPDAT SWV+K+M
Sbjct: 305 PVCECLEKFTPKSPESWNSMDWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTM 364
Query: 248 NLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYIRMSASELG 307
NLKECR CLEN SCMAYT ++I+ SGCA+WFG+LID+ P GQ++YIRM+ASE
Sbjct: 365 NLKECRSICLENCSCMAYTATNIKER-SGCAIWFGDLIDITQLPAAGQEIYIRMNASE-- 421
Query: 308 AKGEPTTKIVLIVISTAALLAVVIAAG-----YLIHKSRRNIVVNIARYFRENRNNRGTE 362
+ + L++++ L++ +A G Y I K + ++ + NR +
Sbjct: 422 ----SSECLSLVLMAVGIALSIFVACGILLVAYYIFKRKAKLIGKVTLTAFSNREE--ND 475
Query: 363 QKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKI 422
Q + DL+LPLF+ TIA AT+ FS N KLGEGGFGPVYKGTL D QEIA K S+
Sbjct: 476 QIDSGPKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAKTHSRS 535
Query: 423 SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKL 482
S QG+ E KNE+IL +KLQHRNLVKLLGCCI GEEK+L+YE+MPNKSLDSFIFDQ R +L
Sbjct: 536 SGQGINEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQTRGEL 595
Query: 483 LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542
LDWSKRF IICG ARGLLYLHQDSRLRI+HRDLKASNVLLD+DMNPKISDFGLAR FGGD
Sbjct: 596 LDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARMFGGD 655
Query: 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNL 602
+TEGNT RVVGTYGYMAPEYA+DG FSVKSDVFSFGIL+LEI+SGKK+RGFYH D+ L+L
Sbjct: 656 QTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRGFYHPDHSLSL 715
Query: 603 IRHAWKLWNEGMPSQLIDACFKDSFNLAEVI-RCIHIGLLCVQQYPEDRPCMPSVILMLG 661
I HAW+LW +G P LI+A +S NL+EVI RCI+I LLCVQQ+P+DRP M +V+ MLG
Sbjct: 716 IGHAWRLWKDGKPLDLIEAFPGESRNLSEVIMRCINISLLCVQQHPDDRPSMATVVWMLG 775
Query: 662 SEIVLPQPKQPGYL 675
E LPQP +PG+
Sbjct: 776 CENTLPQPNEPGFF 789
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113153|ref|XP_002332643.1| predicted protein [Populus trichocarpa] gi|222832838|gb|EEE71315.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 885 bits (2288), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/699 (62%), Positives = 528/699 (75%), Gaps = 54/699 (7%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
SGNLVLR E+ S YLWQSFD+PSDTL+PGMKLGWDL+TGLERR++SW+S DDPSPG+
Sbjct: 137 SGNLVLRDEKSD-SGRYLWQSFDHPSDTLIPGMKLGWDLRTGLERRLSSWRSSDDPSPGD 195
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAAT-LRQNPVFNFSFVSSEDELYYTF 130
TW ++ Q+NPE I+W+GS++++RSGPW G+ F+ A L QNPVF +FVSSEDE+Y ++
Sbjct: 196 LTWGIKLQNNPETIIWRGSQQYFRSGPWTGIAFTGAPELVQNPVFKLNFVSSEDEVYLSY 255
Query: 131 DLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISDL 190
+L + + FSRIV+NQT R+ +TW +ATQ W L +VPRD CD YA CG G CII+DL
Sbjct: 256 NLKNISAFSRIVVNQTTNYREAYTWNEATQTWVLYASVPRDSCDNYASCGANGNCIINDL 315
Query: 191 PVCQCLKGFKPKSR---GYVDWSQGCVRDKSLNYSREDGFIKFTAMKLPDATPSWVSKSM 247
P+C+CLK FKPKS +DWS GCVR+K LN + DGF+K+ +K PDAT SW++KSM
Sbjct: 316 PICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGDGFVKYLGLKWPDATHSWLNKSM 375
Query: 248 NLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYIRMSASELG 307
NL ECR KCL+N SCMAY+NSD+RGGGSGC +W+G LID+R FP GGQ+LYIRM+ S
Sbjct: 376 NLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGGLIDIRQFPAGGQELYIRMNPS--- 432
Query: 308 AKGEPTTKIVLIVISTAALLAVVIAAGYLIHKSRRNIVVNIARYFRENRNNRGTEQKNED 367
E+ ++ +Q +
Sbjct: 433 ----------------------------------------------ESEMDQQNDQITDG 446
Query: 368 QNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGL 427
+N DL+LP FE A I NAT+NFSI KLG+GGFGPVYKGTL D QEIAVKRLS S QG
Sbjct: 447 ENEDLELPQFEFAKIVNATNNFSIENKLGQGGFGPVYKGTLEDGQEIAVKRLSMSSGQGS 506
Query: 428 KELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSK 487
KE KNE+IL +KLQHRNLVKLLGC I EE+LL+YE+MPNKSLDSF+FDQ + KLLDWSK
Sbjct: 507 KEFKNEVILINKLQHRNLVKLLGCSIQREERLLVYEYMPNKSLDSFLFDQTKSKLLDWSK 566
Query: 488 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547
RF+IICG ARGLLYLHQDSRLRIIHRDLK+SNVLLD+DMNPKISDFGLAR FGGD+TEGN
Sbjct: 567 RFNIICGIARGLLYLHQDSRLRIIHRDLKSSNVLLDKDMNPKISDFGLARTFGGDQTEGN 626
Query: 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAW 607
T+RVVGTYGYMAPEYA+DG FSVKSDVFSFGI+LLEIV+GKK+RGFYH DN L+LI +AW
Sbjct: 627 TSRVVGTYGYMAPEYATDGLFSVKSDVFSFGIMLLEIVTGKKSRGFYHPDNSLSLIGYAW 686
Query: 608 KLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLP 667
+LW EG P +L+D ++S+NL+EV++CIHI LLCVQQYPEDRP M SV+LMLG E LP
Sbjct: 687 RLWKEGKPLELVDGLAEESWNLSEVMKCIHISLLCVQQYPEDRPSMASVVLMLGGERTLP 746
Query: 668 QPKQPGYLADRKSTRLDSSLSMPESSSTNTITISELEGR 706
+PK+PG+ DR SS S ESSSTN I+ S LE R
Sbjct: 747 KPKEPGFFKDRGPVEAYSSSSKVESSSTNEISTSVLEPR 785
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 879 bits (2271), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/719 (60%), Positives = 532/719 (73%), Gaps = 31/719 (4%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
SGNLVLR E+D S +YLWQSFDYPSDT+LPGMKLGWDL+ GL+RR+++WKSPDDPS G+
Sbjct: 125 SGNLVLRDEKDVNSGSYLWQSFDYPSDTMLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGD 184
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSA-ATLRQNPVFNFSFVSSEDELYYTF 130
FTW + Q NPEL++WKGS K++RSGPWNG+ FS A LR NPVF F FV + +E+YYT+
Sbjct: 185 FTWGTQLQSNPELVIWKGSEKYFRSGPWNGIGFSGEAALRINPVFYFDFVDNGEEVYYTY 244
Query: 131 DLIDKAVFSRIVMNQTL-YLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISD 189
+L +K++ +R+VMNQT +LRQR+TW + +Q WEL VPRD CD Y LCG YG CIIS
Sbjct: 245 NLKNKSLITRLVMNQTTGFLRQRYTWNEISQTWELYAYVPRDYCDNYNLCGAYGNCIISQ 304
Query: 190 LPVCQCLKGFKPKSR---GYVDWSQGCVRDKSLNYSREDGFIKFTAMKLPDATPSWVSKS 246
PVC+CL+ F PKS ++WSQGCVR+K L+ + DGF+K+ +KLPDAT SWV+K+
Sbjct: 305 SPVCECLEKFTPKSPESWNSMNWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKT 364
Query: 247 MNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYIRMSASEL 306
MNLKECR KCL+N SCMAYT +DI+ SGCA+WFG+LID+R FPDGGQ++YIRM+ASE
Sbjct: 365 MNLKECRSKCLQNCSCMAYTATDIKER-SGCAIWFGDLIDIRQFPDGGQEIYIRMNASE- 422
Query: 307 GAKGEPTTKIVLIVISTAALLAVVIAAG-----YLIHKSRRNIVVNIARYF--------- 352
+ + LI + L++ +A G Y I K + + +
Sbjct: 423 -----SSECLSLIKMEMGIALSIFVACGMLLVAYYIFKRTEKLKAHYSFLLVYHVCDSHS 477
Query: 353 ----RENRNNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTL 408
+ N +Q + D++LPLF+ TIA AT+ FS+N K+GEGGFGPVYKGTL
Sbjct: 478 LLSEKTGGNREENDQIDSGPMEDMELPLFQFTTIAKATNGFSLNNKIGEGGFGPVYKGTL 537
Query: 409 ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 468
D QEIAVK LS+ S QGL E KNE+IL +KLQHRNLVKLLGCCI GEEK+L+YE+MPN+
Sbjct: 538 EDGQEIAVKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNR 597
Query: 469 SLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 528
SLDSFIFDQ R KLLDWSKRF IICG ARGLLYLHQDSRLRI+HRDLKASNVLLD+DMNP
Sbjct: 598 SLDSFIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNP 657
Query: 529 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
KISDFGLAR GGD+TEGNT RV+GTYGYMAPEYA+DG FSVKSDVFSFGIL+LEI+SGK
Sbjct: 658 KISDFGLARMVGGDQTEGNTTRVIGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGK 717
Query: 589 KNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVI-RCIHIGLLCVQQYP 647
K+RGFYH D L+L HAW+LW +G P LI+A +S NL+EVI RCI+I LLCVQ +P
Sbjct: 718 KSRGFYHPDRSLSLTAHAWRLWKDGKPLDLIEAFPGESRNLSEVIMRCINISLLCVQHHP 777
Query: 648 EDRPCMPSVILMLGSEIVLPQPKQPGYLADRKSTRLDSSLSMPESSSTNTITISELEGR 706
+DRP M +V+ MLG E LPQP +PG+ SS S E S N T S L R
Sbjct: 778 DDRPSMATVVWMLGGENTLPQPNEPGFFKGSGPFGPSSSSSNIELYSNNEFTASLLYPR 836
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458261|ref|XP_004146866.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 844 bits (2180), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/698 (58%), Positives = 516/698 (73%), Gaps = 17/698 (2%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
+GNL+L+ D SE WQSFDYP+DTLLPGMKLGWD K G++RR+++WK+ DDPSPG+
Sbjct: 131 NGNLLLK---DAESEETSWQSFDYPTDTLLPGMKLGWDFKNGIQRRLSAWKTSDDPSPGS 187
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAATLRQNPVFNFSFVSSEDELYYTFD 131
T + PE +MW GS ++ RSGPWNGL+FSA P+ +S+V+++ EL Y+++
Sbjct: 188 LTMEMMNTSYPEPVMWNGSSEYMRSGPWNGLQFSAKPTSALPILVYSYVNNKSELSYSYE 247
Query: 132 LIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISDLP 191
LI+ ++ R+V+NQT+ R+ W + +NW+ +PRD CDTY++CG +G C I +P
Sbjct: 248 LINSSLIGRMVLNQTILRREALLWSEPEKNWKPYAAMPRDYCDTYSVCGAFGSCDIEQVP 307
Query: 192 VCQCLKGFKPKSR---GYVDWSQGCVRDKSLNYSREDGFIKFTAMKLPDATPSWVSKSMN 248
CQCL GF P + +D+++GCVR+K LN S + GF K +KLPD SWV++SM+
Sbjct: 308 ACQCLFGFHPNVQEKWNLMDYTEGCVRNKPLNCSDKTGFAKLPGLKLPDTKQSWVNESMS 367
Query: 249 LKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYIRMSASELGA 308
L ECREKCL N SC+A+ N+DIRG GSGCA+WFGEL+D++ GGQDLY+RM ASEL
Sbjct: 368 LNECREKCLRNCSCVAFANTDIRGSGSGCAIWFGELVDIKVVRRGGQDLYVRMLASELET 427
Query: 309 KGEPTTKIVLIVISTAALLAVVIAAGYLIHKSRRNIVVNIARYFRENRNNRGTEQKNEDQ 368
K + + +IV + A L+ ++ G+ + +S+R + G + E Q
Sbjct: 428 KKTSSVAVGVIVGAAALLILGLLLIGFYVIRSKRRKL-----------EATGAGKDLEGQ 476
Query: 369 NIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLK 428
DL+LPLF LATI+NATDNFS KLGEGGFG V++G L D +EIAVKRLS S QG
Sbjct: 477 EDDLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRGRLTDGKEIAVKRLSSYSRQGTD 536
Query: 429 ELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKR 488
E KNE+IL +KLQHRNLVKLLGCCI GEEK+LIYE+MPNKSLDSFIFD R KLLDWSKR
Sbjct: 537 EFKNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMPNKSLDSFIFDSARKKLLDWSKR 596
Query: 489 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 548
F+IICG ARG+LYLHQDSRLRIIHRDLKASNVLLD D+NPKISDFG+AR FGGD+TEGNT
Sbjct: 597 FNIICGVARGILYLHQDSRLRIIHRDLKASNVLLDIDLNPKISDFGMARTFGGDQTEGNT 656
Query: 549 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWK 608
RVVGTYGYMAPEYA DGQFS+KSDVFSFGIL+LEI+SG+KNRGF+ ++ LNLI HAWK
Sbjct: 657 RRVVGTYGYMAPEYAIDGQFSIKSDVFSFGILMLEIISGEKNRGFFRPNHALNLIGHAWK 716
Query: 609 LWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLPQ 668
LWNEG P +LIDA +S+ L+EV+RCIH+ LLC+QQ PEDRP M +V+LML SE L Q
Sbjct: 717 LWNEGKPLELIDASIGESYALSEVLRCIHVSLLCLQQLPEDRPTMSNVVLMLSSEGSLAQ 776
Query: 669 PKQPGYLADRKSTRLDSSLSMPESSSTNTITISELEGR 706
PKQPG+ +R S + S ESS TN +TI+ LE R
Sbjct: 777 PKQPGFYMERDSLEVFSVSGKNESSITNELTITLLEAR 814
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449476944|ref|XP_004154883.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 841 bits (2172), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/698 (58%), Positives = 517/698 (74%), Gaps = 17/698 (2%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
+GNL+L+ D SE WQSFDYP+DTLLPGMKLGWD K G++RR+++WK+ DDPSPG+
Sbjct: 131 NGNLLLK---DAESEETSWQSFDYPTDTLLPGMKLGWDFKNGIQRRLSAWKTSDDPSPGS 187
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAATLRQNPVFNFSFVSSEDELYYTFD 131
T + PE +MW GS ++ RSGPWNGL++SA P+ +S+V+++ EL Y+++
Sbjct: 188 LTMEMMNTSYPEPVMWNGSSEYMRSGPWNGLQYSAKPTSALPILVYSYVNNKSELSYSYE 247
Query: 132 LIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISDLP 191
LI+ ++ R+V+NQT+ R+ W + +NW+ +PRD CDTY++CG +G C I +P
Sbjct: 248 LINSSLIGRMVLNQTILRREALLWSEPEKNWKPYAAMPRDYCDTYSVCGAFGSCDIEQVP 307
Query: 192 VCQCLKGFKPKSR---GYVDWSQGCVRDKSLNYSREDGFIKFTAMKLPDATPSWVSKSMN 248
CQCL GF P + +D+++GCVR+K LN S + GF K +KLPD SWV++SM+
Sbjct: 308 ACQCLFGFHPNVQEKWNLMDYTEGCVRNKPLNCSDKTGFAKLPGLKLPDTKQSWVNESMS 367
Query: 249 LKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYIRMSASELGA 308
L ECREKCL N SC+A+ N+DIRG GSGCA+WFGEL+D++ GGQDLY+RM ASEL
Sbjct: 368 LNECREKCLRNCSCVAFANTDIRGSGSGCAIWFGELVDIKVVRRGGQDLYVRMLASELET 427
Query: 309 KGEPTTKIVLIVISTAALLAVVIAAGYLIHKSRRNIVVNIARYFRENRNNRGTEQKNEDQ 368
K + + +IV + A L+ ++ G+ + +S+R + G + E Q
Sbjct: 428 KKTSSVAVGVIVGAAALLILGLLLIGFYVIRSKRRKL-----------EATGAGKDLEGQ 476
Query: 369 NIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLK 428
DL+LPLF LATI+NATDNFS KLGEGGFG V++G L D +EIAVKRLS S QG
Sbjct: 477 EDDLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRGRLTDGKEIAVKRLSSYSRQGTD 536
Query: 429 ELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKR 488
E KNE+IL +KLQHRNLVKLLGCCI GEEK+LIYE+MPNKSLDSFIFD R KLLDWSKR
Sbjct: 537 EFKNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMPNKSLDSFIFDSARKKLLDWSKR 596
Query: 489 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 548
F+IICG ARG+LYLHQDSRLRIIHRDLKASNVLLD D+NPKISDFG+AR FGGD+TEGNT
Sbjct: 597 FNIICGVARGILYLHQDSRLRIIHRDLKASNVLLDIDLNPKISDFGMARTFGGDQTEGNT 656
Query: 549 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWK 608
RVVGTYGYMAPEYA DGQFS+KSDVFSFGIL+LEI+SG+KNRGF+ ++ LNLI HAWK
Sbjct: 657 RRVVGTYGYMAPEYAIDGQFSIKSDVFSFGILMLEIISGEKNRGFFRPNHALNLIGHAWK 716
Query: 609 LWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLPQ 668
LWNEG P +LIDA +S+ L+EV+RCIH+ LLC+QQ PEDRP M +V+LML SE L Q
Sbjct: 717 LWNEGKPLELIDASIGESYALSEVLRCIHVSLLCLQQLPEDRPTMSNVVLMLSSEGSLAQ 776
Query: 669 PKQPGYLADRKSTRLDSSLSMPESSSTNTITISELEGR 706
PKQPG+ +R S + S ESS+TN +TI+ LE +
Sbjct: 777 PKQPGFYMERDSLEVFSVSGKNESSTTNELTITLLEAK 814
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115136|ref|XP_002316951.1| predicted protein [Populus trichocarpa] gi|222860016|gb|EEE97563.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 834 bits (2155), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/722 (58%), Positives = 517/722 (71%), Gaps = 32/722 (4%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
SGNLVLR + DG S LWQSFDYP DT+LPGMK+GWDL+ G + R++SWKS DDPSPG+
Sbjct: 127 SGNLVLRDKNDGRS-GLLWQSFDYPCDTMLPGMKIGWDLRAGFDWRLSSWKSSDDPSPGD 185
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAAT-LRQNPVFNFSFVSSEDELYYTF 130
FT +ER+ NPE++ WKGS+K YRSGPWNG+ FS +T ++ NPVF F+FVS+ E+YY F
Sbjct: 186 FTMGIERESNPEVVAWKGSKKHYRSGPWNGVGFSGSTEVKPNPVFYFTFVSNNIEVYYIF 245
Query: 131 DL-IDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISD 189
+L + V +R+V+N T RQ +TW + TQ W LQ++VPRD CD Y LCG CI +
Sbjct: 246 NLKSESTVITRLVLNHTTSDRQCYTWNEETQTWVLQVSVPRDHCDNYGLCGANANCIFNA 305
Query: 190 LPVCQCLKGFKPKSR---GYVDWSQGCVRDKSLNYSREDGFIKFTAMKLPDATPSWVSKS 246
+PVCQCL+ FKPKS +DWSQGCVR+K L+ + DGFIKF +KLPDAT SWV+K
Sbjct: 306 IPVCQCLEKFKPKSPEEWNKMDWSQGCVRNKELDCQKGDGFIKFDGLKLPDATHSWVNKD 365
Query: 247 MNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYIRMSASEL 306
MNLKEC+ KCL N SCMAY+N DIRGGGSGCA WFG+L+D+R P GGQ+LYIRM ASE+
Sbjct: 366 MNLKECKAKCLGNCSCMAYSNLDIRGGGSGCANWFGDLMDIRLVPGGGQELYIRMHASEI 425
Query: 307 GAK-GEPTTKIVLIVISTAALLAVVIAAGYLIHKSRRNIVVNIARYFRENRNNRGTEQKN 365
G + + KI I + L+ + Y + K + N + N+ + N
Sbjct: 426 GDREAKANMKIAAIATAVVGLILGTLTISYHVSKEKAKSAENTSS--ERTENDWKNDTNN 483
Query: 366 EDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQ 425
Q D++LPLF + IA+AT+NFS+N KLGEGGFGPVY+G L D EIAVKRLS+ S Q
Sbjct: 484 GGQKEDMELPLFAFSAIADATNNFSVNNKLGEGGFGPVYRGKLEDGLEIAVKRLSRCSGQ 543
Query: 426 GLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDW 485
G E KNE+IL +KLQHRNLVKLLGCC EEK+LIYE+MPN+SLD FIFD+ + +LLDW
Sbjct: 544 GFSEFKNEVILINKLQHRNLVKLLGCCSQREEKMLIYEYMPNRSLDFFIFDETKGRLLDW 603
Query: 486 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545
S+RF+II G ARGLLYLHQDSRLRIIHRDLKASNVLLD MNPKISDFGLAR F D+TE
Sbjct: 604 SRRFNIISGIARGLLYLHQDSRLRIIHRDLKASNVLLDDHMNPKISDFGLARMFVADQTE 663
Query: 546 GNTNRVV---------------------GTYGYMAPEYASDGQFSVKSDVFSFGILLLEI 584
G+T+RV GYMAPEYA+DG FSVKSDVFSFG+LLLEI
Sbjct: 664 GDTSRVTSDSLASSNIPILPLCILTLNASCSGYMAPEYATDGLFSVKSDVFSFGVLLLEI 723
Query: 585 VSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQ 644
+SGKK++GFYH D+ +LI H W+LWNEG S+LIDA +S N +EV+RC+HI LLCVQ
Sbjct: 724 ISGKKSKGFYHPDH--SLIGHTWRLWNEGKASELIDALGDESCNPSEVLRCVHISLLCVQ 781
Query: 645 QYPEDRPCMPSVILMLGSEIVLPQPKQPGYLADRKSTRLDSSLSMPESSSTNTITISELE 704
+P+DRP M SV+ MLG + LP+PK+P +L R SS S SSSTN IT+S E
Sbjct: 782 HHPDDRPSMASVVWMLGGDSALPKPKEPAFLNYRAPGESSSSSSKVGSSSTNEITVSVFE 841
Query: 705 GR 706
R
Sbjct: 842 PR 843
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546914|ref|XP_003541865.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 832 bits (2148), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/701 (57%), Positives = 513/701 (73%), Gaps = 53/701 (7%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
SGNLV+R E+D SE YLW+SF+YP+DT LP MK GWDL+TGL R++ +WKSPDDPSP +
Sbjct: 135 SGNLVIRDEKDANSEDYLWESFNYPTDTFLPEMKFGWDLRTGLNRKLIAWKSPDDPSPSD 194
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAA-TLRQNPVFNFSFVSSEDELYYTF 130
F++ + + PE M KG +KFYRSGPWNGL S + ++ NP+++F FVS++DELYYT+
Sbjct: 195 FSFGMVLNNYPEAYMMKGDQKFYRSGPWNGLHSSGSPQVKANPIYDFKFVSNKDELYYTY 254
Query: 131 DLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISDL 190
L + ++ SR+V+N T Y+R+R+ W ++ Q WE+ +VP DLCD+Y+LCG C+ISD
Sbjct: 255 SLKNSSMISRLVLNATSYVRKRYVWIESKQRWEVYTSVPLDLCDSYSLCGANANCVISDS 314
Query: 191 PVCQCLKGFKPK---SRGYVDWSQGCVRDKSLN--YSREDGFIKFTAMKLPDATPSWVSK 245
PVCQCL+GFKPK + +DWS GC+R+K L+ +DGF K T +K PD T SW+ +
Sbjct: 315 PVCQCLQGFKPKLPEAWSSMDWSHGCIRNKELSCENKNKDGFNKLTLLKTPDTTHSWLDQ 374
Query: 246 SMNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYIRMSASE 305
++ L+EC+ KCL+N SCMAY NSDI G GSGCAMWFG+LID+R F GGQD+Y+R+ ASE
Sbjct: 375 TIGLEECKAKCLDNCSCMAYANSDISGQGSGCAMWFGDLIDIRQFAAGGQDVYVRIDASE 434
Query: 306 LGAKGEPTTKIVLIVISTAALLAVVIAAGYLIHKSRRNIVVNIARYFRENRNNRGTEQKN 365
L +S +I N Q +
Sbjct: 435 L-------------------------------ERSDFSIKSN---------------QNS 448
Query: 366 EDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQ 425
Q D+DLP+F+L+TIA AT NF++ K+GEGGFGPVY+G+L D QEIAVKRLS S Q
Sbjct: 449 GMQVDDMDLPVFDLSTIAKATSNFTVKNKIGEGGFGPVYRGSLTDGQEIAVKRLSASSGQ 508
Query: 426 GLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDW 485
GL E KNE+ L +KLQHRNLVKLLGCC+ GEEK+L+YE+M N SLDSFIFD++R LDW
Sbjct: 509 GLTEFKNEVKLIAKLQHRNLVKLLGCCLEGEEKMLVYEYMLNGSLDSFIFDEQRSGSLDW 568
Query: 486 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545
SKRF+IICG A+GLLYLHQDSRLRIIHRDLKASNVLLD ++NPKISDFG+AR FG D+ E
Sbjct: 569 SKRFNIICGIAKGLLYLHQDSRLRIIHRDLKASNVLLDSELNPKISDFGMARIFGVDQQE 628
Query: 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRH 605
GNT R+VGTYGYMAPEYA+DG FSVKSDVFSFG+LLLEI+SGK++RG+Y+ ++ NLI H
Sbjct: 629 GNTKRIVGTYGYMAPEYATDGLFSVKSDVFSFGVLLLEIISGKRSRGYYNQNHSQNLIGH 688
Query: 606 AWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665
AWKLW EG P +LID +DS +L++++ CIH+ LLCVQQ PEDRP M SV+LML SE+
Sbjct: 689 AWKLWKEGRPLELIDKSIEDSSSLSQMLHCIHVSLLCVQQNPEDRPGMSSVLLMLVSELE 748
Query: 666 LPQPKQPGYLADRKSTRLDSSLSMPESSSTNTITISELEGR 706
LP+PKQPG+ + S DSS S + SSTN ITI+ LE R
Sbjct: 749 LPEPKQPGFFG-KYSGEADSSTSKQQLSSTNEITITLLEAR 788
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545297|ref|XP_003541080.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 821 bits (2120), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/706 (57%), Positives = 505/706 (71%), Gaps = 20/706 (2%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
SGNLVLR E+D E YLWQSFD P+DT LPGMKLGWDLK GL +T+WK+ DDPSPG+
Sbjct: 128 SGNLVLRDEKDTNPENYLWQSFDNPTDTFLPGMKLGWDLKKGLNTVLTAWKNWDDPSPGD 187
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSA-ATLRQNPVFNFSFVSSEDELYYTF 130
FT R + PE +MWKG+ K++RSGPW+G +FS ++ N + N++ VS++DE Y T+
Sbjct: 188 FTDITLRTNYPEEVMWKGTTKYWRSGPWDGTKFSGNPSVPSNAIVNYTIVSNKDEFYATY 247
Query: 131 DLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISDL 190
+ DK++ SRIVMNQ+LY+RQR TW +Q W + +P DLCD Y CG +GIC+
Sbjct: 248 SMTDKSIISRIVMNQSLYVRQRLTWNTDSQTWRVSSELPGDLCDHYNTCGAFGICVAGQA 307
Query: 191 PVCQCLKGFKPKS-RGY--VDWSQGCVRDK--SLNYSREDGFIKFTAMKLPDATPSWVSK 245
PVC+CL GFKPKS R + ++W+QGCV ++ S +DGF KF+ +K PD SWV+
Sbjct: 308 PVCKCLDGFKPKSPRNWNQMNWNQGCVHNQTWSCREKNKDGFTKFSNVKAPDTERSWVNA 367
Query: 246 SMNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYIRMSASE 305
SM L ECR KC EN SCMAY NS+IRG GSGCA+W G+L+D+R P+ GQDLYIR++ SE
Sbjct: 368 SMTLGECRVKCWENCSCMAYANSNIRGEGSGCAIWIGDLLDIRLMPNAGQDLYIRLAVSE 427
Query: 306 LGAKG----EPTTKIVLIVISTAALLAVVIAAGYLIHKSRRNIVVNIARYFRENRNNRGT 361
+ + + K V+++ ST + + +I I+ S RN I G
Sbjct: 428 TAQQSHDQKDNSNKKVVVIASTISSVIAMILIFIFIYWSYRNKNKEIIT---------GI 478
Query: 362 EQK-NEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLS 420
E K NE Q D +LPLF+L IA ATD+FS +KKLGEGGFGPVYKGTL D QE+AVKRLS
Sbjct: 479 EGKSNESQQEDFELPLFDLVLIAQATDHFSDHKKLGEGGFGPVYKGTLPDGQEVAVKRLS 538
Query: 421 KISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERC 480
+ S QGLKE KNE++L ++LQHRNLVK+LGCC +EKLLIYE+M NKSLD F+FD R
Sbjct: 539 QTSRQGLKEFKNEVMLCAELQHRNLVKVLGCCFQDDEKLLIYEYMSNKSLDVFLFDSSRS 598
Query: 481 KLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540
KLLDW KRF II G ARGLLYLHQDSRLRIIHRDLKASNVLLD +MNPKISDFGLAR G
Sbjct: 599 KLLDWPKRFCIINGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGLARMCG 658
Query: 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKL 600
GD+ EG T+R+VGTYGYMAPEYA DG FS+KSDVFSFG+LLLEIVSGKKN ++ ++
Sbjct: 659 GDQIEGETSRIVGTYGYMAPEYAFDGLFSIKSDVFSFGVLLLEIVSGKKNSRLFYPNDYN 718
Query: 601 NLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
NLI HAW+LW EG P Q ID+ +DS L E +RCIHIGLLCVQ +P DRP M SV+++L
Sbjct: 719 NLIGHAWRLWKEGNPMQFIDSSLEDSCILYEALRCIHIGLLCVQHHPNDRPNMASVVVLL 778
Query: 661 GSEIVLPQPKQPGYLADRKSTRLDSSLSMPESSSTNTITISELEGR 706
+E LP PK P YL+ ST +SS S S N +TIS L R
Sbjct: 779 SNENALPLPKDPSYLSKDISTERESSSENFTSVSINDVTISMLSDR 824
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 706 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.457 | 0.412 | 0.631 | 6.5e-188 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.943 | 0.783 | 0.516 | 6.6e-184 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.920 | 0.797 | 0.523 | 7.8e-181 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.941 | 0.788 | 0.503 | 4e-177 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.947 | 0.789 | 0.493 | 1.6e-173 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.967 | 0.822 | 0.439 | 1.3e-148 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.856 | 0.713 | 0.451 | 4.6e-137 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.906 | 0.791 | 0.431 | 1.4e-135 | |
| TAIR|locus:2200923 | 802 | AT1G61550 [Arabidopsis thalian | 0.907 | 0.799 | 0.439 | 7.7e-135 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.903 | 0.793 | 0.445 | 9.8e-135 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1072 (382.4 bits), Expect = 6.5e-188, Sum P(2) = 6.5e-188
Identities = 206/326 (63%), Positives = 258/326 (79%)
Query: 354 ENRNNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQE 413
+ ++R + +K E++ DL+LP +L T++ AT FS KLG+GGFGPVYKGTLA QE
Sbjct: 432 QRESSRVSSRKQEEE--DLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQE 489
Query: 414 IAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSF 473
+AVKRLS+ S QG++E KNEI L +KLQHRNLVK+LG C+ EE++LIYE+ PNKSLDSF
Sbjct: 490 VAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSF 549
Query: 474 IFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 533
IFD+ER + LDW KR II G ARG+LYLH+DSRLRIIHRDLKASNVLLD DMN KISDF
Sbjct: 550 IFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDF 609
Query: 534 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 593
GLAR GGDETE NT RVVGTYGYM+PEY DG FS+KSDVFSFG+L+LEIVSG++NRGF
Sbjct: 610 GLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGF 669
Query: 594 YHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSF-NLAEVIRCIHIGLLCVQQYPEDRPC 652
+ ++KLNL+ HAW+ + E ++ID +S +++EV+R IHIGLLCVQQ P+DRP
Sbjct: 670 RNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPN 729
Query: 653 MPSVILMLGSEIVLPQPKQPGYLADR 678
M V+LML SE++L P+QPG+ +R
Sbjct: 730 MSVVVLMLSSEMLLLDPRQPGFFNER 755
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1784 (633.1 bits), Expect = 6.6e-184, P = 6.6e-184
Identities = 354/686 (51%), Positives = 457/686 (66%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
+GN VLR ++ + LWQSFD+P+DTLLP MKLGWD KTG R I SWKSPDDPS G+
Sbjct: 135 NGNFVLRDSKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGD 194
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAATLRQNPVFN-FSFVSSEDELYYTF 130
F++ +E + PE+ +W + YRSGPWNG+RFS Q + F+F +S++E+ Y+F
Sbjct: 195 FSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSF 254
Query: 131 DLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISDL 190
+ V+SR+ ++ + L QRFTW + QNW P+D CD Y CG YG C +
Sbjct: 255 RITKSDVYSRLSISSSGLL-QRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTS 313
Query: 191 PVCQCLKGFKPKSR---GYVDWSQGCVRDKSLNYSREDGFIKFTAMKLPDATPSWVSKSM 247
PVC C+KGFKP++ G D S GCVR L+ DGF++ MKLPD T + V + +
Sbjct: 314 PVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGI 373
Query: 248 NLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYIRMSASELG 307
+KEC +KCL + +C A+ N+DIRG GSGC W GEL D+R++ GGQDLY+R++A++L
Sbjct: 374 GVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLE 433
Query: 308 AKGEPTTKIVLIVISTAALLAVVIAAGYLI-HKSRRNIVVN--IARYFRENRNNRGTEQ- 363
K + KI+ I + LL + +L K +R+I++ I + +R+ E
Sbjct: 434 DKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVV 493
Query: 364 -------KNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAV 416
E+ DL+LPL E +A AT+NFS KLG+GGFG VYKG L D QE+AV
Sbjct: 494 ISSRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAV 553
Query: 417 KRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFD 476
KRLSK S QG E KNE+ L ++LQH NLV+LL CC+ EK+LIYE++ N SLDS +FD
Sbjct: 554 KRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFD 613
Query: 477 QERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 536
+ R L+W RF II G ARGLLYLHQDSR RIIHRDLKASN+LLD+ M PKISDFG+A
Sbjct: 614 KSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMA 673
Query: 537 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHS 596
R FG DETE NT +VVGTYGYM+PEYA DG FS+KSDVFSFG+LLLEI+S K+N+GFY+S
Sbjct: 674 RIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNS 733
Query: 597 DNKLNLIRHAWKLWNEGMPSQLIDACFKDS---FNLAEVIRCIHIGLLCVQQYPEDRPCM 653
D LNL+ W+ W EG ++ID DS F E++RCI IGLLCVQ+ EDRP M
Sbjct: 734 DRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTM 793
Query: 654 PSVILMLGSE-IVLPQPKQPGYLADR 678
VILMLGSE +PQPK PGY +R
Sbjct: 794 SLVILMLGSESTTIPQPKAPGYCLER 819
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1755 (622.8 bits), Expect = 7.8e-181, P = 7.8e-181
Identities = 358/684 (52%), Positives = 466/684 (68%)
Query: 7 LFVCYSGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDD 66
L + SGNL+ G E LWQSFDYP +T+L GMKLG + KT +E ++SWK+ D
Sbjct: 129 LKISCSGNLI----SSDGEEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKD 184
Query: 67 PSPGNFTWAVERQDNPELIMWK-GSRKF-YRSGPWNGLRFSAATL--RQNPVFNFSFVSS 122
PSPG+FT +++ + P+LI+ K G + YR G WNGL F+ A R+N +F++ F SS
Sbjct: 185 PSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSS 244
Query: 123 EDELYYTFDLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDY 182
E+ Y++ + V SR+V+N T L RF K Q W L P D CD Y++CG Y
Sbjct: 245 AQEVNYSWTPRHRIV-SRLVLNNTGKLH-RFIQSKQNQ-WILANTAPEDECDYYSICGAY 301
Query: 183 GICIIS--DLPVCQCLKGFKPKSRGYVDWSQG---CVRDKSLNYSREDGFIKFTAMKLPD 237
+C I+ + P C CL+GFKPKS + S+G CV + N ++D F+KF +KLPD
Sbjct: 302 AVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPD 361
Query: 238 ATPSW--VSKSMNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQ 295
+ SW M L++C+ KC N SC AY N+DIR GG GC +WFG+L+DMR++ GQ
Sbjct: 362 TSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQ 421
Query: 296 DLYIRMSASELGAKGEPTTKIVLIVISTAALLAVVIAAGYLIHKSRRNIVVNIARYFREN 355
D+YIRM +++ KG ++V +V+ + +AVV+ + R+ I+ RY EN
Sbjct: 422 DVYIRMGFAKIEFKGR---EVVGMVVGSVVAIAVVLVVVFACF--RKKIM---KRYRGEN 473
Query: 356 RNNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIA 415
+G E++ DLDLP+F+ TI+ ATD+FS LG GGFGPVYKG L D QEIA
Sbjct: 474 FR-KGIEEE------DLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIA 526
Query: 416 VKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIF 475
VKRLS S QG++E KNE+ L +KLQHRNLV+LLGCCI GEE +LIYE+MPNKSLD FIF
Sbjct: 527 VKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIF 586
Query: 476 DQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 535
D+ R LDW KR +II G ARG+LYLHQDSRLRIIHRDLKA NVLLD DMNPKISDFGL
Sbjct: 587 DERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGL 646
Query: 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 595
A++FGGD++E +TNRVVGTYGYM PEYA DG FSVKSDVFSFG+L+LEI++GK NRGF H
Sbjct: 647 AKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRH 706
Query: 596 SDNKLNLIRHAWKLWNEGMPSQLIDA-CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMP 654
+D+ LNL+ H WK+W E ++ + +++ + EV+RCIH+ LLCVQQ PEDRP M
Sbjct: 707 ADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMA 766
Query: 655 SVILMLGSEIVLPQPKQPGYLADR 678
SV+LM GS+ LP P QPG+ +R
Sbjct: 767 SVVLMFGSDSSLPHPTQPGFFTNR 790
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1720 (610.5 bits), Expect = 4.0e-177, P = 4.0e-177
Identities = 350/695 (50%), Positives = 466/695 (67%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
+GN +LR D + LWQSFD+P+DTLL MKLGWD KTG R + SWK+ DDPS G
Sbjct: 133 NGNFLLR---DSNNRL-LWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGE 188
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAA--TLRQNPVFNFSFVSSEDELYYT 129
F+ +E + PE + YRSGPWNG+RFS+ T++ + + ++F +S++E+ Y+
Sbjct: 189 FSTKLETSEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMV-YNFTASKEEVTYS 247
Query: 130 FDLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISD 189
+ + ++SR+ +N L QR TW + TQ+W+ P+DLCD Y +CG++G C +
Sbjct: 248 YRINKTNLYSRLYLNSAGLL-QRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNS 306
Query: 190 LPVCQCLKGFKPKSR---GYVDWSQGCVRDKSLNYSREDGFIKFTAMKLPDATPSWVSKS 246
LP C C+KGFKP + D S GC+R L+ DGF + MKLPD T + V +
Sbjct: 307 LPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDRE 366
Query: 247 MNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYIRMSASEL 306
+ LK C+E+CLE+ +C A+ N+DIR GGSGC +W E++DMR++ GGQDLY+R++A+EL
Sbjct: 367 IGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAEL 426
Query: 307 GAKGEPTTKIV--LIVISTAALLAVVIAAGYLIHKSRRNIVV---NIARYFRENR----- 356
K KI+ I +S LL+ VI + K +R+I + N+ + ++
Sbjct: 427 EDKRIKNEKIIGSSIGVSILLLLSFVIFH-FWKRKQKRSITIQTPNVDQVRSQDSLINDV 485
Query: 357 --NNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEI 414
+ RG K E ++ L+LPL EL +A AT+NFS + KLG+GGFG VYKG L D +EI
Sbjct: 486 VVSRRGYTSK-EKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEI 544
Query: 415 AVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI 474
AVKRLSK+S QG E NE+ L +KLQH NLV+LLGCC+ EK+LIYE++ N SLDS +
Sbjct: 545 AVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHL 604
Query: 475 FDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 534
FDQ R L+W KRF II G ARGLLYLHQDSR RIIHRDLKASNVLLD++M PKISDFG
Sbjct: 605 FDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFG 664
Query: 535 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 594
+AR FG +ETE NT RVVGTYGYM+PEYA DG FS+KSDVFSFG+LLLEI+SGK+N+GFY
Sbjct: 665 MARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFY 724
Query: 595 HSDNKLNLIRHAWKLWNEGMPSQLIDACFKDS----FNLAEVIRCIHIGLLCVQQYPEDR 650
+S+ LNL+ W+ W EG +++D DS F E++RCI IGLLCVQ+ EDR
Sbjct: 725 NSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDR 784
Query: 651 PCMPSVILMLGSEIV-LPQPKQPGYLADRKSTRLD 684
P M SV++MLGSE +PQPK+PG+ R D
Sbjct: 785 PVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEAD 819
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1686 (598.6 bits), Expect = 1.6e-173, P = 1.6e-173
Identities = 342/693 (49%), Positives = 455/693 (65%)
Query: 13 GNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTG-LERRITSWKSPDDPSPGN 71
GN VLR ++ +LWQSFD+P+DTLL MK+GWD K+G R + SWK+ DDPS G+
Sbjct: 134 GNFVLRDSKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGD 193
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAATLRQNPV--FNFSFVSSEDELYYT 129
F+ + PE ++ YRSGPW G RFS+ PV + SF + ++ Y+
Sbjct: 194 FSTKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVP-GMKPVDYIDNSFTENNQQVVYS 252
Query: 130 FDLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISD 189
+ + ++S + ++ T L QR TW +A Q+W+ P+DLCD Y CG+YG C +
Sbjct: 253 YRVNKTNIYSILSLSSTGLL-QRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANT 311
Query: 190 LPVCQCLKGFKPKSRGYV--DWSQGCVRDKSLNYSREDGFIKFTAMKLPDATPSWVSKSM 247
P+C C+KGF+P + D S GCVR L+ DGF++ M+LPD T + V K +
Sbjct: 312 SPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGI 371
Query: 248 NLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYIRMSASELG 307
LKEC E+CL+ +C A+ N+DIR GGSGC +W G L D+R++ GGQDLY+R++A +L
Sbjct: 372 GLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLE 431
Query: 308 AKGEPTTKIV--LIVISTAALLAVVIAAGYLIHKSRRNI-----VVNIARYFRENRNN-- 358
K + KI+ I +S LL+ +I + K +R+I +V++ R N
Sbjct: 432 DKRIKSKKIIGSSIGVSILLLLSFIIFH-FWKRKQKRSITIQTPIVDLVRSQDSLMNELV 490
Query: 359 RGTEQKNEDQN-ID-LDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAV 416
+ + +N D L+LPL E +A AT+NFS + KLG+GGFG VYKG L D +EIAV
Sbjct: 491 KASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAV 550
Query: 417 KRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFD 476
KRLSK+S QG E NE+ L +KLQH NLV+LLGCC+ EK+LIYE++ N SLDS +FD
Sbjct: 551 KRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFD 610
Query: 477 QERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 536
Q R L+W KRF II G ARGLLYLHQDSR RIIHRDLKASNVLLD++M PKISDFG+A
Sbjct: 611 QTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMA 670
Query: 537 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHS 596
R FG +ETE NT RVVGTYGYM+PEYA DG FS+KSDVFSFG+LLLEI+SGK+N+GFY+S
Sbjct: 671 RIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNS 730
Query: 597 DNKLNLIRHAWKLWNEGMPSQLIDACFKDS----FNLAEVIRCIHIGLLCVQQYPEDRPC 652
+ LNL+ W+ W EG +++D D+ F E++RCI IGLLCVQ+ EDRP
Sbjct: 731 NRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPV 790
Query: 653 MPSVILMLGSEIV-LPQPKQPGYLADRKSTRLD 684
M SV++MLGSE +PQPK+PG+ R S +D
Sbjct: 791 MSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVD 823
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1451 (515.8 bits), Expect = 1.3e-148, P = 1.3e-148
Identities = 315/716 (43%), Positives = 428/716 (59%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
+GNLVL G + G E LW+SF++P + LP M L D KTG ++ SWKSP DPSPG
Sbjct: 127 TGNLVLLGTTNTGDEI-LWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGR 185
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAATLRQNPVFNFSF-VSSEDELYYTF 130
++ + PEL++WK +RSGPWNG F + F +SS++ +
Sbjct: 186 YSAGLIPLPFPELVVWKDDLLMWRSGPWNGQYFIGLPNMDYRINLFELTLSSDNRGSVSM 245
Query: 131 DLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIIS-- 188
+ +++ + QR W A Q W+ L VP CDTYA CG + C +
Sbjct: 246 SYAGNTLLYHFLLDSEGSVFQR-DWNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFNPG 304
Query: 189 DLPVCQCLKGFKPKSRGYVD---WSQGCVRDKSLNY-SRE--------DGFIKFTAMKLP 236
P C C++GFKP+S + W+QGCVR L SR+ DGF++ MK+P
Sbjct: 305 STPPCMCIRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMKVP 364
Query: 237 DATPSWVSKSMNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQD 296
P N ++C E CL+N SC AY+ G GC +W G L+DM++F G
Sbjct: 365 H-NPQ--RSGANEQDCPESCLKNCSCTAYSFDR----GIGCLLWSGNLMDMQEFSGTGVV 417
Query: 297 LYIRMSASELGAKGEPTTKIVLIVISTAALLA-VVIAAGYLIHKSR---RNIVVNIARYF 352
YIR++ SE + + I + ++ A L A V+ A + I K R RN + R
Sbjct: 418 FYIRLADSEFKKRTNRSIVITVTLLVGAFLFAGTVVLALWKIAKHREKNRNTRLLNERME 477
Query: 353 RENRNNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQ 412
+ N+ G N+ + +LPLFE +A AT+NFSI KLG+GGFG VYKG L +
Sbjct: 478 ALSSNDVGAILVNQYKL--KELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGL 535
Query: 413 EIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDS 472
+IAVKRLS+ S QG++E NE+++ SKLQHRNLV+LLG CI GEE++L+YEFMP LD+
Sbjct: 536 DIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDA 595
Query: 473 FIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 532
++FD + +LLDW RF+II G RGL+YLH+DSRL+IIHRDLKASN+LLD+++NPKISD
Sbjct: 596 YLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISD 655
Query: 533 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRG 592
FGLAR F G+E E +T RVVGTYGYMAPEYA G FS KSDVFS G++LLEIVSG++N
Sbjct: 656 FGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSS 715
Query: 593 FYHSDNKLNLIRHAWKLWNEGMPSQLID-ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
FY+ NL +AWKLWN G L+D F++ F E+ RC+H+GLLCVQ + DRP
Sbjct: 716 FYNDGQNPNLSAYAWKLWNTGEDIALVDPVIFEECFE-NEIRRCVHVGLLCVQDHANDRP 774
Query: 652 CMPSVILMLGSEIV-LPQPKQPGYLADRKSTRLDXXXXXXXXXXXXXXXXXELEGR 706
+ +VI ML SE LP+PKQP ++ R ++ ++ ++ GR
Sbjct: 775 SVATVIWMLSSENSNLPEPKQPAFIPRRGTSEVESSGQSDPRASINNVSLTKITGR 830
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 1342 (477.5 bits), Expect = 4.6e-137, P = 4.6e-137
Identities = 292/647 (45%), Positives = 401/647 (61%)
Query: 55 ERRI-TSWKSPDDPSPGNFTWAVERQDNPELIMWK-GSRKFYRSGPWNGLRFSAATLRQN 112
ER + TSW S DPSPG + ++ ++ + +WK G+ ++RSG WNG+ F R
Sbjct: 181 ERMLFTSWASETDPSPGRYALGLDPGNSGQAYIWKDGNVTYWRSGQWNGVNFIGIPWR-- 238
Query: 113 PVFNFSFVSSEDEL---YYTFDLIDKAVFSRIVM-NQTLYLRQRFTWKKATQNWELQLNV 168
P++ F + D + YYT+ + ++ +V+ N T + +K++Q+WEL
Sbjct: 239 PLYRSGFTPAIDPVLGNYYTYTATNTSLQRFVVLPNGTDIC---YMVRKSSQDWELVWYQ 295
Query: 169 PRDLCDTYALCGDYGICIISD--LPVCQCLKGFKPKSR---GYVDWSQGCVRDKSLNYSR 223
P + C+ YA CG C S C CLKGF PK + +WSQGC+R L
Sbjct: 296 PSNECEYYATCGPNAKCTASQDGKAKCTCLKGFHPKLQEQWNAGNWSQGCIRSPPLGCET 355
Query: 224 E---DGFIKFTAMKLPDATPSWVSKSMNLKECREKCLENSSCMAYTNSDIRGGGSGCAMW 280
DGF+ +K PD + WVS + CR CL N SC AY + +GC W
Sbjct: 356 NQSGDGFLPMGNIKWPDFS-YWVSTVGDEPGCRTVCLNNCSCGAYVYT----ATTGCLAW 410
Query: 281 FGELIDMRDFPDGGQDLYIRMSASELGAKGEPTTKIVLIVISTAALLAVVIAAGYLIHKS 340
ELIDM + G L +++ ASEL P KI I+ +A +L V+ A L K
Sbjct: 411 GNELIDMHELQTGAYTLNLKLPASELRGH-HPIWKIATII--SAIVLFVLAACLLLWWKH 467
Query: 341 RRNIVVNIARYFRENRNNRGTEQKNE----DQNIDLD----------LPLFELATIANAT 386
RNI + +R ++ ++Q + Q+I D L ++ L I AT
Sbjct: 468 GRNIKDAVHGSWRSRHSSTQSQQNSAMLDISQSIRFDDDVEDGKSHELKVYSLDRIRTAT 527
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
NFS + KLGEGGFGPVY GTL +E+AVKRL + S QGL+E KNE+IL +KLQHRNLV
Sbjct: 528 SNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKNEVILIAKLQHRNLV 587
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+LLGCCI EEK+L+YE+MPNKSLD+F+F+ E+ +LLDW KRF II G ARGLLYLH+DS
Sbjct: 588 RLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDS 647
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 566
RLR++HRDLKASN+LLD DM PKISDFG+AR FGGD+ + NTNRVVGT+GYM+PEYA +G
Sbjct: 648 RLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVVGTFGYMSPEYAMEG 707
Query: 567 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDS 626
FSVKSDV+ FG+L+LEI++GK+ F+ ++ LN+ +AW+ WNE ++LID + S
Sbjct: 708 IFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNEDNAAELIDPVIRAS 767
Query: 627 FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV-LPQPKQP 672
++ +V+RCIHI LLCVQ + ++RP +P+VILML ++ LP P+ P
Sbjct: 768 CSVRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPRPP 814
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1328 (472.5 bits), Expect = 1.4e-135, P = 1.4e-135
Identities = 294/681 (43%), Positives = 403/681 (59%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
+GNLV+ D S LW+SF++ DT+LP L ++L TG +R +TSWKS DPSPG+
Sbjct: 126 NGNLVVI---DNNSGRTLWESFEHFGDTMLPFSNLMYNLATGEKRVLTSWKSHTDPSPGD 182
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAATLRQNPVFNFSFVSSEDE----LY 127
FT + Q + +GS+ ++RSGPW RF+ + + + F +D +
Sbjct: 183 FTVQITPQVPSQACTMRGSKTYWRSGPWAKTRFTGIPVMDD-TYTSPFSLQQDTNGSGSF 241
Query: 128 YTFDLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICII 187
F+ K + I +L + Q +WEL P + CD Y CG +GIC++
Sbjct: 242 TYFERNFKLSYIMITSEGSLKIFQH-----NGMDWELNFEAPENSCDIYGFCGPFGICVM 296
Query: 188 SDLPVCQCLKGFKPKS-----RGYVDWSQGCVRDKSL------NYSREDGFIKFTAMKLP 236
S P C+C KGF PKS RG +W+ GCVR L N +GF +K P
Sbjct: 297 SVPPKCKCFKGFVPKSIEEWKRG--NWTDGCVRHTELHCQGNTNGKTVNGFYHVANIKPP 354
Query: 237 DATPSWVSKSMNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQD 296
D + ++ + C + CL N SC+A+ + G GC MW +L+D F GG+
Sbjct: 355 DFYE--FASFVDAEGCYQICLHNCSCLAFAYIN----GIGCLMWNQDLMDAVQFSAGGEI 408
Query: 297 LYIRMSASELGAKGEPTTKIVLIVISTAALLAVVIAAGY--LIHKSRRNIVVNIARYFRE 354
L IR+++SELG G KI++ I + +L ++ A + L +K + + I++ +
Sbjct: 409 LSIRLASSELG--GNKRNKIIVASIVSLSLFVILAFAAFCFLRYKVKHTVSAKISKIASK 466
Query: 355 NRNNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEI 414
N E Q++ L FE+ TI ATDNFS++ KLG+GGFG VYKG L D +EI
Sbjct: 467 EAWNNDLEP----QDVS-GLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEI 521
Query: 415 AVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI 474
AVKRLS S QG +E NEI+L SKLQH+NLV++LGCCI GEE+LL+YEF+ NKSLD+F+
Sbjct: 522 AVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFL 581
Query: 475 FDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 534
FD + +DW KRF+II G ARGL YLH+DS LR+IHRDLK SN+LLD+ MNPKISDFG
Sbjct: 582 FDSRKRLEIDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFG 641
Query: 535 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 594
LAR + G E + NT RV GT GYMAPEYA G FS KSD++SFG++LLEI++G+K F
Sbjct: 642 LARMYQGTEYQDNTRRVAGTLGYMAPEYAWTGMFSEKSDIYSFGVILLEIITGEKISRFS 701
Query: 595 HSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMP 654
+ L+ +AW+ W E L+D DS + EV RC+ IGLLCVQ P DRP
Sbjct: 702 YGRQGKTLLAYAWESWCESGGIDLLDKDVADSCHPLEVERCVQIGLLCVQHQPADRPNTM 761
Query: 655 SVILMLGSEIVLPQPKQPGYL 675
++ ML + L PKQP ++
Sbjct: 762 ELLSMLTTTSDLTSPKQPTFV 782
|
|
| TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1321 (470.1 bits), Expect = 7.7e-135, P = 7.7e-135
Identities = 297/676 (43%), Positives = 411/676 (60%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
SGNL++ + G + LWQSF++ DT+LP L ++ TG +R ++SWKS DP PG
Sbjct: 121 SGNLLVIDKVSGIT---LWQSFEHLGDTMLPYSSLMYNPGTGEKRVLSSWKSYTDPLPGE 177
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAATLRQNPVFN-FSFVSSEDELYYTF 130
F + Q P+ + +GS+ ++RSGPW RF+ L + FS + Y F
Sbjct: 178 FVGYITTQVPPQGFIMRGSKPYWRSGPWAKTRFTGVPLTDESYTHPFSVQQDANGSVY-F 236
Query: 131 DLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISDL 190
+ + F R ++ T + T T +W L ++VP + CD Y +CG +G+C++S
Sbjct: 237 SHLQRN-FKRSLLVLTSEGSLKVTHHNGT-DWVLNIDVPANTCDFYGVCGPFGLCVMSIP 294
Query: 191 PVCQCLKGFKPK-----SRGYVDWSQGCVRDKSL-----NYSRE-DGFIKFTAMKLPDAT 239
P C+C KGF P+ RG +W+ GCVR L + R + F +K PD
Sbjct: 295 PKCKCFKGFVPQFSEEWKRG--NWTGGCVRRTELLCQGNSTGRHVNVFHPVANIKPPDFY 352
Query: 240 PSWVSKSMNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYI 299
+VS S + +EC + CL N SC+A+ + G GC +W EL+D+ F GG+ L I
Sbjct: 353 -EFVS-SGSAEECYQSCLHNCSCLAFAYIN----GIGCLIWNQELMDVMQFSVGGELLSI 406
Query: 300 RMSASELGAKGEPTTKIVLIVISTAALLAVVIAA-GYLIHKSRRNIVVNIARYFRENRNN 358
R+++SE+G T I+ ++S + + + AA G+ ++ + N +V+ RN
Sbjct: 407 RLASSEMGGNQRKKT-IIASIVSISLFVTLASAAFGFWRYRLKHNAIVSKVSLQGAWRN- 464
Query: 359 RGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKR 418
+ K+ED + L FE+ TI AT+NFS+ KLG+GGFGPVYKG L D +EIAVKR
Sbjct: 465 ---DLKSEDVS---GLYFFEMKTIEIATNNFSLVNKLGQGGFGPVYKGKLQDGKEIAVKR 518
Query: 419 LSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQE 478
LS S QG +E NEI+L SKLQH NLV++LGCCI GEE+LL+YEFM NKSLD+FIFD
Sbjct: 519 LSSSSGQGKEEFMNEILLISKLQHINLVRILGCCIEGEERLLVYEFMVNKSLDTFIFDSR 578
Query: 479 RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538
+ +DW KRF II G ARGLLYLH+DSRLRIIHRD+K SN+LLD MNPKISDFGLAR
Sbjct: 579 KRVEIDWPKRFSIIQGIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNPKISDFGLARM 638
Query: 539 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 598
+ G + + NT R+VGT GYM+PEYA G FS KSD +SFG+LLLE++SG+K F +
Sbjct: 639 YEGTKYQDNTRRIVGTLGYMSPEYAWTGVFSEKSDTYSFGVLLLEVISGEKISRFSYDKE 698
Query: 599 KLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658
+ NL+ +AW+ W E +D DS + +EV RC+ IGLLCVQ P DRP ++
Sbjct: 699 RKNLLAYAWESWCENGGVGFLDKDATDSCHPSEVGRCVQIGLLCVQHQPADRPNTLELLS 758
Query: 659 MLGSEIVLPQPKQPGY 674
ML + LP PK+P +
Sbjct: 759 MLTTTSDLPLPKEPTF 774
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1320 (469.7 bits), Expect = 9.8e-135, P = 9.8e-135
Identities = 301/675 (44%), Positives = 398/675 (58%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGN 71
SGNL + D SE LWQSFD+ DTLL L ++L T +R +TSWKS DPSPG+
Sbjct: 127 SGNLKVI---DNVSERALWQSFDHLGDTLLHTSSLTYNLATAEKRVLTSWKSYTDPSPGD 183
Query: 72 FTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAATLRQNPVFNFSFVSSED---ELYY 128
F + Q + + +GS ++RSGPW RF+ + F +D Y
Sbjct: 184 FLGQITPQVPSQGFVMRGSTPYWRSGPWAKTRFTGIPFMDES-YTGPFTLHQDVNGSGYL 242
Query: 129 TFDLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGICIIS 188
T+ D + SRI + ++ ++ WEL P+ LCD Y CG +G+C++S
Sbjct: 243 TYFQRDYKL-SRITLTSEGSIKM---FRDNGMGWELYYEAPKKLCDFYGACGPFGLCVMS 298
Query: 189 DLPVCQCLKGFKPKS-----RGYVDWSQGCVRDKSL----NYSREDGFIKFTAMKLPDAT 239
P+C+C +GF PKS RG +W+ GCVR L N + ED +
Sbjct: 299 PSPMCKCFRGFVPKSVEEWKRG--NWTGGCVRHTELDCLGNSTGEDADDFHQIANIKPPD 356
Query: 240 PSWVSKSMNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGGQDLYI 299
+ S+N +EC ++C+ N SC+A+ I+G GC +W +L+D F G+ L I
Sbjct: 357 FYEFASSVNAEECHQRCVHNCSCLAFAY--IKG--IGCLVWNQDLMDAVQFSATGELLSI 412
Query: 300 RMSASELGAKGEPTTKIVLIVISTAALLAVVIAAGYLIHKSRRNIVVNIARYFRENRNNR 359
R++ SEL T + IV T ++ A G + + R V +IA ++ N
Sbjct: 413 RLARSELDGNKRKKTIVASIVSLTLFMILGFTAFG--VWRCR---VEHIAHISKDAWKN- 466
Query: 360 GTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRL 419
+ K +D L F++ TI NAT+NFS++ KLG+GGFG VYKG L D +EIAVKRL
Sbjct: 467 --DLKPQDVP---GLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRL 521
Query: 420 SKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQER 479
S S QG +E NEI+L SKLQHRNLV++LGCCI EEKLLIYEFM NKSLD+F+FD +
Sbjct: 522 SSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRK 581
Query: 480 CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539
+DW KRF II G ARGLLYLH DSRLR+IHRDLK SN+LLD+ MNPKISDFGLAR +
Sbjct: 582 RLEIDWPKRFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMY 641
Query: 540 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK 599
G E + NT RVVGT GYM+PEYA G FS KSD++SFG+L+LEI+SG+K F +
Sbjct: 642 QGTEYQDNTRRVVGTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEG 701
Query: 600 LNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659
LI +AW+ W+E L+D DS + EV RCI IGLLCVQ P DRP ++ M
Sbjct: 702 KTLIAYAWESWSEYRGIDLLDQDLADSCHPLEVGRCIQIGLLCVQHQPADRPNTLELLAM 761
Query: 660 LGSEIVLPQPKQPGY 674
L + LP PKQP +
Sbjct: 762 LTTTSDLPSPKQPTF 776
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| O81905 | SD18_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5104 | 0.9830 | 0.8164 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| gw1.254.15.1 | annotation not avaliable (816 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 706 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-54 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-54 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-39 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 7e-39 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-35 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-33 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-31 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-30 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-29 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-27 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-26 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-26 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-25 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 1e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-25 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-25 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-25 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-25 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-24 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-23 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-22 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-22 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 6e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-21 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-21 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-20 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-20 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-20 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-20 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-17 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 8e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-15 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-14 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-13 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 1e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-07 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 4e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.003 | |
| pfam08277 | 71 | pfam08277, PAN_3, PAN-like domain | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 1e-54
Identities = 81/206 (39%), Positives = 112/206 (54%), Gaps = 18/206 (8%)
Query: 390 SINKKLGEGGFGPVYKGTL-----ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHR 443
++ KKLGEG FG VYKG L + E+AVK L + SEQ ++E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 444 NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH 503
N+VKLLG C E ++ E+M L S++ ++ L S ARG+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 504 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMAP 560
IHRDL A N L+ +++ KISDFGL+R D + + R G +MAP
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAP 172
Query: 561 EYASDGQFSVKSDVFSFGILLLEIVS 586
E +G+F+ KSDV+SFG+LL EI +
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 2e-54
Identities = 85/206 (41%), Positives = 115/206 (55%), Gaps = 17/206 (8%)
Query: 390 SINKKLGEGGFGPVYKGTLAD-----EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHR 443
++ KKLGEG FG VYKGTL E E+AVK L + SEQ ++E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 444 NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH 503
N+VKLLG C E +++ E+MP L ++ R K L S ARG+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLE 120
Query: 504 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMAP 560
IHRDL A N L+ +++ KISDFGL+R D + + +V G +MAP
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAP 173
Query: 561 EYASDGQFSVKSDVFSFGILLLEIVS 586
E +G+F+ KSDV+SFG+LL EI +
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 3e-52
Identities = 95/287 (33%), Positives = 131/287 (45%), Gaps = 45/287 (15%)
Query: 393 KKLGEGGFGPVYKGTL----ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVK 447
KKLGEG FG VYKG L E+AVK L + SE+ K+ E + KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSFI------FDQERCKLLDWSKRFHIICGTARGLLY 501
LLG C E L+ E+M L ++ F L A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGDETEGNTNRVVGTYGYMAP 560
L + +HRDL A N L+ +D+ KISDFGL+R + D T + +MAP
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 561 EYASDGQFSVKSDVFSFGILLLEIVS-------GKKNRGFYHSDNKLNLIRHAWKLWNEG 613
E DG F+ KSDV+SFG+LL EI + G N + L +R ++L
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------EEVLEYLRKGYRL---P 227
Query: 614 MPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
P + C + L E++ C Q PEDRP ++ L
Sbjct: 228 KP----EYCPDE---LYELMLS------CWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 1e-50
Identities = 79/210 (37%), Positives = 110/210 (52%), Gaps = 21/210 (10%)
Query: 389 FSINKKLGEGGFGPVYKGTL-----ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQH 442
+ KKLGEG FG VYKGTL E ++AVK L + SE+ +E E + KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL 502
N+V+LLG C GE ++ E+MP L F+ ++ + L + A+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY----- 557
+HRDL A N L+ +++ KISDFGL+R D+ G
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-----RKRGGGKLPIKW 170
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVSG 587
MAPE DG+F+ KSDV+SFG+LL EI +
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 2e-49
Identities = 73/194 (37%), Positives = 100/194 (51%), Gaps = 11/194 (5%)
Query: 395 LGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKE-LKNEIILFSKLQHRNLVKLLGCC 452
LGEGGFG VY +++A+K + K L E L EI + KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 453 IHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIH 512
L+ E+ SL + +E L + I+ GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 513 RDLKASNVLLDQD-MNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-YASDGQFSV 570
RDLK N+LLD D K++DFGL++ D++ T +VGT YMAPE G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 571 KSDVFSFGILLLEI 584
KSD++S G++L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 1e-48
Identities = 71/218 (32%), Positives = 109/218 (50%), Gaps = 13/218 (5%)
Query: 389 FSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKE-LKNEIILFSKLQHRNLV 446
+ I +KLGEG FG VY + +A+K + K + +E + EI + KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+L ++ L+ E+ L + ++R +L + RF + L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLHS-- 115
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 566
I+HRDLK N+LLD+D + K++DFGLAR E VGT YMAPE
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGK 171
Query: 567 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIR 604
+ D++S G++L E+++GK F D L L +
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK--PPFPGDDQLLELFK 207
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 5e-48
Identities = 74/250 (29%), Positives = 108/250 (43%), Gaps = 22/250 (8%)
Query: 389 FSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK--ISEQGLKELKNEIILFSKLQHRNL 445
+ + +KLG G FG VYK +I AVK L K + + + EI + +L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD 505
V+L+ + L+ E+ L ++ L + I RGL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLH-- 115
Query: 506 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-YAS 564
IIHRDLK N+LLD++ KI+DFGLA+ + + VGT YMAPE
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEVLLG 172
Query: 565 DGQFSVKSDVFSFGILLLEIVSGK---KNRGFYHSDNKLNLIRHA-----WKLWNEGMPS 616
+ K DV+S G++L E+++GK + I W+ G
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEE 232
Query: 617 --QLIDACFK 624
LI C
Sbjct: 233 AKDLIKKCLN 242
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 3e-44
Identities = 71/210 (33%), Positives = 111/210 (52%), Gaps = 19/210 (9%)
Query: 388 NFSINKKLGEGGFGPVYKGTLADE-QEIAVK--RLSKISEQGLKELKNEIILFSKLQHRN 444
++ + LG G FG VY D + +AVK LS SE+ L+ L+ EI + S LQH N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 445 LVKLLGCCIHGEEK-LLIY-EFMPNKSLDSFIFDQERCKLLDWS--KRF--HIICGTARG 498
+V+ G E+ L I+ E++ SL S + ++ L +++ I+ G
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLPEPVIRKYTRQILEG---- 113
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
L YLH I+HRD+K +N+L+D D K++DFG A+ G ET T V GT +M
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVSGK 588
APE ++ +D++S G ++E+ +GK
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 68/201 (33%), Positives = 108/201 (53%), Gaps = 9/201 (4%)
Query: 389 FSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVK 447
F I +K+G+GGFG VYK +E+A+K + S++ +++ NEI + K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSR 507
G + +E ++ EF SL + + + L S+ ++ +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHS--- 116
Query: 508 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ 567
IIHRD+KA+N+LL D K+ DFGL+ N +VGT +MAPE +
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKP 173
Query: 568 FSVKSDVFSFGILLLEIVSGK 588
+ K+D++S GI +E+ GK
Sbjct: 174 YDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 7e-39
Identities = 43/111 (38%), Positives = 72/111 (64%), Gaps = 2/111 (1%)
Query: 94 YRSGPWNGLRFSAA-TLRQNPVFNFSFVSSEDELYYTFDLIDKAVFSRIVMNQTLYLRQR 152
+RSGPWNG+RFS +++ + ++F + +E+YYT+ + + +++SR+ ++ L +R
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSL-ER 59
Query: 153 FTWKKATQNWELQLNVPRDLCDTYALCGDYGICIISDLPVCQCLKGFKPKS 203
FTW +Q+W L + P+D CD Y CG YG C ++ P C C+KGF PK+
Sbjct: 60 FTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 84/272 (30%), Positives = 130/272 (47%), Gaps = 37/272 (13%)
Query: 389 FSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKL 448
F++ +KLG G FG V++G + +A+K L ++ + E+ +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 449 LGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRL 508
C GE +I E M SL +F+ E ++L + + C A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 509 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF 568
IHRDL A N+L+ +D+ K++DFGLAR D + ++ Y + APE AS G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 569 SVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ----LIDACFK 624
S KSDV+SFGILL E+ + G ++ GM + I A ++
Sbjct: 182 STKSDVWSFGILLYEMFT----YG---------------QVPYPGMNNHEVYDQITAGYR 222
Query: 625 DSFNLAEVIRCIH----IGLLCVQQYPEDRPC 652
+ +C I L C PEDRP
Sbjct: 223 ----MPCPAKCPQEIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 71/214 (33%), Positives = 107/214 (50%), Gaps = 31/214 (14%)
Query: 388 NFSINKKLGEGGFGPVYKG-TLADEQEIAVKRLS--KISEQGLKELKNEIILFSKLQHRN 444
N+ + +G G FG VYKG L +A+K++S KI E+ LK + EI L L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 445 LVKLLGCCIHGEEKLLIY-EFMPNKSLDSFIFDQERCKLLDWSKRFH------IICGTA- 496
+VK +G I + L I E+ N SL I K+F +
Sbjct: 61 IVKYIG-SIETSDSLYIILEYAENGSLRQII------------KKFGPFPESLVAVYVYQ 107
Query: 497 --RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 554
+GL YLH+ +IHRD+KA+N+L +D K++DFG+A + + VVGT
Sbjct: 108 VLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162
Query: 555 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
+MAPE S SD++S G ++E+++G
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 66/227 (29%), Positives = 116/227 (51%), Gaps = 27/227 (11%)
Query: 371 DLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKE 429
+L L ++ + + + + +K+GEG G VYK T A +E+A+K++ ++ +Q +
Sbjct: 3 ELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKEL 61
Query: 430 LKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRF 489
+ NEI++ +H N+V + G+E ++ E+M SL ++ +
Sbjct: 62 IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL---------TDIITQNFVR 112
Query: 490 ----HI--ICG-TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542
I +C +GL YLH +IHRD+K+ N+LL +D + K++DFG F
Sbjct: 113 MNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQ 165
Query: 543 ETEGNTNR--VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 587
T+ + R VVGT +MAPE + K D++S GI+ +E+ G
Sbjct: 166 LTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (329), Expect = 4e-33
Identities = 88/330 (26%), Positives = 135/330 (40%), Gaps = 27/330 (8%)
Query: 388 NFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSK---ISEQGLKELKNEIILFSKLQH-R 443
++ I +KLGEG FG VY D + +A+K L+K + ++ EI + + L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 444 NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH 503
N+VKL L+ E++ SL+ + R L S+ I+ L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 504 QDSRLRIIHRDLKASNVLLDQDMN-PKISDFGLARAFGGDETEGN----TNRVVGTYGYM 558
IIHRD+K N+LLD+D K+ DFGLA+ + + + VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 559 APEYA---SDGQFSVKSDVFSFGILLLEIVSGKK-NRGFYHSDNKLNLIRHAWKLWNEGM 614
APE S S SD++S GI L E+++G G +S ++ +L +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 615 PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLPQPKQPGY 674
S L S + + + P++R S + S +L K
Sbjct: 236 ASPL-----SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL----SHDLLAHLKLKES 286
Query: 675 LADRKSTRLDSSLSMPESSSTNTITISELE 704
DS+ + IS L
Sbjct: 287 DLSDLLKPDDSAPLRLSLPPSLEALISSLN 316
|
Length = 384 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 75/201 (37%), Positives = 104/201 (51%), Gaps = 12/201 (5%)
Query: 389 FSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKL 448
+ +KLG G FG V+ GT ++AVK L K + E + KL+H LV+L
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 449 LGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRL 508
C E ++ E+M SL F+ E KL + + A G+ YL
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE---SR 122
Query: 509 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTNRVVGTYGYMAPEYASD 565
IHRDL A N+L+ +++ KI+DFGLAR DE EG + T APE A+
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANY 178
Query: 566 GQFSVKSDVFSFGILLLEIVS 586
G+F++KSDV+SFGILL EIV+
Sbjct: 179 GRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 70/208 (33%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 393 KKLGEGGFGPVYKGTLADEQ-----EIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLV 446
K+LGEG FG V ++AVK L+ EQ + + EI + L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 447 KLLGCC--IHGEEKLLIYEFMPNKSLDSFI----FDQERCKLLDWSKRFHIICGTARGLL 500
K G C G LI E++P+ SL ++ +LL +S + IC +G+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ---IC---KGMD 123
Query: 501 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTNRVVGTYGYM 558
YL R IHRDL A N+L++ + KISDFGLA+ D + Y
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVS 586
APE +FS SDV+SFG+ L E+ +
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 67/227 (29%), Positives = 111/227 (48%), Gaps = 24/227 (10%)
Query: 388 NFSINKKLGEGGFGPVYKGT-LADEQEIAVKR--LSKISEQGLKELKNEIILFSKLQHRN 444
+ I K++G+G FG VY +D + +K LS +SE+ ++ NE+ + KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERC-------KLLDWSKRFHIICGTAR 497
++K + ++ E+ L I Q++ ++LDW F +C
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW---FVQLC---L 114
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 557
L YLH SR +I+HRD+K N+ L + K+ DFG+++ T VVGT Y
Sbjct: 115 ALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYY 169
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIR 604
++PE + ++ KSD++S G +L E+ + K F +N L L
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLK--HPFE-GENLLELAL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRL-SKISEQGLKELKNEI-ILFSKLQHR 443
+ K LG+G G VYK +I A+K++ E+ K+L E+ L S +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESP 59
Query: 444 NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA-----RG 498
+VK G E ++ E+M SL + ++ + + +G
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLL---KKVGK--IPEP---VLAYIARQILKG 111
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
L YLH IIHRD+K SN+L++ KI+DFG+++ + T N VGT YM
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYM 167
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVSGK 588
+PE +S +D++S G+ LLE GK
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 5e-31
Identities = 70/211 (33%), Positives = 104/211 (49%), Gaps = 16/211 (7%)
Query: 395 LGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNEIILFSKLQHRNLVKLLG 450
LG+G FG V D ++ A+K L K I + ++ E + S++ H +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 451 CCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLR 509
EEKL L+ E+ P L S + +E + ++ + L YLH L
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARFY--AAEIVLALEYLH---SLG 113
Query: 510 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFS 569
II+RDLK N+LLD D + K++DFGLA+ + + NT GT Y+APE +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGYG 171
Query: 570 VKSDVFSFGILLLEIVSGKKNRGFYHSDNKL 600
D +S G+LL E+++GK FY D K
Sbjct: 172 KAVDWWSLGVLLYEMLTGK--PPFYAEDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 10/201 (4%)
Query: 389 FSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVK 447
F I +KLGEG +G VYK Q +A+K + E+ L+E+ EI + + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSR 507
G + ++ E+ S+ + + K L + I+ T +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHS--- 117
Query: 508 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ 567
+ IHRD+KA N+LL+++ K++DFG++ T N V+GT +MAPE +
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTVIGTPFWMAPEVIQEIG 175
Query: 568 FSVKSDVFSFGILLLEIVSGK 588
++ K+D++S GI +E+ GK
Sbjct: 176 YNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 72/215 (33%), Positives = 109/215 (50%), Gaps = 25/215 (11%)
Query: 393 KKLGEGGFGPVYKGTLADE------QEIAVKRLSKISEQGLK-ELKNEIILFSKLQHRNL 445
++LGEG FG VYKG L +A+K L + +E ++ E + E L S LQH N+
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIF-------------DQERCKLLDWSKRFHII 492
V LLG C + +++E++ + L F+ D+ LD S HI
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGDETEGNTNRV 551
A G+ YL S +HRDL A N L+ + + KISDFGL+R + D + +
Sbjct: 131 IQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 552 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+ +M PE G+F+ +SD++SFG++L EI S
Sbjct: 188 LPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 41/231 (17%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSK---ISEQGLKELKNEIILFSKL-Q 441
D+F K +GEG F V +E A+K L K I E+ +K +K E + ++L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 442 HRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFI-----FDQERCKLLDWSKRFHIICGT 495
H ++KL EE L + E+ PN L +I D++ +
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTR--------FYAAEI 111
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV---- 551
L YLH IIHRDLK N+LLD+DM+ KI+DFG A+ + + +
Sbjct: 112 LLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 552 --------------VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
VGT Y++PE ++ SD+++ G ++ ++++GK
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 29/234 (12%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSKISEQGLKE-LKNEIILFSK 439
D + ++LGEG FG V+ G D++ +AVK L + + ++ + E L +
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSF---------IFDQER--CKLLDWSKR 488
QH N+VK G C G+ ++++E+M + L+ F L S+
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 489 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 548
I A G++YL + +HRDL N L+ D+ KI DFG++R D +
Sbjct: 125 LQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDY 177
Query: 549 NRVVGT----YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 598
RV G +M PE +F+ +SDV+SFG++L EI + K + S+
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 94/281 (33%), Positives = 129/281 (45%), Gaps = 49/281 (17%)
Query: 395 LGEGGFGPVYKGTLAD-------EQEIAVKRLSK---ISEQGLKELKNEIILFSKLQHRN 444
LG G FG VY+GT D +AVK L K E+ KE E L S H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCK----LLDWSKRFHIICGTARGLL 500
+VKLLG C+ E + +I E M L S++ D + LL + I A+G +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 501 YLHQDSRLRIIHRDLKASNVLL-----DQDMNPKISDFGLARAFGGDETEGNTNRVVG-- 553
YL Q + IHRDL A N L+ D D KI DFGLAR D + + R G
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR----DIYKSDYYRKEGEG 173
Query: 554 --TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLW 610
+MAPE DG+F+ +SDV+SFG+L+ EI++ G++ Y + N +++H
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP---YPALNNQEVLQHV---- 226
Query: 611 NEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
G Q + C + L C Q P +RP
Sbjct: 227 TAGGRLQKPENCPDKIYQLM---------TNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 69/198 (34%), Positives = 102/198 (51%), Gaps = 23/198 (11%)
Query: 395 LGEGGFGPVYKGTLADEQEIAVKRL---SKISEQGLKELKNEIILFSKLQHRNLVKLLGC 451
+G+G FG V G Q++AVK L S ++ L E + + L+H NLV+LLG
Sbjct: 14 IGKGEFGDVMLGDYRG-QKVAVKCLKDDSTAAQAFLAEAS----VMTTLRHPNLVQLLGV 68
Query: 452 CIHGEEKLLIYEFMPNKSLDSFIFDQERCKL-LDWSKRFHIICGTARGLLYLHQDSRLRI 510
+ G ++ E+M SL ++ + R + L F + G+ YL +
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL--DVCEGMEYLEEK---NF 123
Query: 511 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY--GYMAPEYASDGQF 568
+HRDL A NVL+ +D+ K+SDFGLA+ E + + G + APE + +F
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKF 176
Query: 569 SVKSDVFSFGILLLEIVS 586
S KSDV+SFGILL EI S
Sbjct: 177 STKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 69/197 (35%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCC 452
+KLG G FG V++G + +AVK L K K+ E + KL+H L++L C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 453 IHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIH 512
E ++ E M SL ++ + L + + A G+ YL + IH
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAG-RALKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 513 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMAPEYASDGQFS 569
RDL A NVL+ ++ K++DFGLAR D E G + APE A +FS
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFS 182
Query: 570 VKSDVFSFGILLLEIVS 586
+KSDV+SFGILL EIV+
Sbjct: 183 IKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 10/205 (4%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLA----DEQEIAVKRL-SKISEQGLKELKNEIILFSKLQ 441
+I K +G G FG V +G L E ++A+K L + S++ + E + +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLY 501
H N+++L G ++I E+M N SLD F+ +E + ++ G A G+ Y
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKY 121
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 561
L S + +HRDL A N+L++ ++ K+SDFGL+R E T + APE
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178
Query: 562 YASDGQFSVKSDVFSFGILLLEIVS 586
+ +F+ SDV+SFGI++ E++S
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 23/209 (11%)
Query: 393 KKLGEGGFGPVYKGTLADEQE-----IAVKRL-SKISEQGLKELKNEIILFSKLQHRNLV 446
K LG G FG VYKG E E +A+K L + S + KE+ +E + + + H ++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCK-----LLDWSKRFHIICGTARGLLY 501
+LLG C+ + LI + MP L ++ + LL+W + A+G+ Y
Sbjct: 73 RLLGICL-SSQVQLITQLMPLGCLLDYV-RNHKDNIGSQYLLNWCVQI------AKGMSY 124
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 561
L + R++HRDL A NVL+ + KI+DFGLA+ DE E + +MA E
Sbjct: 125 LEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 562 YASDGQFSVKSDVFSFGILLLEIVS-GKK 589
++ KSDV+S+G+ + E+++ G K
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 6e-28
Identities = 88/268 (32%), Positives = 131/268 (48%), Gaps = 28/268 (10%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
+ + KKLG G FG V+ G ++A+K L K + E L +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+L + E +I E+M N SL F+ E KL +K + A G+ ++
Sbjct: 65 RLYAV-VTQEPIYIITEYMENGSLVDFLKTPEGIKL-TINKLIDMAAQIAEGMAFIE--- 119
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTNRVVGTYGYMAPEYA 563
R IHRDL+A+N+L+ + + KI+DFGLAR +E EG + T APE
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAI 175
Query: 564 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623
+ G F++KSDV+SFGILL EIV+ R Y +I++ + + MP D C
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVT--YGRIPYPGMTNPEVIQNLERGYR--MPRP--DNCP 229
Query: 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
++ + L LC ++ PE+RP
Sbjct: 230 EELYELM---------RLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 67/197 (34%), Positives = 104/197 (52%), Gaps = 8/197 (4%)
Query: 393 KKLGEGGFGPVYKGTLADEQEIAVK--RLSKISEQGLKELKNEIILFSKLQHRNLVKLLG 450
+K+G+G FG VYKG L E+AVK R + + K L+ IL + H N+VKL+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEIL-KQYDHPNIVKLIG 59
Query: 451 CCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRI 510
C+ + ++ E +P SL +F+ +++ L K + A G+ YL +
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 511 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSV 570
IHRDL A N L+ ++ KISDFG++R G + + APE + G+++
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 571 KSDVFSFGILLLEIVSG 587
+SDV+S+GILL E S
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 70/201 (34%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 393 KKLGEGGFGPVYKGTL----ADEQEIAVKRLSKISEQGLK-ELKNEIILFSKLQHRNLVK 447
K+LG G FG V KG E E+AVK L + K E E + ++L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSR 507
L+G C GE +L+ E P L ++ + + D + H + A G+ YL
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV---AMGMAYLESK-- 114
Query: 508 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY--GYMAPEYASD 565
+HRDL A NVLL KISDFG++RA G G + + APE +
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-YRATTAGRWPLKWYAPECINY 172
Query: 566 GQFSVKSDVFSFGILLLEIVS 586
G+FS KSDV+S+G+ L E S
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 7e-27
Identities = 90/269 (33%), Positives = 125/269 (46%), Gaps = 29/269 (10%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
++ + KKLG G FG V+ G + ++AVK L K ++ E L LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+L E +I E+M SL F+ E K+L K A G+ Y+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE--- 120
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY--GYMAPEYAS 564
R IHRDL+A+NVL+ + + KI+DFGLAR +E T R + + APE +
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAIN 177
Query: 565 DGQFSVKSDVFSFGILLLEIVSGKK--NRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622
G F++KSDV+SFGILL EIV+ K G +SD L R E P +L D
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD-- 235
Query: 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
I C ++ E+RP
Sbjct: 236 ---------------IMKTCWKEKAEERP 249
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 75/270 (27%), Positives = 129/270 (47%), Gaps = 31/270 (11%)
Query: 388 NFSINKKLGEGGFGPVYKGTL-ADEQEIAVKR--LSKISEQGLKELKNEIILFSKLQHRN 444
+F I K+G+G FG V+K AD++ A+K+ LSK++ + +E +E + +KL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLD---WSKRFHIICGTARGLLY 501
+++ + + ++ E+ N L + Q L + W RF I GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW--RFFI--QILLGLAH 116
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 561
LH +I+HRD+K+ N+ LD N KI D G+A+ + NT +VGT Y++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 562 YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621
D ++ KSDV++ G++L E +GK + ++N+ LI + +
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHP---FDANNQGALILKIIRGVFPPVSQ----- 223
Query: 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
S LA++I C+ + RP
Sbjct: 224 --MYSQQLAQLID------QCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 75/211 (35%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 387 DNFSINKKLGEGGFGPVYKGT---LADEQ---EIAVKRLSKISEQGLKE-LKNEIILFSK 439
+N S K LG G FG V + T L+ ++AVK L + +E L +E+ + S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 440 L-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARG 498
L H N+V LLG C G L+I E+ L +F+ ++R L A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTNRVVGTY 555
+ +L + IHRDL A NVLL KI DFGLAR D +GN V
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV--- 207
Query: 556 GYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+MAPE + ++ +SDV+S+GILL EI S
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 72/239 (30%), Positives = 109/239 (45%), Gaps = 32/239 (13%)
Query: 370 IDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRL-SKI 422
+ LD P +EL D ++ K LGEG FG V K +AVK L
Sbjct: 1 LPLD-PEWELPR-----DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA 54
Query: 423 SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCK 481
+E+ L +L +E+ + + +H+N++ LLG C ++ E+ + +L F+ + R
Sbjct: 55 TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPP 113
Query: 482 LLDWSKRFHIICG--------------TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 527
S ARG+ +L + IHRDL A NVL+ +D
Sbjct: 114 GEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHV 170
Query: 528 PKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
KI+DFGLAR + T +MAPE D ++ +SDV+SFG+LL EI +
Sbjct: 171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 393 KKLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQGLKELKN--EIILFSKLQHRNLVKLL 449
K+GEG +G VYK EI A+K++ E EI L +L H N++KLL
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 450 GCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLR 509
H + L++EFM + L I ++R + L S + +GL + H
Sbjct: 65 DVFRHKGDLYLVFEFM-DTDLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSH---G 118
Query: 510 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-YASDGQF 568
I+HRDLK N+L++ + K++DFGLAR+FG T+ VV T Y APE D +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGDKGY 176
Query: 569 SVKSDVFSFGILLLEIVSGK 588
S D++S G + E++S +
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 77/216 (35%), Positives = 117/216 (54%), Gaps = 36/216 (16%)
Query: 389 FSINKKLGEGGFGPVYKGT-LADEQEIAVK--RLSKISEQGLKE--LKNEIILFSKLQHR 443
+ +KLGEG +G VYK + +A+K RL E+G+ L+ EI L +L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALR-EISLLKELKHP 58
Query: 444 NLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKL-LDWSKR--FHIICGTARGL 499
N+VKLL IH E KL L++E+ + L ++ D+ L + K + ++ G L
Sbjct: 59 NIVKLL-DVIHTERKLYLVFEYC-DMDLKKYL-DKRPGPLSPNLIKSIMYQLLRG----L 111
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 559
Y H RI+HRDLK N+L+++D K++DFGLARAFG T+ VV T Y A
Sbjct: 112 AYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVV-TLWYRA 166
Query: 560 PE-------YASDGQFSVKSDVFSFGILLLEIVSGK 588
PE Y++ +V D++S G + E+++GK
Sbjct: 167 PEILLGSKHYST----AV--DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-25
Identities = 36/65 (55%), Positives = 46/65 (70%), Gaps = 1/65 (1%)
Query: 223 REDGFIKFTAMKLPDATPSWVSKSMNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFG 282
DGF++ MKLPD T + V +S+ LKEC ++CL N SC AY +DIR GGSGC +W G
Sbjct: 3 GGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIWTG 61
Query: 283 ELIDM 287
EL+DM
Sbjct: 62 ELVDM 66
|
Length = 66 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 37/218 (16%)
Query: 389 FSINKKLGEGGFGPVYKG-TLADEQEIAVKRLSKISEQGLKE-----LKNEIILFSKLQH 442
+ ++GEG +G VYK + +A+K KI + KE EI L KL+H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK---KIRMENEKEGFPITAIREIKLLQKLRH 57
Query: 443 RNLVKLLGCCIHGEEK---LLIYEFMPNKSLDSFI------FDQERCKLLDWSKRFHIIC 493
N+V+L + + K +++E+M + L + F + + K +
Sbjct: 58 PNIVRLK-EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIK--------CYMK 107
Query: 494 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 553
GL YLH + I+HRD+K SN+L++ D K++DFGLAR + + TNRV+
Sbjct: 108 QLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI- 163
Query: 554 TYGYMAPEY---ASDGQFSVKSDVFSFGILLLEIVSGK 588
T Y PE A+ ++ + D++S G +L E+ GK
Sbjct: 164 TLWYRPPELLLGAT--RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 394 KLGEGGFGPVYKG---TLADEQE---IAVKRLSKISEQGLKELKNEIILFSKLQHRNLVK 447
+LGEG FG V+ L EQ+ +AVK L + SE ++ + E L + LQH+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSF---------IFDQER---CKLLDWSKRFHIICGT 495
G C G L+++E+M + L+ F I L + I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 555
A G++YL + L +HRDL N L+ Q + KI DFG++R + R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 556 GYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKK 589
+M PE +F+ +SD++SFG++L EI + GK+
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 88/273 (32%), Positives = 131/273 (47%), Gaps = 38/273 (13%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
++ + KKLG G FG V+ T ++AVK + K ++ E + LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 64
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQE-----RCKLLDWSKRFHIICGTARGLLY 501
KL + E +I EFM SL F+ E KL+D+S + A G+ +
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAF 117
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTNRVVGTYGYM 558
+ Q + IHRDL+A+N+L+ + KI+DFGLAR +E EG + T
Sbjct: 118 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT---- 170
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618
APE + G F++KSDV+SFGILL+EIV+ R Y + +IR G
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVT--YGRIPYPGMSNPEVIRAL----ERGYRMPR 224
Query: 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
+ C ++ +N I + C + PE+RP
Sbjct: 225 PENCPEELYN---------IMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 73/228 (32%), Positives = 107/228 (46%), Gaps = 24/228 (10%)
Query: 385 ATDNFSINKKLGEGGFGPVYKGTL------ADEQEIAVKRLSKI-SEQGLKELKNEIILF 437
D+ ++ + LG G FG VY+G A E ++AVK L + SEQ + E ++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 438 SKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFD----QERCKLLDWSKRFHIIC 493
SK H+N+V+L+G + ++ E M L SF+ + ER L
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 494 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLARAFGGDETEGNTNR 550
A+G YL ++ IHRD+ A N LL KI+DFG+AR R
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 551 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-------GKKNR 591
+ +M PE DG F+ K+DV+SFG+LL EI S G+ N+
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 389 FSINKKLGEGGFGPVYKGTLADE----QEIAVK--RLSKISEQGLKELKNEIILFSKLQH 442
+ K LGEG FG V +G L+ + ++AVK +L + ++E +E H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 443 RNLVKLLGCCIHGEEK------LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI----- 491
N++KL+G C ++I FM + L SF+ +L ++ +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL---YSRLGGLPEKLPLQTLLK 117
Query: 492 -ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGD-ETEGNT 548
+ A G+ YL S IHRDL A N +L +DM ++DFGL++ + GD +G
Sbjct: 118 FMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174
Query: 549 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
++ ++A E +D ++ KSDV++FG+ + EI +
Sbjct: 175 AKM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 65/220 (29%), Positives = 109/220 (49%), Gaps = 29/220 (13%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSK---ISEQGLKELKNEIILF 437
+ ++ ++LG+G FG VY+G E +A+K +++ + E+ E NE +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVM 63
Query: 438 SKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIF----DQERCKLLD--WSKRFHI 491
+ ++V+LLG G+ L++ E M L S++ + E L ++F
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123
Query: 492 ICG-TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 550
+ A G+ YL + +HRDL A N ++ +D+ KI DFG+ R D E + R
Sbjct: 124 MAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYR 176
Query: 551 VVGT----YGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
G +MAPE DG F+ KSDV+SFG++L E+ +
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 85/280 (30%), Positives = 134/280 (47%), Gaps = 39/280 (13%)
Query: 384 NATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKI----SEQGLKELKNEIILFSK 439
N D + I +LG+G FG VYK A +E + +KI SE+ L++ EI + S+
Sbjct: 2 NPNDIWEIIGELGDGAFGKVYK---AQHKETGLFAAAKIIQIESEEELEDFMVEIDILSE 58
Query: 440 LQHRNLVKLLGCCIHGEEKLLIY-EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARG 498
+H N+V L + E KL I EF +LDS + + ER L + ++
Sbjct: 59 CKHPNIVGLYEAYFY-ENKLWILIEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEA 115
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
L +LH ++IHRDLKA N+LL D + K++DFG++ A + + +GT +M
Sbjct: 116 LNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS-AKNKSTLQ-KRDTFIGTPYWM 170
Query: 559 APEYA-----SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG 613
APE D + K+D++S GI L+E+ + H + LN +R K+
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP----HHE--LNPMRVLLKILKSE 224
Query: 614 MPSQLIDACFKDSFN--LAEVIRCIHIGLLCVQQYPEDRP 651
P+ + + SFN L C+ + P+DRP
Sbjct: 225 PPTLDQPSKWSSSFNDFLKS----------CLVKDPDDRP 254
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 74/256 (28%), Positives = 117/256 (45%), Gaps = 38/256 (14%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVK--RLSKISEQGLKELKNEIILFSKLQHRN 444
++ +++G G FG V+ G +++++A+K R +SE+ E E + KL H
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE---EAQVMMKLSHPK 60
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ 504
LV+L G C L++EFM + L ++ Q + G+ YL
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLES 118
Query: 505 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMAPE 561
+ +IHRDL A N L+ ++ K+SDFG+ R D+ +T GT + +PE
Sbjct: 119 SN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPE 171
Query: 562 YASDGQFSVKSDVFSFGILLLEIVSGKK---------------NRGFYHSDNKL------ 600
S ++S KSDV+SFG+L+ E+ S K N GF +L
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVY 231
Query: 601 NLIRHAWKLWNEGMPS 616
L++H WK E PS
Sbjct: 232 ELMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 10/208 (4%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQE-IAVKR--LSKISEQGLKELKNEIILFSKLQHR 443
D++ + + +G G VY E +A+KR L K + EL+ E+ S+ H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHP 59
Query: 444 NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH 503
N+VK + G+E L+ ++ SL + LD + ++ +GL YLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 504 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTNRVVGTYGYMAPE 561
+ + IHRD+KA N+LL +D + KI+DFG++ + GGD T VGT +MAPE
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 562 YASDGQ-FSVKSDVFSFGILLLEIVSGK 588
+ K+D++SFGI +E+ +G
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 87/288 (30%), Positives = 135/288 (46%), Gaps = 53/288 (18%)
Query: 393 KKLGEGGFGPVYK---GTLADE--QEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVK 447
++LG+G FG V L D + +AVK+L + + L++ + EI + LQH N+VK
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 448 LLGCCIH-GEEKL-LIYEFMPNKSL-DSFIFDQERC---KLLDWSKRFHIICGTARGLLY 501
G C G L L+ E++P SL D +ER KLL ++ + IC +G+ Y
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ---IC---KGMEY 123
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG---TYGYM 558
L R +HRDL N+L++ + KI DFGL + D+ E R G + Y
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY- 178
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618
APE ++ +FSV SDV+SFG++L E+ F +SD + ++ Q+
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYEL--------FTYSDKSCSPPAEFMRMMGNDKQGQM 230
Query: 619 IDACFKDSFNLAEVIR----------C---IH-IGLLCVQQYPEDRPC 652
I ++L E+++ C I+ I C P RP
Sbjct: 231 I------VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 84/292 (28%), Positives = 129/292 (44%), Gaps = 46/292 (15%)
Query: 388 NFSINKKLGEGGFGPVYKGT------LADEQEIAVKRLSKISEQG-LKELKNEIILFSKL 440
N + K LGEG FG V K T A +AVK L + + L++L +E L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 441 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI---------------------FDQER 479
H +++KL G C LLI E+ SL SF+ D
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 480 CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539
+ L +RG+ YL + ++++HRDL A NVL+ + KISDFGL+R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 540 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK 599
+++ ++ +MA E D ++ +SDV+SFG+LL EIV+ N Y
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--YPGIAP 235
Query: 600 LNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
L + L G + + C ++ +NL L C +Q P+ RP
Sbjct: 236 ERL----FNLLKTGYRMERPENCSEEMYNLM---------LTCWKQEPDKRP 274
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 67/216 (31%), Positives = 95/216 (43%), Gaps = 46/216 (21%)
Query: 393 KKLGEGGFGPVYKGTLADEQEI-AVKRL-----SKISEQGLKELKNEIILFSKLQHRNLV 446
+LG G G V K +I AVK + I +Q L+EL IL K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD---ILH-KCNSPYIV 62
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRF------HIICGTARGLL 500
G + + + E+M SLD L + R I +GL
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKI--------LKEVQGRIPERILGKIAVAVLKGLT 114
Query: 501 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG--------LARAFGGDETEGNTNRVV 552
YLH + +IIHRD+K SN+L++ K+ DFG LA+ F V
Sbjct: 115 YLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF------------V 160
Query: 553 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
GT YMAPE +SVKSD++S G+ L+E+ +G+
Sbjct: 161 GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 395 LGEGGFGPVYKGTL------ADEQEIAVKRLSKISEQG-LKELKNEIILFSKLQHRNLVK 447
LG G FG V+ E + VK L K ++ E + E+ +F KL H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSFI------FDQERCKLLDWSKRFHIICGTARGLLY 501
LLG C E +I E+ L F+ ++ + L ++ + A G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 561
L S R +HRDL A N L+ K+S L++ E N ++ ++APE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188
Query: 562 YASDGQFSVKSDVFSFGILLLEIVS 586
+ FS KSDV+SFG+L+ E+ +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 72/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 389 FSINKKLGEGGFGPVYKGT-LADEQEIAVKRLS-KISEQGLKELKNEIILFSKLQHRNLV 446
F++ + +G+G FG VYK Q +A+K + + +E +++++ EI S+ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
K G + G + +I E+ S D + LD + I+ GL YLH++
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 566
IHRD+KA+N+LL ++ + K++DFG++ T N VGT +MAPE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLT--STMSKRNTFVGTPFWMAPEVIKQS 173
Query: 567 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDS 626
+ K+D++S GI +E+ G+ H L LI N P L F
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK-----NN--PPSLEGNKFSKP 226
Query: 627 FNLAEVIRCIHIGLLCVQQYPEDRP 651
F + + C+ + P++RP
Sbjct: 227 FK--DFVSL------CLNKDPKERP 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 70/248 (28%), Positives = 110/248 (44%), Gaps = 30/248 (12%)
Query: 388 NFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNEIILFSKLQHR 443
+F + + +G+G FG V D +++ A+K ++K + + ++ + NE + +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 444 NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI-----FDQERCKLLDWSKRFHIICGTARG 498
LV L E L+ + + L + F +E+ K IC
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF--------WICEIVLA 112
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
L YLH IIHRD+K N+LLD+ + I+DF +A D T GT GYM
Sbjct: 113 LEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYM 166
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF-YHSDNKLNLIRHAWK----LWNEG 613
APE +SV D +S G+ E + GK R + HS + IR + L+
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGK--RPYRGHSRTIRDQIRAKQETADVLYPAT 224
Query: 614 MPSQLIDA 621
++ IDA
Sbjct: 225 WSTEAIDA 232
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 7e-24
Identities = 87/270 (32%), Positives = 134/270 (49%), Gaps = 28/270 (10%)
Query: 385 ATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRN 444
++ + KKLG G FG V+ GT ++AVK L K + E + KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ 504
LV+L + E ++ E+M SL F+ D E + L + A G+ Y+
Sbjct: 63 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIE- 119
Query: 505 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY--GYMAPEY 562
R+ IHRDL+++N+L+ + KI+DFGLAR +E T R + + APE
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEA 174
Query: 563 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622
A G+F++KSDV+SFGILL E+V+ K R Y N ++ + + MP C
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVT--KGRVPYPGMNNREVLEQVERGYR--MP------C 224
Query: 623 FKDS-FNLAEVIRCIHIGLLCVQQYPEDRP 651
+D +L E++ L C ++ PE+RP
Sbjct: 225 PQDCPISLHELM------LQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 384 NATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKL-QH 442
+ T F + + +GEG +G VYK ++ ++ I E +E+K E + K H
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNH 62
Query: 443 RNLVKLLGC------CIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRF------H 490
N+ G + ++ L+ E S + D + L KR +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVK-GLRKKGKRLKEEWIAY 117
Query: 491 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 550
I+ T RGL YLH++ ++IHRD+K N+LL ++ K+ DFG++ D T G N
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNT 172
Query: 551 VVGTYGYMAPE-----YASDGQFSVKSDVFSFGILLLEIVSGK 588
+GT +MAPE D + +SDV+S GI +E+ GK
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 62/198 (31%), Positives = 103/198 (52%), Gaps = 7/198 (3%)
Query: 390 SINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKL 448
++ KLG G +G VY+G +AVK L K ++E E + +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 449 LGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRL 508
LG C +I EFM +L ++ + R + ++ ++ + + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 509 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF 568
IHRDL A N L+ ++ K++DFGL+R GD + + APE + +F
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKF 182
Query: 569 SVKSDVFSFGILLLEIVS 586
S+KSDV++FG+LL EI +
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 71/233 (30%), Positives = 117/233 (50%), Gaps = 27/233 (11%)
Query: 388 NFSINKKLGEGGFGPVYKG---TLADEQE---IAVKRLSKISEQGLKELKNEIILFSKLQ 441
N + ++LGEG FG V+ L EQ+ +AVK L S+ K+ E L + LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI----------FDQERCKLLDWSKRFHI 491
H ++VK G C+ G+ ++++E+M + L+ F+ + R L S+ HI
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 492 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 551
A G++YL + +HRDL N L+ +++ KI DFG++R D + RV
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRV 178
Query: 552 VG----TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKL 600
G +M PE +F+ +SDV+S G++L EI + K + S+N++
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 67/199 (33%), Positives = 106/199 (53%), Gaps = 15/199 (7%)
Query: 389 FSINKKLGEGGFGPVYKGTLADEQEIAVKRLS-KISEQGLKELKNEIILFSKLQHRNLVK 447
++ + +GEG FG V +G Q++AVK + ++ Q E E + +KL H+NLV+
Sbjct: 8 LTLGEIIGEGEFGAVLQGEYTG-QKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVR 63
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSR 507
LLG +H ++ E M +L +F+ + R L+ + A G+ YL
Sbjct: 64 LLGVILH-NGLYIVMELMSKGNLVNFLRTRGRA-LVSVIQLLQFSLDVAEGMEYLESK-- 119
Query: 508 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ 567
+++HRDL A N+L+ +D K+SDFGLAR + G N + + APE +
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPV-KWTAPEALKHKK 173
Query: 568 FSVKSDVFSFGILLLEIVS 586
FS KSDV+S+G+LL E+ S
Sbjct: 174 FSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 28/207 (13%)
Query: 395 LGEGGFGPVYKGTLADEQE-IAVKRLS-----KISEQGLKELKNEIILFSKLQHRNLVKL 448
LG G FG VY+G D+ + AVK +S + ++ +K+L+ EI L SKLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 449 LGCCIHGEEKLLIY-EFMPNKSLDSFI-----FDQERCKLLDWSKRFHIICGTARGLLYL 502
LG E+ L I+ E +P SL + F + +L ++++ GL YL
Sbjct: 68 LGT-EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL--YTRQI------LLGLEYL 118
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562
H +HRD+K +N+L+D + K++DFG+A+ G+ +MAPE
Sbjct: 119 HDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEV 172
Query: 563 -ASDGQFSVKSDVFSFGILLLEIVSGK 588
A G + + +D++S G +LE+ +GK
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 65/205 (31%), Positives = 87/205 (42%), Gaps = 21/205 (10%)
Query: 393 KKLGEGGFGPVYKGT----LADEQEIAVKRLSKISEQG-LKELKNEIILFSKLQHRNLVK 447
KKLG+G FG V +G +AVK L + + E + L H NL++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICG----TARGLLYLH 503
L G + + + E P SL D+ R L +C A G+ YL
Sbjct: 61 LYGVVLTHPLMM-VTELAPLGSL----LDRLRKDALG-HFLISTLCDYAVQIANGMRYLE 114
Query: 504 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTNRVVGTYGYMAPE 561
R IHRDL A N+LL D KI DFGL RA D + V + + APE
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPE 170
Query: 562 YASDGQFSVKSDVFSFGILLLEIVS 586
FS SDV+ FG+ L E+ +
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 63/215 (29%), Positives = 121/215 (56%), Gaps = 12/215 (5%)
Query: 376 LFELATIANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELK-NE 433
L + ++ + ++ +K+G+G G VY +A QE+A+K+++ + +Q KEL NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINE 66
Query: 434 IILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIIC 493
I++ + +H N+V L + G+E ++ E++ SL + E C +D + +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETC--MDEGQIAAVCR 122
Query: 494 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 553
+ L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ +T +VG
Sbjct: 123 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 554 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
T +MAPE + + K D++S GI+ +E+V G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 20/209 (9%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKN----EIILFSKL 440
NF I KK+G+G F VYK L D + +A+K++ +I E + + EI L +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKV-QIFEMMDAKARQDCLKEIDLLKQL 59
Query: 441 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI-FDQERCKLLD----WSKRFHIICGT 495
H N++K L I E ++ E L I +++ +L+ W K F +C
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW-KYFVQLC-- 116
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 555
L ++H RI+HRD+K +NV + K+ D GL R F T ++ +VGT
Sbjct: 117 -SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 170
Query: 556 GYMAPEYASDGQFSVKSDVFSFGILLLEI 584
YM+PE + ++ KSD++S G LL E+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 64/205 (31%), Positives = 108/205 (52%), Gaps = 11/205 (5%)
Query: 388 NFSINKKLGEGGFGPVYK-GTLADEQEIAVKR--LSKISEQGLKELKNEIILFSKLQHRN 444
+F + KKLG+G +G VYK L+D Q A+K L +S++ ++ NEI + + + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERC-KLLDWSKRFHIICGTARGLLYLH 503
++ + G + ++ E+ P L I +++ KL+ + + I RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 504 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 563
+ +I+HRDLK++N+LL + KI D G+++ + +GT YMAPE
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVW 173
Query: 564 SDGQFSVKSDVFSFGILLLEIVSGK 588
+S KSD++S G LL E+ +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 45/221 (20%)
Query: 395 LGEGGFGPVYKGTLADEQE-IAVKRL---SKISEQG-------LKELKNEIILFSKLQHR 443
+G+G +G VY E +AVK++ + I+ + +K L++EI L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 444 NLVKLLGCCIHGEEKLLIY----EFMPNKSLDSFI-----FDQERCKLLDWSKRFHIICG 494
N+V+ LG E E++P S+ S + F+++ +
Sbjct: 69 NIVQYLGF----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR--------FFTEQ 116
Query: 495 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR----AFGGDETEGNTNR 550
GL YLH I+HRDLKA N+L+D D KISDFG+++ + D+
Sbjct: 117 VLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ----NMS 169
Query: 551 VVGTYGYMAPEY-ASDGQ-FSVKSDVFSFGILLLEIVSGKK 589
+ G+ +MAPE S Q +S K D++S G ++LE+ +G++
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 3e-23
Identities = 67/214 (31%), Positives = 106/214 (49%), Gaps = 32/214 (14%)
Query: 395 LGEGGFGPVYKGTLADEQEI-AVKR--LSKISEQG-------LKELKNEIILFSKLQHRN 444
+G G FG VY G A E+ AVK+ L +S L L EI L +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRF------HIICGTARG 498
+V+ LG + + + E++P S+ + LL+ F + + +G
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAA---------LLNNYGAFEETLVRNFVRQILKG 118
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG--NTNR--VVGT 554
L YLH IIHRD+K +N+L+D KISDFG+++ + N R + G+
Sbjct: 119 LNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 555 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
+MAPE ++ K+D++S G L++E+++GK
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 3e-23
Identities = 67/202 (33%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLG 450
K+LG G FG V+ G + ++A+K + + +SE E E + KL H NLV+L G
Sbjct: 10 KELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE---EAKVMMKLSHPNLVQLYG 66
Query: 451 CCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRI 510
C ++ E+M N L +++ +ER L + + YL +
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---F 121
Query: 511 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMAPEYASDGQ 567
IHRDL A N L+ +D K+SDFGLAR D+ + GT + PE +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSR 177
Query: 568 FSVKSDVFSFGILLLEIVSGKK 589
FS KSDV+SFG+L+ E+ S K
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 67/204 (32%), Positives = 112/204 (54%), Gaps = 20/204 (9%)
Query: 393 KKLGEGGFGPVYKGTLADEQE-----IAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLV 446
K LG G FG VYKG E E +A+K L++ + + E +E ++ + + H +LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQE----RCKLLDWSKRFHIICGTARGLLYL 502
+LLG C+ +L + + MP+ L ++ + + LL+W + A+G++YL
Sbjct: 73 RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 125
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562
+ R++HRDL A NVL+ + KI+DFGLAR GDE E N + +MA E
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 563 ASDGQFSVKSDVFSFGILLLEIVS 586
+F+ +SDV+S+G+ + E+++
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 4e-23
Identities = 67/205 (32%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 395 LGEGGFGPVYKGTLADEQ-EIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCI 453
LG+G +G VY Q IA+K + + + ++ L EI L S L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 454 HGEEKLLIYEFMPNKSLDSFIFDQERCKLLDW----SKRFHIICGTAR---GLLYLHQDS 506
+ E +P SL + + R K W II T + GL YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALL----RSK---WGPLKDNEQTIIFYTKQILEGLKYLHD-- 126
Query: 507 RLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD 565
+I+HRD+K NVL++ KISDFG ++ G T GT YMAPE
Sbjct: 127 -NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDK 183
Query: 566 GQ--FSVKSDVFSFGILLLEIVSGK 588
G + +D++S G ++E+ +GK
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 5e-23
Identities = 76/209 (36%), Positives = 102/209 (48%), Gaps = 28/209 (13%)
Query: 393 KKLGEGGFGPV----YKGTLADEQE-IAVKRLSKISEQGLKE-LKNEIILFSKLQHRNLV 446
+ LGEG FG V Y E +AVK L + Q K EI + L H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 447 KLLGCCIHGEEK--LLIYEFMPNKSLDSFIFDQE--RCKLLDWSKRFHIICGTARGLLYL 502
K GCC K LI E++P SL ++ + +LL ++++ IC G+ YL
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ---IC---EGMAYL 123
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG-----Y 557
H IHRDL A NVLLD D KI DFGLA+A EG+ V G +
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVFW 176
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVS 586
A E + +FS SDV+SFG+ L E+++
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 393 KKLGEGGFGPVYKGT-LADEQEIAVKRLS--KISEQGLKELKNEIILFSKLQHRNLVKLL 449
+ +G+G FG V K +D + + K + ++E+ ++L +E+ + +L+H N+V+
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 450 GCCIHGEEKLLIY---EFMPNKSLDSFIFDQERCK----LLDWSKRFHIICGTARGLLYL 502
I +Y E+ L I ++CK ++ + I+ L
Sbjct: 66 DR-IIDRSNQTLYIVMEYCEGGDLAQLI---QKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 503 H--QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 560
H D ++HRDLK +N+ LD + N K+ DFGLA+ G D + T VGT YM+P
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSP 179
Query: 561 EYASDGQFSVKSDVFSFGILLLEIVSGK 588
E + + KSD++S G L+ E+ +
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 6e-23
Identities = 72/235 (30%), Positives = 120/235 (51%), Gaps = 26/235 (11%)
Query: 393 KKLGEGGFGPVYKGTL------ADEQEIAVKRLSKISEQGLKE-LKNEIILFSKLQHRNL 445
++LGE FG VYKG L Q +A+K L +E L+E K+E ++ S+LQH N+
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIF-------------DQERCKLLDWSKRFHII 492
V LLG + +I+ + + L F+ D+ L+ + HI+
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGDETEGNTNRV 551
A G+ +L S ++H+DL NVL+ +N KISD GL R + D + N +
Sbjct: 131 TQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187
Query: 552 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRH 605
+ +M+PE G+FS+ SD++S+G++L E+ S G + Y + + + +IR+
Sbjct: 188 LPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 8e-23
Identities = 75/277 (27%), Positives = 120/277 (43%), Gaps = 47/277 (16%)
Query: 393 KKLGEGGFGPVYKGTLADEQEI-AVK--RLSKISEQGLKELKNEIILFSKLQHRNLVKLL 449
K+G G FG VY D E+ AVK R+ + +KE+ +E+ + L+H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 450 GCCIHGEEKLLIYEFMPNKSLDSFI----FDQERC------KLLDWSKRFHIICGTARGL 499
G +H E+ + E+ +L+ + E +LL GL
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLL-------------EGL 112
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE--GNTNRVVGTYGY 557
YLH I+HRD+K +N+ LD + K+ DFG A + T + GT Y
Sbjct: 113 AYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAY 169
Query: 558 MAPEYASDGQFSVK---SDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM 614
MAPE + G+ +D++S G ++LE+ +GK R + DN+ ++ H G
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK--RPWSELDNEFQIMFHV----GAGH 223
Query: 615 PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
+ D+ E + C++ P+ RP
Sbjct: 224 KPPIPDSLQLSP----EGKDFLD---RCLESDPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 76/275 (27%), Positives = 131/275 (47%), Gaps = 40/275 (14%)
Query: 393 KKLGEGGFGPVYK------GTLADEQEIAVKRLSKISEQG--LKELKNEIILFSKLQHRN 444
++LG G F Y+ GTL +++ R + SEQ ++ L+ EI L ++L H +
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS-SEQEEVVEALRKEIRLMARLNHPH 64
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ 504
++++LG L E+M S+ + K + RGL YLH+
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL---RGLSYLHE 121
Query: 505 DSRLRIIHRDLKASNVLLD---QDMNPKISDFGLA-----RAFGGDETEGNTNRVVGTYG 556
+ +IIHRD+K +N+L+D Q + +I+DFG A + G E +G +++GT
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQG---QLLGTIA 173
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616
+MAPE Q+ DV+S G +++E+ + K N L LI +K+ +
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKIASATTAP 230
Query: 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
+ + +L+ +R + L C++ PEDRP
Sbjct: 231 SIPE-------HLSPGLR--DVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-22
Identities = 75/269 (27%), Positives = 143/269 (53%), Gaps = 27/269 (10%)
Query: 376 LFELATIANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELK-NE 433
L + +I + ++ +K+G+G G V+ +A QE+A+K+++ + +Q KEL NE
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN-LQKQPKKELIINE 66
Query: 434 IILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIIC 493
I++ +L++ N+V L + G+E ++ E++ SL + E C +D ++ +
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV--TETC--MDEAQIAAVCR 122
Query: 494 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 553
+ L +LH + ++IHRD+K+ NVLL D + K++DFG ++++ +T +VG
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 554 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG 613
T +MAPE + + K D++S GI+ +E+V G+ Y ++N L R + + G
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP---YLNENPL---RALYLIATNG 231
Query: 614 MPS----QLIDACFKDSFNLAEVIRCIHI 638
P + + F+D N RC+ +
Sbjct: 232 TPELQNPEKLSPIFRDFLN-----RCLEM 255
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 64/228 (28%), Positives = 108/228 (47%), Gaps = 33/228 (14%)
Query: 387 DNFSINKKLGEGGFGPVYK----GTLADEQE--IAVKRLSK-ISEQGLKELKNEIILFSK 439
+N + +G+G FG V++ G L E +AVK L + S + + E L ++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI--------------------FDQER 479
H N+VKLLG C G+ L++E+M L+ F+
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 480 CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-A 538
L +++ I A G+ YL S + +HRDL N L+ ++M KI+DFGL+R
Sbjct: 125 LPL-SCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 539 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+ D + + N + +M PE +++ +SDV+++G++L EI S
Sbjct: 181 YSADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 395 LGEGGFGPVYKGTLAD----EQEIAVKRLSKISE-QGLKELKNEIILFSKLQHRNLVKLL 449
+G+G FG VY GTL D + AVK L++I++ + +++ E I+ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 450 GCCIHGE-EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRL 508
G C+ E L++ +M + L +FI + + F + A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLASK--- 117
Query: 509 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY--GYMAPEYASDG 566
+ +HRDL A N +LD+ K++DFGLAR E N +MA E
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 567 QFSVKSDVFSFGILLLEIVS 586
+F+ KSDV+SFG+LL E+++
Sbjct: 178 KFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 67/202 (33%), Positives = 107/202 (52%), Gaps = 11/202 (5%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
++ + KLG+G FG V+ GT +A+K L K + E + KL+H LV
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 64
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+L + E ++ E+M SL F+ E K L + + A G+ Y+
Sbjct: 65 QLYAV-VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 119
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY--GYMAPEYAS 564
R+ +HRDL+A+N+L+ +++ K++DFGLAR +E T R + + APE A
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 176
Query: 565 DGQFSVKSDVFSFGILLLEIVS 586
G+F++KSDV+SFGILL E+ +
Sbjct: 177 YGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 72/270 (26%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 395 LGEGGFGP--VYKGTLADEQEIAVKR--LSKISEQGLKELKNEIILFSKLQHRNLVKLLG 450
LG+G FG +Y+ T D+ + K L+++SE+ ++ NEI++ S LQH N++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 451 CCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRI 510
+ L+ E+ +L I Q+ +L + + + Y+H+ I
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKG-QLFEEEMVLWYLFQIVSAVSYIHKAG---I 122
Query: 511 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSV 570
+HRD+K N+ L + K+ DFG+++ G + + T VVGT YM+PE +++
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKYNF 180
Query: 571 KSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLA 630
KSD+++ G +L E+++ K+ + + N LNL+ K+ Q ++ +
Sbjct: 181 KSDIWALGCVLYELLTLKRT---FDATNPLNLV---VKI------VQGNYTPVVSVYS-S 227
Query: 631 EVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
E+I +H +QQ PE RP V+
Sbjct: 228 ELISLVH---SLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 71/206 (34%), Positives = 104/206 (50%), Gaps = 25/206 (12%)
Query: 394 KLGEGGFGPVYKG-TLADEQEIAVK--RLSKISEQGLKELKNEIILFSKLQHRNLVKLLG 450
K+GEG +G VYK + +A+K RL E EI L +L H N+V+LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 451 CCIHGEEKL-LIYEFMP---NKSLDS---FIFDQERCKLLDWSKRFHIICGTARGLLYLH 503
+H E KL L++EF+ K +DS D K + + +G+ Y H
Sbjct: 66 V-VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIK-----SYLYQLL---QGIAYCH 116
Query: 504 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 563
R++HRDLK N+L+D++ K++DFGLARAF G T+ VV T Y APE
Sbjct: 117 SH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 171
Query: 564 SDG-QFSVKSDVFSFGILLLEIVSGK 588
Q+S D++S G + E+V+ +
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 77/235 (32%), Positives = 123/235 (52%), Gaps = 23/235 (9%)
Query: 393 KKLGEGGFGPVYKG-TLADEQEIAVKRLSKISE-QGLKELK-NEIILFSKLQHRNLVKLL 449
+K+GEG +G VYKG Q +A+K++ SE +G+ EI L +LQH N+V L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 450 GCCIHGEEKL-LIYEFMP---NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD 505
+ E +L LI+EF+ K LDS Q L S + I+ +G+L+ H
Sbjct: 66 DV-LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCH-- 118
Query: 506 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD 565
R++HRDLK N+L+D K++DFGLARAF G T+ VV T Y APE
Sbjct: 119 -SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLG 175
Query: 566 GQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619
+S D++S G + E+ + + +H D++++ + +++ G P++ +
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMAT---KKPLFHGDSEIDQLFRIFRIL--GTPTEDV 225
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 67/212 (31%), Positives = 109/212 (51%), Gaps = 21/212 (9%)
Query: 388 NFSINKKLGEGGFGPVYKGTLADE-QEIAVKR-----LSKISEQGLKELKNEIILFSKLQ 441
N+ K LG+G FG VY D +E+AVK+ S +++ + L+ EI L LQ
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 442 HRNLVKLLGCCIHGEEKLLIY-EFMPNKSLDSFIFDQERCKLLDWSKR---FHIICGTAR 497
H +V+ G C+ +E L I+ E+MP S+ + + L + R I+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQIL----E 115
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR-VVGTYG 556
G+ YLH + I+HRD+K +N+L D N K+ DFG ++ + G + V GT
Sbjct: 116 GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
+M+PE S + K+DV+S G ++E+++ K
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 5e-22
Identities = 77/281 (27%), Positives = 133/281 (47%), Gaps = 40/281 (14%)
Query: 393 KKLGEGGFGPVYKGTLA----DEQEIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLVK 447
K +G G FG V++G L E +A+K L +E+ ++ +E + + H N+++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWS--KRFHIICGTARGLLYLHQD 505
L G + ++I E+M N +LD ++ D + ++S + ++ G A G+ YL
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYL--- 123
Query: 506 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG--YMAPEYA 563
S + +HRDL A N+L++ ++ K+SDFGL+R D+ EG G + APE
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 564 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623
+ +F+ SDV+SFGI++ E++S + R W + N +
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGE--------------RPYWDMSN-----HEVMKAI 223
Query: 624 KDSFNLAEVIRC----IHIGLLCVQQYPEDRPCMPSVILML 660
D F L + C + L C QQ RP ++ +L
Sbjct: 224 NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 6e-22
Identities = 65/194 (33%), Positives = 102/194 (52%), Gaps = 9/194 (4%)
Query: 395 LGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLK-ELKNEIILFSKLQHRNLVKLLGCCI 453
LG+G FG V+KGTL D+ +AVK + Q LK + +E + + H N+VKL+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 454 HGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHR 513
+ ++ E +P SF+ +++ L + A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 514 DLKASNVLLDQDMNPKISDFGLARAF-GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKS 572
DL A N L+ ++ KISDFG++R G + ++ + APE + G++S +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175
Query: 573 DVFSFGILLLEIVS 586
DV+S+GILL E S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-22
Identities = 35/88 (39%), Positives = 48/88 (54%), Gaps = 10/88 (11%)
Query: 213 CVRDKSLNYSREDGFIKFTAMKLPDATPSWVSKSMNLKECREKCLENSSCMAYTNSDIRG 272
C D S DGF+K +KLPD + +++L+ECRE CL N SC AY ++
Sbjct: 5 CGGDGS-----TDGFLKLPDVKLPDN--ASAITAISLEECREACLSNCSCTAYAYNN--- 54
Query: 273 GGSGCAMWFGELIDMRDFPDGGQDLYIR 300
G GC +W G L ++R GG LY+R
Sbjct: 55 GSGGCLLWNGLLNNLRSLSSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 7e-22
Identities = 74/269 (27%), Positives = 142/269 (52%), Gaps = 27/269 (10%)
Query: 376 LFELATIANATDNFSINKKLGEGGFGPVYKG-TLADEQEIAVKRLSKISEQGLKELK-NE 433
L + ++ + ++ +K+G+G G VY +A QE+A+K+++ + +Q KEL NE
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN-LQQQPKKELIINE 66
Query: 434 IILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIIC 493
I++ + ++ N+V L + G+E ++ E++ SL + E C +D + +
Sbjct: 67 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETC--MDEGQIAAVCR 122
Query: 494 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 553
+ L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ +T +VG
Sbjct: 123 ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 554 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG 613
T +MAPE + + K D++S GI+ +E+V G+ Y ++N L R + + G
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP---YLNENPL---RALYLIATNG 231
Query: 614 MPS----QLIDACFKDSFNLAEVIRCIHI 638
P + + A F+D N RC+ +
Sbjct: 232 TPELQNPERLSAVFRDFLN-----RCLEM 255
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 9e-22
Identities = 70/202 (34%), Positives = 109/202 (53%), Gaps = 11/202 (5%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
++ ++ KLG+G FG V+ GT ++A+K L K + E + KL+H LV
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLV 64
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
L + E ++ EFM SL F+ + + K L + + A G+ Y+
Sbjct: 65 PLYAV-VSEEPIYIVTEFMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIE--- 119
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY--GYMAPEYAS 564
R+ IHRDL+A+N+L+ ++ KI+DFGLAR +E T R + + APE A
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 176
Query: 565 DGQFSVKSDVFSFGILLLEIVS 586
G+F++KSDV+SFGILL E+V+
Sbjct: 177 YGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 57/178 (32%), Positives = 90/178 (50%), Gaps = 12/178 (6%)
Query: 388 NFSINKKLGEGGFGPVYKGT-LADEQEIAVKR--LSKISEQGLKELKNEIILFSKLQHRN 444
+ I ++GEG G V+K + +A+K+ L ++ + EI QH
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRF-HIICGTARGLLYLH 503
+VKLL HG +L+ E+MP+ L + D+ER K + ++ +G+ Y+H
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMH 116
Query: 504 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 561
I+HRDLK +N+L+ D KI+DFGLAR F +E +++ V T Y APE
Sbjct: 117 A---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 65/202 (32%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 395 LGEGGFGPVYKGTLADEQEI-AVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLG 450
LG+GGFG V + ++ A K+L K +G + NE + K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 451 CCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFH---IICGTARGLLYLHQDS 506
++ L L+ M L I++ + F+ IICG L +LHQ
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ-- 113
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 566
RI++RDLK NVLLD N +ISD GLA G + GT GYMAPE
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGE 169
Query: 567 QFSVKSDVFSFGILLLEIVSGK 588
+ D F+ G L E+++G+
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 68/213 (31%), Positives = 108/213 (50%), Gaps = 25/213 (11%)
Query: 384 NATDNFSINKKLGEGGFGPVYK------GTLADEQEIAVKRLSKISEQGLKELKNEIILF 437
+ + + I +LG+G FG VYK G LA + I K SE+ L++ EI +
Sbjct: 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEIL 63
Query: 438 SKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA- 496
+ H +VKLLG + ++ EF P ++D+ + + +R + +IC
Sbjct: 64 ATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQML 120
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
L YLH ++IIHRDLKA NVLL D + K++DFG++ +T + +GT
Sbjct: 121 EALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAK--NVKTLQRRDSFIGTPY 175
Query: 557 YMAPEYA-----SDGQFSVKSDVFSFGILLLEI 584
+MAPE D + K+D++S GI L+E+
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 70/211 (33%), Positives = 104/211 (49%), Gaps = 31/211 (14%)
Query: 393 KKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKN-----EIILFSKLQHRNLV 446
KKLGEG + VYK + +A+K++ + K+ N EI L +L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLL-DWSKRF---HIIC---GTARGL 499
LL H L++EFM D E K++ D S I T RGL
Sbjct: 66 GLLDVFGHKSNINLVFEFMET--------DLE--KVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 559
YLH I+HRDLK +N+L+ D K++DFGLAR+FG + T++VV T Y A
Sbjct: 116 EYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-MTHQVV-TRWYRA 170
Query: 560 PE--YASDGQFSVKSDVFSFGILLLEIVSGK 588
PE + + + V D++S G + E++
Sbjct: 171 PELLFGAR-HYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 64/210 (30%), Positives = 108/210 (51%), Gaps = 25/210 (11%)
Query: 391 INKKLGEGGFGPVYKGTLA----DEQEIAVKRL-SKISEQGLKELKNEIILFSKLQHRNL 445
I + +G G FG V +G L E +A+K L S +E+ ++ +E + + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIIC------GTARGL 499
+ L G ++I EFM N +LDSF+ + +F +I G A G+
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQND--------GQFTVIQLVGMLRGIAAGM 119
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG---TYG 556
YL S + +HRDL A N+L++ ++ K+SDFGL+R D ++ +G
Sbjct: 120 KYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+ APE + +F+ SDV+S+GI++ E++S
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 67/226 (29%), Positives = 109/226 (48%), Gaps = 30/226 (13%)
Query: 391 INKKLGEGGFGPVYKGT------LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRN 444
+ ++LGEG FG V+ D+ +AVK L + K+ + E L + LQH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSF----------IFDQERCKL---LDWSKRFHI 491
+VK G C G+ ++++E+M + L+ F + D + + L S+ HI
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 492 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 551
A G++YL + +HRDL N L+ ++ KI DFG++R D + RV
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRV 181
Query: 552 VG----TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 593
G +M PE +F+ +SDV+SFG++L EI + K F
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 74/211 (35%), Positives = 114/211 (54%), Gaps = 23/211 (10%)
Query: 388 NFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQGLKELK-NEIILFSKLQHRNL 445
NF +KLGEG + VYKG EI A+K + +E+G EI L +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 446 VKLLGCCIHGEEKL-LIYEFMPN---KSLDSFIFDQERCKL-LDWSKRFHIICGTARGLL 500
V+L IH E KL L++E+M K +D+ R L + K F +G+
Sbjct: 61 VRLHDV-IHTENKLMLVFEYMDKDLKKYMDTH---GVRGALDPNTVKSF--TYQLLKGIA 114
Query: 501 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT--NRVVGTYGYM 558
+ H++ R++HRDLK N+L+++ K++DFGLARAFG NT N VV T Y
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVV-TLWYR 167
Query: 559 APEYASDGQ-FSVKSDVFSFGILLLEIVSGK 588
AP+ + +S D++S G ++ E+++G+
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 71/226 (31%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 388 NFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLS---KISEQGLKELKNEIILFSKLQHR 443
NF I KK+G G F VY+ T L D + +A+K++ + + ++ EI L +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 444 NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI--FDQERCKLLD----WSKRFHIICGTAR 497
N++K L I E ++ E L I F +++ +L+ W K F +C
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQK-RLIPERTVW-KYFVQLCSAVE 120
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 557
H SR R++HRD+K +NV + K+ D GL R F T ++ +VGT Y
Sbjct: 121 -----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLI 603
M+PE + ++ KSD++S G LL E+ + + FY +K+NL
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FY--GDKMNLF 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 82/291 (28%), Positives = 131/291 (45%), Gaps = 60/291 (20%)
Query: 397 EGGFGPVYKGTLAD-----EQEIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLVKLLG 450
EG FG ++ G L D E+E+ VK + SE + L E L L H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 451 CCIHGEEK-LLIYEFMPNKSLDSFIFDQERCKLLDWSKR--------FHIICGTARGLLY 501
CI E ++Y +M +L F+ ++C+L + + H+ A G+ Y
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFL---QQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGD-ETEG-NTNRVVGTYGYM 558
LH + +IH+D+ A N ++D+++ KI+D L+R F D G N NR V +M
Sbjct: 133 LH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV---KWM 186
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618
A E + ++S SDV+SFG+LL E+++ + P
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMTLGQ------------------------TPYVE 222
Query: 619 ID-----ACFKDSFNLAEVIRC----IHIGLLCVQQYPEDRPCMPSVILML 660
ID A KD + LA+ I C + C PE+RP ++ L
Sbjct: 223 IDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-21
Identities = 67/211 (31%), Positives = 109/211 (51%), Gaps = 21/211 (9%)
Query: 384 NATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKI----SEQGLKELKNEIILFSK 439
N + + I +LG+G FG VYK A +E V +K+ SE+ L++ EI + +
Sbjct: 2 NPEEFWEIIGELGDGAFGKVYK---AQNKETGVLAAAKVIDTKSEEELEDYMVEIDILAS 58
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICG-TARG 498
H N+VKLL + ++ EF ++D+ + + ER + ++C T
Sbjct: 59 CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEA 115
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
L YLH++ +IIHRDLKA N+L D + K++DFG++ T + +GT +M
Sbjct: 116 LNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWM 170
Query: 559 APEY-----ASDGQFSVKSDVFSFGILLLEI 584
APE + D + K+DV+S GI L+E+
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 92.9 bits (230), Expect = 1e-20
Identities = 71/269 (26%), Positives = 141/269 (52%), Gaps = 27/269 (10%)
Query: 376 LFELATIANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELK-NE 433
L + ++ + ++ +K+G+G G VY +A QE+A+++++ + +Q KEL NE
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINE 67
Query: 434 IILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIIC 493
I++ + ++ N+V L + G+E ++ E++ SL + E C +D + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETC--MDEGQIAAVCR 123
Query: 494 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 553
+ L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ + +VG
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVG 178
Query: 554 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG 613
T +MAPE + + K D++S GI+ +E++ G+ Y ++N L R + + G
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP---YLNENPL---RALYLIATNG 232
Query: 614 MPS----QLIDACFKDSFNLAEVIRCIHI 638
P + + A F+D N RC+ +
Sbjct: 233 TPELQNPEKLSAIFRDFLN-----RCLDM 256
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 34/213 (15%)
Query: 395 LGEGGFGPVYKGTLADEQEIAVKRLS------KISEQGLKELKNEIILFSKLQHRNLVKL 448
LG+G +G VY G Q IAVK++ +E+ ++L+ E+ L L+H N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 449 LGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFH-----IICGTAR----GL 499
LG C+ + EF+P S+ S + RF + C + G+
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSIL------------NRFGPLPEPVFCKYTKQILDGV 115
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF---GGDETEGNTNRVV-GTY 555
YLH + ++HRD+K +NV+L + K+ DFG AR G T N + + GT
Sbjct: 116 AYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172
Query: 556 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
+MAPE ++ + KSD++S G + E+ +GK
Sbjct: 173 YWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 28/221 (12%)
Query: 391 INKKLGEGGFGPV----------YKGTLADEQE-----IAVKRL-SKISEQGLKELKNEI 434
+ +KLGEG FG V + G A E + +AVK L + +++ + EI
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 435 ILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQE-RCKL--------LDW 485
+ S+L++ N+++LLG C+ + +I E+M N L+ F+ +E +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 486 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545
+ ++ A G+ YL + L +HRDL N L+ KI+DFG++R +
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
R V +MA E G+F+ SDV++FG+ L E+ +
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRL------SKISEQGLKELKNEIILFSKL 440
+ +LGEG G V K L + I + + +Q L+EL+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE----INKSC 56
Query: 441 QHRNLVKLLGCCI--HGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRF--HIICGTA 496
+ +VK G + + E+ SLDS I+ + + + ++ I
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
+GL YLH +IIHRD+K SN+LL + K+ DFG++ G+ GT
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSF 168
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
YMAPE +S+ SDV+S G+ LLE+ +
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 65/223 (29%), Positives = 109/223 (48%), Gaps = 20/223 (8%)
Query: 378 ELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILF 437
+L+ + + F + + +G G +G VYKG ++A ++ ++E +E+K EI +
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66
Query: 438 SKL-QHRNLVKLLGCCI------HGEEKLLIYEFMPNKSLDSFIFDQE-RCKLLDWSKRF 489
K HRN+ G I H ++ L+ EF S+ + + + DW
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA-- 124
Query: 490 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 549
+I RGL +LH ++IHRD+K NVLL ++ K+ DFG++ D T G N
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRN 179
Query: 550 RVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSG 587
+GT +MAPE + D + +SD++S GI +E+ G
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 393 KKLGEGGFGPVYKGTL-----ADEQEIAVKRLSKISE-QGLKELKNEIILFSKLQHRNLV 446
++LGE FG +YKG L Q +A+K L I+ Q E + E L ++L H N+V
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIF--------------DQERCKLLDWSKRFHII 492
LLG + +++E++ L F+ D LD HI
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGDETEGNTNRV 551
A G+ YL S +H+DL A N+L+ + ++ KISD GL+R + D +
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 552 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+ +M PE G+FS SD++SFG++L EI S
Sbjct: 188 LPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 25/209 (11%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADE----QEIAVKRLSKISEQGLKELKNEIILFSKLQH 442
DNF K+GEG G V +A + +++AVK++ +Q + L NE+++ QH
Sbjct: 22 DNF---VKIGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH 75
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIIC-GTARGLLY 501
N+V++ + G+E ++ EF+ +L I R ++ +C + L +
Sbjct: 76 PNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMN----EEQIATVCLAVLKALSF 130
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR--VVGTYGYMA 559
LH +IHRD+K+ ++LL D K+SDFG F ++ R +VGT +MA
Sbjct: 131 LHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMA 183
Query: 560 PEYASDGQFSVKSDVFSFGILLLEIVSGK 588
PE S + + D++S GI+++E+V G+
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 37/230 (16%)
Query: 385 ATDNFSINKKLGEGGFGPVYKG-TLADEQEIAVKRLSKISEQGLKEL-----KNEIILFS 438
++ I KLGEG FG VYK + + +A+K++ +E K+ EI +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE---KDGFPITALREIKILK 62
Query: 439 KLQHRNLVKLLGCCI-----HGEEKLLIYEFMPNKSLD-SFIFDQERCKLLDWSKRFHII 492
KL+H N+V L+ + ++ +Y P D S + + KL I
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKL----TESQIK 118
Query: 493 CGTAR---GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF---------- 539
C + G+ YLH++ I+HRD+KA+N+L+D KI+DFGLAR +
Sbjct: 119 CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 540 GGDETEGNTNRVVGTYGYMAPEY-ASDGQFSVKSDVFSFGILLLEIVSGK 588
GG T TN VV T Y PE + +++ D++ G + E+ + +
Sbjct: 176 GGGGTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 5e-20
Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 385 ATDNFSINKKLGEGGFGPVY----KGTLADEQE--IAVKRLSKISEQGLK-ELKNEIILF 437
A + +++++LG+G FG VY KG + DE E +A+K +++ + + E NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 438 SKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIF----DQERCKLL---DWSKRFH 490
+ ++V+LLG G+ L+I E M L S++ + E + K
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 491 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 550
+ A G+ YL+ + + +HRDL A N ++ +D KI DFG+ R + +
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 551 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+ +M+PE DG F+ SDV+SFG++L EI +
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 73/209 (34%), Positives = 110/209 (52%), Gaps = 19/209 (9%)
Query: 388 NFSINKKLGEGGFGPVYKG-TLADEQEIAVK--RLSKISEQGLKELKNEIILFSKLQHRN 444
NF +K+GEG +G VYK + +A+K RL +E EI L +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 445 LVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKL---LDWSKRFHIICGTARGLL 500
+VKLL IH E KL L++EF+ ++ L F+ + L S F ++ +GL
Sbjct: 61 IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLL----QGLA 114
Query: 501 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 560
+ H R++HRDLK N+L++ + K++DFGLARAF G T+ VV T Y AP
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAP 169
Query: 561 EYASDGQF-SVKSDVFSFGILLLEIVSGK 588
E ++ S D++S G + E+V+ +
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 73/214 (34%), Positives = 108/214 (50%), Gaps = 26/214 (12%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQE-IAVK--RLSKISEQGLKELKNEIILFSKLQHR 443
D + +K+GEG +G VYK E IA+K RL + E EI L ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 444 NLVKLLGCCIHGEEKL-LIYEFMP---NKSLDS---FIFDQERCKLLDWSKRFHIICGTA 496
N+V+L +H E++L L++E++ K +DS F + K +
Sbjct: 62 NIVRLQDV-VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ--------IL 112
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTNRVVGTY 555
RG+ Y H R++HRDLK N+L+D+ N K++DFGLARAF G T+ VV T
Sbjct: 113 RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TL 167
Query: 556 GYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 588
Y APE +S D++S G + E+V+ K
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 7e-20
Identities = 73/286 (25%), Positives = 129/286 (45%), Gaps = 50/286 (17%)
Query: 390 SINKKLGEGGFGPVYKGTLADEQEI---AVK--RLSKISEQGLKELKNEIILFSKLQHRN 444
++ K LGEG FG V +G L + I AVK +++ + +++ +E + + H N
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 445 LVKLLGCCIHGEEK------LLIYEFMPNKSLDSFIFDQ---ERCKLLDWSKRFHIICGT 495
+++L+G C+ E ++I FM + L SF+ + + L +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGD-ETEGNTNRVVG 553
A G+ YL S IHRDL A N +L+++MN ++DFGL++ + GD +G ++
Sbjct: 122 ASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM-- 176
Query: 554 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-------GKKNRGFYHSDNKLNLIRHA 606
++A E +D ++ KSDV+SFG+ + EI + G +N Y + N ++
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ- 235
Query: 607 WKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPC 652
P +D + + C P+DRP
Sbjct: 236 --------PPDCLDGLYSLMSS-------------CWLLNPKDRPS 260
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 54/202 (26%), Positives = 103/202 (50%), Gaps = 21/202 (10%)
Query: 395 LGEGGFGPVYKGT-LADEQEIAVKRLSKISEQG-LKELKNEIILFSKLQH---RNLVKLL 449
+G G +G VY+G + + +A+K ++ + + +++ E+ L S+L+ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 450 GCCIHGEEKLLIYEFMPNKSLDSFIFDQ---ERCKLLDWSKRFHIICGTARGLLYLHQDS 506
G + G +I E+ S+ + + E+ + II L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKYIHKVG 121
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 566
+IHRD+KA+N+L+ N K+ DFG+A ++ + VGT +MAPE ++G
Sbjct: 122 ---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 567 Q-FSVKSDVFSFGILLLEIVSG 587
+ + K+D++S GI + E+ +G
Sbjct: 177 KYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 33/216 (15%)
Query: 388 NFSINKKLGEGGFGPVYKGTLA----DEQEIAVKRL-SKISEQGLKELKNEIILFSKLQH 442
I K +G G FG V G L E +A+K L + +E+ ++ +E + + H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIIC------GTA 496
N++ L G + +++ E+M N SLD+F+ + +F +I G A
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD--------GQFTVIQLVGMLRGIA 116
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
G+ YL S + +HRDL A N+L++ ++ K+SDFGL+R D T R G
Sbjct: 117 SGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----G 168
Query: 557 ------YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+ APE + +F+ SDV+S+GI++ E++S
Sbjct: 169 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 67/202 (33%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLG 450
K+LG G FG V G + ++A+K + + +SE E E + KL H LV+L G
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYG 66
Query: 451 CCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRI 510
C ++ E+M N L +++ +E K S+ + G+ YL +
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDVCEGMAYLESK---QF 121
Query: 511 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMAPEYASDGQ 567
IHRDL A N L+D K+SDFGL+R DE + VG+ + PE +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSK 177
Query: 568 FSVKSDVFSFGILLLEIVS-GK 588
FS KSDV++FG+L+ E+ S GK
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 75/254 (29%), Positives = 118/254 (46%), Gaps = 27/254 (10%)
Query: 389 FSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVK 447
F + + +G G +G VYKG ++A ++ ++ +E+K EI + K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 448 LLGCCIH------GEEKLLIYEFMPNKSLDSFIFDQERCKLLD-WSKRFHIICGTARGLL 500
G I ++ L+ EF S+ I + + L + W +I RGL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLS 125
Query: 501 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 560
+LHQ ++IHRD+K NVLL ++ K+ DFG++ D T G N +GT +MAP
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAP 180
Query: 561 EYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLI------RHAWKL 609
E + D + KSD++S GI +E+ G H L LI R K
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240
Query: 610 WNEGMPSQLIDACF 623
W++ S I++C
Sbjct: 241 WSKKFQS-FIESCL 253
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 13/207 (6%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQ-GLKELKNEIILFSKLQHRNL 445
+++ + +++G G +G VYK E+ ++ K+ + ++ EI + + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 446 VKLLGCCIHGEEKLLI-YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ 504
V G +KL I E+ SL Q L + ++ T +GL YLH+
Sbjct: 63 VAYFGS-YLRRDKLWIVMEYCGGGSLQDIY--QVTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 505 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA- 563
IHRD+K +N+LL +D + K++DFG++ T +GT +MAPE A
Sbjct: 120 ---TGKIHRDIKGANILLTEDGDVKLADFGVSAQL--TATIAKRKSFIGTPYWMAPEVAA 174
Query: 564 --SDGQFSVKSDVFSFGILLLEIVSGK 588
G + K D+++ GI +E+ +
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 73/223 (32%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 387 DNFSINKKLGEGGFGPVYK----GTLADEQE----IAVKRLS-KISEQGLKELKNEIILF 437
D + K LGEG FG V + G + +AVK L +++ L +L +E+ L
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 438 SKL-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI-----------FDQERC--KLL 483
+ +H+N++ LLG C +I E+ +L F+ FD + + L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 484 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543
+ ARG+ YL +SR R IHRDL A NVL+ +D KI+DFGLAR +
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
T+ +MAPE D ++ +SDV+SFGIL+ EI +
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 387 DNFSINKKLGEGGFGPVYK------GTLADEQEIAVKRLSKISEQGLKELKNEIILFSKL 440
++ LG G G V K GT+ ++ + + S + +Q L+EL+ + +
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ----IMHEC 60
Query: 441 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRF---------HI 491
+ +V G ++ + EFM SLD K+ I
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRI------------YKKGGPIPVEILGKI 108
Query: 492 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 551
GL YL+ + RI+HRD+K SN+L++ K+ DFG++ G+ +
Sbjct: 109 AVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTF 162
Query: 552 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
VGT YM+PE G+++VKSDV+S GI ++E+ GK
Sbjct: 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 65/208 (31%), Positives = 109/208 (52%), Gaps = 20/208 (9%)
Query: 389 FSINKKLGEGGFGPVYKGTLADEQE-----IAVKRLSK-ISEQGLKELKNEIILFSKLQH 442
F K LG G FG VYKG E E +A+K L + S + KE+ +E + + + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFD-QERC---KLLDWSKRFHIICGTARG 498
++ +LLG C+ +L I + MP L ++ + ++ LL+W + A+G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
+ YL + R++HRDL A NVL+ + KI+DFGLA+ G DE E + +M
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVS 586
A E ++ +SDV+S+G+ + E+++
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 11/217 (5%)
Query: 389 FSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLV 446
F+ +++G+G FG VYKG +E+ ++ + +E +++++ EI + S+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+ G + G + +I E++ S D + L+ + I+ +GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 566
R IHRD+KA+NVLL + + K++DFG+A +T+ N VGT +MAPE
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 567 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLI 603
+ K+D++S GI +E+ G+ H L LI
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 78/273 (28%), Positives = 123/273 (45%), Gaps = 31/273 (11%)
Query: 388 NFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLS---KISEQGLKELKNEIILFSKLQHR 443
NF I KK+G G F VY+ T L D +A+K++ + + + EI L +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 444 NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI--FDQERCKLLD---WSKRFHIICGTARG 498
N++K I E ++ E L I F +++ + + W K F +C
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW-KYFVQLCSALE- 120
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
H SR R++HRD+K +NV + K+ D GL R F T ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618
+PE + ++ KSD++S G LL E+ + + FY +K+NL K+ P
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FY--GDKMNLYSLCKKIEQCDYPPLP 229
Query: 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
D ++ L +C+ PE RP
Sbjct: 230 SDHYSEELRQLVN---------MCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 388 NFSINKKLGEGGFGPV----YKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHR 443
+ + +G+G FG V Y+G ++AVK + ++ + E + ++L+H
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDYRGN-----KVAVKCIK--NDATAQAFLAEASVMTQLRHS 59
Query: 444 NLVKLLGCCIHGEEKLLIY-EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL 502
NLV+LLG + + L I E+M SL ++ + R +L + YL
Sbjct: 60 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL 118
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562
++ +HRDL A NVL+ +D K+SDFGL + E + + APE
Sbjct: 119 EANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEA 170
Query: 563 ASDGQFSVKSDVFSFGILLLEIVS 586
+ +FS KSDV+SFGILL EI S
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 28/206 (13%)
Query: 398 GGFGPVY---KGTLADEQEI-AVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCI 453
G +G V+ K + D I +K+ I + + ++ E + S+ Q +VKL
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 454 HGEEKL-LIYEFMPNKSLDSFI-----FDQERCKLLDWSKRFHIICGTARGLLYLHQDSR 507
G++ L L+ E++P L S + D++ + I L YLH
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR--------IYIAEIVLALEYLHS--- 111
Query: 508 LRIIHRDLKASNVLLDQDMNPKISDFGLA------RAFGGDETEGNTNRVVGTYGYMAPE 561
IIHRDLK N+L+D + + K++DFGL+ R ++ E R+VGT Y+APE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 562 YASDGQFSVKSDVFSFGILLLEIVSG 587
S D +S G +L E + G
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 66/216 (30%), Positives = 97/216 (44%), Gaps = 39/216 (18%)
Query: 389 FSINKKLGEGGFGPVY--KGTLADEQEIAVKRLSKISEQGLKELK-NEII-------LFS 438
+ + ++LG+G FG VY K A +E RL + E + EL NE + L S
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEE----RLKVLKEIPVGELNPNETVQANQEAQLLS 57
Query: 439 KLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCK----------LLDWSKR 488
KL H +VK + + +I E+ + LD E K + +W
Sbjct: 58 KLDHPAIVKFHASFLERDAFCIITEYCEGRDLD---CKLEELKHTGKTLSENQVCEW--- 111
Query: 489 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 548
G+ Y+HQ RI+HRDLKA N+ L ++ KI DFG++R G T
Sbjct: 112 ---FIQLLLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT 164
Query: 549 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEI 584
GT YM+PE + KSD++S G +L E+
Sbjct: 165 --FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 65/216 (30%), Positives = 113/216 (52%), Gaps = 21/216 (9%)
Query: 394 KLGEGGFGPVYKGTLADEQ----EIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLL 449
K+GEG G V +A E+ ++AVK + +Q + L NE+++ QH+N+V++
Sbjct: 28 KIGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 450 GCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA-RGLLYLHQDSRL 508
+ GEE ++ EF+ +L I Q R ++ +C + + L YLH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTD-IVSQTRLN----EEQIATVCESVLQALCYLHSQG-- 137
Query: 509 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF 568
+IHRD+K+ ++LL D K+SDFG D + + +VGT +MAPE S +
Sbjct: 138 -VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPY 194
Query: 569 SVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIR 604
+ D++S GI+++E+V G+ Y SD+ + ++
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPP---YFSDSPVQAMK 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 57/203 (28%), Positives = 105/203 (51%), Gaps = 15/203 (7%)
Query: 393 KKLGEGGFGPVY--KGTLADEQEIAVKRLS--KISEQGLKELKNEIILFSKLQHRNLVKL 448
+ +G G FG V+ + AD++ + +K++ ++++ +NE + L H N+++
Sbjct: 6 RVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 449 LGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCK-LLDWSKRFHIICGTARGLLYLHQDSR 507
+ + +++ E+ P +L +I Q+RC LLD H L ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVHTKL- 121
Query: 508 LRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 566
I+HRDLK N+LLD+ M KI DFG+++ ++ VVGT Y++PE
Sbjct: 122 --ILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEGK 176
Query: 567 QFSVKSDVFSFGILLLEIVSGKK 589
++ KSD+++ G +L E+ S K+
Sbjct: 177 PYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 6e-19
Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 11/217 (5%)
Query: 389 FSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLV 446
F+ +K+G+G FG V+KG Q++ ++ + +E +++++ EI + S+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
K G + + +I E++ S D LD ++ I+ +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 566
+ IHRD+KA+NVLL + K++DFG+A +T+ N VGT +MAPE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 567 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLI 603
+ K+D++S GI +E+ G+ H L LI
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 60/202 (29%), Positives = 108/202 (53%), Gaps = 11/202 (5%)
Query: 389 FSINKKLGEGGFGPVYKGTLADEQEI-AVKRLS-KISEQGLKELKNEIILFSKLQHRNLV 446
F+ +++G+G FG V+KG Q++ A+K + + +E +++++ EI + S+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
K G + G + +I E++ S D R D + ++ +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 566
+ IHRD+KA+NVLL + + K++DFG+A +T+ N VGT +MAPE
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIQQS 176
Query: 567 QFSVKSDVFSFGILLLEIVSGK 588
+ K+D++S GI +E+ G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 8e-19
Identities = 79/296 (26%), Positives = 126/296 (42%), Gaps = 52/296 (17%)
Query: 390 SINKKLGEGGFGPVYKGTLADEQEI-----------------AVKRLSK-ISEQGLKELK 431
+ +KLGEG FG V+ Q+ AVK L S+ ++
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 432 NEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI--------FDQERCKLL 483
E+ + S+L N+ +LLG C +I E+M N L+ F+ K L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 484 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGD 542
+S ++ A G+ YL L +HRDL N L+ ++ KI+DFG++R + D
Sbjct: 128 SFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 543 --ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKL 600
+G R +MA E G+F+ KSDV++FG+ L EI++ + + + H ++
Sbjct: 185 YYRVQG---RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241
Query: 601 ---NLIRHAWKLWNEGMPSQL--IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
N ++G L C KD + L L C ++ EDRP
Sbjct: 242 VIENAGH---FFRDDGRQIYLPRPPNCPKDIYELM---------LECWRRDEEDRP 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 8e-19
Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 27/207 (13%)
Query: 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLG 450
K+LG G FG V+ G + ++A+K +++ +SE+ E E + KL H LV+L G
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPKLVQLYG 66
Query: 451 CCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI-IC-GTARGLLYLHQDSRL 508
C + ++ EFM N L +++ Q + KL SK + +C G+ YL ++S
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYL-RQRQGKL---SKDMLLSMCQDVCEGMEYLERNS-- 120
Query: 509 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG------YMAPEY 562
IHRDL A N L+ K+SDFG+ R DE + G + PE
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-------YTSSSGAKFPVKWSPPEV 172
Query: 563 ASDGQFSVKSDVFSFGILLLEIVSGKK 589
+ ++S KSDV+SFG+L+ E+ + K
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 9e-19
Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 34/215 (15%)
Query: 395 LGEGGFGPVYKGTLADE---QEIAVKRLSK-ISEQGLKELKNEIILFSKL-QHRNLVKLL 449
+GEG FG V K + + + A+KR+ + S+ ++ E+ + KL H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 450 GCCIHGEEKLLIYEFMPNKSL-------------DSFIFDQERCKLLDWSKRFHIICGTA 496
G C H L E+ P+ +L +F L + H A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
RG+ YL Q + IHRDL A N+L+ ++ KI+DFGL+R G V T G
Sbjct: 135 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTMG 183
Query: 557 -----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+MA E + ++ SDV+S+G+LL EIVS
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 393 KKLGEGGFGPVYKG---TLADEQEIAVKRLSKIS-EQGLK-ELKNEIILFSKLQHRNLVK 447
+LG G FG V KG E+ +AVK L + + LK EL E + +L + +V+
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSR 507
++G C E +L+ E L+ F+ + + ++ H + + G+ YL + +
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQV---SMGMKYLEETN- 115
Query: 508 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT----YGYMAPEYA 563
+HRDL A NVLL KISDFGL++A G DE N + + APE
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAPECM 170
Query: 564 SDGQFSVKSDVFSFGILLLEIVS-GKK 589
+ +FS KSDV+SFG+L+ E S G+K
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 64/204 (31%), Positives = 108/204 (52%), Gaps = 20/204 (9%)
Query: 393 KKLGEGGFGPVYKGTLADEQE-----IAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLV 446
K LG G FG VYKG + E +A+K L + S + KE+ +E + + + +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQE----RCKLLDWSKRFHIICGTARGLLYL 502
+LLG C+ +L + + MP L ++ + + LL+W + A+G+ YL
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL 125
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562
+ +R++HRDL A NVL+ + KI+DFGLAR DETE + + +MA E
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 563 ASDGQFSVKSDVFSFGILLLEIVS 586
+F+ +SDV+S+G+ + E+++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 23/203 (11%)
Query: 395 LGEGGFGPVYKGTLADEQEI-AVKRLSK--ISEQGLKE-LKNEIILFSKLQHRNLVKLLG 450
LG GGFG V + + A+K + K I E G +E + +E + + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 451 CCIHG--EEKLLIY---EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD 505
+ ++K IY E+ L + + ++R +++ RF+I C YLH
Sbjct: 59 ---YRTFKDKKYIYMLMEYCLGGELWTIL--RDRGLFDEYTARFYIACVV-LAFEYLH-- 110
Query: 506 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD 565
II+RDLK N+LLD + K+ DFG A+ + T GT Y+APE +
Sbjct: 111 -NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILN 166
Query: 566 GQFSVKSDVFSFGILLLEIVSGK 588
+ D +S GILL E+++G+
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-18
Identities = 74/271 (27%), Positives = 127/271 (46%), Gaps = 36/271 (13%)
Query: 389 FSINKKLGEGGFGPVYKGTLADEQEI-AVKRLS---KISEQGLKELKNEIILFSKLQHRN 444
F+ +++G G FG VY E+ A+K++S K S + +++ E+ +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ 504
++ GC + L+ E+ + D ++ + ++ + H G +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITH---GALQGLAYLHS 143
Query: 505 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY-- 562
+ +IHRD+KA N+LL + K++DFG A N VGT +MAPE
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPEVIL 194
Query: 563 -ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621
+GQ+ K DV+S GI +E+ K + N ++ + H + NE Q +
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQ--NESPTLQSNE- 248
Query: 622 CFKDSF-NLAEVIRCIHIGLLCVQQYPEDRP 651
+ D F N + C+Q+ P+DRP
Sbjct: 249 -WSDYFRNFVDS---------CLQKIPQDRP 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 5e-18
Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 394 KLGEGGFGPVYKGTLADEQEI-AVKRLS---KISEQGLKELKNEIILFSKLQHRNLVKLL 449
++G G FG VY T + E+ AVK++S K + + +++ E+ +L+H N ++
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 450 GCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLR 509
GC + L+ E+ + D ++ + ++ + H G +GL YLH +
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITH---GALQGLAYLHSHN--- 141
Query: 510 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY---ASDG 566
+IHRD+KA N+LL + K++DFG A N VGT +MAPE +G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 567 QFSVKSDVFSFGILLLEIVSGK 588
Q+ K DV+S GI +E+ K
Sbjct: 196 QYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 5e-18
Identities = 68/221 (30%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 389 FSINKKLGEGGFGPVY--------KGTLADEQEIAVKRLSK-ISEQGLKELKNEIILFSK 439
++ K LGEG FG V K +AVK L +++ L +L +E+ +
Sbjct: 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKM 73
Query: 440 L-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI---------FDQERCKLLDWSKRF 489
+ +H+N++ LLG C ++ E+ +L ++ + + CKL + F
Sbjct: 74 IGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 490 H--IICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545
+ C ARG+ YL + + IHRDL A NVL+ +D KI+DFGLAR +
Sbjct: 134 KDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY 190
Query: 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
T +MAPE D ++ +SDV+SFG+LL EI +
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 70/225 (31%), Positives = 109/225 (48%), Gaps = 26/225 (11%)
Query: 385 ATDNFSINKKLGEGGFGPVYKGT---LADEQ-----EIAVKRL-SKISEQGLKELKNEII 435
D + K LGEG FG V L E+ ++AVK L S +E+ L +L +E+
Sbjct: 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75
Query: 436 LFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI-----------FDQERCKLL 483
+ + +H+N++ LLG C +I E+ +L ++ ++ +
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135
Query: 484 DWSKRFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541
S + + C ARG+ YL + + IHRDL A NVL+ +D KI+DFGLAR
Sbjct: 136 QLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 192
Query: 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+ T +MAPE D ++ +SDV+SFG+LL EI +
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 6e-18
Identities = 75/266 (28%), Positives = 124/266 (46%), Gaps = 34/266 (12%)
Query: 393 KKLGEGGFGPVYKGT-LADEQEIAVKRLS---KISEQGLKELKNEIILFSKLQHRNLVKL 448
+++G G FG VY + + +A+K++S K S + +++ E+ +L+H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 449 LGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRL 508
GC + L+ E+ + D I + + K L + I G +GL YLH R
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASD--ILEVHK-KPLQEVEIAAICHGALQGLAYLHSHER- 136
Query: 509 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE--YASD- 565
IHRD+KA N+LL + K++DFG A N VGT +MAPE A D
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPEVILAMDE 188
Query: 566 GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625
GQ+ K DV+S GI +E+ K + N ++ + H + + + S F++
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245
Query: 626 SFNLAEVIRCIHIGLLCVQQYPEDRP 651
+ C+Q+ P+DRP
Sbjct: 246 FVD------------SCLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 6e-18
Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 389 FSINKKLGEGGFGPVYKGTLADE----QEIAVKRLSK--ISEQGLKELKNEIILFSKLQH 442
F++ + LG+G FG V + L E Q++AVK L S ++E E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 443 RNLVKLLGCCIHGEEK------LLIYEFMPNKSLDSFIFDQ---ERCKLLDWSKRFHIIC 493
N++KL+G + K ++I FM + L +F+ E L +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 494 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGD-ETEGNTNRV 551
A G+ YL S IHRDL A N +L+++M ++DFGL++ + GD +G +++
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 552 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
++A E +D ++ SDV++FG+ + EI++
Sbjct: 178 --PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 7e-18
Identities = 67/223 (30%), Positives = 107/223 (47%), Gaps = 26/223 (11%)
Query: 387 DNFSINKKLGEGGFGPVY--------KGTLADEQEIAVKRLS-KISEQGLKELKNEIILF 437
D ++ K LGEG FG V K + +AVK L +E+ L +L +E+ +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 438 SKL-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI-----------FDQERCKLLDW 485
+ +H+N++ LLG C +I E+ +L ++ +D R
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 486 SKRFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543
+ + + C ARG+ YL + + IHRDL A NVL+ ++ KI+DFGLAR +
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
T +MAPE D ++ +SDV+SFG+L+ EI +
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 22/205 (10%)
Query: 393 KKLGEGGFGPVYKGTLADEQE-----IAVKRL-SKISEQGLKELKNEIILFSKLQHRNLV 446
K LG G FG V+KG E + +A+K + + Q +E+ + ++ L H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQER-----CKLLDWSKRFHIICGTARGLLY 501
+LLG C G L+ + P SL + Q R +LL+W + A+G+ Y
Sbjct: 73 RLLGIC-PGASLQLVTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQI------AKGMYY 124
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 561
L + R++HR+L A N+LL D +I+DFG+A D+ + + +MA E
Sbjct: 125 LEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 562 YASDGQFSVKSDVFSFGILLLEIVS 586
G+++ +SDV+S+G+ + E++S
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 9e-18
Identities = 70/259 (27%), Positives = 127/259 (49%), Gaps = 26/259 (10%)
Query: 394 KLGEGGFGPVYKGTLADE-QEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCC 452
K+GEG G V T +++AVK++ +Q + L NE+++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 453 IHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIIC-GTARGLLYLHQDSRLRII 511
+ G+E ++ EF+ +L I R ++ +C R L YLH +I
Sbjct: 89 LVGDELWVVMEFLEGGALTD-IVTHTRMN----EEQIATVCLSVLRALSYLHNQG---VI 140
Query: 512 HRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVK 571
HRD+K+ ++LL D K+SDFG + + + +VGT +MAPE S + +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTE 198
Query: 572 SDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAE 631
D++S GI+++E++ G+ Y ++ L +R + +P ++ KDS ++
Sbjct: 199 VDIWSLGIMVIEMIDGEPP---YFNEPPLQAMRRI----RDNLPPRV-----KDSHKVSS 246
Query: 632 VIRCIHIGLLCVQQYPEDR 650
V+R + L+ V++ P R
Sbjct: 247 VLRGF-LDLMLVRE-PSQR 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 61/198 (30%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 393 KKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLK-ELKNEIILFSKLQHRNLVKLLG 450
+++G G FG V+ G L AD +AVK + LK + E + + H N+V+L+G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 451 CCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRI 510
C + ++ E + +F+ + L + ++ A G+ YL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 511 IHRDLKASNVLLDQDMNPKISDFGLAR--AFGGDETEGNTNRVVGTYGYMAPEYASDGQF 568
IHRDL A N L+ + KISDFG++R G + G ++ + APE + G++
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRY 173
Query: 569 SVKSDVFSFGILLLEIVS 586
S +SDV+SFGILL E S
Sbjct: 174 SSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 33/224 (14%)
Query: 385 ATDNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSK-ISEQGLKELKNEIILF 437
+ + ++ ++LG+G FG VY+G D E +AVK +++ S + E NE +
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63
Query: 438 SKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLD-----------WS 486
++V+LLG G+ L++ E M + L S++ R +
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQ 119
Query: 487 KRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546
+ + A G+ YL+ + +HRDL A N ++ D KI DFG+ R D E
Sbjct: 120 EMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYET 172
Query: 547 NTNRVVGT----YGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+ R G +MAPE DG F+ SD++SFG++L EI S
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 72/223 (32%), Positives = 111/223 (49%), Gaps = 21/223 (9%)
Query: 379 LATIANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEI-IL 436
L ++ + TD + I + +G+G +G VYK T D AVK L IS+ +E++ E IL
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 437 FSKLQHRNLVKLLGC------CIHGEEKLLIYEFMPNKSLDSFIFDQERC-KLLDWSKRF 489
S H N+VK G + G+ L+ E S+ + C + LD +
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQ-LWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131
Query: 490 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 549
+I+ G GL +LH + RIIHRD+K +N+LL + K+ DFG++ NT+
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188
Query: 550 RVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSG 587
VGT +MAPE + D + + DV+S GI +E+ G
Sbjct: 189 --VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 2e-17
Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 47/240 (19%)
Query: 389 FSINKKLGEGGFGPVYKGTLADEQE-IAVKRLSKISEQGLKELKN---EIILFSKLQHRN 444
+ + K +G G +G V +A+K++S + L + K EI L L+H N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLRHEN 60
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSF--------IFDQERCKLLDWSKRF------- 489
++ LL + + S + F + + + K++ S +
Sbjct: 61 IIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIK-SPQPLTDDHIQ 106
Query: 490 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-- 547
+ + RGL YLH +IHRDLK SN+L++ + + KI DFGLAR DE E
Sbjct: 107 YFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 548 TNRVVGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK---KNRGFYHSDNKLNLI 603
T VV T Y APE S +++ D++S G + E+++ K R + +LNLI
Sbjct: 164 TEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID---QLNLI 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 71/270 (26%), Positives = 128/270 (47%), Gaps = 34/270 (12%)
Query: 389 FSINKKLGEGGFGPVYKG-TLADEQEIAVKRLS---KISEQGLKELKNEIILFSKLQHRN 444
FS +++G G FG VY + + + +A+K++S K S + +++ E+ KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ 504
++ GC + L+ E+ + D ++ + ++ + H G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH---GALQGLAYLHS 133
Query: 505 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY-- 562
+ +IHRD+KA N+LL + K+ DFG A N VGT +MAPE
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 563 -ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621
+GQ+ K DV+S GI +E+ ++ ++ N ++ + H + + + S
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNM-NAMSALYHIAQNESPALQSGHWSE 241
Query: 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
F++ + C+Q+ P+DRP
Sbjct: 242 YFRNFVD------------SCLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 69/213 (32%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK--ISEQGLKE-LKNEIILFSKLQH 442
D+F K LG G FG V + A+K LSK I + E + NE + ++H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTAR----- 497
LV L G L+ E++P L F L S RF AR
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGEL----FS-----HLRKSGRFPE--PVARFYAAQ 109
Query: 498 ---GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 554
L YLH L I++RDLK N+LLD D KI+DFG A+ +G T + GT
Sbjct: 110 VVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGT 161
Query: 555 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 587
Y+APE + D ++ GIL+ E+++G
Sbjct: 162 PEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQE-IAVKRLSKISEQGLKELKNEIILFSKLQHRNL 445
DNF K+GEG G V T+ + +AVK++ +Q + L NE+++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIIC-GTARGLLYLHQ 504
V++ + G+E ++ EF+ +L I R ++ +C + L LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMN----EEQIAAVCLAVLKALSVLHA 134
Query: 505 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS 564
+IHRD+K+ ++LL D K+SDFG + + +VGT +MAPE S
Sbjct: 135 QG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELIS 189
Query: 565 DGQFSVKSDVFSFGILLLEIVSGK 588
+ + D++S GI+++E+V G+
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQ----EIAVKRLSKISEQGLKEL-KNEIILFSKLQ 441
++ ++ + +GEG FG VY+G + +AVK + ++E E + +
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI-FDQERCKLLDWSKRFHIICGTARGLL 500
H ++VKL+G ++ E P L S++ ++ L + + L
Sbjct: 66 HPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLS---TALA 121
Query: 501 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 560
YL R +HRD+ A NVL+ K+ DFGL+R DE+ ++ +MAP
Sbjct: 122 YLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGKLPIKWMAP 177
Query: 561 EYASDGQFSVKSDVFSFGILLLEIVS-GKK 589
E + +F+ SDV+ FG+ + EI+ G K
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 395 LGEGGFGPVYKGTLAD-EQEIAVKRLSKIS-EQGLKELKNEIILFSKLQH-RNLVKLLGC 451
+G G FG V K +AVKR+ E+ K L ++ + + +VK G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 452 CIHGEEKLLIYEFMPNKSLDSF---IFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRL 508
+ + E M + SLD F +++ + ++ I T + L YL ++ L
Sbjct: 72 LFREGDCWICMELM-DISLDKFYKYVYEVLK-SVIPEEILGKIAVATVKALNYLKEE--L 127
Query: 509 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE----YAS 564
+IIHRD+K SN+LLD++ N K+ DFG++ G R G YMAPE A
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPERIDPSAR 184
Query: 565 DGQFSVKSDVFSFGILLLEIVSGK 588
DG + V+SDV+S GI L E+ +GK
Sbjct: 185 DG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 14/203 (6%)
Query: 394 KLGEGGFGPVYKGTLADEQ---EIAVKRLSKISEQGLK-ELKNEIILFSKLQHRNLVKLL 449
+LG G FG V KG + ++A+K L +E+ ++ E+ E + +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 450 GCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLR 509
G C E +L+ E L+ F+ ++ + S ++ + G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 510 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY--GYMAPEYASDGQ 567
+HRDL A NVLL KISDFGL++A G D++ R G + + APE + +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY-YKARSAGKWPLKWYAPECINFRK 174
Query: 568 FSVKSDVFSFGILLLEIVS-GKK 589
FS +SDV+S+GI + E S G+K
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 4e-17
Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 388 NFSINKKLGEGGFGPVYKGTLADE-QEIAVKRL-----SKISEQGLKELKNEIILFSKLQ 441
N+ K LG+G FG VY D +E+A K++ S + + + L+ EI L LQ
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 442 HRNLVKLLGCCI-HGEEKLLIY-EFMPNKSLDSFIFDQERC-KLLDWSKRFHIICGTARG 498
H +V+ GC E+ L I+ E+MP S+ DQ + L S G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEG 118
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR-VVGTYGY 557
+ YLH + I+HRD+K +N+L D N K+ DFG ++ G R V GT +
Sbjct: 119 MSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
M+PE S + K+DV+S G ++E+++ K
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 71/208 (34%), Positives = 105/208 (50%), Gaps = 24/208 (11%)
Query: 393 KKLGEGGFGPVY------KGTLADEQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNL 445
+ LGEG FG V +G EQ +AVK L S + +LK EI + L H N+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQ-VAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 446 VKLLGCCIHGEEK--LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI-ICGTARGLLYL 502
VK G C LI EF+P+ SL ++ + L ++ + IC +G+ YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQIC---KGMDYL 125
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE----TEGNTNRVVGTYGYM 558
SR + +HRDL A NVL++ + KI DFGL +A D+ + + + V Y
Sbjct: 126 --GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY--- 179
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVS 586
APE +F + SDV+SFG+ L E+++
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 68/210 (32%), Positives = 108/210 (51%), Gaps = 37/210 (17%)
Query: 395 LGEGGFGPVYKGT-LADEQEIAVKRLS-KISEQG--LKELKNEIILFSKLQ---HRNLVK 447
+GEG +G VYK L + +A+K++ +SE+G L L+ EI L +L+ H N+V+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNIVR 65
Query: 448 LLGCC--IHGEEKL---LIYEFMPNKSLDSFIFDQERC--KLLDWSKRFHIICGTARGLL 500
LL C + +L L++E + ++ L +++ +C L ++ RG+
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHV-DQDLATYL---SKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 501 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 560
+LH RI+HRDLK N+L+ D KI+DFGLAR + T+ VV T Y AP
Sbjct: 122 FLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVV-TLWYRAP 175
Query: 561 E------YASDGQFSVKSDVFSFGILLLEI 584
E YA+ V D++S G + E+
Sbjct: 176 EVLLQSSYAT----PV--DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 69/292 (23%), Positives = 131/292 (44%), Gaps = 42/292 (14%)
Query: 388 NFSINKKLGEGGFGPVYK-------GTLADEQEIAVKRLS-----KISEQGLKELKNEI- 434
+++ + LG G FG VYK L +EI V + + ++ + ++ +E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 435 ILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL-DSFIFDQERCKLLDWSKRFHIIC 493
I+ +L+H N+V+ + + ++ + + L + F +E+ + + ++I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 494 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 553
L YLH++ R I+HRDL +N++L +D I+DFGLA+ E VVG
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ---PESKLTSVVG 175
Query: 554 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNL----IRHAWKL 609
T Y PE + + K+DV++FG +L ++ + + ++S N L+L + ++
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP---FYSTNMLSLATKIVEAVYEP 232
Query: 610 WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661
EGM S+ + C+ E RP + V M+
Sbjct: 233 LPEGMYSEDVTDVITS----------------CLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 75/246 (30%), Positives = 121/246 (49%), Gaps = 21/246 (8%)
Query: 388 NFSINKKLGEGGFGPVYKGTLADE-QEIAVKRL-----SKISEQGLKELKNEIILFSKLQ 441
N+ + K LG G FG VY AD +E+AVK++ S+ + + + L+ EI L L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 442 HRNLVKLLGCCI-HGEEKLLIY-EFMPNKSLDSFIFDQERC--KLLDWSKRFHIICGTAR 497
H +V+ GC E+KL I+ E+MP S I DQ + L + R + +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTR-QILQ 117
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-TNRVVGTYG 556
G+ YLH + I+HRD+K +N+L D N K+ DFG ++ G V GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616
+M+PE S + K+DV+S ++E+++ K Y + + + A + +P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA--MAAIFKIATQPTKPMLPD 232
Query: 617 QLIDAC 622
+ DAC
Sbjct: 233 GVSDAC 238
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-17
Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 389 FSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQGLKE---LKNEIILFSKLQHRN 444
F I ++G+GG+G V+ D EI A+KR+ K L E + E + + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI---ICGTARGLLY 501
LVKLL E L E++P + + + L + RF++
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDA---- 116
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 561
LH L IHRDLK N L+D + K++DFGL++ N VVG+ YMAPE
Sbjct: 117 LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPE 168
Query: 562 YASDGQFSVKSDVFSFGILLLEIVSG 587
+ D +S G +L E + G
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 73/270 (27%), Positives = 113/270 (41%), Gaps = 46/270 (17%)
Query: 395 LGEGGFGPVYKGT-LADEQEIAVKRLS-KISEQGLKELKNEIILFSKLQHRNLVKLLGCC 452
LG G G VYK L + +AVK + I+ + K++ +E+ + K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 453 IHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA----RGLLYLHQDSRL 508
+ EFM SLD + H++ A +GL YL L
Sbjct: 69 FVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS---L 114
Query: 509 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF 568
+I+HRD+K SN+L++ K+ DFG++ VGT YMAPE S Q+
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQY 170
Query: 569 SVKSDVFSFGILLLEIVSGK-------KNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621
+ SDV+S GI +E+ G+ KN+G L I P L
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-------DPPVLPVG 223
Query: 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
F + F +H C+++ P++RP
Sbjct: 224 QFSEKF--------VHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 8e-17
Identities = 31/57 (54%), Positives = 36/57 (63%), Gaps = 5/57 (8%)
Query: 12 SGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPS 68
GNLVL LWQSFD+P+DTLLPG K G ++ G RR+TSWKS DPS
Sbjct: 58 DGNLVLYDNSG----KVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 395 LGEGGFGPVYKGTL---ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLL 449
+GEG FG V + + + A+K L + SE ++ E+ + KL H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 450 GCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA-----RGLLYLHQ 504
G C + + E+ P +L F+ + ++L+ F GTA + LL
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 505 D--------SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
D S + IHRDL A NVL+ +++ KI+DFGL+R G+E
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLPVR 183
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+MA E + ++ KSDV+SFG+LL EIVS
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 9e-17
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 37/228 (16%)
Query: 393 KKLGEGGFGPVYKGTLADEQE-----------------IAVKRL-SKISEQGLKELKNEI 434
+KLGEG FG V+ + + Q+ +AVK L ++ + E+
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70
Query: 435 ILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI---------------FDQER 479
+ S+L+ N+++LLG C+ + +I E+M N L+ F+
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 480 CKL-LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538
C + +S H+ A G+ YL S L +HRDL N L+ +++ KI+DFG++R
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRN 187
Query: 539 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+ R V +MA E G+F+ SDV++FG+ L EI+
Sbjct: 188 LYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 30/209 (14%)
Query: 393 KKLGEGGFGPVYKGTLADEQEI-AVKR----LSKISE-QGLKELKNEIILFSKLQ-HRNL 445
K+LG+G FG VY + E+ A+K+ E L+E+K+ KL H N+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKS----LRKLNEHPNI 60
Query: 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD 505
VKL +E ++E+M +L + D++ K S II +GL ++H
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIH-- 116
Query: 506 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR-----VVGTYGYMAP 560
+ HRDLK N+L+ KI+DFGLAR E +R V T Y AP
Sbjct: 117 -KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIR---SRPPYTDYVSTRWYRAP 167
Query: 561 E-YASDGQFSVKSDVFSFGILLLEIVSGK 588
E +S D+++ G ++ E+ + +
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 66/210 (31%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 395 LGEGGFGPVYKGTLADE---QEIAVKRLSK-ISEQGLKELKNEIILFSKL-QHRNLVKLL 449
+GEG FG V K + + + A+KR+ + S+ ++ E+ + KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 450 GCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA-----RGLLYLHQ 504
G C H L E+ P+ +L F+ + ++L+ F I TA + LL+
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 505 D--------SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
D S+ + IHRDL A N+L+ ++ KI+DFGL+R G E
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+MA E + ++ SDV+S+G+LL EIVS
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 69/208 (33%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 395 LGEGGFGPVY------KGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKL 448
LG+GGFG V G L +++ KRL K +G + E + +K+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 449 LGCCIHGEEKL-LIYEFMPNKSLDSFIF--DQERCKLLDWSKRFH---IICGTARGLLYL 502
+ L L+ M L I+ D+E + F+ II G L +L
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG----LEHL 113
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTNRVVGTYGYMAP 560
HQ RII+RDLK NVLLD D N +ISD GLA G +T+G GT G+MAP
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG----YAGTPGFMAP 166
Query: 561 EYASDGQFSVKSDVFSFGILLLEIVSGK 588
E ++ D F+ G+ L E+++ +
Sbjct: 167 ELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 54/156 (34%), Positives = 87/156 (55%), Gaps = 21/156 (13%)
Query: 394 KLGEGGFGPVYKGTLADEQEI-AVKRLSKISE-QGLKELK-NEIILFSKLQHRNLVKLLG 450
K+GEG +G V+K + EI A+KR+ + +G+ EI L +L+H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 451 CCIHGEEKL-LIYEFMPN---KSLDSF--IFDQERCKLLDWSKRFHIICGTARGLLYLHQ 504
+H ++KL L++E+ K DS D E K S F ++ +GL + H
Sbjct: 67 V-LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK----SFMFQLL----KGLAFCHS 117
Query: 505 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540
++HRDLK N+L++++ K++DFGLARAFG
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 78/278 (28%), Positives = 123/278 (44%), Gaps = 40/278 (14%)
Query: 387 DNFSIN--KKLGEGGFGPVYKGTLA----DEQEIAVKRL-SKISEQGLKELKNEIILFSK 439
DN SI + LG G FG + +G L E +A+ L + S++ + E + +
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGL 499
H N+V+L G G +++ E+M N +LDSF+ E L + ++ G A G+
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGM 120
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG--NTNRVVGTYGY 557
YL S + +H+ L A VL++ D+ KIS F + D++E T +
Sbjct: 121 KYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE---DKSEAIYTTMSGKSPVLW 174
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617
APE FS SDV+SFGI++ E++S + R W M Q
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGE--------------RPYWD-----MSGQ 215
Query: 618 LIDACFKDSFNLAEVIRC---IHIGLL-CVQQYPEDRP 651
+ +D F L C +H +L C Q+ +RP
Sbjct: 216 DVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERP 253
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 54/161 (33%), Positives = 82/161 (50%), Gaps = 17/161 (10%)
Query: 433 EIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHII 492
EI + + H N+VK H E ++ EFM SL+ E+ L D +++ I+
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQ-FLADVARQ--IL 178
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 552
G A YLH R I+HRD+K SN+L++ N KI+DFG++R +T N V
Sbjct: 179 SGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSV 229
Query: 553 GTYGYMAPEYA----SDGQFS-VKSDVFSFGILLLEIVSGK 588
GT YM+PE + G + D++S G+ +LE G+
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 388 NFSINKKLGEGGFGPVY--KGTLADEQEIAVKR--LSKISEQGLKELKNEIILFSKLQHR 443
+ I KK+GEG FG +Y K +D + +K L+K+ + + K E+IL +K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 444 NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH 503
N+V ++ E+ L I +++R L + + GL ++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 504 QDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562
+I+HRD+K+ N+ L ++ M K+ DFG+AR D E VGT Y++PE
Sbjct: 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSME-LAYTCVGTPYYLSPEI 173
Query: 563 ASDGQFSVKSDVFSFGILLLEIVSGK 588
+ ++ K+D++S G +L E+ + K
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 44/223 (19%)
Query: 389 FSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSKI-----SEQGLKELKNEIILFSKL-Q 441
+ I +KLG+G +G V+K +E+ A+K KI + + EI+ +L
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALK---KIFDAFRNATDAQRTFREIMFLQELGD 65
Query: 442 HRNLVKLLGCCIHGEEK----LLIYEFMPNKSLDSFIFDQERCKLL-DWSKRFHIICGTA 496
H N+VKLL + E L++E+M L + I R +L D KR+ I+
Sbjct: 66 HPNIVKLLN--VIKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRY-IMYQLL 117
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV----V 552
+ L Y+H S +IHRDLK SN+LL+ D K++DFGLAR+ + E N V V
Sbjct: 118 KALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL-SELEENPENPVLTDYV 173
Query: 553 GTYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 588
T Y APE Y V D++S G +L E++ GK
Sbjct: 174 ATRWYRAPEILLGSTRYT----KGV--DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-16
Identities = 67/271 (24%), Positives = 121/271 (44%), Gaps = 21/271 (7%)
Query: 395 LGEGGFGPVYKG-TLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCI 453
+ G G YKG ++ + + VK ++ ++ +EI KLQH N+VKL+G C
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLIGLCR 753
Query: 454 HGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHR 513
+ LI+E++ K+L E + L W +R I G A+ L +LH ++
Sbjct: 754 SEKGAYLIHEYIEGKNL------SEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 514 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSD 573
+L +++D P + L D ++ Y+APE + KSD
Sbjct: 808 NLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETKDITEKSD 860
Query: 574 VFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD--SFNLAE 631
++ FG++L+E+++GK + +++ A +++ ID + S N E
Sbjct: 861 IYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNE 919
Query: 632 VIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662
++ +++ L C P RPC V+ L S
Sbjct: 920 IVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 19/212 (8%)
Query: 388 NFSINKKLGEGGFGPVYKGTLADE-QEIAVKRL-----SKISEQGLKELKNEIILFSKLQ 441
N+ + K LG+G FG VY AD +E+AVK++ S + + + L+ EI L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 442 HRNLVKLLGCCIHGEEKLL--IYEFMPNKSLDSFIFDQERC--KLLDWSKRFHIICGTAR 497
H +V+ GC E+ L E MP S I DQ + L + R +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTR-QILE 117
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-TNRVVGTYG 556
G+ YLH + I+HRD+K +N+L D N K+ DFG ++ G V GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
+M+PE S + K+D++S G ++E+++ K
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 71/214 (33%), Positives = 105/214 (49%), Gaps = 40/214 (18%)
Query: 394 KLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQG---LKELKNEIILFSKLQHRNLVKLL 449
++GEG +G VY+ EI A+K++ +E+ + L+ EI L L+H N+V+L
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELK 72
Query: 450 GCCIHGEEKLLIYEFMPNKSLDSFIF------DQERCKLLDWSKR-FH------IICGTA 496
E + K LDS IF +Q+ LLD F ++
Sbjct: 73 -------------EVVVGKHLDS-IFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLL 118
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
RGL YLH++ IIHRDLK SN+LL KI+DFGLAR + G + T +VV T
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLW 173
Query: 557 YMAPE--YASDGQFSVKSDVFSFGILLLEIVSGK 588
Y APE + D+++ G +L E+++ K
Sbjct: 174 YRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 35/229 (15%)
Query: 387 DNFSINKKLGEGGFGPVY------------KGTLADEQE-----IAVKRL-SKISEQGLK 428
+ +KLGEG FG V+ K D +AVK L ++
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 429 ELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI--------FDQERC 480
+ EI + S+L+ N+++LL CI + +I E+M N L+ F+ ++
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 481 KLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AF 539
+ +S + A G+ YL S L +HRDL N L+ ++ KI+DFG++R +
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 540 GGD--ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
GD +G R V +M+ E G+F+ SDV++FG+ L EI++
Sbjct: 182 SGDYYRIQG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 394 KLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQGLKELKN----EIILFSKLQHRNLVKL 448
+GEG +G V K EI A+K+ K SE +++K E+ + +L+H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDD-EDVKKTALREVKVLRQLRHENIVNL 65
Query: 449 LGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRL 508
L++E++ L+ + L I + + Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCH---SH 119
Query: 509 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-YASDGQ 567
IIHRD+K N+L+ + K+ DFG ARA T+ V T Y APE D
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTN 178
Query: 568 FSVKSDVFSFGILLLEIVSG 587
+ DV++ G ++ E++ G
Sbjct: 179 YGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 394 KLGEGGFGPVYKGTLADE-QEIAVKRLSKISEQGLKELKN----EIILFSKLQHRNLVKL 448
+GEG +G V K + Q +A+K+ + + K +K EI + +L+H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNL 65
Query: 449 LGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRL 508
+ + L++EF+ + LD ++ LD S+ + RG+ + H +
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSHN-- 120
Query: 509 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY-ASDGQ 567
IIHRD+K N+L+ Q K+ DFG AR E T+ V T Y APE D +
Sbjct: 121 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTD-YVATRWYRAPELLVGDTK 177
Query: 568 FSVKSDVFSFGILLLEIVSG 587
+ D+++ G L+ E+++G
Sbjct: 178 YGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 70/240 (29%), Positives = 110/240 (45%), Gaps = 38/240 (15%)
Query: 388 NFSINKKLGEGGFGPV----YKGTLADEQEIAVKRLSKI------SEQGLKELKNEIILF 437
+ + K+LG+G +G V T ++E+ +A+K+++ + +++ L+ELK +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELK---LLR 56
Query: 438 SKLQHRNLVKLLGCCI---HGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI--- 491
H+N+ L I +L +YE + L I + L D H
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQP--LTD----AHFQSF 110
Query: 492 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTN 549
I GL Y+H + ++HRDLK N+L++ D KI DFGLAR F E G
Sbjct: 111 IYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 550 RVVGTYGYMAPEYASDGQFSVKS-DVFSFGILLLEIVSGK---KNRGFYHSDNKLNLIRH 605
V T Y APE Q K+ DV+S G +L E++ K K + + +LN I
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQ 224
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 54/227 (23%), Positives = 105/227 (46%), Gaps = 14/227 (6%)
Query: 360 GTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRL 419
+ +++D + D +P + A A+ +++ K L G G V+ T + + V
Sbjct: 39 DSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVV--- 95
Query: 420 SKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQER 479
KI ++G + E +L + H +++++ + G ++ +P+ S D + + +R
Sbjct: 96 LKIGQKGTTLI--EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKR 150
Query: 480 CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539
+ L + I GL YLH RIIHRD+K N+ ++ I D G A+
Sbjct: 151 SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF- 206
Query: 540 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+ GT APE + +++ K+D++S GI+L E+++
Sbjct: 207 --PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 66/240 (27%), Positives = 110/240 (45%), Gaps = 39/240 (16%)
Query: 384 NATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQ--GLKELKNEIILFSKL 440
+ + +GEG +G V T ++A+K++S Q + L+ EI + +
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRF 60
Query: 441 QHRNLVKLLGCCIHG-----EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI---I 492
+H N++ +L + ++ E M L I Q L + HI +
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ---HLSN----DHIQYFL 112
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV- 551
RGL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR D +T +
Sbjct: 113 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLT 167
Query: 552 --VGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK-----KNRGFYHSDNKLNLI 603
V T Y APE + ++ D++S G +L E++S + K+ Y ++LNLI
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD---YL--HQLNLI 222
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 394 KLGEGGFGPVYKG-TLADEQEIAVKRLSKISEQGLK-ELKNEIILFSKLQHRNLVKLLGC 451
KLGEG + VYKG + + +A+K + E+G E+ L L+H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 452 CIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRI 510
IH E+ L L++E++ +K L ++ D + K F + RGL Y H R ++
Sbjct: 73 -IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRKV 125
Query: 511 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-YASDGQFS 569
+HRDLK N+L+++ K++DFGLARA T+ +N VV T Y P+ +S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVV-TLWYRPPDILLGSTDYS 183
Query: 570 VKSDVFSFGILLLEIVSGK 588
+ D++ G + E+ +G+
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 25/207 (12%)
Query: 393 KKLGEGGFGPV----YKGTLADEQEIAVKRLSK---ISEQGLKELKNEIILFSKL-QHRN 444
K LG+G FG V KGT ++ AVK L K + + ++ E + + +H
Sbjct: 1 KVLGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF 57
Query: 445 LVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSK-RFHIICGTARGLLYL 502
L +L C +++L + E++ L +F +R D + RF+ GL +L
Sbjct: 58 LTQLH-SCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAE-IVLGLQFL 112
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGDETEGNTNRVVGTYGYMAPE 561
H+ II+RDLK NVLLD + + KI+DFG+ + G T T+ GT Y+APE
Sbjct: 113 HERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAPE 166
Query: 562 YASDGQFSVKSDVFSFGILLLEIVSGK 588
S + D ++ G+LL E+++G+
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 8e-15
Identities = 86/294 (29%), Positives = 110/294 (37%), Gaps = 92/294 (31%)
Query: 387 DNFSINKKLGEGGFGPVYKGT---LADEQ---EIAVKRLSKISEQGLKE-LKNEIILFSK 439
DN K LG G FG V + T L E +AVK L + +E L +E+ + S
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 440 L-QHRNLVKLLGC-------------CIHG------------------------------ 455
L QH+N+V LLG C +G
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDY 157
Query: 456 ----EEKLLI--------------YEFMPNKSLDSFIFDQERCKL------LDWSKRFHI 491
EK I E P S S D + + LD
Sbjct: 158 KNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRF 217
Query: 492 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET---EGNT 548
A+G+ +L + IHRD+ A NVLL KI DFGLAR D +GN
Sbjct: 218 SSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274
Query: 549 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKK-------NRGFY 594
V +MAPE D ++V+SDV+S+GILL EI S GK N FY
Sbjct: 275 RLPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY 325
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 63/200 (31%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 393 KKLGEGGFGPVYKG-TLADEQEIAVKRLSKISEQGLK-ELKNEIILFSKLQHRNLVKLLG 450
+KLGEG + V+KG + E +A+K + E+G E+ L L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 451 CCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLR 509
+H ++ L L++E++ +K L ++ D + K F + RGL Y H R +
Sbjct: 72 I-VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRK 124
Query: 510 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-YASDGQF 568
++HRDLK N+L+++ K++DFGLARA T+ +N VV T Y P+ ++
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSSEY 182
Query: 569 SVKSDVFSFGILLLEIVSGK 588
S + D++ G + E+ SG+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 33/222 (14%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKE-----LKNEIILFSKLQ 441
D F I ++GEG +G VYK D E+ L K+ KE EI + +L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGEL--VALKKVRLDNEKEGFPITAIREIKILRQLN 64
Query: 442 HRNLVKLLGCCIHGEEKL----------LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI 491
HRN+V L ++ L L++E+M D + L+ +S+
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDH-- 117
Query: 492 ICGTAR----GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547
I + GL Y H+ + L HRD+K SN+LL+ K++DFGLAR + +E+
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 548 TNRVVGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 588
TN+V+ T Y PE + ++ DV+S G +L E+ + K
Sbjct: 175 TNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 53/205 (25%)
Query: 389 FSINKKLGEGGFGPVYKG---TLADEQEIAVKRL--SKISEQGLKELK-NEIILFSKLQH 442
+ I +G G +G VYK D +E A+K+ K G+ + EI L +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 443 RNLVKLLGCCIHGEEKL--LIYEF-------------------MPNKSLDSFIFDQERCK 481
N+V L+ + +K L++++ +P + S ++ +
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW-----Q 116
Query: 482 LLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLAR 537
+L+ G+ YLH + ++HRDLK +N+L+ + KI D GLAR
Sbjct: 117 ILN-------------GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
Query: 538 AFGGD-ETEGNTNRVVGTYGYMAPE 561
F + + + VV T Y APE
Sbjct: 161 LFNAPLKPLADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 395 LGEGGFGPV------YKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKL 448
LG+GGFG V G + +++ KRL K S + + L+ EI+ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 449 LGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRL 508
L+ M L I++ + L+ + H G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHS---M 114
Query: 509 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF 568
I++RD+K NVLLD N ++SD GLA +T + GT GYMAPE + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPY 171
Query: 569 SVKSDVFSFGILLLEIVSGK 588
S D F+ G + E+V+G+
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 384 NATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISE-QGLKELKNEIILFSKLQH 442
N ++F + +++G G +G VYK + E+A ++ K+ + ++ EII+ +H
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL 502
N+V G + ++ + EF SL L S+ ++ T +GL YL
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY---HVTGPLSESQIAYVSRETLQGLYYL 122
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562
H + +HRD+K +N+LL + + K++DFG++ T +GT +MAPE
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEV 177
Query: 563 AS---DGQFSVKSDVFSFGILLLEI 584
A+ G ++ D+++ GI +E+
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 395 LGEGGFGPV------YKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKL 448
LG+GGFG V G + +++ KR+ K +G NE + K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGESMALNEKQILEKVNSRFVVSL 65
Query: 449 LGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFH---IICGTARGLLYLHQD 505
+ L+ M L I+ + F+ I CG L LHQ+
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLHQE 121
Query: 506 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD 565
RI++RDLK N+LLD + +ISD GLA +T VGT GYMAPE +
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKN 175
Query: 566 GQFSVKSDVFSFGILLLEIVSGK 588
+++ D ++ G LL E+++G+
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 34/92 (36%), Positives = 56/92 (60%), Gaps = 6/92 (6%)
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
RGL YL + + +I+HRD+K SN+L++ K+ DFG++ G + N VGT
Sbjct: 110 RGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRS 163
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
YM+PE ++V+SD++S G+ L+E+ G+
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 78/243 (32%), Positives = 117/243 (48%), Gaps = 40/243 (16%)
Query: 393 KKLGEGGFGPVY---KGTLADEQEI-AVKRLSKISEQGLK-----ELKNEIILFSKLQHR 443
K LG+G FG V+ K T D ++ A+K L K + LK K E + +++ H
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHP 58
Query: 444 NLVKLLGCCIHGEEKL-LIYEFMPNKSL-----DSFIFDQERCKLLDWSKRFHIICGTAR 497
+VKL E KL LI +F+ L +F +E K + A
Sbjct: 59 FIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--------LAELAL 109
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 557
L +LH L II+RDLK N+LLD++ + K++DFGL++ + E GT Y
Sbjct: 110 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEY 164
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK--LNLIRHAWKLWNEGMP 615
MAPE + + +D +SFG+L+ E+++G + F D K + +I A KL GMP
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG--SLPFQGKDRKETMTMILKA-KL---GMP 218
Query: 616 SQL 618
L
Sbjct: 219 QFL 221
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 46/226 (20%)
Query: 387 DNFSINKKLGEGGFGPVYK------GTLADEQEIAVKRL-SKISEQGLKELKNEI-ILFS 438
D+ + ++LG G +G V K GT+ +AVKR+ + ++ Q K L ++ I
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTI-----MAVKRIRATVNSQEQKRLLMDLDISMR 55
Query: 439 KLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRF------HII 492
+ V G + + E M + SLD F K+ D I
Sbjct: 56 SVDCPYTVTFYGALFREGDVWICMEVM-DTSLDKFYK-----KVYDKGLTIPEDILGKIA 109
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-TNRV 551
+ L YLH S+L +IHRD+K SNVL++++ K+ DFG++ G + V
Sbjct: 110 VSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS---------GYLVDSV 158
Query: 552 V-----GTYGYMAPEY----ASDGQFSVKSDVFSFGILLLEIVSGK 588
G YMAPE + + VKSDV+S GI ++E+ +G+
Sbjct: 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLS---KISEQGLKELKNEIILFSKLQH 442
D+ K +G G FG V+ E A+K ++ I + + + NE + ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 443 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFH---IICGTARG 498
+++L H + L ++ E++P L S++ + + + + F+ I+C
Sbjct: 61 PFIIRLF-WTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCA---- 113
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
L YLH I++RDLK N+LLD++ + K++DFG A+ + T + GT Y+
Sbjct: 114 LEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYL 165
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVSGK 588
APE + D ++ GIL+ E++ G
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 47/195 (24%)
Query: 394 KLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQ------GLKELKNEIILFSKLQHRNLV 446
K+G+G FG V+K ++I A+K++ +E+ L+E+K IL L+H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK---IL-QLLKHENVV 74
Query: 447 KLLGCCIHGEEK---------LLIYEF--------MPNKSLDSFIFDQERCKLLDWSKRF 489
L+ C + L++EF + NK++ F K
Sbjct: 75 NLIEIC-RTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIK-------- 122
Query: 490 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-- 547
++ GL Y+H R +I+HRD+KA+N+L+ +D K++DFGLARAF +
Sbjct: 123 KVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 548 -TNRVVGTYGYMAPE 561
TNRVV T Y PE
Sbjct: 180 YTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 22/208 (10%)
Query: 393 KKLGEGGFGPVYKG---TLADEQEIAVKRL---SKISEQGLKELKNEIILFSKLQHRNLV 446
++G G FG V G + + VK L + EQ L E+ + +L H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL--FLQEVQPYRELNHPNVL 58
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRF--HIICGTARGLLYLHQ 504
+ LG CI LL+ EF P L +++ K + C A GLL+LHQ
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 505 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGDETEGNTNRVVGTYGYMAPEYA 563
IH DL N L D++ KI D+GLA + D V ++APE
Sbjct: 119 ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELV 174
Query: 564 SDGQFSV-------KSDVFSFGILLLEI 584
+ KS+++S G+ + E+
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 32/208 (15%)
Query: 395 LGEGGFGPV----YKGTLADEQEIAVKRLSK---ISEQGLKELKNEIILF---SKLQHRN 444
LG G FG V YK T + A+K L K I+ ++ L E +F + +H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFI----FDQERCKLLDWSKRFHIICGTARGLL 500
LV L C + + E+ L I F + R F+ C GL
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAV-------FYAAC-VVLGLQ 115
Query: 501 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGDETEGNTNRVVGTYGYMA 559
YLH++ +I++RDLK N+LLD + KI+DFGL + G + T+ GT ++A
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFLA 169
Query: 560 PEYASDGQFSVKSDVFSFGILLLEIVSG 587
PE ++ ++ D + G+L+ E++ G
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 393 KKLGEGGFGPVY---KGTLADEQEI-AVKRLSKISEQGLKELKNE-IILFSKLQHRNLVK 447
K + +G FG VY K + D I +K+ I++ + +K E I+ + + + K
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLL-----DWSKRFHIICGTARGLLYL 502
L + L+ E++ S I K L DW+K++ I G+ L
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLI------KTLGGLPEDWAKQY--IAEVVLGVEDL 113
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562
HQ IIHRD+K N+L+DQ + K++DFGL+R G E + + VGT Y+APE
Sbjct: 114 HQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLENK----KFVGTPDYLAPET 164
Query: 563 ASDGQFSVKSDVFSFGILLLEIVSG 587
SD +S G ++ E + G
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 18/208 (8%)
Query: 384 NATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQG--LKELKNEIILFSKLQ 441
N ++ + +++G G +G VYK E+A ++ K+ E G ++ EI + + +
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL-EPGDDFSLIQQEIFMVKECK 64
Query: 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSL-DSFIFDQERCKLLDWSKRFHIIC-GTARGL 499
H N+V G + E+ + E+ SL D + +L + +C T +GL
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL-----QIAYVCRETLQGL 119
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 559
YLH ++ HRD+K +N+LL + + K++DFG+A T +GT +MA
Sbjct: 120 AYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMA 174
Query: 560 PEYAS---DGQFSVKSDVFSFGILLLEI 584
PE A+ +G ++ D+++ GI +E+
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-14
Identities = 72/221 (32%), Positives = 99/221 (44%), Gaps = 45/221 (20%)
Query: 389 FSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELK------NEIILFSKLQ 441
F + LG+GGFG V + A + A K+L K + +K+ K NE + K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVN 58
Query: 442 HRNLVKLL-------GCCI------HGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKR 488
R +V L C+ G+ K IY FD+ER
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG------FDEERAVFY----A 108
Query: 489 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 548
I CG L LH R RI++RDLK N+LLD + +ISD GLA EG T
Sbjct: 109 AEITCG----LEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEI----PEGET 157
Query: 549 NR-VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
R VGT GYMAPE + +++ D + G L+ E++ GK
Sbjct: 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 78/269 (28%), Positives = 108/269 (40%), Gaps = 74/269 (27%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQE------IAVKRL---SKISEQGLKELKNEI-IL 436
D + K LG G FG V + + ++ +AVK L + SE K L E+ IL
Sbjct: 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEY--KALMTELKIL 64
Query: 437 FSKLQHRNLVKLLGCCIHGEEKLLI------------------YEFMPNKS--------- 469
H N+V LLG C L++ F P ++
Sbjct: 65 IHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMK 124
Query: 470 --------LDS-----------FIFD------QERCKLLDWSKRF----HIICGT---AR 497
LDS FI D +E + + K +I + AR
Sbjct: 125 QKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVAR 184
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 557
G+ +L SR + IHRDL A N+LL ++ KI DFGLAR D +
Sbjct: 185 GMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVS 586
MAPE D ++ +SDV+SFG+LL EI S
Sbjct: 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 57/192 (29%), Positives = 87/192 (45%), Gaps = 32/192 (16%)
Query: 411 EQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 468
Q +A+K+LS+ + K E++L + H+N++ LL F P K
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FTPQK 88
Query: 469 SLDSF--------IFDQERCK----LLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 516
SL+ F + D C+ LD + +++ G+ +LH IIHRDLK
Sbjct: 89 SLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 145
Query: 517 ASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFS 576
SN+++ D KI DFGLAR G T VV Y Y APE + D++S
Sbjct: 146 PSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWS 202
Query: 577 FGILLLEIVSGK 588
G ++ E++ G
Sbjct: 203 VGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-13
Identities = 30/81 (37%), Positives = 43/81 (53%), Gaps = 6/81 (7%)
Query: 222 SREDGFIKFTAMKLPDATPSWVSKSMNLKECREKCLE-NSSCMAYTNSDIRGGGSGCAMW 280
+D F++ KLP + +S +L+EC KCL N SC ++T ++ G GC +W
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNN---GTKGCLLW 56
Query: 281 -FGELIDMRDFPDGGQDLYIR 300
L D R FP GG DLY +
Sbjct: 57 SESSLGDARLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 37/213 (17%)
Query: 393 KKLGEGGFGPV---YKGTLADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVK 447
K +G G G V Y L E+ +A+K+LS+ ++ K E++L + H+N++
Sbjct: 30 KPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSF--------IFDQERCKL----LDWSKRFHIICGT 495
LL F P KSL+ F + D C++ LD + +++
Sbjct: 88 LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 555
G+ +LH IIHRDLK SN+++ D KI DFGLAR G T V T
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTR 189
Query: 556 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
Y APE + D++S G ++ E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHR--- 443
D+F +LG G G V K I ++L + + ++N+II ++ H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNS 62
Query: 444 -NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL 502
+V G E + E M SLD + + +R K + RGL YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---VSIAVLRGLAYL 119
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562
+ + +I+HRD+K SN+L++ K+ DFG++ G + N VGT YM+PE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173
Query: 563 ASDGQFSVKSDVFSFGILLLEIVSGK 588
+SV+SD++S G+ L+E+ G+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 69/212 (32%), Positives = 102/212 (48%), Gaps = 35/212 (16%)
Query: 393 KKLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQGLKELKNEIILFSK------LQHRNL 445
K LG+G FG V L E A+K L K + L++ E + + +H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKK--DVVLEDDDVECTMVERRVLALAWEHPFL 58
Query: 446 VKLLGCCIHGEEKLL-IYEFMPNKSL-----DSFIFDQERCKLLDWSKRFH---IICGTA 496
L C +E L + E++ L S FD+ R RF+ IICG
Sbjct: 59 THLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARA-------RFYAAEIICG-- 108
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
L +LH+ II+RDLK NVLLD+D + KI+DFG+ + E + +T GT
Sbjct: 109 --LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPD 161
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
Y+APE +++ D +SFG+LL E++ G+
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 43/214 (20%)
Query: 395 LGEGGFGPVYKGTLAD-EQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGC 451
+G G +G V +++A+K+LS+ S K E+ L + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 452 CIHGEEKLLIYEFMPNKSLDSF----------------IFDQERCKLLDWSKRFHIICGT 495
F P SL+ F I + KL D +F ++
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQ--KLSDDHIQF-LVYQI 127
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 555
RGL Y+H IIHRDLK SN+ +++D KI DFGLAR T+ V T
Sbjct: 128 LRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATR 179
Query: 556 GYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGK 588
Y APE + ++ D++S G ++ E+++GK
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 41/214 (19%)
Query: 395 LGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKN-----EIILFSKLQHR--NLV 446
+G G G VYK +AVK++ + + +E K +++L S H +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKS---HDCPYIV 77
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRF-------HIICGTARGL 499
K G I + + E M S D KLL + + + L
Sbjct: 78 KCYGYFITDSDVFICMELM------STCLD----KLLKRIQGPIPEDILGKMTVAIVKAL 127
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN-RVVGTYGYM 558
YL + +IHRD+K SN+LLD N K+ DFG++ G + R G YM
Sbjct: 128 HYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS----GRLVDSKAKTRSAGCAAYM 181
Query: 559 APEY----ASDGQFSVKSDVFSFGILLLEIVSGK 588
APE + ++ +++DV+S GI L+E+ +G+
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 389 FSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRN 444
F + LG+GGFG V + A + A KRL K +G NE + K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFH---IICGTARGLLY 501
+V L + L+ M L I++ + F+ I+CG L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----LED 117
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA-RAFGGDETEGNTNRVVGTYGYMAP 560
LH+++ ++RDLK N+LLD + +ISD GLA + G+ G VGT GYMAP
Sbjct: 118 LHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAP 170
Query: 561 EYASDGQFSVKSDVFSFGILLLEIVSGK 588
E ++ ++++ D + G L+ E++ G+
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 41/215 (19%)
Query: 393 KKLGEGGFGPVYKGTLA----DEQEIAVKRL--SKISEQGLKELKNEIILFSKLQHRNLV 446
KK+GEG FG K L D ++ +K + SK+S + +E + E+ + S ++H N+V
Sbjct: 6 KKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62
Query: 447 KL------LGC-------CIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIIC 493
+ G C G+ +Y+ + + F DQ +LDW F IC
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGD----LYKKINAQRGVLFPEDQ----ILDW---FVQIC 111
Query: 494 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 553
L ++H +I+HRD+K+ N+ L +D K+ DFG+AR T +G
Sbjct: 112 ---LALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIG 163
Query: 554 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
T Y++PE + ++ KSD+++ G +L E+ + K
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 39/211 (18%)
Query: 394 KLGEGGFGPVYKG-TLADEQEIAVKRLSKISEQGLK-ELKNEIILFSKLQHRNLVKLLGC 451
KLGEG + VYKG + Q +A+K + E+G E L L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHD 70
Query: 452 CIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKR-----------FHIICGTARGL 499
IH ++ L L++E++ D + + +D F ++ RGL
Sbjct: 71 IIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLL----RGL 116
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 559
Y HQ R++HRDLK N+L+ + K++DFGLARA ++ +N VV T Y
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARA-KSVPSKTYSNEVV-TLWYRP 171
Query: 560 PEY---ASDGQFSVKSDVFSFGILLLEIVSG 587
P+ +++ +S D++ G + E+ +G
Sbjct: 172 PDVLLGSTE--YSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 74/273 (27%), Positives = 127/273 (46%), Gaps = 34/273 (12%)
Query: 393 KKLGEGGFGPVYKGTL----ADEQEIAVKRLS--KISEQGLKELKNEIILFSKLQHRNLV 446
+ +G+G +G V +L D ++ +K+L+ S + K + E L S+L+H N+V
Sbjct: 6 RVVGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 447 KLLGCCIHGEEKLL--IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ 504
GE+ LL + F L + +++ KLL ++ A L YLH+
Sbjct: 63 AYRESW-EGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 505 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS 564
I+HRDLK NV L + K+ D G+AR +T ++GT YM+PE S
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFS 175
Query: 565 DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624
+ ++ KSDV++ G + E+ + K H+ N ++ +++ +P D
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLK------HAFNAKDMNSLVYRIIEGKLPPMPKDY--- 226
Query: 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI 657
S L E+I +L + PE RP + S++
Sbjct: 227 -SPELGELIA----TMLSKR--PEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 395 LGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLK-ELKNEIILFSKLQHRNLVKLL 449
LG+G FG V L + + AVK L K + + ++ + + IL H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 450 GCCIHGEEKLL-IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRL 508
CC ++L + EF+ L +F ++ + D ++ L++LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG-- 116
Query: 509 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF 568
II+RDLK NVLLD + + K++DFG+ + G T+ GT Y+APE + +
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKE--GIFNGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 569 SVKSDVFSFGILLLEIVSG 587
D ++ G+LL E++ G
Sbjct: 174 GPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 66/202 (32%), Positives = 108/202 (53%), Gaps = 17/202 (8%)
Query: 393 KKLGEGGFGPVYKG-TLADEQEIAVKRLSKISEQGLK-ELKNEIILFSKLQHRNLVKLLG 450
+KLGEG + VYKG + + Q +A+K +S +E+G+ E L L+H N+V LL
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLH 69
Query: 451 CCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLR 509
IH +E L ++E+M + L ++ Q L ++ R + RGL Y+H
Sbjct: 70 DIIHTKETLTFVFEYM-HTDLAQYMI-QHPGGLHPYNVRLFMF-QLLRGLAYIH---GQH 123
Query: 510 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY---ASDG 566
I+HRDLK N+L+ K++DFGLARA ++ ++ VV T Y P+ A+D
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-TLWYRPPDVLLGATD- 180
Query: 567 QFSVKSDVFSFGILLLEIVSGK 588
+S D++ G + +E++ G+
Sbjct: 181 -YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 64/200 (32%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 394 KLGEGGFGPVYKG-TLADEQEIAVKRLSKISEQGLK-ELKNEIILFSKLQHRNLVKLLGC 451
KLGEG + V+KG + E +A+K + E+G E+ L L+H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 452 CIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI-ICGTARGLLYLHQDSRLR 509
IH E L L++E++ + L ++ + C L I + RGL Y H + +
Sbjct: 72 -IHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 510 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-YASDGQF 568
I+HRDLK N+L+++ K++DFGLARA T+ +N VV T Y P+ ++
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 569 SVKSDVFSFGILLLEIVSGK 588
S D++ G +L E+ +G+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 379 LATIANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK------ISEQGLKELK 431
T+ T+ + + +G G FG V Q +A+K++ K ++++ +ELK
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 432 NEIILFSKLQHRNLVKLLGCCIHGEEKL-LIYEFMP---NKSLDSFIFDQERCKLLDWSK 487
L L+H N++ L I E + + E + ++ L S +++ +
Sbjct: 62 ----LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYF---- 113
Query: 488 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547
+ I+ RGL Y+H ++HRDLK SN+L++++ + KI DFGLAR +
Sbjct: 114 LYQIL----RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQ 161
Query: 548 TNRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGK 588
V T Y APE Q + V+ D++S G + E++ GK
Sbjct: 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 53/235 (22%)
Query: 391 INKKLGEGGFGPVYKG-TLADEQEIAVKR--LSKISEQGLKELKN------------EII 435
LGEG +G V K + +A+K+ + +IS K+ + E+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 436 LFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN---KSLDSFIF---DQERCKLLDWSKRF 489
+ ++++H N++ L+ + G+ L+ + M + K +D I Q +C LL
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILL------ 126
Query: 490 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD------- 542
I+ GL LH+ +HRDL +N+ ++ KI+DFGLAR +G
Sbjct: 127 QIL----NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 543 ------ETEGNTNRVVGTYGYMAPEY---ASDGQFSVKSDVFSFGILLLEIVSGK 588
E T++VV T Y APE A F+V D++S G + E+++GK
Sbjct: 180 KDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 388 NFSINKKLGEGGFGPVY---KGTLADEQEI-AVKRLSKIS----EQGLKELKNEIILFSK 439
NF + + LG G +G V+ K D ++ A+K L K + + + + E +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 440 LQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARG 498
++ + L + KL LI +++ L + ++ +E + R +I A
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESE--VRVYI----AEI 114
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
+L L +L II+RD+K N+LLD + + ++DFGL++ F +E E GT YM
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 559 APEY--ASDGQFSVKSDVFSFGILLLEIVSG 587
APE G D +S G+L E+++G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 393 KKLGEGGFGPVYKGTLADEQE-IAVKRLSK----ISEQGLKELKNEIILFSKLQHRNLVK 447
K LG+G FG V L + E AVK L K I + + + +L ++ L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 448 LLGCCIHGEEKLL-IYEFMPNKSLDSFIFDQERCKLLDWSKRFH---IICGTARGLLYLH 503
L C +E L + EF+ L I D+ R L + F+ I+CG L +LH
Sbjct: 61 LY-CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAEIVCG----LQFLH 113
Query: 504 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR--AFGGDETEGNTNRVVGTYGYMAPE 561
II+RDLK NV+LD+D + KI+DFG+ + FG + + GT Y+APE
Sbjct: 114 SKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTPDYIAPE 166
Query: 562 YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK 599
+++ D +SFG+LL E++ G+ +H D++
Sbjct: 167 ILQGLKYTFSVDWWSFGVLLYEMLIGQSP---FHGDDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-13
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 37/213 (17%)
Query: 393 KKLGEGGFGPV---YKGTLADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVK 447
K +G G G V Y L ++ +A+K+LS+ ++ K E++L + H+N++
Sbjct: 23 KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSF--------IFDQERCKL----LDWSKRFHIICGT 495
LL F P KSL+ F + D C++ LD + +++
Sbjct: 81 LLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 128
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 555
G+ +LH IIHRDLK SN+++ D KI DFGLAR G T V T
Sbjct: 129 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTR 182
Query: 556 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
Y APE + D++S G ++ E+V K
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-13
Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 39/226 (17%)
Query: 381 TIANATDNFSINKKLGEGGFGPVYKGTLADEQ-EIAVKRLSKISEQGL--KELKNEIILF 437
TI + + +G G +G V +AVK+LS+ + + K E+ L
Sbjct: 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 438 SKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSF-------------IFDQERC-KLL 483
++H N++ LL F P +SL+ F + + +C KL
Sbjct: 71 KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 118
Query: 484 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543
D +F +I RGL Y+H IIHRDLK SN+ +++D KI DFGLAR DE
Sbjct: 119 DDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDE 173
Query: 544 TEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGK 588
G V T Y APE + ++ D++S G ++ E+++G+
Sbjct: 174 MTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 388 NFSINKKLGEGGFG-PVYKGTLADEQEIAVK--RLSKISEQGLKELKNEIILFSKLQHRN 444
+++ + +GEG FG + + +Q+ A+K RL K S +++ + E +L +K++H N
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPN 59
Query: 445 LVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKL------LDWSKRFHIICGTAR 497
+V + L ++ E+ L I Q R KL L W F +C
Sbjct: 60 IVAFKES-FEADGHLYIVMEYCDGGDLMQKIKLQ-RGKLFPEDTILQW---FVQMC---L 111
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 557
G+ ++H+ R++HRD+K+ N+ L Q+ K+ DFG AR T VGT Y
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYY 166
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
+ PE + ++ KSD++S G +L E+ + K
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 77/276 (27%), Positives = 110/276 (39%), Gaps = 82/276 (29%)
Query: 387 DNFSINKKLGEGGFGPVYKGT------LADEQEIAVKRLSKISEQG-----LKELKNEII 435
D + K LG G FG V + A + +AVK L + + + ELK I
Sbjct: 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---I 63
Query: 436 LFSKLQHRNLVKLLGCCIHGEEKLLIY------------------EFMPNKS-------- 469
L H N+V LLG C L++ EF+P K+
Sbjct: 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQG 123
Query: 470 --------------LDS-----------FIFDQERCKLL-------DWSKRF----HIIC 493
LDS F+ ++ + D K+ +IC
Sbjct: 124 KSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLIC 183
Query: 494 GT---ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 550
+ A+G+ +L SR + IHRDL A N+LL ++ KI DFGLAR D
Sbjct: 184 YSFQVAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 551 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+MAPE D ++++SDV+SFG+LL EI S
Sbjct: 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 64/222 (28%), Positives = 108/222 (48%), Gaps = 42/222 (18%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQG----LKELKNEIILFSKLQ 441
D + ++ EG +G VY+ EI A+K+L K+ ++ + L+ EI + KLQ
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLR-EINILLKLQ 62
Query: 442 HRNLVKL----LGCCIHGEEKLLIYEFMPN--KSL-----DSFIFDQERC---KLLDWSK 487
H N+V + +G + + ++ E++ + KSL F+ + +C +LL
Sbjct: 63 HPNIVTVKEVVVGSNLD--KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLL---- 116
Query: 488 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547
G+ +LH + I+HRDLK SN+LL+ KI DFGLAR +G
Sbjct: 117 ---------SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG--SPLKP 162
Query: 548 TNRVVGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 588
++V T Y APE ++S D++S G + E+++ K
Sbjct: 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 31/208 (14%)
Query: 395 LGEGGFGPV------YKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKL 448
LG+GGFG V G + +++ KR+ K +G NE + K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKRILEKVNSRFVVSL 65
Query: 449 LGCCIHGEEKLLIYEFMPNKSLDSFI-------FDQERCKLLDWSKRFHIICGTARGLLY 501
+ L+ M L I FD++R + CG
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY----AAELCCG------- 114
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR-VVGTYGYMAP 560
L R RI++RDLK N+LLD + +ISD GLA EG T R VGT GYMAP
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI----PEGETVRGRVGTVGYMAP 170
Query: 561 EYASDGQFSVKSDVFSFGILLLEIVSGK 588
E ++ +++ D + G L+ E++ G+
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHR--- 443
D+F +LG G G V+K + I ++L + + ++N+II ++ H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNS 62
Query: 444 -NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL 502
+V G E + E M SLD + R K + +GL YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYL 119
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562
+ + +I+HRD+K SN+L++ K+ DFG++ G + N VGT YM+PE
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173
Query: 563 ASDGQFSVKSDVFSFGILLLEIVSGK 588
+SV+SD++S G+ L+E+ G+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 393 KKLGEGGFGPVYKGTL-ADEQEIAVKRLSK----ISEQGLKELKNEIILFSKLQHRNLVK 447
K LG+G FG V+ L Q A+K L K + + + + +L +H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 448 LLGCCIHGEEKLL-IYEFMPNKSLDSFIFDQERCKLLDWSK-RFH---IICGTARGLLYL 502
L C +E L + E++ L +F + C D + F+ IICG L +L
Sbjct: 61 LY-CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICG----LQFL 112
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGDETEGNTNRVVGTYGYMAPE 561
H I++RDLK N+LLD D + KI+DFG+ + GD T GT Y+APE
Sbjct: 113 HSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTCTFCGTPDYIAPE 166
Query: 562 YASDGQFSVKSDVFSFGILLLEIVSGK 588
+++ D +SFG+LL E++ G+
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 32/188 (17%)
Query: 414 IAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLD 471
+AVK+LS+ ++ K E++L + H+N++ LL F P KSL+
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQKSLE 96
Query: 472 SF--------IFDQERCKL----LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 519
F + D C++ LD + +++ G+ +LH IIHRDLK SN
Sbjct: 97 EFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 153
Query: 520 VLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGI 579
+++ D KI DFGLAR + T VV Y Y APE + D++S G
Sbjct: 154 IVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 210
Query: 580 LLLEIVSG 587
++ E+V G
Sbjct: 211 IMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 393 KKLGEGGFGPVYKGTLADEQE-IAVKRLSKISEQGLKELKN--EIILFSKLQHRNLVKLL 449
K +G G +G V ++ E +A+K+++ + + + EI L L H N++ +
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 450 GCC--IHGE---EKLLIYEFMPNKSLDSFI-----FDQERCKLLDWSKRFHIICGTARGL 499
H E + ++YE M + L I + C+ + ++ RGL
Sbjct: 71 DIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYF----LYQLL----RGL 121
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 559
Y+H + ++HRDLK SN+LL+ + + KI DFGLAR E V T Y A
Sbjct: 122 KYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVTRWYRA 176
Query: 560 PE-YASDGQFSVKSDVFSFGILLLEIVSGK 588
PE + +++ DV+S G + E++ K
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 68/262 (25%), Positives = 116/262 (44%), Gaps = 60/262 (22%)
Query: 387 DNFSINKKLGEGGFGPVYKG-TLADEQEIAVKR-LSKISEQGLKELK-NEIILFSKLQHR 443
D + +K+GEG +G VYK + +A+K+ ++ E+G+ EI L L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 444 N-LVKLLGCCIHGEEKL------LIYEF-------------------MPNKSLDSFIFDQ 477
+V+LL H EEK L++E+ +P K++ SF++
Sbjct: 61 IYIVRLL-DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMY-- 117
Query: 478 ERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLA 536
+ K G+ + H + ++HRDLK N+L+D+ KI+D GL
Sbjct: 118 QLLK----------------GVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158
Query: 537 RAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYH 595
RAF + T+ +V T Y APE +S D++S G + E+ + +
Sbjct: 159 RAF-SIPVKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP---LFP 213
Query: 596 SDNKLNLIRHAWKLWNEGMPSQ 617
D++L + H +KL G P++
Sbjct: 214 GDSELQQLLHIFKLL--GTPTE 233
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 39/212 (18%)
Query: 395 LGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGL--KELKNEIILFSKLQHRNLVKLLGC 451
+G G +G V Q++AVK+LS+ + + + E+ L ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 452 CIHGEEKLLIYEFMPNKSLDSF-------------IFDQERC-KLLDWSKRFHIICGTAR 497
F P S+++F + + +C KL D +F +I R
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-LIYQLLR 129
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 557
GL Y+H IIHRDLK SNV +++D +I DFGLAR DE G V T Y
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRWY 181
Query: 558 MAPEYASDG-QFSVKSDVFSFGILLLEIVSGK 588
APE + ++ D++S G ++ E++ GK
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 393 KKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLK-ELKNEIILFSKLQHRNLVK 447
K LG+G FG V L E+ A+K L K + + + + + IL +H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 448 LLGCCIHGEEKLL-IYEFMPNKSLDSFIFDQERCKLLDWSK-RFHIICGTARGLLYLHQD 505
L CC +++L + E++ L +F +R + D + RF+ T L++LH+
Sbjct: 61 LH-CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTL-ALMFLHRH 115
Query: 506 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD 565
+I+RDLK N+LLD + + K++DFG+ + G T GT Y+APE +
Sbjct: 116 G---VIYRDLKLDNILLDAEGHCKLADFGMCKE--GILNGVTTTTFCGTPDYIAPEILQE 170
Query: 566 GQFSVKSDVFSFGILLLEIVSGK 588
++ D ++ G+L+ E+++G+
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 387 DNFSINKKLGEGGFGPVYKG-TLADEQEIAVKRLSKISEQGLK-ELKNEIILFSKLQHRN 444
D++ +KLGEG + VYKG + + + +A+K + E+G E L L+H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 445 LVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH 503
+V LL IH +E L L++E++ + L ++ + K F + RGL Y+H
Sbjct: 65 IV-LLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLF--LFQLLRGLSYIH 120
Query: 504 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-Y 562
Q I+HRDLK N+L+ K++DFGLARA + +N VV T Y P+
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVV-TLWYRPPDVL 175
Query: 563 ASDGQFSVKSDVFSFGILLLEIVSG 587
++S D++ G + +E++ G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 9/95 (9%)
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA--FGGDETEGNTNRVVG 553
A GL +LH II+RDLK NV+LD + + KI+DFG+ + FGG T G
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFCG 163
Query: 554 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
T Y+APE + + D ++FG+LL E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 394 KLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQGL--KELKNEIILFSKLQHRNLVKLLG 450
K+GEG +G V+K + +I A+K+ + + + K EI + +L+H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 451 CCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRI 510
+ L++E+ + L+ ++ + + II T + + + H+
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHK---HNC 121
Query: 511 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY-ASDGQFS 569
IHRD+K N+L+ + K+ DFG AR G + V T Y APE D Q+
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTG--PGDDYTDYVATRWYRAPELLVGDTQYG 179
Query: 570 VKSDVFSFGILLLEIVSG 587
DV++ G + E+++G
Sbjct: 180 PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 395 LGEGGFGPVYKGTLADEQEI-AVKRLSKIS---EQGLKELKNEIILFSKLQHRN--LVKL 448
+G GGFG VY AD ++ A+K L K +QG NE I+ S + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 449 LGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFH---IICGTARGLLYLHQ 504
+ H +KL I + M L + + + RF+ II G H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLE------HM 113
Query: 505 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS 564
+R +++RDLK +N+LLD+ + +ISD GLA F + + VGT+GYMAPE
Sbjct: 114 HNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQ 168
Query: 565 DGQ-FSVKSDVFSFGILLLEIVSG 587
G + +D FS G +L +++ G
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 67/210 (31%), Positives = 94/210 (44%), Gaps = 36/210 (17%)
Query: 395 LGEGGFGPVYKGTLADEQEI-AVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLG 450
+G GGFG VY AD ++ A+K L K +QG NE I+ S LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55
Query: 451 C----CIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL---- 502
C C + Y F L SFI D L + H + A Y
Sbjct: 56 CPFIVC-------MSYAFHTPDKL-SFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107
Query: 503 ----HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
H +R +++RDLK +N+LLD+ + +ISD GLA F + + VGT+GYM
Sbjct: 108 LGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYM 162
Query: 559 APEYASDG-QFSVKSDVFSFGILLLEIVSG 587
APE G + +D FS G +L +++ G
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 63/200 (31%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 393 KKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEI----ILFSKLQHRNLVK 447
K +G+G FG V +D AVK L K + KE + + +L L+H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSR 507
L E+ + +++ L F +ERC L+ RF+ A + YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGEL-FFHLQRERC-FLEPRARFYA-AEVASAIGYLHS--- 114
Query: 508 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ 567
L II+RDLK N+LLD + ++DFGL + G E E T+ GT Y+APE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 568 FSVKSDVFSFGILLLEIVSG 587
+ D + G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
RGL YLH I+HRD+K N+L++ + KI DFGLAR DE++ T VV Y
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 557 YMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGK 588
Y APE + ++ D++S G + E++ +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 55/225 (24%), Positives = 89/225 (39%), Gaps = 52/225 (23%)
Query: 391 INKKLGEGGFGPVYK----GTLADEQEIAVKR--LSKISEQGLKELKNEIILFSKLQHRN 444
I K + + K TL +AVK+ L S++ LK L+ EII +LQH N
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTL-----VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFH------------II 492
++ + I E ++ M S C+ L + H I+
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGS----------CEDL---LKTHFPEGLPELAIAFIL 107
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 552
L Y+H IHR +KAS++LL D +S + + G RVV
Sbjct: 108 KDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM---IKHGKRQRVV 161
Query: 553 GTYG--------YMAPE--YASDGQFSVKSDVFSFGILLLEIVSG 587
+ +++PE + ++ KSD++S GI E+ +G
Sbjct: 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 393 KKLGEGGFGPVYKGTL---ADEQEIAVKRL-SKISEQGLKELKNEIILFSKLQHRNLVKL 448
K++G G FG V G + ++ VK L S Q + E + LQH NL++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 449 LGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLL--DWSKRFHIICGTARGLLYLHQDS 506
LG C LL+ EF P L ++ + +L+ D + + C A GLL+LH+++
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD- 565
IH DL N LL D+ KI D+GL+ ++ +++ ++APE +
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 566 -GQFSV-----KSDVFSFGILLLEIVSGKKNRGFYHSDNKL 600
G V +S+V+S G+ + E+ + SD ++
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV 218
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 64/239 (26%), Positives = 104/239 (43%), Gaps = 51/239 (21%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQGLKELKNEIILFSKLQHRN- 444
D+F + K +G G FG V+ D ++ A+K L K +K +N+I R+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRK--SDMIK--RNQIAHV--RAERDI 54
Query: 445 --------LVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGT 495
+VKL EE L L+ E+MP L + + ++ + + RF+I
Sbjct: 55 LADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDV--FPEETARFYI---- 107
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG-GDETEGNTNR---- 550
A +L L +L IHRD+K N+L+D D + K++DFGL + + E N
Sbjct: 108 AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 551 ----------------------VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 587
VGT Y+APE + ++ D +S G++L E++ G
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 393 KKLGEGGFGPVYKGT-LADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLL 449
K++G G +G V +++A+K+LS+ SE K E+ L +QH N++ LL
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80
Query: 450 G---CCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+ G+E Y MP D + L K +++ GL Y+H
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG 137
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 566
IIHRDLK N+ +++D KI DFGLAR + T V T Y APE +
Sbjct: 138 ---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YVVTRWYRAPEVILNW 189
Query: 567 -QFSVKSDVFSFGILLLEIVSGK 588
++ D++S G ++ E+++GK
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 26/204 (12%)
Query: 394 KLGEGGFGPVYKG-TLADEQEIAVKRLSKISEQGLKELKN--EIILFSKLQ-HRNLVKLL 449
K+GEG F V K + + A+K + K + L+++ N EI +L H N+++L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL- 63
Query: 450 GCCIHGEEKL----LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD 505
+ + K L++E M + +L I ++R L + + + L ++H++
Sbjct: 64 -IEVLFDRKTGRLALVFELM-DMNLYELIKGRKRP--LPEKRVKSYMYQLLKSLDHMHRN 119
Query: 506 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTNRVVGTYGYMAPE-Y 562
I HRD+K N+L+ D K++DFG R TE + T Y APE
Sbjct: 120 G---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE-----YISTRWYRAPECL 170
Query: 563 ASDGQFSVKSDVFSFGILLLEIVS 586
+DG + K D+++ G + EI+S
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 388 NFSINKKLGEGGFGPVY---KGTLADEQEI-AVKRLSKIS----EQGLKELKNEIILFSK 439
NF + K LG G +G V+ K + D ++ A+K L K + + + + E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 440 LQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARG 498
++ + L + KL LI +++ L + + +ER K + I G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEI-- 114
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
+L L +L II+RD+K N+LLD + + ++DFGL++ F DE E GT YM
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173
Query: 559 APEY--ASDGQFSVKSDVFSFGILLLEIVSG 587
AP+ DG D +S G+L+ E+++G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 40/91 (43%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 555
ARG+ +L SR + IHRDL A N+LL ++ KI DFGLAR D
Sbjct: 184 ARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 556 GYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+MAPE D ++ +SDV+SFG+LL EI S
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 394 KLGEGGFGPVYK------GTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVK 447
+LG+G +G VYK G +EI RL + E ++ E+ + K +V
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE-LDESKFNQIIMELDILHKAVSPYIVD 63
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSR 507
G + E+M SLD + + I +GL +L ++
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE-- 121
Query: 508 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG- 566
IIHRD+K +NVL++ + K+ DFG++ + N +G YMAPE G
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPERIKSGG 177
Query: 567 -----QFSVKSDVFSFGILLLEIVSGK 588
++V+SDV+S G+ +LE+ G+
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 32/232 (13%)
Query: 393 KKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKL--- 448
+ LG G G V+ +D ++ +AVK++ Q +K EI + +L H N+VK+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 449 -----------LGCCIHGEEKLLIYEFMPN---KSLDSFIFDQERCKLLDWSKRFHIICG 494
+G ++ E+M L+ +E +L +
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ-------- 122
Query: 495 TARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGD-ETEGNTNRVV 552
RGL Y+H + ++HRDLK +NV ++ D+ KI DFGLAR +G + +
Sbjct: 123 LLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179
Query: 553 GTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLI 603
T Y +P S ++ D+++ G + E+++GK H ++ LI
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 36/211 (17%)
Query: 394 KLGEGGFGPVYKGTLADE--QEIAVKRLS-KISEQG--LKELKNEIIL--FSKLQHRNLV 446
++GEG +G V+K + +A+KR+ + E+G L ++ +L +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 447 KLLGCCIHG----EEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA----- 496
+L C E KL L++E + DQ+ LD + T
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 497 ---RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 553
RGL +LH R++HRDLK N+L+ K++DFGLAR + + VV
Sbjct: 118 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVV 171
Query: 554 TYGYMAPEYASDGQFSVKSDVFSFGILLLEI 584
T Y APE ++ D++S G + E+
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 6e-11
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQ--EIAVKRLSK---ISEQGLKELKNEIILFSKLQ 441
++F+ + LG G FG V T +E +A+KR K I ++ + + +E + + +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICG---TARG 498
H V L G L+ EF+ +F L +KRF G A+
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTF---------LRRNKRFPNDVGCFYAAQI 140
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
+L L I++RDLK N+LLD+D K++DFG A+ + T + GT Y+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYI 195
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVSG 587
APE + +D ++ GI + EI+ G
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 19/217 (8%)
Query: 384 NATDNFSINKKLGEGGFGPVYK-GTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ- 441
+ +D + I + +G+G +G V+K + + AVK L I + +E++ E + L
Sbjct: 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSD 73
Query: 442 HRNLVKLLGC-----CIHGEEKLLIYEFMPNKSLDSFIFDQ-ERCKLLDWSKRFHIICGT 495
H N+VK G +G++ L+ E S+ + +R + ++ +I+
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 555
GL +LH + + IHRD+K +N+LL + K+ DFG++ NT+ VGT
Sbjct: 134 LMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTP 188
Query: 556 GYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSG 587
+MAPE + D + + DV+S GI +E+ G
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 393 KKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEI----ILFSKLQHRNLVK 447
K +G+G FG V A+E+ AVK L K + KE K+ + +L ++H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSR 507
L ++ + +++ L + +ERC L+ RF+ A L YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGEL-FYHLQRERC-FLEPRARFYA-AEIASALGYLHS--- 114
Query: 508 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ 567
L I++RDLK N+LLD + ++DFGL + E G T+ GT Y+APE
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 568 FSVKSDVFSFGILLLEIVSG 587
+ D + G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 388 NFSINKKLGEGGFGPVY---KGTLADEQEI-AVKRLSKIS----EQGLKELKNEIILFSK 439
NF + K LG G +G V+ K T D ++ A+K L K + + ++ + E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 440 LQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARG 498
++ + L E KL LI +++ + + ++ ++ + RF+ +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS--EDEVRFY----SGEI 114
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
+L L +L I++RD+K N+LLD + + ++DFGL++ F +E E T GT YM
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYM 173
Query: 559 APEYA-SDGQFSVKSDVFSFGILLLEIVSG 587
APE G D +S GIL+ E+++G
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 59/230 (25%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADE----QEIAVKRLSKISE------QGLKELKNEIIL 436
+ + +G G +G V A + +++A+K++ + + L+ELK +
Sbjct: 5 SRYKPIENIGSGAYGVVCS---AIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----I 57
Query: 437 FSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDS---FIFDQERCKLLDWSKRFHIIC 493
+H N++ + P + + D L HII
Sbjct: 58 LRHFKHDNIIAIRDI------------LRPPGADFKDVYVVMDLMESDL------HHIIH 99
Query: 494 GTA---------------RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538
RGL Y+H + +IHRDLK SN+L+++D +I DFG+AR
Sbjct: 100 SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156
Query: 539 FGGDETEGNT--NRVVGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIV 585
TE V T Y APE S +++ D++S G + E++
Sbjct: 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 67/257 (26%), Positives = 111/257 (43%), Gaps = 48/257 (18%)
Query: 381 TIANATDNFSINKKLGEGGFGPV-YKGTLADEQEIAVKRLSKI--SEQGLKELKNEIILF 437
TI D + K++G G +G V ++A+K+L + SE K E+ L
Sbjct: 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 68
Query: 438 SKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSF----------------IFDQERCK 481
++H N++ LL F P+ SLD F + E+
Sbjct: 69 KHMKHENVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK-- 114
Query: 482 LLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541
L + ++ +GL Y+H IIHRDLK N+ +++D KI DFGLAR
Sbjct: 115 -LSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR---- 166
Query: 542 DETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKL 600
+T+ V T Y APE + ++ D++S G ++ E+++GK + + L
Sbjct: 167 -QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP---LFKGHDHL 222
Query: 601 NLIRHAWKLWNEGMPSQ 617
+ + K+ G PS+
Sbjct: 223 DQLMEIMKV--TGTPSK 237
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 39/91 (42%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 555
ARG+ +L + +HRDL A NVLL Q KI DFGLAR D +
Sbjct: 247 ARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 556 GYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+MAPE D ++ SDV+S+GILL EI S
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 393 KKLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQGLKELKNEI----ILFSKLQHRNLVK 447
K +G+G FG V + + AVK L K + KE K+ + +L ++H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 448 LLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
L +KL + +++ L F +ER + RF+ A L YLH
Sbjct: 61 L-HYSFQTADKLYFVLDYVNGGEL-FFHLQRERS-FPEPRARFYA-AEIASALGYLHS-- 114
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 566
L II+RDLK N+LLD + ++DFGL + G E T+ GT Y+APE
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 567 QFSVKSDVFSFGILLLEIVSG 587
+ D + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 37/227 (16%)
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
LL +H +IHRD+K++N+LL + K+ DFG ++ + ++ GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618
APE +S K+D+FS G+LL E+++ K+ + +N ++ + +P +
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRP---FDGENMEEVMHKTLAGRYDPLPPSI 269
Query: 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPC------MPSVILMLGS--EIVLPQPK 670
S + E++ LL P+ RP MP L + EIV QP
Sbjct: 270 -------SPEMQEIVT----ALLSSD--PKRRPSSSKLLNMPICKLFISGLLEIVQTQPG 316
Query: 671 QPGYLADRKSTRLDSS------------LSMPESSSTNTITISELEG 705
G L D S ++ + M ES ST + + LEG
Sbjct: 317 FSGPLRDTISRQIQQTKQLLQVERRRIVRQMEESLST-AASTTILEG 362
|
Length = 496 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 36/79 (45%), Positives = 45/79 (56%), Gaps = 6/79 (7%)
Query: 511 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDET---EGNTNRVVGTYGYMAPEYASDGQ 567
IHRDL A N+LL KI DFGLAR D +GN V +MAPE +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV---KWMAPESIFNCV 292
Query: 568 FSVKSDVFSFGILLLEIVS 586
++ +SDV+S+GILL EI S
Sbjct: 293 YTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 395 LGEGGFGPVYKGTLADEQEIAVKRLSKIS----EQGLKELKNEIILFSKLQHRNLVKLLG 450
+G G + V L +I ++ K ++ + ++ E +F + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 451 CCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI--ICGTARGLLYLHQDSR 507
C +L L+ E++ L F ++R KL + RF+ IC L +LH+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDL-MFHMQRQR-KLPEEHARFYAAEIC---IALNFLHERG- 116
Query: 508 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ 567
II+RDLK NVLLD D + K++D+G+ + G T+ GT Y+APE +
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKE--GLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 568 FSVKSDVFSFGILLLEIVSGK 588
+ D ++ G+L+ E+++G+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 28/210 (13%)
Query: 395 LGEGGFGPVYKGTLAD--------EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
LG+G F ++KG + + E+ +K L K + + S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
G C+ G+E +++ E++ SLD+++ + + W + + A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 507 RLRIIHRDLKASNVLL-----DQDMNP---KISDFGLARAFGGDETEGNTNRVVGTYGYM 558
+ H ++ A NVLL + NP K+SD G++ E R+ ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----PWV 171
Query: 559 APEYASDGQ-FSVKSDVFSFGILLLEIVSG 587
PE + Q S+ +D +SFG L EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 70/275 (25%), Positives = 121/275 (44%), Gaps = 45/275 (16%)
Query: 325 ALLAVVIAAGYLIHKSRRNIVVNIARYFRENRNNRGTEQKNEDQNIDLDLPLFELATIAN 384
L ++V+ + + +NI + RY + R R + K ED
Sbjct: 2 GLNSLVLDLDFPALRKNKNIDNFLNRYEKIVRKIRKLQMKAED----------------- 44
Query: 385 ATDNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSKI-----SEQGLKELKNEIILFS 438
+ + K +G G FG V Q++ A+K LSK S+ + +I+ F+
Sbjct: 45 ----YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 439 KLQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTAR 497
+ V L C ++ L ++ E+MP L + + + + + W+K + TA
Sbjct: 101 ---NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--KWAKFY-----TAE 150
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG-NTNRVVGTYG 556
+L L + +IHRD+K N+LLD+ + K++DFG DET + VGT
Sbjct: 151 VVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPD 208
Query: 557 YMAPEY----ASDGQFSVKSDVFSFGILLLEIVSG 587
Y++PE DG + + D +S G+ L E++ G
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 394 KLGEGGFGPVYKGTLADE-QEIAVKRLS-KISEQGLK-ELKNEIILFSKLQ---HRNLVK 447
++G G +G VYK +A+K + + +E GL E+ L +L+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 448 LLGCCIHG----EEKL-LIYEFMPNKSLDSFI-------FDQERCKLLDWSKRFHIICGT 495
L+ C E K+ L++E + ++ L +++ E K D ++F
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIK--DLMRQF------ 117
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 555
RGL +LH + I+HRDLK N+L+ K++DFGLAR + + VV T
Sbjct: 118 LRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTL 171
Query: 556 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
Y APE ++ D++S G + E+ K
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 36/104 (34%), Positives = 58/104 (55%), Gaps = 10/104 (9%)
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV-VGTYGY 557
L YLH +++RDLK N++LD+D + KI+DFGL + ++G T + GT Y
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE---GISDGATMKTFCGTPEY 161
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSD-NKL 600
+APE D + D + G+++ E++ G+ FY+ D KL
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 8e-10
Identities = 61/234 (26%), Positives = 102/234 (43%), Gaps = 47/234 (20%)
Query: 389 FSINKKLGEGGFGPVYKG-TLADEQEIAVKRLSK-ISEQGL--KELKNEIILFSKLQHRN 444
+ I + +G+GG G VY + +A+K++ + +SE L K E + + L H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 445 LVKLLGCCIHGEEKLLIYEFMP---NKSLDSFIFDQERCKLLDWSKR------------- 488
+V + C G+ +Y MP +L S + + + L SK
Sbjct: 64 IVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSI 118
Query: 489 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE--- 545
FH IC T Y+H S+ ++HRDLK N+LL I D+G A +E +
Sbjct: 119 FHKICATIE---YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 546 ---GNTN----------RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
N ++VGT YMAPE S +D+++ G++L ++++
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 29/211 (13%)
Query: 388 NFSINKKLGEGGFGPV----YKGTLADEQEIAVKRLSK---ISEQGLKELKNEIILFSKL 440
+F + + LG G FG V +KGT + A+K L K + + ++ + E + +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 441 QHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGL 499
H +V ++ C E ++ + EF+ L + + R D +K +H A +
Sbjct: 76 SHPFIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN-DVAKFYH-----AELV 128
Query: 500 L---YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
L YLH II+RDLK N+LLD + K++DFG A+ + T + GT
Sbjct: 129 LAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPE 180
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVSG 587
Y+APE D ++ G+LL E ++G
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 34/94 (36%), Positives = 56/94 (59%), Gaps = 7/94 (7%)
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV-VGT 554
+ GL +LH+ II+RDLK NV+LD + + KI+DFG+ + +G T R GT
Sbjct: 111 SVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE---HMVDGVTTRTFCGT 164
Query: 555 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
Y+APE + + D +++G+LL E+++G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 395 LGEGGFGPVYKGTLADEQEI-AVKRLSKISEQGLKELKNEI----ILFSKLQHRN--LVK 447
+G+G FG VY+ D + I A+K LSK KE+ + I IL L + +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSR 507
L + L+ ++M L F Q+ + + +F+I A +L L +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYI----AELVLALEHLHK 114
Query: 508 LRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGDETEGNTNRVVGTYGYMAPEYASDG 566
I++RDLK N+LLD + + DFGL++A ++T TN GT Y+APE D
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEYLAPEVLLDE 171
Query: 567 Q-FSVKSDVFSFGILLLEIVSG 587
+ ++ D +S G+L+ E+ G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 1e-09
Identities = 71/251 (28%), Positives = 112/251 (44%), Gaps = 44/251 (17%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKE-----LKNEIILFSKLQ 441
+ + + KK+G G FG V+ QE + IS +GLKE L E+ + +L+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELK 70
Query: 442 HRNLVKLLGCCIH-GEEKLLI-YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGL 499
H+N+V+ + ++ +KL I EF L I ++C + H I R L
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI---QKCYKMFGKIEEHAIVDITRQL 127
Query: 500 L----YLHQ----DSRLRIIHRDLKASNVLLD-------------QDMN----PKISDFG 534
L Y H + R++HRDLK N+ L ++N KI DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 535 LARAFGGDETEGNTNRVVGTYGYMAPEYA--SDGQFSVKSDVFSFGILLLEIVSGKKNRG 592
L++ G E + VGT Y +PE + KSD+++ G ++ E+ SGK
Sbjct: 188 LSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP-- 242
Query: 593 FYHSDNKLNLI 603
F+ ++N LI
Sbjct: 243 FHKANNFSQLI 253
|
Length = 1021 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 555
A GL +LH II+RDLK NV+LD + + KI+DFG+ + D T GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTP 165
Query: 556 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
Y+APE + + D ++FG+LL E+++G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 19/215 (8%)
Query: 389 FSINKKLGEGGFGPVYKGTL---ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL 445
++I L G G V+ T +++ VK ++ G K EI + + HR +
Sbjct: 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAI 148
Query: 446 VKLLGCCIHG-EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ 504
+ L IH K + MP D F + +R L + I L YLH
Sbjct: 149 INL----IHAYRWKSTVCMVMPKYKCDLFTY-VDRSGPLPLEQAITIQRRLLEALAYLHG 203
Query: 505 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS 564
IIHRD+K N+ LD+ N + DFG A GT +PE +
Sbjct: 204 RG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLA 260
Query: 565 DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK 599
+ K+D++S G++L E+ KN + K
Sbjct: 261 LDPYCAKTDIWSAGLVLFEMSV--KNVTLFGKQVK 293
|
Length = 392 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 32/101 (31%), Positives = 54/101 (53%), Gaps = 7/101 (6%)
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
L YLH +++RD+K N++LD+D + KI+DFGL + G GT Y+
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYL 162
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK 599
APE D + D + G+++ E++ G+ FY+ D++
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 557
L YLH + +++RDLK N++LD+D + KI+DFGL + G + GT Y
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEY 162
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK 599
+APE D + D + G+++ E++ G+ FY+ D++
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 7/102 (6%)
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 557
L YLH +I++RDLK N++LD+D + KI+DFGL + G GT Y
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEY 161
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK 599
+APE D + D + G+++ E++ G+ FY+ D++
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 6e-09
Identities = 46/189 (24%), Positives = 83/189 (43%), Gaps = 18/189 (9%)
Query: 412 QEIAVKRLSKISEQGLKE---LKNEIILFSKLQHRNLVKLLGCCIHGEEKLL-IYEFMPN 467
E+A+K L + + + + E L ++L H N+V LL L ++E++P
Sbjct: 4 HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63
Query: 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQ 524
++L + L + ++ L H I+HRDLK N+++
Sbjct: 64 RTLREVLAAD---GALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGV 117
Query: 525 DMNPKISDFGLARAFGGDE-----TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGI 579
+ K+ DFG+ G T T V+GT Y APE + SD++++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 580 LLLEIVSGK 588
+ LE ++G+
Sbjct: 178 IFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 31/214 (14%)
Query: 395 LGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNE----------IILFSKLQHRN 444
LG+G F +YKG L + ++ + + LK L ++ L S+L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ 504
LVKL G C+ +E +++ E++ LD F+ ++ L W + + A L YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 505 DSRLRIIHRDLKASNVLLDQDMNP-------KISDFGLARAFGGDETEGNTNRVVGTYGY 557
+++H ++ N+L+ + K+SD G+ E V +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------VERIPW 170
Query: 558 MAPEYASDGQFSVKS--DVFSFGILLLEIVSGKK 589
+APE +GQ S+ D +SFG LLEI S +
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 395 LGEGGFGPVYKGTLADEQEIAVKRLSKIS----EQGLKELKNEIILFSKLQHRNLVKLLG 450
+G G + V L + I ++ K ++ + ++ E +F + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 451 CCIHGEEKLL-IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLR 509
C E +L + E++ L F ++R KL + RF+ + L YLH+
Sbjct: 63 SCFQTESRLFFVIEYVNGGDL-MFHMQRQR-KLPEEHARFYS-AEISLALNYLHERG--- 116
Query: 510 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFS 569
II+RDLK NVLLD + + K++D+G+ + G T+ GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 570 VKSDVFSFGILLLEIVSGK 588
D ++ G+L+ E+++G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 35/95 (36%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGDETEGNTNRVVGTY 555
R L Y+H + + HRDLK N+L + D KI DFGLAR AF T V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 556 GYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGK 588
Y APE +++ D++S G + E+++GK
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 393 KKLGEGGFGPVY---KGTLADEQEI-AVKRLSKI----SEQGLKELKNEIILFSKLQHRN 444
K LG+GG+G V+ K T AD +I A+K L K +++ K E + ++H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ 504
+V L+ G + LI E++ L F+ + ++ + F++ + L +LHQ
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYL-SEISLALEHLHQ 118
Query: 505 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN--TNRVVGTYGYMAPEY 562
II+RDLK N+LLD + K++DFGL + + T+ GT YMAPE
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEYMAPEI 171
Query: 563 ASDGQFSVKSDVFSFGILLLEIVSG 587
D +S G L+ ++++G
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 50/209 (23%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRL------SKISEQGLKELKNEIILFSK 439
+ F + +GEG +G V K + +EI A+K+ ++ E L+ELK +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK----MLRT 56
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGL 499
L+ N+V+L + L++E++ K++ + + + + + I + +
Sbjct: 57 LKQENIVELKEAFRRRGKLYLVFEYV-EKNMLELLEEMPNGVPPEKVRSY--IYQLIKAI 113
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 559
+ H++ I+HRD+K N+L+ + K+ DFG AR + + N V T Y +
Sbjct: 114 HWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRS 169
Query: 560 PEYASDGQFSVKSDVFSFGILLLEIVSGK 588
PE + D++S G +L E+ G+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 65/234 (27%), Positives = 95/234 (40%), Gaps = 51/234 (21%)
Query: 393 KKLGEGGFGPVY----KGTLADEQEIAVKRLSKISEQGLKELKN---EIILFSKLQHRNL 445
K LG+G G V+ KGT + A+K L K ++K E + + L H L
Sbjct: 7 KLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFL 63
Query: 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFH---IICGTARGLLYL 502
L L+ ++ P L + Q L + RF+ ++ L YL
Sbjct: 64 PTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA----LEYL 119
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL-------------ARAFGG-------- 541
H L I++RDLK N+LL + + +SDF L A G
Sbjct: 120 HL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 542 ------DETEGNTNRVVGTYGYMAPEYAS-DGQ-FSVKSDVFSFGILLLEIVSG 587
+E +N VGT Y+APE S DG +V D ++ GILL E++ G
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 48/145 (33%), Positives = 75/145 (51%), Gaps = 17/145 (11%)
Query: 449 LGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI--ICGTARGLLYLHQD 505
L C E +L + EF+ L F ++R KL + RF+ I L +LH+
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL-MFHMQRQR-KLPEEHARFYSAEIS---LALNFLHER 115
Query: 506 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY--A 563
II+RDLK NVLLD + + K++D+G+ + G T+ GT Y+APE
Sbjct: 116 G---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GIRPGDTTSTFCGTPNYIAPEILRG 170
Query: 564 SDGQFSVKSDVFSFGILLLEIVSGK 588
D FSV D ++ G+L+ E+++G+
Sbjct: 171 EDYGFSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 24/222 (10%)
Query: 378 ELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSKI-----SEQGLKELK 431
++ + ++F + K +G G FG V +++ A+K LSK S+ +
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 432 NEIILFSKLQHRNLVKLLGCCIHGEEKLL--IYEFMPNKSLDSFIFDQERCKLLDWSKRF 489
+I+ + +V+L ++K L + E+MP L + + + + + W+ RF
Sbjct: 94 RDIMAHA--NSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE--KWA-RF 146
Query: 490 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 549
+ TA +L L + IHRD+K N+LLD+ + K++DFG + +
Sbjct: 147 Y----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-RCD 201
Query: 550 RVVGTYGYMAPEY----ASDGQFSVKSDVFSFGILLLEIVSG 587
VGT Y++PE DG + + D +S G+ L E++ G
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 32/76 (42%), Positives = 42/76 (55%)
Query: 511 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSV 570
+HRDL A NVL+ + KI DFGLAR D + +MAPE + ++
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 571 KSDVFSFGILLLEIVS 586
SDV+SFGILL EI +
Sbjct: 321 LSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 395 LGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNEIILFSKLQHRNLVKLLG 450
+G+G FG V + D Q I A+K + K +S + E + +++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 451 CCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRI 510
E+ L+ F+ L F Q + RF+ TA L L + +
Sbjct: 61 SFQSPEKLYLVLAFINGGEL--FHHLQREGRFDLSRARFY----TAELLCALENLHKFNV 114
Query: 511 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSV 570
I+RDLK N+LLD + + DFGL + D+ + TN GT Y+APE ++
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGYTK 172
Query: 571 KSDVFSFGILLLEIVSG 587
D ++ G+LL E+++G
Sbjct: 173 AVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 4e-08
Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 29/171 (16%)
Query: 429 ELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE---FMPNKSLD----SFIFDQERCK 481
+L+NEI+ +L H N++K+ E++L E +M + D SF++D+
Sbjct: 209 QLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEA--- 257
Query: 482 LLDWSKR------FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 535
DW R I+ + Y+H ++IHRD+K N+ L+ D + DFG
Sbjct: 258 -FDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGT 313
Query: 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
A F E E VGT +PE + + +D++S G++LL+++S
Sbjct: 314 AMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 58/200 (29%), Positives = 86/200 (43%), Gaps = 13/200 (6%)
Query: 393 KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEI----ILFSKLQHRNLVK 447
K +G+G FG V D + AVK L K KE K+ + +L ++H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSR 507
L E+ + +F+ L F Q + RF+ A L YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYA-AEIASALGYLHS--- 114
Query: 508 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ 567
+ I++RDLK N+LLD + ++DFGL + G T GT Y+APE
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 568 FSVKSDVFSFGILLLEIVSG 587
+ D + G +L E++ G
Sbjct: 173 YDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 54/235 (22%), Positives = 103/235 (43%), Gaps = 31/235 (13%)
Query: 393 KKLGEGGFGPVYKGTLADEQEIA---VKRLSKISEQGLKELKNEIIL----FSKLQHRNL 445
+++G G FG V + + +A VK L + KE +NE + + LQH N+
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELK--ANASSKE-QNEFLQQGDPYRILQHPNI 57
Query: 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQE----RCKLLDWSKRFHIICGTARGLLY 501
++ LG C+ LL++E+ L S++ ++ +LL + + C A G+ +
Sbjct: 58 LQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTH 114
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGDETEGNTNRVVGTYGYMAP 560
+H + +H DL N L D+ K+ D+G+ + + D E ++ V ++AP
Sbjct: 115 MH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAP 170
Query: 561 EYASDGQFSV-------KSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWK 608
E + + S+V++ G+ L E+ Y + ++ H K
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP--YSHLSDREVLNHVIK 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 70/300 (23%), Positives = 118/300 (39%), Gaps = 79/300 (26%)
Query: 414 IAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSF 473
+ + L +E+ LK L+NE++L +H N++ G +I FM S +S
Sbjct: 30 VRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSL 89
Query: 474 I---FDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 530
+ F + + L + I+ G RGL YLHQ+ IHR++KAS++L+ D +
Sbjct: 90 LKTYFPEGMSEALIGN----ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSL 142
Query: 531 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ--------------FSVKSDVFS 576
S GL+ + G +VV Y P++++ ++VKSD++S
Sbjct: 143 S--GLSHLYSLVR-NGQKAKVV----YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYS 195
Query: 577 FGILLLEIVSG--------------KKNRGFYHSDNKLNLIRHA---WKLWNEGMPSQLI 619
GI E+ +G +K +G +S + K G+ S +
Sbjct: 196 VGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIG 255
Query: 620 DACFKDS----------------------FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI 657
++ NL E LC+QQ PE RP S++
Sbjct: 256 ESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVE---------LCLQQDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 394 KLGEGGFGPVYKGTLAD---EQEIAVKRL--SKISEQGLKELKNEIILFSKLQHRNLVKL 448
K+G G +G VYK D E+E A+K++ + IS +E I L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE----IALLRELKHPNVIAL 63
Query: 449 LGCCI-HGEEKL-LIYEFMPNKSLDSFIFDQ-----ERCKLLDWSKRFHIICGTARGLLY 501
+ H + K+ L++++ + F + ++ L S ++ G+ Y
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 502 LHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGD-ETEGNTNRVVGTYG 556
LH + ++HRDLK +N+L+ + KI+D G AR F + + + VV T+
Sbjct: 124 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 557 YMAPEYASDGQFSVKS-DVFSFGILLLEIVSGK 588
Y APE + K+ D+++ G + E+++ +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 60/249 (24%), Positives = 109/249 (43%), Gaps = 35/249 (14%)
Query: 353 RENRNNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQ 412
R + NN G ++ E + ID D+ + ++ + +G G FG VY+ D
Sbjct: 40 RSHNNNAGEDEDEE-KMIDNDIN-------RSPNKSYKLGNIIGNGSFGVVYEAICIDTS 91
Query: 413 E-IAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGC----CIHGEEKLL----IYE 463
E +A+K++ Q + E+++ L H N++ L C EK + + E
Sbjct: 92 EKVAIKKVL----QDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME 147
Query: 464 FMP---NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 520
F+P +K + + + L + +C R L Y+H I HRDLK N+
Sbjct: 148 FIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC---RALAYIHSKF---ICHRDLKPQNL 201
Query: 521 LLDQDMNP-KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA-SDGQFSVKSDVFSFG 578
L+D + + K+ DFG A+ + + + + Y APE ++ D++S G
Sbjct: 202 LIDPNTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLG 258
Query: 579 ILLLEIVSG 587
++ E++ G
Sbjct: 259 CIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 44/163 (26%), Positives = 70/163 (42%), Gaps = 22/163 (13%)
Query: 433 EIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHII 492
E + + H ++++L G + + LI +P D + C L KR I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLY------CYLAA--KRNIAI 181
Query: 493 C-------GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545
C R + YLH++ RIIHRD+KA N+ ++ + + DFG A F D
Sbjct: 182 CDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINA 237
Query: 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
GT APE + + D++S GI+L E+ +
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 394 KLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLK-ELKNEIILFSKLQHRNLVKLLGCC 452
K+G G +G VYK D ++ L +I G+ EI L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 453 I-HGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLY-----LHQD 505
+ H + K+ L++++ + F R + K + G + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKF--HRASKAN-KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 506 SRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGD-ETEGNTNRVVGTYGYMAP 560
++HRDLK +N+L+ + KI+D G AR F + + + VV T+ Y AP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 561 EYASDGQFSVKS-DVFSFGILLLEIVSGK 588
E + K+ D+++ G + E+++ +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 4e-07
Identities = 18/44 (40%), Positives = 25/44 (56%), Gaps = 2/44 (4%)
Query: 665 VLPQPKQPGYLADRKSTRLDSSLSMP--ESSSTNTITISELEGR 706
+PQPKQPG+ R DSS S ES + N +T+S ++ R
Sbjct: 5 EIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 39/141 (27%), Positives = 69/141 (48%), Gaps = 24/141 (17%)
Query: 460 LIYEFMPNKSLDSF------IFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHR 513
L+ E+ P L S FD++ +F++ A +L +H ++ +HR
Sbjct: 78 LVMEYQPGGDLLSLLNRYEDQFDEDMA-------QFYL----AELVLAIHSVHQMGYVHR 126
Query: 514 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY------ASDGQ 567
D+K NVL+D+ + K++DFG A ++ N+ VGT Y+APE G
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 568 FSVKSDVFSFGILLLEIVSGK 588
+ V+ D +S G++ E++ G+
Sbjct: 186 YGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 387 DNFSINKKLGEGGFGPV----YKGTLADEQEIAVKRLSKI-----SEQGLKELKNEIILF 437
+++ + K +G G FG V +K T + A+K LSK S+ + +I+ F
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 438 SKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTAR 497
+ +V+L ++ E+MP L + + + + + W+ RF+ TA
Sbjct: 100 ANSPW--VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE--KWA-RFY----TAE 150
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 557
+L L + IHRD+K N+LLD+ + K++DFG + + VGT Y
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDY 209
Query: 558 MAPEY----ASDGQFSVKSDVFSFGILLLEIVSG 587
++PE DG + + D +S G+ L E++ G
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 27/217 (12%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQGLKELKNEIILFSKLQHRNL 445
D+F I K +G G FG V + + I A+K L+K + LK + E F + RN+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW--EMLK--RAETACFR--EERNV 54
Query: 446 --------VKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA 496
+ L E L L+ ++ L + + E +L + RF+I A
Sbjct: 55 LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYI----A 109
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
+L +H +L +HRD+K NVLLD + + +++DFG D T ++ VGT
Sbjct: 110 EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPD 168
Query: 557 YMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGK 588
Y++PE G++ + D +S G+ + E++ G+
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 24/78 (30%), Positives = 47/78 (60%)
Query: 509 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF 568
+++HRDLK++N+ L K+ DFG ++ + + + GT Y+APE ++
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 569 SVKSDVFSFGILLLEIVS 586
S K+D++S G++L E+++
Sbjct: 249 SKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 63/250 (25%), Positives = 99/250 (39%), Gaps = 64/250 (25%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQGLKE----LKNEIILFSKLQ 441
D+F K +G G FG V D I A+K+L K SE KE ++ E + ++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRK-SEMLEKEQVAHVRAERDILAEAD 59
Query: 442 HRNLVKLLGCCIHGEEKL-LIYEFMPNKSL-------DSFIFDQERCKLLDWSKRFHIIC 493
+ +VKL E L LI E++P + D+F ++ RF+I
Sbjct: 60 NPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE---------TRFYI-- 107
Query: 494 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD----------E 543
A +L + +L IHRD+K N+LLD + K+SDFGL
Sbjct: 108 --AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSH 165
Query: 544 TEGNTNR--------------------------VVGTYGYMAPEYASDGQFSVKSDVFSF 577
+ VGT Y+APE ++ + D +S
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225
Query: 578 GILLLEIVSG 587
G+++ E++ G
Sbjct: 226 GVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 57/238 (23%), Positives = 98/238 (41%), Gaps = 43/238 (18%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNEIILFSKLQH 442
++F K +G G FG V D + A+K L K + ++ + ++ E + +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL 502
+VK+ LI EF+P + + + ++ L + +F+I A +L +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYI----AETVLAI 114
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA----------------RAFGGDETEG 546
+L IHRD+K N+LLD + K+SDFGL + D T
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 547 NTN-----------------RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 587
N N VGT Y+APE ++ D +S G+++ E++ G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 43/238 (18%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNEIILFSKLQH 442
D+F K +G G FG V D I A+K L K + ++ + ++ E + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL 502
+VK+ LI EF+P + + + ++ L + + +F+I A +L +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYI----AETVLAI 114
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG----------------GDETEG 546
+L IHRD+K N+LLD + K+SDFGL D +
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 547 NTN-----------------RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 587
N N VGT Y+APE ++ D +S G+++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 36/213 (16%)
Query: 395 LGEGGFGPVYKGTLAD-----------EQEIAVKRLSKISEQGLKELKNEII----LFSK 439
LG G +Y G L E+EI V + K+ + +++ + +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKV--ILKVLDPSHRDISLAFFETASMMRQ 60
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGL 499
+ H+++V L G C+ E +++ EF+ LD F+ + W +F + A L
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASAL 118
Query: 500 LYLHQDSRLRIIHRDLKASNVLL-----DQDMNP--KISDFGLARAFGGDETEGNTNRVV 552
YL +D L +H ++ N+LL D + P K+SD G+ T + V
Sbjct: 119 SYL-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI------TVLSRQECV 169
Query: 553 GTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEI 584
++APE D + S+ +D +SFG L EI
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 46/172 (26%), Positives = 76/172 (44%), Gaps = 44/172 (25%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNE--------- 433
+ F I K + G FG VY G + ++ AVK + K I++ + +++ E
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 434 ---IILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI-----FDQERCKLLDW 485
+ L+ LQ N V L+ E++ + S + FD+E
Sbjct: 64 PFIVHLYYSLQSANNV------------YLVMEYLIGGDVKSLLHIYGYFDEE------- 104
Query: 486 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537
+I A L YLH+ IIHRDLK N+L+ + + K++DFGL++
Sbjct: 105 MAVKYI-SEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 62/257 (24%), Positives = 96/257 (37%), Gaps = 69/257 (26%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNEIILFSKLQH 442
++F K +G+G FG V D +I A+K L K + L +K E + ++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSL-------DSFIFDQERCKLLDWSKRFHIICGT 495
+V L + LI EF+P L D+F D RF++
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED---------VTRFYM---- 107
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--------------GG 541
A +L + +L IHRD+K N+L+D+ + K+SDFGL+ F G
Sbjct: 108 AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK 167
Query: 542 DETEGNTNR-------------------------------VVGTYGYMAPEYASDGQFSV 570
NR VGT Y+APE +
Sbjct: 168 SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227
Query: 571 KSDVFSFGILLLEIVSG 587
+ D +S G ++ E + G
Sbjct: 228 ECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 10/106 (9%)
Query: 488 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547
RF++ A +L + +L +HRD+K NVLLD++ + +++DFG D T
Sbjct: 105 RFYL----AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-Q 159
Query: 548 TNRVVGTYGYMAPEY-----ASDGQFSVKSDVFSFGILLLEIVSGK 588
+N VGT Y++PE G++ + D +S G+ + E++ G+
Sbjct: 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 34/149 (22%), Positives = 54/149 (36%), Gaps = 17/149 (11%)
Query: 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV--KLLG 450
K L G VY DE + +K + +E + I+ L + L K+L
Sbjct: 4 KLLKGGLTNRVYLLGTKDE-DYVLKINPSREKGADREREVAILQL--LARKGLPVPKVLA 60
Query: 451 CCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLY-LHQDSRLR 509
L+ E++ ++LD +++ I LL LHQ L
Sbjct: 61 SGESDGWSYLLMEWIEGETLDEVSEEEKE-----------DIAEQLAELLAKLHQLPLLV 109
Query: 510 IIHRDLKASNVLLDQDMNPKISDFGLARA 538
+ H DL N+L+D I D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 19/157 (12%)
Query: 436 LFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGT 495
L S++ H +L + G C+ G E +++ EF+ + LD + ++ + W + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVL-----LDQDMNP--KISDFGLARAFGGDETEGNT 548
A L YL + ++H ++ A N+L L + +P K+SD G+ +F E
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV--SFTALSREERV 181
Query: 549 NRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEI 584
R+ ++APE G S +D +SFG LLEI
Sbjct: 182 ERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 55/250 (22%), Positives = 96/250 (38%), Gaps = 61/250 (24%)
Query: 389 FSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNEIILFSKLQHRN 444
F K +G G FG V D + A+K L K + +K E + ++ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSF-----IFDQERCKLLDWSKRFHIICGTARGL 499
+VKL + + +++P + S IF+++ RF+I A
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-------RFYI----AELT 111
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF-----------GG------- 541
+ ++ IHRD+K N+L+D+D + K++DFGL F G
Sbjct: 112 CAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSM 171
Query: 542 ---DETEGNTNR--------------------VVGTYGYMAPEYASDGQFSVKSDVFSFG 578
+E +VGT Y+APE ++ D +S G
Sbjct: 172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231
Query: 579 ILLLEIVSGK 588
++L E++ G+
Sbjct: 232 VILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 60/283 (21%), Positives = 123/283 (43%), Gaps = 53/283 (18%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
++F I K +G G FG E+AV +L + ++ N+ + + +
Sbjct: 1 EDFEILKVIGRGAFG-----------EVAVVKLKNADKVFAMKILNKWEMLKRAETACFR 49
Query: 447 KLLGCCIHGEEK---LLIYEFMPNKSL----DSFI-------FDQERCKLLDWSKRFHII 492
+ ++G+ + L Y F +L D ++ + +L + RF++
Sbjct: 50 EERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL- 108
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 552
A ++ + +L +HRD+K N+L+D + + +++DFG D T ++ V
Sbjct: 109 ---AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAV 164
Query: 553 GTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAW 607
GT Y++PE G++ + D +S G+ + E++ G+ FY +L+
Sbjct: 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP--FYAE----SLVETYG 218
Query: 608 KLWNEG----MPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQY 646
K+ N P+Q+ D S + ++IR L+C +++
Sbjct: 219 KIMNHKERFQFPAQVTDV----SEDAKDLIR----RLICSREH 253
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 47/197 (23%), Positives = 95/197 (48%), Gaps = 24/197 (12%)
Query: 403 VYKGTLADEQEIAVKRLSKISEQGLKEL----KNEIILFSKLQHRNLVKLLGCCIHGEEK 458
+YKG ++ E+ ++ K +G K L +NEI ++ N++K+ G I +
Sbjct: 36 IYKGIFNNK-EVIIRTFKK-FHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 459 L----LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHR 513
L LI E+ L + D+E K L + + + +GL L++ ++ ++
Sbjct: 94 LPRLSLILEYCTRGYLREVL-DKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYK 147
Query: 514 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD--GQFSVK 571
+L + + L+ ++ KI GL + + N N +V Y + + +D ++++K
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFK-NVNFMV----YFSYKMLNDIFSEYTIK 202
Query: 572 SDVFSFGILLLEIVSGK 588
D++S G++L EI +GK
Sbjct: 203 DDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 56/245 (22%), Positives = 96/245 (39%), Gaps = 55/245 (22%)
Query: 393 KKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNEIILFSKLQHRNLVKL 448
K LG G FG V D + A+K L K ++ + +K E + ++ + +VKL
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 449 LGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRL 508
+ + +++P + S + E + RF+I A L + ++
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYI----AELTLAIESVHKM 120
Query: 509 RIIHRDLKASNVLLDQDMNPKISDFGLARAFG---------------------------- 540
IHRD+K N+L+D D + K++DFGL F
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 541 -----GDETEGNTNR------------VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLE 583
GD + R +VGT Y+APE ++ D +S G++L E
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240
Query: 584 IVSGK 588
++ G+
Sbjct: 241 MLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 40/181 (22%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKR--LSKISEQGLKELKNEIILFSKLQHRN 444
D+F + KKLGEG FG VYK +L ++Q + L K +E G EI + +++ R
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----AVEIWMNERVR-RA 186
Query: 445 LVKLLGCCIHG-------------------EEKLLIYEFMPNK----SLDSFIFDQERCK 481
++G E + + + M +K +++ ++ +
Sbjct: 187 CPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLL-GKVQD 245
Query: 482 LLDWSKRFHIICGTA-RGLLY----LHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGL 535
L +R + I T R +L+ LH I+HRD+K N++ + KI D G
Sbjct: 246 LPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGA 302
Query: 536 A 536
A
Sbjct: 303 A 303
|
Length = 566 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 16/106 (15%)
Query: 495 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR----AFGGDETEGNTNR 550
T L YLH I+HRDLK N+L+ + K++DFGL++ + + EG+ +
Sbjct: 110 TVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 551 ---------VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 587
V GT Y+APE + D ++ GI+L E + G
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 21/200 (10%)
Query: 389 FSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVK 447
F+I++ L G G V++ + D Q + VK S +E L +L H ++
Sbjct: 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSV------HEARLLRRLSHPAVLA 224
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLL----YLH 503
LL + G L+ +P D + + R + L ++ + AR LL Y+H
Sbjct: 225 LLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ----VTAVARQLLSAIDYIH 277
Query: 504 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 563
+ IIHRD+K NVL++ + + DFG A G + + GT APE
Sbjct: 278 GEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVL 334
Query: 564 SDGQFSVKSDVFSFGILLLE 583
+ ++ D++S G+++ E
Sbjct: 335 AGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 30/127 (23%), Positives = 52/127 (40%), Gaps = 45/127 (35%)
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF----------GGDETEGNT-------- 548
++ IHRD+K N+L+D+D + K++DFGL F GD ++
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 549 ---------------------------NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 581
+ +VGT Y+APE ++ D +S G++L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 582 LEIVSGK 588
E++ G+
Sbjct: 239 YEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 30/86 (34%), Positives = 41/86 (47%), Gaps = 8/86 (9%)
Query: 387 DNFSINKKLGEGGFGPVYKGT---LADEQE---IAVKRLSKISEQGLKE-LKNEIILFSK 439
+ S K LG G FG V + T L +AVK L + +E L +E+ + S
Sbjct: 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 94
Query: 440 L-QHRNLVKLLGCCIHGEEKLLIYEF 464
L H N+V LLG C G L+I E+
Sbjct: 95 LGNHINIVNLLGACTVGGPTLVITEY 120
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|219775 pfam08277, PAN_3, PAN-like domain | Back alignment and domain information |
|---|
Score = 36.2 bits (84), Expect = 0.004
Identities = 11/32 (34%), Positives = 22/32 (68%), Gaps = 1/32 (3%)
Query: 239 TPSWVSKSMNLKECREKCLENSSCM-AYTNSD 269
+ + + S++ ++C KC E+S+C+ AY NS+
Sbjct: 12 SNTSSTTSLSWEDCVTKCYEDSTCVLAYFNSE 43
|
Length = 71 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 706 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.65 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.42 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.12 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.01 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.94 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.84 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.68 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.56 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.56 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.55 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.48 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.47 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.47 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.42 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.4 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.24 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.2 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.19 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.15 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.08 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 98.07 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.0 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.98 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.93 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.82 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.8 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.8 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.79 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.79 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.74 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.63 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.55 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.47 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.46 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.25 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.22 | |
| PLN02236 | 344 | choline kinase | 97.11 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.09 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.05 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.02 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.84 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.79 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.76 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.72 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.44 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.41 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.25 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.12 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.01 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 95.87 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.8 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.74 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-54 Score=452.92 Aligned_cols=290 Identities=43% Similarity=0.751 Sum_probs=256.6
Q ss_pred CCCcccHHHHHHhccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEE
Q 005236 373 DLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCC 452 (706)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 452 (706)
....|++.++..++++|.-.+.||+|+||.||+|.+.++..||||++.....+...+|.+|+.++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45669999999999999999999999999999999999999999998765443145699999999999999999999999
Q ss_pred EeCC-eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEe
Q 005236 453 IHGE-EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 531 (706)
Q Consensus 453 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 531 (706)
.+.+ +++||||||++|+|.++|+..... .++|..|++||.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999876544 78999999999999999999999988899999999999999999999999
Q ss_pred eeccccccCCCCCccccccc-ccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 005236 532 DFGLARAFGGDETEGNTNRV-VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLW 610 (706)
Q Consensus 532 Dfgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 610 (706)
|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+...+.....++.|++..+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999664321 1111112 79999999999999999999999999999999999999887655555666899999999
Q ss_pred hcCCCccccccccc-CcCCH-HHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 611 NEGMPSQLIDACFK-DSFNL-AEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 611 ~~~~~~~~~d~~~~-~~~~~-~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
..+...+++|+.+. +.... +++.+++.++++|++.+|.+||+|.||+++|+.+..
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 99999999999987 56664 789999999999999999999999999999966533
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=388.72 Aligned_cols=256 Identities=32% Similarity=0.516 Sum_probs=208.6
Q ss_pred CCCccceeccCCceeEEEEEeCCCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC-eeEEEEec
Q 005236 388 NFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE-EKLLIYEF 464 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~ 464 (706)
++.+.+.||+|+||+||+|.+.....||||++.... ....+.|.+|+.++.+++|||||+++|+|.+.. ...+||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 445557799999999999999766669999997632 222679999999999999999999999999888 79999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-CeEEeeeccccccCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFGGDE 543 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfgla~~~~~~~ 543 (706)
|++|+|.++++.. ....+++..+++|+.+||+||.|||+++. ||||||||+||||+.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999775 34679999999999999999999999864 99999999999999998 99999999998754321
Q ss_pred CcccccccccccCccCccccc--cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYAS--DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
.......||..|||||++. ...|+.|+||||||++||||+||+.||..... ... +...........+...
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~---~~~v~~~~~Rp~~p~~ 270 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQV---ASAVVVGGLRPPIPKE 270 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHH---HHHHHhcCCCCCCCcc
Confidence 2222367999999999999 56999999999999999999999999875443 111 2222222222222221
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
....+..++.+||+.||..||++.+++..|+.+
T Consensus 271 ---------~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 271 ---------CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred ---------CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 223456788899999999999999999999865
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=364.03 Aligned_cols=252 Identities=28% Similarity=0.387 Sum_probs=207.9
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc-cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC-eeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE-EKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e 463 (706)
++++..+.||+|..|+|||++++ .++.+|+|++.. ..+...+++.+|++++++.+|||||+++|+|.... ...++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 35666789999999999999995 477889999854 45666789999999999999999999999999988 5999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
||++|+|++++... +.+++...-+|+.++++||.|||+.. .||||||||+||||+..|.+||+|||.++.+.+.
T Consensus 159 YMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999999654 45889999999999999999999732 3999999999999999999999999999987433
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--CCCchhHHHHHHHHhhcCCCcccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH--SDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
..+..+||..|||||.+.+..|+.++||||||++++|+.+|+.|+.... .....++... +-.+.++.+.+.
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~----Iv~~ppP~lP~~ 305 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA----IVDEPPPRLPEG 305 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH----HhcCCCCCCCcc
Confidence 4456899999999999999999999999999999999999999976541 1222222222 223333333222
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+. .++.+++..||+.||.+||+++|+++.
T Consensus 306 ----~fS----~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 ----EFS----PEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ----cCC----HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 122 256789999999999999999999753
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=365.61 Aligned_cols=201 Identities=31% Similarity=0.516 Sum_probs=181.9
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
..+|.+.++||+|+|++||+|+++ ++..||||.+.+. ..+..+.+..|+++|+.++|||||+|++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 468999999999999999999984 4789999998764 6777888999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC------CCeEEeeeccc
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD------MNPKISDFGLA 536 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~------~~~kl~Dfgla 536 (706)
|||.||+|.+||+... .+++.....++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999997654 5899999999999999999999998 9999999999999865 46899999999
Q ss_pred cccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 005236 537 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 595 (706)
Q Consensus 537 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~ 595 (706)
+.+.. .......+|++-|||||++...+|+.|+|+||+|+|||++++|+.||....
T Consensus 163 R~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 163 RFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 98753 233445799999999999999999999999999999999999999986433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=377.70 Aligned_cols=247 Identities=28% Similarity=0.417 Sum_probs=209.9
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCc---cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSK---ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
..|...+.||+|||+.||+++. ..|+.||+|++.+ ......+.+.+|+++.++|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999998 7799999999976 24455678899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
|+|++++|.+++. +.+.+++.++.++..||+.||.|||+.+ |+|||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999985 4567999999999999999999999998 999999999999999999999999999988644
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
.. .....+|||.|+|||++.....+..+||||+|||+|-||.|++||+...-.+....+.. -....+..+
T Consensus 172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~----~~Y~~P~~l---- 241 (592)
T KOG0575|consen 172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL----NEYSMPSHL---- 241 (592)
T ss_pred cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh----cCccccccc----
Confidence 33 33458999999999999999999999999999999999999999875332222222211 111112111
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
...+.+|+..+|+.+|.+|||+++|+.
T Consensus 242 ---------s~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 242 ---------SAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ---------CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 124567899999999999999999985
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=381.09 Aligned_cols=256 Identities=32% Similarity=0.506 Sum_probs=210.6
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
+.+++.++||+|.||.||.|.++....||+|.++.. ....+.|.+|+.+|++|+|+|||+++++|..++.++||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 345567899999999999999988889999998654 2334678899999999999999999999999899999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
.|+|.+||.. .....+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+.+..+.+..
T Consensus 285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999999976 33466889999999999999999999988 9999999999999999999999999999655444432
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
.....-+..|.|||.+....++.|||||||||+||||+| |+.|+......+..+.+.. ..+-+.+..
T Consensus 361 -~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~---GyRlp~P~~-------- 428 (468)
T KOG0197|consen 361 -SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER---GYRLPRPEG-------- 428 (468)
T ss_pred -cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc---cCcCCCCCC--------
Confidence 223445789999999999999999999999999999999 7878655444333333222 221111111
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
....+.+|+..||+.+|++|||++.+...|+...
T Consensus 429 -----CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 429 -----CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred -----CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 2235667999999999999999999999988653
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=365.31 Aligned_cols=252 Identities=25% Similarity=0.342 Sum_probs=201.5
Q ss_pred hccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchh-------hHHHHHHHHHHHhhcCCcceeeeEeEEEeCC
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQ-------GLKELKNEIILFSKLQHRNLVKLLGCCIHGE 456 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 456 (706)
..+.|.+.+.||+|+||.|-+|.. +.++.||||++++.... ......+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456788999999999999999987 56999999999763111 1234579999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC---CCeEEeee
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDF 533 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~~kl~Df 533 (706)
..||||||++||.|.+++-.+. .+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999996654 3666677789999999999999999 9999999999999766 78999999
Q ss_pred ccccccCCCCCcccccccccccCccCccccccCCC---CcchhhHHHHHHHHHHHhCCCCCCCCCCCC-chhHHHHHHHH
Q 005236 534 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF---SVKSDVFSFGILLLEIVSGKKNRGFYHSDN-KLNLIRHAWKL 609 (706)
Q Consensus 534 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~sDv~SlGvil~elltG~~p~~~~~~~~-~~~~~~~~~~~ 609 (706)
|+|+..+. .......+||+.|.|||++.+... ..+.|+||+|||||-+|+|.+||.....+. ..+.+..
T Consensus 324 GlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~---- 396 (475)
T KOG0615|consen 324 GLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK---- 396 (475)
T ss_pred chhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc----
Confidence 99998752 234556899999999999987643 347899999999999999999997654443 2222221
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 610 WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 610 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+... +.+ ....+-..+..+++.+||..||++|||+.|+++
T Consensus 397 ---G~y~--f~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 ---GRYA--FGP----LQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ---Cccc--ccC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1110 000 001122346778999999999999999999975
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=392.72 Aligned_cols=260 Identities=30% Similarity=0.469 Sum_probs=217.0
Q ss_pred cCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCccchh-hHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSKISEQ-GLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 459 (706)
.+.+..+.||+|+||+||+|+.. +.+.||||.++..... ..++|++|+++++.++|||||+|+|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 45666799999999999999853 3567999999875544 7889999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhccc-------c----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCe
Q 005236 460 LIYEFMPNKSLDSFIFDQE-------R----CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 528 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 528 (706)
+|+|||..|+|.+||.... . ...++..+.+.||.|||.||+||-++. +|||||..+|+||.++..+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 9999999999999997421 1 234888999999999999999999887 9999999999999999999
Q ss_pred EEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHH
Q 005236 529 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAW 607 (706)
Q Consensus 529 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 607 (706)
||+||||++.+.+.++........-+++|||||.|..++||.+||||||||+|||+++ |+.|+.....++-.+.
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~----- 717 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC----- 717 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH-----
Confidence 9999999998876666554444556899999999999999999999999999999999 8888766554433222
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 608 KLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 608 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
+..+..-+-.+ ....++..|+..||+.+|.+||+++||-..|+....
T Consensus 718 --i~~g~lL~~Pe---------~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 718 --IRAGQLLSCPE---------NCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred --HHcCCcccCCC---------CCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 23333322222 233467889999999999999999999999986543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=345.75 Aligned_cols=259 Identities=27% Similarity=0.400 Sum_probs=208.0
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEe-EEEeCCe-eEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLG-CCIHGEE-KLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lV 461 (706)
.+|.+.++||+|.||+|||++. .+|..+|.|.+.- .+.+..+.+..|+.+|++|+|||||++++ -+.+... +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4688999999999999999986 6799999999863 45566778999999999999999999998 5555554 8999
Q ss_pred EecCCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCceEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 462 YEFMPNKSLDSFIFDQ-ERCKLLDWSKRFHIICGTARGLLYLHQDS-RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
|||+..|+|...|... +..+.+++..+++++.|++.||..+|.+- +..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999753 34567899999999999999999999842 234999999999999999999999999999998
Q ss_pred CCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 540 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 540 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
.+... .....+|||.||+||.+.+.+|+.||||||+||++|||..-+.||... +-.++- +.+..+..+.+.
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~----~KI~qgd~~~~p 249 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLC----KKIEQGDYPPLP 249 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHH----HHHHcCCCCCCc
Confidence 65433 334478999999999999999999999999999999999999998643 222222 222333333232
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
+.. -...+..++..|+..||+.||+.-.+++.+..
T Consensus 250 ~~~--------YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 DEH--------YSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHH--------hhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 211 12244567789999999999996666655554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=348.80 Aligned_cols=240 Identities=27% Similarity=0.381 Sum_probs=199.0
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|++.++||+|+||+||.++.++ ++.+|+|++++. .....+..++|..++.+++||+||+++-.|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4789999999999999999999855 788999999763 334577889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
+||+.||.|..+|.++. .+++..+..++.+|+.||.|||+++ ||||||||+|||||++|+++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999996544 4788888999999999999999998 99999999999999999999999999996432
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC--CCcccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG--MPSQLI 619 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 619 (706)
+ ...+...+||+.|||||++....|+..+|.||+|+++|||++|.+||...+.....+. ..... ..+..+
T Consensus 178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~------I~~~k~~~~p~~l 249 (357)
T KOG0598|consen 178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDK------ILKGKLPLPPGYL 249 (357)
T ss_pred C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHH------HhcCcCCCCCccC
Confidence 2 2344458999999999999999999999999999999999999999864332211111 11111 111111
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP 651 (706)
+ ..+.+++...|+.+|++|-
T Consensus 250 s------------~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 250 S------------EEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred C------------HHHHHHHHHHhccCHHHhc
Confidence 1 2455788899999999995
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=350.49 Aligned_cols=267 Identities=26% Similarity=0.366 Sum_probs=212.4
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 459 (706)
...+|.+++.||+|+|++|++|+.+ .++++|||++.+. .+.-.+-+..|-..|.+| .||.|++|+-.|.+...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3468999999999999999999985 4889999999652 333345567888999999 8999999999999999999
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
+|+||+++|+|.++|.+. ..+++.....++.+|+.||+|||+.| ||||||||+|||||+||++||+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999654 45888889999999999999999998 999999999999999999999999999998
Q ss_pred CCCCCc---------ccc--cccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH
Q 005236 540 GGDETE---------GNT--NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWK 608 (706)
Q Consensus 540 ~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 608 (706)
...... ... ...+||..|.+||++.....+..+|+|+||||||+|+.|++||....+ .........
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---yliFqkI~~ 301 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---YLIFQKIQA 301 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---HHHHHHHHH
Confidence 543222 111 347899999999999999999999999999999999999999864332 111111111
Q ss_pred HhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHh-------cCCCCCCCCCCCCc
Q 005236 609 LWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML-------GSEIVLPQPKQPGY 674 (706)
Q Consensus 609 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L-------~~~~~~~~p~~p~~ 674 (706)
+.-..+ ..+. ..+.+|+...|-.||.+|+|.++|-+.. +.+....+|+.-++
T Consensus 302 -l~y~fp---------~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~py 360 (604)
T KOG0592|consen 302 -LDYEFP---------EGFP----EDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQPY 360 (604)
T ss_pred -hcccCC---------CCCC----HHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccCC
Confidence 111111 1111 2455788899999999999999998764 33344555554444
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=343.72 Aligned_cols=257 Identities=28% Similarity=0.410 Sum_probs=204.5
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC--eeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE--EKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~e 463 (706)
.+|...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+.+|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 467888999999999999999865 8899999986653333778999999999999999999999855554 6899999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-CCCeEEeeeccccccCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGD 542 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfgla~~~~~~ 542 (706)
|+++|+|.+++.+... .+++..+.++..||++||+|||+++ |+||||||+||||+. ++.+||+|||+++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999976543 5899999999999999999999998 999999999999999 799999999999987541
Q ss_pred -CCcccccccccccCccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 543 -ETEGNTNRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 543 -~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
..........||+.|||||++.++. ...++|||||||++.||+||++||... .....+..........+.+.+
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~ip~ 246 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPEIPD 246 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCCCCc
Confidence 1122334578999999999999643 335999999999999999999998653 111222222222222222222
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
. . .....+++..|++.+|++|||+.++++..--
T Consensus 247 ~-----l----s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 247 S-----L----SDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred c-----c----CHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 1 1 1245578899999999999999999987643
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=369.84 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=214.4
Q ss_pred CCCccceeccCCceeEEEEEeCC----CcEEEEEEcCc-cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLAD----EQEIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
...|.++||.|.||.|++|+++- ...||||.|+. ..++....|..|+.+|.+++||||++|.|+.......++|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 45677999999999999999843 45799999986 45667789999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
|||+||+|+.||+.+. ..+.+.++.-++++||.||+||-+.+ +|||||.++||||+.+..+|++|||+++.+..+
T Consensus 710 EyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999999997665 44888889999999999999999988 999999999999999999999999999988655
Q ss_pred CC-cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 543 ET-EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 543 ~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.. ...+....-+.+|.|||.|...++|.+|||||||+++||.++ |++|+-.+...+ .+....+-++-
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd---VIkaIe~gyRL-------- 853 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VIKAIEQGYRL-------- 853 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH---HHHHHHhccCC--------
Confidence 42 222233344689999999999999999999999999999888 999975444332 22222221111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCCCC
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLP 667 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~~~ 667 (706)
..+++....+.+|++.|||+|-.+||.+.+|+.+|.+.+..|
T Consensus 854 -----PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 854 -----PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred -----CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 122234456778999999999999999999999998875554
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=324.84 Aligned_cols=263 Identities=22% Similarity=0.297 Sum_probs=205.9
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
+.|+..-++|+|+||+|||++.++ |+.||||++... ++...+-..+|+.++++++|||+|.|+.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 467888899999999999999966 899999998543 34445677899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
||+..-|.++-+. ..-++...+.+++.|+++|+.|+|+++ +|||||||+||||+.+|.+||+|||+|+.+..
T Consensus 82 ~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-- 153 (396)
T KOG0593|consen 82 YCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-- 153 (396)
T ss_pred ecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence 9988777665432 234788889999999999999999998 99999999999999999999999999998852
Q ss_pred CcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh---------cC
Q 005236 544 TEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWN---------EG 613 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---------~~ 613 (706)
.....+..+.|..|.|||.+.+ .+|....||||+||++.||++|.+-|...+.-+.+.+|......+. .+
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 2233455789999999999987 6899999999999999999999988765554444444443322111 11
Q ss_pred CCcccccccccCcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHH
Q 005236 614 MPSQLIDACFKDSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVI 657 (706)
Q Consensus 614 ~~~~~~d~~~~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~ 657 (706)
....+.=+.+....+++ -..-+++++..||+.||.+|++-++++
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 11111111111111111 112467899999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=353.63 Aligned_cols=266 Identities=27% Similarity=0.446 Sum_probs=209.8
Q ss_pred HHHHHhccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe
Q 005236 380 ATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEE 457 (706)
Q Consensus 380 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 457 (706)
.+.....+++.+.+.||+|.||+||+|++.+ .||||++.. ...+..+.|++|+..+++-+|.||+-++|+|.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 3344445677788999999999999999965 599999865 455678999999999999999999999999988777
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.+|..+|+|.+|+.+|+..+ ..++..+.+.||.|||+||.|||.++ |||||||..||++.+++.+||+||||+.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 99999999999999997654 34788889999999999999999998 9999999999999999999999999986
Q ss_pred ccCCCCCcccccccccccCccCccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYASDG---QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM 614 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 614 (706)
.-..-..........|...|||||+++.. +|+..+||||||+|+|||++|..|+.....+.....+ -+...
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV------GrG~l 610 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV------GRGYL 610 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe------ccccc
Confidence 53222122223345688999999999754 7999999999999999999999998733322221111 11111
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 615 PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 615 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
.++.... .-....+|.+|+..||..++++||.+.+|+.+|+.+..
T Consensus 611 ~pd~s~~------~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 611 MPDLSKI------RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred Cccchhh------hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1111110 01123356678889999999999999999998887644
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=351.43 Aligned_cols=261 Identities=30% Similarity=0.446 Sum_probs=203.0
Q ss_pred ccCCCccceeccCCceeEEEEEe------CCCcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCC-
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL------ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGE- 456 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 456 (706)
.++|++.++||+|+||.||+|.. ..+..||||++... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46899999999999999999974 22467999998653 233456789999999999 8999999999887644
Q ss_pred eeEEEEecCCCCChhhhhhcccc---------------------------------------------------------
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQER--------------------------------------------------------- 479 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 479 (706)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999964321
Q ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccCc
Q 005236 480 --CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 557 (706)
Q Consensus 480 --~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y 557 (706)
...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134778888999999999999999987 999999999999999999999999999875433222222234567889
Q ss_pred cCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHH
Q 005236 558 MAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCI 636 (706)
Q Consensus 558 ~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 636 (706)
+|||++.+..++.++||||||++||||++ |+.||....... .. ......+...... .. ....+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~----~~~~~~~~~~~~~-----~~----~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EF----CQRLKDGTRMRAP-----EN----ATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HH----HHHHhcCCCCCCC-----CC----CCHHHH
Confidence 99999999999999999999999999997 999976433211 11 1111111111110 01 112466
Q ss_pred HHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 637 HIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 637 ~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
+++.+||+.+|.+|||+.||++.|+.+.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 7999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=330.44 Aligned_cols=263 Identities=25% Similarity=0.363 Sum_probs=207.6
Q ss_pred hccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
..++|++.++||.|..++||+|+. ..+..||||++.-. .....+.+.+|+..++.++||||++++..|..+..+++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 346899999999999999999987 55789999998653 2334789999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
.||.+|++.+++...-. .-+++..+..|+.++++||.|||.+| .||||||+.||||+++|.+||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999976443 33888899999999999999999998 999999999999999999999999987765432
Q ss_pred CCcc--cccccccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 543 ETEG--NTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 543 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
.... .....+||+.|||||++.. ..|+.|+||||||++..||.+|+.||..+++...+ ...+....+...
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL------l~tLqn~pp~~~ 253 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL------LLTLQNDPPTLL 253 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH------HHHhcCCCCCcc
Confidence 2111 1155789999999999654 47999999999999999999999998766653221 111222222111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
-..+..+.+..--..+.+++..||+.||.+|||++++++
T Consensus 254 -t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 -TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred -cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111111111111224567888999999999999999974
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=337.88 Aligned_cols=267 Identities=24% Similarity=0.303 Sum_probs=206.1
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC--CeeEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--EEKLL 460 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 460 (706)
.+.|+.+++||+|.||.||+|+. ..|+.||+|++.... +.......+|+.+|++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35788889999999999999997 568899999987643 44556778999999999999999999998877 68899
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
|+|||+. +|.-++... .-.++..++..++.||+.||+|+|+.+ |+|||||.+|||||.+|.+||+|||||+++.
T Consensus 196 VFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999976 677766432 234788999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc--c
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS--Q 617 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 617 (706)
.......++ .+-|.-|.|||.+.+. .|+.+.|+||.||||.||++|++.+......+.+..|........+..+. .
T Consensus 270 ~~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 655444444 5669999999999875 89999999999999999999999876544444444443332211121111 0
Q ss_pred -----cccccccCcCCHHHH-----HHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 618 -----LIDACFKDSFNLAEV-----IRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 618 -----~~d~~~~~~~~~~~~-----~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+.+.-.....+.|. ..+++|+..+|..||.+|.|+.+++..
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111110101112221 145788889999999999999998753
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=340.02 Aligned_cols=254 Identities=23% Similarity=0.286 Sum_probs=208.6
Q ss_pred hccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
..++|+++++||+|+||.||+++-++ |..+|+|++++. .....+..+.|-.+|....+|.||+|+-.|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45899999999999999999999865 888999999874 34556778899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||++||++..+|.. ...+++.....++.+++.|+..||..| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 9999999999999954 356889999999999999999999998 9999999999999999999999999996431
Q ss_pred CC----------------------CCc-----cc------------------ccccccccCccCccccccCCCCcchhhH
Q 005236 541 GD----------------------ETE-----GN------------------TNRVVGTYGYMAPEYASDGQFSVKSDVF 575 (706)
Q Consensus 541 ~~----------------------~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~s~~sDv~ 575 (706)
.. ... .. ....+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 000 00 0024799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCC---
Q 005236 576 SFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPC--- 652 (706)
Q Consensus 576 SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt--- 652 (706)
|||||+||||.|-+||....+.+....+......+.-+.-..+ ..++.+||.+||. ||++|--
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~-------------s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDL-------------SDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcc-------------cHHHHHHHHHHhc-CHHHhcCccc
Confidence 9999999999999999876666655555544444332222111 1466788999999 9999975
Q ss_pred hhHHHH
Q 005236 653 MPSVIL 658 (706)
Q Consensus 653 ~~ev~~ 658 (706)
++||-+
T Consensus 439 ~~EIK~ 444 (550)
T KOG0605|consen 439 AEEIKK 444 (550)
T ss_pred HHHHhc
Confidence 556554
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=340.45 Aligned_cols=264 Identities=25% Similarity=0.406 Sum_probs=202.7
Q ss_pred cCCCccceeccCCceeEEEEEeCC-----------------CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeee
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-----------------EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKL 448 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l 448 (706)
++|++.++||+|+||.||++.+.+ +..||+|.+... .......+.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578999999999999999998633 336999998653 34445679999999999999999999
Q ss_pred EeEEEeCCeeEEEEecCCCCChhhhhhccc----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 005236 449 LGCCIHGEEKLLIYEFMPNKSLDSFIFDQE----------------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIH 512 (706)
Q Consensus 449 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH 512 (706)
++++.+.+..++||||+++++|.+++.... ....+++..+++++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999985432 1134678889999999999999999988 999
Q ss_pred cccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhC--CCC
Q 005236 513 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG--KKN 590 (706)
Q Consensus 513 ~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG--~~p 590 (706)
|||||+|||+++++.+||+|||+++.+.............++..|+|||++....++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999876433322223334567899999999988999999999999999999975 455
Q ss_pred CCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 591 RGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
+..... ...+................. . .......+.+++.+||+.+|.+|||+++|.+.|++
T Consensus 242 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTD---EQVIENAGEFFRDQGRQVYLF-R-----PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCH---HHHHHHHHHHhhhcccccccc-C-----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 443222 222222222221111100000 0 00112346789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=353.64 Aligned_cols=262 Identities=31% Similarity=0.449 Sum_probs=208.2
Q ss_pred ccCCCccceeccCCceeEEEEEeCC--C--cE-EEEEEcCc---cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD--E--QE-IAVKRLSK---ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEE 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 457 (706)
-++..+.++||+|+||.||+|++.. + .. ||||..+. ......+++.+|+++|++++|||||+++|++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3566777999999999999999743 2 23 89998874 456778899999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
+++|||+|+||+|.++|..... .++..+++.++.+.|+||+|||+++ +|||||.++|+|+..++.+||+|||+++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999966543 6899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCc
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (706)
.-. ..........-+.+|+|||.+....|+.++|||||||++||+++ |..|+...... .... .....+...
T Consensus 311 ~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~---kI~~~~~r~ 382 (474)
T KOG0194|consen 311 AGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKA---KIVKNGYRM 382 (474)
T ss_pred CCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHH---HHHhcCccC
Confidence 632 11111212346789999999999999999999999999999999 78886543221 1111 111222221
Q ss_pred ccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCCCCCC
Q 005236 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLPQP 669 (706)
Q Consensus 617 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~~~~p 669 (706)
.... ..+. .+..++..|++.+|++||+|.++.+.|+.+.....+
T Consensus 383 ~~~~------~~p~---~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 383 PIPS------KTPK---ELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCC------CCHH---HHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1111 2222 344567799999999999999999999987555444
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=369.75 Aligned_cols=258 Identities=32% Similarity=0.496 Sum_probs=212.2
Q ss_pred cCCCccceeccCCceeEEEEEeCC--C----cEEEEEEcCc-cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD--E----QEIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~--~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 459 (706)
+..++.+.||+|+||.||+|...+ + ..||||.+.+ .+.+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 456677999999999999998743 3 3499999977 46677889999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhcc----cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecc
Q 005236 460 LIYEFMPNKSLDSFIFDQ----ERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 535 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgl 535 (706)
+++|||++|+|..||++. .....+...+.+.++.+||+|+.||++++ +|||||..+|+||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999764 12456899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCC
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGM 614 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 614 (706)
|+.+...++........-+.+|||||.+..+.+|.|+|||||||+|||++| |..||...+..+ .... ....+.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---v~~~---~~~ggR 922 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---VLLD---VLEGGR 922 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---HHHH---HHhCCc
Confidence 997665555544444456789999999999999999999999999999999 778865433221 1111 111221
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 615 PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 615 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
+. ........+.+|+..||+.+|++||++..+++.+..+
T Consensus 923 L~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 923 LD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred cC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 11 1112334667899999999999999999999988766
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=309.15 Aligned_cols=277 Identities=27% Similarity=0.375 Sum_probs=211.3
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchh--hHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQ--GLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
++|...++||+|.||.||+|++ ..|+.||||+++..... ......+|+..++.++|+||+.|+++|-..+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999997 55899999998654322 24567899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
||+. +|...|++.. ..++...+..++.++++|++|+|.+. |+||||||.|+|++++|.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9964 8999996544 56888999999999999999999987 9999999999999999999999999999986543
Q ss_pred CcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh---cCCCcc--
Q 005236 544 TEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWN---EGMPSQ-- 617 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~-- 617 (706)
.... ..+-|.-|.|||.+.+ ..|+...|+||.|||+.||+-|.+-|... ...+......+.+. +..+++
T Consensus 156 ~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~---sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 156 RIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD---SDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred cccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC---chHHHHHHHHHHcCCCCcccCcccc
Confidence 3222 2367899999999876 57999999999999999999998765433 33333333333322 222211
Q ss_pred -cccc---------cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCCCCCCCCCCccc
Q 005236 618 -LIDA---------CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLPQPKQPGYLA 676 (706)
Q Consensus 618 -~~d~---------~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~~~~p~~p~~~~ 676 (706)
+.|. .....+ ......+++++..++..||.+|++++|++++=- ....|.|..|.-.+
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y-f~~~P~pt~~~~lp 297 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKHPY-FKSLPLPTPPSKLP 297 (318)
T ss_pred ccccHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcchh-hhcCCCCCChhhCc
Confidence 1110 000011 112234578999999999999999999987643 22345554444333
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=326.62 Aligned_cols=268 Identities=29% Similarity=0.422 Sum_probs=205.9
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhh--cCCcceeeeEeEEEeCC----eeE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSK--LQHRNLVKLLGCCIHGE----EKL 459 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~ 459 (706)
.+...+.++||+|+||.||||++.+ +.||||++. .+..+.|++|-.+++. ++|+||++++++-..+. +++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccC-ceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 3556777999999999999999954 899999985 4556678888877765 58999999999987666 889
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceEecccCCCcEEEcCCCCeEEeee
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD------SRLRIIHRDLKASNVLLDQDMNPKISDF 533 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------~~~~ivH~Dikp~Nill~~~~~~kl~Df 533 (706)
||+||.++|+|.+||.. ..++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+||
T Consensus 285 LVt~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 99999999999999954 4589999999999999999999975 3568999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccCccCccccccC-CCC-----cchhhHHHHHHHHHHHhCCCCCCC------CCCCC---
Q 005236 534 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFS-----VKSDVFSFGILLLEIVSGKKNRGF------YHSDN--- 598 (706)
Q Consensus 534 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s-----~~sDv~SlGvil~elltG~~p~~~------~~~~~--- 598 (706)
|+|..+........+...+||.+|||||++.+. ++. .+.||||+|.|||||++.-..... ..+-+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999998766666666668999999999999764 232 468999999999999996543311 00000
Q ss_pred -chhHHHHHHHHh-hcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 599 -KLNLIRHAWKLW-NEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 599 -~~~~~~~~~~~~-~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
..--+...+... .+...+.+.+..... ..+.-+.+.+..||..||+.|-|+.=|.+.+..+.-
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 000011122211 222223333333322 334456778899999999999999999988877643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=314.06 Aligned_cols=236 Identities=26% Similarity=0.318 Sum_probs=195.9
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.+.||.|+||.|.+++.+. |..+|+|++.+. .....+...+|..+|+.+.||+++++++.+.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 578899999999999999999854 778999999763 3344567789999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||++||-|..+|++.. .+++..+..+|.||+.||+|||+.+ |++|||||+|||||.+|++||+|||.|+.+.
T Consensus 124 eyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-- 195 (355)
T ss_pred eccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence 9999999999996543 4888899999999999999999988 9999999999999999999999999999863
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
..+-..+|||.|+|||++....+..++|.|||||++|||+.|.+||....+....+.|.. ..-..+..+.+
T Consensus 196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~-----~~v~fP~~fs~- 266 (355)
T KOG0616|consen 196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE-----GKVKFPSYFSS- 266 (355)
T ss_pred ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh-----CcccCCcccCH-
Confidence 235568999999999999999999999999999999999999999865444211111111 01111222221
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCC
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDR 650 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~R 650 (706)
.+.+|+...|+.|-.+|
T Consensus 267 -----------~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 267 -----------DAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -----------HHHHHHHHHHhhhhHhh
Confidence 34467778888888888
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=342.09 Aligned_cols=251 Identities=27% Similarity=0.443 Sum_probs=206.3
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
...|...++||+|+.|.||.++. ..++.||||++........+-+.+|+.+|+..+|+|||+++..+..++++++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 35677789999999999999986 56889999998765555567789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
|++|+|.+.+.. ..+++.++..|..+++.||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999999843 33889999999999999999999998 99999999999999999999999999988755444
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
.....+||+.|||||++....|.+|.||||||++++||+-|++||-. +.....+ +.....+.+ ++-.+
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln---E~PlrAl---yLIa~ng~P-~lk~~--- 492 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN---ENPLRAL---YLIATNGTP-KLKNP--- 492 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC---CChHHHH---HHHhhcCCC-CcCCc---
Confidence 33447899999999999999999999999999999999999999643 2222211 112222222 11110
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
..--..+.+++.+||+.|+++||+++|+++.
T Consensus 493 ----~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 493 ----EKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ----cccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 0111234578889999999999999999863
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=338.74 Aligned_cols=262 Identities=24% Similarity=0.330 Sum_probs=207.1
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHH--HHHHHHHHhhcC-CcceeeeEeEEEeCC-eeE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKE--LKNEIILFSKLQ-HRNLVKLLGCCIHGE-EKL 459 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~ 459 (706)
..++|.+.++||.|.||.||+|+.+ .+..||||++++.-.. +++ =.+|+..|++|+ |||||+|..++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3468999999999999999999874 4888999998664332 333 357999999998 999999999999988 999
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
+|||||+ .+|.+++.+. ...+++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+||.+
T Consensus 87 fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 9999995 5899999765 567999999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCcccccccccccCccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 540 GGDETEGNTNRVVGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 540 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
.+. ...+..+.|.-|.|||++. ..-|+.+.|+||+|||++|+.+-++.|....+ .+.+.....++..+.....
T Consensus 161 ~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE---~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 161 RSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE---IDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred ccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH---HHHHHHHHHHhCCCccccc
Confidence 543 3445578999999999875 56899999999999999999999988754333 3333333333322111111
Q ss_pred -----------------ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHh
Q 005236 619 -----------------IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 619 -----------------~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L 660 (706)
....+...... ...++++++..|++.||.+|||++|.+++-
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 11111111111 334678899999999999999999998764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=341.56 Aligned_cols=242 Identities=29% Similarity=0.442 Sum_probs=196.8
Q ss_pred CCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCC
Q 005236 389 FSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 468 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 468 (706)
+..++-||.|+.|-||+|+++ ++.||||+++... ..++.-|++|+||||+.|.|+|.....++||||||..|
T Consensus 126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 344578999999999999995 5689999885432 34677899999999999999999999999999999999
Q ss_pred ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccc
Q 005236 469 SLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 548 (706)
Q Consensus 469 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 548 (706)
-|...|+.. ..+.......|..+||.||.|||.+. |||||||.-||||..+..+||+|||.++.+... ...
T Consensus 198 qL~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STk 268 (904)
T KOG4721|consen 198 QLYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STK 268 (904)
T ss_pred cHHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhh
Confidence 999999654 35788888999999999999999987 999999999999999999999999999986433 233
Q ss_pred cccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCC
Q 005236 549 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFN 628 (706)
Q Consensus 549 ~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 628 (706)
..+.||..|||||+|.+.+.+.|+|||||||||||||||..|+...+.... .|.+ +. ..+.-...
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI------IwGV---Gs------NsL~LpvP 333 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI------IWGV---GS------NSLHLPVP 333 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee------EEec---cC------CcccccCc
Confidence 447899999999999999999999999999999999999999754332111 1111 00 01111112
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 629 LAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 629 ~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
-.....+.-|+.+||+..|..||++.+++..|.=
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 2233355668889999999999999999999974
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=337.94 Aligned_cols=264 Identities=27% Similarity=0.425 Sum_probs=217.1
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhh-HHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQG-LKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
+...+.++||+|-||.|.+.....+..||||+++...... .++|.+|+.+|.+++|||||+|+|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 4567889999999999999999888999999998754444 589999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++|+|.+|+..++... +.-....+|+.||+.||+||.+.+ +|||||.++|+|++.++++||+|||+++.+...++.
T Consensus 618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999997764322 455667789999999999999887 999999999999999999999999999988777766
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS--GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
......+-+++|||||.+..+++|.++|||+||+++||+++ ...|++....+ ..++..-.....+.....+.
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~l~--- 767 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVVLS--- 767 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCcceecc---
Confidence 66666788999999999999999999999999999999866 67776554432 22333333333332222111
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.+......+.++++.||..+.++||++++|...|+..
T Consensus 768 ---~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 768 ---RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1112233566899999999999999999999999764
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=344.19 Aligned_cols=260 Identities=30% Similarity=0.417 Sum_probs=203.1
Q ss_pred ccCCCccceeccCCceeEEEEEe------CCCcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL------ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEE 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 457 (706)
.++|++.++||+|+||.||+|+. ..+..||||+++.. .....+.+.+|+.++..+ +||||+++++++..++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35789999999999999999974 23568999998643 233456788999999999 89999999999999999
Q ss_pred eEEEEecCCCCChhhhhhcccc----------------------------------------------------------
Q 005236 458 KLLIYEFMPNKSLDSFIFDQER---------------------------------------------------------- 479 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 479 (706)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864321
Q ss_pred --------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 480 --------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 480 --------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788899999999999999999987 999999999999999999999999999876433222
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
.......++..|+|||++.+..++.++||||||+++|||++ |..||....... ... +.+..+..... .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~----~~~~~~~~~~~-~---- 339 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFY----KMIKEGYRMLS-P---- 339 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHH----HHHHhCccCCC-C----
Confidence 22222345678999999999999999999999999999998 888865432211 111 11112111110 0
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
... ..++.+++.+||+.+|++||++.||+++|+..
T Consensus 340 -~~~---~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 -ECA---PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -CCC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 001 12466899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=338.50 Aligned_cols=248 Identities=24% Similarity=0.372 Sum_probs=203.3
Q ss_pred HhccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc----ch-hhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCC
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI----SE-QGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGE 456 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 456 (706)
...+.|.+.+.||+|.||.|+.|+. ..+..||+|.+.+. .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999987 45799999976552 12 34567778999999999 999999999999999
Q ss_pred eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-CCeEEeeecc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGL 535 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfgl 535 (706)
..++||||+.+|+|.+++.+. ..+.+....+++.|++.|++|+|+.+ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 999999999999999999763 44777999999999999999999988 9999999999999999 9999999999
Q ss_pred ccccCCCCCcccccccccccCccCccccccCC-CC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ-FS-VKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG 613 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 613 (706)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||... +...+... +..+
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~---~~~~l~~k----i~~~ 238 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS---NVPNLYRK----IRKG 238 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc---cHHHHHHH----HhcC
Confidence 99763 1223344578999999999999987 86 7899999999999999999998751 11122211 1111
Q ss_pred C--CcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHH
Q 005236 614 M--PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI 657 (706)
Q Consensus 614 ~--~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~ 657 (706)
. .+..+. ...+..++.+||+.+|.+|+++.+++
T Consensus 239 ~~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 EFKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1 111110 23566789999999999999999999
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.30 Aligned_cols=260 Identities=32% Similarity=0.460 Sum_probs=203.1
Q ss_pred ccCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEE 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 457 (706)
.++|.+.+.||+|+||.||+|+.. ++..||||++... .....+.+.+|+.+++.+ +||||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357999999999999999998752 2457999998653 334456788999999999 89999999999999999
Q ss_pred eEEEEecCCCCChhhhhhcccc----------------------------------------------------------
Q 005236 458 KLLIYEFMPNKSLDSFIFDQER---------------------------------------------------------- 479 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 479 (706)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999864311
Q ss_pred ---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccc
Q 005236 480 ---------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 550 (706)
Q Consensus 480 ---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 550 (706)
...+++..+++++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+...........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 123678889999999999999999987 99999999999999999999999999986543322212222
Q ss_pred cccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCH
Q 005236 551 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNL 629 (706)
Q Consensus 551 ~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 629 (706)
..++..|||||++.+..++.++||||||+++|||++ |+.||........ . ............. ...
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~---~---~~~~~~~~~~~~~-----~~~-- 340 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK---F---YKMVKRGYQMSRP-----DFA-- 340 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH---H---HHHHHcccCccCC-----CCC--
Confidence 345678999999999999999999999999999997 9999764332211 1 1111111110000 011
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 630 AEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 630 ~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
...+.+++..||+.+|.+||++.+|+++|+.+
T Consensus 341 --~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 341 --PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred --CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 12466788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=331.93 Aligned_cols=247 Identities=26% Similarity=0.408 Sum_probs=204.1
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
++|.+.+.||+|.||.||||+.+. .+.||+|.+.+ ..++..+.+.+|++++++++|||||.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578899999999999999999865 67899999865 455667889999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+.| +|..+|.+..+ ++++.+..++.+++.||.|||+.. |+|||+||+|||++..+++|++|||+|+.....
T Consensus 82 ~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN- 153 (808)
T ss_pred hhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence 9988 99999966543 889999999999999999999987 999999999999999999999999999976432
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
......+.|||-|||||...+.+|+..+|.||+|||+||+++|++||-.. ....++ ..+..++....
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---si~~Lv---~~I~~d~v~~p------ 220 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---SITQLV---KSILKDPVKPP------ 220 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---HHHHHH---HHHhcCCCCCc------
Confidence 22344578999999999999999999999999999999999999997421 111111 11111111110
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
......+..++...|+.||..|.|..+++..
T Consensus 221 -----~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 221 -----STASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -----ccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 0122345677788999999999999998753
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.12 Aligned_cols=244 Identities=20% Similarity=0.318 Sum_probs=195.5
Q ss_pred ceeccCCceeEEEEEeCCCcEEEEEEcCccchhh---HHHHHHHHHHHhhcCCcceeeeEeEEEe----CCeeEEEEecC
Q 005236 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQG---LKELKNEIILFSKLQHRNLVKLLGCCIH----GEEKLLIYEFM 465 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~ 465 (706)
..||+|++|.||+|.. +++.||||++....... .+.+.+|+.++.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6899999999999998 68899999997643322 5778899999999999999999999977 34678999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
++|+|.+++... ..+++...+.++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999999653 3578899999999999999999984 5 7899999999999999999999999998653221
Q ss_pred cccccccccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ....... ........+ +
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~~~~~i---~~~~~~~~~-~-- 244 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIYDLI---INKNNSLKL-P-- 244 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HHHHHHH---HhcCCCCCC-C--
Confidence 12467899999999976 6899999999999999999999999864321 1111111 111111111 1
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
......+.+++.+||+.||.+|||++||++.|+..
T Consensus 245 ------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 245 ------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred ------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 01122466889999999999999999999999865
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=327.14 Aligned_cols=251 Identities=26% Similarity=0.360 Sum_probs=198.4
Q ss_pred CCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 388 NFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.|++.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999987 468899999986432 2234567889999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999998886432 235788999999999999999999988 9999999999999999999999999998753221
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
......||..|+|||++.+..++.++|||||||++|||++|+.||...........+.. ...... ..+
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~~~~~-~~~----- 224 (285)
T cd05631 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR---RVKEDQ-EEY----- 224 (285)
T ss_pred ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH---Hhhccc-ccC-----
Confidence 12235689999999999999999999999999999999999999865433221111111 111111 011
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCC-----hhHHHH
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPC-----MPSVIL 658 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~ev~~ 658 (706)
....+ ..+.+|+..||+.+|.+||+ ++++++
T Consensus 225 ~~~~s----~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 225 SEKFS----EDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CccCC----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01111 24567889999999999997 677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.75 Aligned_cols=248 Identities=26% Similarity=0.434 Sum_probs=206.3
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCc-cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
..|+..+.||+|.||.||+|.+.. ++.||+|++.. ......+.+++|+.++..++|+||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 457777999999999999999854 78899999865 3445578899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
|.+|++.+.|... ..+++..+.-++.++..||.|||.++ .+|||||+.||||..+|.+||+|||.+-.+.....
T Consensus 93 ~~gGsv~~lL~~~---~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG---NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhccC---CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999998432 23467777778899999999999998 99999999999999999999999999987755444
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
.. ...+||+.|||||++....|+.|+||||||++.+||.+|.+|+...++..-..++- ... .|.+.
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-------k~~-----PP~L~ 232 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-------KSA-----PPRLD 232 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-------CCC-----CCccc
Confidence 33 55899999999999998899999999999999999999999988777644333221 111 22222
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+.+. ..+.+++..||+.+|+.||++.++++
T Consensus 233 ~~~S----~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 233 GDFS----PPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccC----HHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 2222 23567888999999999999999975
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=322.49 Aligned_cols=258 Identities=26% Similarity=0.364 Sum_probs=199.2
Q ss_pred HhccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccch--------------hhHHHHHHHHHHHhhcCCcceeee
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISE--------------QGLKELKNEIILFSKLQHRNLVKL 448 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l 448 (706)
...++|++.+.||+|.||.|-+|+. .+++.||||++.+... ...+...+|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3457999999999999999999997 4688999999865211 123578899999999999999999
Q ss_pred EeEEEe--CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC
Q 005236 449 LGCCIH--GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 526 (706)
Q Consensus 449 ~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 526 (706)
+.+..+ .+.+|||+|||..|.+...= .....++..++++++.++..||+|||.++ ||||||||+|+||+++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 999865 45889999999988875432 22223889999999999999999999999 99999999999999999
Q ss_pred CeEEeeeccccccCCC---CCcccccccccccCccCccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc
Q 005236 527 NPKISDFGLARAFGGD---ETEGNTNRVVGTYGYMAPEYASDGQ----FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK 599 (706)
Q Consensus 527 ~~kl~Dfgla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDv~SlGvil~elltG~~p~~~~~~~~~ 599 (706)
++||+|||.+..+... .........+|||.|||||.+.++. .+.+.||||+||+||.|+.|+.||-. +..
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~---~~~ 324 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD---DFE 324 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc---chH
Confidence 9999999999876322 1112233478999999999997743 34688999999999999999999743 112
Q ss_pred hhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 600 LNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
.++... +.++ . +.-....+.-..+.+|++.+|+.||+.|.+..+|....=-
T Consensus 325 ~~l~~K---Ivn~-p--------L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 325 LELFDK---IVND-P--------LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred HHHHHH---HhcC-c--------ccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 222211 1111 1 1111111233456689999999999999999999887743
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=339.60 Aligned_cols=245 Identities=26% Similarity=0.389 Sum_probs=201.8
Q ss_pred HHhccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCe
Q 005236 383 ANATDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEE 457 (706)
Q Consensus 383 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 457 (706)
....++|.+.++||+|+||+|+++..+. ++.+|||.+++. .....+..+.|..++.... ||.|++|+.+|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3445789999999999999999999865 778999999873 4566788899999888775 9999999999999999
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
++.||||+.||++..++ ....+++..+..+|..|+.||+|||+++ ||+||||.+|||||.+|++||+||||++
T Consensus 444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999965544 2345899999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
.--. ....+...+||+.|||||++.+..|+..+|.|||||+|||||.|+.||...+.++..+-|.. +..
T Consensus 517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~------d~~--- 585 (694)
T KOG0694|consen 517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN------DEV--- 585 (694)
T ss_pred ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc------CCC---
Confidence 6421 23356679999999999999999999999999999999999999999865444332221111 110
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCCh
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCM 653 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 653 (706)
.++.-...+.+.++..+|..+|++|--+
T Consensus 586 --------~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 --------RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --------CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 0111122356678889999999999877
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=336.42 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=201.7
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.++||+|+||.||+|+... ++.||||++.... ....+.+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 468999999999999999999864 7899999986532 234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 999999999999543 34788899999999999999999988 99999999999999999999999999986532
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC-cccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP-SQLIDA 621 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~d~ 621 (706)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. .+..... ....++
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~ 225 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK----YWKETLQRPVYDDP 225 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH----hccccccCCCCCcc
Confidence 2234578999999999999999999999999999999999999986433221111111 1111000 000000
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. ......+.+++..||+.+|.+||+++++++.
T Consensus 226 ~------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 R------FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred c------cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0 0112345678889999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=323.56 Aligned_cols=250 Identities=36% Similarity=0.575 Sum_probs=193.6
Q ss_pred ccceeccCCceeEEEEEeC-----CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 391 INKKLGEGGFGPVYKGTLA-----DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 391 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+.+.||.|.||.||+|.+. .+..|+||.++.. .....+.+.+|+..+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4589999999999999987 2568999999653 444578999999999999999999999999988889999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++|+|.++|... ....+++..++.|+.||++||.|||+.+ ++|+||+++||++++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999765 2345899999999999999999999987 99999999999999999999999999987633333
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
............|+|||.+....++.++||||||+++|||++ |+.|+... ...+..... .........+
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~~~~----~~~~~~~~~~--- 228 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEIIEKL----KQGQRLPIPD--- 228 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHHHHH----HTTEETTSBT---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccc----cccccceecc---
Confidence 223333457789999999999999999999999999999999 67775433 222222222 1111111111
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHh
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L 660 (706)
. ....+..++..||+.+|.+||+++++++.|
T Consensus 229 --~----~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 229 --N----CPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --T----SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --c----hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0 112456789999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.26 Aligned_cols=257 Identities=30% Similarity=0.490 Sum_probs=205.7
Q ss_pred cCCCccceeccCCceeEEEEEeCC------CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 459 (706)
++|++.+.||+|+||.||+|.... ...|++|.+... .....+.+.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 478899999999999999998743 257999998643 3344567899999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC
Q 005236 460 LIYEFMPNKSLDSFIFDQER-------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 526 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 526 (706)
++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999965321 145788899999999999999999988 99999999999999999
Q ss_pred CeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHH
Q 005236 527 NPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRH 605 (706)
Q Consensus 527 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 605 (706)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||...... +..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~-- 236 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVI-- 236 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH--
Confidence 999999999987543332223334456889999999998999999999999999999998 99887543221 111
Q ss_pred HHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 606 AWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 606 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
..+.......... .....+.+++.+||+.+|.+||+++||++.|++
T Consensus 237 --~~i~~~~~~~~~~---------~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 --EMIRSRQLLPCPE---------DCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHcCCcCCCcc---------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1122222111111 112356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=333.33 Aligned_cols=248 Identities=25% Similarity=0.320 Sum_probs=207.1
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
.-|++++.||.|+-|.|-.|++ ..|+.+|||++.+. .......+.+|+.+|+.+.|||++++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 5688999999999999999998 55999999999764 3344567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|-|.++|..++ .+.+.+..+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|..-..
T Consensus 92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~- 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP- 164 (786)
T ss_pred EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC-
Confidence 9999999999997654 4888899999999999999999998 99999999999999999999999999986322
Q ss_pred CCcccccccccccCccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
.......+|++.|.|||++.+.+|. .++||||.|||||.||||+.||+ +++...+..++.+.. -.++..+.
T Consensus 165 --gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV~~G~--f~MPs~Is- 236 (786)
T KOG0588|consen 165 --GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKVQRGV--FEMPSNIS- 236 (786)
T ss_pred --CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHHHcCc--ccCCCcCC-
Confidence 2233457999999999999999986 78999999999999999999986 333334443333211 11112222
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHh
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L 660 (706)
.++.+|+..|+..||++|.|++||++.-
T Consensus 237 -----------~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 237 -----------SEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred -----------HHHHHHHHHHhccCccccccHHHHhhCc
Confidence 1455788899999999999999999863
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.97 Aligned_cols=255 Identities=31% Similarity=0.452 Sum_probs=205.2
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 36789999999999999999998888899999986533 23578899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999996543 345788899999999999999999987 999999999999999999999999999876432211
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
......++..|+|||++....++.++||||||+++|||++ |+.||..... ......... .......
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~----~~~~~~~----- 226 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSALQR----GYRMPRM----- 226 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHHHc----CCCCCCC-----
Confidence 1222345678999999998899999999999999999998 8888753221 112222111 1110000
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
... ...+.+++.+|++.+|++||+++++.++|+.
T Consensus 227 ~~~----~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 ENC----PDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCC----CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011 1246678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=335.42 Aligned_cols=245 Identities=22% Similarity=0.282 Sum_probs=198.3
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 67999999999999999999985 4789999998653 2234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999999653 34788888899999999999999988 999999999999999999999999999875322
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...... ....+... + .
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~----~i~~~~~~-~-p-- 235 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT---PFRIYE----KILAGRLK-F-P-- 235 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC---HHHHHH----HHhcCCcC-C-C--
Confidence 123578999999999999999999999999999999999999975322 111111 11111110 0 0
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCC-----hhHHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPC-----MPSVILM 659 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~ev~~~ 659 (706)
...+ ..+.+++..||+.||.+||+ +++++..
T Consensus 236 --~~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 236 --NWFD----GRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --CCCC----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0111 24567899999999999997 6777643
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=337.14 Aligned_cols=261 Identities=30% Similarity=0.407 Sum_probs=204.6
Q ss_pred ccCCCccceeccCCceeEEEEEeCC------CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEE 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 457 (706)
.++|.+.++||+|+||.||+|+... +..||||++... .....+.+.+|+.+++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4689999999999999999998632 346999999653 3344567899999999996 9999999999999999
Q ss_pred eEEEEecCCCCChhhhhhcccc----------------------------------------------------------
Q 005236 458 KLLIYEFMPNKSLDSFIFDQER---------------------------------------------------------- 479 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 479 (706)
.++||||+++|+|.++|.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999999864311
Q ss_pred -----------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC
Q 005236 480 -----------------------------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ 524 (706)
Q Consensus 480 -----------------------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~ 524 (706)
...+++..++.++.||++||+|||+.+ |+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124778888999999999999999987 999999999999999
Q ss_pred CCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHH
Q 005236 525 DMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLI 603 (706)
Q Consensus 525 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~ 603 (706)
++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....+.. ..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--FY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--HH
Confidence 99999999999987643322222233456788999999999999999999999999999997 8888754322111 11
Q ss_pred HHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 604 RHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 604 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
.....+...... . .....+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 351 ----~~~~~~~~~~~~-----~----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 ----NKIKSGYRMAKP-----D----HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ----HHHhcCCCCCCC-----c----cCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 111111111100 0 11235678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.60 Aligned_cols=245 Identities=22% Similarity=0.270 Sum_probs=198.2
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.++||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47889999999999999999985 58899999985422 234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999999643 34788899999999999999999988 999999999999999999999999999865321
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ....... ..... .+
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~~~~~i----~~~~~-~~---- 217 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---FGIYEKI----LAGKL-EF---- 217 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH----HhCCc-CC----
Confidence 2235689999999999999999999999999999999999999754321 1111111 11111 00
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCC-----hhHHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPC-----MPSVILM 659 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~ev~~~ 659 (706)
.... ...+.+++.+||+.||.+||+ ++|+++.
T Consensus 218 -~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 218 -PRHL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -CccC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0111 124567889999999999995 7777755
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.56 Aligned_cols=255 Identities=26% Similarity=0.393 Sum_probs=201.7
Q ss_pred cCCCccceeccCCceeEEEEEeC----CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA----DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
++|++.+.||+|+||.||+|.++ .+..||+|.+... .....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 57889999999999999999863 3568999998764 334456789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999996532 35889999999999999999999988 99999999999999999999999998765422
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||...... ..+.. ..........
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~----~~~~~~~~~~- 230 (266)
T cd05064 160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKA----VEDGFRLPAP- 230 (266)
T ss_pred cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHH----HHCCCCCCCC-
Confidence 111 11112345678999999999999999999999999999875 99997543221 11111 1111111110
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.. ....+.+++..||+.+|.+||++++|.+.|+..
T Consensus 231 ----~~----~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 231 ----RN----CPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CC----CCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01 122466788999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.25 Aligned_cols=252 Identities=26% Similarity=0.423 Sum_probs=201.7
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
++|++.+.||+|+||.||++.++++..+|+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 468888999999999999999988889999987643 2234678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 999999986433 35789999999999999999999988 999999999999999999999999999865322211
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......++..|+|||++.+..++.++||||||+++|||++ |+.||.... .......... +.... .+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~---~~~~~~~i~~----~~~~~--~~---- 223 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS---NYEVVEMISR----GFRLY--RP---- 223 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHC----CCCCC--CC----
Confidence 1122345678999999998899999999999999999999 888875322 1222222111 11100 00
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
.. ....+.+++.+||+.+|.+||+++++++.|.
T Consensus 224 ~~---~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 KL---ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CC---CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00 1135678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.22 Aligned_cols=199 Identities=27% Similarity=0.373 Sum_probs=174.6
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.++|++.+.||+|+||.||+++.. .+..+|+|.+... .....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 368999999999999999999985 4778899988653 33445789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ .|+||||||+|||+++++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 99999999999643 34788999999999999999999853 3999999999999999999999999999865322
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 593 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~ 593 (706)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 22335689999999999999999999999999999999999999854
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=344.09 Aligned_cols=253 Identities=17% Similarity=0.232 Sum_probs=202.6
Q ss_pred cCCCccceeccCCceeEEEEEeCC--CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD--EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
..|.+.+.||+|+||.||+|.... ++.||+|.+..........+..|+.+++.++|||||++++++...+..++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 348899999999999999998643 567888887655555566788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 465 MPNKSLDSFIFDQ-ERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 465 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
+++|+|.++|.+. .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999988643 22345788899999999999999999987 9999999999999999999999999998764433
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... .. .+....+.
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~~~~~---~~-~~~~~~~~---- 292 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---REIMQQ---VL-YGKYDPFP---- 292 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH---HH-hCCCCCCC----
Confidence 22233446799999999999999999999999999999999999999753221 111111 11 11111110
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
... ...+.+++..||+.+|.+||++.+++.
T Consensus 293 -~~~----s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 -CPV----SSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -ccC----CHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011 124667889999999999999999864
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=316.88 Aligned_cols=255 Identities=30% Similarity=0.451 Sum_probs=204.6
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
.++|++.+.||+|++|.||+|...+++.||+|.+.... ...+++.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35788999999999999999998888899999986533 33567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999996543 345789999999999999999999987 999999999999999999999999999876522111
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
.......+..|+|||++.+..++.++||||||+++|||++ |+.|+..... ....... ........
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~~~~~~------ 225 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQQV----DQGYRMPC------ 225 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----HcCCCCCC------
Confidence 1111223468999999999999999999999999999999 8888753221 1111111 11110000
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
.......+.+++.+|++.+|.+||++.+|++.|+.
T Consensus 226 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 226 ---PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 00112356789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.81 Aligned_cols=259 Identities=27% Similarity=0.439 Sum_probs=202.8
Q ss_pred hccCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEE 457 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 457 (706)
..++|++.+.||+|+||.||+|... .+..||+|++... ......++.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4568999999999999999999763 2467999998643 23345678899999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhhcccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEE
Q 005236 458 KLLIYEFMPNKSLDSFIFDQER-------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 530 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 530 (706)
.++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999865321 234678889999999999999999987 999999999999999999999
Q ss_pred eeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHH
Q 005236 531 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKL 609 (706)
Q Consensus 531 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 609 (706)
+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..|+..... ..... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~----~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLR----F 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----H
Confidence 99999986543322222222345788999999999999999999999999999999 6777643221 11111 1
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 610 WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 610 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
..........+ . ....+.+++.+||+.+|++|||+.|+++.|++
T Consensus 234 ~~~~~~~~~~~-----~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLDKPD-----N----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCCCCC-----C----CCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111111 1 12246789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=372.72 Aligned_cols=263 Identities=25% Similarity=0.460 Sum_probs=211.6
Q ss_pred hccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
....+...+.||+|+||.||+|+. .++..||||++...... ...|+..+++++|||||+++++|.+.+..++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 345677888999999999999997 56889999998653322 2346888999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++|+|.++++ .++|..+.+++.||++||+|||+....+|+||||||+||+++.++..++. ||.......+
T Consensus 764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 999999999994 27899999999999999999997655669999999999999999988875 6665443211
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
....+|+.|+|||++.+..++.++|||||||++|||+||+.|+..... .......+.............+|+.+
T Consensus 836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccc
Confidence 123678999999999999999999999999999999999999843222 22334445444444444445556555
Q ss_pred cC--cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 624 KD--SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 624 ~~--~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
.. ..+.++..++.+++.+||+.+|++||+|+||++.|+....
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 33 3455677788999999999999999999999999997643
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.71 Aligned_cols=257 Identities=28% Similarity=0.472 Sum_probs=205.6
Q ss_pred cCCCccceeccCCceeEEEEEeCC------CcEEEEEEcCccchh-hHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSKISEQ-GLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 459 (706)
++|.+.+.||+|+||.||+|+..+ ++.||||.+...... ..+.+.+|+.++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 568889999999999999998743 478999998764433 5678999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhccc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCe
Q 005236 460 LIYEFMPNKSLDSFIFDQE-----------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 528 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 528 (706)
+||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999996532 1244788899999999999999999988 9999999999999999999
Q ss_pred EEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHH
Q 005236 529 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAW 607 (706)
Q Consensus 529 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 607 (706)
||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ......
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~~- 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIECI- 237 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH-
Confidence 9999999986543322222223456788999999999999999999999999999998 99987533221 122111
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 608 KLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 608 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
..+....... . ....+.+++..||+.+|.+||++.||++.|+.
T Consensus 238 ---~~~~~~~~~~-----~----~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 ---TQGRLLQRPR-----T----CPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ---HcCCcCCCCC-----C----CCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111111110 1 12346689999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=322.30 Aligned_cols=260 Identities=28% Similarity=0.464 Sum_probs=208.1
Q ss_pred cCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57889999999999999999852 245689999877666667789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhccc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEE
Q 005236 461 IYEFMPNKSLDSFIFDQE----------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 530 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 530 (706)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999996432 2235899999999999999999999988 999999999999999999999
Q ss_pred eeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHH
Q 005236 531 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKL 609 (706)
Q Consensus 531 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 609 (706)
+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~~---- 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIEC---- 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----
Confidence 99999986643322222233446788999999999999999999999999999998 88886533221 11111
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 610 WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 610 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
...+...... ...+ ..+.+++.+||+.+|.+|||++||++.|+.+..
T Consensus 235 i~~~~~~~~~-----~~~~----~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 235 ITQGRVLQRP-----RTCP----KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHcCCcCCCC-----CCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1111111111 1111 246789999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=325.62 Aligned_cols=264 Identities=23% Similarity=0.293 Sum_probs=197.2
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
++|++.++||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999875 57899999986432 22345678999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++ +|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 985 8988885432 34788899999999999999999988 9999999999999999999999999998653221
Q ss_pred cccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc-----
Q 005236 545 EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL----- 618 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 618 (706)
.......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+............+.+
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 11223467899999999865 56899999999999999999999998643322221111111100000000000
Q ss_pred ----ccccccCcCC----HHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 619 ----IDACFKDSFN----LAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 619 ----~d~~~~~~~~----~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
..+....... ......+.+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000 001124568999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=322.95 Aligned_cols=260 Identities=27% Similarity=0.440 Sum_probs=209.1
Q ss_pred cCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999752 345689999877666666789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC
Q 005236 461 IYEFMPNKSLDSFIFDQE-------------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 527 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~ 527 (706)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999996532 1234789999999999999999999988 999999999999999999
Q ss_pred eEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHH
Q 005236 528 PKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHA 606 (706)
Q Consensus 528 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 606 (706)
++|+|||++................++..|+|||++.+..++.++||||||+++|||++ |+.|+...... ..+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~--- 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVI--- 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---
Confidence 99999999986543322222233456789999999999999999999999999999999 99887543221 111
Q ss_pred HHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 607 WKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 607 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
.....+....... .....+.+++.+||+.+|.+||++++|+++|+.+..
T Consensus 236 -~~~~~~~~~~~~~---------~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 236 -ECITQGRVLERPR---------VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -HHHhCCCCCCCCc---------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1122222211111 112346689999999999999999999999998733
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=327.31 Aligned_cols=265 Identities=21% Similarity=0.276 Sum_probs=200.2
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
++|++.+.||+|+||.||+++.+ +++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999985 4788999998643 23345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|++++.|..+... ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 9999877765432 245888899999999999999999987 9999999999999999999999999998764322
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH--------HH-hhcCC
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAW--------KL-WNEGM 614 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~--------~~-~~~~~ 614 (706)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+.... .. .....
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 12223568999999999999899999999999999999999999986433221111111100 00 00000
Q ss_pred CcccccccccCcCCH------HHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 615 PSQLIDACFKDSFNL------AEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 615 ~~~~~d~~~~~~~~~------~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
......+........ .....+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000001000000 01224778999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=316.48 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=204.5
Q ss_pred cCCCccceeccCCceeEEEEEeCC----CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD----EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
++|++.+.||+|+||.||+|.+.. ...||||.+... .......+.+|+.++++++||||+++++.+...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578999999999999999998743 457999998653 344456789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999996533 35889999999999999999999987 99999999999999999999999999998752
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
...........++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ....... ........
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~~~-- 229 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAV----EDGYRLPP-- 229 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHH----HcCCCCCC--
Confidence 222222222345678999999999999999999999999999998 9888743221 1111111 11111000
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.......+.+++.+|++.+|++||++.||++.|+.+
T Consensus 230 -------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 -------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.83 Aligned_cols=255 Identities=32% Similarity=0.503 Sum_probs=208.9
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
..+|++.++||.|+||.||+|+..+++.+++|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45789999999999999999999889999999998766656778999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++.... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999997543 345789999999999999999999987 999999999999999999999999999876432211
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
.....++..|+|||.+....++.++||||||+++|+|++ |+.|+..... ........ .......
T Consensus 161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~----~~~~~~~------ 225 (261)
T cd05148 161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQIT----AGYRMPC------ 225 (261)
T ss_pred --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHH----hCCcCCC------
Confidence 112345778999999998899999999999999999998 8888754321 12222211 1110000
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
.......+.+++.+||+.+|.+|||++++++.|+.
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 226 ---PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 01112346689999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=327.58 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=209.7
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe-eEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEE-KLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~ 462 (706)
++|..+++||+|+||.++..+.+ +.+.+|+|++.. ......+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 67899999999999999999874 477899998754 344455678899999999999999999999999988 89999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
+|++||+|.+.|.+++ ...++++.++.|+.||+.|+.|||+.. |+|||||+.|||++.++.+||+|||+|+.+..+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999997665 567899999999999999999999776 999999999999999999999999999998655
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
.. .....+||+.||.||.+.+.+|..|+|||||||++|||++-+++|... +...++....+.. ..+.
T Consensus 160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~---~m~~Li~ki~~~~--------~~Pl 226 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS---NMSELILKINRGL--------YSPL 226 (426)
T ss_pred hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc---chHHHHHHHhhcc--------CCCC
Confidence 42 344578999999999999999999999999999999999999997543 3334444433322 1111
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.. .....+..++..|++.+|+.||++.+++.+
T Consensus 227 p~-----~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 PS-----MYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred Cc-----cccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11 112245568889999999999999999865
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=318.48 Aligned_cols=257 Identities=28% Similarity=0.439 Sum_probs=203.0
Q ss_pred cCCCccceeccCCceeEEEEEe-----CCCcEEEEEEcCc-cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-----ADEQEIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
++|++.++||+|+||.||+|.. ..++.+++|.+.. ........+.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5688889999999999999985 2457899999875 334445788999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhccc--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC
Q 005236 461 IYEFMPNKSLDSFIFDQE--------------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 526 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 526 (706)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985322 1235788899999999999999999987 99999999999999999
Q ss_pred CeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHH
Q 005236 527 NPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRH 605 (706)
Q Consensus 527 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 605 (706)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..... ......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 999999999987643332222333445778999999988899999999999999999999 8888643221 111111
Q ss_pred HHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 606 AWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 606 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
. ........ .... ...+.+++.+||+.+|.+||++.+|.+.|..
T Consensus 239 ~----~~~~~~~~-----~~~~----~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 V----RKRQLLPC-----SEDC----PPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H----HcCCcCCC-----CCCC----CHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 11111110 0111 1246678899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=332.21 Aligned_cols=261 Identities=30% Similarity=0.441 Sum_probs=203.3
Q ss_pred ccCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCccc-hhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeC-C
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSKIS-EQGLKELKNEIILFSKL-QHRNLVKLLGCCIHG-E 456 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 456 (706)
.++|++.+.||+|+||.||+|... .++.||+|++.... ....+.+..|+.++.++ +||||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357999999999999999999742 24689999986532 33456788899999999 899999999988654 5
Q ss_pred eeEEEEecCCCCChhhhhhcccc---------------------------------------------------------
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQER--------------------------------------------------------- 479 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 479 (706)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999999854321
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccCcc
Q 005236 480 -CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558 (706)
Q Consensus 480 -~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~ 558 (706)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 125789999999999999999999987 9999999999999999999999999998764333222233345677899
Q ss_pred CccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHH
Q 005236 559 APEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIH 637 (706)
Q Consensus 559 aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 637 (706)
|||++.+..++.++|||||||++|||++ |+.||......+. . ............ . ......+.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---~---~~~~~~~~~~~~-~--------~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---F---CRRLKEGTRMRA-P--------EYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH---H---HHHHhccCCCCC-C--------ccCCHHHHH
Confidence 9999999999999999999999999998 9988754322111 1 111111111111 0 011235678
Q ss_pred HHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 638 IGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 638 l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
++.+||+.+|++||++.||+++|+.+.
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=325.25 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=201.1
Q ss_pred cCCCccceeccCCceeEEEEEeCC-Cc----EEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQ----EIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
.+|++.+.||+|+||.||+|++.. +. .||+|.+... .....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 568999999999999999998643 33 4899998653 345567889999999999999999999998764 5789
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
|+||+++|+|.+++.... ..+++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999996543 35788899999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
............++..|+|||++.+..++.++||||||+++|||++ |+.|+..... ..+. ............
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~----~~~~---~~~~~~~~~~~~ 233 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEIS---SILEKGERLPQP 233 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHH---HHHhCCCCCCCC
Confidence 4332222222345678999999999999999999999999999998 9998753221 1111 111111110000
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
... ...+.+++..||+.+|.+||++.+++..|....
T Consensus 234 -----~~~----~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 234 -----PIC----TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred -----CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 011 124567899999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=321.80 Aligned_cols=264 Identities=24% Similarity=0.389 Sum_probs=201.6
Q ss_pred cCCCccceeccCCceeEEEEEeCC---------------CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD---------------EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLG 450 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~ 450 (706)
++|++.++||+|+||.||+++..+ ...||+|.++.. .....+.+.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 579999999999999999987643 224899998653 3444567899999999999999999999
Q ss_pred EEEeCCeeEEEEecCCCCChhhhhhcccc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEE
Q 005236 451 CCIHGEEKLLIYEFMPNKSLDSFIFDQER---------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 521 (706)
Q Consensus 451 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nil 521 (706)
++...+..++||||+++++|.+++..... ...+++..+++++.|++.||+|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999864321 124688899999999999999999988 999999999999
Q ss_pred EcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCCCc
Q 005236 522 LDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS--GKKNRGFYHSDNK 599 (706)
Q Consensus 522 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt--G~~p~~~~~~~~~ 599 (706)
+++++.+||+|||++..+.............++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence 99999999999999986543322222223445778999999999999999999999999999998 4455543222
Q ss_pred hhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 600 LNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
...+......+.......... .... ....+.+++.+|++.+|.+||+|.+|++.|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~--~~~~----~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLS--QTPL----CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHHhhhhccccccCC--CCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 122222222111111100000 0000 11357789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=330.76 Aligned_cols=248 Identities=25% Similarity=0.359 Sum_probs=192.7
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
++|+..++||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45677899999999999999975 5889999998653 334456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.... ...+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999986532 2456777889999999999999988 9999999999999999999999999998764221
Q ss_pred cccccccccccCccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||......+....... .. ........
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~-~~~~~~~~ 297 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA---IC-MSQPPEAP 297 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH---Hh-ccCCCCCC
Confidence 12233578999999998743 2345689999999999999999999863222211111111 10 01111110
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. .....+.+++.+||+.+|++||+++||++.
T Consensus 298 -----~----~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 298 -----A----TASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -----C----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 112246678999999999999999999875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=331.27 Aligned_cols=241 Identities=21% Similarity=0.259 Sum_probs=192.8
Q ss_pred ceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCC
Q 005236 393 KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 468 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 468 (706)
+.||+|+||.||+++.. +++.||||++... .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999874 5889999998653 2334567788999999999999999999999999999999999999
Q ss_pred ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccc
Q 005236 469 SLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 548 (706)
Q Consensus 469 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 548 (706)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~ 152 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM 152 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence 999988643 35788999999999999999999988 999999999999999999999999998753211 1122
Q ss_pred cccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCC
Q 005236 549 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFN 628 (706)
Q Consensus 549 ~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 628 (706)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... .. .... .+ ....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~---~~-~~~~-~~-----p~~~- 218 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFEL---IL-MEEI-RF-----PRTL- 218 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHHH---HH-cCCC-CC-----CCCC-
Confidence 335799999999999999999999999999999999999999753221 111111 11 1111 00 0111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCC-----ChhHHHH
Q 005236 629 LAEVIRCIHIGLLCVQQYPEDRP-----CMPSVIL 658 (706)
Q Consensus 629 ~~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~ 658 (706)
...+.+++.+||+.||++|| ++.++++
T Consensus 219 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 219 ---SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ---CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 12456788999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.29 Aligned_cols=257 Identities=26% Similarity=0.302 Sum_probs=208.3
Q ss_pred ccCCCccceeccCCceeEEEEEeCCC-cEEEEEEcCccchhhHHHHHHHHHHHhhcC-CcceeeeEeEE-Ee------CC
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADE-QEIAVKRLSKISEQGLKELKNEIILFSKLQ-HRNLVKLLGCC-IH------GE 456 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~-~~------~~ 456 (706)
..++++.+.|.+|||+.||.|++..+ .++|+|++-..++...+.+.+|+.+|++|+ |+|||.+++.. .. .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 35678889999999999999999776 999999988789999999999999999997 99999999932 21 12
Q ss_pred eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 536 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla 536 (706)
+.+|.||||.||.|-++|....... +++.++++|+.++++|+.+||... ++|||||||.+||||..+++.||||||.|
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence 5689999999999999997655434 999999999999999999999884 78999999999999999999999999998
Q ss_pred cccCCCCCcc-------cccccccccCccCcccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH
Q 005236 537 RAFGGDETEG-------NTNRVVGTYGYMAPEYA---SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHA 606 (706)
Q Consensus 537 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~---~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~ 606 (706)
.......... ......-|+.|.|||.+ .+..+++|+|||+|||+||-|+....||+....-
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--------- 264 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--------- 264 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---------
Confidence 7532221110 00112468999999987 5779999999999999999999999998643211
Q ss_pred HHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 607 WKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 607 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.+++....-........++.+||..||+.||.+||++-+|+..+-.+
T Consensus 265 ----------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 265 ----------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ----------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 22222222122234455778899999999999999999999888766
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=333.47 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=199.0
Q ss_pred ccCCCccceeccCCceeEEEEEeCC--CcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD--EQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
.++|.+.+.||+|+||.||+|+... +..||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3679999999999999999998644 368999988542 23345678899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999999654 34788999999999999999999988 9999999999999999999999999998753
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .... . +.
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~~~~i~----~~~~-~-~p 248 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP---LLIYQKIL----EGII-Y-FP 248 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH---HHHHHHHh----cCCC-C-CC
Confidence 21 2235789999999999998999999999999999999999999854221 11111111 1111 0 01
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCC-----ChhHHHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP-----CMPSVILM 659 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~~ 659 (706)
...+ ..+.+++.+||+.+|++|+ +++++++.
T Consensus 249 ----~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 249 ----KFLD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----CCCC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1111 2355788999999999995 89988765
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=296.01 Aligned_cols=249 Identities=27% Similarity=0.350 Sum_probs=205.8
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|++.+.||+|-||.||.|+.+. +-.||+|++.+. ..+...++.+|+++-+.|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 4789999999999999999999854 667899998763 233456889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
+||..+|.|...|.... ...+++.....++.|+|.||.|+|..+ +|||||||+|+|++.++.+||+|||-+..-.
T Consensus 101 lEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 99999999999997443 345778888899999999999999887 9999999999999999999999999887532
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
.......+||..|.+||...+...+...|+|++|++.||++.|.+||+....++....+.... +..+
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~----------~~~p 242 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD----------LKFP 242 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc----------ccCC
Confidence 233445789999999999999999999999999999999999999997655333322222211 1111
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.. -...+.+++..|+..+|.+|.+..||+..
T Consensus 243 ---~~----is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 ---ST----ISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ---cc----cChhHHHHHHHHhccCccccccHHHHhhh
Confidence 01 11246689999999999999999999864
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=328.53 Aligned_cols=242 Identities=23% Similarity=0.282 Sum_probs=192.0
Q ss_pred eccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCCh
Q 005236 395 LGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 470 (706)
Q Consensus 395 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 470 (706)
||+|+||.||+++.. +++.||+|++... .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999985 4788999998642 334456788999999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccc
Q 005236 471 DSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 550 (706)
Q Consensus 471 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 550 (706)
.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 9999653 34788999999999999999999988 9999999999999999999999999998642221 12234
Q ss_pred cccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHH
Q 005236 551 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLA 630 (706)
Q Consensus 551 ~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 630 (706)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ...... .. .+. ...+
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~---~~~~---~~~~~~-~~-~~~-----~~~~-- 217 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV---NEMY---RKILQE-PL-RFP-----DGFD-- 217 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH---HHHH---HHHHcC-CC-CCC-----CcCC--
Confidence 5789999999999999999999999999999999999999753221 1111 111111 11 010 1111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 631 EVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 631 ~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
..+.+++..||+.||.+||++..+.+.|.
T Consensus 218 --~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 218 --RDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred --HHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 24567889999999999987655555444
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=327.25 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=196.3
Q ss_pred CCCccceeccCCceeEEEEEeC----CCcEEEEEEcCcc----chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCee
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA----DEQEIAVKRLSKI----SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 458 (706)
+|++.++||+|+||.||+++.. .++.||+|++.+. .....+.+..|+.++..+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788999999999999999763 5788999998642 223345678899999999 599999999999999999
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999998653 34788999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCCcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+... .. ....
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~--~~-~~~~-- 228 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR--IL-KCDP-- 228 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH--Hh-cCCC--
Confidence 5332221 22235799999999999865 4789999999999999999999998654333222222111 11 1110
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCC-----ChhHHHHH
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP-----CMPSVILM 659 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~~ 659 (706)
.+....+ ..+.+++.+||+.||.+|| +++++++.
T Consensus 229 ----~~~~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 229 ----PFPSFIG----PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ----CCCCCCC----HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0011111 2355788899999999999 66677653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=321.03 Aligned_cols=263 Identities=24% Similarity=0.317 Sum_probs=196.8
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccch-hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISE-QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.++|.+.++||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999985 588999999865332 223467889999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|++ ++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 5777777543 245788889999999999999999988 9999999999999999999999999997543211
Q ss_pred CcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC---Cc---
Q 005236 544 TEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM---PS--- 616 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~--- 616 (706)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||..... ....+........... ..
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchh
Confidence 12223567899999999865 4588999999999999999999999864322 1122222111111000 00
Q ss_pred ---cccccccc--CcCCHH-------HHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 617 ---QLIDACFK--DSFNLA-------EVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 617 ---~~~d~~~~--~~~~~~-------~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
........ ...... ....+.+++..||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000 000111 0124568899999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=296.39 Aligned_cols=265 Identities=23% Similarity=0.268 Sum_probs=208.1
Q ss_pred hccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC-----ee
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE-----EK 458 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 458 (706)
..++|++.++||+|||+-||.++. .++..+|+|++.....++.+..++|++..++++|||+++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 347899999999999999999985 568899999998777788899999999999999999999998876544 48
Q ss_pred EEEEecCCCCChhhhhhcccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQER-CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
|++++|...|+|.+.+..... ...+++.++++|+.+|++||++||+.. ++++||||||.|||+.+++.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999976543 347999999999999999999999985 479999999999999999999999999987
Q ss_pred ccCCC-----CCc--ccccccccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC-CCchhHHHHH
Q 005236 538 AFGGD-----ETE--GNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHS-DNKLNLIRHA 606 (706)
Q Consensus 538 ~~~~~-----~~~--~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvil~elltG~~p~~~~~~-~~~~~~~~~~ 606 (706)
...-. +.. ........|..|.|||.+. +..++.++|||||||+||+|+.|..||+.... .....+...
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~- 256 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ- 256 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee-
Confidence 53211 000 0111235688999999985 45688999999999999999999999864322 111111111
Q ss_pred HHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 607 WKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 607 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
.+.+.-..+..-...+.+++.+||+.||.+||++.+++..+..++
T Consensus 257 -------------n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 257 -------------NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -------------ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 000000000012235678899999999999999999999887653
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=320.08 Aligned_cols=257 Identities=25% Similarity=0.365 Sum_probs=200.6
Q ss_pred cCCCccceeccCCceeEEEEEeCC-Cc----EEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQ----EIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
++|++.+.||+|+||.||+|++.. ++ .+++|++.... .....++..|+..+++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 578888999999999999998743 43 47888875432 334567888999999999999999999875 456789
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
++||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 999999999999996533 45889999999999999999999987 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
............++..|+|||++.+..++.++||||||+++|||++ |+.|+....... . ...+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~~~- 232 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---V----PDLLEKGERLAQ- 232 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCCcCCC-
Confidence 4332223334557789999999998999999999999999999998 998875432211 1 111111111110
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
+. .. ...+.+++.+|+..+|++|||+.|+++.|.....
T Consensus 233 -~~---~~----~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 233 -PQ---IC----TIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -CC---CC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 00 01 1245678889999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=331.15 Aligned_cols=193 Identities=21% Similarity=0.293 Sum_probs=167.0
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
..+|++.++||+|+||.||++... .++.||+|+.. .+.+.+|+.++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999984 57889999753 24567899999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+. ++|..++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 95 6888887543 34788999999999999999999987 9999999999999999999999999997542211
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRG 592 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~ 592 (706)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+-
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 112233579999999999999999999999999999999999998753
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=309.62 Aligned_cols=263 Identities=26% Similarity=0.368 Sum_probs=204.2
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEe-----CCe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIH-----GEE 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 457 (706)
...|...+.||+|+||.|.++... +|+.||||++.. ......++..+|+.+++.++|+||+.+.+++.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345666799999999999999984 589999999973 455667888999999999999999999999875 346
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.|+|+|+| +.+|...|+.+ +.++......+++||++||+|+|+.+ ++||||||+|+|++.+..+||+|||+|+
T Consensus 101 vYiV~elM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 79999999 66898888543 33888889999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH---------
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAW--------- 607 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~--------- 607 (706)
...........+..+.|.-|.|||++.. ..||...||||+|||+.||++|++-|...+.-+...++....
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 8755433334456889999999999855 689999999999999999999999886544433333332211
Q ss_pred --------HHhhc--CCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHh
Q 005236 608 --------KLWNE--GMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 608 --------~~~~~--~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L 660 (706)
..+.. ..++.-+...+. ..+ ..+++++.+||..||.+|+|++|+++.-
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~----p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFP-NAN----PLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcC-CCC----HHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 11110 000000011111 111 1456888899999999999999998653
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=313.16 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=203.0
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
.+|.+.++||+|+||.||+|...+ ++.||+|++... ....+++.+|+.++++++||||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 457888999999999999999754 788999988653 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999986533 245789999999999999999999887 999999999999999999999999999876432211
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+..... .... ............
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~----~~~~~~~~~~~~----- 227 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVY----ELLEKGYRMERP----- 227 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH----HHHHCCCCCCCC-----
Confidence 1112234668999999999999999999999999999998 8888653221 1111 111111111110
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
... ...+.+++.+||+.+|++||++.+++++|+.+
T Consensus 228 ~~~----~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 EGC----PPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCC----CHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111 13466789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=333.66 Aligned_cols=253 Identities=21% Similarity=0.281 Sum_probs=194.1
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.|++.++||+|+||+||+|+.. .++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999874 4789999998653 23445678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 99999999998653 34788888899999999999999987 9999999999999999999999999986432110
Q ss_pred Cc---------------------------------------------ccccccccccCccCccccccCCCCcchhhHHHH
Q 005236 544 TE---------------------------------------------GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFG 578 (706)
Q Consensus 544 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlG 578 (706)
.. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 00 001234699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHH--hcCCCCCCCCChhHH
Q 005236 579 ILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLL--CVQQYPEDRPCMPSV 656 (706)
Q Consensus 579 vil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~--cl~~~p~~RPt~~ev 656 (706)
|++|||++|+.||........ .. ..........+ ... ...+ ..+.+++.+ |+..++..||+++|+
T Consensus 236 ~il~elltG~~Pf~~~~~~~~---~~---~i~~~~~~~~~-~~~--~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTET---QL---KVINWENTLHI-PPQ--VKLS----PEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHH---HH---HHHccccccCC-CCC--CCCC----HHHHHHHHHHccCcccccCCCCHHHH
Confidence 999999999999864332111 11 11110000000 000 0111 134455555 566777779999999
Q ss_pred HHH
Q 005236 657 ILM 659 (706)
Q Consensus 657 ~~~ 659 (706)
+..
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.63 Aligned_cols=199 Identities=26% Similarity=0.375 Sum_probs=173.5
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.++|++.++||+|+||.||++.+. .+..+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368999999999999999999986 4778888887653 33445678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ .++|+||||+|||+++++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 99999999999643 34788888999999999999999742 3999999999999999999999999999765321
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 593 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~ 593 (706)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12235689999999999998999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=340.69 Aligned_cols=257 Identities=21% Similarity=0.286 Sum_probs=203.5
Q ss_pred HhccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC----
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE---- 456 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 456 (706)
...++|.+.++||+|+||.||+++. .+++.||||++.. ........+.+|+..+..++|+||++++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457999999999999999999987 4689999999854 34555677889999999999999999988775432
Q ss_pred ----eeEEEEecCCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEe
Q 005236 457 ----EKLLIYEFMPNKSLDSFIFDQE-RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 531 (706)
Q Consensus 457 ----~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 531 (706)
..++||||+++|+|.++|.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 3679999999999999996532 2346888999999999999999999987 9999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh
Q 005236 532 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWN 611 (706)
Q Consensus 532 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 611 (706)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....... . .
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---~~~~~~~---~-~ 258 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---MEEVMHK---T-L 258 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHH---H-h
Confidence 9999987644333333344679999999999999999999999999999999999999985322 1111111 1 1
Q ss_pred cCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 612 EGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 612 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+....+. ... ...+.+++..||+.+|.+||++.+++..
T Consensus 259 ~~~~~~~~-----~~~----~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRYDPLP-----PSI----SPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCCCCCC-----CCC----CHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111110 111 1246678999999999999999999864
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.44 Aligned_cols=256 Identities=25% Similarity=0.434 Sum_probs=197.6
Q ss_pred CCccceeccCCceeEEEEEeCCCc---EEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC------Ce
Q 005236 389 FSINKKLGEGGFGPVYKGTLADEQ---EIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG------EE 457 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 457 (706)
|.+.++||+|+||.||+|++.+.. .+|+|.++.. .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 456789999999999999985533 5899987643 345567889999999999999999999987542 24
Q ss_pred eEEEEecCCCCChhhhhhcc---cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeec
Q 005236 458 KLLIYEFMPNKSLDSFIFDQ---ERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 534 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 534 (706)
.++||||+++|+|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999988432 12345889999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcC
Q 005236 535 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEG 613 (706)
Q Consensus 535 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 613 (706)
+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||.... ....... ...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~----~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE---NSEIYDY----LRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH----HHcC
Confidence 9987643322112222346778999999999999999999999999999999 788864322 1111111 1111
Q ss_pred CCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 614 MPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 614 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
....... . ....+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 231 ~~~~~~~-----~----~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLKQPP-----D----CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCCC-----C----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111100 1 112456899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=329.76 Aligned_cols=201 Identities=25% Similarity=0.357 Sum_probs=174.1
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.+.||+|+||+||+++.. .++.||||++.+.. ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999875 47899999986532 233467888999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 999999999999653 35889999999999999999999988 999999999999999999999999999765321
Q ss_pred CCc---------------------------------ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 005236 543 ETE---------------------------------GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 589 (706)
Q Consensus 543 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~ 589 (706)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCC
Q 005236 590 NRGF 593 (706)
Q Consensus 590 p~~~ 593 (706)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.46 Aligned_cols=256 Identities=25% Similarity=0.414 Sum_probs=200.5
Q ss_pred CCccceeccCCceeEEEEEeCC----CcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe-----
Q 005236 389 FSINKKLGEGGFGPVYKGTLAD----EQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEE----- 457 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 457 (706)
|.+.+.||+|+||.||+|.... +..||+|+++.. .....+.+.+|+..++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998743 367999998643 34446789999999999999999999999876554
Q ss_pred -eEEEEecCCCCChhhhhhccc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeee
Q 005236 458 -KLLIYEFMPNKSLDSFIFDQE---RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 533 (706)
Q Consensus 458 -~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 533 (706)
.++||||+++++|..++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999999985432 2245889999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhc
Q 005236 534 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNE 612 (706)
Q Consensus 534 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 612 (706)
|+++...............++..|+|||++....++.++||||||+++|||++ |..|+..... ........ .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~----~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLR----H 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH----c
Confidence 99987644332222222345678999999988899999999999999999999 8888643221 12211111 1
Q ss_pred CCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 613 GMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 613 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
+....... .....+.+++.+||+.+|.+||++.||++.|+.+
T Consensus 231 ~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRLKQPE---------DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCCCc---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111111 1123567888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=319.35 Aligned_cols=264 Identities=27% Similarity=0.405 Sum_probs=205.4
Q ss_pred cCCCccceeccCCceeEEEEEeCC-----------------CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeee
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-----------------EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKL 448 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l 448 (706)
.+|++.++||+|+||.||++...+ +..||+|.+... .....+.+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 578999999999999999998643 245899998653 34456789999999999999999999
Q ss_pred EeEEEeCCeeEEEEecCCCCChhhhhhccc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcE
Q 005236 449 LGCCIHGEEKLLIYEFMPNKSLDSFIFDQE--------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 520 (706)
Q Consensus 449 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Ni 520 (706)
++++..++..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence 999999999999999999999999996543 1235889999999999999999999987 99999999999
Q ss_pred EEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCCC
Q 005236 521 LLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS--GKKNRGFYHSDN 598 (706)
Q Consensus 521 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt--G~~p~~~~~~~~ 598 (706)
++++++.++|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~--- 238 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT--- 238 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC---
Confidence 999999999999999987543332222334456789999999998899999999999999999998 555653322
Q ss_pred chhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 599 KLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
...........+........... .......+.+++.+||+.+|.+|||+.||++.|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLPR------PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hHHHHHHHHhccccccccccCCC------ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 12222222222211111111110 00111357789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=317.75 Aligned_cols=258 Identities=31% Similarity=0.445 Sum_probs=202.1
Q ss_pred CCCccceeccCCceeEEEEEeCC------CcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
+|++.+.||+|+||.||+|+... ...+++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999998632 3568888886543 3445678999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhccc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCc
Q 005236 461 IYEFMPNKSLDSFIFDQE---------------------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 519 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~N 519 (706)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999985421 1234788999999999999999999887 9999999999
Q ss_pred EEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 005236 520 VLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDN 598 (706)
Q Consensus 520 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~ 598 (706)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 9999999999999999986533322222223445778999999988899999999999999999998 8888743221
Q ss_pred chhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 599 KLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
..... ........... .. ....+.+++.+||+.+|.+||++.|+++.|+...
T Consensus 236 -~~~~~----~~~~~~~~~~~-----~~----~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 236 -ERLFN----LLKTGYRMERP-----EN----CSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred -HHHHH----HHhCCCCCCCC-----CC----CCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 11111 11111111100 11 1135668899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=311.67 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=201.5
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
++|++.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688889999999999999998877789999886433 234678999999999999999999999999889999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 999999986533 25889999999999999999999987 999999999999999999999999999865432211
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ...... ..........
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~----~~~~~~~~~~----- 224 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKV----SQGLRLYRPH----- 224 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH----hcCCCCCCCC-----
Confidence 1112335678999999998889999999999999999999 88887543321 111111 1111110000
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
. ....+.+++.+||+.+|.+||++.+|++.|+
T Consensus 225 ~----~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 L----ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred C----CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0 1235678999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=317.98 Aligned_cols=257 Identities=28% Similarity=0.440 Sum_probs=201.7
Q ss_pred cCCCccceeccCCceeEEEEEeCC------CcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 459 (706)
.+|.+.++||+|+||.||+|...+ ++.||+|++.... ....+.+.+|+.++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 357788999999999999998643 4789999997543 233567889999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC
Q 005236 460 LIYEFMPNKSLDSFIFDQE-------------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 526 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 526 (706)
+++||+++++|.+++.... ....+++..+.+++.|++.||+|||+.+ ++||||||.||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985321 1234788889999999999999999987 99999999999999999
Q ss_pred CeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHH
Q 005236 527 NPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRH 605 (706)
Q Consensus 527 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 605 (706)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+..... .....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~- 237 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVIE- 237 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH-
Confidence 999999999887543322222233456789999999998899999999999999999998 7777643221 11111
Q ss_pred HHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 606 AWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 606 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
...........+ .. ...+.+++..||+.+|.+||++.+|++.|++
T Consensus 238 ---~i~~~~~~~~~~-----~~----~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 ---MIRNRQVLPCPD-----DC----PAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---HHHcCCcCCCCC-----CC----CHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111211111111 11 2235678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=299.32 Aligned_cols=281 Identities=23% Similarity=0.283 Sum_probs=206.5
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhh--HHHHHHHHHHHhhcCCcceeeeEeEEEe--CCeeE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQG--LKELKNEIILFSKLQHRNLVKLLGCCIH--GEEKL 459 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 459 (706)
..++|+.++.|++|.||.||+|+++ .++.||+|+++...+.. --.-.+|+.++.+.+|||||.+..+..- -+..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3467899999999999999999985 47789999996533211 1245789999999999999999887753 35789
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
+|||||+. +|..+|..-. +.+...++.-+..|+++|++|||... |+||||||+|+|+...|.+||+|||+|+.+
T Consensus 154 ~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 99999965 7888885543 46788888899999999999999887 999999999999999999999999999988
Q ss_pred CCCCCcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 540 GGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 540 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
+... ...+..+-|.-|.|||.+.+. .|+...|+||+|||+.||+++++.|.....-+....|-.......+..++.+
T Consensus 228 gsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 228 GSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 6442 223446779999999999875 7999999999999999999999987654443333333332222222222211
Q ss_pred cc--------------ccccCcCCHH-HHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCCCCCCCCCCc
Q 005236 619 ID--------------ACFKDSFNLA-EVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLPQPKQPGY 674 (706)
Q Consensus 619 ~d--------------~~~~~~~~~~-~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~~~~p~~p~~ 674 (706)
.. ..++..+... ....-.+++...|.+||.+|.|++|.++.= -..+.|.|..|..
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~-~F~e~P~p~~P~~ 375 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE-YFRETPLPIDPSM 375 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc-ccccCCCCCChhh
Confidence 11 0111111111 113446788899999999999999987542 1244444444443
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=312.73 Aligned_cols=248 Identities=26% Similarity=0.393 Sum_probs=195.1
Q ss_pred ceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCCh
Q 005236 393 KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 470 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 470 (706)
++||+|+||.||+|++. +++.+|+|.+... .......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999985 6888999987643 344557799999999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccc
Q 005236 471 DSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 550 (706)
Q Consensus 471 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 550 (706)
.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998543 235789999999999999999999887 99999999999999999999999999986532211111111
Q ss_pred cccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCH
Q 005236 551 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNL 629 (706)
Q Consensus 551 ~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 629 (706)
...+..|+|||.+.+..++.++||||||+++|||++ |..|+...... ... ............+
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~----~~~~~~~~~~~~~--------- 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTR----EAIEQGVRLPCPE--------- 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHH----HHHHcCCCCCCcc---------
Confidence 223567999999999999999999999999999998 88876532221 111 1111111111100
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 630 AEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 630 ~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
.....+.+++.+||+.+|++|||+.+|.++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 11235677999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=320.80 Aligned_cols=261 Identities=22% Similarity=0.314 Sum_probs=192.5
Q ss_pred cCCCccceeccCCceeEEEEEeC--CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhc---CCcceeeeEeEEEe-----
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA--DEQEIAVKRLSKIS--EQGLKELKNEIILFSKL---QHRNLVKLLGCCIH----- 454 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 454 (706)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 37899999999999999999873 46789999886422 22234556677776665 69999999999863
Q ss_pred CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeec
Q 005236 455 GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 534 (706)
Q Consensus 455 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 534 (706)
....++||||++ ++|.+++..... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999997 589988864332 34788999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC
Q 005236 535 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM 614 (706)
Q Consensus 535 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 614 (706)
+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|++||......+ .+...........
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~ 229 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPG 229 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCC
Confidence 99875432 22334568999999999999999999999999999999999999986533222 2221111111000
Q ss_pred Cccc------ccccc--cCcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 615 PSQL------IDACF--KDSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 615 ~~~~------~d~~~--~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
..+. ....+ ......+ ....+.+++.+||+.+|++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 00000 0000111 1124568999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=329.35 Aligned_cols=265 Identities=22% Similarity=0.342 Sum_probs=194.1
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC-----eeE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE-----EKL 459 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 459 (706)
+|++.++||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788999999999999999975 5889999998642 2234457889999999999999999999886432 479
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
+||||++ ++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 6898888543 34889999999999999999999988 999999999999999999999999999865
Q ss_pred CCCCC-cccccccccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH--------H
Q 005236 540 GGDET-EGNTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAW--------K 608 (706)
Q Consensus 540 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~--------~ 608 (706)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.... .
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32221 112234578999999999876 678999999999999999999999985432211111110000 0
Q ss_pred HhhcCCCccccccccc-CcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 609 LWNEGMPSQLIDACFK-DSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 609 ~~~~~~~~~~~d~~~~-~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+........+..... ...... ....+.+++..||+.+|++|||++|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000000000 000000 01245689999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.16 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=201.3
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999985 58899999986532 234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999654 45888999999999999999999987 999999999999999999999999999876433
Q ss_pred C---------------------------CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 005236 543 E---------------------------TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 595 (706)
Q Consensus 543 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~ 595 (706)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0012233568999999999999999999999999999999999999986433
Q ss_pred CCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCC-hhHHHHH
Q 005236 596 SDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPC-MPSVILM 659 (706)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-~~ev~~~ 659 (706)
.. ........ +..... + .. . .. ....+.+++..|++ +|.+||+ ++++++.
T Consensus 235 ~~---~~~~~i~~-~~~~~~--~-p~-~-~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQ---ETYNKIIN-WKESLR--F-PP-D-PP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH---HHHHHHhc-cCCccc--C-CC-C-CC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11 11111111 001000 0 00 0 00 11245578889997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.81 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=203.7
Q ss_pred cCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
.+|.+.++||+|+||.||++... ++..+++|.+........+.+.+|+.+++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46788899999999999999742 356789999887777777889999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhcccc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCe
Q 005236 461 IYEFMPNKSLDSFIFDQER------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 528 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 528 (706)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999965421 134788999999999999999999988 9999999999999999999
Q ss_pred EEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHH
Q 005236 529 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAW 607 (706)
Q Consensus 529 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 607 (706)
||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~- 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAIECI- 237 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHHHHH-
Confidence 9999999986543322222223345788999999999999999999999999999998 88886432211 111111
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 608 KLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 608 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
.......... .. ...+.+++.+||+.+|.+||+++||++.|+
T Consensus 238 ---~~~~~~~~~~-----~~----~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 ---TQGRELERPR-----TC----PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---HcCccCCCCC-----CC----CHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111111111 11 124567899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.96 Aligned_cols=241 Identities=22% Similarity=0.286 Sum_probs=192.0
Q ss_pred ceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCC
Q 005236 393 KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 468 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 468 (706)
+.||+|+||.||+++.. +++.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999974 5889999998653 2334566788999999999999999999999999999999999999
Q ss_pred ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccc
Q 005236 469 SLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 548 (706)
Q Consensus 469 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 548 (706)
+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 999888543 34788999999999999999999988 9999999999999999999999999987532211 112
Q ss_pred cccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCC
Q 005236 549 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFN 628 (706)
Q Consensus 549 ~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 628 (706)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... .... .. . +....+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~---~~~~-~~-~-----~p~~~~ 219 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFEL---ILME-EI-R-----FPRTLS 219 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH---HhcC-CC-C-----CCCCCC
Confidence 2356899999999999999999999999999999999999997543221 11111 1111 10 0 001111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCC-----ChhHHHH
Q 005236 629 LAEVIRCIHIGLLCVQQYPEDRP-----CMPSVIL 658 (706)
Q Consensus 629 ~~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~ 658 (706)
..+.+++..||+.+|.+|| ++.++++
T Consensus 220 ----~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 220 ----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ----HHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 2455788899999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=311.58 Aligned_cols=247 Identities=24% Similarity=0.398 Sum_probs=207.2
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCc---cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSK---ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
.+|++.+.||+|.||.|-++.. ..|+.||||.+++ .++++.-.+++|+++|+.|+||||+.++.+|+..+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 5789999999999999999987 6799999999876 46677888999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||..+|.|.+|+.+. ..+++.+..+++.||..|+.|+|.+. ++|||||.+|||||.++++||+|||++..+..+
T Consensus 133 EYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999654 45899999999999999999999887 999999999999999999999999999886433
Q ss_pred CCcccccccccccCccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
......+|++-|.+||++.+.+|. +..|-|||||+||-|+.|.-||+..+- ..++.. +..+...+
T Consensus 207 ---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvrQ----Is~GaYrE---- 272 (668)
T KOG0611|consen 207 ---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVRQ----ISRGAYRE---- 272 (668)
T ss_pred ---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHHH----hhcccccC----
Confidence 233458999999999999999985 789999999999999999999865332 122211 11111111
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHh
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L 660 (706)
. +..-.+.-|+.|||..+|++|.|+.+|+...
T Consensus 273 ----P---~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 ----P---ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ----C---CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 0 1111234578899999999999999998765
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=327.64 Aligned_cols=242 Identities=21% Similarity=0.269 Sum_probs=193.4
Q ss_pred ceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCC
Q 005236 393 KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 468 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 468 (706)
+.||+|+||.||+++.. +++.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999975 5889999998653 2344567888999999999999999999999999999999999999
Q ss_pred ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccc
Q 005236 469 SLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 548 (706)
Q Consensus 469 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 548 (706)
+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 999888543 34889999999999999999999987 9999999999999999999999999987532211 122
Q ss_pred cccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCC
Q 005236 549 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFN 628 (706)
Q Consensus 549 ~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 628 (706)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... .... .. .+ ....+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~~~---~~~~-~~-~~-----p~~~~ 219 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFEL---ILME-DI-KF-----PRTLS 219 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HHHHHH---hccC-Cc-cC-----CCCCC
Confidence 335789999999999999999999999999999999999999854221 111111 1111 00 00 01111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCC-----ChhHHHHH
Q 005236 629 LAEVIRCIHIGLLCVQQYPEDRP-----CMPSVILM 659 (706)
Q Consensus 629 ~~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~~ 659 (706)
..+.+++.+||+.||.+|| ++.|+++.
T Consensus 220 ----~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 220 ----ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ----HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2456788899999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=312.64 Aligned_cols=252 Identities=28% Similarity=0.433 Sum_probs=200.1
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
.+|++.+.||+|+||.||+|.++.+..+|+|.+.... .....+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3578889999999999999998877889999885432 234568889999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 999999996543 35889999999999999999999988 999999999999999999999999999865322111
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ....... ........ .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~-----~ 224 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVESVS----AGYRLYRP-----K 224 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHHHH----cCCcCCCC-----C
Confidence 1111234568999999999999999999999999999999 78887543221 1111111 11100000 0
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
. ....+.+++.+||+.+|++|||++||++.|.
T Consensus 225 ~----~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 225 L----APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred C----CCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 1 1235678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=324.34 Aligned_cols=241 Identities=25% Similarity=0.328 Sum_probs=191.4
Q ss_pred ceeccCCceeEEEEEe----CCCcEEEEEEcCcc----chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 393 KKLGEGGFGPVYKGTL----ADEQEIAVKRLSKI----SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
++||+|+||.||+++. ..++.||||.+... .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999986 34788999998652 223345678899999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++... ..+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 9999999998543 34677888889999999999999988 9999999999999999999999999987542221
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..... ... .... .+ .
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~---~~~~~---~~~-~~~~-~~-~---- 220 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR---KKTID---KIL-KGKL-NL-P---- 220 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH---HHHHH---HHH-cCCC-CC-C----
Confidence 122335789999999999998999999999999999999999999854321 11111 111 1111 11 0
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCC-----ChhHHHH
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRP-----CMPSVIL 658 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~ 658 (706)
... ...+.+++.+||+.+|++|| +++++++
T Consensus 221 ~~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 221 PYL----TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCC----CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 011 12456788999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.61 Aligned_cols=263 Identities=25% Similarity=0.396 Sum_probs=201.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-----------------CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeee
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-----------------DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKL 448 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l 448 (706)
++|++.++||+|+||.||++... +...+|+|++... .....+.+.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998642 2346899998753 34456789999999999999999999
Q ss_pred EeEEEeCCeeEEEEecCCCCChhhhhhcccc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcE
Q 005236 449 LGCCIHGEEKLLIYEFMPNKSLDSFIFDQER--------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 520 (706)
Q Consensus 449 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Ni 520 (706)
++++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999965321 134778889999999999999999988 99999999999
Q ss_pred EEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCCC
Q 005236 521 LLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS--GKKNRGFYHSDN 598 (706)
Q Consensus 521 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt--G~~p~~~~~~~~ 598 (706)
|+++++.++|+|||+++.+.............++..|+|||......++.++||||||+++|||++ |..|+......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE- 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence 999999999999999986543322222222345678999999988899999999999999999998 66676432221
Q ss_pred chhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 599 KLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
..+................. .. .. ....+.+++.+||+.+|.+||++.||++.|+
T Consensus 241 --~~~~~~~~~~~~~~~~~~~~-~~-~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 --QVIENTGEFFRDQGRQVYLP-KP-AL----CPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred --HHHHHHHHHHhhccccccCC-CC-CC----CCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11211111111111100000 00 01 1135668999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.02 Aligned_cols=258 Identities=30% Similarity=0.454 Sum_probs=201.6
Q ss_pred ccCCCccceeccCCceeEEEEEeCC------CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 458 (706)
.++|.+.+.||+|+||.||+|.+.+ +..|++|.+... .......+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678999999999999999998854 567899988643 334456789999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhcccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC---CeEEe
Q 005236 459 LLIYEFMPNKSLDSFIFDQER----CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKIS 531 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl~ 531 (706)
++||||+++++|.+++..... ...+++..+++++.||+.||+|||+.+ ++|+||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999965431 235889999999999999999999987 99999999999998765 59999
Q ss_pred eeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHh
Q 005236 532 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLW 610 (706)
Q Consensus 532 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 610 (706)
|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||...... ..... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~----~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEF----V 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----H
Confidence 9999987633222222222334568999999999999999999999999999997 88887532221 11111 1
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 611 NEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 611 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
........ .... ...+.+++.+|++.+|.+||++.+|++.|+.
T Consensus 235 ~~~~~~~~-----~~~~----~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 235 TGGGRLDP-----PKGC----PGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HcCCcCCC-----CCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 11111010 0011 1346678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=321.61 Aligned_cols=240 Identities=26% Similarity=0.339 Sum_probs=187.4
Q ss_pred ceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhh-cCCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSK-LQHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
+.||+|+||.||+|+..+ ++.||||.+... .....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999854 778999998653 22334555667777665 4899999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 9999988643 34788889999999999999999987 9999999999999999999999999998643222 22
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcC
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSF 627 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 627 (706)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... +..... . +. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~----i~~~~~-~-~~----~~~ 219 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDS----ILNDRP-H-FP----RWI 219 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHH----HHcCCC-C-CC----CCC
Confidence 3345789999999999999999999999999999999999999864322 111111 111110 0 00 111
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCChh-HHH
Q 005236 628 NLAEVIRCIHIGLLCVQQYPEDRPCMP-SVI 657 (706)
Q Consensus 628 ~~~~~~~~~~l~~~cl~~~p~~RPt~~-ev~ 657 (706)
...+.+++..||+.+|.+||++. +++
T Consensus 220 ----~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 220 ----SKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred ----CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 12345788899999999999986 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.73 Aligned_cols=252 Identities=26% Similarity=0.316 Sum_probs=198.3
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.|++.++||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999974 58899999986532 2223457789999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998886432 245889999999999999999999988 9999999999999999999999999998753222
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
. .....|+..|+|||++.+..++.++||||+|+++|||++|+.||...........+ ........ ...
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~---~~~~~~~~-~~~----- 224 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV---ERRVKEDQ-EEY----- 224 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH---HHHhhhcc-ccc-----
Confidence 1 12346899999999999999999999999999999999999998643322111111 11111111 000
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCC-----ChhHHHHH
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRP-----CMPSVILM 659 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~~ 659 (706)
.......+.+++..||+.||.+|| ++.++++.
T Consensus 225 ----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 225 ----SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ----CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 001122456789999999999999 77787554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.86 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=205.9
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc---cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK---ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.++||+|+||.||+|+.. +++.||||.+.. ........+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999974 688999998754 23344567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 463 EFMPNKSLDSFIFDQE-RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
||+++++|.+++.... ....++...+..++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886432 2345788899999999999999999987 99999999999999999999999999987643
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+..... ........ ..........
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~----~~~~~~~~~~-- 229 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQK----IEQCDYPPLP-- 229 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHHH----HhcCCCCCCC--
Confidence 221 11234678899999999988899999999999999999999999743211 11111111 1111111110
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.......+.+++.+||+.+|.+||++.+|++.|++.
T Consensus 230 ------~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 230 ------TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ------hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 011123567889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=332.10 Aligned_cols=253 Identities=22% Similarity=0.279 Sum_probs=196.8
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.+.||+|+||.||+++.. .++.||||++... .......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999985 5889999998653 2334566889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999998653 34889999999999999999999988 999999999999999999999999998765321
Q ss_pred CCcc------------------------------------cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh
Q 005236 543 ETEG------------------------------------NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586 (706)
Q Consensus 543 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt 586 (706)
.... .....+||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112468999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCC---hhHHHHH
Q 005236 587 GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPC---MPSVILM 659 (706)
Q Consensus 587 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt---~~ev~~~ 659 (706)
|+.||..... ....... ........+... . ..+ ..+.+++..|+. +|.+|++ ++|+++.
T Consensus 235 G~~Pf~~~~~---~~~~~~i---~~~~~~~~~~~~-~--~~s----~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNP---QETYRKI---INWKETLQFPDE-V--PLS----PEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCH---HHHHHHH---HcCCCccCCCCC-C--CCC----HHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999854322 1111111 110000001000 0 111 234567778886 9999998 8887763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.94 Aligned_cols=253 Identities=21% Similarity=0.258 Sum_probs=198.3
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|.+.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999985 5889999998653 2234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999996542 35888999999999999999999988 999999999999999999999999999876433
Q ss_pred CCcccccccccccCccCccccc------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYAS------DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (706)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ..... .........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~---~i~~~~~~~ 228 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS---AKTYN---NIMNFQRFL 228 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH---HHHHH---HHHcCCCcc
Confidence 221 222356899999999986 45678999999999999999999999754222 11111 111111111
Q ss_pred ccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 617 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+.+ .. .....+.+++..|++ +|.+||++++++..
T Consensus 229 ~~~~-----~~--~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 KFPE-----DP--KVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCC-----CC--CCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1100 00 011235567788998 99999999999853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.02 Aligned_cols=263 Identities=29% Similarity=0.423 Sum_probs=206.2
Q ss_pred ccCCCccceeccCCceeEEEEEeC--------CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeC
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA--------DEQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHG 455 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 455 (706)
.++|.+.+.||+|+||.||+++.. ++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467889999999999999999741 2457899988643 344567889999999999 899999999999999
Q ss_pred CeeEEEEecCCCCChhhhhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE
Q 005236 456 EEKLLIYEFMPNKSLDSFIFDQER-------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 522 (706)
Q Consensus 456 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill 522 (706)
...++||||+++++|.+++..... ...+++..+..++.||++||.|||+.+ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999975321 235788889999999999999999987 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchh
Q 005236 523 DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLN 601 (706)
Q Consensus 523 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~ 601 (706)
++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+..... ..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~ 247 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE 247 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HH
Confidence 9999999999999987644333222333456778999999998899999999999999999998 7777643211 11
Q ss_pred HHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCCCC
Q 005236 602 LIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLP 667 (706)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~~~ 667 (706)
.. ............. .....+.+++..||+.+|.+||++.||++.|+.+..+.
T Consensus 248 ~~----~~~~~~~~~~~~~---------~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 248 LF----KLLKEGHRMDKPA---------NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HH----HHHHcCCcCCCCC---------CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 11 1111111111100 11234667899999999999999999999998875543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=328.11 Aligned_cols=262 Identities=27% Similarity=0.408 Sum_probs=203.3
Q ss_pred hccCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCccc-hhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCC
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSKIS-EQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGE 456 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 456 (706)
..++|.+.++||+|+||.||+|++. .++.||||++.... ....+.+.+|+.++.++. ||||+++++++....
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3357888999999999999999863 24679999997542 333457889999999997 999999999999999
Q ss_pred eeEEEEecCCCCChhhhhhcccc---------------------------------------------------------
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQER--------------------------------------------------------- 479 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 479 (706)
..++||||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999965321
Q ss_pred --------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEE
Q 005236 480 --------------------------------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 521 (706)
Q Consensus 480 --------------------------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nil 521 (706)
...+++..++.++.||+.||+|||+.+ ++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 123677788899999999999999887 999999999999
Q ss_pred EcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCch
Q 005236 522 LDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKL 600 (706)
Q Consensus 522 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~ 600 (706)
+++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-- 349 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-- 349 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--
Confidence 99999999999999987533222222222456789999999998899999999999999999998 888865432211
Q ss_pred hHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 601 NLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
.. ......+...... .. ....+.+++..||+.+|.+||+++||++.|+.++
T Consensus 350 -~~---~~~~~~~~~~~~p-----~~----~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 -QF---YNAIKRGYRMAKP-----AH----ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -HH---HHHHHcCCCCCCC-----CC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11 1111111110000 01 1235667888999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=318.21 Aligned_cols=263 Identities=25% Similarity=0.409 Sum_probs=201.0
Q ss_pred cCCCccceeccCCceeEEEEEe-----CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC--CeeE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-----ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--EEKL 459 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 459 (706)
.+|++.+.||+|+||.||++.. ..+..||+|++........+.+.+|+.++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788999999999999999974 34788999999877667778899999999999999999999987543 4678
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999999543 235889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCcc-cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC--------Cc-hhHHHHHHHH
Q 005236 540 GGDETEG-NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSD--------NK-LNLIRHAWKL 609 (706)
Q Consensus 540 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~--------~~-~~~~~~~~~~ 609 (706)
....... ......++..|+|||++.+..++.++||||||+++|||++|..++...... .. ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 4322211 111223445699999999889999999999999999999987764321110 00 0000001111
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 610 WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 610 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
........ ........+.+++.+||+.+|++|||++||++.|+.+
T Consensus 239 ~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLP---------APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111000 0001123567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=332.60 Aligned_cols=253 Identities=22% Similarity=0.272 Sum_probs=194.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.++||+|+||.||+++.. +++.||||++.+. .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999874 5889999998653 2334567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999998643 34788888999999999999999988 999999999999999999999999999643210
Q ss_pred CC------------cc---------------------------------cccccccccCccCccccccCCCCcchhhHHH
Q 005236 543 ET------------EG---------------------------------NTNRVVGTYGYMAPEYASDGQFSVKSDVFSF 577 (706)
Q Consensus 543 ~~------------~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~Sl 577 (706)
.. .. ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 00 0012468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCC---CChh
Q 005236 578 GILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDR---PCMP 654 (706)
Q Consensus 578 Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R---Pt~~ 654 (706)
||++|||++|+.||..... ........ .......+.+ ... ....+.+++..||+ +|.+| |++.
T Consensus 235 Gvil~elltG~~Pf~~~~~---~~~~~~i~---~~~~~~~~p~-----~~~--~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENS---HETYRKII---NWRETLYFPD-----DIH--LSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCH---HHHHHHHH---ccCCccCCCC-----CCC--CCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 9999999999999854322 11111111 1000000100 000 11235578888997 66665 5888
Q ss_pred HHHHH
Q 005236 655 SVILM 659 (706)
Q Consensus 655 ev~~~ 659 (706)
|++..
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 88875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=323.27 Aligned_cols=244 Identities=25% Similarity=0.341 Sum_probs=190.7
Q ss_pred CCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHH---hhcCCcceeeeEeEEEeCCeeEEE
Q 005236 389 FSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILF---SKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
|++.+.||+|+||.||+|... +++.||||++... .....+.+..|+.++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999875 5889999998653 223345666676654 567899999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++++|..++.. ..+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999988843 35899999999999999999999988 99999999999999999999999999875322
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
. ........|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ...... .. ..... .
T Consensus 154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~~~~~~---i~-~~~~~-~--- 220 (324)
T cd05589 154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---EEVFDS---IV-NDEVR-Y--- 220 (324)
T ss_pred C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---HHHHHH---HH-hCCCC-C---
Confidence 1 1122345789999999999999999999999999999999999999754321 111111 11 11110 0
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCC-----hhHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPC-----MPSVIL 658 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~ev~~ 658 (706)
.... ...+.+++.+||+.||.+||+ +.++++
T Consensus 221 --p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 221 --PRFL----SREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --CCCC----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0011 123567899999999999994 566654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=312.49 Aligned_cols=257 Identities=26% Similarity=0.453 Sum_probs=204.8
Q ss_pred cCCCccceeccCCceeEEEEEeCC------CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 459 (706)
++|.+.+.||+|+||.||+|.... +..||+|.+... .......+.+|+.++..++||||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 578899999999999999998743 367999998653 3344567889999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhcccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEee
Q 005236 460 LIYEFMPNKSLDSFIFDQER-------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 532 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 532 (706)
+||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+||++++++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECC
Confidence 99999999999999965321 234788899999999999999999887 99999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhh
Q 005236 533 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWN 611 (706)
Q Consensus 533 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 611 (706)
||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ....... .
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~----~ 235 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFV----I 235 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHH----h
Confidence 999987644332222233456789999999998899999999999999999998 8888743222 1111111 1
Q ss_pred cCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 612 EGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 612 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
......... .. ...+.+++..||+.+|.+|||+.++++.|+.
T Consensus 236 ~~~~~~~~~-----~~----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DGGHLDLPE-----NC----PDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCCCCCCCC-----CC----CHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111111111 11 2356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.19 Aligned_cols=259 Identities=30% Similarity=0.441 Sum_probs=204.5
Q ss_pred ccCCCccceeccCCceeEEEEEeCC------CcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEE 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 457 (706)
.++|++.+.||+|+||.||++.... ...+|+|.+... .......+.+|+.++.++ +||||+++++++..+..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 3678899999999999999998743 357899988653 344456788999999999 79999999999999999
Q ss_pred eEEEEecCCCCChhhhhhcc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC
Q 005236 458 KLLIYEFMPNKSLDSFIFDQ-------------ERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ 524 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~ 524 (706)
.+++|||+++++|.+++... .....+++..++.++.|++.||+|||+.+ |+||||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence 99999999999999999643 22346889999999999999999999887 999999999999999
Q ss_pred CCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHH
Q 005236 525 DMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLI 603 (706)
Q Consensus 525 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~ 603 (706)
++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..|+..... ....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~ 244 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EELF 244 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---HHHH
Confidence 99999999999987643322222222345678999999999999999999999999999998 8888643221 1111
Q ss_pred HHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 604 RHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 604 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
........... .......+.+++.+|++.+|.+|||+.|+++.|+.+
T Consensus 245 ----~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 245 ----KLLKEGYRMEK---------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ----HHHHcCCcCCC---------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11111111110 011123566899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.40 Aligned_cols=259 Identities=27% Similarity=0.410 Sum_probs=205.4
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-----CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEe-CCee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-----EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIH-GEEK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 458 (706)
.++|.+.+.||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4688999999999999999999865 678999988653 34456778999999999999999999998876 4678
Q ss_pred EEEEecCCCCChhhhhhccccc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeee
Q 005236 459 LLIYEFMPNKSLDSFIFDQERC-----KLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 533 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 533 (706)
++++||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999999654322 46889999999999999999999887 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhc
Q 005236 534 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNE 612 (706)
Q Consensus 534 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 612 (706)
|+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.|+.... ....... ...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~----~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID---PFEMAAY----LKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC---HHHHHHH----HHc
Confidence 99986543322222222345778999999998899999999999999999999 999875322 1222111 111
Q ss_pred CCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 613 GMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 613 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
....... .. ....+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 235 ~~~~~~~-----~~----~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 235 GYRLAQP-----IN----CPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CCCCCCC-----Cc----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1110000 00 112466899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=313.29 Aligned_cols=247 Identities=26% Similarity=0.327 Sum_probs=192.8
Q ss_pred eccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCCh
Q 005236 395 LGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 470 (706)
Q Consensus 395 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 470 (706)
||+|+||+||++... +++.+|+|++.... ....+.+..|+.++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 57899999986532 23346678899999999999999999999999999999999999999
Q ss_pred hhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccccc
Q 005236 471 DSFIFDQE-RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 549 (706)
Q Consensus 471 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 549 (706)
..++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 98885432 3346889999999999999999999987 99999999999999999999999999987543222 222
Q ss_pred ccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCH
Q 005236 550 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNL 629 (706)
Q Consensus 550 ~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 629 (706)
...||+.|+|||++.+..++.++||||||+++|||++|+.||........... ........ .. .+ ...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~--~~~~~~~~-~~-~~-----~~~--- 223 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE--LKQRILND-SV-TY-----PDK--- 223 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH--HHHhhccc-CC-CC-----ccc---
Confidence 35689999999999999999999999999999999999999864332211111 11111111 00 00 001
Q ss_pred HHHHHHHHHHHHhcCCCCCCCC-----ChhHHHHH
Q 005236 630 AEVIRCIHIGLLCVQQYPEDRP-----CMPSVILM 659 (706)
Q Consensus 630 ~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~~ 659 (706)
....+.+++..||+.+|++|| +++++++.
T Consensus 224 -~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 -FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred -CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 122456788999999999999 66666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.37 Aligned_cols=260 Identities=29% Similarity=0.419 Sum_probs=202.9
Q ss_pred ccCCCccceeccCCceeEEEEEeCC--------CcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeC
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD--------EQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHG 455 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 455 (706)
.++|.+.+.||+|+||.||+++... ...+|+|.+... .......+..|+.+++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3679999999999999999997532 346999998753 344556788999999999 799999999999999
Q ss_pred CeeEEEEecCCCCChhhhhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE
Q 005236 456 EEKLLIYEFMPNKSLDSFIFDQER-------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 522 (706)
Q Consensus 456 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill 522 (706)
+..++||||+++++|.+++..... ...+++..+++++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999975421 134788999999999999999999887 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchh
Q 005236 523 DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLN 601 (706)
Q Consensus 523 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~ 601 (706)
+.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.|+..... ..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---~~ 250 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EE 250 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---HH
Confidence 9999999999999986543222112222334578999999999999999999999999999998 7787643221 11
Q ss_pred HHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 602 LIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
... ........+... .....+.+++..||+.+|.+||+|.+|++.|+.+.
T Consensus 251 ~~~----~~~~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 251 LFK----LLKEGHRMDKPS---------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred HHH----HHHcCCCCCCCC---------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 111 111111111100 11235667899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=331.03 Aligned_cols=254 Identities=19% Similarity=0.234 Sum_probs=198.3
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
..++|++.++||+|+||.||+++.. .++.||+|.+.+. .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3468999999999999999999985 4789999998642 22334567889999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+++|+|.+++... .++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999998542 3677888899999999999999988 9999999999999999999999999998754
Q ss_pred CCCCcccccccccccCccCccccccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDG----QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (706)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..... ........
T Consensus 194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~---i~~~~~~~ 266 (370)
T cd05596 194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSK---IMDHKNSL 266 (370)
T ss_pred CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---HHHHH---HHcCCCcC
Confidence 3221 122345799999999998653 4789999999999999999999998643221 11111 11111110
Q ss_pred ccccccccCcCCHHHHHHHHHHHHHhcCCCCCC--CCChhHHHHH
Q 005236 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPED--RPCMPSVILM 659 (706)
Q Consensus 617 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--RPt~~ev~~~ 659 (706)
.+.+ .. .....+.+++..||+.+|.+ ||+++|++..
T Consensus 267 ~~~~-----~~--~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TFPD-----DI--EISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCC-----cC--CCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1100 00 01134567889999999987 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.65 Aligned_cols=260 Identities=27% Similarity=0.413 Sum_probs=201.9
Q ss_pred cCCCccceeccCCceeEEEEEeCC-C--cEEEEEEcCc-cchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-E--QEIAVKRLSK-ISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 461 (706)
++|++.+.||+|+||.||+|...+ + ..+++|.++. ......+.+.+|+.++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999998854 3 2478888864 3344567789999999999 799999999999999999999
Q ss_pred EecCCCCChhhhhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCe
Q 005236 462 YEFMPNKSLDSFIFDQE-------------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 528 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 528 (706)
|||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996532 1235788999999999999999999987 9999999999999999999
Q ss_pred EEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHH
Q 005236 529 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAW 607 (706)
Q Consensus 529 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 607 (706)
||+|||++...... ........+..|+|||++....++.++|||||||++|||++ |+.||...... .....
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~~~-- 230 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELYEK-- 230 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH--
Confidence 99999998643111 11111233567999999998899999999999999999998 99997543221 11111
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCCCCC
Q 005236 608 KLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLPQ 668 (706)
Q Consensus 608 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~~~~ 668 (706)
...+..... .... ...+.+++..||+.+|.+||++.++++.|+.......
T Consensus 231 --~~~~~~~~~-----~~~~----~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 231 --LPQGYRMEK-----PRNC----DDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred --HhcCCCCCC-----CCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111111110 0011 1245689999999999999999999999987754433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.12 Aligned_cols=258 Identities=28% Similarity=0.442 Sum_probs=208.8
Q ss_pred HHHhccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 382 IANATDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 382 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
+.....++.+..+||-|.||.||.|.|+. ...||||.++. +....++|.+|+.+|+.++|||+|+|+|+|..+...||
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 33334567788999999999999999965 66899999965 34457899999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
|.|||..|+|.+||++..+ ..++...++++|.||+.||+||..++ +|||||.++|+||.++..+|++||||+++..
T Consensus 341 iTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 9999999999999987654 55777788999999999999999887 9999999999999999999999999999986
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
.+.+.... ...-++.|.|||.+....++.|+|||+|||+||||.| |..|+...+ . ..+..++..+...+-.
T Consensus 417 gDTYTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid----l---SqVY~LLEkgyRM~~P 488 (1157)
T KOG4278|consen 417 GDTYTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID----L---SQVYGLLEKGYRMDGP 488 (1157)
T ss_pred CCceeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc----H---HHHHHHHhccccccCC
Confidence 65443322 2344679999999999999999999999999999998 666643221 1 1222222222222211
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
.. +...+..|++.||+.+|.+||++.|+-+.++
T Consensus 489 eG---------CPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 489 EG---------CPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred CC---------CCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 11 2336778999999999999999999877665
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=307.74 Aligned_cols=269 Identities=22% Similarity=0.308 Sum_probs=206.6
Q ss_pred HhccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHh--hcCCcceeeeEeEEEeCC----e
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFS--KLQHRNLVKLLGCCIHGE----E 457 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~~----~ 457 (706)
....+..+.+.||+|.||.||+|.+ .|+.||||++....+. .+.+|.++++ .|+|+||+.+++.-..+. .
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc-cCCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3346788999999999999999999 4779999999765544 4555666654 569999999999876543 6
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCceEecccCCCcEEEcCCCCeEEee
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ-----DSRLRIIHRDLKASNVLLDQDMNPKISD 532 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-----~~~~~ivH~Dikp~Nill~~~~~~kl~D 532 (706)
++||.+|.+.|||.+||.+ ..++....++++..+|.||++||- ++++.|.|||||++||||..++.+.|+|
T Consensus 284 LwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 7999999999999999954 458999999999999999999994 4788899999999999999999999999
Q ss_pred eccccccCCC--CCcccccccccccCccCccccccC----CC--CcchhhHHHHHHHHHHHh----C------CCCCCCC
Q 005236 533 FGLARAFGGD--ETEGNTNRVVGTYGYMAPEYASDG----QF--SVKSDVFSFGILLLEIVS----G------KKNRGFY 594 (706)
Q Consensus 533 fgla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~----~~--s~~sDv~SlGvil~ellt----G------~~p~~~~ 594 (706)
+|||.....+ ......+..+||.+|||||++... .+ -..+||||||.|+||+.- | +.||-..
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999887544 233456678999999999999653 12 136899999999999864 2 2444322
Q ss_pred CCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 595 HSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
-+.++ -.+..++..-....+..++.+ ..+-+.+..+.+++..||..+|.-|-|+--+-+.|.++..
T Consensus 440 Vp~DP--s~eeMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 440 VPSDP--SFEEMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCC--CHHHHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 22221 122222222223333333333 3345677788899999999999999999999998887643
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=310.16 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=198.4
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
++|++.++||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999987 45788999988643 344456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999997543 3677888899999999999999988 999999999999999999999999999865322
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
......++..|+|||++.+..++.++||||||+++|+|++|+.||..........................+. .
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~ 222 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP----V 222 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCC----C
Confidence 1223578999999999999999999999999999999999999986533222211111111111111111110 0
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
... ...+.+++.+||+.+|++||+++|+++.
T Consensus 223 ~~~----~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 GQF----SEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CcC----CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111 1245678999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=331.52 Aligned_cols=200 Identities=24% Similarity=0.364 Sum_probs=171.7
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.|++.++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999974 57889999986532 3345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++|+|.+++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999998653 34788888899999999999999988 9999999999999999999999999986431100
Q ss_pred C---------------------------------------------cccccccccccCccCccccccCCCCcchhhHHHH
Q 005236 544 T---------------------------------------------EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFG 578 (706)
Q Consensus 544 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlG 578 (706)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0001224689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCC
Q 005236 579 ILLLEIVSGKKNRGF 593 (706)
Q Consensus 579 vil~elltG~~p~~~ 593 (706)
|++|||++|+.||..
T Consensus 236 vil~elltG~~Pf~~ 250 (382)
T cd05625 236 VILYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=302.70 Aligned_cols=267 Identities=25% Similarity=0.292 Sum_probs=203.1
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccch--hhHHHHHHHHHHHhhcCCcc-eeeeEeEEEeCC------
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISE--QGLKELKNEIILFSKLQHRN-LVKLLGCCIHGE------ 456 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------ 456 (706)
..|...++||+|.||+||+|+. ..|+.||+|++....+ ..-....+|+.++++++|+| ||+|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4567778899999999999998 4588999999865433 23456689999999999999 999999999877
Q ss_pred eeEEEEecCCCCChhhhhhccccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERC-KLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 535 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgl 535 (706)
..++|+||++ -+|..++...... ..++...+..+..||++||+|||+++ |+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7889999995 4899998665432 34666888999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM 614 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 614 (706)
|+.+.-.. ......++|.-|.|||++.+. .|+...||||+|||+.||+++++-|......+....+-.......+..
T Consensus 167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 99754211 123346789999999999886 899999999999999999999988765444222222222222222222
Q ss_pred Ccccc---cc-----cccCcCCHHH-----HHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 615 PSQLI---DA-----CFKDSFNLAE-----VIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 615 ~~~~~---d~-----~~~~~~~~~~-----~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
++.+. +. .+....++.. .....+++.+||+.+|.+|.|++.++++
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 22211 10 0110111111 0245788999999999999999999886
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=307.59 Aligned_cols=253 Identities=30% Similarity=0.473 Sum_probs=200.8
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
++|++.++||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++||||+++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 57889999999999999999988888999999865332 3467899999999999999999999874 456899999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++..+......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 84 KGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 999999996533 234789999999999999999999987 999999999999999999999999999875432211
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....... ......... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~~~~-----~ 226 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQV----ERGYRMPCP-----Q 226 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----HcCCCCCCC-----C
Confidence 1112335678999999988899999999999999999999 8888753221 1111111 111111110 0
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
.....+.+++.+|++.+|.+|||+.++.+.|+.
T Consensus 227 ----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 227 ----DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 112346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.44 Aligned_cols=267 Identities=28% Similarity=0.346 Sum_probs=198.2
Q ss_pred CCccceeccCCceeEEEEEe-----CCCcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC--CeeEE
Q 005236 389 FSINKKLGEGGFGPVYKGTL-----ADEQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--EEKLL 460 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 460 (706)
|++.+.||+|+||+||++.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988653 357789999986542 34456788999999999999999999988764 35789
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999999999542 3899999999999999999999987 9999999999999999999999999998764
Q ss_pred CCCCcc-cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 541 GDETEG-NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 541 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+......- .................+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhh
Confidence 322211 1122345667999999998899999999999999999999999865422110 00000000000000000011
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
+..............+.+++..||+.+|++|||+++|+++|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 10000000111123567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=312.74 Aligned_cols=260 Identities=26% Similarity=0.443 Sum_probs=202.1
Q ss_pred hccCCCccceeccCCceeEEEEEeCC------CcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEE 457 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 457 (706)
..++|++.++||+|+||.||+|..++ +..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 34689999999999999999997542 4579999886432 3334567889999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhhcccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEE
Q 005236 458 KLLIYEFMPNKSLDSFIFDQER-------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 530 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 530 (706)
.++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999965321 234567788899999999999999987 999999999999999999999
Q ss_pred eeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHH
Q 005236 531 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKL 609 (706)
Q Consensus 531 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 609 (706)
+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ..... .
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~~----~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVLK----F 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----H
Confidence 99999986543322222222345678999999999999999999999999999999 6777643221 11111 1
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 610 WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 610 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
...+...... .. ....+.+++.+||+.+|.+|||+.++++.|+..
T Consensus 234 ~~~~~~~~~~-----~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 VMDGGYLDQP-----DN----CPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHcCCCCCCC-----CC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1111111110 01 123567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=328.27 Aligned_cols=254 Identities=19% Similarity=0.240 Sum_probs=195.7
Q ss_pred hccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
..++|++.+.||+|+||.||+++... ++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 44789999999999999999999854 788999998642 22334567899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999998542 3788888999999999999999988 9999999999999999999999999998763
Q ss_pred CCCCcccccccccccCccCccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQ----FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (706)
.... .......||+.|+|||++.... ++.++||||+||++|||++|+.||..... ..... .........
T Consensus 194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~---~~~~~---~i~~~~~~~ 266 (370)
T cd05621 194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL---VGTYS---KIMDHKNSL 266 (370)
T ss_pred cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH---HHHHH---HHHhCCccc
Confidence 2211 1223467999999999997643 78899999999999999999999854321 11111 111111110
Q ss_pred ccccccccCcCCHHHHHHHHHHHHHhcCCCCCC--CCChhHHHHH
Q 005236 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPED--RPCMPSVILM 659 (706)
Q Consensus 617 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--RPt~~ev~~~ 659 (706)
.+.. . ..-...+.+++..||+.++.+ ||+++|+++.
T Consensus 267 ~~p~-----~--~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NFPE-----D--VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCC-----c--ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1100 0 011123456777888755543 8899999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=323.27 Aligned_cols=241 Identities=24% Similarity=0.311 Sum_probs=191.3
Q ss_pred CCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCc-ceeeeEeEEEeCCeeEEEE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHR-NLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~ 462 (706)
+|++.+.||+|+||.||+|+..+ ++.||||++... .....+.+..|..++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47889999999999999999854 678999998653 234456788899999999765 5888999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999999988543 34788899999999999999999987 999999999999999999999999998753211
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .... .+
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~----~~~~-~~---- 220 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQSIM----EHNV-SY---- 220 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHH----cCCC-CC----
Confidence 1 122345789999999999999999999999999999999999999854322 11111111 1111 00
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCCh
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCM 653 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 653 (706)
....+ ..+.+++.+||+.+|.+||+.
T Consensus 221 -~~~~~----~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 -PKSLS----KEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCC----HHHHHHHHHHhhcCHHHcCCC
Confidence 01111 245678899999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=310.21 Aligned_cols=259 Identities=25% Similarity=0.375 Sum_probs=205.4
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.+.||+|+||.||+++. .+++.++||.+... .....+.+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788899999999999999997 46889999987542 3334567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 463 EFMPNKSLDSFIFDQE-RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
||+++++|.+++.... ....+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999986422 2346889999999999999999999987 99999999999999999999999999887543
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
... ......++..|+|||++.+..++.++||||||+++|||++|..|+...... ...... ...........
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~----~~~~~~~~~~~-- 229 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK----KIEQCDYPPLP-- 229 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhh----hhhcCCCCCCC--
Confidence 221 112346888999999999989999999999999999999999997432211 111111 11111111110
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.. .....+.+++.+||+.+|.+||||.+|+++++..
T Consensus 230 --~~----~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 230 --SD----HYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --cc----cccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 00 1123466788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=320.59 Aligned_cols=248 Identities=21% Similarity=0.325 Sum_probs=193.9
Q ss_pred ceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
+.||+|+||.||+++.. +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999985 5789999998653 233456688899999888 799999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
|+|..++... ..+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~ 152 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence 9999888543 35899999999999999999999988 999999999999999999999999998753111 112
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC--chhHHHHHHHHhhcCCCcccccccccC
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN--KLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .........+........ + ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----p~ 226 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR-I-----PR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC-C-----CC
Confidence 234578999999999999999999999999999999999999986432221 111111222222222111 1 11
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCC------hhHHHH
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPC------MPSVIL 658 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt------~~ev~~ 658 (706)
..+ ..+.+++.+||+.||.+||+ ++++++
T Consensus 227 ~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 227 SLS----VKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCC----HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 111 24567889999999999998 567664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.14 Aligned_cols=241 Identities=26% Similarity=0.339 Sum_probs=189.2
Q ss_pred ceeccCCceeEEEEEeCC-CcEEEEEEcCccc---hhhHHHHHHHHHHHhh-cCCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLAD-EQEIAVKRLSKIS---EQGLKELKNEIILFSK-LQHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
+.||+|+||.||+|+... ++.||||+++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999854 7889999986531 2334556677888776 4899999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAK 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCc
Confidence 9999998543 34788899999999999999999987 999999999999999999999999998753211 112
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcC
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSF 627 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 627 (706)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....... ....+ .+. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i----~~~~~--~~~----~~~ 219 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSI----RMDNP--CYP----RWL 219 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHH----HhCCC--CCC----ccC
Confidence 2345689999999999999999999999999999999999999854322 1111111 11111 011 111
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCChh-HHHH
Q 005236 628 NLAEVIRCIHIGLLCVQQYPEDRPCMP-SVIL 658 (706)
Q Consensus 628 ~~~~~~~~~~l~~~cl~~~p~~RPt~~-ev~~ 658 (706)
+ ..+.+++.+||+.+|.+||++. ++.+
T Consensus 220 ~----~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 220 T----REAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred C----HHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1 2456788999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=310.51 Aligned_cols=259 Identities=27% Similarity=0.383 Sum_probs=201.8
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCc----EEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQ----EIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
++|++.++||+|+||.||+|++. ++. .||+|.+... .....+.+.+|+.++..++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 57888999999999999999863 343 4899998653 44456788999999999999999999999875 45789
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
+|||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 ~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 999999999999986532 45889999999999999999999987 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
............++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ...... +.........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~----~~~~~~~~~~ 233 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDL----LEKGERLPQP 233 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----HHCCCcCCCC
Confidence 3322212222345678999999999999999999999999999998 8888753221 111111 1111111110
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCCCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLP 667 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~~~ 667 (706)
. . ....+.+++..||+.+|++||++.++++.|+.....|
T Consensus 234 ~-----~----~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 234 P-----I----CTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred c-----c----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0 1 1224567899999999999999999999998765443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=314.26 Aligned_cols=259 Identities=31% Similarity=0.453 Sum_probs=203.9
Q ss_pred ccCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEE 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 457 (706)
.++|.+.+.||+|+||.||++... .+..||||.++.. .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357999999999999999999752 2457999988754 334456789999999999 79999999999999999
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999996533 234799999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCc
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (706)
.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... .. ......+...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---~~---~~~~~~~~~~ 263 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---KF---YKLIKEGYRM 263 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---HH---HHHHHcCCcC
Confidence 7643322112222346788999999999999999999999999999998 888865332211 11 1111111111
Q ss_pred ccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 617 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.. ... ....+.+++.+||+.+|++||++.||++.|+..
T Consensus 264 ~~-----~~~----~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 AQ-----PEH----APAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CC-----CCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 001 113567899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=307.54 Aligned_cols=253 Identities=28% Similarity=0.434 Sum_probs=200.5
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
++|++.++||+|+||.||+|++.+...||+|++.... ...+.+.+|+.++++++||||+++++.+. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 5699999999999999999998777789999987532 23467899999999999999999999874 456799999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+++|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||.++.+......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 999999996532 245789999999999999999999987 999999999999999999999999999866432211
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ...... ........
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~~~~~~----~~~~~~~~-------- 223 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQ----VERGYRMP-------- 223 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---HHHHHH----HhcCCCCC--------
Confidence 1122346678999999998899999999999999999999 7777653221 111111 11111100
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
........+.+++.+|++.+|++||++++++++|+.
T Consensus 224 -~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 224 -CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred -CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 011122356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=331.45 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=193.3
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
.+|++.++||+|+||.||+++.. .++.||||.+.+.. ....+.+.+|+.++++++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999975 47899999986532 233467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|.+++... ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999999653 34788888899999999999999988 999999999999999999999999998533100
Q ss_pred CC-----------------------------------------cccccccccccCccCccccccCCCCcchhhHHHHHHH
Q 005236 543 ET-----------------------------------------EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 581 (706)
Q Consensus 543 ~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil 581 (706)
.. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00 0001124699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCC---ChhHHHH
Q 005236 582 LEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP---CMPSVIL 658 (706)
Q Consensus 582 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP---t~~ev~~ 658 (706)
|||++|+.||......+ ...... .+... ..+.. ..... ..+.+++..|+ .+|.+|+ ++.|+++
T Consensus 235 yell~G~~Pf~~~~~~~---~~~~i~-~~~~~--~~~~~---~~~~s----~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAE---TQLKVI-NWETT--LHIPS---QAKLS----REASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHH---HHHHHh-ccCcc--ccCCC---CCCCC----HHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 99999999986433211 111110 00000 00000 01111 12345566665 4999999 7888875
Q ss_pred H
Q 005236 659 M 659 (706)
Q Consensus 659 ~ 659 (706)
.
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=312.06 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=202.7
Q ss_pred ccCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 458 (706)
.++|++.+.||+|+||.||++... .+..||+|.+... .....+.+.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 367899999999999999999864 3678999998653 344457799999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhccc-------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCc
Q 005236 459 LLIYEFMPNKSLDSFIFDQE-------------------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 519 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~N 519 (706)
++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999996431 1124678889999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 005236 520 VLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDN 598 (706)
Q Consensus 520 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~ 598 (706)
|++++++.+||+|||+++.+..............+..|+|||.+.+..++.++|||||||++|||++ |..|+.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999886543322222222344678999999998999999999999999999998 7777642211
Q ss_pred chhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 599 KLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
.+.. ............+ .....+.+++.+||+.+|.+|||+.||++.|+.
T Consensus 239 -~~~~----~~~~~~~~~~~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 -EEVI----YYVRDGNVLSCPD---------NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -HHHH----HHHhcCCCCCCCC---------CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111 1111121111100 112356789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=306.73 Aligned_cols=259 Identities=26% Similarity=0.378 Sum_probs=206.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc---cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK---ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.+.||+|+||.||+|... +++.+|+|.++. ......+.+.+|+.++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999986 788999998753 23334678899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 463 EFMPNKSLDSFIFDQE-RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
||+++++|..++.... ....+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986532 2345789999999999999999999987 99999999999999999999999999886533
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ....... ....+.......
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~----~~~~~~~~~~~~- 230 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCK----KIEKCDYPPLPA- 230 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHh----hhhcCCCCCCCh-
Confidence 221 12234678899999999988999999999999999999999999743221 1111111 111111111100
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
......+.+++.+||+.+|.+||++.+|+++|++.
T Consensus 231 -------~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 231 -------DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -------hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 01123456789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=322.30 Aligned_cols=241 Identities=24% Similarity=0.310 Sum_probs=191.1
Q ss_pred CCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEEE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 462 (706)
+|.+.+.||+|+||.||+|+... ++.||||.+.+. .....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47888999999999999999854 678999998653 223345667788888777 5899999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999999988543 34788999999999999999999987 999999999999999999999999999754221
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .... .+ .
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~----~~~~-~~-p-- 221 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIM----EHNV-AY-P-- 221 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHHH----hCCC-CC-C--
Confidence 1 122345789999999999999999999999999999999999999864322 12211111 1111 00 0
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCCh
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCM 653 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 653 (706)
... ...+.+++.+||+.+|.+|++.
T Consensus 222 --~~~----s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 --KSM----SKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CcC----CHHHHHHHHHHcccCHHhcCCC
Confidence 011 1245678899999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=304.75 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=202.8
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+|++.+.||+|++|.||+|+.. +++.|++|.+.. ......+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999985 578899998754 2445567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999997542 346889999999999999999999887 99999999999999999999999999987643322
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
......+++.|+|||++.+..++.++||||||+++|||++|+.|+.... ....... ........+..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~----~~~~~~~~~~~---- 223 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILK----IIRGVFPPVSQ---- 223 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHH----HHcCCCCCCcc----
Confidence 1223467889999999999999999999999999999999999975432 1111111 11111111111
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 -----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 -----MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -----ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 112346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=309.25 Aligned_cols=249 Identities=26% Similarity=0.320 Sum_probs=193.0
Q ss_pred eccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCCh
Q 005236 395 LGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 470 (706)
Q Consensus 395 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 470 (706)
||+|+||.||+++.+ +++.+|+|++.... ......+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 48899999986421 12234556799999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccc
Q 005236 471 DSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 550 (706)
Q Consensus 471 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 550 (706)
.+++.... ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 98886543 234788999999999999999999987 9999999999999999999999999998754321 1223
Q ss_pred cccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHH
Q 005236 551 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLA 630 (706)
Q Consensus 551 ~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 630 (706)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...........+ ....... .... . ....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~--~~~~~~~-~~~~-~----~~~~--- 222 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL--KRRTLED-EVKF-E----HQNF--- 222 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH--HHHhhcc-cccc-c----cccC---
Confidence 46899999999999989999999999999999999999997643321111111 1111111 1100 0 0011
Q ss_pred HHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 631 EVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 631 ~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
...+.+++..||+.+|++||+++|+++.+..
T Consensus 223 -~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 223 -TEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred -CHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 1245688999999999999999887754443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=316.57 Aligned_cols=260 Identities=29% Similarity=0.423 Sum_probs=203.4
Q ss_pred cCCCccceeccCCceeEEEEEeCC--------CcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD--------EQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGE 456 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 456 (706)
.+|++.+.||+|+||.||+++... ...||+|.+... .....+++.+|+.++.++ +||||+++++++....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468899999999999999997521 236899988643 344567899999999999 7999999999999999
Q ss_pred eeEEEEecCCCCChhhhhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQE-------------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 523 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~ 523 (706)
..+++|||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999996532 1234788899999999999999999987 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhH
Q 005236 524 QDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNL 602 (706)
Q Consensus 524 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~ 602 (706)
+++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+..... ...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~ 245 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EEL 245 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHH
Confidence 999999999999987643222222222344568999999999999999999999999999998 7787643221 111
Q ss_pred HHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 603 IRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 603 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
.............. .....+.+++.+||+.+|.+||++.|+++.|+.+..
T Consensus 246 ----~~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 246 ----FKLLKEGHRMDKPA---------NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred ----HHHHHcCCCCCCCC---------CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11111111111111 112246688999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=318.67 Aligned_cols=243 Identities=23% Similarity=0.344 Sum_probs=189.4
Q ss_pred ceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
+.||+|+||.||+++.. +++.+|+|++.+. .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999985 4788999998653 233456678888888776 799999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 9999888543 34888999999999999999999988 9999999999999999999999999987532111 12
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC--chhHHHHHHHHhhcCCCcccccccccC
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN--KLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ................. .+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~-----p~ 226 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RI-----PR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-CC-----CC
Confidence 234578999999999999999999999999999999999999986422211 11111122222222111 01 01
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCCh
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCM 653 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 653 (706)
.. ...+.+++.+||+.||.+||+.
T Consensus 227 ~~----~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 227 SL----SVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CC----CHHHHHHHHHHhcCCHHHcCCC
Confidence 11 1245678899999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.34 Aligned_cols=254 Identities=23% Similarity=0.358 Sum_probs=199.7
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++.+..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5799999999999999999997 457889999987555455667889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||++..+.....
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 89 GGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 999999998543 34788999999999999999999987 99999999999999999999999999987632211
Q ss_pred ccccccccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 546 GNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
......++..|+|||.+. ...++.++||||||+++|||++|+.|+....+..... .. .... +..+.
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~-~~~~---~~~~~ 230 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LM-SKSN---FQPPK 230 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------ee-ecCC---CCCCC
Confidence 122346888999999984 3457889999999999999999999974322111100 00 0000 00011
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHh
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L 660 (706)
+.... .....+.+++.+||+.+|++||+++++++.|
T Consensus 231 ~~~~~--~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LKDKT--KWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Ccccc--ccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11000 1113566889999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=307.05 Aligned_cols=256 Identities=27% Similarity=0.445 Sum_probs=202.0
Q ss_pred cCCCccceeccCCceeEEEEEeCC-C---cEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-E---QEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
++|+..+.||+|+||.||+|+... + ..+++|.+... .....+.+..|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467888999999999999999753 3 36899998654 344567889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999986432 45889999999999999999999987 99999999999999999999999999986643
Q ss_pred CCCccc-ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 542 DETEGN-TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 542 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
...... ......+..|+|||++....++.++||||||+++|||++ |+.|+..... ...... +.........
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~----i~~~~~~~~~ 232 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKA----INDGFRLPAP 232 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHH----HhcCCCCCCC
Confidence 221111 111223467999999998899999999999999999997 9999753221 111111 1111110000
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
......+.+++.+|++.+|.+||++.+|++.|+.+
T Consensus 233 ---------~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 233 ---------MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01123567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.10 Aligned_cols=237 Identities=24% Similarity=0.287 Sum_probs=185.3
Q ss_pred ceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHH-HHhhcCCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEII-LFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999985 58899999986532 222344555544 56789999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT 152 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence 9999988543 34788889999999999999999988 999999999999999999999999998753211 112
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcC
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSF 627 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 627 (706)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... .. .... .+ ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~---i~-~~~~-~~-----~~~~ 219 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---AEMYDN---IL-NKPL-RL-----KPNI 219 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH---HHHHHH---HH-cCCC-CC-----CCCC
Confidence 2345789999999999999999999999999999999999999753221 111111 11 1111 01 0111
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCChh
Q 005236 628 NLAEVIRCIHIGLLCVQQYPEDRPCMP 654 (706)
Q Consensus 628 ~~~~~~~~~~l~~~cl~~~p~~RPt~~ 654 (706)
...+.+++.+||+.+|.+||++.
T Consensus 220 ----~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 220 ----SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ----CHHHHHHHHHHhhcCHHhCCCCC
Confidence 22456788999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=324.88 Aligned_cols=242 Identities=21% Similarity=0.260 Sum_probs=191.9
Q ss_pred ceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCC
Q 005236 393 KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 468 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 468 (706)
+.||+|+||.||+++.. .++.||+|.+... .......+..|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999874 5889999998653 2334567788999999999999999999999999999999999999
Q ss_pred ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 469 SLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 469 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
+|..++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 999888543 358899999999999999999997 56 9999999999999999999999999987532221 11
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcC
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSF 627 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 627 (706)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... ...... .+ ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~~----i~~~~~-~~-----p~~~ 219 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFEL----ILMEEI-RF-----PRTL 219 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHHH----HhcCCC-CC-----CCCC
Confidence 22356899999999999999999999999999999999999998543221 11111 111110 00 0111
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCC-----ChhHHHHH
Q 005236 628 NLAEVIRCIHIGLLCVQQYPEDRP-----CMPSVILM 659 (706)
Q Consensus 628 ~~~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~~ 659 (706)
+ ..+.+++.+||+.||.+|+ +++++++.
T Consensus 220 ~----~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 220 S----PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C----HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1 2355788899999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=305.02 Aligned_cols=253 Identities=29% Similarity=0.451 Sum_probs=200.0
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
++|.+.++||+|+||.||+|.+..+..+|+|++.... ...+.+.+|+.++++++|||++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688899999999999999998887789999886432 23467889999999999999999999875 456899999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 999999996532 245789999999999999999999887 999999999999999999999999999875332211
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......++..|+|||++.+..++.++||||||+++|||++ |+.|+..... ....... .........
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~~~~~~~------ 225 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQV----ERGYRMPCP------ 225 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCCCCCCC------
Confidence 1122345678999999998899999999999999999999 8888753221 1111111 111111100
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
......+.+++.+||+.+|.+||++++|+++|+.
T Consensus 226 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 ---QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0112346678899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=308.69 Aligned_cols=254 Identities=27% Similarity=0.417 Sum_probs=191.6
Q ss_pred ceeccCCceeEEEEEeCC---CcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCC
Q 005236 393 KKLGEGGFGPVYKGTLAD---EQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 468 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 468 (706)
+.||+|+||.||+|...+ +..+|+|++.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999998744 4578999886533 334457889999999999999999999999999999999999999
Q ss_pred Chhhhhhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 469 SLDSFIFDQER--CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 469 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+|.+++..... ....++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999965432 234677788899999999999999987 9999999999999999999999999997643332222
Q ss_pred cccccccccCccCccccccC-------CCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 547 NTNRVVGTYGYMAPEYASDG-------QFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~-------~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+ ...... .. ....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~~---~~-~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYTV---RE-QQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHh---hc-ccCCC
Confidence 22334578899999998642 35789999999999999996 999985433211 111111 11 11111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
.++.+..... ..+.+++..|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLPLS----DRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCCCC----hHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1222111111 13456778898 58999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=304.59 Aligned_cols=246 Identities=30% Similarity=0.418 Sum_probs=193.8
Q ss_pred eeccCCceeEEEEEe---CCCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCC
Q 005236 394 KLGEGGFGPVYKGTL---ADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 468 (706)
Q Consensus 394 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 468 (706)
+||+|+||.||+|.+ .+++.+|+|++... .....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999975 34678999998643 2344678899999999999999999999875 55778999999999
Q ss_pred ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc-c
Q 005236 469 SLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG-N 547 (706)
Q Consensus 469 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~-~ 547 (706)
+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||.||++++++.+||+|||+++......... .
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 999998543 34788999999999999999999988 9999999999999999999999999998764332211 1
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCc
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDS 626 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 626 (706)
.....++..|+|||.+....++.++||||||+++|||++ |+.||..... ...... ...+...... ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~----i~~~~~~~~~-----~~ 222 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQM----IESGERMECP-----QR 222 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHCCCCCCCC-----CC
Confidence 122334678999999988889999999999999999998 9999764322 111111 1111111111 11
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 627 FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 627 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
. ...+.+++.+||+.+|++||++.+|++.|++
T Consensus 223 ~----~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 223 C----PPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred C----CHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1 1245689999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=322.45 Aligned_cols=242 Identities=22% Similarity=0.325 Sum_probs=191.4
Q ss_pred ceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
++||+|+||.||+|+... ++.||||++... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999854 789999998653 233455677888888866 799999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 9999888543 34788899999999999999999988 9999999999999999999999999987542221 12
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcC
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSF 627 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 627 (706)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...... ....... .. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~~~~~~---i~~~~~~---~p----~~~ 219 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDLFES---ILHDDVL---YP----VWL 219 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---HHHHHH---HHcCCCC---CC----CCC
Confidence 2335689999999999999999999999999999999999999864322 121111 1111110 00 011
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCC-------ChhHHHHH
Q 005236 628 NLAEVIRCIHIGLLCVQQYPEDRP-------CMPSVILM 659 (706)
Q Consensus 628 ~~~~~~~~~~l~~~cl~~~p~~RP-------t~~ev~~~ 659 (706)
+ ..+.+++..||+.+|.+|| +++++++.
T Consensus 220 ~----~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 220 S----KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred C----HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1 2456788999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=305.43 Aligned_cols=254 Identities=31% Similarity=0.469 Sum_probs=202.4
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
.++|++.++||+|+||.||+|..++++.||+|.+..... ..+.+.+|+.++++++||||+++++++ ..+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 367899999999999999999998899999999865332 346788999999999999999999986 456789999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999986543 345788999999999999999999887 999999999999999999999999999876422211
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
......++..|+|||++....++.++||||||+++|||++ |+.||..... ....... .........+
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~----~~~~~~~~~~---- 226 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNL----ERGYRMPRPD---- 226 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHH----HcCCCCCCCC----
Confidence 1122345678999999998899999999999999999999 9999753221 1111111 1111111111
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
.. ...+.+++.+|++.+|++||++++++..|+.
T Consensus 227 -~~----~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 227 -NC----PEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CC----CHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11 1246789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=321.82 Aligned_cols=236 Identities=25% Similarity=0.322 Sum_probs=187.6
Q ss_pred ceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
+.||+|+||.||+|+.+ +++.||||++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999985 4788999998653 233456677888888876 699999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
|+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 9999988543 34788999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcC
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSF 627 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 627 (706)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... +...... + . ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~----i~~~~~~-~-~----~~~ 219 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---DDLFEA----ILNDEVV-Y-P----TWL 219 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHH----HhcCCCC-C-C----CCC
Confidence 2335789999999999999999999999999999999999999864322 111111 1111110 0 0 011
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCCh
Q 005236 628 NLAEVIRCIHIGLLCVQQYPEDRPCM 653 (706)
Q Consensus 628 ~~~~~~~~~~l~~~cl~~~p~~RPt~ 653 (706)
...+.+++.+||+.||.+||++
T Consensus 220 ----~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 220 ----SQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred ----CHHHHHHHHHHcccCHHHCCCC
Confidence 1245678899999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=318.21 Aligned_cols=242 Identities=26% Similarity=0.304 Sum_probs=192.0
Q ss_pred ceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
+.||+|+||.||+|.... ++.||||++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999854 778999998753 233456677888888887 699999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 9999888543 34889999999999999999999988 9999999999999999999999999987532111 12
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcC
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSF 627 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 627 (706)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ...... ....... +. ...
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~~~----i~~~~~~--~~----~~~ 219 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELFQS----ILEDEVR--YP----RWL 219 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHHHH----HHcCCCC--CC----CcC
Confidence 2335689999999999999999999999999999999999999853321 111111 1111110 00 111
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCCh-----hHHHHH
Q 005236 628 NLAEVIRCIHIGLLCVQQYPEDRPCM-----PSVILM 659 (706)
Q Consensus 628 ~~~~~~~~~~l~~~cl~~~p~~RPt~-----~ev~~~ 659 (706)
...+.+++.+||+.||.+||++ .++++.
T Consensus 220 ----~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 220 ----SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ----CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1245678999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=314.12 Aligned_cols=258 Identities=29% Similarity=0.424 Sum_probs=202.0
Q ss_pred cCCCccceeccCCceeEEEEEeC--------CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA--------DEQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGE 456 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 456 (706)
++|.+.++||+|+||.||+++.. ....+|+|.+... .......+..|+.+++++ +||||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57889999999999999999752 2456899988653 344567788999999999 6999999999999999
Q ss_pred eeEEEEecCCCCChhhhhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQE-------------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 523 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~ 523 (706)
..++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999996532 1245888999999999999999999987 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhH
Q 005236 524 QDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNL 602 (706)
Q Consensus 524 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~ 602 (706)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..... ...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EEL 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence 999999999999987643222222222334568999999999999999999999999999999 8888643221 111
Q ss_pred HHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 603 IRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 603 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
... ........... .....+.+++.+||+.+|.+||++.|+++.|...
T Consensus 246 ~~~----~~~~~~~~~~~---------~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 246 FKL----LREGHRMDKPS---------NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HHH----HHcCCCCCCCC---------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111 11111111111 1122456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=303.98 Aligned_cols=251 Identities=29% Similarity=0.459 Sum_probs=203.5
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
.++|++.+.||+|+||.||+|... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357889999999999999999875 78899999976544 5678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999965432 35899999999999999999999988 99999999999999999999999999987532211
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
....+..|+|||++....++.++||||||+++|||++ |+.|+..... ....... .........+
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~~~~~---- 222 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHV----EKGYRMEAPE---- 222 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----hcCCCCCCcc----
Confidence 2334668999999998899999999999999999997 9888753321 1111111 1111111111
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
. ....+.+++.+||+.+|.+||+++||+++|+++
T Consensus 223 -~----~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 223 -G----CPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -C----CCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1 123566889999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.25 Aligned_cols=259 Identities=30% Similarity=0.431 Sum_probs=199.7
Q ss_pred cCCCccceeccCCceeEEEEEe------CCCcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeC-Ce
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL------ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHG-EE 457 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 457 (706)
++|++.+.||+|+||.||+|+. ..++.||||++... .......+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 6799999999999999999974 34678999998653 233456788999999999 689999999988654 46
Q ss_pred eEEEEecCCCCChhhhhhcccc----------------------------------------------------------
Q 005236 458 KLLIYEFMPNKSLDSFIFDQER---------------------------------------------------------- 479 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 479 (706)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999999864210
Q ss_pred ------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccccccccc
Q 005236 480 ------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 553 (706)
Q Consensus 480 ------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 553 (706)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 123678888999999999999999987 99999999999999999999999999987533322222222345
Q ss_pred ccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHH
Q 005236 554 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEV 632 (706)
Q Consensus 554 t~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 632 (706)
+..|+|||.+.+..++.++||||||+++|||++ |..|+...... .... .....+...... ...+
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~----~~~~~~~~~~~~-----~~~~---- 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFC----RRLKEGTRMRAP-----DYTT---- 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHH----HHHhccCCCCCC-----CCCC----
Confidence 678999999999999999999999999999997 88887543221 1111 111111111110 0111
Q ss_pred HHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 633 IRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 633 ~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
..+.+++..||+.+|.+||++.||++.|+.+
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2466888999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=325.32 Aligned_cols=238 Identities=24% Similarity=0.295 Sum_probs=189.8
Q ss_pred ceeccCCceeEEEEEe----CCCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 393 KKLGEGGFGPVYKGTL----ADEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
+.||+|+||.||+++. ..++.+|+|++.... ......+..|+.++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6899999999999875 357899999986532 2234567789999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 99999998543 34889999999999999999999988 9999999999999999999999999998653221 1
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCc
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDS 626 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 626 (706)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ...... .... .. .+ ...
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~~---i~~~-~~-~~-----p~~ 220 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETMTM---ILKA-KL-GM-----PQF 220 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHHHHH---HHcC-CC-CC-----CCC
Confidence 22335789999999999998999999999999999999999999754221 111111 1111 11 00 001
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChhH
Q 005236 627 FNLAEVIRCIHIGLLCVQQYPEDRPCMPS 655 (706)
Q Consensus 627 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~e 655 (706)
.+ ..+.+++.+||+.||++||++.+
T Consensus 221 ~~----~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 221 LS----PEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CC----HHHHHHHHHHhhcCHhHcCCCCC
Confidence 11 23557888999999999999666
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=317.27 Aligned_cols=240 Identities=26% Similarity=0.328 Sum_probs=188.3
Q ss_pred ceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
++||+|+||.||+|+.. .++.||+|.++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999985 47899999986532 23345667788777654 899999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence 9999988543 34788899999999999999999988 999999999999999999999999998753211 112
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcC
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSF 627 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 627 (706)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....... ..... .+ ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~~----~~~~~-~~-----~~~~ 219 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESI----RVDTP-HY-----PRWI 219 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHH----HhCCC-CC-----CCCC
Confidence 2345789999999999999999999999999999999999999853321 1111111 11110 00 0111
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCChh-HHH
Q 005236 628 NLAEVIRCIHIGLLCVQQYPEDRPCMP-SVI 657 (706)
Q Consensus 628 ~~~~~~~~~~l~~~cl~~~p~~RPt~~-ev~ 657 (706)
+ ..+.+++.+||+.||.+||++. ++.
T Consensus 220 ~----~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 220 T----KESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred C----HHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1 2455788899999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=306.27 Aligned_cols=249 Identities=29% Similarity=0.416 Sum_probs=198.6
Q ss_pred ceeccCCceeEEEEEeCC--C--cEEEEEEcCccch-hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLAD--E--QEIAVKRLSKISE-QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
++||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998743 2 3689999977555 667789999999999999999999999988 889999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc-c
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE-G 546 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~-~ 546 (706)
++|.+++.+... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999976443 56899999999999999999999987 999999999999999999999999999876442211 1
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......++..|+|||++....++.++||||||+++|||++ |+.|+..... .+....... ........ .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~---~~~~~~~~-----~ 224 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILKKIDK---EGERLERP-----E 224 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHh---cCCcCCCC-----c
Confidence 2223457789999999999999999999999999999999 9999743222 111111111 11100000 0
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
.....+.+++.+|++.+|.+||++.+|++.|.
T Consensus 225 ----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 ----ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11235667999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=293.76 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=197.9
Q ss_pred hccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcC--ccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLS--KISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
..++|++.++||+|.|+.||+... ..|+.+|+|.+. +....+.+.+.+|+.+-+.|+|||||+|.....+....++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 346889999999999999999876 458888888764 23445788999999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC---CCeEEeeeccccc
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLARA 538 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~~kl~Dfgla~~ 538 (706)
+|+|.|++|..=|... ...++..+-+.+.||+++|.|.|..+ |||||+||.|+++... --+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999997666433 34677888899999999999999998 9999999999999543 4589999999998
Q ss_pred cCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
++.. ......+|||+|||||++...+|+..+|||+.|||||-|+.|.+||...+.. .+.+...... .......
T Consensus 163 l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I~~g~-yd~~~~~ 235 (355)
T KOG0033|consen 163 VNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQIKAGA-YDYPSPE 235 (355)
T ss_pred eCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHHhccc-cCCCCcc
Confidence 8622 2233468999999999999999999999999999999999999997542221 2221111110 0011111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHH
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI 657 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~ 657 (706)
.+ .. ...+.+|+.+||..||.+|.|+.|.+
T Consensus 236 w~-----~i----s~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 236 WD-----TV----TPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred cC-----cC----CHHHHHHHHHHhccChhhhccHHHHh
Confidence 11 11 12455788999999999999998876
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=307.54 Aligned_cols=261 Identities=25% Similarity=0.310 Sum_probs=194.3
Q ss_pred CCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC-----eeEEE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE-----EKLLI 461 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lV 461 (706)
.|...+++|.|+||.||+|.+.. ++.||||+.-...+ --..|+.+|++++|||||+|.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46667999999999999999854 68999999754322 2346899999999999999998887533 23589
Q ss_pred EecCCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-CCeEEeeecccccc
Q 005236 462 YEFMPNKSLDSFIFDQ-ERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAF 539 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfgla~~~ 539 (706)
||||+. +|...++.. .....++...+.-+..||.+||.|||+.+ |+||||||+|+|||.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999976 888888642 12234666667778999999999999987 9999999999999977 99999999999987
Q ss_pred CCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhc------
Q 005236 540 GGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNE------ 612 (706)
Q Consensus 540 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------ 612 (706)
...+.. ....-|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|...+..+.+.++.........
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 544332 33567889999999977 58999999999999999999999998765554444444443221111
Q ss_pred --C----CCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 613 --G----MPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 613 --~----~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. ..+.+...-+..........+.++++.++|+++|.+|.++.|++..
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0 0111111111111112223356789999999999999999998753
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=307.61 Aligned_cols=256 Identities=26% Similarity=0.403 Sum_probs=200.8
Q ss_pred cCCCccceeccCCceeEEEEEeCC-C---cEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-E---QEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
..|++.+.||+|+||.||+|.+.. + ..||||.+... .....+.|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357888999999999999999753 3 36999998654 455567899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999986532 45789999999999999999999987 99999999999999999999999999886543
Q ss_pred CCCcccccccc---cccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 542 DETEGNTNRVV---GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 542 ~~~~~~~~~~~---gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
........... .+..|+|||++....++.++||||||+++|||++ |..||..... ......... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~---~~~~~~ 232 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQ---DYRLPP 232 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHc---CCcCCC
Confidence 22211111111 2457999999999999999999999999999886 9988753221 111111111 100000
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
. .. ....+.+++..||+.+|.+||++.+|+.+|+..
T Consensus 233 -~-----~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 -P-----MD----CPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -c-----cc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 01 122456789999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=304.87 Aligned_cols=255 Identities=31% Similarity=0.486 Sum_probs=204.4
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
.++|++.++||+|+||.||+|..++++.+|||.+.... ...+.+.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46899999999999999999999888899999986533 33567899999999999999999999999888999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+......
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999996543 245889999999999999999999987 999999999999999999999999999876432111
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ................. .
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~----~---- 227 (261)
T cd05034 160 -AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT---NREVLEQVERGYRMPRP----P---- 227 (261)
T ss_pred -hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCCCCC----C----
Confidence 1112234568999999999899999999999999999999 898874322 11122211111100000 0
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
.. ...+.+++.+|++.+|.+||+++++.+.|+.
T Consensus 228 -~~----~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 228 -NC----PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CC----CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01 2346678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=324.92 Aligned_cols=262 Identities=19% Similarity=0.252 Sum_probs=199.2
Q ss_pred ccCCCccceeccCCceeEEEEEeC---CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA---DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
..+|.+.+.||+|+||.||++... .++.|++|.+... +...+|+.++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999999763 3567999987542 23467999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
|++. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 688888832 345899999999999999999999988 999999999999999999999999999876443
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc--c---
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS--Q--- 617 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~--- 617 (706)
..........||+.|+|||++....++.++|||||||++|||++|+.||...........+....+........ .
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 33333334679999999999999999999999999999999999999986544332222222222211110000 0
Q ss_pred --c------ccccccCcCCHH-------HHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 618 --L------IDACFKDSFNLA-------EVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 618 --~------~d~~~~~~~~~~-------~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
+ ............ ....+.+++.+||+.+|++|||+.|++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000000000000 01245678899999999999999999876
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=317.58 Aligned_cols=244 Identities=23% Similarity=0.350 Sum_probs=192.0
Q ss_pred ceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
+.||+|+||.||+++.. +++.+|+|++... .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999985 4788999998753 233456788999999888 699999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDT 152 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCc
Confidence 9999888543 34889999999999999999999988 999999999999999999999999998753211 112
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcC
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSF 627 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 627 (706)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||................+........ + . ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~-p----~~~ 226 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR-I-P----RFL 226 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC-C-C----CCC
Confidence 234578999999999999999999999999999999999999986543332222222222222221111 1 0 011
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCChh
Q 005236 628 NLAEVIRCIHIGLLCVQQYPEDRPCMP 654 (706)
Q Consensus 628 ~~~~~~~~~~l~~~cl~~~p~~RPt~~ 654 (706)
+ ..+.+++.+||+.||.+||+++
T Consensus 227 ~----~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 227 S----VKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred C----HHHHHHHHHHhccCHHHcCCCC
Confidence 1 2356788999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=324.72 Aligned_cols=262 Identities=23% Similarity=0.336 Sum_probs=196.5
Q ss_pred CCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC-----eeE
Q 005236 388 NFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE-----EKL 459 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 459 (706)
+|++.++||+|+||.||++.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999997 46889999998653 3334567889999999999999999999998776 789
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
+||||+. ++|.+++... ..+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 5787777433 35889999999999999999999988 999999999999999999999999999865
Q ss_pred CCCCCcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH------------
Q 005236 540 GGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHA------------ 606 (706)
Q Consensus 540 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~------------ 606 (706)
...... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||...........+...
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 332221 12234678999999998774 5799999999999999999999998654322211111110
Q ss_pred ----HHHh-hcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 607 ----WKLW-NEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 607 ----~~~~-~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
...+ .............. ........+.+++.+||+.||.+|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYT--LSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcc--cCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 00000000000000 000112356789999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=305.90 Aligned_cols=256 Identities=27% Similarity=0.430 Sum_probs=201.7
Q ss_pred cCCCccceeccCCceeEEEEEeCC----CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD----EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
++|++.+.||+|+||.||+|.+.. +..+|+|.+... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 578889999999999999998742 336899988653 234457889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999996543 35788999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCcc-cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 542 DETEG-NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 542 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
..... ......++..|+|||++.+..++.++||||||+++||+++ |+.||...... ....... .......
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~----~~~~~~~- 230 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIE----EGYRLPA- 230 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHh----CCCcCCC-
Confidence 32211 1112233568999999998899999999999999999887 99997543221 1111111 1110000
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
. . .....+.+++.+|++.+|.+||+|.++++.|+..
T Consensus 231 ---~-~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 231 ---P-M----DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---C-C----CCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 0 0122456789999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=326.68 Aligned_cols=195 Identities=24% Similarity=0.327 Sum_probs=168.1
Q ss_pred hccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
...+|.+.+.||+|+||.||++.... ++.||||... ...+.+|+.++++++|||||++++++..+...++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34689999999999999999999854 7889999642 2345789999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
++. ++|..++.... ..+++..++.++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 241 ~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 241 KYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred ccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 995 68888875432 35899999999999999999999988 9999999999999999999999999998764332
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNR 591 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~ 591 (706)
.........||..|+|||++.+..++.++|||||||+||||++|..++
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 222223457999999999999999999999999999999999988764
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.97 Aligned_cols=250 Identities=34% Similarity=0.499 Sum_probs=201.8
Q ss_pred ceeccCCceeEEEEEeCC----CcEEEEEEcCccchh-hHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLAD----EQEIAVKRLSKISEQ-GLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
+.||+|+||.||+|.... +..+++|.+...... ..+.+.+|+.+++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999854 778999998764333 367899999999999999999999999999999999999999
Q ss_pred CChhhhhhcccc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 468 KSLDSFIFDQER------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 468 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
++|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999976421 356899999999999999999999987 99999999999999999999999999988654
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
...........++..|+|||.+....++.++||||||+++|||++ |..|+..... ...... ...........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~~~~~~ 230 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEY----LRKGYRLPKPE 230 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH----HHcCCCCCCCc
Confidence 332223334567889999999988899999999999999999999 5888765421 111111 11111111100
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
.. ...+.+++.+||+.+|.+|||+.|++..|+
T Consensus 231 -----~~----~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 231 -----YC----PDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----cC----ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11 235667889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.66 Aligned_cols=259 Identities=19% Similarity=0.224 Sum_probs=197.5
Q ss_pred HHHHhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC
Q 005236 381 TIANATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE 456 (706)
Q Consensus 381 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 456 (706)
.+....++|++.+.||+|+||.||+++.. .++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++.+.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 33445589999999999999999999985 4778999998642 2233456788999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 536 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla 536 (706)
..++||||+++|+|.+++... .++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 999999999999999998542 3678888899999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccCccCccccccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhc
Q 005236 537 RAFGGDETEGNTNRVVGTYGYMAPEYASDG----QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNE 612 (706)
Q Consensus 537 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 612 (706)
+.+..... .......||+.|+|||++... .++.++|||||||++|||++|+.||..... .... ......
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~---~~i~~~ 262 (371)
T cd05622 190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTY---SKIMNH 262 (371)
T ss_pred eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH---HHHH---HHHHcC
Confidence 87643221 122346799999999998754 378999999999999999999999854221 1111 111111
Q ss_pred CCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCC--CCChhHHHHHh
Q 005236 613 GMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPED--RPCMPSVILML 660 (706)
Q Consensus 613 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--RPt~~ev~~~L 660 (706)
.....+.+ .. .....+.+++..||+..+.+ ||+++|+++..
T Consensus 263 ~~~~~~~~-----~~--~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 263 KNSLTFPD-----DN--DISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCcccCCC-----cC--CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11111111 00 11123556888999844433 77888888754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.71 Aligned_cols=247 Identities=28% Similarity=0.401 Sum_probs=196.5
Q ss_pred ceeccCCceeEEEEEeCCCcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCChh
Q 005236 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLD 471 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 471 (706)
++||+|+||.||+|...+++.+|+|.+.... ......+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4799999999999998888999999987643 333457889999999999999999999999999999999999999999
Q ss_pred hhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccccccc
Q 005236 472 SFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 551 (706)
Q Consensus 472 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 551 (706)
+++.... ..+++..+..++.|++.+|.|||+.+ ++|+||||+||++++++.+||+|||++......... .....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 9985432 35789999999999999999999987 999999999999999999999999998754322111 11122
Q ss_pred ccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHH
Q 005236 552 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLA 630 (706)
Q Consensus 552 ~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 630 (706)
.++..|+|||++....++.++||||||+++|||++ |..||..... ...... ........... .
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~---~~~~~~----~~~~~~~~~~~---------~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN---QQAREQ----VEKGYRMSCPQ---------K 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHH----HHcCCCCCCCC---------C
Confidence 34678999999998899999999999999999998 8888753221 111111 11111111111 1
Q ss_pred HHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 631 EVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 631 ~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
....+.+++.+|++.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1235678999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.19 Aligned_cols=262 Identities=23% Similarity=0.327 Sum_probs=196.3
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
++|.+.++||+|+||.||+|+.. .++.||+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999985 57789999986432 22334677899999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++ +|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 985 7888775432 34788889999999999999999988 99999999999999999999999999976432211
Q ss_pred cccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc-----
Q 005236 545 EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL----- 618 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 618 (706)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+............+.+
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1223467899999999865 46899999999999999999999998654332222222111100000000000
Q ss_pred -cc---------ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 619 -ID---------ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 619 -~d---------~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.+ +....... ....+.+++.+||+.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPR--LDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccC--CCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00 00000000 1124568999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=312.61 Aligned_cols=265 Identities=22% Similarity=0.272 Sum_probs=198.8
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
++|++.++||+|+||.||++... ++..+|+|.+... .....+.+.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999975 4777888887643 344456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++... ..+++..+..++.|+++||.|||+.. +++|+||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 9999999999643 45788899999999999999999742 3999999999999999999999999998764321
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC---------
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP--------- 615 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 615 (706)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+........................
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 122356889999999998888999999999999999999999997532211100000000000000000
Q ss_pred --------cccccccccC---c-CCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHh
Q 005236 616 --------SQLIDACFKD---S-FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 616 --------~~~~d~~~~~---~-~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L 660 (706)
.++.+..... . ........+.+++.+||+.+|.+||++++|++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000000 0 0000122467899999999999999999998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=329.27 Aligned_cols=252 Identities=28% Similarity=0.430 Sum_probs=209.0
Q ss_pred CCccceeccCCceeEEEEEe-CCC----cEEEEEEcCc-cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 389 FSINKKLGEGGFGPVYKGTL-ADE----QEIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
.+..++||+|+||+||||.+ ..+ .+||+|++.. ...+..+++.+|+.+|.+++||||+||+++|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 44558999999999999987 333 4689998865 45566789999999999999999999999998766 88999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
+||+.|+|.+|++.+. ..+-.+..+.|..|||+||.|||++. ++||||..+||||.+-.++||.|||+++.+..+
T Consensus 777 q~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999997643 55788899999999999999999887 999999999999999999999999999999877
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
..........-.+.|||-|.+....|+.++|||||||++||++| |..|+.....++..++++...+ +
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR---------L--- 919 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER---------L--- 919 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc---------C---
Confidence 76666666667889999999999999999999999999999999 8888765544433333222111 1
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
+...-..+.+..++.+||..|+..||+++++...+.+
T Consensus 920 ----sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 920 ----SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred ----CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 1122344567789999999999999999999876643
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=308.86 Aligned_cols=252 Identities=32% Similarity=0.498 Sum_probs=198.9
Q ss_pred CCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhH--HHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 389 FSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGL--KELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
|++.+.||+|+||+||+++... ++.+|+|.+........ .....|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678999999999999999865 56899999976544332 23456999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++. ....+++..+..++.||++||.+||+.+ ++|+||||+||++++++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence 9999999996 2345789999999999999999999988 9999999999999999999999999998641 122
Q ss_pred ccccccccccCccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 546 GNTNRVVGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~-~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
.......++..|+|||++. ...++.++||||+|+++|+|++|..|+......+.......... ....... ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~----~~ 225 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK---RPLPSSS----QQ 225 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH---THHHHHT----TS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc---ccccccc----cc
Confidence 2334467899999999998 88999999999999999999999999764411122222211111 0000000 00
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
... ....+.+++..||+.+|++||++.++++
T Consensus 226 ~~~---~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SRE---KSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTT---SHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cch---hHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0146678999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=320.24 Aligned_cols=240 Identities=23% Similarity=0.264 Sum_probs=186.9
Q ss_pred ceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHH-HHhhcCCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEII-LFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
+.||+|+||.||+++.. +++.+|+|++... .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999874 5889999998653 2233445555654 56779999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 152 (325)
T cd05604 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT 152 (325)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence 9999888543 35788999999999999999999988 999999999999999999999999998753211 112
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcC
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSF 627 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 627 (706)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... .. .... . +. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~---~~-~~~~-~-~~----~~~ 219 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV---AEMYDN---IL-HKPL-V-LR----PGA 219 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH---HHHHHH---HH-cCCc-c-CC----CCC
Confidence 2345789999999999999999999999999999999999999754221 111111 11 1111 0 00 111
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCChhHHH
Q 005236 628 NLAEVIRCIHIGLLCVQQYPEDRPCMPSVI 657 (706)
Q Consensus 628 ~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~ 657 (706)
...+.+++..||+.+|.+||++.+.+
T Consensus 220 ----~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 220 ----SLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred ----CHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 12455788899999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.91 Aligned_cols=263 Identities=25% Similarity=0.381 Sum_probs=201.5
Q ss_pred cCCCccceeccCCceeEEEEEe-----CCCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC--Cee
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-----ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--EEK 458 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 458 (706)
..|++.+.||+|+||.||+++. ..+..||+|.+... .....+.+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3578889999999999999974 34778999998654 344457899999999999999999999998875 567
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 89999999999999985432 35799999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCc-ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC--------CCchhHHHHHHHH
Q 005236 539 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHS--------DNKLNLIRHAWKL 609 (706)
Q Consensus 539 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~--------~~~~~~~~~~~~~ 609 (706)
+...... .......++..|+|||++.+..++.++||||||+++|||++++.|...... .............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433221 112234567789999999988999999999999999999998766321100 0000011111111
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 610 WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 610 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
...+......+ . ....+.+++.+||+.+|.+||+++++++.|+.+
T Consensus 239 ~~~~~~~~~~~-----~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRLPRPP-----N----CPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccCCCCC-----C----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111111110 1 123577899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=331.07 Aligned_cols=260 Identities=19% Similarity=0.287 Sum_probs=190.4
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC--------C
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--------E 456 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 456 (706)
..+|++.++||+|+||.||+|+.. .++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999985 57899999885422 2345799999999999999999887532 2
Q ss_pred eeEEEEecCCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-CeEEeeec
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQ-ERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFG 534 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg 534 (706)
..++||||+++ +|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 45689999985 677666432 23356889999999999999999999988 99999999999999665 79999999
Q ss_pred cccccCCCCCcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC
Q 005236 535 LARAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG 613 (706)
Q Consensus 535 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 613 (706)
+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||...... ..+....+.....
T Consensus 217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~---~~~~~i~~~~~~p 290 (440)
T PTZ00036 217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV---DQLVRIIQVLGTP 290 (440)
T ss_pred cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCC
Confidence 998764322 12235689999999998764 6899999999999999999999998543321 2222221111111
Q ss_pred CC---------------cccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 614 MP---------------SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 614 ~~---------------~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.. ..+....+...+.......+.+++.+||+.+|.+|||+.|+++.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 00000000000000112356789999999999999999999843
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.98 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=196.3
Q ss_pred CCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 389 FSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
|++.+.||+|+||.||++... .++.||+|.+.... ....+.+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677799999999999999985 57899999886432 22345677899999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999886433 234888999999999999999999887 99999999999999999999999999876532221
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||..................... .. .
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~-----~ 225 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE----EY-----S 225 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh----hc-----C
Confidence 12246899999999999999999999999999999999999998643222111111111111110 00 0
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCC-----hhHHHH
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPC-----MPSVIL 658 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~ev~~ 658 (706)
.... ..+.+++..||+.+|++||| ++|+++
T Consensus 226 ~~~~----~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 EKFS----PDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ccCC----HHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1111 23567888999999999999 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=339.68 Aligned_cols=260 Identities=20% Similarity=0.266 Sum_probs=200.2
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.++||+|+||.||+|+.. .++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999985 4889999998652 2334567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeec
Q 005236 463 EFMPNKSLDSFIFDQE--------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 534 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 534 (706)
||+++++|.+++.... .....++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 1223567788899999999999999987 9999999999999999999999999
Q ss_pred cccccCCCCC----------------cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 005236 535 LARAFGGDET----------------EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 598 (706)
Q Consensus 535 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~ 598 (706)
+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 001123469999999999999999999999999999999999999985422111
Q ss_pred chhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCC-ChhHHHHHhcCC
Q 005236 599 KLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP-CMPSVILMLGSE 663 (706)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-t~~ev~~~L~~~ 663 (706)
+... .... .+.... + ... ....+.+++.+||+.+|.+|| +++++++.|+..
T Consensus 239 ----i~~~-~~i~--~P~~~~-p--~~~----iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ----ISYR-DVIL--SPIEVA-P--YRE----IPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ----hhhh-hhcc--Chhhcc-c--ccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1000 0000 000000 0 001 112356788999999999995 667777776644
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=312.69 Aligned_cols=255 Identities=28% Similarity=0.442 Sum_probs=199.1
Q ss_pred cCCCccceeccCCceeEEEEEeCC-Cc--EEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQ--EIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 461 (706)
++|++.+.||+|+||.||+|.+.. +. .+++|.+... .......+.+|+.++.++ +||||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 578899999999999999999743 43 4678877543 344567889999999999 899999999999999999999
Q ss_pred EecCCCCChhhhhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCe
Q 005236 462 YEFMPNKSLDSFIFDQE-------------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 528 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 528 (706)
|||+++++|.+++.... ....+++..++.++.||++||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999996542 1235789999999999999999999887 9999999999999999999
Q ss_pred EEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHH
Q 005236 529 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAW 607 (706)
Q Consensus 529 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 607 (706)
||+|||+++.... ........++..|+|||++.+..++.++||||||+++|||+| |..||...... .....
T Consensus 164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~-- 235 (303)
T cd05088 164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEK-- 235 (303)
T ss_pred EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHHH--
Confidence 9999999864211 111112234678999999988889999999999999999998 99987532221 11111
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 608 KLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 608 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.......... ... ...+.+++.+||+.+|.+||+++++++.|+..
T Consensus 236 --~~~~~~~~~~-----~~~----~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 236 --LPQGYRLEKP-----LNC----DDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred --HhcCCcCCCC-----CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111110000 011 12456799999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=324.70 Aligned_cols=202 Identities=26% Similarity=0.360 Sum_probs=174.0
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.+.||+|+||.||+++.. .++.||||++... .....+.+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999985 4889999998643 2334567888999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999998643 34788899999999999999999988 999999999999999999999999998754321
Q ss_pred CCc---------------------------------ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 005236 543 ETE---------------------------------GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 589 (706)
Q Consensus 543 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~ 589 (706)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00113469999999999999999999999999999999999999
Q ss_pred CCCCC
Q 005236 590 NRGFY 594 (706)
Q Consensus 590 p~~~~ 594 (706)
||...
T Consensus 235 Pf~~~ 239 (360)
T cd05627 235 PFCSE 239 (360)
T ss_pred CCCCC
Confidence 98643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.61 Aligned_cols=246 Identities=25% Similarity=0.339 Sum_probs=193.3
Q ss_pred CCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 389 FSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
|+..+.||+|+||+||+|... +++.+|+|.+.... ......+.+|+.++++++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999884 58899999986532 22345678899999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 99999998886543 235899999999999999999999987 9999999999999999999999999997643221
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
......|+..|+|||++.+..++.++|+||||+++|||++|+.||...........+ ......... .+ .
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~---~~~~~~~~~--~~----~ 225 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV---DRRVLETEE--VY----S 225 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhhhcccc--cc----C
Confidence 112346899999999999999999999999999999999999998643221111111 111111110 00 1
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChh
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMP 654 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ 654 (706)
...+ ..+.+++..||+.+|++||++.
T Consensus 226 ~~~~----~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 226 AKFS----EEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred ccCC----HHHHHHHHHHccCCHhHcCCCc
Confidence 1111 2346788899999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.25 Aligned_cols=263 Identities=28% Similarity=0.421 Sum_probs=203.8
Q ss_pred cCCCccceeccCCceeEEEEEeC-----CCcEEEEEEcCccchh-hHHHHHHHHHHHhhcCCcceeeeEeEEEe--CCee
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-----DEQEIAVKRLSKISEQ-GLKELKNEIILFSKLQHRNLVKLLGCCIH--GEEK 458 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 458 (706)
++|++.+.||+|+||.||+|+.. .++.+|||.+...... ..+.+.+|+.+++.++||||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999863 3678999998764432 56789999999999999999999999887 5578
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999996543 25889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCCc-ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCch--------hHHHHHHHH
Q 005236 539 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKL--------NLIRHAWKL 609 (706)
Q Consensus 539 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~--------~~~~~~~~~ 609 (706)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6532221 1122234566799999999889999999999999999999999886432211100 001111111
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 610 WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 610 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
......... .......+.+++.+||+.+|.+||||.||+++|+.+
T Consensus 239 ~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPR---------PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCC---------CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111000 011124577899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.64 Aligned_cols=240 Identities=22% Similarity=0.371 Sum_probs=188.0
Q ss_pred ceeccCCceeEEEEEeCC-------------CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeE
Q 005236 393 KKLGEGGFGPVYKGTLAD-------------EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 459 (706)
+.||+|+||.||+|+... ...|++|.+........+.+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358899887655556678889999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC-------eEEee
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-------PKISD 532 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-------~kl~D 532 (706)
+||||+++++|..++.... ..+++..+++++.||++||+|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999999885432 35788999999999999999999987 999999999999987664 89999
Q ss_pred eccccccCCCCCcccccccccccCccCccccc-cCCCCcchhhHHHHHHHHHHH-hCCCCCCCCCCCCchhHHHHHHHHh
Q 005236 533 FGLARAFGGDETEGNTNRVVGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIV-SGKKNRGFYHSDNKLNLIRHAWKLW 610 (706)
Q Consensus 533 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDv~SlGvil~ell-tG~~p~~~~~~~~~~~~~~~~~~~~ 610 (706)
||++...... ....++..|+|||.+. ...++.++||||||+++|||+ +|+.|+......+ .. ...
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~~---~~~ 222 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE----KE---RFY 222 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH----HH---HHH
Confidence 9998764221 2245788999999987 467899999999999999998 5777754321111 11 111
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 611 NEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 611 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
.. .. ....+ ....+.+++..||+.||.+||++.+|++.|+
T Consensus 223 ~~-~~-~~~~~---------~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EG-QC-MLVTP---------SCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hc-Cc-cCCCC---------ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 11 10 01110 1234567899999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=302.32 Aligned_cols=252 Identities=27% Similarity=0.395 Sum_probs=199.3
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc-----hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS-----EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
++|.+.+.||+|++|.||++... .++.+++|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999874 58899999875421 2234578899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999998543 34788888999999999999999988 9999999999999999999999999998653
Q ss_pred CCCCccc-ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 541 GDETEGN-TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 541 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
....... .....++..|+|||++.+..++.++||||||+++|||++|+.||.... ..... ...........+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~---~~~~~~~~~~~~- 228 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE---AMAAI---FKIATQPTNPQL- 228 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc---hHHHH---HHHhccCCCCCC-
Confidence 3211111 123457889999999999999999999999999999999999974321 11111 111111111111
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.... ...+.+++..||+.+|.+|||+.++++.
T Consensus 229 ----~~~~----~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 229 ----PSHV----SPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CccC----CHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111 1245678899999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=300.08 Aligned_cols=253 Identities=25% Similarity=0.274 Sum_probs=204.5
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.+.||.|.-|+||++.+.+ +...|+|++.+. ..+...+.+.|.+||+.++||.|+.||+.++.+...++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 567888999999999999999966 588999999764 3444567788999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC-
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG- 541 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~- 541 (706)
|||+||+|..+++.+. .+.+++..+..+|.+++.||+|||-.| ||.|||||+||||.++|++-|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999886554 466888899999999999999999988 99999999999999999999999999754310
Q ss_pred -------C------------------------C-C---------------------cccccccccccCccCccccccCCC
Q 005236 542 -------D------------------------E-T---------------------EGNTNRVVGTYGYMAPEYASDGQF 568 (706)
Q Consensus 542 -------~------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 568 (706)
+ . . ....+..+||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 0 011223579999999999999999
Q ss_pred CcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCC
Q 005236 569 SVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPE 648 (706)
Q Consensus 569 s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 648 (706)
+.++|.|+|||+|||||.|+.||......+....+... +....+ ...-...+.+||...|..||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----~l~Fp~----------~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----PLKFPE----------EPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----CCcCCC----------CCcchhHHHHHHHHHhccChh
Confidence 99999999999999999999999776655443332210 111110 112233566889999999999
Q ss_pred CCCC----hhHHHH
Q 005236 649 DRPC----MPSVIL 658 (706)
Q Consensus 649 ~RPt----~~ev~~ 658 (706)
+|-. +.||-+
T Consensus 378 kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKR 391 (459)
T ss_pred hhhccccchHHhhc
Confidence 9998 777754
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=315.63 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=208.0
Q ss_pred hccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccch---hhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCeeE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISE---QGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 459 (706)
..+.|++.+.||+|.||.||+++.+. |+.+|+|.+.+... ...+.+.+|+.+|+++. |||||.+++.+++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 44689999999999999999999866 99999999976433 34568999999999998 999999999999999999
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC----CCeEEeeecc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISDFGL 535 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~----~~~kl~Dfgl 535 (706)
+|||++.||.|.+.|... .+++.....++.|++.+++|||+.+ ++||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999765 2899999999999999999999988 9999999999999643 4799999999
Q ss_pred ccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||...........+ ..+..
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i-------~~~~~ 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI-------LRGDF 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH-------HcCCC
Confidence 998754 33445689999999999999999999999999999999999999998654433322211 11111
Q ss_pred cccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 616 SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 616 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
++.++.+.. -...+.+++..|+..||.+|+|+.++++.
T Consensus 256 -~f~~~~w~~-----is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -DFTSEPWDD-----ISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -CCCCCCccc-----cCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 111111111 12345678899999999999999999994
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.47 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=188.1
Q ss_pred ceeccCCceeEEEEEeCC---CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCC
Q 005236 393 KKLGEGGFGPVYKGTLAD---EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 468 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 468 (706)
++||+|+||.||+|...+ ...+++|.+... .......+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997643 346888887543 3344567889999999999999999999999999999999999999
Q ss_pred Chhhhhhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 469 SLDSFIFDQER--CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 469 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 233567788899999999999999987 9999999999999999999999999987643322222
Q ss_pred cccccccccCccCcccccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 547 NTNRVVGTYGYMAPEYASD-------GQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~-------~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
......++..|+|||++.. ..++.++||||||+++|||++ |..|+..... ....... .... ...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~---~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD---EQVLKQV---VREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHH---hhcc-CccC
Confidence 2233446778999998743 356889999999999999999 6777643221 1111111 1111 1111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
..+.+....+ ..+.+++..|+ .+|.+|||+++|+++|.
T Consensus 231 ~~~~~~~~~~----~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDLKYS----DRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccccCC----HHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1222211222 22345666787 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=300.47 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=193.2
Q ss_pred eeccCCceeEEEEEeC---CCcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCC
Q 005236 394 KLGEGGFGPVYKGTLA---DEQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKS 469 (706)
Q Consensus 394 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 469 (706)
.||+|+||.||+|.+. .+..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 34569999986543 344567999999999999999999999875 457899999999999
Q ss_pred hhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc-cc
Q 005236 470 LDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG-NT 548 (706)
Q Consensus 470 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~-~~ 548 (706)
|.+++... ...+++..+++++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+....... ..
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99998643 245889999999999999999999987 9999999999999999999999999998654332211 11
Q ss_pred cccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcC
Q 005236 549 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSF 627 (706)
Q Consensus 549 ~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 627 (706)
....++..|+|||.+....++.++||||||+++|||++ |+.||...... ... .....+..... +
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~~~~~~~-~------- 220 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVM----SFIEQGKRLDC-P------- 220 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHH----HHHHCCCCCCC-C-------
Confidence 11234578999999988889999999999999999996 99997543221 111 11111111111 0
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 628 NLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 628 ~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
......+.+++..||+.+|++||++.+|++.|+..
T Consensus 221 -~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 -AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11123556789999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=300.91 Aligned_cols=249 Identities=26% Similarity=0.384 Sum_probs=197.4
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEE-eCCeeEEEEecC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCI-HGEEKLLIYEFM 465 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~~ 465 (706)
++|.+.+.||+|+||.||++... +..+++|.+.... ..+.+.+|+.++++++|+|++++++++. +++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 57889999999999999999875 6789999886432 3467889999999999999999999765 456789999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999986533 245889999999999999999999987 9999999999999999999999999988643221
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
....++..|+|||++....++.++||||||+++|||++ |+.|+..... ...... ..........+
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~~~~~~---- 222 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR----VEKGYKMDAPD---- 222 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HhcCCCCCCCC----
Confidence 12334668999999999899999999999999999998 8888643211 111111 11111111111
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
. ....+.+++.+|++.+|.+|||+.++++.|+.+
T Consensus 223 -~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 223 -G----CPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -C----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1 123456789999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.45 Aligned_cols=248 Identities=29% Similarity=0.439 Sum_probs=197.0
Q ss_pred ceeccCCceeEEEEEeCCCcEEEEEEcCccch-hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCChh
Q 005236 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSKISE-QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLD 471 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 471 (706)
++||+|+||.||++.+.+++.|++|++..... ...+.+.+|+.++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999987799999999865433 35678999999999999999999999999999999999999999999
Q ss_pred hhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccccccc
Q 005236 472 SFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 551 (706)
Q Consensus 472 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 551 (706)
+++.... ..+++..++.++.+++.+|.|||+.+ ++||||+|+||+++.++.+||+|||+++..............
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9986532 35788899999999999999999987 999999999999999999999999999865422211111222
Q ss_pred ccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHH
Q 005236 552 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLA 630 (706)
Q Consensus 552 ~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 630 (706)
..+..|+|||.+.+..++.++||||||+++|||++ |..|+....... .... ......... ...
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~----~~~~~~~~~---------~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRER----IESGYRMPA---------PQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHH----HhcCCCCCC---------Ccc
Confidence 34667999999988899999999999999999999 777764432211 1111 111110000 001
Q ss_pred HHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 631 EVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 631 ~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
....+.+++.+|++.+|.+||++.||++.|.
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1235678999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=303.79 Aligned_cols=249 Identities=29% Similarity=0.440 Sum_probs=193.7
Q ss_pred ceeccCCceeEEEEEeCC-Cc--EEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLAD-EQ--EIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
+.||+|+||.||+|++.+ +. .+++|.+... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999854 33 4688888653 345567889999999999 799999999999999999999999999
Q ss_pred CChhhhhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeec
Q 005236 468 KSLDSFIFDQE-------------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 534 (706)
Q Consensus 468 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 534 (706)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999996532 1234788999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcC
Q 005236 535 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEG 613 (706)
Q Consensus 535 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 613 (706)
++..... .........+..|+|||++....++.++||||||+++|||++ |..||...... ..... ....
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~----~~~~ 227 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEK----LPQG 227 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHHH----HhCC
Confidence 9863211 111111234567999999988899999999999999999997 99987432211 11111 1111
Q ss_pred CCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 614 MPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 614 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
...+... . ....+.+++.+|++.+|.+|||+.++++.|+.+
T Consensus 228 ~~~~~~~-----~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YRLEKPL-----N----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCCCCCC-----c----CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 1111100 1 112466899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.99 Aligned_cols=251 Identities=23% Similarity=0.393 Sum_probs=201.6
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
..+|++.+.||+|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.+.||||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35899999999999999999987 45889999998765555567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999999853 24788899999999999999999988 99999999999999999999999999886532221
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
......+++.|+|||.+.+..++.++|||||||++|||++|+.||...... .... ........ .+..
T Consensus 172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~---~~~~---~~~~~~~~-~~~~---- 238 (296)
T cd06654 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALY---LIATNGTP-ELQN---- 238 (296)
T ss_pred --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH---HhHH---HHhcCCCC-CCCC----
Confidence 122346889999999999888999999999999999999999998543221 1111 11111111 1000
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
...-...+.+++.+||+.+|++||++.|+++.
T Consensus 239 ---~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 ---PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ---ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00111245678899999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.01 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=199.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
++|++.+.||+|+||.||+++.. .++.||+|.+... .....+.+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46889999999999999999985 6889999988643 444467889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|..++........+++..+..++.||+.||.|||+.. +++|+||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999999865433446899999999999999999999742 3999999999999999999999999999765322
Q ss_pred cccccccccccCccCccccccC------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDG------QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||....... .... ...........+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~-~~~~~~~~~~~~ 230 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQ-LSAIVDGDPPTL 230 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHH-HHHHhhcCCCCC
Confidence 12224578899999998554 35889999999999999999999975422211 1111 111111111111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.. .....+.+++.+||+.+|.+||++++++..
T Consensus 231 ~~---------~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 231 PS---------GYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred Cc---------ccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11 112345678899999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=304.59 Aligned_cols=252 Identities=27% Similarity=0.465 Sum_probs=200.5
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
.+|++.+.||+|+||.||+|.+.++..+|+|++.... .....+.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4688889999999999999998778899999886432 234578899999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+++|.+++.... ..+++..+..++.|++.+|+|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 999999986433 34788999999999999999999987 999999999999999999999999999865432211
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......++.+|+|||.+.+..++.++||||||+++|||++ |+.|+..... ....... ..... ...+..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~----~~~~~--~~~~~~-- 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETI----NAGFR--LYKPRL-- 225 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHH----hCCCC--CCCCCC--
Confidence 1112235678999999998899999999999999999998 8888753221 1111111 11100 001100
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
....+.+++.+||+.+|.+||++.||++.|.
T Consensus 226 -----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 -----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1235778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.35 Aligned_cols=201 Identities=24% Similarity=0.335 Sum_probs=172.6
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|.+.++||+|+||.||+++.. .++.||+|.+.+. .....+.+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999985 4778999998652 2233456788999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999996532 35788889999999999999999988 999999999999999999999999999876433
Q ss_pred CCcccccccccccCccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGKKNRGF 593 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~SlGvil~elltG~~p~~~ 593 (706)
... ......||+.|+|||++.+ ..++.++||||||++||||++|+.||..
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 221 1223568999999999875 4678999999999999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.35 Aligned_cols=193 Identities=23% Similarity=0.330 Sum_probs=164.5
Q ss_pred HhccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
....+|++.+.||+|+||.||+|+... ++.||+|..... ....|+.++++++||||+++++++.+....++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 344689999999999999999999854 678899975432 2356899999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 5888887543 345889999999999999999999988 999999999999999999999999999753221
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNR 591 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~ 591 (706)
.......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1222356899999999999999999999999999999999976554
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.21 Aligned_cols=239 Identities=23% Similarity=0.320 Sum_probs=186.1
Q ss_pred eeccCCceeEEEEEeCC-------------------------CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeee
Q 005236 394 KLGEGGFGPVYKGTLAD-------------------------EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKL 448 (706)
Q Consensus 394 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 448 (706)
.||+|+||.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13588998866555555678899999999999999999
Q ss_pred EeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC--
Q 005236 449 LGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-- 526 (706)
Q Consensus 449 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-- 526 (706)
++++.+....++||||+++|+|..++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999998543 245788999999999999999999887 99999999999998654
Q ss_pred -----CeEEeeeccccccCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHH-hCCCCCCCCCCCCc
Q 005236 527 -----NPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIV-SGKKNRGFYHSDNK 599 (706)
Q Consensus 527 -----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~ell-tG~~p~~~~~~~~~ 599 (706)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3899999998653211 12356788999998865 56899999999999999995 68888754322111
Q ss_pred hhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 600 LNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
...... ...... .. ...+.+++..||+.+|.+||++++|++.|.
T Consensus 231 ---~~~~~~---~~~~~~--------~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ---ERFYEK---KHRLPE--------PS----CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHHHh---ccCCCC--------CC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111000 000000 00 124667899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=299.64 Aligned_cols=248 Identities=33% Similarity=0.475 Sum_probs=195.0
Q ss_pred ceeccCCceeEEEEEeCC----CcEEEEEEcCccch-hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLAD----EQEIAVKRLSKISE-QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
++||+|+||.||+|+... +..+|+|.+..... ...+.+.+|+.+++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997632 26899999875433 34568899999999999999999999875 5678999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc-
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG- 546 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~- 546 (706)
++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999996543 5789999999999999999999987 9999999999999999999999999998764332211
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......++..|+|||.+....++.++||||||+++|||++ |+.||..... ........ ........ .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~----~~~~~~~~-----~ 221 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE----SGERLPRP-----E 221 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH----cCCcCCCC-----C
Confidence 1111234568999999999999999999999999999998 8998754322 12222211 11111110 0
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.. ...+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 222 ~~----~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 222 EC----PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11 13566899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=300.81 Aligned_cols=254 Identities=31% Similarity=0.463 Sum_probs=202.3
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
.++|.+.++||+|+||.||++...++..+++|.+... ....+.+.+|+.++++++|+||+++++.+.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4688999999999999999999888888999988653 3345678899999999999999999999887 7789999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999996543 345788899999999999999999887 999999999999999999999999999876432211
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
......++..|+|||++....++.++|+||||+++|+|++ |+.||..... ...... ..........
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~----~~~~~~~~~~----- 225 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRA----LERGYRMPRP----- 225 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHH----HhCCCCCCCc-----
Confidence 1122345678999999998899999999999999999999 8888753221 111111 1111111111
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
. .....+.+++.+|++.+|++||++.+|.++|+.
T Consensus 226 ~----~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 E----NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred c----cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1 112346688999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=318.51 Aligned_cols=242 Identities=24% Similarity=0.295 Sum_probs=186.0
Q ss_pred ceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHH-HHHhhcCCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEI-ILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
+.||+|+||.||+++.. +++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999985 46789999986432 12233444444 456789999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
++|.+++... ..+....+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 9999998643 34677788889999999999999988 9999999999999999999999999997542211 12
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcC
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSF 627 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 627 (706)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....... ... .. .+ . ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i---~~~-~~-~~-~----~~~ 219 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNI---LNK-PL-QL-K----PNI 219 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---HHHHHHH---HhC-Cc-CC-C----CCC
Confidence 3345799999999999999999999999999999999999999853221 1111111 111 10 00 0 011
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 628 NLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 628 ~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
...+.+++..||+.+|.+||++.+.+..
T Consensus 220 ----~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 220 ----TNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred ----CHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 1235578889999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=308.81 Aligned_cols=262 Identities=24% Similarity=0.341 Sum_probs=196.6
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+|++.+.||+|++|.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999985 5889999998643 223346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
++ ++|.+++........+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 688888865544466899999999999999999999987 9999999999999999999999999998653221
Q ss_pred cccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC---C------
Q 005236 545 EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG---M------ 614 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~------ 614 (706)
.......+++.|+|||++.+. .++.++||||||+++|||++|+.||........ .. .....+... .
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LF-RIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HH-HHHHHhCCCChhhhhcchh
Confidence 111223568899999988654 578999999999999999999999754322111 10 000000000 0
Q ss_pred -------CcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 615 -------PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 615 -------~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
........+.... ..-..++.+++.+||+.||.+|||+.+|+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAV-KNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hHHHHhhccccCcchhHHhc-CCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000000 0011245689999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=315.47 Aligned_cols=237 Identities=23% Similarity=0.276 Sum_probs=184.5
Q ss_pred ceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHH-HHhhcCCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEII-LFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
++||+|+||.||+|+.. +++.||+|++.+.. ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999985 57889999986432 222344555554 67889999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET 152 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence 9999888543 34778888899999999999999987 999999999999999999999999998753221 112
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcC
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSF 627 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 627 (706)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...... .. .... .+. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~---i~-~~~~-~~~-----~~- 218 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQMYDN---IL-HKPL-QLP-----GG- 218 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HHHHHH---Hh-cCCC-CCC-----CC-
Confidence 2345789999999999999999999999999999999999999754221 111111 11 1111 110 01
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCChh
Q 005236 628 NLAEVIRCIHIGLLCVQQYPEDRPCMP 654 (706)
Q Consensus 628 ~~~~~~~~~~l~~~cl~~~p~~RPt~~ 654 (706)
....+.+++.+||+.+|.+||+..
T Consensus 219 ---~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 ---KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---CCHHHHHHHHHHccCCHhhcCCCC
Confidence 122466789999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.92 Aligned_cols=263 Identities=23% Similarity=0.267 Sum_probs=194.7
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC-----
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE----- 456 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 456 (706)
..++|++.+.||+|+||.||+++.. .++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999874 4889999998642 3344567889999999999999999999986543
Q ss_pred -eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecc
Q 005236 457 -EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 535 (706)
Q Consensus 457 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgl 535 (706)
..++||||+++ +|...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999976 4555552 23678888999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHH-----------
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIR----------- 604 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~----------- 604 (706)
++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 97643221 2233568999999999999999999999999999999999999986432211100000
Q ss_pred -H----HHHHhhc-CCC-----cccccccccC---cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 605 -H----AWKLWNE-GMP-----SQLIDACFKD---SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 605 -~----~~~~~~~-~~~-----~~~~d~~~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. ....... ... .++....... .........+.+++.+||+.||++|||+.|++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 0000000 000 0000000000 0000112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=302.82 Aligned_cols=238 Identities=24% Similarity=0.408 Sum_probs=188.4
Q ss_pred ceeccCCceeEEEEEeCCCc-----------EEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 393 KKLGEGGFGPVYKGTLADEQ-----------EIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999986533 4778877544333 6788999999999999999999999988 778999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-------CeEEeeec
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-------NPKISDFG 534 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-------~~kl~Dfg 534 (706)
|||+++++|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999965432 5788999999999999999999887 99999999999999888 79999999
Q ss_pred cccccCCCCCcccccccccccCccCccccccC--CCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCCchhHHHHHHHHhh
Q 005236 535 LARAFGGDETEGNTNRVVGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIVSG-KKNRGFYHSDNKLNLIRHAWKLWN 611 (706)
Q Consensus 535 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDv~SlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~ 611 (706)
++..... .....++..|+|||++... .++.++||||||+++|||++| ..|+....... .... +.
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~----~~ 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERF----YQ 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHH----Hh
Confidence 9986532 1224567789999999876 789999999999999999995 66654332111 1111 11
Q ss_pred cCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 612 EGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 612 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
...... .+ ....+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 221 ~~~~~~--~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQHRLP--MP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCCCCC--CC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 110000 00 0146678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=305.73 Aligned_cols=253 Identities=23% Similarity=0.388 Sum_probs=199.2
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
++|.+.++||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 57888899999999999999874 58889999987655555667889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 999999998543 35789999999999999999999988 9999999999999999999999999987653221
Q ss_pred ccccccccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 546 GNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
.......|+..|+|||++. ...++.++|||||||++|||++|+.|+........ .. .......... .
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~---~~---~~~~~~~~~~----~ 230 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LF---LMTKSNFQPP----K 230 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh---HH---hhhccCCCCC----c
Confidence 1223356899999999974 45688999999999999999999999743222111 10 0000111101 0
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
+...... ...+.+++.+||+.+|++||++++|++.
T Consensus 231 ~~~~~~~--~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 LKDKMKW--SNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccccCCC--CHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 1110010 1245678999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.26 Aligned_cols=261 Identities=21% Similarity=0.312 Sum_probs=196.0
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
++|.+.++||+|+||.||+|+.. .++.||+|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 67999999999999999999885 57889999986432 23345677899999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
++ ++|.+++.... ..+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 58888885432 34788899999999999999999987 99999999999999999999999999976432211
Q ss_pred cccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhc---CCCccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNE---GMPSQLID 620 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d 620 (706)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...... ............ .....+.+
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCChhhchhhhc
Confidence 11224568899999998654 5788999999999999999999998643322 111111111110 00000000
Q ss_pred ---------ccccCc----CCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 621 ---------ACFKDS----FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 621 ---------~~~~~~----~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+..... ........+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 00001124568999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=304.35 Aligned_cols=253 Identities=28% Similarity=0.410 Sum_probs=201.1
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
.+.|++.++||+|+||.||+|+... ++.+++|.+........+.+.+|+.+++.++||||+++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 3679999999999999999999854 789999999877777778899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|..++.+.. ..+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 91 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-- 163 (292)
T cd06644 91 CPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-- 163 (292)
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence 99999998875433 35889999999999999999999887 999999999999999999999999998764221
Q ss_pred cccccccccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 545 EGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
........++..|+|||++. ...++.++|||||||++|||++|+.|+..... ... ..... ........
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~---~~~~~-~~~~~~~~ 236 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRV---LLKIA-KSEPPTLS 236 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH---HHH---HHHHh-cCCCccCC
Confidence 11223356788999999985 34578899999999999999999999754321 111 11111 11111110
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. ... ....+.+++.+||+.+|++||+++++++.
T Consensus 237 ~---~~~----~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 237 Q---PSK----WSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred C---Ccc----cCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 001 11245678899999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=301.02 Aligned_cols=250 Identities=28% Similarity=0.424 Sum_probs=190.8
Q ss_pred ceeccCCceeEEEEEeCC----CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEe-CCeeEEEEecCC
Q 005236 393 KKLGEGGFGPVYKGTLAD----EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIH-GEEKLLIYEFMP 466 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~~ 466 (706)
+.||+|+||.||+|.+.+ ...+|+|++... .....+.+.+|+.+++.++||||+++++++.. +...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998632 357999998543 34456788899999999999999999998764 456789999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc-
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE- 545 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~- 545 (706)
+++|.+++.... ..+++..++.++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||+++.+......
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999996432 33677788899999999999999887 999999999999999999999999999865332111
Q ss_pred -ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 546 -GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK-KNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 546 -~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
.......++..|+|||.+....++.++||||||+++|||++|. +|+... ........ ........ . .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~---~~~~~~~~---~~~~~~~~-~-~--- 224 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---DSFDITVY---LLQGRRLL-Q-P--- 224 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHH---HhcCCCCC-C-C---
Confidence 1112234577899999998889999999999999999999965 444321 11222211 11111110 0 0
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
... ...+.+++..||+.+|++||++.||++.|+..
T Consensus 225 -~~~----~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 225 -EYC----PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred -CcC----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 001 12466899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.97 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=201.6
Q ss_pred cCCCccceeccCCceeEEEEEeCC-Cc----EEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQ----EIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
++|++.+.||+|+||.||+|..++ +. .+|+|.+.... .....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 578888999999999999998743 32 58999886543 4456788999999999999999999999987 78899
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 999999999999996543 34889999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
............++..|+|||.+....++.++||||||+++|||++ |+.|+...... +... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~~~- 232 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPD----LLEKGERLPQ- 232 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHH----HHhCCCCCCC-
Confidence 3322222222334678999999988899999999999999999999 99997543221 1111 1111111000
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
+ .. ....+.+++..||..+|.+||++.++++.|....
T Consensus 233 -~---~~----~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 233 -P---PI----CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred -C---CC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 00 1124567889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=315.11 Aligned_cols=241 Identities=24% Similarity=0.317 Sum_probs=190.4
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCeeEEEE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 462 (706)
+|.+.+.||+|+||.||+++.. +++.||+|++.+. .....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999975 5889999998653 2234466778888888885 577888999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 999999999998543 34889999999999999999999988 999999999999999999999999998754222
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .... .+.
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~----~~~~-~~p--- 221 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSIM----EHNV-SYP--- 221 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHH----hCCC-CCC---
Confidence 1 122335689999999999999999999999999999999999999854322 11111111 1111 000
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCCh
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCM 653 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 653 (706)
... ...+.+++.+||+.+|.+|++.
T Consensus 222 --~~~----~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 --KSL----SKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --ccC----CHHHHHHHHHHcccCHhhCCCC
Confidence 011 1245678899999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=300.74 Aligned_cols=249 Identities=28% Similarity=0.444 Sum_probs=201.1
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
++|++.+.||+|+||.||+|...+ ++.+++|.+..... .+.+.+|+.++++++||||+++++.+.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 689999999999999999999865 78999999865432 678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999998543 246899999999999999999999987 99999999999999999999999999987643221
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......++..|+|||++.+..++.++||||||+++|||++|+.|+.......... .. .......+ ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~------~~-~~~~~~~~-----~~ 221 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF------MI-PNKPPPTL-----SD 221 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh------hh-ccCCCCCC-----Cc
Confidence 2223457889999999999999999999999999999999999976432211100 00 00000000 00
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.......+.+++.+||+.+|.+|||++||++
T Consensus 222 --~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 222 --PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0011124667889999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=299.85 Aligned_cols=254 Identities=20% Similarity=0.372 Sum_probs=187.5
Q ss_pred ceeccCCceeEEEEEeCCC---cEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCC
Q 005236 393 KKLGEGGFGPVYKGTLADE---QEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNK 468 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 468 (706)
++||+|+||.||+|...++ ..+++|.+... .....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999976443 34667766543 2345678999999999999999999999999999999999999999
Q ss_pred Chhhhhhcccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 469 SLDSFIFDQER-CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 469 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
+|.+++.+... ....++..+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999975432 234667778899999999999999987 99999999999999999999999999864322211122
Q ss_pred ccccccccCccCcccccc-------CCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 548 TNRVVGTYGYMAPEYASD-------GQFSVKSDVFSFGILLLEIVSG-KKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~-------~~~s~~sDv~SlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+.... ........ ..+ ....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~---~~~~~~~~---~~~-~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS---DREVLNHV---IKD-QQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH---Hhh-cccccC
Confidence 223567889999999853 2457899999999999999975 55653221 11222211 111 111222
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
++.+....+ ..+.+++..|+ .+|.+||++++|++.|.
T Consensus 231 ~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222222222 23445777898 57999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.91 Aligned_cols=201 Identities=24% Similarity=0.329 Sum_probs=172.1
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999975 4889999998642 2334566889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999999542 234788899999999999999999988 999999999999999999999999999765432
Q ss_pred CCcccccccccccCccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGKKNRGF 593 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~SlGvil~elltG~~p~~~ 593 (706)
.. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 21 11223468999999999863 4578899999999999999999999753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.25 Aligned_cols=260 Identities=22% Similarity=0.285 Sum_probs=190.9
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhc---CCcceeeeEeEEEeC-----C
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--EQGLKELKNEIILFSKL---QHRNLVKLLGCCIHG-----E 456 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~ 456 (706)
+|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999985 58889999886432 12233456677776655 799999999988642 4
Q ss_pred eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 536 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla 536 (706)
..++||||+++ +|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999985 8888885433 244889999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC---
Q 005236 537 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG--- 613 (706)
Q Consensus 537 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 613 (706)
+...... ......+|..|+|||++.+..++.++|||||||++|||++|++||....... ............
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~ 229 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPED 229 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHHHHHHhCCCChh
Confidence 8754221 1223567899999999999999999999999999999999999975432211 111111111000
Q ss_pred CCc-------ccccccccC---cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 614 MPS-------QLIDACFKD---SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 614 ~~~-------~~~d~~~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
... ....+.... .........+.+++.+||+.||++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 000000000 000011234568999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.70 Aligned_cols=257 Identities=27% Similarity=0.444 Sum_probs=199.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCc----EEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQ----EIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
++|+..+.||+|+||.||+|++. ++. .+|+|.+.... .....++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 56788899999999999999874 333 47888886532 33345788999999999999999999998754 5679
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 999999999999986432 35788899999999999999999987 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~----~~~~~~~~~~~- 232 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIP----DLLEKGERLPQ- 232 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHH----HHHHCCCCCCC-
Confidence 3332222333446778999999999999999999999999999998 8888743221 1111 11111111000
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
... ....+..++..|+..+|++||++.+|++.|+.+..
T Consensus 233 ----~~~----~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 233 ----PPI----CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred ----CCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 001 12346678999999999999999999999987533
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=305.32 Aligned_cols=257 Identities=25% Similarity=0.352 Sum_probs=202.9
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
++|++.++||+|+||.||++... +++.+|+|++... .....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 57888999999999999999975 5788999987543 344467889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++... +.+++..+..++.+++.+|.|||+.. .++|+||+|+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 9999999988543 35889999999999999999999742 2999999999999999999999999998754221
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC-----chhHHHHHHHHhhcCCCcccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN-----KLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 619 (706)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....... .............+. ...+.
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 234 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-PPRLP 234 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-CCCCC
Confidence 1223568999999999988899999999999999999999999987543321 111111111221111 11110
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
. ......+.+++.+|++.+|.+|||++||+++.-
T Consensus 235 ~--------~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 235 S--------SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred c--------hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0 011234667899999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=299.77 Aligned_cols=255 Identities=25% Similarity=0.374 Sum_probs=197.1
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
++.+.....||+|+||.||+|++. ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|+||
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 445555579999999999999975 4778999998776666778899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-CCCeEEeeeccccccCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfgla~~~~~~~ 543 (706)
+++++|.+++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+|||++.......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 999999999965432212377888899999999999999887 999999999999986 6799999999998653322
Q ss_pred CcccccccccccCccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
. ......++..|+|||++... .++.++||||||+++|+|++|+.|+....... .......... ....
T Consensus 164 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~--~~~~---- 232 (268)
T cd06624 164 P--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK--IHPE---- 232 (268)
T ss_pred C--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc--cCCC----
Confidence 1 12224578999999998664 37899999999999999999999975322111 1111000000 0000
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
+.. .....+.+++.+||+.+|.+|||+.|+++.
T Consensus 233 -~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 233 -IPE----SLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -CCc----ccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 011 112346678999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=301.46 Aligned_cols=251 Identities=28% Similarity=0.438 Sum_probs=198.6
Q ss_pred CCCccceeccCCceeEEEEEeCCCcEEEEEEcCccc------hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKIS------EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
+|++.+.||+|+||.||+|...+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999998888999999875321 22345688999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999999653 24788888999999999999999987 99999999999999999999999999986532
Q ss_pred CCC----cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 542 DET----EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 542 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
... ........++..|+|||++.+..++.++||||||+++|||++|+.||..... ......... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~--~~~~~~~ 229 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR---LAAMFYIGA--HRGLMPR 229 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh---HHHHHHhhh--ccCCCCC
Confidence 111 1112234688999999999998999999999999999999999999853221 111111000 0011111
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+ .... ...+.+++.+||+.+|.+||++.|+++
T Consensus 230 ~-----~~~~----~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 230 L-----PDSF----SAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C-----CCCC----CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 1111 234567899999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=298.76 Aligned_cols=250 Identities=23% Similarity=0.348 Sum_probs=200.0
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc-cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
+|++.++||+|+||.||+++.. +++.+|+|.+.. ......+.+.+|+.++++++||||+++++.+..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999985 588899998754 23445678889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++.... ...++...++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 9999999885432 345788899999999999999999988 99999999999999999999999999986533211
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......+++.|+|||++.+..++.++||||||+++|+|++|+.||.... ....... . ..+....+..
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~---~~~~~~~---~-~~~~~~~~~~----- 222 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS---WKNLILK---V-CQGSYKPLPS----- 222 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC---HHHHHHH---H-hcCCCCCCCc-----
Confidence 1223568899999999998899999999999999999999999975322 1111111 1 1111111110
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.. ...+.+++.+||+.+|.+||++.+|+..
T Consensus 223 ~~----~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 HY----SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cc----CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11 1245678899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=305.19 Aligned_cols=252 Identities=26% Similarity=0.389 Sum_probs=198.8
Q ss_pred CCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 388 NFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
.|++.+.||+|+||.||+|.... +..+++|.+........+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 36778999999999999999865 67789998876666667889999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+++|..++.... ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 86 GGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 999998875422 45889999999999999999999987 9999999999999999999999999987653221 1
Q ss_pred cccccccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 547 NTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
......++..|+|||++. ...++.++|||||||++|||++|+.|+..... ........ ... ...+..+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~---~~~-~~~~~~~ 231 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRVLLKIA---KSE-PPTLAQP 231 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHHHHHHh---hcC-CCCCCCc
Confidence 223356889999999984 34678899999999999999999999754221 11111111 111 1111000
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHh
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L 660 (706)
... ...+.+++..||+.+|.+||++.++++.-
T Consensus 232 ---~~~----~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 232 ---SRW----SSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred ---ccc----CHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 011 12456788999999999999999987544
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=305.40 Aligned_cols=240 Identities=25% Similarity=0.423 Sum_probs=188.3
Q ss_pred ceeccCCceeEEEEEeCC--------CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 393 KKLGEGGFGPVYKGTLAD--------EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+.||+|+||.||+|.... ...+++|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999998743 234888887665555667889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC--------eEEeeeccc
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--------PKISDFGLA 536 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~--------~kl~Dfgla 536 (706)
+++|+|..++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999996543 35788899999999999999999987 999999999999988765 699999988
Q ss_pred cccCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCCCchhHHHHHHHHhhcCC
Q 005236 537 RAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGK-KNRGFYHSDNKLNLIRHAWKLWNEGM 614 (706)
Q Consensus 537 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 614 (706)
..... .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+..... ..... .....
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~---~~~~~----~~~~~- 221 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS---QKKLQ----FYEDR- 221 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH---HHHHH----HHHcc-
Confidence 75432 122457889999999986 45899999999999999999995 44332111 11111 11110
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 615 PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 615 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
..+.. . ....+.+++..||+.+|.+|||++++++.|+
T Consensus 222 -~~~~~-----~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -HQLPA-----P----KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -ccCCC-----C----CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01111 0 1134678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=301.74 Aligned_cols=249 Identities=27% Similarity=0.447 Sum_probs=201.6
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
++|++.+.||.|+||.||+|+.. +++.+++|.+.... ......+.+|+.+++.++||||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999985 57899999986532 44456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999998543 5889999999999999999999987 9999999999999999999999999998764322
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
.......++..|+|||++.+..++.++||||||+++|||++|+.|+...... .... .........+...
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~~~~----~~~~~~~~~~~~~--- 221 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---RVLF----LIPKNNPPSLEGN--- 221 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---HHHH----HhhhcCCCCCccc---
Confidence 1223356788999999999989999999999999999999999998543321 1111 1111111111110
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.. ...+.+++..||+.+|++|||++++++.
T Consensus 222 -~~----~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 -KF----SKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -cc----CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 01 1245678889999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=302.52 Aligned_cols=251 Identities=34% Similarity=0.501 Sum_probs=196.0
Q ss_pred ceeccCCceeEEEEEeCC-------CcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 393 KKLGEGGFGPVYKGTLAD-------EQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+.||+|+||.||+|+..+ ++.+++|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999998753 2578999876532 34466889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccc----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-----CeEEeeecc
Q 005236 465 MPNKSLDSFIFDQE----RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-----NPKISDFGL 535 (706)
Q Consensus 465 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-----~~kl~Dfgl 535 (706)
+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 2234788999999999999999999887 99999999999999887 899999999
Q ss_pred ccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCC
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGM 614 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 614 (706)
++.+.............++..|+|||++.+..++.++||||||+++|||++ |+.|+..... ....... ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~----~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHV----TAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHH----hcCC
Confidence 986543322222223345788999999999999999999999999999998 9988753221 1111111 1111
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 615 PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 615 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
..... . .....+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 231 ~~~~~-------~--~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RLQKP-------E--NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ccCCc-------c--cchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 10000 0 112345689999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=314.95 Aligned_cols=258 Identities=29% Similarity=0.457 Sum_probs=205.7
Q ss_pred ceeccCCceeEEEEEeCCC-cEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCChh
Q 005236 393 KKLGEGGFGPVYKGTLADE-QEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLD 471 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 471 (706)
-+||+|.||+||.|++.+. ..+|||.+........+-+.+|+.+-++|+|.|||+++|.+.+++..-+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 3799999999999998664 578999998777777788899999999999999999999999999999999999999999
Q ss_pred hhhhcccccCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc-CCCCeEEeeeccccccCCCCCcccc
Q 005236 472 SFIFDQERCKLL--DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGDETEGNT 548 (706)
Q Consensus 472 ~~l~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~ 548 (706)
++|+.+ .+++ .+.++-.+-.||++||.|||++. |||||||-.||||+ -.|.+||+|||.++.+.. ....+
T Consensus 661 sLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~T 733 (1226)
T KOG4279|consen 661 SLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCT 733 (1226)
T ss_pred HHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCccc
Confidence 999643 3444 67788889999999999999987 99999999999997 568999999999998743 33345
Q ss_pred cccccccCccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCc
Q 005236 549 NRVVGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDS 626 (706)
Q Consensus 549 ~~~~gt~~y~aPE~~~~~--~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 626 (706)
....||..|||||++..+ .|..++|||||||++.||.||++||........ .+++-++.+ ....
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGmyK------vHP~ 799 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGMYK------VHPP 799 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhccee------cCCC
Confidence 567899999999999765 688999999999999999999999854322111 111112211 0112
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH--HhcCCCCCCCCCC
Q 005236 627 FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL--MLGSEIVLPQPKQ 671 (706)
Q Consensus 627 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~--~L~~~~~~~~p~~ 671 (706)
.+.+-..++..++++|+..+|.+||+++++++ +|+--...+.|+.
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~l 846 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKL 846 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCCC
Confidence 23344556778999999999999999999985 3443333344443
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=316.71 Aligned_cols=260 Identities=23% Similarity=0.282 Sum_probs=195.7
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC------
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG------ 455 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 455 (706)
..++|.+.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3478999999999999999999874 4788999998653 334456788999999999999999999987543
Q ss_pred CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecc
Q 005236 456 EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 535 (706)
Q Consensus 456 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgl 535 (706)
...++||||+++ +|.+++.. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999975 66666632 3778888999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhc---
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNE--- 612 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--- 612 (706)
++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 246 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGTPCP 246 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCH
Confidence 98653221 223356899999999999999999999999999999999999998543321 111111111000
Q ss_pred ---------------CCC-------ccccccccc---CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 613 ---------------GMP-------SQLIDACFK---DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 613 ---------------~~~-------~~~~d~~~~---~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
..+ ..+...... ..........+.+++.+||+.||.+|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 000000000 00011112356789999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=319.24 Aligned_cols=260 Identities=25% Similarity=0.290 Sum_probs=195.3
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC------
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG------ 455 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 455 (706)
..++|.+.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999874 5789999998653 333456788899999999999999999988643
Q ss_pred CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecc
Q 005236 456 EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 535 (706)
Q Consensus 456 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgl 535 (706)
...++||||+++ +|.+.+. ..+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 346999999975 5666553 23778888999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh----
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWN---- 611 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---- 611 (706)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 239 (355)
T cd07874 166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTPCP 239 (355)
T ss_pred cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCH
Confidence 9865322 1223357899999999999999999999999999999999999998543211 11111110000
Q ss_pred --------------cCC--C-----ccc-cccccc--CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 612 --------------EGM--P-----SQL-IDACFK--DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 612 --------------~~~--~-----~~~-~d~~~~--~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
... . ... .+.... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 0 000 000000 00001112356789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=306.15 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=201.7
Q ss_pred hccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
...+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 346899999999999999999997 4688999999876555556778999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999999853 34788899999999999999999987 9999999999999999999999999998653322
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
. ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......... .....+.. .+..
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~~~-~~~~--- 237 (297)
T cd06656 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGTP-ELQN--- 237 (297)
T ss_pred c--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCCCC-CCCC---
Confidence 1 1223467889999999999999999999999999999999999985432211100 00001100 0000
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.......+.+++.+||+.+|.+||++++|++
T Consensus 238 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 238 ----PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011123567889999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=296.36 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=202.5
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+|+..+.||+|+||.||.++.. +++.+++|++... .....+.+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999874 5788999987542 445567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++.... ...+++..+..++.|++++|.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999996543 345789999999999999999999987 99999999999999999999999999987643322
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
......+++.|+|||.+.+..++.++||||||+++|||++|+.|+..... ..... ... .+......
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~~~~~---~~~-~~~~~~~~----- 222 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNLVV---KIV-QGNYTPVV----- 222 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHH-cCCCCCCc-----
Confidence 22335689999999999988899999999999999999999999753221 11111 111 11111111
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHh
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L 660 (706)
.. ....+.+++.+||+.+|.+||+++++++.+
T Consensus 223 ~~----~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 SV----YSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cc----cCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11 123466788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=307.39 Aligned_cols=250 Identities=24% Similarity=0.419 Sum_probs=201.0
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
.+|++.+.||.|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4699999999999999999987 568899999986655555678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|..++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 99999998853 24789999999999999999999988 99999999999999999999999999886543322
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||....... .... ..... ...+..+ .
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~---~~~~---~~~~~-~~~~~~~---~ 239 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYL---IATNG-TPELQNP---E 239 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHhcC-CcccCCc---c
Confidence 1223468889999999999899999999999999999999999975432211 1111 11111 1111000 0
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
..+ ..+.+++.+||+.+|.+||++.++++.
T Consensus 240 ~~~----~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 240 KLS----PIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cCC----HHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 111 235578899999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=298.89 Aligned_cols=249 Identities=27% Similarity=0.423 Sum_probs=197.3
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccch---------hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISE---------QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEE 457 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 457 (706)
+|.+...||+|+||.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999874 578899998754321 223578899999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999999543 34788889999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCCCcc----cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC
Q 005236 538 AFGGDETEG----NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG 613 (706)
Q Consensus 538 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 613 (706)
.+....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...+.... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~----~~ 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIFKIG----EN 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH---HHHHHHHh----cc
Confidence 764321111 11224578899999999998999999999999999999999999754221 11111111 11
Q ss_pred CCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 614 MPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 614 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
....+. . .....+.+++.+||+.+|.+||++.||++
T Consensus 228 ~~~~~~-----~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ASPEIP-----S----NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCCcCC-----c----ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111110 1 11234567889999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=302.60 Aligned_cols=256 Identities=27% Similarity=0.416 Sum_probs=201.5
Q ss_pred cCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCccchh-hHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSKISEQ-GLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 459 (706)
++|++.+.||+|+||.||+|+.+ +.+.+++|.+...... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999864 2457899988654433 4678999999999999999999999999989999
Q ss_pred EEEecCCCCChhhhhhccccc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeee
Q 005236 460 LIYEFMPNKSLDSFIFDQERC------KLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 533 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 533 (706)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999654422 25899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhc
Q 005236 534 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNE 612 (706)
Q Consensus 534 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 612 (706)
|+++....... .......++..|+|||.+.+...+.++||||||+++|+|++ |..||..... ...... ...
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~----~~~ 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNR----LQA 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHH----HHc
Confidence 99875432221 12223456788999999988889999999999999999999 7777643221 111111 111
Q ss_pred CCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 613 GMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 613 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
....... .... ...+.+++.+||+.+|.+||++.|+++.|.
T Consensus 234 ~~~~~~~----~~~~----~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELPV----PEGC----PSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCCC----CCCC----CHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111000 0111 125667999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=305.13 Aligned_cols=265 Identities=23% Similarity=0.324 Sum_probs=199.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999986 58899999885432 2234567899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++++|..++... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 99999998877432 34889999999999999999999987 9999999999999999999999999998764332
Q ss_pred CcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH--------HhhcCC
Q 005236 544 TEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWK--------LWNEGM 614 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~--------~~~~~~ 614 (706)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+..... .+....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223457889999999876 5688999999999999999999999864332221111111100 000000
Q ss_pred -CcccccccccCcCCHHH-----HHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 615 -PSQLIDACFKDSFNLAE-----VIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 615 -~~~~~d~~~~~~~~~~~-----~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
......+........+. ...+.+++.+||+.+|++||++.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000011111111111 2356789999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=300.18 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=198.2
Q ss_pred CCccceeccCCceeEEEEEeC----CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC------
Q 005236 389 FSINKKLGEGGFGPVYKGTLA----DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE------ 456 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 456 (706)
|.+.+.||+|+||.||+|.+. .++.||||.+... .....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999863 3678999988653 3445678899999999999999999999886543
Q ss_pred eeEEEEecCCCCChhhhhhccc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeee
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQE---RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 533 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 533 (706)
..++++||+++|+|..++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2378899999999998875322 2234788899999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhc
Q 005236 534 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNE 612 (706)
Q Consensus 534 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 612 (706)
|+++...............+++.|++||.+....++.++||||||+++|||++ |+.|+.... ......... ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~---~~~~~~~~~---~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE---NSEIYNYLI---KG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC---HHHHHHHHH---cC
Confidence 99987643332222223455678999999999999999999999999999999 788864322 111111111 11
Q ss_pred CCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 613 GMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 613 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.... . .......+.+++.+||+.+|.+||++++|++.|+++
T Consensus 232 ~~~~-~---------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRLK-Q---------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcCC-C---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110 0 001123577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=309.70 Aligned_cols=197 Identities=25% Similarity=0.408 Sum_probs=160.6
Q ss_pred cceeccCCceeEEEEEeC---CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEe--CCeeEEEEecCC
Q 005236 392 NKKLGEGGFGPVYKGTLA---DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIH--GEEKLLIYEFMP 466 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~ 466 (706)
.++||+|+||.||+|+.. .++.+|+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999864 45789999986432 23457789999999999999999999864 346789999986
Q ss_pred CCChhhhhhccc------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE----cCCCCeEEeeeccc
Q 005236 467 NKSLDSFIFDQE------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLA 536 (706)
Q Consensus 467 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~~kl~Dfgla 536 (706)
+ +|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 7877774321 2235788899999999999999999988 9999999999999 46678999999999
Q ss_pred cccCCCCC-cccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 005236 537 RAFGGDET-EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFY 594 (706)
Q Consensus 537 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~ 594 (706)
+.+..... ........+|+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87643322 122334678999999999977 46899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=328.94 Aligned_cols=264 Identities=20% Similarity=0.263 Sum_probs=191.6
Q ss_pred HHHhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCC------cceeeeEeEEEe
Q 005236 382 IANATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQH------RNLVKLLGCCIH 454 (706)
Q Consensus 382 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~ 454 (706)
+....++|++.++||+|+||.||+|... .++.||||++.... .....+..|+.++.+++| ++|+++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3345688999999999999999999975 47789999986432 233456667777777654 458899998876
Q ss_pred C-CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEcCCC------
Q 005236 455 G-EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDM------ 526 (706)
Q Consensus 455 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~------ 526 (706)
. .+.++|||++ +++|.+++... ..+++..+..++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 5 4788999988 77888888543 3588899999999999999999974 6 99999999999998765
Q ss_pred ----------CeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 005236 527 ----------NPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHS 596 (706)
Q Consensus 527 ----------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~ 596 (706)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred cccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 49999999886422 122346799999999999999999999999999999999999999865433
Q ss_pred CCchhHHHHHHHH----hhc----CCCccccc------cccc--------C---cCCHHHHHHHHHHHHHhcCCCCCCCC
Q 005236 597 DNKLNLIRHAWKL----WNE----GMPSQLID------ACFK--------D---SFNLAEVIRCIHIGLLCVQQYPEDRP 651 (706)
Q Consensus 597 ~~~~~~~~~~~~~----~~~----~~~~~~~d------~~~~--------~---~~~~~~~~~~~~l~~~cl~~~p~~RP 651 (706)
.+....+...... +.. ....++++ +... . .........+++|+..||+.||.+||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 2222222111000 000 00000000 0000 0 00011123467899999999999999
Q ss_pred ChhHHHH
Q 005236 652 CMPSVIL 658 (706)
Q Consensus 652 t~~ev~~ 658 (706)
|++|+++
T Consensus 431 ta~e~L~ 437 (467)
T PTZ00284 431 NARQMTT 437 (467)
T ss_pred CHHHHhc
Confidence 9999986
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=298.50 Aligned_cols=254 Identities=22% Similarity=0.361 Sum_probs=202.8
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
.++|++.+.||.|+||.||+|... +++.+++|.+........+.+.+|+.++++++||||+++++++..+...+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367899999999999999999985 4778999998766555678899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++... ...++...+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999988653 235788999999999999999999987 99999999999999999999999999986543211
Q ss_pred cccccccccccCccCccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDG---QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
......++..|+|||.+... .++.++||||||+++|||++|+.|+....... .... ..........
T Consensus 157 --~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~---~~~~---~~~~~~~~~~--- 225 (262)
T cd06613 157 --KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR---ALFL---ISKSNFPPPK--- 225 (262)
T ss_pred --ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHhccCCCcc---
Confidence 12234678899999999776 88999999999999999999999975433211 1111 1111000000
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+. ........+.+++.+||+.+|.+|||+++|+.
T Consensus 226 -~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 -LK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -cc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 01112235678999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=295.51 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=198.4
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC-CeeEEEEe
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG-EEKLLIYE 463 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e 463 (706)
+|++.+.||+|++|.||+++.. +++.+|+|++... .....+.+.+|+.++++++|||++++++.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5889999999999999999975 4778999998542 334556789999999999999999999887644 46789999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++++|.+++.... ...+++.++..++.+++.||++||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999996532 345899999999999999999999988 9999999999999999999999999998764322
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
. ......+++.|+|||++.+..++.++||||||++++||++|+.|+..... .... .... .+....+
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---~~~~---~~~~-~~~~~~~----- 222 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---NSLV---YRII-EGKLPPM----- 222 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHH---HHHH-hcCCCCC-----
Confidence 1 22235678999999999999999999999999999999999998753221 1111 1111 1111111
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.. .....+.+++.+|++.+|++||++.++++.
T Consensus 223 ~~----~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 PK----DYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cc----ccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01 112356689999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=309.78 Aligned_cols=201 Identities=22% Similarity=0.332 Sum_probs=171.5
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.++||+|+||.||+++.+. ++.+|+|.+.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478999999999999999999865 678999998642 2223455888999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|.+++.+.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999996532 34788889999999999999999988 999999999999999999999999999765322
Q ss_pred CCcccccccccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005236 543 ETEGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGF 593 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvil~elltG~~p~~~ 593 (706)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 21 1223357999999999986 34688999999999999999999999853
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=299.86 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=199.9
Q ss_pred cCCCccceeccCCceeEEEEEeCC----CcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD----EQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
++|.+.++||+|+||.||+|...+ ...|+||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 568888999999999999998743 2468999886544 4556789999999999999999999998865 557899
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999996532 34789999999999999999999987 99999999999999999999999999987643
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.... ......++..|+|||.+....++.++||||||+++|||++ |+.||...... ...... .........
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~----~~~~~~~~~- 230 (270)
T cd05056 160 ESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRI----ENGERLPMP- 230 (270)
T ss_pred ccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH----HcCCcCCCC-
Confidence 3221 1122334568999999988899999999999999999996 99997543221 111111 111111110
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
... ...+.+++.+|+..+|.+|||+.++++.|+.+
T Consensus 231 ----~~~----~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 231 ----PNC----PPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred ----CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 12466788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=304.48 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=198.3
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
.|+..+.||+|+||.||+|.+. +++.||+|.+... .....+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4667789999999999999875 4778999988643 2344568899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++.. ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence 99999998843 34788999999999999999999887 9999999999999999999999999998754322
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
.......++..|+|||++.+..++.++||||||+++|||++|+.|+........ .. ......... +.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~----~~~~~~~~~-----~~- 222 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LF----LIPKNSPPT-----LE- 222 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hh----hhhcCCCCC-----CC-
Confidence 112234578899999999999999999999999999999999999753322111 10 011111111 11
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
......+.+++.+||+.+|.+||+|.+|++.
T Consensus 223 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 ---GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1122356688999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.59 Aligned_cols=255 Identities=28% Similarity=0.376 Sum_probs=203.5
Q ss_pred hccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCeeEEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 461 (706)
....|++.++||+||.+.||++...+.+.+|+|++.. .+.+....+.+|+.+|.+|+ |.+||+|++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3467999999999999999999998888999998743 56777899999999999996 99999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||= ..+|..+|..... ....| .+..+..||+.++.++|.++ |||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 439 mE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 9974 6699999965432 23334 66778899999999999998 99999999999984 57899999999999988
Q ss_pred CCCcccccccccccCccCccccccC-----------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDG-----------QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLW 610 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 610 (706)
+.........+||+.||+||.+... ..+.++||||+|||||+|+.|+.||..+. ..+.......
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~aKl~aI~ 586 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQIAKLHAIT 586 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHHHHHHhhc
Confidence 8777777778999999999999643 25689999999999999999999985322 1222222211
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 611 NEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 611 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
..+. ++--+.+ ..-.++++++..||+.||.+||++.||++.
T Consensus 587 ~P~~--~Iefp~~------~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 587 DPNH--EIEFPDI------PENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred CCCc--cccccCC------CCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1111 1111111 111227789999999999999999999875
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.24 Aligned_cols=251 Identities=35% Similarity=0.552 Sum_probs=199.2
Q ss_pred CCccceeccCCceeEEEEEeCC-----CcEEEEEEcCccchh-hHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 389 FSINKKLGEGGFGPVYKGTLAD-----EQEIAVKRLSKISEQ-GLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
+++.+.||.|+||.||+++..+ +..||+|.+...... ..+.+..|+.++..++|+||+++++.+.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999854 378999998654332 5678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999965332 22799999999999999999999987 999999999999999999999999999876543
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
...... ...++..|+|||.+....++.++||||+|++++||++ |+.|+.... ......... .........
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~---~~~~~~~~~----~~~~~~~~~- 227 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS---NEEVLEYLK----KGYRLPKPE- 227 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHh----cCCCCCCCC-
Confidence 222211 2347789999999988899999999999999999998 777764321 111111111 111111111
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHh
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L 660 (706)
. ....+.+++.+|++.+|++|||+.|+++.|
T Consensus 228 ----~----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 228 ----N----CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----c----CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1 123466789999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=296.77 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=198.7
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc-----hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS-----EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|+.++++++||||+++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999986 68899999875432 33567889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++++|.+++... ..+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999999643 34788999999999999999999988 99999999999999999999999999887543
Q ss_pred CCCcccccccccccCccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||..... .... ...........+ .
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~~---~~~~~~~~~~~~-~ 224 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAV---FKIGRSKELPPI-P 224 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHHH---HHHHhcccCCCc-C
Confidence 22 123356888999999998776 89999999999999999999999754331 1111 111110111111 1
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
... ...+.+++.+||+.+|.+||++.++++.
T Consensus 225 ----~~~----~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 225 ----DHL----SDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----CCc----CHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 111 1245678899999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=303.57 Aligned_cols=261 Identities=26% Similarity=0.332 Sum_probs=197.7
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccch-----hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISE-----QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
+|.+.+.||+|+||.||+|... +++.|+||++..... .....+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999975 588999999865332 2345677899999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999996543 35899999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC------
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM------ 614 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 614 (706)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|.+++..... ...............
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD---IDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc---HHHHHHHHHHcCCCchhhhhh
Confidence 221 1222356788999998855 4678999999999999999999777643222 122211111110000
Q ss_pred ---CcccccccccCcCCH-----HHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 615 ---PSQLIDACFKDSFNL-----AEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 615 ---~~~~~d~~~~~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
............... .....+.+++.+||+.+|.+|||++||++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000001111 112456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=333.20 Aligned_cols=255 Identities=23% Similarity=0.319 Sum_probs=196.2
Q ss_pred hccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC--CeeE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--EEKL 459 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 459 (706)
..++|.+.++||+|+||.||+++... ++.+|+|.+.. ........+..|+.++++++|||||++++++... ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 44789999999999999999999854 66788998754 2344567889999999999999999999988654 4689
Q ss_pred EEEecCCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCC----CceEecccCCCcEEEcC----------
Q 005236 460 LIYEFMPNKSLDSFIFDQE-RCKLLDWSKRFHIICGTARGLLYLHQDSR----LRIIHRDLKASNVLLDQ---------- 524 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~ivH~Dikp~Nill~~---------- 524 (706)
+||||+++++|.++|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999996532 23468999999999999999999998531 24999999999999964
Q ss_pred -------CCCeEEeeeccccccCCCCCcccccccccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 005236 525 -------DMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFYH 595 (706)
Q Consensus 525 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvil~elltG~~p~~~~~ 595 (706)
.+.+||+|||++..+.... ......||+.|+|||++.. ..++.++||||||||||||++|+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3358999999998753322 1233578999999999864 458899999999999999999999985322
Q ss_pred CCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 596 SDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
. ...++. .+.......+ ... ...+.+|+..||+.+|.+||++.|++.
T Consensus 248 ~--~~qli~----~lk~~p~lpi------~~~----S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 N--FSQLIS----ELKRGPDLPI------KGK----SKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred c--HHHHHH----HHhcCCCCCc------CCC----CHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1 111111 1111110000 001 134667899999999999999999983
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.72 Aligned_cols=253 Identities=23% Similarity=0.416 Sum_probs=198.7
Q ss_pred CCCccceeccCCceeEEEEEeCC--CcEEEEEEcCcc----------chhhHHHHHHHHHHHhh-cCCcceeeeEeEEEe
Q 005236 388 NFSINKKLGEGGFGPVYKGTLAD--EQEIAVKRLSKI----------SEQGLKELKNEIILFSK-LQHRNLVKLLGCCIH 454 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 454 (706)
+|++.+.||+|+||.||+|.... ++.+|+|.+... .......+..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999865 678999987432 22334567788888765 799999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCcEEEcCCCCeEEee
Q 005236 455 GEEKLLIYEFMPNKSLDSFIFDQ-ERCKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISD 532 (706)
Q Consensus 455 ~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~D 532 (706)
.+..++||||+++++|.+++... .....+++..++.++.|++.+|.|||+ .+ ++|+||+|+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988542 223458889999999999999999996 44 99999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhc
Q 005236 533 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNE 612 (706)
Q Consensus 533 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 612 (706)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.... ....... ...
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~---~~~~~~~----~~~ 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN---MLSLATK----IVE 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC---HHHHHHH----Hhh
Confidence 99998754332 2234568899999999998889999999999999999999999974321 1111111 111
Q ss_pred CCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 613 GMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 613 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
...... ..... ...+.+++.+||+.||.+||++.||..+|+
T Consensus 228 ~~~~~~----~~~~~----~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 AVYEPL----PEGMY----SEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCCcC----CcccC----CHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111111 01011 124567888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.79 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=203.3
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
++|++.+.||.|+||.||+|... ++..+++|++... .....+.+.+|+..++.++|+||+++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999974 5778999998643 233567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976443356889999999999999999999988 99999999999999999999999999987643322
Q ss_pred c--ccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 545 E--GNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 545 ~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
. .......++..|+|||++... .++.++||||||+++|||++|+.|+....... .... .... ....+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~---~~~~-~~~~~--- 227 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLML---TLQN-DPPSL--- 227 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHH---HhcC-CCCCc---
Confidence 2 122334688999999998877 78999999999999999999999975432211 1111 1111 11111
Q ss_pred cccCcCC-HHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 622 CFKDSFN-LAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 622 ~~~~~~~-~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
..... ..-...+.+++..||+.+|++||++++|++
T Consensus 228 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 --ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred --CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000 011234568899999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=298.34 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=199.2
Q ss_pred CCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccc------hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 388 NFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKIS------EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
+|+..+.||+|+||.||+|.. .+++.+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999987 558899999886432 2245788999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-CeEEeeecccccc
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAF 539 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfgla~~~ 539 (706)
||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999998643 35788999999999999999999988 99999999999998776 5999999999876
Q ss_pred CCCCCc--ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 540 GGDETE--GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 540 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
...... .......++..|+|||.+.+..++.++||||+|+++|+|++|+.|+...........+ ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~ 231 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKIASATTAPS 231 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---HHHhccCCCCC
Confidence 433211 1122346889999999998889999999999999999999999997543322211111 11111111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
........+.+++.+||+.+|.+||++.|+++
T Consensus 232 ---------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 232 ---------IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---------CchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11112234667889999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=303.52 Aligned_cols=253 Identities=27% Similarity=0.412 Sum_probs=201.4
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
.++|++.+.||.|+||.||+|... +++.+|+|.+........+.+..|+.++++++||||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467999999999999999999985 5789999998766666678899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 99999999986532 35889999999999999999999988 9999999999999999999999999987643221
Q ss_pred cccccccccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 545 EGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
.......++..|+|||.+. ...++.++||||||+++|||++|+.|+...... .... .. .......+.
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~---~~~~---~~-~~~~~~~~~ 229 (280)
T cd06611 158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM---RVLL---KI-LKSEPPTLD 229 (280)
T ss_pred -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH---HHHH---HH-hcCCCCCcC
Confidence 1222356889999999985 345778999999999999999999997543221 1111 11 111111110
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+ ... ...+.+++..||+.+|.+||++.+|++.
T Consensus 230 ~~---~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 QP---SKW----SSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred Cc---ccC----CHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00 001 1245678889999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=295.82 Aligned_cols=250 Identities=27% Similarity=0.388 Sum_probs=191.9
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-----chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC--Cee
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-----SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--EEK 458 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 458 (706)
.+|+..+.||+|+||.||+|... .+..|++|++... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36889999999999999999885 4889999987542 223456788999999999999999999998753 567
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
+++|||+++++|.+++... ..+++...+.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999999643 34788889999999999999999887 99999999999999999999999999986
Q ss_pred cCCCCC-cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 539 FGGDET-EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 539 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
+..... ........++..|+|||++.+..++.++||||||+++|||++|+.||..... ...+. ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~---~~~~~---~~~~~~~~~~ 229 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIF---KIATQPTNPQ 229 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch---HHHHH---HHhcCCCCCC
Confidence 532211 1112234578899999999998999999999999999999999999753211 11111 1111111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+ ....+ ..+..++ .||..+|++||+++||++
T Consensus 230 ~-----~~~~~----~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 230 L-----PSHIS----EHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred C-----chhcC----HHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1 00111 1222343 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=308.51 Aligned_cols=199 Identities=20% Similarity=0.269 Sum_probs=165.7
Q ss_pred ccceeccC--CceeEEEEEe-CCCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 391 INKKLGEG--GFGPVYKGTL-ADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 391 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
+.++||+| +|++||+++. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45889999 7899999987 45889999998653 2344567888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+++.||+.+.........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999986432 234789999999999999999999988 999999999999999999999999876543211110
Q ss_pred -----ccccccccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005236 546 -----GNTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGF 593 (706)
Q Consensus 546 -----~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvil~elltG~~p~~~ 593 (706)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 01122356778999999976 4689999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=295.95 Aligned_cols=253 Identities=26% Similarity=0.361 Sum_probs=205.2
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccch-hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISE-QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
++|++.+.||+|++|.||+++... ++.++||++..... ...+.+.+|+..+.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 468889999999999999999865 88999999876443 4567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
+++++|.+++... ..+++..++.++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999654 458899999999999999999999 77 9999999999999999999999999998764332
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
.. .....++..|+|||.+....++.++||||||+++|||++|+.|+................ ......+..
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~--- 225 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPPPSLPA--- 225 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCCCCCCc---
Confidence 22 123567899999999999999999999999999999999999976543312222222211 111111100
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. .....+.+++.+||+.+|.+||++.++++.
T Consensus 226 --~---~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 226 --E---EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --c---cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 012356678889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=302.39 Aligned_cols=252 Identities=27% Similarity=0.424 Sum_probs=196.2
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeC------C
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHG------E 456 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~ 456 (706)
+.+.|++.+.||+|+||.||+|... .++.||+|.+.... .....+..|+.++.++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567899999999999999999885 47789999885433 3346788999999998 699999999998753 4
Q ss_pred eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 536 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla 536 (706)
..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 5789999999999999986532 345789999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh
Q 005236 537 RAFGGDETEGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWN 611 (706)
Q Consensus 537 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 611 (706)
....... .......|+..|+|||++. ...++.++|||||||++|||++|+.|+........ . .....
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~---~---~~~~~ 230 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---L---FLIPR 230 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH---H---HHHhc
Confidence 8653221 2223456889999999986 34688899999999999999999999753321111 1 11111
Q ss_pred cCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 612 EGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 612 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
. ......+. .. ...+.+++.+||+.+|.+|||+.|+++
T Consensus 231 ~-~~~~~~~~----~~----~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 N-PAPRLKSK----KW----SKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred C-CCCCCCCC----Cc----CHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1 11111110 11 124667899999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.49 Aligned_cols=259 Identities=24% Similarity=0.332 Sum_probs=194.0
Q ss_pred HhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC-----
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG----- 455 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 455 (706)
...++|.+.+.||+|+||.||+|... .++.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999874 5788999998653 223345678899999999999999999987643
Q ss_pred -CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeec
Q 005236 456 -EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 534 (706)
Q Consensus 456 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 534 (706)
...++++|++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3568999988 7889887743 34889999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC
Q 005236 535 LARAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG 613 (706)
Q Consensus 535 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 613 (706)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .............
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~ 235 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI---DQLKRIMEVVGTP 235 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHhCCC
Confidence 99865322 223568999999999877 57899999999999999999999997542211 1111111111000
Q ss_pred CCccccccc-----------cc--CcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 614 MPSQLIDAC-----------FK--DSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 614 ~~~~~~d~~-----------~~--~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
..+..... +. ...+.. ....+.+++.+||+.||.+|||++|++..
T Consensus 236 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 -SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred -CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00 000000 01135689999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=303.01 Aligned_cols=263 Identities=28% Similarity=0.391 Sum_probs=202.5
Q ss_pred ccHHHHHHhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEe
Q 005236 377 FELATIANATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIH 454 (706)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 454 (706)
+....+..+.++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++++ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 444556667889999999999999999999984 57889999886532 2345678899999999 89999999999875
Q ss_pred C-----CeeEEEEecCCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCe
Q 005236 455 G-----EEKLLIYEFMPNKSLDSFIFDQE-RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 528 (706)
Q Consensus 455 ~-----~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 528 (706)
. ...++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 35799999999999999886422 2345889999999999999999999987 9999999999999999999
Q ss_pred EEeeeccccccCCCCCcccccccccccCccCccccccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHH
Q 005236 529 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-----QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLI 603 (706)
Q Consensus 529 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~ 603 (706)
||+|||+++.+..... ......++..|+|||.+... .++.++|||||||++|||++|+.|+...... ..+
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~---~~~ 242 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV---KTL 242 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH---HHH
Confidence 9999999987543221 12234688999999998643 3689999999999999999999997543221 111
Q ss_pred HHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 604 RHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 604 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.... ......+.++ ......+.+++.+||+.+|++||++.|+++.
T Consensus 243 ---~~~~-~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 ---FKIP-RNPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ---HHHh-cCCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111 1111111111 0112246789999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.16 Aligned_cols=198 Identities=24% Similarity=0.343 Sum_probs=170.9
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-C-----cceeeeEeEEEeCCeeEE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-H-----RNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 460 (706)
+|.+.+.||+|.||.|.++.+. .++.||||+++. ......+...|+.+|..|+ | -|+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7899999999999999999985 488999999965 4445667788999999997 4 389999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC--CeEEeeeccccc
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM--NPKISDFGLARA 538 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~--~~kl~Dfgla~~ 538 (706)
|+|.+ .-+|.++|..+. ...++...+..++.||+.||.+||+.+ |||+||||+||||.+.+ .+||+|||.|..
T Consensus 266 VfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999 569999996544 456899999999999999999999888 99999999999997654 699999999987
Q ss_pred cCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHS 596 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~ 596 (706)
..... . ...-+..|.|||+|.+.+|+.+.||||||||+.||++|.+.|.....
T Consensus 341 ~~q~v----y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 341 ESQRV----Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cCCcc----e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 53221 1 46678899999999999999999999999999999999877654333
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=283.56 Aligned_cols=254 Identities=24% Similarity=0.338 Sum_probs=200.7
Q ss_pred HHhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--------chhhHHHHHHHHHHHhhc-CCcceeeeEeEE
Q 005236 383 ANATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--------SEQGLKELKNEIILFSKL-QHRNLVKLLGCC 452 (706)
Q Consensus 383 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 452 (706)
....+.|.-.+.||.|..++|-+...+ .+++.|+|++... ...-.++-..|+.+++++ -||+|+.+.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 334467888899999999999988774 5788999987431 122245567899999998 599999999999
Q ss_pred EeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEee
Q 005236 453 IHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 532 (706)
Q Consensus 453 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 532 (706)
+.....++|+|.|+.|.|.++|... -.+++++..+|+.|+.+|++|||..+ ||||||||+|||++++.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 9999999999999999999999543 45889999999999999999999988 99999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccCccCcccccc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH
Q 005236 533 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASD------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHA 606 (706)
Q Consensus 533 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~ 606 (706)
||++..+.... .....+|||+|+|||.+.. ..|+...|+||.|||+|.|+.|.+||- +.... ..
T Consensus 167 FGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw--HRkQm-----lM 236 (411)
T KOG0599|consen 167 FGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW--HRKQM-----LM 236 (411)
T ss_pred cceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh--HHHHH-----HH
Confidence 99999875433 3445799999999999853 468889999999999999999999963 21110 11
Q ss_pred HHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 607 WKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 607 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.+++.++.. ++..+.+.+ -...+.+++.+||+.||.+|.|.+|+++
T Consensus 237 LR~ImeGky-qF~speWad-----is~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 237 LRMIMEGKY-QFRSPEWAD-----ISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHhccc-ccCCcchhh-----ccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 122223222 122222211 1224568999999999999999999975
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=301.48 Aligned_cols=261 Identities=25% Similarity=0.377 Sum_probs=199.8
Q ss_pred HHHHHhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEeEEE----
Q 005236 380 ATIANATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLGCCI---- 453 (706)
Q Consensus 380 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~---- 453 (706)
..+..+.++|++.+.||+|+||.||+++.. .++.+|+|.+.... .....+.+|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 445567789999999999999999999884 47889999876432 2235688899999999 6999999999885
Q ss_pred -eCCeeEEEEecCCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEe
Q 005236 454 -HGEEKLLIYEFMPNKSLDSFIFDQ-ERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 531 (706)
Q Consensus 454 -~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 531 (706)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 345689999999999999988643 22345788889999999999999999987 9999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccccCccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH
Q 005236 532 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHA 606 (706)
Q Consensus 532 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~ 606 (706)
|||+++...... .......|+..|+|||++.. ..++.++|||||||++|||++|+.|+...... ....
T Consensus 167 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~---~~~~-- 239 (286)
T cd06638 167 DFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---RALF-- 239 (286)
T ss_pred cCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh---HHHh--
Confidence 999998753221 12233468999999999853 45788999999999999999999997543221 1110
Q ss_pred HHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHh
Q 005236 607 WKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 607 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L 660 (706)
.. .......+.++. .. ...+.+++.+||+.+|.+|||+.||++.+
T Consensus 240 -~~-~~~~~~~~~~~~---~~----~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 -KI-PRNPPPTLHQPE---LW----SNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -hc-cccCCCcccCCC---Cc----CHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 10 011111111110 01 12466789999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=316.32 Aligned_cols=252 Identities=27% Similarity=0.381 Sum_probs=203.6
Q ss_pred cCCCccceeccCCceeEEEEEeCC--Cc--EEEEEEcCccchh-hHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD--EQ--EIAVKRLSKISEQ-GLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
++.++.++||+|.||+|++|.|.. |+ .||||.+...... ....|.+|+.+|.+|+|||+++|||+..+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 345667899999999999999853 44 5899999765443 67899999999999999999999999887 788999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
||.++.|+|.+.|++ .....+-...+..++.|||.||.||.++. +|||||..+|+||-..-.+||+||||.+.++.
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999987 33455778888999999999999999987 99999999999999999999999999998865
Q ss_pred CCCc-ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 542 DETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 542 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
.+.. .......-...|.|||.+....++.++|||+|||+||||+| |+.||.....-..+..++. .+.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~------~er----- 333 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA------GER----- 333 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc------ccc-----
Confidence 4433 33334456788999999999999999999999999999999 6777654333222222211 000
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
+ .-...+.+++.+++..||..+|++|||+..|.+.
T Consensus 334 ---L--pRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 334 ---L--PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ---C--CCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 1 1112244567889999999999999999999733
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=298.07 Aligned_cols=248 Identities=26% Similarity=0.422 Sum_probs=200.4
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
..|+..+.||+|+||.||+|... .++.||+|.+... .....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777899999999999999985 4788999988643 344567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999999853 34788888999999999999999887 99999999999999999999999999987643221
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
......++..|+|||++.+..++.++||||||+++|||++|+.|+.......... ........
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~~~~~-------- 219 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-------LIPKNNPP-------- 219 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-------hhhcCCCC--------
Confidence 2223457889999999998899999999999999999999999975432211110 00111111
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.........+.+++..||+.+|.+||+++++++.
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 -TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1111233456789999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=309.60 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=204.5
Q ss_pred cCCCccceeccCCceeEEEEEeCC---C--cEEEEEEcCc-cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD---E--QEIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
+..++.++||.|-||.||+|...+ | -.||||..+. ......+.|..|..+|++++||||++|+|+|.+ ...++
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 445666899999999999998633 2 3589999876 455668899999999999999999999999965 56899
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
|||.++-|-|.+||..+. ..++......++.||+.||.|||+.. +|||||..+||||.....+||+|||+++.+.
T Consensus 468 vmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 999999999999996543 45888889999999999999999987 9999999999999999999999999999986
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
.+...... ...-++.|||||.+.-..+|.+||||-|||.+||+++ |.+||......+-.-.+ ..+....
T Consensus 543 d~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-------EnGeRlP-- 612 (974)
T KOG4257|consen 543 DDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-------ENGERLP-- 612 (974)
T ss_pred ccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-------cCCCCCC--
Confidence 55544333 4567889999999999999999999999999999987 89998654433221111 1111111
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
.+..+.-.+..++.+||+++|.+||.+.|+...|..
T Consensus 613 -------~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 613 -------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred -------CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 111223356678999999999999999998876643
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=294.99 Aligned_cols=247 Identities=28% Similarity=0.439 Sum_probs=195.8
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
++|++.+.||+|+||.||++.. .++.+|+|.+.... ..+.+.+|+.++++++||||+++++++.. +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence 5688999999999999999975 57789999986432 24678899999999999999999999865 45799999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999996543 235788999999999999999999887 999999999999999999999999998764221
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......+..|+|||.+.+..++.++||||||+++|||++ |+.||..... ...... .......... .
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~----~~~~~~~~~~-----~ 220 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---KEVKEC----VEKGYRMEPP-----E 220 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---HHHHHH----HhCCCCCCCC-----C
Confidence 112234568999999998899999999999999999998 8888753322 111111 1111111111 1
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
.. ...+.+++.+||+.+|.+||++++|++.|+.
T Consensus 221 ~~----~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 GC----PADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred cC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11 2345678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=305.66 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=197.8
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
.|.....||+|+||.||++... ++..||||++........+.+.+|+.+++.++||||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444578999999999999874 578999999876555566788999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence 9999998843 24788999999999999999999987 99999999999999999999999999876532221
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCc
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDS 626 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 626 (706)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ........ ......+ ...
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~----~~~~~~~-----~~~ 241 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRRIR----DNLPPRV-----KDS 241 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH----hcCCCcc-----ccc
Confidence 22235688999999999988999999999999999999999999753221 11111111 1111111 111
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 627 FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 627 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.. ....+.+++..|++.+|.+|||++|+++.
T Consensus 242 ~~--~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 HK--VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cc--cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11 11245578889999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=305.86 Aligned_cols=262 Identities=24% Similarity=0.346 Sum_probs=197.8
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
++|++.++||+|+||.||+|..+ .++.||+|++.... ....+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999986 48899999875422 2235678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++++|..+.... ..+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 99999998877432 23789999999999999999999987 9999999999999999999999999998754322
Q ss_pred CcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC--CCccc--
Q 005236 544 TEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG--MPSQL-- 618 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-- 618 (706)
. ......++..|+|||++.+ ..++.++||||||+++|||++|++|+..... .............- .....
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD---IDQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHHHhCCCchhhHHHhc
Confidence 1 2223457889999999875 4578899999999999999999988753221 11111111110000 00000
Q ss_pred ----c----cccccCcCCH-----HHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 619 ----I----DACFKDSFNL-----AEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 619 ----~----d~~~~~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. .+........ .....+.+++.+||+.+|.+||+++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0 0000000000 112357789999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=303.09 Aligned_cols=196 Identities=27% Similarity=0.420 Sum_probs=159.7
Q ss_pred ceeccCCceeEEEEEeCC---CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEe--CCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLAD---EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIH--GEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~ 467 (706)
.+||+|+||.||+|+..+ +..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 689999999999999753 5689999886532 23467889999999999999999999864 4577899999875
Q ss_pred CChhhhhhcc------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE----cCCCCeEEeeecccc
Q 005236 468 KSLDSFIFDQ------ERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLAR 537 (706)
Q Consensus 468 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~~kl~Dfgla~ 537 (706)
+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777776422 12235788889999999999999999988 9999999999999 566799999999998
Q ss_pred ccCCCCCc-ccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 005236 538 AFGGDETE-GNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFY 594 (706)
Q Consensus 538 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~ 594 (706)
.+...... .......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76433221 12234578999999999876 45899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=312.66 Aligned_cols=240 Identities=23% Similarity=0.267 Sum_probs=182.5
Q ss_pred eccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhc---CCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 395 LGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKL---QHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 395 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
||+|+||.||+|+.. .++.||||++.... ......+..|..++... +||||++++..+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999985 48899999986422 22233445566666655 699999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 9999988543 34788999999999999999999988 9999999999999999999999999997642221 12
Q ss_pred ccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCc
Q 005236 548 TNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDS 626 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 626 (706)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .... ..+..+.. .+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---~~~~----~~i~~~~~-~~~~----~~ 220 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---QQMY----RNIAFGKV-RFPK----NV 220 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---HHHH----HHHHcCCC-CCCC----cc
Confidence 2345799999999998764 589999999999999999999999753221 1111 11111111 0100 01
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCC----hhHHHH
Q 005236 627 FNLAEVIRCIHIGLLCVQQYPEDRPC----MPSVIL 658 (706)
Q Consensus 627 ~~~~~~~~~~~l~~~cl~~~p~~RPt----~~ev~~ 658 (706)
. ...+.+++.+||+.+|.+||+ +.++++
T Consensus 221 ~----~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 221 L----SDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred C----CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1 123457889999999999995 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=303.35 Aligned_cols=263 Identities=23% Similarity=0.321 Sum_probs=196.0
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccch-hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISE-QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.++|++.+.||+|++|.||+|+.+ +++.||||.+..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367999999999999999999985 578999999864322 223456789999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++ +|.+++.... ..+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 9985 8999886543 35788999999999999999999987 9999999999999999999999999987643211
Q ss_pred CcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC---ccc-
Q 005236 544 TEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP---SQL- 618 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~- 618 (706)
. ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||..... ................. ...
T Consensus 158 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred c--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhh
Confidence 1 1112346789999999875 4688999999999999999999999753321 11111111111111000 000
Q ss_pred -----c--------cccccC-cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 619 -----I--------DACFKD-SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 619 -----~--------d~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
. ...+.. .........+.+++..||+.+|.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 000000 001111245668999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.81 Aligned_cols=255 Identities=25% Similarity=0.381 Sum_probs=196.9
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc----------hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS----------EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE 456 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 456 (706)
+|.+.+.||+|+||.||+|... +++.+|+|.+.... ....+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999874 58899999875311 112356888999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 536 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla 536 (706)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999999654 35788889999999999999999987 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccCccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC
Q 005236 537 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQ--FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM 614 (706)
Q Consensus 537 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 614 (706)
+...............++..|+|||.+.... ++.++||||||+++|||++|..|+.... ... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~---~~~---~~~~~~~~~~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE---AIA---AMFKLGNKRS 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc---hHH---HHHHhhcccc
Confidence 8653322222233456889999999987654 8899999999999999999999974211 111 1111111111
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 615 PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 615 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
...+ ..... ......+.+++..||+.+|.+||++.+|++.
T Consensus 230 ~~~~-~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPI-PPDVS----MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcC-Ccccc----ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111 11110 1112356678899999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=293.47 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=199.9
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+|++.+.||+|+||.||+++.. +++.+++|++... .....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4888999999999999999874 5789999998642 344456889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999886432 234788899999999999999999987 99999999999999999999999999987533211
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
......|++.|+|||++.+..++.++||||||+++++|++|+.|+... +...... ..... ......
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~---~~~~~-~~~~~~----- 222 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKNLVL---KIIRG-SYPPVS----- 222 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC---CHHHHHH---HHhcC-CCCCCc-----
Confidence 122345788999999999889999999999999999999999997532 1111111 11111 111110
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
......+.+++.+||+.+|.+||+|.+|++.
T Consensus 223 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 223 ----SHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ----ccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0112246678999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=298.40 Aligned_cols=262 Identities=24% Similarity=0.332 Sum_probs=200.3
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+|++.+.||+|+||.||+|+.. +++.|++|++.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999984 58899999986533 33456889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+ +++|.+++.... ..+++..++.++.||++||+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999986543 55899999999999999999999987 99999999999999999999999999987643321
Q ss_pred cccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC---c---c
Q 005236 545 EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP---S---Q 617 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~---~ 617 (706)
.......++..|+|||.+.+. .++.++||||+|+++|||++|++++.... ................. . +
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN---DIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC---HHHHHHHHHHHcCCCChHHHhhccC
Confidence 112235688999999998654 46899999999999999999977764322 22222222221111100 0 0
Q ss_pred ccc--c---cccCcCCH-----HHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 618 LID--A---CFKDSFNL-----AEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 618 ~~d--~---~~~~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
+.+ . ........ .....+.+++.+||+.+|++||++++++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0 00000000 112567789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=294.38 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=199.7
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEe--CCeeEEEE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIH--GEEKLLIY 462 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 462 (706)
+|++.+.||.|+||.||++... +++.+|+|.+.. ......+.+..|+.++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999874 578899998864 334456778899999999999999999998764 34678999
Q ss_pred ecCCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 463 EFMPNKSLDSFIFDQE-RCKLLDWSKRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
||+++++|.+++.... ....+++..++.++.||+.||.|||..+ ...++|+||+|+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999996532 2356889999999999999999999322 223999999999999999999999999999876
Q ss_pred CCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 540 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 540 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
...... .....++..|+|||.+....++.++||||||+++|+|++|+.|+.... ...... .........+.
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~----~~~~~~~~~~~ 231 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLAS----KIKEGKFRRIP 231 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHH----HHhcCCCCCCc
Confidence 433221 223468999999999999899999999999999999999999976433 111111 11122211111
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
......+.+++.+||+.+|.+||++++|+++
T Consensus 232 ---------~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 232 ---------YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---------cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1112356789999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.59 Aligned_cols=243 Identities=28% Similarity=0.427 Sum_probs=194.5
Q ss_pred CCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 388 NFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
-|.-++.||.|+||-||-+++ .+.+.||||+++-. +...++.+.+|+..|++++|||++.+.|+|..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 355668999999999999998 45778999998643 44456789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
||- |+-.+++.-+ .+++.+.++..|..+.+.||+|||+++ .||||||+.|||+.+.|.+||+|||.|....
T Consensus 107 YCl-GSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--- 177 (948)
T KOG0577|consen 107 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA--- 177 (948)
T ss_pred HHh-ccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC---
Confidence 994 5666666432 256788888899999999999999998 9999999999999999999999999997643
Q ss_pred CcccccccccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
..+.++|||.|||||+|. .+.|+-|+||||||++..||...++|.-... ....... +.....+-+-.
T Consensus 178 ---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN---AMSALYH----IAQNesPtLqs 247 (948)
T KOG0577|consen 178 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYH----IAQNESPTLQS 247 (948)
T ss_pred ---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch---HHHHHHH----HHhcCCCCCCC
Confidence 344579999999999985 4689999999999999999999999853222 1111111 11122222211
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI 657 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~ 657 (706)
.+-...+..++-.||+.-|.+|||.++++
T Consensus 248 --------~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 248 --------NEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred --------chhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 22334567889999999999999998876
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=292.69 Aligned_cols=249 Identities=27% Similarity=0.410 Sum_probs=205.6
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
-|.++++||+|+||.|||+.++ .|+.+|||++.. ..+++++.+|+.++++.+.|++|++||.+.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4667799999999999999985 489999999854 4467899999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
-|+..+.++.. .+++++.++..++...++||+|||... -||||||+.|||++-+|++||+|||.|-.+. ....
T Consensus 112 AGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTMA 184 (502)
T KOG0574|consen 112 AGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTMA 184 (502)
T ss_pred CCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh--hhHH
Confidence 99999999643 467999999999999999999999876 7999999999999999999999999997653 2233
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCc
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDS 626 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 626 (706)
..+...||+.|||||++..-.|..++||||||+...||..|++|+...++-.....+ .-..++.+..
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-------PT~PPPTF~K------ 251 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-------PTKPPPTFKK------ 251 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-------cCCCCCCCCC------
Confidence 445688999999999999999999999999999999999999998776654322211 1111111111
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 627 FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 627 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
..+-...+-+++..||-.+|++|.|+-++++.
T Consensus 252 -PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 -PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred -hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 11122355678999999999999998887653
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=294.63 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=194.8
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc-----chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC--Cee
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI-----SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--EEK 458 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 458 (706)
++|++.+.||+|+||.||+|...+ +..|+||.+... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 478999999999999999999854 889999987532 223456788999999999999999999998764 467
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||+++++|.+++... ..+++...++++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999998643 34788888999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCC-cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 539 FGGDET-EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 539 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||..... ...+ ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~---~~~~~~~~~~- 228 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA---MAAI---FKIATQPTNP- 228 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch---HHHH---HHHhcCCCCC-
Confidence 532211 1122234588899999999988899999999999999999999999753211 1111 1111111100
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.........+.+++..|+. +|.+||+++||++.
T Consensus 229 --------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 229 --------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1111222355677888885 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=297.51 Aligned_cols=259 Identities=25% Similarity=0.295 Sum_probs=200.2
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC--CeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--EEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 462 (706)
++|+..+.||.|++|.||++... .++.+|+|.+... .......+.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999985 4788999988653 334567789999999999999999999998654 3689999
Q ss_pred ecCCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 463 EFMPNKSLDSFIFDQE-RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
||+++++|.+++.... ....++...+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999875422 2345788899999999999999999988 99999999999999999999999999876432
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC--CCchhHHHHHHHHhhcCCCcccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHS--DNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ....+...+.. ......+.
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 229 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----NMPNPELK 229 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----cCCchhhc
Confidence 11 1234578899999999999999999999999999999999999865422 11122222111 11111111
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
+. .... ..-...+.+++.+||+.+|.+|||+.||++.
T Consensus 230 ~~-~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 230 DE-PGNG--IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred cC-CCCC--CchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 11 1100 1112356789999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.62 Aligned_cols=257 Identities=20% Similarity=0.211 Sum_probs=199.8
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.+.||+|+||.||++.... ++.|++|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468899999999999999999854 7889999886532 233567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999999543 34788899999999999999999987 999999999999999999999999998742110
Q ss_pred CC-------------cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH
Q 005236 543 ET-------------EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKL 609 (706)
Q Consensus 543 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 609 (706)
.. ........++..|+|||.+.+..++.++||||||+++|||++|+.||.... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~---~~~~~~~---- 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT---PEELFGQ---- 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH----
Confidence 00 001112457889999999998899999999999999999999999975321 1111111
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 610 WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 610 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
....... .+..... ....+.+++.+||+.+|++||+..++.+.|+..
T Consensus 228 ~~~~~~~---~~~~~~~----~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 228 VISDDIE---WPEGDEA----LPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHhcccC---CCCcccc----CCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 1111100 0000001 112356789999999999999988888888764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=301.71 Aligned_cols=266 Identities=21% Similarity=0.304 Sum_probs=200.0
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
++|++.+.||+|+||.||+|... +++.|++|++... .....+.+.+|+.++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999986 4789999988642 23345788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|++++.|..++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99998777665332 34789999999999999999999987 9999999999999999999999999998764432
Q ss_pred CcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhc---------C
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNE---------G 613 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---------~ 613 (706)
. .......++..|+|||++.+. .++.++||||||+++|+|++|+.|+......+....+......... .
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 2 122235678899999999888 8899999999999999999999987543221111111110000000 0
Q ss_pred CCc--cccccc----ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 614 MPS--QLIDAC----FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 614 ~~~--~~~d~~----~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
... +..+.. +...........+.+++..||+.+|++||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 000000 0000000113457789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=297.85 Aligned_cols=254 Identities=26% Similarity=0.361 Sum_probs=201.4
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
++|++.+.||+|+||.||++... +++.+++|++... .....+.+.+|+.++++++||||+++++.+......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46788899999999999999986 5888999988654 334567789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
+++++|.+++.... ..++...+.+++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||.+..+....
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999996543 567888999999999999999998 76 9999999999999999999999999987653221
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
. ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ........... ......+...
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~-- 227 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIV-NEPPPRLPSG-- 227 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHh-cCCCCCCChh--
Confidence 1 11567889999999999999999999999999999999999975432211 11111111111 1111111110
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. ....+.+++..||..+|.+|||+.+++..
T Consensus 228 --~----~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 228 --K----FSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred --h----cCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0 12245678899999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=304.24 Aligned_cols=268 Identities=21% Similarity=0.292 Sum_probs=197.4
Q ss_pred CCCccceeccCCceeEEEEEeCC---CcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC--CeeE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLAD---EQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--EEKL 459 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 459 (706)
+|.+.++||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999999854 7899999987632 33456778899999999999999999999988 7899
Q ss_pred EEEecCCCCChhhhhhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC----CCCeEEeee
Q 005236 460 LIYEFMPNKSLDSFIFDQER--CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ----DMNPKISDF 533 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~----~~~~kl~Df 533 (706)
+||||+++ +|.+++..... ...++...+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 66666643221 236788999999999999999999988 999999999999999 999999999
Q ss_pred ccccccCCCCC-cccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCch------hHHHH
Q 005236 534 GLARAFGGDET-EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKL------NLIRH 605 (706)
Q Consensus 534 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~------~~~~~ 605 (706)
|++..+..... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||......... .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643222 1222345678999999988764 5889999999999999999999998654433200 01111
Q ss_pred HHHHhhcCCC------------cccccccccCc---CCH--------HHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 606 AWKLWNEGMP------------SQLIDACFKDS---FNL--------AEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 606 ~~~~~~~~~~------------~~~~d~~~~~~---~~~--------~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
....+..... ....+...... ..+ .....+.+++.+||+.+|++|||+.|+++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111100000 00000000000 011 112357789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=303.87 Aligned_cols=253 Identities=24% Similarity=0.267 Sum_probs=198.7
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccch---hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISE---QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.+.||+|+||.||++...+ ++.+|+|.+..... ...+.+.+|+.+++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468889999999999999999865 88999999865322 24567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+.+++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999986432 345888999999999999999999987 999999999999999999999999998765321
Q ss_pred CCc---------------------------ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 005236 543 ETE---------------------------GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 595 (706)
Q Consensus 543 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~ 595 (706)
... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 01123467889999999999899999999999999999999999975432
Q ss_pred CCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCC----hhHHHH
Q 005236 596 SDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPC----MPSVIL 658 (706)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt----~~ev~~ 658 (706)
.... . ......... . .... .....+.+++.+||+.+|++||+ ++|++.
T Consensus 237 ~~~~---~---~~~~~~~~~--~-----~~~~--~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDET---F---SNILKKEVT--F-----PGSP--PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHH---H---HHHhcCCcc--C-----CCcc--ccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2111 1 111111100 0 0000 02235667899999999999999 555555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=303.20 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=197.0
Q ss_pred CCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 389 FSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
|.....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334468999999999999875 5889999998654445567788999999999999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
++|..++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+..... .
T Consensus 103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 173 (297)
T cd06659 103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 173 (297)
T ss_pred CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence 999988743 34789999999999999999999988 99999999999999999999999999876533221 2
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcC
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSF 627 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 627 (706)
.....++..|+|||++.+..++.++||||||+++|||++|+.||..... ...... ........... . ...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~----~~~~~~~~~~~--~-~~~ 243 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKR----LRDSPPPKLKN--A-HKI 243 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH----HhccCCCCccc--c-CCC
Confidence 2235688999999999988999999999999999999999999753221 111111 11111110000 0 011
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 628 NLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 628 ~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
...+.+++.+||+.+|.+||++++|++.
T Consensus 244 ----~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 ----SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ----CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1235678889999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=297.09 Aligned_cols=254 Identities=28% Similarity=0.427 Sum_probs=198.6
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCC------
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGE------ 456 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------ 456 (706)
..++|++.+.||+|++|.||+|... +++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4689999999999999999999985 577899998865443 346789999999999 6999999999997654
Q ss_pred eeEEEEecCCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQE-RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 535 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgl 535 (706)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999986532 2356889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccCccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLW 610 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 610 (706)
+....... .......++..|+|||++.. ..++.++||||||+++|+|++|+.||...... .... +..
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~---~~~ 231 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RALF---KIP 231 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHHH---Hhh
Confidence 87653221 12223568899999998754 35778999999999999999999998532211 1111 111
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 611 NEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 611 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
......+.. .......+.+++.+||..||++|||+.+|++
T Consensus 232 -~~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 -RNPPPTLKS-------PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -ccCCCCCCc-------hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111111 1112235668999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=293.04 Aligned_cols=252 Identities=27% Similarity=0.453 Sum_probs=199.4
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccch--hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISE--QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+|.+.+.||+|+||.||+|... +++.+++|.+..... ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999874 688999999865433 3678899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999998643 34788889999999999999999988 99999999999999999999999999987643322
Q ss_pred ccc--ccccccccCccCccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 545 EGN--TNRVVGTYGYMAPEYASDGQ---FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 545 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
... .....++..|+|||++.... ++.++||||||+++|||++|+.||..... ... .... .. ......+.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~~-~~~~--~~-~~~~~~~~ 228 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQ-IMFH--VG-AGHKPPIP 228 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hHH-HHHH--Hh-cCCCCCCC
Confidence 111 22356788999999998766 89999999999999999999999854321 111 1111 11 11111111
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+ .. .....+.+++.+||+.+|.+||++.|++.
T Consensus 229 ~-----~~--~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 D-----SL--QLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred c-----cc--ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 00 01223457888999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=289.88 Aligned_cols=249 Identities=24% Similarity=0.402 Sum_probs=198.8
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+|++.+.||+|+||.||++... .++.+|||++... .....+.+.+|+.++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999874 5788999988543 334567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-CCeEEeeeccccccCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAFGGDE 543 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfgla~~~~~~~ 543 (706)
+++++|.+++.... ...+++..+..++.+++++|+|||+.+ ++|+||+|+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999996533 345788999999999999999999987 9999999999999865 468999999998764322
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
......++..|+|||.+....++.++||||||+++|+|++|+.|+..... ........ ......+.+
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~----~~~~~~~~~--- 223 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKIM----SGTFAPISD--- 223 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHHH----hcCCCCCCC---
Confidence 12234678899999999988899999999999999999999999754322 11111111 111111111
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.. ...+.+++.+||+.+|.+|||+.|+++.
T Consensus 224 --~~----~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 224 --RY----SPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --Cc----CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11 1245678899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=288.91 Aligned_cols=252 Identities=28% Similarity=0.431 Sum_probs=204.0
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC--CeeEEEE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--EEKLLIY 462 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 462 (706)
+|.+.+.||+|++|.||+|... +++.|++|++.... ....+.+.+|+.++++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999986 68899999986543 35577899999999999999999999999988 8899999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++++|.+++.... .+++..+..++.|++++|+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999996543 6899999999999999999999987 999999999999999999999999999876544
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
..........++..|+|||.+.....+.++||||||+++++|++|+.|+.... .................+.+
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~-- 227 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPPEIPE-- 227 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCcCCCc--
Confidence 32212334568899999999998889999999999999999999999976543 11111111111111111111
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.....+.+++.+|++.+|.+||++.++++.
T Consensus 228 -------~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 228 -------HLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -------ccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 112356678899999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=300.18 Aligned_cols=244 Identities=27% Similarity=0.340 Sum_probs=197.1
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47889999999999999999985 5889999988642 2234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++++|.+++... ..++...+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998654 45788999999999999999999987 999999999999999999999999999876433
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.|+..... ...... .. .+.. .+ .
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~---~~-~~~~-~~-~-- 218 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQIYEK---IL-EGKV-RF-P-- 218 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH---Hh-cCCc-cC-C--
Confidence 2234688999999999888899999999999999999999999753321 111111 11 1111 00 0
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCC-----ChhHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRP-----CMPSVIL 658 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~ 658 (706)
... ...+.+++.+||+.+|.+|| +++|++.
T Consensus 219 --~~~----~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 219 --SFF----SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred --ccC----CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 011 12456788999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=309.74 Aligned_cols=245 Identities=24% Similarity=0.387 Sum_probs=192.6
Q ss_pred CccceeccCCceeEEEEEeCC-CcEEEEEEc--Cc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe--eEEEE
Q 005236 390 SINKKLGEGGFGPVYKGTLAD-EQEIAVKRL--SK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEE--KLLIY 462 (706)
Q Consensus 390 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~--~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lV~ 462 (706)
+..++||+|+|-+||||.+.. |.+||=-.+ .. ..+...+.|..|+.+|+.|+|||||+++..+.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 455899999999999999843 666652211 11 355667899999999999999999999999987665 67899
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-CCCeEEeeeccccccCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGG 541 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfgla~~~~~ 541 (706)
|.|..|+|..|+.+..+ ++.+.+..|+.||++||.|||++. ++|||||||-.||+|+. -|.+||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999976554 788899999999999999999985 68999999999999985 48999999999998643
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
.. .....|||.|||||... ..|...+||||||+.++||+|+..|+.... .......++.....+.....+-|+
T Consensus 199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~--n~AQIYKKV~SGiKP~sl~kV~dP 271 (632)
T KOG0584|consen 199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT--NPAQIYKKVTSGIKPAALSKVKDP 271 (632)
T ss_pred cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC--CHHHHHHHHHcCCCHHHhhccCCH
Confidence 32 22378999999999886 899999999999999999999999975322 222222222221111112222222
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.+.++|..||.. ..+|||+.|+++
T Consensus 272 ------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 272 ------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 355788999999 999999999985
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.24 Aligned_cols=261 Identities=22% Similarity=0.312 Sum_probs=193.6
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+|++.+.||+|+||.||+|+.. +|+.+|+|++... .......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999985 5889999998642 222335678899999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
++ ++|.+++... ...+++..+..++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 97 4787777543 245899999999999999999999987 9999999999999999999999999998653221
Q ss_pred cccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC------cc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP------SQ 617 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 617 (706)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.|+.... .................. ..
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC--CHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 112234578899999998764 47899999999999999999998853221 111111111111100000 00
Q ss_pred ccc----ccccCcCC-----HHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 618 LID----ACFKDSFN-----LAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 618 ~~d----~~~~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+.+ +....... ......+.+++.+||+.||.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 00000000 011235568999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=297.03 Aligned_cols=262 Identities=24% Similarity=0.350 Sum_probs=198.2
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccch-hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISE-QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
+|++.++||.|++|.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999985 588899999865432 23466788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++ +|.+++........+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 88888866554456899999999999999999999987 99999999999999999999999999976532211
Q ss_pred ccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC---------CC
Q 005236 546 GNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG---------MP 615 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~ 615 (706)
......++..|++||.+.+. .++.++||||||+++|||++|+.||......+ ............ ..
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED---QLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhHHHHhcC
Confidence 11224568899999988654 57899999999999999999999976433222 111111111000 00
Q ss_pred ccccccccc------CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 616 SQLIDACFK------DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 616 ~~~~d~~~~------~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
..+...... ..........+.+++..|++.+|.+||+++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000 0000011234668999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=295.81 Aligned_cols=264 Identities=24% Similarity=0.351 Sum_probs=195.4
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++++|.+.+.||+|+||.||+|... +++.|++|++.... ......+.+|+.+++.++|+||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999874 58899999986532 223346788999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+. ++|.+++.... ..+.+..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 67777664332 34677888899999999999999987 999999999999999999999999999764321
Q ss_pred CCcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC--------
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG-------- 613 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 613 (706)
.. ......++..|+|||++.+. .++.++||||||+++|||++|+.||..... ..+.+...+.....+
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhhhh
Confidence 11 12234578899999998764 578999999999999999999999864322 112222222111100
Q ss_pred -----CCcccccccccCc-----CCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 614 -----MPSQLIDACFKDS-----FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 614 -----~~~~~~d~~~~~~-----~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
...+......... ........+.+++.+|++.||.+|||++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000 00011234567889999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=288.81 Aligned_cols=250 Identities=30% Similarity=0.459 Sum_probs=203.5
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
+|++.+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++||||+++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999985 688999999977655567889999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+++|.+++.... ..+++..+..++.|++.+|.+||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999986542 45899999999999999999999977 99999999999999999999999999987643322
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCc
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDS 626 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 626 (706)
.....++..|+|||.+....++.++||||||+++|+|++|+.|+...... ....... ......+...
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~~~----- 220 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALFKIA----TNGPPGLRNP----- 220 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHH----hcCCCCcCcc-----
Confidence 23456889999999998888999999999999999999999997543211 1111111 1111111111
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 627 FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 627 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. .-...+.+++..||+.+|.+|||+.|+++.
T Consensus 221 ~--~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 E--KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred c--ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 002346678899999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=299.30 Aligned_cols=262 Identities=23% Similarity=0.281 Sum_probs=193.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCe-----
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEE----- 457 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 457 (706)
++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999985 58899999875432 223457888999999995 6999999999987665
Q ss_pred eEEEEecCCCCChhhhhhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-CCCeEEeeec
Q 005236 458 KLLIYEFMPNKSLDSFIFDQER--CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFG 534 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfg 534 (706)
.++||||+++ +|.+++..... ...+++..++.++.||++||.|||+.+ ++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 78888865432 246899999999999999999999987 999999999999998 8999999999
Q ss_pred cccccCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC
Q 005236 535 LARAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG 613 (706)
Q Consensus 535 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 613 (706)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||..... .............+
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE---LQQLLHIFKLLGTP 231 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHhCCC
Confidence 9986532211 1122356788999998865 4679999999999999999999998754322 11111111111000
Q ss_pred CC---cccc------------cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 614 MP---SQLI------------DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 614 ~~---~~~~------------d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.. .... ...+. .........+.+++..||+.+|.+||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000 00000 000011234678999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=298.79 Aligned_cols=264 Identities=24% Similarity=0.310 Sum_probs=196.6
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC--CeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--EEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 461 (706)
++|++.+.||+|+||.||+|+.+ +++.+++|.+.... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57899999999999999999986 47889999986432 22234567899999999999999999999877 889999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++ +|.+++.... ..+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999975 8988886533 35899999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH--------HHHhhc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHA--------WKLWNE 612 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~ 612 (706)
.. .......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||...........+... +..+..
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 32 112234578899999998764 4689999999999999999999998643322111111100 000000
Q ss_pred ------CCCcccccccccCcCCHH-HHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 613 ------GMPSQLIDACFKDSFNLA-EVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 613 ------~~~~~~~d~~~~~~~~~~-~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
..........+...+... ....+.+++..||+.+|++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000011111111111 1234567899999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=295.06 Aligned_cols=248 Identities=27% Similarity=0.352 Sum_probs=199.7
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
..+.|+.-++||+||||.||-.+.. .|+.+|.|++.+. ..+......+|-.++.+++.+.||.+--+|+..+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3467888899999999999999875 4888999988552 23444567889999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
|+..|+||+|.-+|++... ..+++.+++.+|.+|+.||++||... ||.||+||+|||||+.|+++|+|+|||..+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999987665 55899999999999999999999887 9999999999999999999999999999875
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
..+.. ...+||.+|||||++.+..|+...|.||+||+||||+.|+.||.........+.+...... ...++.
T Consensus 339 ~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~----~~~ey~- 410 (591)
T KOG0986|consen 339 EGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE----DPEEYS- 410 (591)
T ss_pred CCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc----chhhcc-
Confidence 43322 2248999999999999999999999999999999999999998765544333222221111 111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPC 652 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt 652 (706)
+.++ .++..+....|+.||.+|--
T Consensus 411 ----~kFS----~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 411 ----DKFS----EEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred ----cccC----HHHHHHHHHHHccCHHHhcc
Confidence 1122 23445667889999999963
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=296.92 Aligned_cols=251 Identities=25% Similarity=0.407 Sum_probs=201.1
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
.++|.+.+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 368999999999999999999874 5788999998655555567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 9999999998542 3678899999999999999999988 99999999999999999999999999876543222
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
......+++.|+|||.+....++.++||||||+++|++++|+.||........... ....+.. .+ .
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~~~-~~-----~ 236 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGTP-EL-----Q 236 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCCCC-CC-----C
Confidence 12234688899999999888899999999999999999999999854322111000 0001110 00 0
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
........+.+++..||+.+|.+||++.+++.+
T Consensus 237 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 --NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000112245678899999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=293.35 Aligned_cols=247 Identities=27% Similarity=0.435 Sum_probs=198.1
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
-|++.+.||+|+||.||+|... +++.+|+|.+... .....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4677899999999999999874 5789999987543 2344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++.. ..+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999999853 34789999999999999999999987 99999999999999999999999999876533211
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......++..|+|||.+.+..++.++||||||+++|+|++|..|+...... .... .........+ ..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~----~~~~~~~~~~-----~~ 223 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM---KVLF----LIPKNNPPTL-----EG 223 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH---HHHH----HHhcCCCCCC-----Cc
Confidence 122346788999999998888999999999999999999999997532211 1111 1111111111 11
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. ....+.+++.+||+.+|.+||++.++++.
T Consensus 224 ~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 N----YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred c----cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1 12345678999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=294.17 Aligned_cols=248 Identities=24% Similarity=0.412 Sum_probs=197.4
Q ss_pred CCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcC---CcceeeeEeEEEeCCeeEEEE
Q 005236 388 NFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQ---HRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~ 462 (706)
.|++.+.||+|+||.||+|.. .+++.+++|.+... .....+.+.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999997 46889999988653 3445667889999999997 999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999988542 5889999999999999999999988 999999999999999999999999999876433
Q ss_pred CCcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
.. ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.|+...... ..+. .........+.
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~----~~~~~~~~~~~-- 223 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF---RAMM----LIPKSKPPRLE-- 223 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh---hhhh----ccccCCCCCCC--
Confidence 21 22234688999999998654 5789999999999999999999998543211 1110 01111111111
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
... ....+.+++.+||+.+|.+||++.|+++.
T Consensus 224 ---~~~---~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 224 ---DNG---YSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---ccc---CCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 110 12356678899999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=293.54 Aligned_cols=247 Identities=25% Similarity=0.330 Sum_probs=199.3
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
+|++.+.||.|+||.||++... .++.+|+|.+... .....+.+.+|+.++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788999999999999999986 4889999998653 22456789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++++|.+++... ..+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998554 35788999999999999999999987 9999999999999999999999999998764332
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+............ ..... .......
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~--~~~~~~~-- 223 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----AKQET--ADVLYPA-- 223 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----HHhcc--ccccCcc--
Confidence 223356788999999999888999999999999999999999997654432111111 11111 0000110
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCCh--hHHH
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCM--PSVI 657 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~--~ev~ 657 (706)
.....+.+++.+||+.+|.+||++ +|++
T Consensus 224 ------~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 224 ------TWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ------cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111456688999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=293.49 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=191.6
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc-hhhHHHHHHHHHH-HhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS-EQGLKELKNEIIL-FSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
++|++.+.||+|+||.||+++.. +++.||+|++.... ......+..|+.. ++.++||||+++++++......++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999985 58899999986532 2233455556665 666789999999999999999999999
Q ss_pred cCCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 464 FMPNKSLDSFIFDQ-ERCKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 464 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|++ ++|.+++... .....+++..++.++.||+.||+|||++ + ++||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 6888887542 2235689999999999999999999986 5 99999999999999999999999999986532
Q ss_pred CCCcccccccccccCccCcccccc----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASD----GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+.... ........ ... .....
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~---~~~-~~~~~ 227 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK--TPFQQLKQ---VVE-EPSPQ 227 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc--cCHHHHHH---HHh-cCCCC
Confidence 21 1122457889999998865 456899999999999999999999975322 11111111 111 11111
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+... .. ...+.+++..||+.+|.+||++++|++
T Consensus 228 ~~~~----~~----~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 LPAE----KF----SPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCcc----cc----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 11 124567889999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=296.33 Aligned_cols=261 Identities=23% Similarity=0.321 Sum_probs=197.3
Q ss_pred CCccceeccCCceeEEEEEeCC-CcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC--CeeEEEEe
Q 005236 389 FSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--EEKLLIYE 463 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e 463 (706)
|++.++||+|+||.||+|+..+ ++.+|+|++.... ....+.+.+|+.++++++||||+++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5678999999999999999864 7899999987642 33456788999999999999999999999988 78999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++ +|.+++.... ..+++..++.++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 8888885432 45889999999999999999999987 9999999999999999999999999998764332
Q ss_pred CcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC---CCccc-
Q 005236 544 TEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG---MPSQL- 618 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~- 618 (706)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... ............. ....+
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL---EQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchhhccccc
Confidence 11 1222456788999998765 46789999999999999999999997543322 1111111111100 00000
Q ss_pred -------------ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 619 -------------IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 619 -------------~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
....+...........+.+++.+||+.+|.+||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000000013457789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=296.68 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=203.5
Q ss_pred HhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
...+.|+..+.||+|++|.||+|... +++.+++|++..... ..+.+.+|++++++++|+||+++++.+......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35577889999999999999999986 588999999865444 5678899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999996543 36899999999999999999999987 999999999999999999999999998765322
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
.. ......++..|+|||++.+..++.++||||||+++|+|++|+.|+...... ..... .. ......+...
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~~~~---~~-~~~~~~~~~~- 239 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RALFL---IT-TKGIPPLKNP- 239 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---HH-hcCCCCCcch-
Confidence 11 122345788999999999889999999999999999999999997532221 11111 11 1111111110
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
... ...+.+++.+||+.+|.+||++.+|++.
T Consensus 240 --~~~----~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 240 --EKW----SPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred --hhC----CHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 001 1246678999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=299.57 Aligned_cols=263 Identities=24% Similarity=0.312 Sum_probs=194.5
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC--CeeEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--EEKLL 460 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 460 (706)
.++|++.++||+|+||.||+|... .++.||+|++.... ......+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999985 48899999986432 12233567899999999999999999998765 46899
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+++ +|.+++.... ..+++..+..++.||++||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 7888875432 45889999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC---CCc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG---MPS 616 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 616 (706)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ............. ..+
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI---EQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChhhch
Confidence 3221 1122345788999999865 56899999999999999999999998643222 2222111111100 000
Q ss_pred ccc-----cc-cc--cCcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 617 QLI-----DA-CF--KDSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 617 ~~~-----d~-~~--~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+. .. .+ ....... ....+.+++..||+.||++|||++|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 00 00 0000000 12345679999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=294.01 Aligned_cols=247 Identities=24% Similarity=0.390 Sum_probs=197.6
Q ss_pred CCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 389 FSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999987 46888999998655555566788999999999999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++........ .
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~ 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence 999999855 34788999999999999999999988 99999999999999999999999999876533221 1
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcC
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSF 627 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 627 (706)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.|+... .......... ......... ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~---~~~~~~~~~~----~~~~~~~~~-----~~ 239 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE---PPLQAMKRIR----DNLPPKLKN-----LH 239 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC---CHHHHHHHHH----hcCCCCCcc-----cc
Confidence 22345889999999999888999999999999999999999997432 1122221111 111111110 00
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 628 NLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 628 ~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.....+.+++.+||+.+|.+||++.++++
T Consensus 240 --~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 --KVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 01135678999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=293.73 Aligned_cols=248 Identities=22% Similarity=0.330 Sum_probs=204.4
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.=|.+.+.||+|.|.+|-++++ =.|..||||++.+. .......+.+|++-|+.++|||||+||.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4577889999999999999886 46899999999764 33445678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc-CCCCeEEeeeccccccCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~Dfgla~~~~~~ 542 (706)
.=++|+|.+||-.++. -+.+....+++.||+.|+.|.|..+ +|||||||+||.+- .-|-+||.|||++..+.+.
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999976653 4788889999999999999999877 99999999998765 5688999999999876543
Q ss_pred CCcccccccccccCccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
+ .....+|+..|.|||++.+..|+ ++.||||||||||.|++|+.||......+.+..|-..
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC--------------- 234 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC--------------- 234 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc---------------
Confidence 3 33457899999999999999987 5789999999999999999998765544433332111
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
-. ..+-.-..++.+|+..||..||.+|.+.+||+..
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 00 1111223467889999999999999999999753
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=305.64 Aligned_cols=267 Identities=22% Similarity=0.312 Sum_probs=197.1
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC-----ee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE-----EK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 458 (706)
.++|++.++||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999874 5889999998643 2334566888999999999999999999876543 57
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++|+||+++ +|..++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 77777633 34889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCcc-cccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc
Q 005236 539 FGGDETEG-NTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616 (706)
Q Consensus 539 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (706)
........ ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..... .............+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~---~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY---LHQLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCCHH
Confidence 54322111 1223568899999998755 5689999999999999999999999754221 11111111111111000
Q ss_pred ---cccccc---------ccCcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHHH--hcCC
Q 005236 617 ---QLIDAC---------FKDSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVILM--LGSE 663 (706)
Q Consensus 617 ---~~~d~~---------~~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~~--L~~~ 663 (706)
.+.+.. ........ ....+.+++.+||+.+|++|||+.|+++. ++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 000000 00000000 12346789999999999999999999987 5543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=295.11 Aligned_cols=258 Identities=27% Similarity=0.425 Sum_probs=197.8
Q ss_pred HHHHHHhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEe--
Q 005236 379 LATIANATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIH-- 454 (706)
Q Consensus 379 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-- 454 (706)
+..+..+.+.|++.+.||+|+||.||+|+.. .++.+|+|.+.... ....++..|+.++.++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3344455678999999999999999999984 57889999875433 3346788899999998 69999999999863
Q ss_pred ----CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEE
Q 005236 455 ----GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 530 (706)
Q Consensus 455 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 530 (706)
....+++|||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 457899999999999999986533 244778888999999999999999988 999999999999999999999
Q ss_pred eeeccccccCCCCCcccccccccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHH
Q 005236 531 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRH 605 (706)
Q Consensus 531 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~ 605 (706)
+|||++....... .......|+..|+|||.+. ...++.++||||||+++|||++|+.||...... ..+..
T Consensus 163 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---~~~~~ 237 (282)
T cd06636 163 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM---RALFL 237 (282)
T ss_pred eeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH---hhhhh
Confidence 9999987653211 1223356889999999986 346888999999999999999999997533211 11111
Q ss_pred HHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 606 AWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 606 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
. .......+. .... ...+.+++..||+.+|.+||++.||++
T Consensus 238 ---~-~~~~~~~~~----~~~~----~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 ---I-PRNPPPKLK----SKKW----SKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---H-hhCCCCCCc----cccc----CHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 011111110 0011 124667899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=297.52 Aligned_cols=261 Identities=24% Similarity=0.317 Sum_probs=194.7
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+|++.+.||.|++|.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999885 58899999886432 22345788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+. ++|..++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+.....
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 68988886543 345889999999999999999999987 99999999999999999999999999886533211
Q ss_pred cccccccccccCccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC---------
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM--------- 614 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 614 (706)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.||...... ..............
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHhCCCChhhhhhhhH
Confidence 122235688999999887644 688999999999999999999997543221 11111111100000
Q ss_pred -------CcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 615 -------PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 615 -------~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
........+.... ......+.+++.+||+.||.+|||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVV-PPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhhcccccccCHHHHc-ccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000000 0001235678999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=304.28 Aligned_cols=260 Identities=25% Similarity=0.288 Sum_probs=196.0
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC------
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG------ 455 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 455 (706)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3478999999999999999999974 5889999998642 334456778899999999999999999988643
Q ss_pred CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecc
Q 005236 456 EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 535 (706)
Q Consensus 456 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgl 535 (706)
...++||||+.+ +|.+.+... ++...+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 356999999964 787777422 788889999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh-----
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLW----- 610 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~----- 610 (706)
++....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. ..........
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 238 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI---DQWNKIIEQLGTPSD 238 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhcCCCCH
Confidence 987533221 22345788999999999999999999999999999999999997543221 1111110000
Q ss_pred -------------hcCC-------CcccccccccC----cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 611 -------------NEGM-------PSQLIDACFKD----SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 611 -------------~~~~-------~~~~~d~~~~~----~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.... ..++....+.. .........+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 00111110000 0011123356789999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=317.68 Aligned_cols=267 Identities=20% Similarity=0.261 Sum_probs=187.2
Q ss_pred HhccCCCccceeccCCceeEEEEEeCC--CcEEEEE------------------EcCccchhhHHHHHHHHHHHhhcCCc
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTLAD--EQEIAVK------------------RLSKISEQGLKELKNEIILFSKLQHR 443 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~ 443 (706)
...++|++.++||+|+||.||++..+. +...++| ++. ........+.+|+.++++++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999987532 2112222 111 1223345688999999999999
Q ss_pred ceeeeEeEEEeCCeeEEEEecCCCCChhhhhhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEE
Q 005236 444 NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQER--CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 521 (706)
Q Consensus 444 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nil 521 (706)
||+++++++...+..++|+|++. ++|.+++..... ...........++.||+.||+|||+.+ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 99999999999999999999985 567776643221 122335567789999999999999988 999999999999
Q ss_pred EcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchh
Q 005236 522 LDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLN 601 (706)
Q Consensus 522 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~ 601 (706)
|+.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|..++..........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 999999999999999876432221 2223579999999999999999999999999999999999886433222222212
Q ss_pred HHHHHHHHhh---cCCCc---cc---------------ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 602 LIRHAWKLWN---EGMPS---QL---------------IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 602 ~~~~~~~~~~---~~~~~---~~---------------~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+........ +..+. .+ +...+.... ....+.+++.+||+.||.+|||+.|++..
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLG---LPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcC---CChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 2111111110 00000 00 000000000 01134567889999999999999999864
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=298.73 Aligned_cols=265 Identities=23% Similarity=0.317 Sum_probs=193.9
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC------
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE------ 456 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 456 (706)
.++|++.++||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999985 58899999885432 222345678999999999999999999987654
Q ss_pred --eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeec
Q 005236 457 --EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 534 (706)
Q Consensus 457 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 534 (706)
..++||||+.+ +|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 34999999975 787777433 235789999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCCCc--ccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh
Q 005236 535 LARAFGGDETE--GNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWN 611 (706)
Q Consensus 535 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 611 (706)
++..+...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...........+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99876432211 112234578899999988664 478899999999999999999998754332222222222111100
Q ss_pred cCCCccc------------------ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 612 EGMPSQL------------------IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 612 ~~~~~~~------------------~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
....+.. ....+... .+...+.+++.+||+.+|.+|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000 00000000 012345689999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=295.64 Aligned_cols=260 Identities=24% Similarity=0.313 Sum_probs=194.3
Q ss_pred CCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 389 FSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
|++.+.||.|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567899999999999999975 68899999986432 233457888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
+ ++|.+++..... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 689998865432 35899999999999999999999987 99999999999999999999999999976532211
Q ss_pred ccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC---------C
Q 005236 546 GNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM---------P 615 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~ 615 (706)
......++..|+|||++.+. .++.++||||||+++|||++|+.||........ .....+...... .
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ---LFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhhhhhc
Confidence 11223568899999988664 578999999999999999999999754322111 111111000000 0
Q ss_pred ccccc-------ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 616 SQLID-------ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 616 ~~~~d-------~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+... ..... ........+.+++.+||+.+|.+|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 231 PDYKPTFPKWARQDLSK-VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhcccccccchhh-hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 00000 000011356689999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.10 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=194.5
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.+.|.+.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356889999999999999999985 5889999988542 233456788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||++ |+|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 56766664322 35899999999999999999999987 99999999999999999999999999876432
Q ss_pred CCCcccccccccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
. ....++..|+|||++. ...++.++||||||+++|||++|+.|+..... ..... ... ......+
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~---~~~~~---~~~-~~~~~~~ 234 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALY---HIA-QNDSPTL 234 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH---HHHHH---HHh-cCCCCCC
Confidence 1 2245788999999884 45688999999999999999999999743221 11111 111 1111111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHh
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L 660 (706)
.. ......+.+++.+||+.+|.+||++.+|+...
T Consensus 235 ~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 235 SS--------NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred Cc--------hhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00 01123467889999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=305.25 Aligned_cols=250 Identities=27% Similarity=0.437 Sum_probs=201.8
Q ss_pred cCCCccceeccCCceeEEEEEeCCCc-EEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQ-EIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
+.|.|+-.||.|+||.||++..++.. ..|.|.+...+...++.+.-|+++|+..+||+||+|++.|...+.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 56788889999999999999987644 34678887778888999999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
.||..+..+..-. ..+.+..+..+.+|++.||.|||+++ |||||||+.|||+.-+|.++|+|||.+.... ...
T Consensus 112 ~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STR 184 (1187)
T ss_pred CCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHH
Confidence 9999999986644 45888999999999999999999998 9999999999999999999999999986531 122
Q ss_pred ccccccccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 546 GNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.......|||.|||||+.. ..+|+.++||||||++|.||.-+.+|-.. -+.. .-...+.. ..++.++.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe---lnpM---RVllKiaK-SePPTLlq 257 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE---LNPM---RVLLKIAK-SEPPTLLQ 257 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc---cchH---HHHHHHhh-cCCCcccC
Confidence 2334578999999999875 45899999999999999999999998432 1222 11222222 22222322
Q ss_pred c-cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 621 A-CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 621 ~-~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+ .| ...+.+++..||..||..||++.++++
T Consensus 258 PS~W--------s~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 PSHW--------SRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cchh--------hhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1 12 223457888999999999999999875
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=291.20 Aligned_cols=258 Identities=19% Similarity=0.212 Sum_probs=181.9
Q ss_pred ccCCCccceeccCCceeEEEEEeCCC----cEEEEEEcCccchhhH-----------HHHHHHHHHHhhcCCcceeeeEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADE----QEIAVKRLSKISEQGL-----------KELKNEIILFSKLQHRNLVKLLG 450 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~ 450 (706)
.++|.+.++||+|+||.||+|...++ ..+|+|.......... .....+...+..++|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999997554 4556665322211110 11223334556678999999999
Q ss_pred EEEeCC----eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC
Q 005236 451 CCIHGE----EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 526 (706)
Q Consensus 451 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 526 (706)
++.... ..++++|++.. ++.+.+... ...++..+..++.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876544 34677887643 555555322 22467788899999999999999987 99999999999999999
Q ss_pred CeEEeeeccccccCCCCCc-----ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchh
Q 005236 527 NPKISDFGLARAFGGDETE-----GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLN 601 (706)
Q Consensus 527 ~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~ 601 (706)
.++|+|||+|+.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999999876432111 12223469999999999999999999999999999999999999987543222111
Q ss_pred HHHH--HHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 602 LIRH--AWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 602 ~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
.... .......+.. .+. .. ...+.+++..|++.+|++||+++++++.|.
T Consensus 244 ~~~~~~~~~~~~~~~~--~~~-----~~----~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIKRLHEGKI--KIK-----NA----NKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHHHhhhhhh--ccC-----CC----CHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1100 1111111110 000 01 134667888999999999999999998764
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=289.54 Aligned_cols=241 Identities=28% Similarity=0.369 Sum_probs=187.4
Q ss_pred eccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCCh
Q 005236 395 LGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 470 (706)
Q Consensus 395 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 470 (706)
||+|+||+||++... +++.+|+|.+.... ....+.+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999874 58899999886422 22345667899999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccc
Q 005236 471 DSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 550 (706)
Q Consensus 471 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 550 (706)
.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++...... .....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence 999965432 35789999999999999999999988 999999999999999999999999998865331 11223
Q ss_pred cccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHH
Q 005236 551 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLA 630 (706)
Q Consensus 551 ~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 630 (706)
..++..|+|||++.+..++.++||||||+++|+|++|+.||...........+... ... ....+ ....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~-~~~~~-----~~~~--- 221 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR---TLE-MAVEY-----PDKF--- 221 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc---ccc-ccccC-----CccC---
Confidence 45788999999998888999999999999999999999998543332111111110 000 00000 0111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCChhH
Q 005236 631 EVIRCIHIGLLCVQQYPEDRPCMPS 655 (706)
Q Consensus 631 ~~~~~~~l~~~cl~~~p~~RPt~~e 655 (706)
...+.+++..||+.+|.+||+..+
T Consensus 222 -~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 222 -SPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred -CHHHHHHHHHHccCChhHccCCCc
Confidence 224567889999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=286.73 Aligned_cols=250 Identities=25% Similarity=0.408 Sum_probs=198.3
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+|++.+.||+|+||.||+|..+ ++..+|+|.+... .....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999985 4788999988543 223456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-CeEEeeeccccccCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFGGDE 543 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfgla~~~~~~~ 543 (706)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999865332 35789999999999999999999987 99999999999999886 46999999998764322
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
. ......|++.|+|||++.+..++.++||||||+++|||++|+.|+.... .... ...... .....+.
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~---~~~~~~-~~~~~~~---- 223 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN---LHQL---VLKICQ-GYFAPIS---- 223 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHH---HHHHhc-ccCCCCC----
Confidence 1 1223468899999999988899999999999999999999999974321 1111 111111 1111111
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
... ...+.+++.+|++.+|++|||+.||++.
T Consensus 224 -~~~----~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 224 -PNF----SRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCC----CHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011 1246678899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.14 Aligned_cols=258 Identities=21% Similarity=0.256 Sum_probs=190.6
Q ss_pred CCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc-hhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeC--CeeEEEEe
Q 005236 389 FSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS-EQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHG--EEKLLIYE 463 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~e 463 (706)
|++.++||+|+||.||+|... +++.+|+|+++... ........+|+.++.++. ||||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 667899999999999999974 58899999986532 222234457888888885 99999999999987 88999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++. +.+||+|||+++.+....
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 57877775432 46899999999999999999999987 999999999999999 999999999998764322
Q ss_pred CcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhc----------
Q 005236 544 TEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNE---------- 612 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---------- 612 (706)
. .....++..|+|||++.. ..++.++|||||||++|||++|+.||..... .+.+.........
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE---LDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH---HHHHHHHHHHcCCCCHHHHHhhc
Confidence 1 122457889999997644 5678999999999999999999999854332 1122111111100
Q ss_pred -CCCcccccccccC----cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 613 -GMPSQLIDACFKD----SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 613 -~~~~~~~d~~~~~----~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
........+.... .........+.+++.+||+.+|++||+++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000000 0000123467789999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=292.79 Aligned_cols=255 Identities=27% Similarity=0.359 Sum_probs=193.0
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc-hhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCeeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS-EQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 463 (706)
++|...++||+|+||.||+++.. .++.+|+|++.... ......+.+|+.++.++. ||||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35667789999999999999985 47899999986532 344567889999999996 9999999999999999999999
Q ss_pred cCCCCChhhhhhc--ccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 464 FMPNKSLDSFIFD--QERCKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 464 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
|+.. +|.++... ......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||+++.+.
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9864 55443321 11224588999999999999999999975 5 9999999999999999999999999998653
Q ss_pred CCCCcccccccccccCccCccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDG---QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
... ......++..|+|||++... .++.++||||||+++|||++|+.||.... .......+.... ....
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~-~~~~ 230 (288)
T cd06616 160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG-DPPI 230 (288)
T ss_pred cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC-CCCc
Confidence 321 11224578899999999776 68999999999999999999999975432 111111111111 1111
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
+. ..........+.+++.+||+.+|.+|||+++|++.
T Consensus 231 ~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LS-----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CC-----CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 11111122356789999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=294.01 Aligned_cols=263 Identities=24% Similarity=0.319 Sum_probs=194.0
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
++|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999985 58899999885432 2334678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-CCCeEEeeeccccccCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGD 542 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfgla~~~~~~ 542 (706)
|++ ++|.+++..... ..+++..+..++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 578777744332 23577888899999999999999987 999999999999985 567999999999865332
Q ss_pred CCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcc----
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ---- 617 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 617 (706)
.. ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||..... ...+.........+....
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE---IDELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChhhcccc
Confidence 11 1122457889999999866 4678999999999999999999999754322 111211111111110000
Q ss_pred --ccc-----ccccCc----CCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 618 --LID-----ACFKDS----FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 618 --~~d-----~~~~~~----~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
+.+ +..... ........+.+++.+||+.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 000000 000112246789999999999999999999863
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=293.75 Aligned_cols=254 Identities=28% Similarity=0.421 Sum_probs=197.3
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.|...+.||+|+||.||+|+.. ++..+|+|++... .....+.+.+|+.++++++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4677899999999999999974 5789999998642 23345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++ +|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9975 777776433 245889999999999999999999988 99999999999999999999999999875422
Q ss_pred CcccccccccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.....++..|+|||++. ...++.++||||||+++|||++|+.|+..... ...... ........ ...
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~---~~~~~~~~-~~~ 246 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYH---IAQNESPT-LQS 246 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHH---HHhccCCC-CCC
Confidence 22346788999999974 45789999999999999999999999753211 111111 11111110 000
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCCCCC
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLPQ 668 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~~~~ 668 (706)
......+.+++.+||+.+|.+||++.+|++.+--....+.
T Consensus 247 --------~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 247 --------NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred --------ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 0111245678999999999999999999987765544443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=302.00 Aligned_cols=264 Identities=23% Similarity=0.322 Sum_probs=196.9
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC-----Ce
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG-----EE 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 457 (706)
.++|.+.+.||+|+||.||+|+.. .++.||||++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999974 5889999998642 233455678899999999999999999988654 34
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 6888888543 35889999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC-
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP- 615 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 615 (706)
...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ..............
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~ 231 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEE 231 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChH
Confidence 753321 11223467889999998865 468999999999999999999999985432211 11111111100000
Q ss_pred ----------cccc-------cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH--hcC
Q 005236 616 ----------SQLI-------DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM--LGS 662 (706)
Q Consensus 616 ----------~~~~-------d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~--L~~ 662 (706)
...+ +...... .......+.+++.+||+.+|++|||++|+++. ++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARL-FPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHH-cccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 0000 0000000 00112346789999999999999999999977 544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.63 Aligned_cols=264 Identities=24% Similarity=0.339 Sum_probs=195.7
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC-----
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE----- 456 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 456 (706)
..++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999985 47899999986432 233456788999999999999999999987655
Q ss_pred -----eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEe
Q 005236 457 -----EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 531 (706)
Q Consensus 457 -----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 531 (706)
..++|+||+++ +|...+... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999986 666666433 245889999999999999999999987 9999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 005236 532 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLW 610 (706)
Q Consensus 532 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 610 (706)
|||++..+..... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..... ...........
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~---~~~~~~~~~~~ 234 (302)
T cd07864 159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE---LAQLELISRLC 234 (302)
T ss_pred cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHh
Confidence 9999987643221 11122346778999998865 4578999999999999999999998753222 22222222211
Q ss_pred hcCCC---ccccc--------------ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 611 NEGMP---SQLID--------------ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 611 ~~~~~---~~~~d--------------~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
..... +.+.. ..+..... .....+.+++..||+.+|.+||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11110 00000 00000000 012356789999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=302.64 Aligned_cols=267 Identities=25% Similarity=0.360 Sum_probs=196.4
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeC--Cee
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHG--EEK 458 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 458 (706)
..++|++.+.||+|+||.||+|.+. +++.+|||++.. ........+..|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3468999999999999999999985 578899998854 2333455677899999999 999999999998654 367
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||++ ++|..++... .+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5898888542 5788889999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCCc---ccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH-------
Q 005236 539 FGGDETE---GNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAW------- 607 (706)
Q Consensus 539 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~------- 607 (706)
+...... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6433221 12233568899999998765 567899999999999999999999975433221111110000
Q ss_pred -HHhhcCCCccccccccc-CcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 608 -KLWNEGMPSQLIDACFK-DSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 608 -~~~~~~~~~~~~d~~~~-~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
..+.......+++.... ...... ....+.+++.+||+.+|.+|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000001100000 000000 12356789999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=290.44 Aligned_cols=256 Identities=23% Similarity=0.326 Sum_probs=198.7
Q ss_pred CCCccceeccCCceeEEEEEeC----CCcEEEEEEcCccc----hhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCee
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA----DEQEIAVKRLSKIS----EQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 458 (706)
+|++.+.||+|+||.||+++.. +++.||||.+.... ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999999853 46789999886432 22345688999999999 599999999999999999
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||+++++|.+++... ..+++..+..++.|++++|.|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999998543 34788889999999999999999887 99999999999999999999999999887
Q ss_pred cCCCCCcccccccccccCccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASDGQ--FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (706)
+...... ......++..|+|||.+.+.. .+.++||||||+++|||++|+.|+...........+ ..........
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~--~~~~~~~~~~- 230 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI--SRRILKSKPP- 230 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH--HHHHHccCCC-
Confidence 5433211 122345789999999987655 788999999999999999999997543222111111 1111111100
Q ss_pred ccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 617 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.....+ ..+.+++.+||+.+|++|||++++.+.|+..
T Consensus 231 ------~~~~~~----~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 231 ------FPKTMS----AEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ------CCcccC----HHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 001111 2356788999999999999999999988764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=285.69 Aligned_cols=242 Identities=24% Similarity=0.335 Sum_probs=191.7
Q ss_pred eccCCceeEEEEEeCC-CcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCCh
Q 005236 395 LGEGGFGPVYKGTLAD-EQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 470 (706)
Q Consensus 395 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 470 (706)
||.|++|.||+++... ++.+++|.+.... ....+.+.+|+.++++++||||+++++.+.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999854 8899999986532 23456789999999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccc
Q 005236 471 DSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 550 (706)
Q Consensus 471 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 550 (706)
.+++... ..+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||+++...... ....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 9999653 34788899999999999999999987 9999999999999999999999999998764322 2223
Q ss_pred cccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHH
Q 005236 551 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLA 630 (706)
Q Consensus 551 ~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 630 (706)
..++..|+|||.+....++.++|+||||+++|||++|+.|+.....+ ....... ............ .
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~---~~~~~~~~~~~~-----~---- 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PMEIYND---ILKGNGKLEFPN-----Y---- 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HHHHHHH---HhccCCCCCCCc-----c----
Confidence 46788999999998888999999999999999999999998654321 1111111 111011100000 0
Q ss_pred HHHHHHHHHHHhcCCCCCCCCC-----hhHHHH
Q 005236 631 EVIRCIHIGLLCVQQYPEDRPC-----MPSVIL 658 (706)
Q Consensus 631 ~~~~~~~l~~~cl~~~p~~RPt-----~~ev~~ 658 (706)
....+.+++..||+.+|.+||+ ++|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1235678999999999999999 555544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=286.50 Aligned_cols=245 Identities=23% Similarity=0.225 Sum_probs=188.3
Q ss_pred ceeccCCceeEEEEEeC-CCcEEEEEEcCccch---hhHHHHHHHHHH-HhhcCCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISE---QGLKELKNEIIL-FSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
+.||+|+||.||+|... +++.||+|.+..... .....+..|..+ ....+||||+++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999884 578999999865322 222334455544 4455899999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 9999998543 34788999999999999999999987 99999999999999999999999999876432
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcC
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSF 627 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 627 (706)
.....++..|+|||.+.+..++.++||||||+++|||++|..|+..... ....... ...... . ......
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~----~~~~~~-~-~~~~~~-- 218 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFDNI----LSRRIN-W-PEEVKE-- 218 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH----HhcccC-C-CCcccc--
Confidence 2234578899999999888899999999999999999999999753221 1111111 111100 0 000000
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 628 NLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 628 ~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
.....+.+++.+||+.+|.+||++.++.+.|..
T Consensus 219 --~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 219 --FCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred --cCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 112346678999999999999998877776654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=281.76 Aligned_cols=247 Identities=28% Similarity=0.433 Sum_probs=199.9
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccch--hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISE--QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+|++.+.||+|++|.||+++.. .++.+++|.+..... ...+.+.+|++++++++|||++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999875 578899999876443 4567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998544 45899999999999999999999887 99999999999999999999999999987643322
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
. .....++..|+|||......++.++||||+|+++|+|++|+.|+..... ... ....... ....+.
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~---~~~~~~~-~~~~~~----- 220 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAA---LFRIVQD-DHPPLP----- 220 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHH---HHHHhcc-CCCCCC-----
Confidence 1 2234678899999999888899999999999999999999999753221 111 1111111 111111
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
... ...+.+++.+||+.+|++||++.+++.
T Consensus 221 ~~~----~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 EGI----SPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCC----CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111 124567889999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=291.41 Aligned_cols=260 Identities=26% Similarity=0.352 Sum_probs=198.2
Q ss_pred CCccceeccCCceeEEEEEeC-CCcEEEEEEcCccch--hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 389 FSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISE--QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
|++.+.||+|++|.||++... +++.+++|++..... .....+..|+.++++++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999985 588899999865322 34567888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++ +|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 75 8888875533 45889999999999999999999988 9999999999999999999999999998765433
Q ss_pred ccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC---Cccccc-
Q 005236 546 GNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM---PSQLID- 620 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d- 620 (706)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||..... .+.+........... ...+.+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE---IDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCchHhcccchhh
Confidence 112224577889999998876 789999999999999999999988754332 222222111111110 000000
Q ss_pred -----ccc--cCcCC-----HHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 621 -----ACF--KDSFN-----LAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 621 -----~~~--~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
... ..... ......+.+++..||+.+|.+||++++++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 00000 1123467789999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=284.47 Aligned_cols=248 Identities=22% Similarity=0.268 Sum_probs=188.2
Q ss_pred HHHHhccCCCcccee--ccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCC
Q 005236 381 TIANATDNFSINKKL--GEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGE 456 (706)
Q Consensus 381 ~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 456 (706)
+.....++|++.+.+ |+|+||.||++..+ ++..+|+|.+...... .. |+.....+ +||||+++++.+...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~--e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---AI--EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---hh--hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 344455677787777 99999999999974 5778899987543211 11 22222222 7999999999999999
Q ss_pred eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-CeEEeeecc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGL 535 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfgl 535 (706)
..++||||+++++|.+++.... .+++..+..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 9999999999999999996543 6899999999999999999999988 99999999999999998 999999999
Q ss_pred ccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
++..... ....++..|+|||++.+..++.++||||||+++|||++|+.||....... ....... ... ....
T Consensus 157 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~-~~~-~~~~ 227 (267)
T PHA03390 157 CKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLL-KRQ-QKKL 227 (267)
T ss_pred ceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHH-Hhh-cccC
Confidence 8865322 12457899999999999999999999999999999999999986332221 1111111 111 1100
Q ss_pred cccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCC-hhHHHH
Q 005236 616 SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPC-MPSVIL 658 (706)
Q Consensus 616 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-~~ev~~ 658 (706)
.... .....+.+++..||+.+|.+||+ ++++++
T Consensus 228 -~~~~---------~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 -PFIK---------NVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -Cccc---------ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1110 11224567889999999999996 688874
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=282.34 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=202.9
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+|.+.+.||+|+||.||++... +++.+++|++.... ....+.+.+|+++++.++|||++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999985 58899999986542 35567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 465 MPNKSLDSFIFDQE-RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 465 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999996532 2356899999999999999999999987 9999999999999999999999999998764432
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
.......+++.|+|||.+....++.++||||+|+++++|++|+.|+.... ....... . .......+..
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~---~-~~~~~~~~~~--- 225 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALK---I-LKGQYPPIPS--- 225 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHHH---H-hcCCCCCCCC---
Confidence 12223468889999999998899999999999999999999999975432 1111111 1 1111111111
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. ....+.+++.+||+.+|.+||++.|+++.
T Consensus 226 --~----~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 --Q----YSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred --C----CCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 11345678999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=287.36 Aligned_cols=242 Identities=26% Similarity=0.317 Sum_probs=184.1
Q ss_pred eeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHH---hhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 394 KLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILF---SKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 394 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..++ ...+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999985 47899999885421 12222334444433 33479999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+++|.+++..+ ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---- 150 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc----
Confidence 99999988643 34899999999999999999999988 999999999999999999999999998765322
Q ss_pred cccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 547 NTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......|+..|+|||.+.. ..++.++|||||||++|||++|+.||.......... +... ... ....+ ..
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~---~~~-~~~~~-----~~ 220 (279)
T cd05633 151 KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRM---TLT-VNVEL-----PD 220 (279)
T ss_pred CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHH---hhc-CCcCC-----cc
Confidence 1223468999999999864 568999999999999999999999986443322111 1111 000 00011 11
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCC-----ChhHHHHH
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRP-----CMPSVILM 659 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~~ 659 (706)
.. ...+.+++..||+.||.+|| +++|+++.
T Consensus 221 ~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 221 SF----SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cc----CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11 22456788999999999999 59999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=294.93 Aligned_cols=261 Identities=23% Similarity=0.317 Sum_probs=191.6
Q ss_pred ceeccC--CceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEG--GFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
..||+| +||+||+++.. .++.||+|.+.. ......+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 567777 89999999984 689999999864 2334457889999999999999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc-
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG- 546 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~- 546 (706)
++|.+++..... ..+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999999865432 34788888999999999999999887 9999999999999999999999998654332111110
Q ss_pred ----cccccccccCccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH-----------
Q 005236 547 ----NTNRVVGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKL----------- 609 (706)
Q Consensus 547 ----~~~~~~gt~~y~aPE~~~~~--~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~----------- 609 (706)
......++..|+|||++.+. .++.++||||||+++|||++|+.||....... .........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccc
Confidence 11112346679999999764 57899999999999999999999985432211 000000000
Q ss_pred ------------h---------hcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 610 ------------W---------NEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 610 ------------~---------~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. .........+..+...........+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 0000000111111111122234567899999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=291.14 Aligned_cols=244 Identities=24% Similarity=0.388 Sum_probs=194.5
Q ss_pred cceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCCh
Q 005236 392 NKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 470 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 470 (706)
..+||+|+||.||++... +++.||||++........+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 368999999999999884 6889999998655555567789999999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccc
Q 005236 471 DSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 550 (706)
Q Consensus 471 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 550 (706)
.+++.. ..+++..+..++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||++........ ....
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~ 175 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS 175 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence 998743 23788899999999999999999987 99999999999999999999999999876533221 1223
Q ss_pred cccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHH
Q 005236 551 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLA 630 (706)
Q Consensus 551 ~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 630 (706)
..++..|+|||.+.+..++.++||||||+++|||++|..|+..... ........ ......+.. + ...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~~----~~~~~~~~~--~-~~~--- 242 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIR----DNLPPKLKN--L-HKV--- 242 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH----hhCCcccCC--c-ccC---
Confidence 4678999999999888899999999999999999999999753221 11111111 111111100 0 001
Q ss_pred HHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 631 EVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 631 ~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
...+.+++.+||+.+|.+||++.++++
T Consensus 243 -~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 -SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred -CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 123557888999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=289.63 Aligned_cols=247 Identities=25% Similarity=0.323 Sum_probs=196.3
Q ss_pred eccCCceeEEEEEeCC-CcEEEEEEcCccch---hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCCh
Q 005236 395 LGEGGFGPVYKGTLAD-EQEIAVKRLSKISE---QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 470 (706)
Q Consensus 395 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 470 (706)
||+|+||.||+++... ++.+++|.+..... ...+.+.+|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999865 88999999865433 4567889999999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC------
Q 005236 471 DSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET------ 544 (706)
Q Consensus 471 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~------ 544 (706)
.+++.... .+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99996533 5889999999999999999999987 99999999999999999999999999886533211
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
........++..|+|||.+.....+.++||||||+++|||++|+.||...... ..... .. .+... ...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~---~~-~~~~~-~~~---- 222 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQN---IL-NGKIE-WPE---- 222 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---Hh-cCCcC-CCc----
Confidence 11223356788999999998888999999999999999999999997543211 11111 11 11110 000
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
.. .....+.+++.+||+.+|.+|||+.++.+.|+.
T Consensus 223 -~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 223 -DV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred -cc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00 012345678999999999999999888887764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=316.65 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=192.9
Q ss_pred HHhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEe------
Q 005236 383 ANATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIH------ 454 (706)
Q Consensus 383 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 454 (706)
.+...+|+..+.||+||||.|||++.+ ||+.||||++... +......+.+|+.++++|+|||||+++..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 456678999999999999999999984 7999999998653 44556678999999999999999999753211
Q ss_pred --------------------------------------------------------------------------------
Q 005236 455 -------------------------------------------------------------------------------- 454 (706)
Q Consensus 455 -------------------------------------------------------------------------------- 454 (706)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHH
Q 005236 455 -------------------------G--------EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLY 501 (706)
Q Consensus 455 -------------------------~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~ 501 (706)
+ ..+||-||||+..+|.+++.++.-.. .....++++.+|++||.|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 0 12367799999999999886654321 456788999999999999
Q ss_pred HHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC---C-------------CCCcccccccccccCccCcccccc
Q 005236 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG---G-------------DETEGNTNRVVGTYGYMAPEYASD 565 (706)
Q Consensus 502 LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~---~-------------~~~~~~~~~~~gt~~y~aPE~~~~ 565 (706)
+|+++ ||||||||.||+++++..+||+|||+|.... . .......+..+||.-|+|||++.+
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99998 9999999999999999999999999998721 0 011113345689999999999976
Q ss_pred CC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHh
Q 005236 566 GQ---FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLC 642 (706)
Q Consensus 566 ~~---~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~c 642 (706)
.. |+.|+|+||||||++||+. ||.. ..+.+... ..++.+..+.- ..+...+...-.+++.++
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T-----sMERa~iL-~~LR~g~iP~~------~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGT-----SMERASIL-TNLRKGSIPEP------ADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCc-----hHHHHHHH-HhcccCCCCCC------cccccccchHHHHHHHHH
Confidence 54 9999999999999999985 3321 11222221 22223332221 111223344456799999
Q ss_pred cCCCCCCCCChhHHHH
Q 005236 643 VQQYPEDRPCMPSVIL 658 (706)
Q Consensus 643 l~~~p~~RPt~~ev~~ 658 (706)
++.||.+|||+.|++.
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999874
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=301.27 Aligned_cols=264 Identities=20% Similarity=0.312 Sum_probs=196.9
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEe----CCee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIH----GEEK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 458 (706)
.++|++.+.||+|+||.||+|... .++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999975 58899999986532 2345677889999999999999999988763 3467
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 5898888543 34899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCCcc--cccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 539 FGGDETEG--NTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 539 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..+........ ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~---~~~~~~~~~~g-~~~ 232 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV---HQLKLILSVLG-SPS 232 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH---HHHHHHHHHhC-CCh
Confidence 54322211 1123468899999999866 46889999999999999999999998543221 11111111100 000
Q ss_pred cccccc------------c-ccCcCCH-----HHHHHHHHHHHHhcCCCCCCCCChhHHHHHh
Q 005236 616 SQLIDA------------C-FKDSFNL-----AEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 616 ~~~~d~------------~-~~~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L 660 (706)
.++++. . ....... .....+.+++..||+.+|.+||++++++..-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 000000 0 0000111 1134577899999999999999999988743
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=287.49 Aligned_cols=251 Identities=24% Similarity=0.310 Sum_probs=192.7
Q ss_pred CCCccceeccCCceeEEEEEe----CCCcEEEEEEcCccc----hhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCee
Q 005236 388 NFSINKKLGEGGFGPVYKGTL----ADEQEIAVKRLSKIS----EQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 458 (706)
+|++.+.||+|+||.||+++. .+|+.||+|++.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999986 367899999986532 22346788899999999 599999999999999999
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||+|+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999998643 34778888899999999999999987 99999999999999999999999999987
Q ss_pred cCCCCCcccccccccccCccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (706)
....... ......|+..|+|||.+... .++.++||||||+++|+|++|+.|+...........+ ..........
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~--~~~~~~~~~~- 230 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSEPP- 230 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHH--HHHhhccCCC-
Confidence 5432211 22235688999999998753 4688999999999999999999997543222111111 1111111110
Q ss_pred ccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCC-----ChhHHHH
Q 005236 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP-----CMPSVIL 658 (706)
Q Consensus 617 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~ 658 (706)
. .... ...+.+++..||+.+|.+|| ++.+++.
T Consensus 231 -~-----~~~~----~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 231 -Y-----PQEM----SALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -C-----CccC----CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 0011 12456788999999999997 5565554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=282.70 Aligned_cols=249 Identities=27% Similarity=0.382 Sum_probs=201.6
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+|++.++||+|+||.||+++.. +++.+++|++... .......+.+|+.++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999874 5788999998653 334456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 465 MPNKSLDSFIFDQE-RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 465 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
+++++|.+++.+.. ....+++..++.++.|++.||+|||+.+ ++|+||+|.||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999986532 2355889999999999999999999987 999999999999999999999999999876443
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
......++..|+|||.+.+..++.++|+||||+++|||++|+.|+..... ...... ........+.
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~----~~~~~~~~~~---- 222 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYK----VQRGKYPPIP---- 222 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH----HhcCCCCCCc----
Confidence 12224578899999999999999999999999999999999999754321 111111 1111111111
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
......+.+++..|++.+|.+||++.++++.
T Consensus 223 -----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 223 -----PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -----hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1122356789999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.59 Aligned_cols=247 Identities=23% Similarity=0.367 Sum_probs=202.9
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
-...|.+.+.||+|.|+.|.+|+.. .+..||||.+.+. +....+.+.+|+++|..++|||||+++.+.+....+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3467999999999999999999974 5889999999764 334445688999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+.+|.+.++|..+.. +.......++.|+..|++|+|+++ |+|||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999977654 444777889999999999999998 99999999999999999999999999998742
Q ss_pred CCCcccccccccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.......+|++.|.|||++.+..+ .+++|+||+|++||-|+.|..||+...- .++-+
T Consensus 208 ---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-------------------k~Lr~ 265 (596)
T KOG0586|consen 208 ---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-------------------KELRP 265 (596)
T ss_pred ---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-------------------ccccc
Confidence 233445789999999999998876 4789999999999999999999864221 22222
Q ss_pred ccccCcCCHH--HHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 621 ACFKDSFNLA--EVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 621 ~~~~~~~~~~--~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
..+.+.+.+. ---.+-+++..+|-.+|.+|++++++.+.
T Consensus 266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 2222211111 11245578889999999999999999753
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=290.71 Aligned_cols=252 Identities=24% Similarity=0.387 Sum_probs=192.2
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccc-hhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCeeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKIS-EQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 463 (706)
++|++.+.||+|+||.||+|..++ ++.||||.+.... .....++..|+.++.+.. ||||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 678899999999999999999865 8899999986532 233456677777777775 9999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
|+++ +|.+++.... ..+++..+..++.||+.||+|||+. + |+||||+|+||++++++.+||+|||++..+...
T Consensus 95 ~~~~-~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMST-CLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccCc-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9854 6777664422 3688999999999999999999974 5 999999999999999999999999999765332
Q ss_pred CCcccccccccccCccCccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQ----FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
.. .....++..|+|||.+.... ++.++||||||+++|||++|+.||...... ..... ...... ...+
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~---~~~~~~-~~~~ 239 (296)
T cd06618 169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLT---KILQEE-PPSL 239 (296)
T ss_pred Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHH---HHhcCC-CCCC
Confidence 21 12235788999999987554 889999999999999999999997532111 11111 111111 1111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHh
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L 660 (706)
... . .....+.+++.+||+.+|.+||+++++++..
T Consensus 240 ~~~-----~--~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 240 PPN-----E--GFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCC-----C--CCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 100 0 1123467889999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=301.65 Aligned_cols=204 Identities=29% Similarity=0.443 Sum_probs=177.1
Q ss_pred CCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC------eeE
Q 005236 388 NFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE------EKL 459 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 459 (706)
-|...+.||+|+||.||+|+. ..|+.||||.+... .....+...+|++++++++|||||++++.-.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 355668999999999999996 55999999998763 3445678889999999999999999999865543 568
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc--CCC--CeEEeeecc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDM--NPKISDFGL 535 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~--~~kl~Dfgl 535 (706)
+|||||.+|+|...|.+.++..-+++.+.+.++..++.||.|||+++ |+||||||.||++- ++| .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999998888888999999999999999999999988 99999999999984 334 479999999
Q ss_pred ccccCCCCCcccccccccccCccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSD 597 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~ 597 (706)
|+.+..+. .....+||..|++||... ...|+..+|.|||||++||.+||..||......
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99875443 445578999999999998 488999999999999999999999998765443
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=288.51 Aligned_cols=259 Identities=23% Similarity=0.299 Sum_probs=194.2
Q ss_pred CCccceeccCCceeEEEEEeCC-CcEEEEEEcCccch-hhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCeeEEEEecC
Q 005236 389 FSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISE-QGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
|.+.+.||+|++|.||+|+..+ ++.|+||++..... .......+|+..+++++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5678999999999999999854 78899999865322 22334557899999999 999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
+++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 889998886543 245899999999999999999999987 9999999999999999999999999998653321
Q ss_pred ccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC-----------
Q 005236 546 GNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG----------- 613 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 613 (706)
......++..|+|||++.. ..++.++|+||||++++||++|+.|+......+. ...........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ---LYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH---HHHHHHhcCCCChhhhhhHhhh
Confidence 1123457889999998854 5689999999999999999999988754332111 11111100000
Q ss_pred --CCccccccc----ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 614 --MPSQLIDAC----FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 614 --~~~~~~d~~----~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.....+... +..... .....+.+++..||+.+|++|||++|++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hccccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000 000000 012457789999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=280.93 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=194.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-----chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC--Cee
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-----SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--EEK 458 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 458 (706)
.+|.+.+.||+|+||.||+|++. +++.+++|.+... .......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999974 4889999987431 234456888999999999999999999998764 457
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++|+||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999998543 34788889999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCC-cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 539 FGGDET-EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 539 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||.... ....+ .+....+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~---~~~~~~~~~~~ 229 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE---AMAAI---FKIATQPTKPM 229 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC---HHHHH---HHHHcCCCCCC
Confidence 532111 111123468899999999998889999999999999999999999975321 11111 11111111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+ . ..-...+.+++.+|++ +|.+||+..+++.
T Consensus 230 ~-p--------~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 230 L-P--------DGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred C-C--------cccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1 1 1111346678889999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=290.98 Aligned_cols=263 Identities=22% Similarity=0.232 Sum_probs=192.6
Q ss_pred CccceeccCCceeEEEEEeCCCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 390 SINKKLGEGGFGPVYKGTLADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 390 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
.+.+.+|.|+++.||++.. +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445566666666666655 6889999998653 455667899999999999999999999999999999999999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC---
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET--- 544 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~--- 544 (706)
++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+..+.....
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 999999965432 34788888999999999999999988 99999999999999999999999999876532211
Q ss_pred --cccccccccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh----cC---
Q 005236 545 --EGNTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWN----EG--- 613 (706)
Q Consensus 545 --~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~----~~--- 613 (706)
........++..|+|||++.. ..++.++||||||+++|||++|+.||...... ............ ..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchh
Confidence 111223457788999999876 35889999999999999999999998643221 111111110000 00
Q ss_pred ----CCcc----cccccc----cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 614 ----MPSQ----LIDACF----KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 614 ----~~~~----~~d~~~----~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.... ..++.. ...........+.+++.+||+.+|++|||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 000000 000111122356789999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=295.01 Aligned_cols=263 Identities=22% Similarity=0.289 Sum_probs=194.3
Q ss_pred cCCC-ccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhh--------------HHHHHHHHHHHhhcCCcceeeeEe
Q 005236 387 DNFS-INKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQG--------------LKELKNEIILFSKLQHRNLVKLLG 450 (706)
Q Consensus 387 ~~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~ 450 (706)
++|. +.+.||+|+||.||+|... .++.||||++....... ...+.+|+.++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 4577999999999999975 58899999885432111 125778999999999999999999
Q ss_pred EEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEE
Q 005236 451 CCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 530 (706)
Q Consensus 451 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 530 (706)
++..++..++||||++ ++|.+++... ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 5898888542 34788999999999999999999987 999999999999999999999
Q ss_pred eeeccccccCCCCC------------cccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCC
Q 005236 531 SDFGLARAFGGDET------------EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSD 597 (706)
Q Consensus 531 ~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~ 597 (706)
+|||+++....... ........++..|+|||.+.+. .++.++||||||+++|||++|+.|+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999987642111 1111123467889999998764 4789999999999999999999997644322
Q ss_pred CchhHHHHHHHHhhcCCC---cccc------------cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHh
Q 005236 598 NKLNLIRHAWKLWNEGMP---SQLI------------DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~---~~~~------------d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L 660 (706)
............... .... ........ ......+.+++..||+.+|++||+++|++..-
T Consensus 241 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 241 ---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIF-PNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred ---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhC-cCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 222222111111100 0000 00000000 01123467899999999999999999998643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=314.38 Aligned_cols=260 Identities=31% Similarity=0.429 Sum_probs=205.5
Q ss_pred ccCCCccceeccCCceeEEEEEeCC--------CcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeC
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD--------EQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHG 455 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 455 (706)
.++..+.+.||+|.||.|++|.... ...||||.++.. .....+.+..|+.+|+.+ +||||+.++|+|..+
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 3455677799999999999998531 457999998753 345678899999999998 699999999999999
Q ss_pred CeeEEEEecCCCCChhhhhhccc-----cc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE
Q 005236 456 EEKLLIYEFMPNKSLDSFIFDQE-----RC--------KLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 522 (706)
Q Consensus 456 ~~~~lV~e~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill 522 (706)
...++|+||++.|+|.++|+... .. ..+.....+.++.|||.||+||++.. +|||||.++||||
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 99999999999999999997654 00 23888999999999999999999887 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCCCcc-cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCch
Q 005236 523 DQDMNPKISDFGLARAFGGDETEG-NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKL 600 (706)
Q Consensus 523 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~ 600 (706)
.++..+||+|||+|+......... ......-+..|||||.+....|+.|+|||||||+||||+| |..|+..... ..
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~~ 529 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--TE 529 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--HH
Confidence 999999999999999765444332 2111114567999999999999999999999999999999 6677543111 11
Q ss_pred hHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 601 NLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
++. +.++++...+... ....++.+++..||+.+|++||++.++++.++..
T Consensus 530 ~l~----~~l~~G~r~~~P~---------~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 530 ELL----EFLKEGNRMEQPE---------HCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHH----HHHhcCCCCCCCC---------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 222 2233333222211 1233566899999999999999999999999884
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=285.42 Aligned_cols=259 Identities=23% Similarity=0.316 Sum_probs=192.9
Q ss_pred CCccceeccCCceeEEEEEeCC-CcEEEEEEcCccc--hhhHHHHHHHHHHHhhc---CCcceeeeEeEEEeCCe-----
Q 005236 389 FSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKIS--EQGLKELKNEIILFSKL---QHRNLVKLLGCCIHGEE----- 457 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 457 (706)
|++.+.||+|+||.||+|+.+. ++.+|+|++.... ......+.+|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678999999999999999865 8899999986422 22234566787777665 59999999999988776
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.+++|||+++ +|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 79888865332 35889999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC--
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP-- 615 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 615 (706)
.+..... .....++..|+|||++.+..++.++||||||+++|||++|+.|+...... +..............
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA---DQLDKIFDVIGLPSEEE 229 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH---HHHHHHHHHcCCCChHh
Confidence 7643321 12235788999999999999999999999999999999999887543221 222222111110000
Q ss_pred --------cccccccccCc---CCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 616 --------SQLIDACFKDS---FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 616 --------~~~~d~~~~~~---~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
........... ........+.+++.+||+.+|.+||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000000 00112245668999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=289.43 Aligned_cols=249 Identities=28% Similarity=0.374 Sum_probs=199.6
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 461 (706)
++|.+.+.||+|+||.||+|+.. +++.+++|.+... .....+.+..|+.++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999985 6889999988652 2344567889999999998 99999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999999654 35899999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCc------------------ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHH
Q 005236 542 DETE------------------GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLI 603 (706)
Q Consensus 542 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~ 603 (706)
.... .......++..|+|||++....++.++||||||++++++++|+.|+..... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~ 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTF 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHH
Confidence 3211 122334678999999999888899999999999999999999999764331 1111
Q ss_pred HHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCCh----hHHHH
Q 005236 604 RHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCM----PSVIL 658 (706)
Q Consensus 604 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~----~ev~~ 658 (706)
..... ....... .. ...+.+++.+||+.+|.+||++ +++++
T Consensus 232 ~~~~~--~~~~~~~--------~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 QKILK--LEYSFPP--------NF----PPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHh--cCCCCCC--------cc----CHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11110 0000000 11 2346689999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=296.93 Aligned_cols=262 Identities=25% Similarity=0.339 Sum_probs=199.5
Q ss_pred CCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC-----eeE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE-----EKL 459 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 459 (706)
+|.+.+.||+|++|.||+|+... ++.++||++.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 57888999999999999999854 8899999987643 444578899999999999999999999988775 789
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
+||||++ ++|.+++.... .+++..+..++.||+.||+|||+.+ |+|+||||.|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 48888885432 6889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCc-ccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC--
Q 005236 540 GGDETE-GNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP-- 615 (706)
Q Consensus 540 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 615 (706)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+. .............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEED 230 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChhH
Confidence 443210 122334678899999999887 899999999999999999999999854432211 1111111100000
Q ss_pred ---------cccccc-cccCcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 616 ---------SQLIDA-CFKDSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 616 ---------~~~~d~-~~~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
...+.. ......... ....+.+++..||+.+|.+||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000 000000000 12346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=277.38 Aligned_cols=264 Identities=24% Similarity=0.361 Sum_probs=212.2
Q ss_pred HHHHHhccCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCc-cchhhHHHHHHHHHHHhhcCCcceeeeEeEE
Q 005236 380 ATIANATDNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLVKLLGCC 452 (706)
Q Consensus 380 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 452 (706)
.++....++++....+-+|.||.||.|.+. +.+.|.+|.++. .+..+...+..|.-++..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 445555677888899999999999999663 345678888765 4555677889999999999999999999999
Q ss_pred EeC-CeeEEEEecCCCCChhhhhh-----cccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC
Q 005236 453 IHG-EEKLLIYEFMPNKSLDSFIF-----DQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 526 (706)
Q Consensus 453 ~~~-~~~~lV~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 526 (706)
.+. ...+++|.++.-|+|..||. +......++-.+...++.|++.|++|||.++ +||.||.++|++|++..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 865 46789999999999999997 4455566778888999999999999999988 99999999999999999
Q ss_pred CeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHH
Q 005236 527 NPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRH 605 (706)
Q Consensus 527 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 605 (706)
++||+|=.+++.+-+.+.......-..+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+. ..+
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm---~~y 510 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM---EHY 510 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH---HHH
Confidence 999999999998766555544444456789999999999999999999999999999998 8888765444322 222
Q ss_pred HHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 606 AWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 606 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
.. ++. ++...++ ...++..++.-||...|++||+.++++.-|..
T Consensus 511 lk----dGy-------RlaQP~N--CPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 511 LK----DGY-------RLAQPFN--CPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred Hh----ccc-------eecCCCC--CcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 11 111 1111222 23356678889999999999999999998864
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=295.42 Aligned_cols=264 Identities=23% Similarity=0.318 Sum_probs=196.2
Q ss_pred HHHHHHhccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC
Q 005236 379 LATIANATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG 455 (706)
Q Consensus 379 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 455 (706)
..++....++|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345666779999999999999999999987 46889999998653 233356788899999999999999999988643
Q ss_pred ------CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeE
Q 005236 456 ------EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 529 (706)
Q Consensus 456 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 529 (706)
...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3457788876 7899887743 24789999999999999999999988 99999999999999999999
Q ss_pred EeeeccccccCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH
Q 005236 530 ISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWK 608 (706)
Q Consensus 530 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 608 (706)
|+|||+++.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ........
T Consensus 161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~---~~~~~~~~ 232 (345)
T cd07877 161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILR 232 (345)
T ss_pred Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHH
Confidence 999999876422 1223467889999999866 56889999999999999999999997532221 11111111
Q ss_pred HhhcCCCcccccccc-----------c--CcCCH-----HHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 609 LWNEGMPSQLIDACF-----------K--DSFNL-----AEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 609 ~~~~~~~~~~~d~~~-----------~--~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
... .....+..... . ..... .....+.+++..||+.+|.+||++.+++..
T Consensus 233 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 233 LVG-TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhC-CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 00000000000 0 00000 012246689999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=290.87 Aligned_cols=264 Identities=23% Similarity=0.327 Sum_probs=194.9
Q ss_pred HHhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEe-CCee
Q 005236 383 ANATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIH-GEEK 458 (706)
Q Consensus 383 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 458 (706)
...+++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 345688999999999999999999875 6889999987542 22345678899999999999999999999876 5678
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||+ +++|..++.. ..+++.....++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999998 5689888743 24677888889999999999999987 99999999999999999999999999875
Q ss_pred cCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH--------HHH
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHA--------WKL 609 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~--------~~~ 609 (706)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+... ...
T Consensus 158 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 422 1122457889999999866 57899999999999999999999997543321111111100 000
Q ss_pred hhcCCCcccccccc-cCcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 610 WNEGMPSQLIDACF-KDSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 610 ~~~~~~~~~~d~~~-~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.......+++.... ....... ....+.+++.+||+.+|++||++++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000 0000111 12356788999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=289.22 Aligned_cols=264 Identities=23% Similarity=0.317 Sum_probs=192.5
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC------
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE------ 456 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 456 (706)
.++|++.++||+|+||.||+|+.. +++.+|||++.... ......+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999975 57899999885432 222346778999999999999999999876543
Q ss_pred --eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeec
Q 005236 457 --EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 534 (706)
Q Consensus 457 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 534 (706)
..++||||+.+ +|...+... ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999975 566666432 235899999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCCCcc---------cccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHH
Q 005236 535 LARAFGGDETEG---------NTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIR 604 (706)
Q Consensus 535 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~ 604 (706)
+++......... ......+++.|+|||.+.+. .++.++||||||+++|||++|++||......... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~---~ 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL---H 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence 998654322111 11234578889999988654 5889999999999999999999997543322211 1
Q ss_pred HHHHHhhcCCC---------cccccccc--cCcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 605 HAWKLWNEGMP---------SQLIDACF--KDSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 605 ~~~~~~~~~~~---------~~~~d~~~--~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
........... ....+... ....... ....+.+++.+||+.+|.+|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11111110000 00000000 0000010 1135678999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=296.02 Aligned_cols=262 Identities=24% Similarity=0.321 Sum_probs=193.1
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC------
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE------ 456 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 456 (706)
.++|.+.+.||+|+||.||+|+.. .++.||||++... .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999974 5889999998642 2233456889999999999999999999987543
Q ss_pred eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 536 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla 536 (706)
..++|+||+.. +|..++ ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999964 666654 134788999999999999999999987 999999999999999999999999998
Q ss_pred cccCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC--
Q 005236 537 RAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG-- 613 (706)
Q Consensus 537 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-- 613 (706)
+.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ..............
T Consensus 165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 236 (342)
T cd07879 165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGP 236 (342)
T ss_pred cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCH
Confidence 76422 1123467889999999876 4689999999999999999999999864221 11111111110000
Q ss_pred ---------CCcccccccc-cCcCCH-----HHHHHHHHHHHHhcCCCCCCCCChhHHHHH--hcCCC
Q 005236 614 ---------MPSQLIDACF-KDSFNL-----AEVIRCIHIGLLCVQQYPEDRPCMPSVILM--LGSEI 664 (706)
Q Consensus 614 ---------~~~~~~d~~~-~~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~--L~~~~ 664 (706)
.......... ....+. .....+.+++..||+.+|.+||+++|++.. ++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000000000 000000 011246689999999999999999999854 55543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=294.96 Aligned_cols=261 Identities=23% Similarity=0.313 Sum_probs=194.5
Q ss_pred HHHhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC--
Q 005236 382 IANATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE-- 456 (706)
Q Consensus 382 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 456 (706)
+....++|++.+.||+|+||.||++... ++..||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445688999999999999999999874 5889999998542 2334567889999999999999999999987654
Q ss_pred ----eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEee
Q 005236 457 ----EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 532 (706)
Q Consensus 457 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 532 (706)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 358999999 7799888743 34889999999999999999999987 99999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH--
Q 005236 533 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKL-- 609 (706)
Q Consensus 533 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~-- 609 (706)
||++...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...... .........
T Consensus 162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---~~~~~~~~~~~ 233 (343)
T cd07880 162 FGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL---DQLMEIMKVTG 233 (343)
T ss_pred cccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcC
Confidence 9999865321 122457889999999876 46889999999999999999999997543211 111110000
Q ss_pred ---------hhcCCCcccccccccC-cCCH-----HHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 610 ---------WNEGMPSQLIDACFKD-SFNL-----AEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 610 ---------~~~~~~~~~~d~~~~~-~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+............... .... .....+.+++.+|++.+|.+|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000000 0000 01124668999999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=291.90 Aligned_cols=265 Identities=23% Similarity=0.308 Sum_probs=191.8
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC---------
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--------- 455 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 455 (706)
..+|.+.+.||.|+||.||+|... .++.||+|++........+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999985 4889999998665556667889999999999999999999776543
Q ss_pred -----CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc-CCCCeE
Q 005236 456 -----EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPK 529 (706)
Q Consensus 456 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~k 529 (706)
...++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 588887743 24788999999999999999999987 99999999999997 456789
Q ss_pred EeeeccccccCCCCCc-ccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 005236 530 ISDFGLARAFGGDETE-GNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAW 607 (706)
Q Consensus 530 l~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 607 (706)
|+|||+++.+...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||................
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999865322111 11122457889999998754 568889999999999999999999985432211111000000
Q ss_pred H--------HhhcCCCcccccccccCcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 608 K--------LWNEGMPSQLIDACFKDSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 608 ~--------~~~~~~~~~~~d~~~~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
. ...................... ....+.+++.+||+.+|.+|||++|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0 0000000000000000000000 1134668999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=279.36 Aligned_cols=242 Identities=27% Similarity=0.319 Sum_probs=184.3
Q ss_pred eeccCCceeEEEEEeC-CCcEEEEEEcCccch---hhHHHHHHHHH---HHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 394 KLGEGGFGPVYKGTLA-DEQEIAVKRLSKISE---QGLKELKNEII---LFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 394 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
.||+|+||.||++... .++.||+|.+..... .....+..|.. .++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999874 478999998865321 11222334433 3444579999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+++|..++... ..+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||++..+...
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---- 150 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence 99999988543 45899999999999999999999987 999999999999999999999999998765322
Q ss_pred cccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 547 NTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......|+..|+|||.+.+. .++.++||||+|+++|||++|+.||........... .. ..... ...+ ..
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~~---~~~~~-~~~~-----~~ 220 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DR---MTLTM-AVEL-----PD 220 (278)
T ss_pred CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-HH---Hhhcc-CCCC-----CC
Confidence 12234689999999999754 689999999999999999999999865432221111 11 11100 0111 01
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCC-----ChhHHHHH
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRP-----CMPSVILM 659 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~~ 659 (706)
.. ...+.+++.+||+.+|.+|| ++.++++.
T Consensus 221 ~~----s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 221 SF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred cC----CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11 13466788899999999999 89999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=283.59 Aligned_cols=244 Identities=28% Similarity=0.454 Sum_probs=190.4
Q ss_pred CCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 389 FSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
|...++||+|+||.||+|+.. .++.|++|++... .....+.+.+|+.++++++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666688999999999999974 5788999998642 233446788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+. ++|.+++... ...+++..+..++.||+.+|.|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 96 5777776433 245889999999999999999999988 9999999999999999999999999986432
Q ss_pred cccccccccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
......|+..|+|||++. ...++.++||||||+++|||++|..|+..... ...... ..... .......
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~---~~~~~~---~~~~~-~~~~~~~ 243 (313)
T cd06633 173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYH---IAQND-SPTLQSN 243 (313)
T ss_pred --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHH---HHhcC-CCCCCcc
Confidence 122356888999999984 45688999999999999999999999643221 111111 11111 1111111
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.. ...+.+++.+||+.+|.+||++.+++..
T Consensus 244 ----~~----~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 244 ----EW----TDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----cc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 1235678899999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=321.84 Aligned_cols=253 Identities=26% Similarity=0.366 Sum_probs=196.6
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
+-++.....||.|.||.||.+... +|.-.|+|.+.. ........+.+|..++..++|||+|+++|+-.+++..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 345666789999999999999875 477789998754 23444567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
|||++|+|.+.+.... ..++.....+-.|++.|+.|||+++ ||||||||.||+|+.+|.+|++|||.|..+...
T Consensus 1314 EyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999985432 2445555567789999999999999 999999999999999999999999999988654
Q ss_pred C--CcccccccccccCccCccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 543 E--TEGNTNRVVGTYGYMAPEYASDG---QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 543 ~--~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
. .........||+.|||||++.+. .-..++||||+|||+.||+||++||...+.+ ..|-+ +...+..++
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aIMy---~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---WAIMY---HVAAGHKPQ 1461 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---hHHHh---HHhccCCCC
Confidence 2 12233457899999999999764 3557899999999999999999998654431 11111 111222222
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
+... + ..+-.+++..||+.||.+|-++.|+++.
T Consensus 1462 ~P~~-l--------s~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 IPER-L--------SSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred Cchh-h--------hHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2211 1 1123468889999999999888776654
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.09 Aligned_cols=261 Identities=25% Similarity=0.324 Sum_probs=189.3
Q ss_pred CCCccceeccCCceeEEEEEeCC---CcEEEEEEcCcc--chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeC----Ce
Q 005236 388 NFSINKKLGEGGFGPVYKGTLAD---EQEIAVKRLSKI--SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHG----EE 457 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 457 (706)
+|++.+.||+|+||.||+++... ++.||+|++... .....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47888999999999999999753 678999998642 222356778899999999 599999999876533 35
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.++++||+. ++|.+++... ..+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688889886 6898888543 35889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCc--ccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh---
Q 005236 538 AFGGDETE--GNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWN--- 611 (706)
Q Consensus 538 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--- 611 (706)
.+...... .......|+..|+|||++.+ ..++.++||||+|+++|+|++|+.||....... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 230 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPD 230 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCC
Confidence 76432211 11233568999999998765 468999999999999999999999875432211 1111110000
Q ss_pred --------cCCCcccccccc-cCcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 612 --------EGMPSQLIDACF-KDSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 612 --------~~~~~~~~d~~~-~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
............ ....... ....+.+++.+||+.+|.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000 0000000 1235668999999999999999999863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=285.30 Aligned_cols=250 Identities=28% Similarity=0.405 Sum_probs=193.7
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc---cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK---ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
+.|...+.||+|+||.||+|+.. +++.+++|.+.. ......+.+.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34677789999999999999985 577899998753 23334567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+. |+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 57877764332 34788999999999999999999987 999999999999999999999999998765321
Q ss_pred CCcccccccccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+....... ... .. .........
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~---~~-~~~~~~~~~ 235 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALY---HI-AQNESPALQ 235 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HHH---HH-hhcCCCCcC
Confidence 2345788999999974 3567889999999999999999999964322111 111 11 111111110
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
. . .....+.+++.+||+.+|.+||++++|+...--.
T Consensus 236 ~----~----~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 236 S----G----HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred c----c----cccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 0 0 1112356788999999999999999999775433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=272.07 Aligned_cols=242 Identities=22% Similarity=0.285 Sum_probs=194.7
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
..++|..+++||+|.||.|.+++-+ .++.+|+|++++. .......-..|-++++..+||.+..|--.|...+.+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3478999999999999999999875 4888999999773 34445566779999999999999999888999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||..||.|.-+|.+. ..+++.....+-.+|+.||.|||+.+ ||.||||.+|.|+|.+|++||+|||+++.--
T Consensus 246 VMeyanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999999888543 34777777888899999999999988 9999999999999999999999999998632
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.....+...+|||.|+|||++....|....|.|.+||++|||++|+.||...+.+...+++.-. +-..+.-+.
T Consensus 320 --~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-----d~kFPr~ls 392 (516)
T KOG0690|consen 320 --KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-----DLKFPRTLS 392 (516)
T ss_pred --cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-----hccCCccCC
Confidence 2223455689999999999999999999999999999999999999998544433333332211 111111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCC
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP 651 (706)
.++..|..-.|..||.+|.
T Consensus 393 ------------~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 393 ------------PEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ------------HHHHHHHHHHhhcChHhhc
Confidence 1234566678999999996
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=283.79 Aligned_cols=258 Identities=26% Similarity=0.342 Sum_probs=196.5
Q ss_pred CCccceeccCCceeEEEEEeCC-CcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 389 FSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
|++.+.||+|++|.||+|+... ++.+++|.+.... ....+.+..|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5667899999999999999864 8899999987642 334567888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
+ ++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58999996542 35889999999999999999999988 99999999999999999999999999987543221
Q ss_pred ccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC-----------
Q 005236 546 GNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG----------- 613 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 613 (706)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... .............
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI---DQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHHHhCCCcHHHHHhhccc
Confidence 12223457789999998776 8899999999999999999999887543221 1111111111000
Q ss_pred -----CCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 614 -----MPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 614 -----~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
..+........... ......+.+++..||+.+|++||++++|+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000000 001235778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=267.23 Aligned_cols=281 Identities=23% Similarity=0.280 Sum_probs=202.8
Q ss_pred cCCCccceeccCCceeEEEEEeCC-----CcEEEEEEcCccch--hhHHHHHHHHHHHhhcCCcceeeeEeEEEe-CCee
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-----EQEIAVKRLSKISE--QGLKELKNEIILFSKLQHRNLVKLLGCCIH-GEEK 458 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 458 (706)
..|+...+||+|.||.||+|.-.+ .+.+|+|+++.... ......-+|+.+++.++||||+.|..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 578899999999999999996432 34789999865422 123456789999999999999999999988 6788
Q ss_pred EEEEecCCCCChhhhhhcc--cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC----CCeEEee
Q 005236 459 LLIYEFMPNKSLDSFIFDQ--ERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISD 532 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~----~~~kl~D 532 (706)
++++||.+. +|.+.|+.+ ...+.++...+..|+.||+.|+.|||+.- |+||||||.||||..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999976 788888643 33457888899999999999999999875 9999999999999887 8999999
Q ss_pred eccccccCCCCC-cccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc------hhHHH
Q 005236 533 FGLARAFGGDET-EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK------LNLIR 604 (706)
Q Consensus 533 fgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~------~~~~~ 604 (706)
||+++.+...-. ......++-|.-|.|||.+.+. .||.+.||||.|||+.||+|-++.|.....+.. .+...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 999998854322 2244567889999999999874 799999999999999999999888754322111 11222
Q ss_pred HHHHHhhc---CCCccc----------ccccccCcCC--HHHH--------HHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 605 HAWKLWNE---GMPSQL----------IDACFKDSFN--LAEV--------IRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 605 ~~~~~~~~---~~~~~~----------~d~~~~~~~~--~~~~--------~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
...+++.- ..++.+ .+.......+ +... ....+|...+|+.||.+|.|+++.++..-
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 22222211 111110 0100000011 1110 02568889999999999999999876543
Q ss_pred CCCCCCCCCCC
Q 005236 662 SEIVLPQPKQP 672 (706)
Q Consensus 662 ~~~~~~~p~~p 672 (706)
- ...+.||.|
T Consensus 340 F-~~d~lpp~p 349 (438)
T KOG0666|consen 340 F-TEDPLPPLP 349 (438)
T ss_pred c-ccCCCCCCc
Confidence 2 233344444
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=277.84 Aligned_cols=250 Identities=26% Similarity=0.365 Sum_probs=192.0
Q ss_pred CCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc-----chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI-----SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
+|.+.++||+|+||.||++.... +..+++|.++.. .......+..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999998754 344555554331 222344567899999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 462 YEFMPNKSLDSFIFDQ-ERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
|||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988642 23356899999999999999999999987 999999999999975 569999999998753
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..|+.... ..... .... ......+
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~---~~~~~---~~~~-~~~~~~~-- 225 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN---FLSVV---LRIV-EGPTPSL-- 225 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHH---HHHH-cCCCCCC--
Confidence 3221 2223457889999999988889999999999999999999999974321 11111 1111 1111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.......+.+++.+||+.+|++||++.|+++.
T Consensus 226 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 226 -------PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -------cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11112356678999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=295.60 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=195.3
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe----
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEE---- 457 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 457 (706)
..++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999985 4788999998642 23344667889999999999999999988876554
Q ss_pred --eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecc
Q 005236 458 --KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 535 (706)
Q Consensus 458 --~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgl 535 (706)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5699988854 35899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM 614 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 614 (706)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ............ ..
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~-~~ 235 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH---IDQLKRIMNLVG-TP 235 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcC-CC
Confidence 9865322 223467889999999865 3678999999999999999999999753322 111111111110 00
Q ss_pred Cccc------------cccccc-CcCCH-----HHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 615 PSQL------------IDACFK-DSFNL-----AEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 615 ~~~~------------~d~~~~-~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
...+ +..... ...+. .....+.+++.+||+.+|.+|||+.||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000 000000 00000 012467789999999999999999999763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=259.99 Aligned_cols=252 Identities=23% Similarity=0.377 Sum_probs=191.5
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCc-cchhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCeeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSK-ISEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 463 (706)
++.+.+..||.|..|+|++.+... |..+|||...+ .+....+++...+.++.+-+ +|+||+.+|+|.......+.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 345566789999999999999865 78899999876 45566778888888887765 9999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
.|.- .++.++.+- .+++++..+=++...+++||.||.+++ .|+|||+||+|||+|+.|++||+|||++-++-...
T Consensus 172 lMs~-C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMST-CAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHH-HHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 9843 344444332 244777777788899999999999876 59999999999999999999999999997764322
Q ss_pred CcccccccccccCccCccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDG---QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
......|-+.|||||.+.-. .|+.++||||||+.|+||.||+.||..... ..+...... ++ .++ .++
T Consensus 247 ---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--dFe~ltkvl---n~-ePP-~L~ 316 (391)
T KOG0983|consen 247 ---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--DFEVLTKVL---NE-EPP-LLP 316 (391)
T ss_pred ---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--cHHHHHHHH---hc-CCC-CCC
Confidence 22346788999999999643 788999999999999999999999764322 122222222 11 111 111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
+... +.. .+.+++..||+.|+.+||...++++.
T Consensus 317 ~~~g--FSp----~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 317 GHMG--FSP----DFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cccC--cCH----HHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1111 221 35578889999999999999998864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=307.58 Aligned_cols=146 Identities=27% Similarity=0.420 Sum_probs=131.2
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|.+.++||+|+||.||+|.+. .++.||||++... .......+..|+.++..++||||++++..+......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 368999999999999999999986 5889999998643 234456788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
|||+++++|.+++... ..+++..++.++.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999543 34788889999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-34 Score=267.75 Aligned_cols=256 Identities=27% Similarity=0.341 Sum_probs=193.6
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEEEec
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+.+-+..||.|+||+|+|-..+ .|+.+|||+++.. .....+++..|.+...+- +.||||+++|++..+...++.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3444578999999999999874 5899999999764 346778899999876554 799999999999999999999999
Q ss_pred CCCCChhhhhhc--ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 465 MPNKSLDSFIFD--QERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 465 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
|. .+|+.+... ..+...+++..+-+|..-.++||.||.+.- .|||||+||+||||+..|.+||+|||++-.+..+
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 94 455544321 122345777777788888999999998753 6999999999999999999999999998765322
Q ss_pred CCcccccccccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
- ....-.|-..|||||.+.. ..|+.+|||||||++|||+.||+.|+..+.. ..+...+. ..+.++.+..
T Consensus 222 i---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~V-v~gdpp~l~~ 292 (361)
T KOG1006|consen 222 I---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQV-VIGDPPILLF 292 (361)
T ss_pred H---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHH-HcCCCCeecC
Confidence 1 2223467788999999964 3589999999999999999999999765443 12222222 2333333322
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
+ ....+-...++.++-.||..|-.+||...++.++
T Consensus 293 ~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 D----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred c----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1 1112233467789999999999999999998765
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-33 Score=275.37 Aligned_cols=241 Identities=24% Similarity=0.324 Sum_probs=191.1
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 460 (706)
..+|.++.+||+|+||.|.++..+. .+.+|||++++. ...+.+.-+.|-++|+.. +-|.++.+..+|..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 4578899999999999999998765 567899999763 334455667788888777 46789999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+.||+|--+|.+-.+ +.+..+..+|.+||.||-+||+++ ||.||||..||||+.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999888865443 566778889999999999999998 9999999999999999999999999998521
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.....+...+||+.|+|||++...+|...+|.|||||+||||+.|++||+..+.++....+ ... ..
T Consensus 502 --~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI---~eh----nv----- 567 (683)
T KOG0696|consen 502 --FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI---MEH----NV----- 567 (683)
T ss_pred --cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---HHc----cC-----
Confidence 1223455689999999999999999999999999999999999999998764443322222 111 10
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCC
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP 651 (706)
.++-.-..+++.+....|..+|.+|.
T Consensus 568 -----syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 568 -----SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -----cCcccccHHHHHHHHHHhhcCCcccc
Confidence 11111122445667778889999984
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-33 Score=282.98 Aligned_cols=242 Identities=26% Similarity=0.365 Sum_probs=193.2
Q ss_pred ceeccCCceeEEEEEe-CCCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCC
Q 005236 393 KKLGEGGFGPVYKGTL-ADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKS 469 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 469 (706)
++||.|.||+||-|+. +.|+.||||++.+ ...+...++++|+.+|++++||.||.|...|+..+..++|||-+.|.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 7899999999999997 5699999999866 344455789999999999999999999999999999999999997665
Q ss_pred hhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC---CCeEEeeeccccccCCCCCcc
Q 005236 470 LDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 470 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~~kl~Dfgla~~~~~~~~~~ 546 (706)
|.-.|. .+ ...+++..-..++.||+.||.|||.++ |+|+||||+|||+.+. -.+||+|||.|++++....
T Consensus 650 LEMILS-sE-kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-- 722 (888)
T KOG4236|consen 650 LEMILS-SE-KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-- 722 (888)
T ss_pred HHHHHH-hh-cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence 655553 33 245777777788999999999999998 9999999999999754 4699999999999865433
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCc
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDS 626 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 626 (706)
....+||+.|+|||+++++.|...-|+||+|||+|--++|..||.. .++..+.+..+.-++....+.++-.
T Consensus 723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~------ 793 (888)
T KOG4236|consen 723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISP------ 793 (888)
T ss_pred -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCH------
Confidence 2347899999999999999999999999999999999999999742 2233344444433333333333322
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChhHHH
Q 005236 627 FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI 657 (706)
Q Consensus 627 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~ 657 (706)
.+++++-..||..-++|-+..+-+
T Consensus 794 -------~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 794 -------EAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred -------HHHHHHHHHHHHHHHHhcchHhhc
Confidence 345677788888888887776543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=293.71 Aligned_cols=261 Identities=28% Similarity=0.438 Sum_probs=211.6
Q ss_pred cHHHHHHhccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEe-
Q 005236 378 ELATIANATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIH- 454 (706)
Q Consensus 378 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 454 (706)
.+..+...++-|++.+.||+|.+|.||+++. ++++.+|+|++.. .....++++.|.++++.+ .|||++.+++++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 4455566678899999999999999999997 5588889988754 334457889999999888 69999999999974
Q ss_pred ----CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEE
Q 005236 455 ----GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 530 (706)
Q Consensus 455 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 530 (706)
++.++||||||.+|+..+++.... ...+.|..+..|++.++.||.+||... ++|||||-.|||++.++.+||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 568899999999999999997655 567899999999999999999999877 999999999999999999999
Q ss_pred eeeccccccCCCCCcccccccccccCccCccccccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHH
Q 005236 531 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-----QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRH 605 (706)
Q Consensus 531 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~ 605 (706)
+|||++..+ +.+....+...||+.|||||++... .|+.++|+||||++..||--|.+|+...++...+.++
T Consensus 165 vDFGvSaQl--dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I-- 240 (953)
T KOG0587|consen 165 VDFGVSAQL--DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-- 240 (953)
T ss_pred eeeeeeeee--ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC--
Confidence 999999876 3344556668999999999999653 5778999999999999999999998766654332221
Q ss_pred HHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 606 AWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 606 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
....++.+.. ...-..++.+++..||..|-++||++.++++.
T Consensus 241 -----pRNPPPkLkr-------p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 -----PRNPPPKLKR-------PKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -----CCCCCccccc-------hhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1111122211 12234466789999999999999999998753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=286.56 Aligned_cols=241 Identities=23% Similarity=0.270 Sum_probs=192.9
Q ss_pred hccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 462 (706)
.+++|.+...+|.|+|+.|-.+.. ..++..+||++.+.. ....+|+.++... +||||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 467899999999999999999887 457889999997652 2234566555544 7999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE-cCCCCeEEeeeccccccCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill-~~~~~~kl~Dfgla~~~~~ 541 (706)
|.+.++-|.+.+..... ....+..|+.+|+.++.|||+++ +|||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~~----~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE----FCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcch----hHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999988887754432 22677789999999999999998 9999999999999 6999999999999987654
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
+ ....+-|..|.|||++....+++++|+||||++||+||+|+.|+...+.+ ......+..+...+.
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s~~--- 534 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFSEC--- 534 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCccccc---
Confidence 3 23356688999999999999999999999999999999999998754443 112222222222211
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
-...+.+|+.+||+.||.+||+|.++...
T Consensus 535 ---------vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 535 ---------VSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ---------cCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 12245678999999999999999998653
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=272.57 Aligned_cols=236 Identities=27% Similarity=0.330 Sum_probs=189.7
Q ss_pred eccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCCh
Q 005236 395 LGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 470 (706)
Q Consensus 395 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 470 (706)
||+|+||.||++... +++.+++|.+.... ......+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999985 48899999886532 23456889999999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccc
Q 005236 471 DSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 550 (706)
Q Consensus 471 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 550 (706)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 99996442 4789999999999999999999987 9999999999999999999999999998754322 12233
Q ss_pred cccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHH
Q 005236 551 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLA 630 (706)
Q Consensus 551 ~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 630 (706)
..++..|+|||.+.+...+.++|+||||+++|||++|+.||..... ......... .........
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~--~~~~~~~~~----------- 216 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILK--DPLRFPEFL----------- 216 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhc--CCCCCCCCC-----------
Confidence 5678899999999988899999999999999999999999753322 111111111 000111111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCChhH
Q 005236 631 EVIRCIHIGLLCVQQYPEDRPCMPS 655 (706)
Q Consensus 631 ~~~~~~~l~~~cl~~~p~~RPt~~e 655 (706)
...+.+++.+||..+|++||++.+
T Consensus 217 -~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 -SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -CHHHHHHHHHHhcCCHhhCCCccc
Confidence 234567899999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=302.66 Aligned_cols=208 Identities=24% Similarity=0.339 Sum_probs=181.9
Q ss_pred cHHHHHHhccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCc---cchhhHHHHHHHHHHHhhcCCcceeeeEeEEE
Q 005236 378 ELATIANATDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSK---ISEQGLKELKNEIILFSKLQHRNLVKLLGCCI 453 (706)
Q Consensus 378 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 453 (706)
...++....++|.++++||+|+||.|..++.+. ++.||+|++++ ........|..|-.+|..-+.+=|+.|+-+|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 345556667899999999999999999999865 77889999987 33455678999999999999999999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeee
Q 005236 454 HGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 533 (706)
Q Consensus 454 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 533 (706)
+..++|+|||||+||+|-.+|.... .+++..+..++..|+.||.-||+.| +|||||||.|||||..|++||+||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 9999999999999999999995443 5888888899999999999999888 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccCccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005236 534 GLARAFGGDETEGNTNRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGKKNRG 592 (706)
Q Consensus 534 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~SlGvil~elltG~~p~~ 592 (706)
|.+-.+..+. .......+|||.|++||++.. +.|...+|.||+||++|||+.|..||-
T Consensus 220 GsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 220 GSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred hhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 9998765333 334456799999999999953 578899999999999999999999974
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=259.63 Aligned_cols=253 Identities=22% Similarity=0.268 Sum_probs=193.2
Q ss_pred hccCCCcc-ceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEe----CCe
Q 005236 385 ATDNFSIN-KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIH----GEE 457 (706)
Q Consensus 385 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 457 (706)
.+++|++. ++||-|--|.|.....+ .++.+|+|++... ...++|+++--.. .|||||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45677765 68999999999998875 4778999988532 3457788875555 69999999999864 346
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---CCCeEEeeec
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFG 534 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Dfg 534 (706)
+++|||.|+||.|...|.++.. ..+++.++-.|..||+.|+.|||+.+ |.||||||+|+|... +-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 7899999999999999976543 55889999999999999999999988 999999999999964 4579999999
Q ss_pred cccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC
Q 005236 535 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM 614 (706)
Q Consensus 535 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 614 (706)
+|+.... .......+-|+.|.|||++....|+...|+||+||++|-|++|.+||-..+......-.. ..+..+.
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk---~rI~~gq 283 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---RRIRTGQ 283 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHH---hHhhccC
Confidence 9997432 233345678999999999999999999999999999999999999985444321111100 1111111
Q ss_pred CcccccccccCcCCHHHH-HHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 615 PSQLIDACFKDSFNLAEV-IRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 615 ~~~~~d~~~~~~~~~~~~-~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. ++.+ ....++ +.+.+++...|..+|.+|.|+.+++..
T Consensus 284 y-~FP~------pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 Y-EFPE------PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred c-cCCC------hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 0 1111 112222 244578899999999999999999864
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=256.58 Aligned_cols=254 Identities=23% Similarity=0.279 Sum_probs=197.0
Q ss_pred ceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCeeEEEEecCCCCCh
Q 005236 393 KKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKLLIYEFMPNKSL 470 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL 470 (706)
+.||+|+|+.|--+.. ..++++|||++.+.......++.+|++++...+ |+||+.|+.+|+++...|||||-|.||.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 7899999999998864 679999999998887777889999999999986 99999999999999999999999999999
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC---eEEeeeccccccCC--CC--
Q 005236 471 DSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLARAFGG--DE-- 543 (706)
Q Consensus 471 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---~kl~Dfgla~~~~~--~~-- 543 (706)
..+|.++ +.+++.++.++...|+.||.+||.++ |.||||||+|||-....+ +||+||.+..-+.. +-
T Consensus 164 LshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9999654 44888999999999999999999998 999999999999976654 79999998765422 11
Q ss_pred -CcccccccccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc----hh----HHHHHHHH
Q 005236 544 -TEGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK----LN----LIRHAWKL 609 (706)
Q Consensus 544 -~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~----~~----~~~~~~~~ 609 (706)
+.......+|+..|||||+.. ...|+.+.|.||||||||-||+|.+||...-..+- .+ -.......
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 112233468899999999873 24688999999999999999999999975433211 11 11112222
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 610 WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 610 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+.++.. ++.|..+.. -..+..+++...+-.++.+|-++.+++.
T Consensus 318 IQEGkY-eFPdkdWah-----IS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEGKY-EFPDKDWAH-----ISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhccCC-cCChhhhHH-----hhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 233322 222322211 1124456788888899999999988876
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=265.57 Aligned_cols=221 Identities=20% Similarity=0.150 Sum_probs=173.7
Q ss_pred CCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCChhhhhhc
Q 005236 398 GGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFD 476 (706)
Q Consensus 398 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 476 (706)
|.+|.||++++. +++.+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999984 57899999986543 233455555666799999999999999999999999999999999865
Q ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccC
Q 005236 477 QERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556 (706)
Q Consensus 477 ~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 556 (706)
.. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 42 4889999999999999999999987 999999999999999999999999988765321 112345678
Q ss_pred ccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHH
Q 005236 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCI 636 (706)
Q Consensus 557 y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 636 (706)
|+|||.+....++.++||||+|+++|||++|+.|+....... ......+ +.... ...+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~~~~~-----~~~~~----~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTHTTLN-----IPEWV----SEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccccccC-----CcccC----CHHHH
Confidence 999999988889999999999999999999998754221100 0000000 01111 12456
Q ss_pred HHHHHhcCCCCCCCCChhH
Q 005236 637 HIGLLCVQQYPEDRPCMPS 655 (706)
Q Consensus 637 ~l~~~cl~~~p~~RPt~~e 655 (706)
+++.+||+.||.+||++.+
T Consensus 207 ~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 207 SLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHccCCHHHhcCCCc
Confidence 7899999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=275.59 Aligned_cols=269 Identities=22% Similarity=0.276 Sum_probs=216.1
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcE-EEEEEcCc---cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQE-IAVKRLSK---ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
..+++++..||-|+||.|=++..+.... +|+|.+++ ......+.+..|-.+|...+.|.||++|..|.+....|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 3566777889999999999998866443 78887765 3445567788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
||-|-||.|...|.+.. .++......++..+.+|++|||.++ ||.|||||+|++++.+|-+||.|||+|+.++.
T Consensus 499 mEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999997654 3667777888999999999999988 99999999999999999999999999999854
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
. ..+-..+||+.|.|||++.+...+.++|.||||+++|||++|.+||...++-...+++......+.-+ +.+
T Consensus 573 g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I--- 644 (732)
T KOG0614|consen 573 G---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRI--- 644 (732)
T ss_pred C---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--ccc---
Confidence 3 34556899999999999999999999999999999999999999998777766666665544433211 111
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCC-----hhHHHHHh-------cCC--CCCCCCCCCCcccCC
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPC-----MPSVILML-------GSE--IVLPQPKQPGYLADR 678 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~ev~~~L-------~~~--~~~~~p~~p~~~~~~ 678 (706)
.....+++...+..+|.+|-- +.++-+.- +++ ..+++|-.|.....-
T Consensus 645 ----------~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~pt 705 (732)
T KOG0614|consen 645 ----------TKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPT 705 (732)
T ss_pred ----------chhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcc
Confidence 124457788888899999986 55555432 222 456666667655443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=266.90 Aligned_cols=258 Identities=27% Similarity=0.331 Sum_probs=193.6
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcC--ccch-----hhHHHHHHHHHHHhhcCCcceeeeEeEEEe-C
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLS--KISE-----QGLKELKNEIILFSKLQHRNLVKLLGCCIH-G 455 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~ 455 (706)
..++|-++.+||+|||+.|||+.+- ..+.||||+-. +... ...+...+|..+-+.|.||.||++|+++.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3467888899999999999999874 46678888742 2222 223456789999999999999999999965 4
Q ss_pred CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---CCCeEEee
Q 005236 456 EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISD 532 (706)
Q Consensus 456 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~D 532 (706)
+..+-|+|||+|.+|+-||..+ +.+++.++..|+.||+.||.||.+.. ++|||-||||.||||-+ -|.+||.|
T Consensus 541 dsFCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 5778999999999999999654 45899999999999999999999874 78999999999999954 47899999
Q ss_pred eccccccCCCCCc-----ccccccccccCccCcccccc----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHH
Q 005236 533 FGLARAFGGDETE-----GNTNRVVGTYGYMAPEYASD----GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLI 603 (706)
Q Consensus 533 fgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~ 603 (706)
||+++....+... ..+....||..|++||.+.- ..++.|+||||+|||+|..+.|++||..... ...+
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs---QQdI 693 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS---QQDI 693 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh---HHHH
Confidence 9999988654333 23455789999999998853 3688999999999999999999999864221 1111
Q ss_pred HHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHH
Q 005236 604 RHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI 657 (706)
Q Consensus 604 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~ 657 (706)
.....++..... .+ . .+... .-++..++.+||++--++|....+++
T Consensus 694 LqeNTIlkAtEV-qF-P--~KPvV----sseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 LQENTILKATEV-QF-P--PKPVV----SSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred Hhhhchhcceec-cC-C--CCCcc----CHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111111111100 00 0 00011 12345688999999999998777665
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=264.96 Aligned_cols=262 Identities=20% Similarity=0.253 Sum_probs=201.0
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhcC--Ccc----eeeeEeEEEeCCee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQ--HRN----LVKLLGCCIHGEEK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~n----iv~l~~~~~~~~~~ 458 (706)
.++|.+...+|+|.||.|-+..+.. +..||||+++.. ....+..+-|+++++++. -|+ +|.+.++|...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 6899999999999999999998754 678999998543 344566778999999994 233 78888899999999
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC--------------
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-------------- 524 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~-------------- 524 (706)
++|+|.+ |-++.++|..+. ...++...+..++.|+++++++||+.. ++|-||||+|||+-+
T Consensus 167 Civfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999998 668999996543 456788999999999999999999987 999999999999831
Q ss_pred ------CCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 005236 525 ------DMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 598 (706)
Q Consensus 525 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~ 598 (706)
+..+||+|||.|..-.... ...+.|..|.|||++.+-.++.++||||+||||.|+.+|...|...+..+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3458999999998743222 44788999999999999999999999999999999999999876555433
Q ss_pred chhHHHHHHHHhhcCCC-------------------------ccccccccc----CcCCHHHHHHHHHHHHHhcCCCCCC
Q 005236 599 KLNLIRHAWKLWNEGMP-------------------------SQLIDACFK----DSFNLAEVIRCIHIGLLCVQQYPED 649 (706)
Q Consensus 599 ~~~~~~~~~~~~~~~~~-------------------------~~~~d~~~~----~~~~~~~~~~~~~l~~~cl~~~p~~ 649 (706)
.+.+.+.....+...++ ....+.+.. ...+-.+..++.+|+..||.+||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 33333322211110000 000110000 1122346678899999999999999
Q ss_pred CCChhHHHH
Q 005236 650 RPCMPSVIL 658 (706)
Q Consensus 650 RPt~~ev~~ 658 (706)
|+|+.|++.
T Consensus 397 RiTl~EAL~ 405 (415)
T KOG0671|consen 397 RITLREALS 405 (415)
T ss_pred cccHHHHhc
Confidence 999999985
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=290.95 Aligned_cols=262 Identities=19% Similarity=0.241 Sum_probs=167.1
Q ss_pred hccCCCccceeccCCceeEEEEEeCC-----CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeE------EE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLAD-----EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGC------CI 453 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 453 (706)
..++|++.++||+|+||.||+|++.+ +..||||++...... +....| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999999854 588999987643221 111111 1122222222222211 24
Q ss_pred eCCeeEEEEecCCCCChhhhhhccccc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 005236 454 HGEEKLLIYEFMPNKSLDSFIFDQERC-----------------KLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 516 (706)
Q Consensus 454 ~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik 516 (706)
.+...++||||+++++|.+++...... .......+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566889999999999999998643210 01122345678999999999999987 9999999
Q ss_pred CCcEEEcC-CCCeEEeeeccccccCCCCCcccccccccccCccCccccccC----------------------CCCcchh
Q 005236 517 ASNVLLDQ-DMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG----------------------QFSVKSD 573 (706)
Q Consensus 517 p~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~sD 573 (706)
|+|||+++ ++.+||+|||+|+.+..... .......+++.|||||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 58999999999986533221 122346789999999966322 2345679
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH------HHhhcCCCcccccccccCcCCH--HHHHHHHHHHHHhcCC
Q 005236 574 VFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAW------KLWNEGMPSQLIDACFKDSFNL--AEVIRCIHIGLLCVQQ 645 (706)
Q Consensus 574 v~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~~~--~~~~~~~~l~~~cl~~ 645 (706)
||||||+||||+++..+... +......... ..+....... ..+.+...++. .......+|+.+||+.
T Consensus 362 VwSlGviL~el~~~~~~~~~----~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS----NLIQFNRQLKRNDYDLVAWRKLVEPR-ASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch----HHHHHHHHHHhcCCcHHHHHHhhccc-cchhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999999997655321 1111100000 0000000000 00000000000 0111334789999999
Q ss_pred CCCCCCChhHHHHH
Q 005236 646 YPEDRPCMPSVILM 659 (706)
Q Consensus 646 ~p~~RPt~~ev~~~ 659 (706)
||++|||++|+++.
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=279.95 Aligned_cols=263 Identities=20% Similarity=0.246 Sum_probs=179.4
Q ss_pred hccCCCccceeccCCceeEEEEEe-----------------CCCcEEEEEEcCccchhhHH--------------HHHHH
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTL-----------------ADEQEIAVKRLSKISEQGLK--------------ELKNE 433 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~E 433 (706)
..++|++.++||+|+||.||+|.. ..++.||||++........+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999964 23567999998653322222 23447
Q ss_pred HHHHhhcCCcce-----eeeEeEEEe--------CCeeEEEEecCCCCChhhhhhcccc---------------------
Q 005236 434 IILFSKLQHRNL-----VKLLGCCIH--------GEEKLLIYEFMPNKSLDSFIFDQER--------------------- 479 (706)
Q Consensus 434 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~--------------------- 479 (706)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.++|+....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876654 677777753 3568999999999999999864211
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccC
Q 005236 480 CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 559 (706)
Q Consensus 480 ~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 559 (706)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123467788899999999999999987 99999999999999999999999999976533211 11112345789999
Q ss_pred ccccccCCC----------------------CcchhhHHHHHHHHHHHhCCC-CCCCCCCCCc-h---hHHHHHHHHhhc
Q 005236 560 PEYASDGQF----------------------SVKSDVFSFGILLLEIVSGKK-NRGFYHSDNK-L---NLIRHAWKLWNE 612 (706)
Q Consensus 560 PE~~~~~~~----------------------s~~sDv~SlGvil~elltG~~-p~~~~~~~~~-~---~~~~~~~~~~~~ 612 (706)
||.+..... ..+.||||+||+++||++|.. |+........ . ......|+....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998854321 134799999999999999875 5432111100 0 011111222211
Q ss_pred CCCcccccccccCcCCHHHHHHHHHHHHHhcCCCC---CCCCChhHHHHH
Q 005236 613 GMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYP---EDRPCMPSVILM 659 (706)
Q Consensus 613 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p---~~RPt~~ev~~~ 659 (706)
... +....+. .-....+++..+|..+| .+|+|++|+++.
T Consensus 459 ~~~----~~~~~d~----~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QKY----DFSLLDR----NKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cCC----Ccccccc----cChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 111 1000011 11245678888888765 789999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=257.13 Aligned_cols=238 Identities=28% Similarity=0.364 Sum_probs=191.2
Q ss_pred CceeEEEEEeCC-CcEEEEEEcCccchhh-HHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCChhhhhhc
Q 005236 399 GFGPVYKGTLAD-EQEIAVKRLSKISEQG-LKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFD 476 (706)
Q Consensus 399 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 476 (706)
+||.||+|+... ++.+++|++....... .+.+.+|+..+++++|+||+++++.+......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 8899999987654444 68899999999999999999999999999999999999999999999865
Q ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccC
Q 005236 477 QERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556 (706)
Q Consensus 477 ~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 556 (706)
... +++..++.++.+++.++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 432 788999999999999999999987 9999999999999999999999999998764332 2234567889
Q ss_pred ccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHH
Q 005236 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCI 636 (706)
Q Consensus 557 y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 636 (706)
|++||.+....++.++||||||+++++|++|..|+.... ..... ............ ... . .....+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~----~~~~~~~~~~~~-~~~---~---~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLEL----FKKIGKPKPPFP-PPE---W---KISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHH----HHHHhccCCCCc-ccc---c---cCCHHHH
Confidence 999999998889999999999999999999999875421 11111 111111111100 000 0 0123567
Q ss_pred HHHHHhcCCCCCCCCChhHHHH
Q 005236 637 HIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 637 ~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+++.+|+..+|.+||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 7999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=269.65 Aligned_cols=210 Identities=23% Similarity=0.362 Sum_probs=176.7
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
...|..++.||-|+||.|.+++-.+ ...+|+|.|++.+ .......+.|-.||.....+-||+|+-.|.+.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3568888999999999999998655 5568999997743 44556788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||++||++-.+|-+. ..+.+..+..++.++..|+++.|..| +|||||||+|||||.+|++||.||||+.-+.-
T Consensus 708 MdYIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EeccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 9999999999988543 34677778889999999999999888 99999999999999999999999999864310
Q ss_pred ----------CC----Ccc--------------------------cccccccccCccCccccccCCCCcchhhHHHHHHH
Q 005236 542 ----------DE----TEG--------------------------NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 581 (706)
Q Consensus 542 ----------~~----~~~--------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil 581 (706)
+. +.. .....+||+.|+|||++....++..+|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 00 000 00124799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCchh
Q 005236 582 LEIVSGKKNRGFYHSDNKLN 601 (706)
Q Consensus 582 ~elltG~~p~~~~~~~~~~~ 601 (706)
|||+.|+.||-...+.+...
T Consensus 862 ~em~~g~~pf~~~tp~~tq~ 881 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQY 881 (1034)
T ss_pred HHHhhCCCCccCCCCCccee
Confidence 99999999997666655443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=250.94 Aligned_cols=248 Identities=23% Similarity=0.342 Sum_probs=195.9
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 460 (706)
.++|.+.++||+|+|..|..++++. .+.+|+|++++. ..++.+-.+.|-.+.... +||.+|-|..+|..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 4689999999999999999999854 677899988762 334445556677776665 79999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
|.||++||+|--++.++.+ ++++.+..+..+|..||.|||+.+ ||.||||..|+|+|.+|++||.|+|+++.--
T Consensus 329 vieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999999877755443 788888889999999999999998 9999999999999999999999999998621
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCch-hHHHHHHHHhhcCCCcccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKL-NLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 619 (706)
.....+...+||+.|+|||++++..|....|.|+|||+++||+.|+.||+....++.. +...+..+.+.+...+-
T Consensus 403 --~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri-- 478 (593)
T KOG0695|consen 403 --GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI-- 478 (593)
T ss_pred --CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc--
Confidence 2233456689999999999999999999999999999999999999999865444332 22333334433322210
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP 651 (706)
..+. ..++..+...-|..||.+|.
T Consensus 479 ----prsl----svkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 ----PRSL----SVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ----ccee----ehhhHHHHHHhhcCCcHHhc
Confidence 0011 12345677788999999984
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=253.22 Aligned_cols=266 Identities=23% Similarity=0.343 Sum_probs=193.3
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEe--------C
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIH--------G 455 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 455 (706)
..|.-..+||+|.||.||+|+.++ ++.||+|++-..+ +..-....+|+.++..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 356666899999999999999854 7778998763322 2223456789999999999999999988753 2
Q ss_pred CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecc
Q 005236 456 EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 535 (706)
Q Consensus 456 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgl 535 (706)
...++||++|+. +|.-+|.+. ...++..++.++..++..||.|+|... |+|||+||.|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 347999999965 677777432 245788899999999999999999776 99999999999999999999999999
Q ss_pred ccccCCCCC--cccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhc
Q 005236 536 ARAFGGDET--EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNE 612 (706)
Q Consensus 536 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 612 (706)
++.+..... .......+-|..|.+||.+.+ .+++++.|||.-|||+.||.++.+.+..........++......+..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 987743322 222333456999999999876 57999999999999999999999886544433333334333222222
Q ss_pred CCCccc-----c-----cccccCcCC-HHH-H------HHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 613 GMPSQL-----I-----DACFKDSFN-LAE-V------IRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 613 ~~~~~~-----~-----d~~~~~~~~-~~~-~------~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
..++.. . .+..++... .++ + ...++++..++..||.+||.+.+++.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 221111 0 111111111 011 1 14678899999999999999988764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=229.22 Aligned_cols=264 Identities=24% Similarity=0.324 Sum_probs=192.3
Q ss_pred CCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 388 NFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+|...++||+|.||+||||+..+ ++.||+|+++.. .+..-....+|+-+++.++|.|||+++++...+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45666899999999999999855 678999988642 333345778999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
|. .+|..+...- ...++.+.+..++.|+++||.+.|+++ +.|||+||+|.||+.+|++|++|||+++.++-...
T Consensus 83 cd-qdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 94 4677666432 245888899999999999999999998 99999999999999999999999999998743211
Q ss_pred cccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCc---ccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPS---QLI 619 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 619 (706)
-....+-|.-|.+|.++.+. -|+...|+||-|||+.|+.. |++.|...+.++....+-+......+...+ .+.
T Consensus 157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 12234568999999999775 68999999999999999987 444444333333333343333333333222 222
Q ss_pred cccccCcC----CHHHHH-----HHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 620 DACFKDSF----NLAEVI-----RCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 620 d~~~~~~~----~~~~~~-----~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
|...-..+ ...++. +=.++....+.-+|..|.++++.++.
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 21111111 111111 11245556666789999998887653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=236.03 Aligned_cols=204 Identities=28% Similarity=0.391 Sum_probs=167.4
Q ss_pred hccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCc-cchhhHHHHHHHHHHHhh-cCCcceeeeEeEEEeCCeeEEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSK-ISEQGLKELKNEIILFSK-LQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lV 461 (706)
..+...-...||+|++|.|-+-++ .+|+..|+|++.. .+.+..++..+|+.+..+ ..+|.+|.++|........++.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 345566678999999999999887 5689999999975 355667788889987655 4799999999999999999999
Q ss_pred EecCCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 462 YEFMPNKSLDSFIFDQ-ERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||.|. .+|+.+-.+- .+...+++..+=+||..+.+||.|||++ +.+||||+||+||||+.+|++||+|||++-.+.
T Consensus 124 ME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 99994 4776665432 3445688888889999999999999995 469999999999999999999999999998764
Q ss_pred CCCCcccccccccccCccCcccccc----CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASD----GQFSVKSDVFSFGILLLEIVSGKKNRGFY 594 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDv~SlGvil~elltG~~p~~~~ 594 (706)
.+-. .....|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|++.+
T Consensus 201 dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 201 DSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 3221 112356788999999853 37999999999999999999999997644
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=276.73 Aligned_cols=245 Identities=25% Similarity=0.355 Sum_probs=185.6
Q ss_pred CCccceeccCCce-eEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 389 FSINKKLGEGGFG-PVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 389 ~~~~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
|.-.+.+|.|.-| .||+|.. +++.||||++-. .......+|+..++.- +|||||++++.-.++..+|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 3444778999887 5799998 678999998743 3345667899999887 5999999999999999999999999
Q ss_pred CCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---C--CCeEEeeeccccccC
Q 005236 467 NKSLDSFIFDQ-ERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---D--MNPKISDFGLARAFG 540 (706)
Q Consensus 467 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~---~--~~~kl~Dfgla~~~~ 540 (706)
..+|.+++... .......-...+.+..|+++||++||+.+ ||||||||+||||+. + ..++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56999999653 11111111344678899999999999977 999999999999976 3 478999999999987
Q ss_pred CCCCcc-cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 541 GDETEG-NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG-KKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 541 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
.+.... ......||-+|+|||.+....-+.++||||+|||+|+.++| ..||+..... ...+......-..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--------~~NIl~~~~~L~~ 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--------QANILTGNYTLVH 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--------hhhhhcCccceee
Confidence 654432 34557899999999999999889999999999999999996 8888632211 1111111111000
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHH
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI 657 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~ 657 (706)
+... .++ .+.+|+.+|++.+|..||++.+|+
T Consensus 735 ----L~~~--~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 735 ----LEPL--PDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred ----eccC--chH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 1111 111 567899999999999999999996
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-31 Score=247.61 Aligned_cols=263 Identities=23% Similarity=0.315 Sum_probs=193.3
Q ss_pred ccceeccCCceeEEEEEe-CCCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC-----CeeEEEE
Q 005236 391 INKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG-----EEKLLIY 462 (706)
Q Consensus 391 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~ 462 (706)
-.+.||.|+||.||.+++ .+|+.|++|++... +-..-+.+.+|+.++...+|.|++..++..... .+.|+|.
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 348899999999999998 56999999998653 233456788999999999999999988876543 2557888
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
|.|. .+|...|.. .+.++...+.-+++||++||+|||+.+ |+||||||.|.|++.+..+||+|||+++....+
T Consensus 137 ELmQ-SDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 137 ELMQ-SDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHH-hhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence 8884 467776643 345777777778999999999999998 999999999999999999999999999987666
Q ss_pred CCcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH--------HhhcC
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWK--------LWNEG 613 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~--------~~~~~ 613 (706)
+....+. .+-|..|.|||.+.+. .|+.+.||||+|||+.||+-.+..|....+-+.++++..... ..-++
T Consensus 210 ~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 210 DRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 6555444 4568999999999874 799999999999999999988887765555444444432211 11011
Q ss_pred CCcccc-----ccccc----CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 614 MPSQLI-----DACFK----DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 614 ~~~~~~-----d~~~~----~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
--..++ .+.+. -......-.+.+++...++..||.+|.+..+.+..+.
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 000000 00000 0111111123456777899999999999999887663
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=229.40 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=191.7
Q ss_pred hccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCC--eeEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGE--EKLL 460 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~l 460 (706)
..++|++.+++|+|-|+.||.|.. .+.++++||.++... .+.+++|+.++..|. ||||++|++...+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 357899999999999999999985 567889999986533 467899999999998 999999999987654 5579
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-CCeEEeeecccccc
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAF 539 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfgla~~~ 539 (706)
|+||+++.+...+. ..++...+..++.++++||.|+|+.| |.|||+||.|++||.. -.++|+|+|+|.+.
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998887655 34666778889999999999999998 9999999999999965 46999999999987
Q ss_pred CCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH----------
Q 005236 540 GGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWK---------- 608 (706)
Q Consensus 540 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~---------- 608 (706)
..... .+..+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||-.- .++..+++..+.-
T Consensus 184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG-~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG-HDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC-CCCHHHHHHHHHHhChHHHHHHH
Confidence 54332 233456778889999865 46888999999999999999999997322 2222222222111
Q ss_pred -Hhh---cCC------------CcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 609 -LWN---EGM------------PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 609 -~~~---~~~------------~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+. ++. +..++...-+... ..++++++-..|..|-.+|||++|.+..
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~----~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLV----SPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccC----ChHHHHHHHHHHhhccccccchHHHhcC
Confidence 000 000 0111111111111 1356678889999999999999998753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-27 Score=232.85 Aligned_cols=211 Identities=36% Similarity=0.563 Sum_probs=182.8
Q ss_pred eccCCceeEEEEEeCC-CcEEEEEEcCccchh-hHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCChhh
Q 005236 395 LGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQ-GLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDS 472 (706)
Q Consensus 395 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 472 (706)
||+|.+|.||+++..+ ++.+++|++...... ..+.+.+|+..++.++|++|+++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 889999998764432 45688999999999999999999999999999999999999999999
Q ss_pred hhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-CCCeEEeeeccccccCCCCCccccccc
Q 005236 473 FIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGDETEGNTNRV 551 (706)
Q Consensus 473 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~ 551 (706)
++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 986542 35788999999999999999999987 999999999999999 89999999999987543221 12234
Q ss_pred ccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHH
Q 005236 552 VGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLA 630 (706)
Q Consensus 552 ~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 630 (706)
.+...|++||.+... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999999887 888999999999999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCChhHHHHHh
Q 005236 631 EVIRCIHIGLLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 631 ~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L 660 (706)
..+.+++..|++.+|.+||++.++++.|
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3455788899999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=212.67 Aligned_cols=109 Identities=45% Similarity=1.029 Sum_probs=104.6
Q ss_pred eeeCCCCCCcccccc-ccccCcceeEEeecCCeeEEEEEccCCceEEEEEEecccceEEEEEEeccCcceEEEEeccCCC
Q 005236 94 YRSGPWNGLRFSAAT-LRQNPVFNFSFVSSEDELYYTFDLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDL 172 (706)
Q Consensus 94 w~sg~w~g~~~s~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G~~~~~~~w~~~~~~W~~~~~~p~~~ 172 (706)
||+|+|||..|+++| +....++.+.|+.++++.+++|.+.+.++++|++|+.+| ++++|.|++..+.|.+.|++|.|+
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G-~l~~~~w~~~~~~W~~~~~~p~d~ 79 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDG-QLQRYIWNESTQSWSVFWSAPKDQ 79 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeee-EEEEEEEecCCCcEEEEEEecccC
Confidence 899999999999999 667788999999999999999999999999999999999 899999999999999999999999
Q ss_pred CccCCCCCCCccccCCCCCcccccCCcccCC
Q 005236 173 CDTYALCGDYGICIISDLPVCQCLKGFKPKS 203 (706)
Q Consensus 173 C~~~~~CG~~g~C~~~~~~~C~C~~Gf~~~~ 203 (706)
||+|+.||+||+|+.+..+.|+||+||+|++
T Consensus 80 Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 80 CDVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 9999999999999988889999999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=240.23 Aligned_cols=131 Identities=28% Similarity=0.417 Sum_probs=109.7
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-----Cc---ceeeeEeEEEe---
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-----HR---NLVKLLGCCIH--- 454 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~---niv~l~~~~~~--- 454 (706)
.+|.+.++||.|.|++||++.+. +.+.||+|+.+. .....+....|+.+|++++ |+ .||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 68999999999999999999884 467899998853 3344567789999999884 33 59999999975
Q ss_pred -CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE
Q 005236 455 -GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 522 (706)
Q Consensus 455 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill 522 (706)
+.+.+||+|++ |.+|..+|.... ..-++...+.+|+.||+.||.|||.++ .|||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56899999999 667878775433 345889999999999999999999987 69999999999998
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=252.80 Aligned_cols=196 Identities=29% Similarity=0.399 Sum_probs=167.8
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccch--------hhHHHHHHHHHHHhhcC---CcceeeeEeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISE--------QGLKELKNEIILFSKLQ---HRNLVKLLGCCI 453 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 453 (706)
..+|+..+.+|.|+||.|+.+.++. ...|+||.+.+..- ..+-.+-.|+.+|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3568999999999999999999865 56788898765211 11223557999999997 999999999999
Q ss_pred eCCeeEEEEecC-CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEee
Q 005236 454 HGEEKLLIYEFM-PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 532 (706)
Q Consensus 454 ~~~~~~lV~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 532 (706)
+.+.+||+||-. ++-+|.++|..+. .+++.+...|+.|++.|+++||+++ |||||||-+||.|+.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 999999999977 4668999996544 4888999999999999999999999 99999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccCccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCC
Q 005236 533 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSGKKNR 591 (706)
Q Consensus 533 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDv~SlGvil~elltG~~p~ 591 (706)
||.|....+ ......+||..|.|||++.+.+|- ...|||++|++||.++....|+
T Consensus 714 fgsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 714 FGSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred ccchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 999987543 334558899999999999998875 5689999999999999888885
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-28 Score=247.40 Aligned_cols=267 Identities=19% Similarity=0.171 Sum_probs=202.6
Q ss_pred HhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcC------CcceeeeEeEEEeCC
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQ------HRNLVKLLGCCIHGE 456 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~ 456 (706)
....+|.+.-..|+|-|++|.+|.+. .|+.||||++... +.-.+.=+.|+++|.+|+ .-|+++|+..|...+
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 34468888889999999999999984 4889999999653 333455578999999996 347999999999999
Q ss_pred eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-CCeEEeeecc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGL 535 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfgl 535 (706)
+++||+|-+ .-+|.+.|......-.+....+..++.|+..||..|-..+ |+|.||||.||||++. ..+||||||.
T Consensus 508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcc
Confidence 999999988 4589999987666667888899999999999999999887 9999999999999976 4689999999
Q ss_pred ccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
|...+.++ ...+.-+..|.|||++.+.+|+...|+||+||.||||.||+..|........+.+.-.....+...++
T Consensus 584 A~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 584 ASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred cccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 98754332 23355677899999999999999999999999999999999987654443333332221111110000
Q ss_pred ---------------------------------------ccccccccc----CcCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 005236 616 ---------------------------------------SQLIDACFK----DSFNLAEVIRCIHIGLLCVQQYPEDRPC 652 (706)
Q Consensus 616 ---------------------------------------~~~~d~~~~----~~~~~~~~~~~~~l~~~cl~~~p~~RPt 652 (706)
.++...++. .......+..+.+|+-.|+..||++|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 000000000 0112233446778899999999999999
Q ss_pred hhHHHHH
Q 005236 653 MPSVILM 659 (706)
Q Consensus 653 ~~ev~~~ 659 (706)
..++++.
T Consensus 740 ~nqAL~H 746 (752)
T KOG0670|consen 740 VNQALKH 746 (752)
T ss_pred HHHHhcC
Confidence 9998753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=229.00 Aligned_cols=198 Identities=33% Similarity=0.474 Sum_probs=172.1
Q ss_pred CCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchh-hHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 389 FSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQ-GLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
|.+.+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|+..+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999975 889999999765444 67889999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||++........ .
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 9999999865332 1788899999999999999999987 99999999999999999999999999987643321 1
Q ss_pred cccccccccCccCcccc-ccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005236 547 NTNRVVGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGKKNRG 592 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~-~~~~~s~~sDv~SlGvil~elltG~~p~~ 592 (706)
......++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 22335678899999998 66788889999999999999999999973
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=230.27 Aligned_cols=261 Identities=25% Similarity=0.255 Sum_probs=191.7
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC------e
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE------E 457 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 457 (706)
.+|.-.+.+|.|.- .|..+.+ -.++.||+|++.. ......+...+|..++..++|+||++++.++.... +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777788888888 5555554 3588999998754 33455677889999999999999999999997543 5
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.|+|||+| ..+|...+. -.++-.++.+|+.|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 68999999 458888775 23677888899999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHH------------
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRH------------ 605 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~------------ 605 (706)
.-..+ ......+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|...+.-+....+..
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 74322 344557889999999999999999999999999999999999977642211111111100
Q ss_pred ----HHHHhh------cCCCcc-cccccccCc--CCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHh
Q 005236 606 ----AWKLWN------EGMPSQ-LIDACFKDS--FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 606 ----~~~~~~------~~~~~~-~~d~~~~~~--~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L 660 (706)
++.... .-...+ +.|..+... .+..+...+.+++.+||-.+|++|.+++++++.-
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 010000 000111 112222111 1112233455789999999999999999998764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-27 Score=249.27 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=199.9
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
..++|++...+|.|.||.|||+++. .++..|+|.++.....+...++.|+-+++..+|||||.+++.+...+.+++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3478999999999999999999985 588899999987777778889999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
||.+|+|.+.-+-. ..+++.++.+..++..+||+|||+++ -+|||||-.|||+++.|.+|++|||.+-.+..
T Consensus 93 ycgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita-- 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA-- 164 (829)
T ss_pred ecCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--
Confidence 99999999876432 45777788888899999999999998 79999999999999999999999999876532
Q ss_pred CcccccccccccCccCcccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYA---SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~---~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.........||+.|||||+. +.+.|..++|||++|+...|+---++|.-..++.....+... ....+
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk-----S~~qp----- 234 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK-----SGFQP----- 234 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc-----cCCCC-----
Confidence 22233447899999999987 356799999999999999999888777432222111111100 01111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+.+++.-... ..+-+++..|+..+|.+||+++.+++
T Consensus 235 p~lkDk~kws--~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLKDKTKWS--EFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CcccCCccch--HHHHHHHHHHhcCCCccCCChhhhee
Confidence 1122222221 23446888999999999999988764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=226.20 Aligned_cols=201 Identities=26% Similarity=0.448 Sum_probs=167.0
Q ss_pred HHHhccCCCccceeccCCceeEEEEEeC----CCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCC
Q 005236 382 IANATDNFSINKKLGEGGFGPVYKGTLA----DEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGE 456 (706)
Q Consensus 382 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 456 (706)
+....+.|..+++||.|.|++||++++. ....||+|.+...+. ...+.+|++++..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445578899999999999999999874 367899999866443 356899999999995 999999999999999
Q ss_pred eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-CCCeEEeeecc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGL 535 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfgl 535 (706)
...+|+||++.....+++.. ++..++..+++.+.+||+++|.+| ||||||||+|+|.+. -+.-.|+|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999999988843 668888999999999999999998 999999999999985 46789999999
Q ss_pred ccccCCCC-------------Cc-----------------------------ccccccccccCccCcccccc-CCCCcch
Q 005236 536 ARAFGGDE-------------TE-----------------------------GNTNRVVGTYGYMAPEYASD-GQFSVKS 572 (706)
Q Consensus 536 a~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~s~~s 572 (706)
|....... .. .......||++|.|||++.. ...+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 98321000 00 00112469999999999866 4678999
Q ss_pred hhHHHHHHHHHHHhCCCCCCC
Q 005236 573 DVFSFGILLLEIVSGKKNRGF 593 (706)
Q Consensus 573 Dv~SlGvil~elltG~~p~~~ 593 (706)
||||.|||++-+++++.||-.
T Consensus 260 Diws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred ceeeccceeehhhcccccccc
Confidence 999999999999999999744
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-25 Score=210.56 Aligned_cols=254 Identities=21% Similarity=0.326 Sum_probs=185.5
Q ss_pred hccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEe-EEEeCCeeEEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLG-CCIHGEEKLLI 461 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~~~lV 461 (706)
..+.|.+.+.||+|.||.+-++.++. .+.+|+|.+.+.. ...++|.+|...--.| .|.||+.-|+ .|...+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 34789999999999999999999865 6788999886532 3457888888765555 5899998775 46667788899
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc--CCCCeEEeeecccccc
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDFGLARAF 539 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~~~kl~Dfgla~~~ 539 (706)
+||++.|+|..-+.. ..+-+....+++.|++.|+.|||+++ +||||||.+||||- +..++||+|||+.+..
T Consensus 101 qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999999887743 33666777889999999999999998 99999999999994 4458999999998764
Q ss_pred CCCCCcccccccccccCccCccccccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC
Q 005236 540 GGDETEGNTNRVVGTYGYMAPEYASDG-----QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM 614 (706)
Q Consensus 540 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 614 (706)
+.-. ....-+..|-+||..... ...+.+|||.||++++.++||..|+.-. .......+.+..|..+.
T Consensus 174 g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka---~~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 174 GTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA---SIMDKPYWEWEQWLKRK 245 (378)
T ss_pred Ccee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh---hccCchHHHHHHHhccc
Confidence 3211 112345679999987543 3467899999999999999999998632 22233344455555444
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHh
Q 005236 615 PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 615 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L 660 (706)
...+.+. -..+. .++.++-.+-+..++++|=...++.++.
T Consensus 246 ~~~~P~~--F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 246 NPALPKK--FNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred CccCchh--hcccC----HHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 4332221 11122 1344556678999999996555555544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=263.56 Aligned_cols=197 Identities=17% Similarity=0.205 Sum_probs=137.3
Q ss_pred hcCC-cceeeeEeEE-------EeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 005236 439 KLQH-RNLVKLLGCC-------IHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRI 510 (706)
Q Consensus 439 ~l~h-~niv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 510 (706)
.++| +||+++++.| .+.+..++++||+ +++|.++|... ...+++.+++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4556 5788888877 2334567888987 66999999643 245899999999999999999999988 9
Q ss_pred EecccCCCcEEEcCCC-------------------CeEEeeeccccccCCCCC--------------cccccccccccCc
Q 005236 511 IHRDLKASNVLLDQDM-------------------NPKISDFGLARAFGGDET--------------EGNTNRVVGTYGY 557 (706)
Q Consensus 511 vH~Dikp~Nill~~~~-------------------~~kl~Dfgla~~~~~~~~--------------~~~~~~~~gt~~y 557 (706)
+||||||+||||+..+ .+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 9999999999996544 455666666553211000 0001123578889
Q ss_pred cCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHH
Q 005236 558 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIH 637 (706)
Q Consensus 558 ~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 637 (706)
||||++.+..++.++|||||||+||||++|..|+... ......... .. ..+.. .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~-----~~~~~~~~~----~~----~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK-----SRTMSSLRH----RV----LPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH-----HHHHHHHHH----hh----cChhh-----hhcCHHHHH
Confidence 9999999999999999999999999999988774311 111111110 00 01000 111223457
Q ss_pred HHHHhcCCCCCCCCChhHHHHH
Q 005236 638 IGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 638 l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
++.+||+.+|.+||+|.||++.
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 7889999999999999999763
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=203.19 Aligned_cols=168 Identities=17% Similarity=0.168 Sum_probs=123.8
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
|+|.+++... ...+++..++.++.||++||+|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 6899999643 245899999999999999999999875 999999999999999 99998753221
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcC
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSF 627 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 627 (706)
..||+.|||||++.+..++.++|||||||++|||++|+.|+...... ................... ....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~-----~~~~ 133 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADDPRDR-----SNLE 133 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCCcccc-----ccHH
Confidence 25889999999999999999999999999999999999997532211 1111111111111110000 0000
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 628 NLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 628 ~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
...+...+.+++..||+.+|.+||++.|+++.+..
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 11111257889999999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=218.37 Aligned_cols=176 Identities=21% Similarity=0.211 Sum_probs=135.3
Q ss_pred HHhccCCCccceeccCCceeEEEEEeC--CCcEEEEEEcCcc-----chhhHHHHHHHHHHHhhcCCcceee-eEeEEEe
Q 005236 383 ANATDNFSINKKLGEGGFGPVYKGTLA--DEQEIAVKRLSKI-----SEQGLKELKNEIILFSKLQHRNLVK-LLGCCIH 454 (706)
Q Consensus 383 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~ 454 (706)
....++|.+.+.||+|+||+||+|+.. +++.+|||++... .....+.+.+|+.++++++|+|+++ ++.
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 344578999999999999999999874 4677899986532 2233567999999999999999985 443
Q ss_pred CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeccc-CCCcEEEcCCCCeEEeee
Q 005236 455 GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDL-KASNVLLDQDMNPKISDF 533 (706)
Q Consensus 455 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Di-kp~Nill~~~~~~kl~Df 533 (706)
....++||||+++++|.. +. .. . ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+||
T Consensus 90 ~~~~~LVmE~~~G~~L~~-~~-~~-----~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHL-AR-PH-----G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred cCCcEEEEEccCCCCHHH-hC-cc-----c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 246899999999999963 21 10 1 1457889999999999988 999999 999999999999999999
Q ss_pred ccccccCCCCCccc------ccccccccCccCccccccCC------CCcchhhH
Q 005236 534 GLARAFGGDETEGN------TNRVVGTYGYMAPEYASDGQ------FSVKSDVF 575 (706)
Q Consensus 534 gla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~s~~sDv~ 575 (706)
|+|+.+........ .....+++.|+|||.+.... .+..+|-|
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99998754322111 12456888999999996542 33446666
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-22 Score=211.66 Aligned_cols=259 Identities=23% Similarity=0.267 Sum_probs=192.2
Q ss_pred CCCccceeccCCceeEEEEEeCCC--cEEEEEEcCccchhhHHHHHHHHHHHhhcCC----cceeeeEeEE-EeCCeeEE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLADE--QEIAVKRLSKISEQGLKELKNEIILFSKLQH----RNLVKLLGCC-IHGEEKLL 460 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 460 (706)
+|.+.++||+|+||.||++..... ..+|+|............+..|..++..+.+ +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999998664 4788887755433333378889999988873 5899999988 47778899
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-----CCeEEeeecc
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-----MNPKISDFGL 535 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~-----~~~kl~Dfgl 535 (706)
||+.+ |.+|.++..... ...++..+.++|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 889999775544 466899999999999999999999998 9999999999999865 4699999999
Q ss_pred cc--ccCCCCC----cc-c-ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 005236 536 AR--AFGGDET----EG-N-TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAW 607 (706)
Q Consensus 536 a~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 607 (706)
++ .+..... .. . .....||.+|+++..+.+.+.+.+.|+||++.++.|++.|..|+................
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 99 3322211 11 1 223569999999999999999999999999999999999999985544322221111111
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 608 KLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 608 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
. ...... .......+.. ++...+-..+..++|....+...|...
T Consensus 254 ~---~~~~~~------~~~~~~~~~~---~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 254 R---KLLTDR------FGDLKPEEFA---KILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred h---hhcccc------ccCCChHHHH---HHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 1 111100 0111222333 333344447899999999999988655
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.2e-23 Score=195.79 Aligned_cols=251 Identities=21% Similarity=0.305 Sum_probs=187.0
Q ss_pred CCCccceeccCCceeEEEEEeCCCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 388 NFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
+..+..+|.+...|..|+|+++. ..+++|++.. ......+.|..|.-.++.+.||||+++++.|....++.++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 34455789999999999999954 4566777643 23333467888998999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
+.|+|...|++... -..+..+..+++..||+|++|||+..+ -|.---|.+..++||++.+++|+- +-+++ .
T Consensus 270 p~gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kf------s 340 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKF------S 340 (448)
T ss_pred cchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-cccee------e
Confidence 99999999987543 346778889999999999999999863 244456899999999999988742 11111 0
Q ss_pred ccccccccccCccCccccccCCCC---cchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFS---VKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s---~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
.......-.+.||+||.+...+-+ .++|+|||+++||||.|.+.||....+-+-.-.+ ..++....+
T Consensus 341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki------aleglrv~i---- 410 (448)
T KOG0195|consen 341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI------ALEGLRVHI---- 410 (448)
T ss_pred eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh------hhccccccC----
Confidence 011112346899999999876543 5799999999999999999999876654332111 112211111
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
++-....+.+++.-|+..||.+||.+..|+-.|+.-
T Consensus 411 -----ppgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 411 -----PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred -----CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 111123466788899999999999999999988753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-20 Score=197.92 Aligned_cols=262 Identities=29% Similarity=0.373 Sum_probs=196.6
Q ss_pred CCccceeccCCceeEEEEEeCCCcEEEEEEcCccchh---hHHHHHHHHHHHhhcCCc-ceeeeEeEEEeCCeeEEEEec
Q 005236 389 FSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQ---GLKELKNEIILFSKLQHR-NLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e~ 464 (706)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +|+++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677899999999999999987 78899988653322 467899999999999988 799999999777778999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-CeEEeeeccccccCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFGGDE 543 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfgla~~~~~~~ 543 (706)
+.+++|.+++........+.......++.|++.++.|+|..+ ++|||+||+||+++..+ .++++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977643321125788889999999999999999988 99999999999999998 79999999998654433
Q ss_pred Ccc----cccccccccCccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc
Q 005236 544 TEG----NTNRVVGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616 (706)
Q Consensus 544 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (706)
... ......|+..|+|||.+.. ...+...|+||+|++++++++|..|+...... ................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 221 2355789999999999987 57899999999999999999999995443321 0011111111111111
Q ss_pred ccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 617 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.. ...............+.+++..|+..+|..|.++.+....
T Consensus 234 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SL-ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cc-ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 0000000001122345678889999999999999987764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.1e-21 Score=179.00 Aligned_cols=212 Identities=20% Similarity=0.298 Sum_probs=173.5
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCC-cceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQH-RNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e 463 (706)
...|.++++||.|+||.+|.|.. .+|.+||||.-+..... -++..|..+...|+| ..|..+..+..++..-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 46899999999999999999986 67999999986543322 356788999999975 678888899999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC---CCeEEeeeccccccC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLARAFG 540 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~~kl~Dfgla~~~~ 540 (706)
.+ |-+|.+++.-.. ..++..+++-+|-|++.-++|+|..+ +|||||||+|+|..-+ ..+.|+|||+|+.+.
T Consensus 92 LL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 778888875433 23778899999999999999999988 9999999999999644 458999999999875
Q ss_pred CCCCc-----ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHH
Q 005236 541 GDETE-----GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRH 605 (706)
Q Consensus 541 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~ 605 (706)
..... .......||.+|.+-....+.+.+.+.|+-|+|.+|..+.-|..||............+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk 235 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK 235 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH
Confidence 43222 122346799999999988888999999999999999999999999977665544444333
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.9e-22 Score=219.81 Aligned_cols=252 Identities=23% Similarity=0.274 Sum_probs=184.4
Q ss_pred CccceeccCCceeEEEEEeCC-CcEEEEEEcC-----ccchhh-HHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 390 SINKKLGEGGFGPVYKGTLAD-EQEIAVKRLS-----KISEQG-LKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 390 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~-----~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
.....+|.|++|.|+...... ....+.|... ...... ...+..|+-+-..++|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 455899999999887776532 3323333321 112211 223667888888999999988888777777666679
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++ +|..++... ..+...++..++.|+..|++|||+.+ |.|||+|++|+++..+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 999988554 34677788889999999999999998 999999999999999999999999999877544
Q ss_pred CCc--ccccccccccCccCccccccCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 543 ETE--GNTNRVVGTYGYMAPEYASDGQFSV-KSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 543 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~-~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
... ......+|+..|+|||++.+..|.+ ..||||.|+++..|++|+.||......+.... .........+.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~------~~~~~~~~~~~ 547 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK------TNNYSDQRNIF 547 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh------hhccccccccc
Confidence 333 4455678999999999999999986 48999999999999999999866544333210 00000000000
Q ss_pred cccccCcCCH--HHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 620 DACFKDSFNL--AEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 620 d~~~~~~~~~--~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
. +...+ ....+...++..+|+.+|.+|.||++|++
T Consensus 548 ~----~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 E----GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred c----ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 00111 11224567889999999999999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-20 Score=180.91 Aligned_cols=206 Identities=21% Similarity=0.342 Sum_probs=171.0
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
-+|++.++||+|.||+++.|+. -+++.||||.-...++ .-++..|....+.|. .++|...+-+..++-+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 4899999999999999999986 5789999997654333 246778888888885 78999999888889999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-----CCeEEeeecccccc
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-----MNPKISDFGLARAF 539 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~-----~~~kl~Dfgla~~~ 539 (706)
+ |-+|.+++.=.. ..++.+++..+|.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 678887764222 34788999999999999999999998 9999999999999644 45899999999987
Q ss_pred CCCCCcc-----cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCch
Q 005236 540 GGDETEG-----NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKL 600 (706)
Q Consensus 540 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~ 600 (706)
....+.. ......||.+||+-....+.+.+.+.|+-|+|-++...|-|..||.....+...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK 245 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK 245 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH
Confidence 5433221 223356999999999999999999999999999999999999999876655443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-21 Score=186.96 Aligned_cols=171 Identities=15% Similarity=0.188 Sum_probs=133.1
Q ss_pred hccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhh---HHH------HHHHHHHHhhcCCcceeeeEeEEEeC
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQG---LKE------LKNEIILFSKLQHRNLVKLLGCCIHG 455 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~------~~~E~~~l~~l~h~niv~l~~~~~~~ 455 (706)
..++|++.++||.|+||.||.... ++..+|||.+....... ... +.+|+..+.+++||+|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 357999999999999999999766 57789999996532222 222 67899999999999999999886643
Q ss_pred --------CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC
Q 005236 456 --------EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 527 (706)
Q Consensus 456 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~ 527 (706)
...++||||++|.+|.++.. ++. ....+++.+|..+|..+ ++|||+||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999988741 222 24568999999999988 99999999999999998
Q ss_pred eEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHH
Q 005236 528 PKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIV 585 (706)
Q Consensus 528 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ell 585 (706)
++|+|||.......+... ..+.....+..++|+||||+.+..+.
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988754211111 11344455678999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-20 Score=179.17 Aligned_cols=139 Identities=19% Similarity=0.165 Sum_probs=108.3
Q ss_pred cceeccCCceeEEEEEeCCCcEEEEEEcCccchh--h------------------------HHHHHHHHHHHhhcCCcce
Q 005236 392 NKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQ--G------------------------LKELKNEIILFSKLQHRNL 445 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni 445 (706)
...||+|+||.||+|...+|+.||||+++..... . ......|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4789999999999999888999999998643110 0 1123459999999988776
Q ss_pred eeeEeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecccCCCcEEEcC
Q 005236 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL-HQDSRLRIIHRDLKASNVLLDQ 524 (706)
Q Consensus 446 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~Dikp~Nill~~ 524 (706)
.....+.. ...++||||+++++|...+... ..++......++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333222 2348999999998876553222 3478889999999999999999 6777 99999999999998
Q ss_pred CCCeEEeeecccccc
Q 005236 525 DMNPKISDFGLARAF 539 (706)
Q Consensus 525 ~~~~kl~Dfgla~~~ 539 (706)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8e-21 Score=210.84 Aligned_cols=252 Identities=16% Similarity=0.170 Sum_probs=179.2
Q ss_pred CCCccceeccCCceeEEEEEeCCCcEEEEEEcCccc-hhhHHHHHHHHHH--HhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 388 NFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKIS-EQGLKELKNEIIL--FSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
++...+.||.+.|=+|.++++++|. |+||++-+.. ...++.++++++- ...++|||.+++.-.-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5677799999999999999998886 8999875533 3334444443333 5566899999988776666677888888
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC--C
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG--D 542 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~--~ 542 (706)
+.+ +|.+.|- .+..+...+...|+.|+++||...|..+ |.|+|||.+||||+.-.-+.|+||..-+...- +
T Consensus 103 vkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 844 7777773 3455777788889999999999999988 99999999999999999999999998765321 1
Q ss_pred C---CcccccccccccCccCccccccC----------C-CCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHH
Q 005236 543 E---TEGNTNRVVGTYGYMAPEYASDG----------Q-FSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAW 607 (706)
Q Consensus 543 ~---~~~~~~~~~gt~~y~aPE~~~~~----------~-~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 607 (706)
. ..........-..|+|||.+... . .+++.||||+||++.||++ |+++|.. .++..+..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYRS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHhc
Confidence 1 11122233455689999988441 2 6789999999999999988 6777642 11111111
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 608 KLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 608 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
+. .......++.-.+ ..+..+++.|++.||.+|-++++.++.-++.
T Consensus 250 -----~~-~~~~e~~Le~Ied----~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 250 -----GN-ADDPEQLLEKIED----VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred -----cC-ccCHHHHHHhCcC----ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 00 0000000100000 1345788999999999999999999886554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=173.88 Aligned_cols=140 Identities=19% Similarity=0.210 Sum_probs=110.8
Q ss_pred cceeccCCceeEEEEEeCCCcEEEEEEcCccchh--------------------------hHHHHHHHHHHHhhcCCcce
Q 005236 392 NKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQ--------------------------GLKELKNEIILFSKLQHRNL 445 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 445 (706)
...||+|+||.||+|+..+|+.||||++...... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4789999999999999888999999998653210 01234678999999999987
Q ss_pred eeeEeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCcEEEcC
Q 005236 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQ 524 (706)
Q Consensus 446 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dikp~Nill~~ 524 (706)
.....+... ..++||||++++++....... ..++......++.|++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544444332 348999999998654432221 246778889999999999999999 77 99999999999999
Q ss_pred CCCeEEeeeccccccC
Q 005236 525 DMNPKISDFGLARAFG 540 (706)
Q Consensus 525 ~~~~kl~Dfgla~~~~ 540 (706)
++.++|+|||++..+.
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8999999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=191.09 Aligned_cols=216 Identities=24% Similarity=0.331 Sum_probs=162.2
Q ss_pred HhhcCCcceeeeEeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 005236 437 FSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 516 (706)
Q Consensus 437 l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik 516 (706)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+... ...+++.....++..|++||+|||+.. -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 35689999999999999999999999999999999999763 345889999999999999999999865 23999999
Q ss_pred CCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccC-------CCCcchhhHHHHHHHHHHHhCCC
Q 005236 517 ASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-------QFSVKSDVFSFGILLLEIVSGKK 589 (706)
Q Consensus 517 p~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~sDv~SlGvil~elltG~~ 589 (706)
+.|++++....+||+|||+.................-..-|.|||.++.. ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998876431111111122345679999999764 25778999999999999999999
Q ss_pred CCCCCCCCCc-hhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 590 NRGFYHSDNK-LNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 590 p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
||........ .+.+............+.+.. .. +....+..++..||..+|.+||++++|-..++..
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~-----~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIEL-----LN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhh-----hh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 9876443332 233333222111111111111 10 1122567788999999999999999999988865
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-18 Score=165.99 Aligned_cols=184 Identities=18% Similarity=0.177 Sum_probs=138.9
Q ss_pred CccceeccCCceeEEEEEeCCCcEEEEEEcCccch----hhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCeeEEEEec
Q 005236 390 SINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISE----QGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 390 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
.+...|++|+||+||.+.. .+.+++.+.+..... .....+.+|+.++++|+ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3558999999999997766 677788777754332 11235789999999995 5889999886 456999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeccc-CCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDL-KASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Di-kp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
+.|.+|...+.. ....++.|++.+|.++|.++ |+|||| ||.|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999998754311 11347789999999999998 999999 7999999999999999999998654322
Q ss_pred Cc----cc-------ccccccccCccCccccccC-CCC-cchhhHHHHHHHHHHHhCCCCC
Q 005236 544 TE----GN-------TNRVVGTYGYMAPEYASDG-QFS-VKSDVFSFGILLLEIVSGKKNR 591 (706)
Q Consensus 544 ~~----~~-------~~~~~gt~~y~aPE~~~~~-~~s-~~sDv~SlGvil~elltG~~p~ 591 (706)
.. .. ......++.|++|+...-. ..+ ...+.++.|.-+|.++|++.+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 10 00 1112357788888765332 333 5779999999999999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-19 Score=190.20 Aligned_cols=186 Identities=28% Similarity=0.347 Sum_probs=153.3
Q ss_pred eeccCCceeEEEEEe----CCCcEEEEEEcCccchhh--HHHHHHHHHHHhhcC-CcceeeeEeEEEeCCeeEEEEecCC
Q 005236 394 KLGEGGFGPVYKGTL----ADEQEIAVKRLSKISEQG--LKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 394 ~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
.+|+|.||.|+.++- +.+..+|+|.+.+..... ......|..++..++ ||.+|++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998653 346778888886532211 125567888888887 9999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+|.|...+.... ..+......+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 999988774433 3455556667788999999999888 99999999999999999999999999987532211
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 593 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~ 593 (706)
.+||..|||||++. .....+|.||||++++||+||..||..
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28999999999998 677899999999999999999999764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.3e-18 Score=170.15 Aligned_cols=233 Identities=23% Similarity=0.299 Sum_probs=147.9
Q ss_pred CCCccceeccCCceeEEEEEeCC-CcEEEEEEcCc---cchhhHHHHHHHHHHHhhcCC-----------cceeeeEeE-
Q 005236 388 NFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSK---ISEQGLKELKNEIILFSKLQH-----------RNLVKLLGC- 451 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h-----------~niv~l~~~- 451 (706)
.+...+.||.|+++.||.+++.+ ++++|||.+.. ......+++++|...+..+.+ .-++++--.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45567899999999999999965 88999998743 233456778888766666433 112222111
Q ss_pred -------EEeCC--------eeEEEEecCCCCChhhhhh---cccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 005236 452 -------CIHGE--------EKLLIYEFMPNKSLDSFIF---DQER-CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIH 512 (706)
Q Consensus 452 -------~~~~~--------~~~lV~e~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH 512 (706)
+.... ..+++|+-+ -++|.+++. .... ...+....++.+..|+++.+++||+.+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11111 235677777 567777753 2211 122344555677789999999999998 999
Q ss_pred cccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCcccccc--------CCCCcchhhHHHHHHHHHH
Q 005236 513 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD--------GQFSVKSDVFSFGILLLEI 584 (706)
Q Consensus 513 ~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDv~SlGvil~el 584 (706)
+||+|+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999988764321111 234578999997744 2578899999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCC
Q 005236 585 VSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDR 650 (706)
Q Consensus 585 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 650 (706)
.+|+.|+........... .+. .+. .-...+..|+..+|+.+|++|
T Consensus 244 WC~~lPf~~~~~~~~~~~-------------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW-------------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG-------------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc-------------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999875433222111 111 112 223345578889999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.8e-18 Score=163.76 Aligned_cols=136 Identities=20% Similarity=0.290 Sum_probs=105.6
Q ss_pred CccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhc-----CCcceeeeEeEEEeCC---e-eEE
Q 005236 390 SINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKL-----QHRNLVKLLGCCIHGE---E-KLL 460 (706)
Q Consensus 390 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~l 460 (706)
.-.+.||+|+||.||. .++....+||++........+.+.+|+.+++.+ .||||+++++++.+.. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457999999999996 443333479988654444567899999999999 5799999999998864 3 337
Q ss_pred EEec--CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceEecccCCCcEEEcC----CCCeEEeee
Q 005236 461 IYEF--MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGL-LYLHQDSRLRIIHRDLKASNVLLDQ----DMNPKISDF 533 (706)
Q Consensus 461 V~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~ivH~Dikp~Nill~~----~~~~kl~Df 533 (706)
|+|| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 5589999999542 24444 35677888777 9999998 999999999999974 347999994
Q ss_pred ccc
Q 005236 534 GLA 536 (706)
Q Consensus 534 gla 536 (706)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-18 Score=198.05 Aligned_cols=197 Identities=22% Similarity=0.291 Sum_probs=157.3
Q ss_pred hccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcC---CcceeeeEeEEEeCCeeEEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ---HRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV 461 (706)
..+.|.|.+.||+|+||+||+|...+|+.||+|.-+..+.= +|---.+++.+|+ -+-|+.+..+..-.+..+||
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 44678999999999999999999988999999987543211 1111122333333 23455666666667888999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-------CCCeEEeeec
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-------DMNPKISDFG 534 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~-------~~~~kl~Dfg 534 (706)
+||.+-|+|.+++. ..+.++|.....++.|+++.++.||..+ |||+||||+|+||.. ...++|+|||
T Consensus 773 ~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecc
Confidence 99999999999996 4466899999999999999999999998 999999999999952 3458999999
Q ss_pred cccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 005236 535 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN 590 (706)
Q Consensus 535 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p 590 (706)
.+.....-.........++|-.+--+|...+.+++.++|.|.++.+++-||.|+..
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 98765433333344556789999999999999999999999999999999999864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.8e-17 Score=160.08 Aligned_cols=134 Identities=20% Similarity=0.261 Sum_probs=113.1
Q ss_pred ceeccCCceeEEEEEeCCCcEEEEEEcCccch--------hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSKISE--------QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+.||+|++|.||+|.. .+..+++|+...... .....+.+|+.++..++|++|.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 6799999999999988 667899997643211 1124578899999999999988877777777888999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++|++|.+++.... . .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999885321 2 77889999999999999988 99999999999999 78999999999875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.2e-17 Score=161.52 Aligned_cols=150 Identities=17% Similarity=0.167 Sum_probs=114.5
Q ss_pred HHHHHhccCCCccceeccCCceeEEEEE--eCCCcEEEEEEcCccchh------------------------hHHHHHHH
Q 005236 380 ATIANATDNFSINKKLGEGGFGPVYKGT--LADEQEIAVKRLSKISEQ------------------------GLKELKNE 433 (706)
Q Consensus 380 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E 433 (706)
..+......|.+.+.||+|+||.||+|. ..+|+.||||++...... ....+..|
T Consensus 21 ~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 100 (237)
T smart00090 21 YSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKE 100 (237)
T ss_pred HHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHH
Confidence 3444444568899999999999999998 567999999988642210 11235789
Q ss_pred HHHHhhcCCcc--eeeeEeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 005236 434 IILFSKLQHRN--LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRII 511 (706)
Q Consensus 434 ~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iv 511 (706)
+..+.++.+.. +.++++. ...++||||+++.+|...+... ..+.......++.||+.++.+||+.+ .++
T Consensus 101 ~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g--~ii 171 (237)
T smart00090 101 FRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEG--ELV 171 (237)
T ss_pred HHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcC--CEE
Confidence 99999997633 3444433 2358999999999987665222 23455567789999999999999876 399
Q ss_pred ecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 512 HRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 512 H~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
||||||+||+++ ++.++|+|||.+...
T Consensus 172 H~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 172 HGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred eCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 999999999999 889999999998764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.3e-18 Score=177.66 Aligned_cols=243 Identities=21% Similarity=0.255 Sum_probs=158.4
Q ss_pred CCccceeccCCceeEEEEEeCCC----cEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeE------eEEEe---
Q 005236 389 FSINKKLGEGGFGPVYKGTLADE----QEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLL------GCCIH--- 454 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~------~~~~~--- 454 (706)
..+.+..+..+++.+...+..++ ..++.+..............+++-.+... +|++.+..- .....
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v 325 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV 325 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence 34446667777777766654332 22333333222212222233333333333 444433221 01111
Q ss_pred --CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEee
Q 005236 455 --GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 532 (706)
Q Consensus 455 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 532 (706)
...+++.|+++...+|.+||.+.......++...+.++.|++.++.| ++ .+|+|+||.||+...+..+||.|
T Consensus 326 ~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 326 GKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred ccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhh
Confidence 22468999999999999999877777778899999999999999999 55 99999999999999999999999
Q ss_pred eccccccCCCC----CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCCchhHHHHHH
Q 005236 533 FGLARAFGGDE----TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG-KKNRGFYHSDNKLNLIRHAW 607 (706)
Q Consensus 533 fgla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG-~~p~~~~~~~~~~~~~~~~~ 607 (706)
||+........ ........+||..||+||.+.+..|+.|+||||||+||+|++.- ..+++ -....
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----------r~~t~ 469 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----------RIATL 469 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----------HHHhh
Confidence 99987654433 22234557899999999999999999999999999999999982 22211 01111
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHH
Q 005236 608 KLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSV 656 (706)
Q Consensus 608 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev 656 (706)
.-++.+.++ +......+. -..+..+++...|.+||++.++
T Consensus 470 ~d~r~g~ip----~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 470 TDIRDGIIP----PEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hhhhcCCCC----hHHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence 112222222 111111111 2357779999999999955444
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.5e-16 Score=155.23 Aligned_cols=144 Identities=17% Similarity=0.161 Sum_probs=112.0
Q ss_pred HHHHhccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccch----------------------hhHHHHHHHHHHHh
Q 005236 381 TIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISE----------------------QGLKELKNEIILFS 438 (706)
Q Consensus 381 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~ 438 (706)
++......|.+.+.||+|+||.||++...+|+.||||++..... .....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 34444445888899999999999999998899999998643210 01123677889999
Q ss_pred hcCCcc--eeeeEeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 005236 439 KLQHRN--LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 516 (706)
Q Consensus 439 ~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik 516 (706)
.+.|++ +++.++ ....++||||+++++|...... .....++.+++.++.++|+.+ ++|+|||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 998874 444443 2455899999999999765421 234578899999999999987 9999999
Q ss_pred CCcEEEcCCCCeEEeeeccccccC
Q 005236 517 ASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 517 p~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
|+||++++++.++|+|||++..+.
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=155.63 Aligned_cols=130 Identities=22% Similarity=0.327 Sum_probs=107.1
Q ss_pred eeccCCceeEEEEEeCCCcEEEEEEcCccc--------hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 394 KLGEGGFGPVYKGTLADEQEIAVKRLSKIS--------EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 394 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
.||+|+||.||+|.. ++..+++|...... .....++.+|+.++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999995 56789999854321 112356788999999999987766565666777789999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
+|++|.+++..... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988743211 68999999999999988 99999999999999 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=177.70 Aligned_cols=137 Identities=20% Similarity=0.295 Sum_probs=112.2
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEE-cCcc-------chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKR-LSKI-------SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEE 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 457 (706)
...|...+.||+|+||.||+|.+.+.. +++|+ +.+. .....+.+.+|+.++..++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345566799999999999999885544 33333 2221 11223568899999999999999988888877778
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ +++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999999884 34678999999999999988 9999999999999 67899999999997
Q ss_pred c
Q 005236 538 A 538 (706)
Q Consensus 538 ~ 538 (706)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 6
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.6e-17 Score=125.20 Aligned_cols=66 Identities=45% Similarity=1.013 Sum_probs=59.2
Q ss_pred ccCCCceEEeeccCCCCCCccccccccCHhHHHHHHhhcCccccccccccCCCCceeeeeecccccc
Q 005236 221 YSREDGFIKFTAMKLPDATPSWVSKSMNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDM 287 (706)
Q Consensus 221 c~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~~~~c~~~~~~l~d~ 287 (706)
|+.+|+|+++++|++|++....+..++++++|++.||+||||+||+|.+.+ ++++|.+|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 455799999999999999877776789999999999999999999998766 678999999999984
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1e-15 Score=153.34 Aligned_cols=197 Identities=21% Similarity=0.272 Sum_probs=132.5
Q ss_pred CCcceeeeEeEEEeC---------------------------CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHH
Q 005236 441 QHRNLVKLLGCCIHG---------------------------EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIIC 493 (706)
Q Consensus 441 ~h~niv~l~~~~~~~---------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 493 (706)
+|||||++.++|.+. ..+|+||.-. ..+|.+++..+. .+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC----CchHHHHHHHH
Confidence 599999999887641 2457888766 458888885433 45556667889
Q ss_pred HHHHHHHHHHhCCCCceEecccCCCcEEEc--CCC--CeEEeeeccccccCCCC----CcccccccccccCccCcccccc
Q 005236 494 GTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDM--NPKISDFGLARAFGGDE----TEGNTNRVVGTYGYMAPEYASD 565 (706)
Q Consensus 494 ~ia~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~--~~kl~Dfgla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~ 565 (706)
|+++|+.|||.++ |.|||+|++||||. +|+ .+.|+|||.+---.... .....-..-|.-.-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 99999999999993 444 47899999875422110 1111112346778999999865
Q ss_pred CCC------CcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHH
Q 005236 566 GQF------SVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIG 639 (706)
Q Consensus 566 ~~~------s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~ 639 (706)
.+- -.|+|.|+.|.+.||+++...||-. ..+..++... +.+...+.+.+ ..+. .+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~-rGem~L~~r~-----Yqe~qLPalp~-----~vpp----~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK-RGEMLLDTRT-----YQESQLPALPS-----RVPP----VARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccc-cchheechhh-----hhhhhCCCCcc-----cCCh----HHHHHH
Confidence 431 2589999999999999999999743 1111111111 12222222222 1111 244688
Q ss_pred HHhcCCCCCCCCChhHHHHHh
Q 005236 640 LLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 640 ~~cl~~~p~~RPt~~ev~~~L 660 (706)
...|+.||.+||+..=..-.|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 889999999999876555554
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.7e-17 Score=141.39 Aligned_cols=62 Identities=52% Similarity=0.816 Sum_probs=50.2
Q ss_pred CceEEEEecCCcEEEEecCCCCCceEEEeecCCCcccccCCCcccceeecCCceEEEecCCCCCCC
Q 005236 3 ALSFLFVCYSGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPS 68 (706)
Q Consensus 3 ~~~~~~l~~sGNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgqklg~~~~tg~~~~L~Sw~s~~dps 68 (706)
.+..|+|+|+|||||++..+ .+|||||||||||+||+|+|+.+..++.+..++||++.+|||
T Consensus 53 ~~~~~~L~~~GNlvl~d~~~----~~lW~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 53 SGCYLVLQDDGNLVLYDSSG----NVLWQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp SSEEEEEETTSEEEEEETTS----EEEEESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred cCeEEEEeCCCCEEEEeecc----eEEEeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 47789999999999998644 899999999999999999999988888777899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.7e-16 Score=175.27 Aligned_cols=214 Identities=23% Similarity=0.273 Sum_probs=141.3
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
.+|..++.|..|+||.||.++++. .+..|+| +.+..-- +++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li----lRn---ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI----LRN---ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh----hhc---cccccCCccee-------------------
Confidence 688899999999999999999865 5567773 3221110 011 22222333333
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
|+-...+.. .+.++. +++.+++|||+.+ |+|||+||.|.+|+.-|++|+.|||+++........
T Consensus 136 --gDc~tllk~---~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLLKN---IGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhccc---CCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 333333321 122332 2378999999888 999999999999999999999999999864211000
Q ss_pred -------------ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhc
Q 005236 546 -------------GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNE 612 (706)
Q Consensus 546 -------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 612 (706)
......+||+.|+|||++....|...+|.|++|+|+||.+-|..||....+++....+..-...|.+
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 0122458999999999999999999999999999999999999998654433322221111111111
Q ss_pred CCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHH
Q 005236 613 GMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI 657 (706)
Q Consensus 613 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~ 657 (706)
+ +..-..++.+++.+.|+.+|..|--....+
T Consensus 280 ~--------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 280 E--------------DEALPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred c--------------CcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence 1 111122455677889999999996444333
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.9e-15 Score=136.57 Aligned_cols=135 Identities=23% Similarity=0.204 Sum_probs=114.8
Q ss_pred ccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCC--cceeeeEeEEEeCCeeEEEEecCCCC
Q 005236 391 INKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQH--RNLVKLLGCCIHGEEKLLIYEFMPNK 468 (706)
Q Consensus 391 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~g 468 (706)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++++++.+....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999855 7899998865433 4678899999999976 58999998888778899999999998
Q ss_pred ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 469 SLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 469 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
.+..+ +......++.+++++|++||......++|+|++|.||++++.+.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77653 4456677899999999999986545699999999999999999999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.1e-15 Score=142.19 Aligned_cols=136 Identities=21% Similarity=0.221 Sum_probs=97.8
Q ss_pred cceeccCCceeEEEEEeCCCcEEEEEEcCccchh--hHHH----------------------HHHHHHHHhhcCCcc--e
Q 005236 392 NKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQ--GLKE----------------------LKNEIILFSKLQHRN--L 445 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 445 (706)
.+.||+|+||.||+|...+++.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4789999999999999888999999987542211 1111 135666666665443 4
Q ss_pred eeeEeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCcEEEcC
Q 005236 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQ 524 (706)
Q Consensus 446 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dikp~Nill~~ 524 (706)
.+.+++ ...++||||++++++......... .. .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444433 346899999999654321111100 11 5567899999999999998 76 99999999999999
Q ss_pred CCCeEEeeecccccc
Q 005236 525 DMNPKISDFGLARAF 539 (706)
Q Consensus 525 ~~~~kl~Dfgla~~~ 539 (706)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 999999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.2e-14 Score=142.32 Aligned_cols=134 Identities=16% Similarity=0.197 Sum_probs=104.5
Q ss_pred ceec-cCCceeEEEEEeCCCcEEEEEEcCccc-------------hhhHHHHHHHHHHHhhcCCcce--eeeEeEEEeCC
Q 005236 393 KKLG-EGGFGPVYKGTLADEQEIAVKRLSKIS-------------EQGLKELKNEIILFSKLQHRNL--VKLLGCCIHGE 456 (706)
Q Consensus 393 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~ 456 (706)
..|| .|+.|+||++... +..++||++.... ......+.+|+.++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 8999999999885 6788998774311 1223567889999999998885 67777654432
Q ss_pred e----eEEEEecCCC-CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEe
Q 005236 457 E----KLLIYEFMPN-KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 531 (706)
Q Consensus 457 ~----~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 531 (706)
. .++|||++++ .+|.+++... .++.. .+.+|+.+|.+||+.+ |+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 6998887432 23332 3578999999999998 9999999999999999999999
Q ss_pred eeccccc
Q 005236 532 DFGLARA 538 (706)
Q Consensus 532 Dfgla~~ 538 (706)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999876
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.8e-16 Score=172.28 Aligned_cols=256 Identities=25% Similarity=0.326 Sum_probs=187.9
Q ss_pred cCCCccceeccCCceeEEEEEeCC--CcEEEEEEcCccc--hhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD--EQEIAVKRLSKIS--EQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 461 (706)
..|.+.+.||+|+|+.|-...... ...+|+|.+.... ....+.+..|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 467788889999999998887643 4456777665432 334455666877777776 99999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEecccCCCcEEEcCCC-CeEEeeecccccc
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH-QDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAF 539 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfgla~~~ 539 (706)
.+|..++++.+.+... .....+....-.++.|+..++.|+| ..+ +.||||||+|.+++..+ .++++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999999888421 1113445566778999999999999 776 99999999999999999 9999999999987
Q ss_pred CC-CCCccccccccc-ccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc
Q 005236 540 GG-DETEGNTNRVVG-TYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616 (706)
Q Consensus 540 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (706)
.. +.........+| ++.|+|||...+. -.....|+||.|+++.-+++|..|+.......... ..+... .....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~~~---~~~~~ 251 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWKSN---KGRFT 251 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeeccc---ccccc
Confidence 66 555555556778 9999999999885 44678999999999999999999987654433110 000000 00000
Q ss_pred ccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 617 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.. .+ .... ....++...++..+|..|.+.+++..
T Consensus 252 ~~---~~-~~~~----~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 252 QL---PW-NSIS----DQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cC---cc-ccCC----hhhhhcccccccCCchhccccccccc
Confidence 00 00 0011 12345666788899999999888753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.7e-13 Score=144.91 Aligned_cols=140 Identities=26% Similarity=0.287 Sum_probs=99.2
Q ss_pred ceeccCCceeEEEEEeCCCcEEEEEEcCccchhhH------------------------------H----------HHHH
Q 005236 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGL------------------------------K----------ELKN 432 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~ 432 (706)
+.||.|++|+||+|++++|+.||||+.+....... + .+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999865321110 0 1334
Q ss_pred HHHHHhhcC----CcceeeeEeEEE-eCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 005236 433 EIILFSKLQ----HRNLVKLLGCCI-HGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTAR-GLLYLHQDS 506 (706)
Q Consensus 433 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~l~~LH~~~ 506 (706)
|+..+.++. |.+-+.+-.++. .....+|||||++|++|.++...... .. .+..++..++. .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 555554442 322223222222 23467999999999999987643211 11 23456666666 478889887
Q ss_pred CCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 507 ~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
++|+|+||.||++++++.++++|||++..+.
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999998753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.4e-13 Score=110.51 Aligned_cols=72 Identities=19% Similarity=0.270 Sum_probs=62.9
Q ss_pred ccCCCceEEeeccCCCCCCccccccccCHhHHHHHHhh---cCccccccccccCCCCceeeeeeccc-ccccccCCCCcc
Q 005236 221 YSREDGFIKFTAMKLPDATPSWVSKSMNLKECREKCLE---NSSCMAYTNSDIRGGGSGCAMWFGEL-IDMRDFPDGGQD 296 (706)
Q Consensus 221 c~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---~CsC~a~~~~~~~~~~~~c~~~~~~l-~d~~~~~~~~~d 296 (706)
|.....|+++.+|++|++.. +++++|++.|++ ||||+||+|.+. +.||.+|.+++ +|.+++...+.|
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~~g~~ 75 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFSHGFD 75 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccCCCce
Confidence 34457899999999999864 789999999999 999999999753 35899999999 999999888999
Q ss_pred EEEEe
Q 005236 297 LYIRM 301 (706)
Q Consensus 297 lylr~ 301 (706)
+|+|.
T Consensus 76 Ly~r~ 80 (80)
T cd00129 76 LYENK 80 (80)
T ss_pred eEeEC
Confidence 99983
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.7e-13 Score=133.18 Aligned_cols=203 Identities=20% Similarity=0.207 Sum_probs=139.1
Q ss_pred HHHhhcCCcceeeeEeEEEeC-----CeeEEEEecCCCCChhhhhhcccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 005236 435 ILFSKLQHRNLVKLLGCCIHG-----EEKLLIYEFMPNKSLDSFIFDQER-CKLLDWSKRFHIICGTARGLLYLHQDSRL 508 (706)
Q Consensus 435 ~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~ 508 (706)
.-+-.+.|.|||+++.|+.+. ....++.|||..|+|..+|++..+ .+.+......+|..||..||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 345566799999999987643 356899999999999999976433 345777777889999999999999975 6
Q ss_pred ceEecccCCCcEEEcCCCCeEEeeeccccccC--CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh
Q 005236 509 RIIHRDLKASNVLLDQDMNPKISDFGLARAFG--GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586 (706)
Q Consensus 509 ~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt 586 (706)
+|+|+++.-+.|++..+|-+||.--.-..... ............+-++|.|||+=...+.+..+|||+||+..+||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 79999999999999999988885311111000 0000112223456789999999888888999999999999999988
Q ss_pred CCCCCCC-CCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 587 GKKNRGF-YHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 587 G~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
|..-... .........+........ +++- ..++..|++..|..||+|.+++.
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~~le--------n~lq------------r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVIIGLE--------NGLQ------------RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcceeehhhhhhhheeecc--------Cccc------------cCcCcccccCCCCCCcchhhhhc
Confidence 7653211 111111111111111111 1111 12444799999999999998864
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-12 Score=108.38 Aligned_cols=80 Identities=43% Similarity=0.944 Sum_probs=66.2
Q ss_pred CccccCC---CceEEeeccCCCCCCccccccccCHhHHHHHHhhcCccccccccccCCCCceeeeeecccccccccCCCC
Q 005236 218 SLNYSRE---DGFIKFTAMKLPDATPSWVSKSMNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPDGG 294 (706)
Q Consensus 218 ~~~c~~~---~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~~~~c~~~~~~l~d~~~~~~~~ 294 (706)
+++|... ++|++++++++|++.... .++++++|++.||+||+|+||+|.+ ++++|.+|.+.+.+++.....+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence 3456543 789999999999987653 7889999999999999999999975 3578999999999987755556
Q ss_pred ccEEEEec
Q 005236 295 QDLYIRMS 302 (706)
Q Consensus 295 ~dlylr~s 302 (706)
.++|||++
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 88999874
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=8.9e-12 Score=118.37 Aligned_cols=130 Identities=25% Similarity=0.172 Sum_probs=97.5
Q ss_pred ceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCccee-eeEeEEEeCCeeEEEEecCCCCChh
Q 005236 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV-KLLGCCIHGEEKLLIYEFMPNKSLD 471 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~gsL~ 471 (706)
+.|+.|.++.||+++.. ++.+++|....... ....+..|+..+..+.+.+++ +++.. .....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 67899999999999875 77899998754322 123467899999988765554 44443 234468999999999886
Q ss_pred hhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 472 SFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 472 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
... . ....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 430 0 11235678999999999876 23469999999999999 67899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.7e-12 Score=139.97 Aligned_cols=147 Identities=20% Similarity=0.204 Sum_probs=92.8
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhh----------------------------------HHHH
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQG----------------------------------LKEL 430 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~~~ 430 (706)
...|.. +.||.|++|+||+|++++ |+.||||+++....+. .+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456776 789999999999999987 9999999986532110 1112
Q ss_pred ------HHHHHHHhhcC----CcceeeeEeEEEe-CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHH-HH
Q 005236 431 ------KNEIILFSKLQ----HRNLVKLLGCCIH-GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA-RG 498 (706)
Q Consensus 431 ------~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia-~~ 498 (706)
.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++-.-.. ...+.. .++...+ .-
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~--~g~d~~---~la~~~v~~~ 272 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA--AGTDMK---LLAERGVEVF 272 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh--cCCCHH---HHHHHHHHHH
Confidence 23333333332 3333333333322 346789999999999987431111 111111 1222111 12
Q ss_pred HHHHHhCCCCceEecccCCCcEEEcCCC----CeEEeeeccccccCC
Q 005236 499 LLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFGLARAFGG 541 (706)
Q Consensus 499 l~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~Dfgla~~~~~ 541 (706)
+..++..+ ++|+|+||.||+++.++ .++++|||++..+..
T Consensus 273 ~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 273 FTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 23344455 99999999999999988 999999999987643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=8.3e-12 Score=133.61 Aligned_cols=248 Identities=22% Similarity=0.308 Sum_probs=175.3
Q ss_pred CCCccceecc--CCceeEEEEEe---CCCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCeeE
Q 005236 388 NFSINKKLGE--GGFGPVYKGTL---ADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 388 ~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 459 (706)
.+-+.+.+|. |.+|.||.+.. .++..+|+|+-+. ..+.....=.+|+....+++ |+|.++.+..+..++..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556688999 99999999987 3477889998433 22233334456666666674 999999999999999999
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceEecccCCCcEEEcCC-CCeEEeeec
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTAR----GLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFG 534 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfg 534 (706)
+-.|++. .+|..+.+.. ...++...++....+... ||.++|+.+ ++|-|+||.||++..+ ..++++|||
T Consensus 195 iqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999885 7777776443 234566667777777777 999999987 9999999999999999 899999999
Q ss_pred cccccCCCCCcc---cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh
Q 005236 535 LARAFGGDETEG---NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWN 611 (706)
Q Consensus 535 la~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 611 (706)
+...++...... ......|...|++||.. ...++..+|+|++|.+..+-.+|......-... .|...+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~~~r 339 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWSQLR 339 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC--------Cccccc
Confidence 999886544222 11223577899999987 567788999999999999999987664321000 011111
Q ss_pred cCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 612 EGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 612 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
... +-+....+ . ..++..++.++++.+|..|++.+.+..
T Consensus 340 ~~~---ip~e~~~~-~----s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QGY---IPLEFCEG-G----SSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccc---CchhhhcC-c----chhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111 11111110 0 112223677899999999999877653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1e-09 Score=118.71 Aligned_cols=166 Identities=16% Similarity=0.232 Sum_probs=124.7
Q ss_pred CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHH
Q 005236 409 ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKR 488 (706)
Q Consensus 409 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~ 488 (706)
.++.+|.|+.....+....+..++-+..++.++||||++++.........|+|+|-+. .|..++.+ +.....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHH
Confidence 4577888888766555445567788889999999999999999999999999999874 45555533 224555
Q ss_pred HHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCC
Q 005236 489 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF 568 (706)
Q Consensus 489 ~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 568 (706)
..-+.||+.||.+||+.+ .++|++|.-..|+|++.|+-||++|.++........ .......-..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence 667899999999999765 599999999999999999999999998865321111 111112233566666553222
Q ss_pred CcchhhHHHHHHHHHHHhCC
Q 005236 569 SVKSDVFSFGILLLEIVSGK 588 (706)
Q Consensus 569 s~~sDv~SlGvil~elltG~ 588 (706)
-..|.|-||++++|++.|.
T Consensus 182 -~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -cchhhhhHHHHHHHHhCcc
Confidence 3569999999999999993
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.9e-10 Score=112.07 Aligned_cols=142 Identities=19% Similarity=0.236 Sum_probs=109.2
Q ss_pred ceeccCCceeEEEEEeCCCcEEEEEEcCccch-hhHHHHHHHHHHHhhcCCc--ceeeeEeEEEeCC---eeEEEEecCC
Q 005236 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSKISE-QGLKELKNEIILFSKLQHR--NLVKLLGCCIHGE---EKLLIYEFMP 466 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lV~e~~~ 466 (706)
+.|+.|..+.||+++..+|+.+++|....... .....+..|+.++..+.+. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999987778999998754322 2356788999999999763 4566777765532 5689999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS---------------------------------------- 506 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~---------------------------------------- 506 (706)
+.++.+.+.. ..++...+..++.++++.|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9998876521 23566667777888888888887421
Q ss_pred -------------CCceEecccCCCcEEEcC--CCCeEEeeeccccc
Q 005236 507 -------------RLRIIHRDLKASNVLLDQ--DMNPKISDFGLARA 538 (706)
Q Consensus 507 -------------~~~ivH~Dikp~Nill~~--~~~~kl~Dfgla~~ 538 (706)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.2e-10 Score=101.98 Aligned_cols=131 Identities=19% Similarity=0.278 Sum_probs=101.9
Q ss_pred ceeccCCceeEEEEEeCCCcEEEEEE-cCcc--ch-----hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 393 KKLGEGGFGPVYKGTLADEQEIAVKR-LSKI--SE-----QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~--~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
..+++|+-+.+|.+.+.+. .+++|. +++. .+ -..+.-.+|+.++.+++--.|..-+-+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 4678999999999977443 466664 3331 11 1234567899999999766666555666788888999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++|..|.+.+... ...++..+-.-+.-||..+ |+|+||+++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888543 2456778888899999998 99999999999998776 99999999975
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.9e-09 Score=103.07 Aligned_cols=135 Identities=15% Similarity=0.139 Sum_probs=97.1
Q ss_pred ceeccCCceeEEEEEeCC-------CcEEEEEEcCcc-------------c---------hhhHHHH----HHHHHHHhh
Q 005236 393 KKLGEGGFGPVYKGTLAD-------EQEIAVKRLSKI-------------S---------EQGLKEL----KNEIILFSK 439 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~----~~E~~~l~~ 439 (706)
-.||.|--+.||.|...+ +..+|||+.+.. . ....+.+ ++|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999998653 478999976320 0 0012233 389999999
Q ss_pred cCC--cceeeeEeEEEeCCeeEEEEecCCCCChhh-hhhcccccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEeccc
Q 005236 440 LQH--RNLVKLLGCCIHGEEKLLIYEFMPNKSLDS-FIFDQERCKLLDWSKRFHIICGTARGLLYL-HQDSRLRIIHRDL 515 (706)
Q Consensus 440 l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~Di 515 (706)
+.. -++.+.+++ ...++||||+.+..+.. .+.+ ..++......+..+++.+|..| |..+ ++|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 864 355666654 56789999998764432 2211 1234455667788999999999 7777 999999
Q ss_pred CCCcEEEcCCCCeEEeeecccccc
Q 005236 516 KASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 516 kp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
++.|||++ ++.+.|+|||.+...
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeC
Confidence 99999997 468999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.9e-09 Score=98.56 Aligned_cols=143 Identities=24% Similarity=0.295 Sum_probs=106.8
Q ss_pred ccceeccCCceeEEEEEeCCCcEEEEEE-cCcc-------chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 391 INKKLGEGGFGPVYKGTLADEQEIAVKR-LSKI-------SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 391 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
....|-+|+-+.|+++.+. |+..+||. +.+. ..-..++.++|+..+.++.--.|.--.-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578999999999999984 55556663 3331 1123456788999999987666655555677777888999
Q ss_pred ecCCC-CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC---eEEeeeccccc
Q 005236 463 EFMPN-KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLARA 538 (706)
Q Consensus 463 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---~kl~Dfgla~~ 538 (706)
||+++ .++.+++...-.....+ .....++..|-+.+.-||... |+|+||..+||+|..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 57888886543322222 223678889999999999887 999999999999987654 58999999875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.3e-10 Score=121.51 Aligned_cols=248 Identities=19% Similarity=0.175 Sum_probs=172.5
Q ss_pred HhccCCCccceeccCCceeEEEEEe--CCCcEEEEEEcCccchhhHHH--HHHHHHHHhhc-CCcceeeeEeEEEeCCee
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTL--ADEQEIAVKRLSKISEQGLKE--LKNEIILFSKL-QHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 458 (706)
....+|..+..||.|.|+.|++... .++..+++|.+.+.......+ -..|+.+...+ .|.++++.+..+..-+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456788999999999999999765 357789999876543332222 23466666555 588999988888888888
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-CCeEEeeecccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLAR 537 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfgla~ 537 (706)
++=-||++++++...+ .-...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 8999999999988766 22344777888999999999999999876 9999999999999886 889999999986
Q ss_pred ccCCCCCcccccccccccCcc--CccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 538 AFGGDETEGNTNRVVGTYGYM--APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
.+..... .....-+++ +|+......+-.+.|++|||.-+.|.++|..-.+.... +..+..+..
T Consensus 416 ~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------~~~i~~~~~ 480 (524)
T KOG0601|consen 416 RLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------SLTIRSGDT 480 (524)
T ss_pred ccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCccccc----------ceeeecccc
Confidence 4321111 112233444 55556667888999999999999999998764211000 000011111
Q ss_pred cccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 616 SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 616 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
.. ..+. . .....+..-++..++..||.+.++..+.+-
T Consensus 481 p~-----~~~~--~---~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 481 PN-----LPGL--K---LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred cC-----CCch--H---HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 11 1110 1 122234456788999999999888776653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.2e-08 Score=105.16 Aligned_cols=170 Identities=22% Similarity=0.317 Sum_probs=130.7
Q ss_pred CceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEe----CCeeEEEEecCCC-CChhh
Q 005236 399 GFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIH----GEEKLLIYEFMPN-KSLDS 472 (706)
Q Consensus 399 ~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~~~-gsL~~ 472 (706)
--.+.||+.. .+|..|++|+++....+.......-++.++++.|+|+|++..++.. ...+++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3457899986 5799999999965444444444556788999999999999998873 3467899999986 57877
Q ss_pred hhhccc------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 473 FIFDQE------------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 473 ~l~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
+-+... .....++..+|.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 665322 1123667889999999999999999998 8889999999999999999999888877654
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN 590 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p 590 (706)
.+... -+ +--.+-|.=.||.+++-|.||...
T Consensus 445 ~d~~~----------------~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPTE----------------PL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCCc----------------ch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 43311 01 112467899999999999999654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.6e-08 Score=99.83 Aligned_cols=141 Identities=18% Similarity=0.116 Sum_probs=101.1
Q ss_pred ceeccCCceeEEEEEeCCCcEEEEEEcCccchh-hHH----------HHHHHHHHHhhcCCcce--eeeEeEEEeC----
Q 005236 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQ-GLK----------ELKNEIILFSKLQHRNL--VKLLGCCIHG---- 455 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~h~ni--v~l~~~~~~~---- 455 (706)
+.+-.-....|+++.+ +|+.+.||+....... ..+ .+.+|...+.++...+| ++.+++....
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445677766 6778999977443211 111 47789999988854443 4455565432
Q ss_pred -CeeEEEEecCCCC-ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-------CC
Q 005236 456 -EEKLLIYEFMPNK-SLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-------DM 526 (706)
Q Consensus 456 -~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~-------~~ 526 (706)
...++|+|++++- +|.+++.+.. ....+...+..++.+++..+.-||..+ |+|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 3468999999986 8999885322 123455677789999999999999998 999999999999985 46
Q ss_pred CeEEeeeccccc
Q 005236 527 NPKISDFGLARA 538 (706)
Q Consensus 527 ~~kl~Dfgla~~ 538 (706)
.+.|+||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=5.3e-10 Score=125.83 Aligned_cols=206 Identities=21% Similarity=0.271 Sum_probs=147.0
Q ss_pred HHhccCCCccceeccCCceeEEEEEeCC-CcEEEEE---EcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCee
Q 005236 383 ANATDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVK---RLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 383 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK---~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 458 (706)
....+.+.+.+-+-+|.++.++.+.-.. +...+.| ...+......+.+..+-.+.-..+||-+++...-+.-....
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 3456788888899999999998775422 2222222 22222222334444444444445567777666555667788
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
+|+++|..+++|...|+... ..+..-....+..+..+++|||... +.|+|++|.|+++..+++.++.|||....
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred chhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence 99999999999999886543 2333344456667888999999876 89999999999999999999999985433
Q ss_pred cCC---------------------CCCc--------ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 005236 539 FGG---------------------DETE--------GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 589 (706)
Q Consensus 539 ~~~---------------------~~~~--------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~ 589 (706)
.+. .... .......+|+.|.+||...+......+|.|++|++++|.++|.+
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 210 0000 01223578999999999999999999999999999999999999
Q ss_pred CCCCC
Q 005236 590 NRGFY 594 (706)
Q Consensus 590 p~~~~ 594 (706)
|+...
T Consensus 1034 p~na~ 1038 (1205)
T KOG0606|consen 1034 PFNAE 1038 (1205)
T ss_pred CCCCc
Confidence 97543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.1e-08 Score=94.47 Aligned_cols=125 Identities=22% Similarity=0.262 Sum_probs=82.4
Q ss_pred eEEEEEeCCCcEEEEEEcCccc--------------h------------hhHHHHHHHHHHHhhcCCc--ceeeeEeEEE
Q 005236 402 PVYKGTLADEQEIAVKRLSKIS--------------E------------QGLKELKNEIILFSKLQHR--NLVKLLGCCI 453 (706)
Q Consensus 402 ~Vy~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 453 (706)
.||.|...++..+|||...... . ......++|...|.++..- ++.+.+.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899999999999999763210 0 0123567899999999866 45666644
Q ss_pred eCCeeEEEEecCC--CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHH-HHhCCCCceEecccCCCcEEEcCCCCeEE
Q 005236 454 HGEEKLLIYEFMP--NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLY-LHQDSRLRIIHRDLKASNVLLDQDMNPKI 530 (706)
Q Consensus 454 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~-LH~~~~~~ivH~Dikp~Nill~~~~~~kl 530 (706)
....+||||++ |..+..+... . ++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~-~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV-D----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC-G----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhc-c----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999998 5555443321 1 1123445677778885555 56776 9999999999999988 9999
Q ss_pred eeecccccc
Q 005236 531 SDFGLARAF 539 (706)
Q Consensus 531 ~Dfgla~~~ 539 (706)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=5.1e-07 Score=92.66 Aligned_cols=194 Identities=15% Similarity=0.172 Sum_probs=128.6
Q ss_pred CccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceee--------eEeEEEeCCeeEEE
Q 005236 390 SINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVK--------LLGCCIHGEEKLLI 461 (706)
Q Consensus 390 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------l~~~~~~~~~~~lV 461 (706)
...+.||+|+-+.+|-.-. -...+.|+.+........+...| +...-.||-+-. |+|- ..+...-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk~a~--la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQKVAE--LAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHHHHHHHH--hccCCCCcchhhhhcccHHHhhCC-CccceeEEe
Confidence 4558899999999995422 12235566655444333222222 122224554322 1111 111224577
Q ss_pred EecCCCCC-hhhhhh---cccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 462 YEFMPNKS-LDSFIF---DQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 462 ~e~~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
|..+++.- ...++. +.......+|...++.+..+|.+.+.||++| .+-+|+.++|+||.+++.+.|.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 88777652 222221 2344566899999999999999999999998 8889999999999999999999844333
Q ss_pred ccCCCCCcccccccccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhC-CCCCCCC
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSG-KKNRGFY 594 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvil~elltG-~~p~~~~ 594 (706)
.. .......-.+|...|.+||.-. +..-+...|-|.||+++++++.| +.||...
T Consensus 166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 22 1122223357889999999764 33556789999999999999987 8998754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.1e-07 Score=89.08 Aligned_cols=135 Identities=19% Similarity=0.195 Sum_probs=94.9
Q ss_pred CCccceeccCCceeEEEEEeCCCcEEEEEEcCcc--------------------c--hhhHHHHHHHHHHHhhcCCc--c
Q 005236 389 FSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKI--------------------S--EQGLKELKNEIILFSKLQHR--N 444 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--------------------~--~~~~~~~~~E~~~l~~l~h~--n 444 (706)
..+.++||-|--+.||.|....|.++|||.=+.. + .-.....++|.+.|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4566899999999999999999999999953210 0 01123467899999998755 5
Q ss_pred eeeeEeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC
Q 005236 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ 524 (706)
Q Consensus 445 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~ 524 (706)
+.+.++. +.-.+||||++|--|...-. ..-+... ++..|++-+..+-..| |||+|+.+-||+|++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~---il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDE---ILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC-----cccCHHH---HHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 5555543 45689999999976654321 1122233 3334444444444445 999999999999999
Q ss_pred CCCeEEeeeccccc
Q 005236 525 DMNPKISDFGLARA 538 (706)
Q Consensus 525 ~~~~kl~Dfgla~~ 538 (706)
+|.+.++||-.+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999987754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.7e-07 Score=88.64 Aligned_cols=107 Identities=26% Similarity=0.290 Sum_probs=84.6
Q ss_pred HHHHHHHHHHHhhcCCcc--eeeeEeEEEeCC----eeEEEEecCCCC-ChhhhhhcccccCCCCHHHHHHHHHHHHHHH
Q 005236 427 LKELKNEIILFSKLQHRN--LVKLLGCCIHGE----EKLLIYEFMPNK-SLDSFIFDQERCKLLDWSKRFHIICGTARGL 499 (706)
Q Consensus 427 ~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l 499 (706)
.....+|...+..+.... ..+.+++..... ..++|+|++++. +|.+++..... .+......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 346778888888886443 455666665532 348999999984 89998865332 55566788999999999
Q ss_pred HHHHhCCCCceEecccCCCcEEEcCCC---CeEEeeecccccc
Q 005236 500 LYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLARAF 539 (706)
Q Consensus 500 ~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl~Dfgla~~~ 539 (706)
+-||..+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999998 99999999999999887 8999999988763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.2e-07 Score=99.68 Aligned_cols=140 Identities=16% Similarity=0.202 Sum_probs=90.9
Q ss_pred ceeccCCceeEEEEEeCCCcEEEEEEcCccchhh------------------------------HH----H------HHH
Q 005236 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQG------------------------------LK----E------LKN 432 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~----~------~~~ 432 (706)
+-|+.++-|+||+|++++|+.||||+.+..-... .+ . +..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6889999999999999999999999986532211 01 1 223
Q ss_pred HHHHHhhcC-----CcceeeeEeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 005236 433 EIILFSKLQ-----HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARG-LLYLHQDS 506 (706)
Q Consensus 433 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~-l~~LH~~~ 506 (706)
|..-+.+++ .|++.--.-+..-.....|+|||++|-.+.+...-.. ...+.+. ++..++++ +..+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 333333331 2332211112223467799999999999988853222 2234332 33333332 22333344
Q ss_pred CCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 507 ~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
++|.|.+|.||+++.+|++.+.|||+...+.
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999987764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.7e-06 Score=82.90 Aligned_cols=140 Identities=14% Similarity=0.113 Sum_probs=104.1
Q ss_pred eccCCceeEEEEEeCCCcEEEEEEcCcc------chhhHHHHHHHHHHHhhcCCcc--eeeeEeEEEeC----CeeEEEE
Q 005236 395 LGEGGFGPVYKGTLADEQEIAVKRLSKI------SEQGLKELKNEIILFSKLQHRN--LVKLLGCCIHG----EEKLLIY 462 (706)
Q Consensus 395 lg~G~~g~Vy~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~----~~~~lV~ 462 (706)
-|+||-+-|++.... |+.+.+|+-... .+.....|.+|...+.++..-+ +.+.+.+.... ..-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 356899999997764 447999987521 1345678999999999986433 44444222221 1357999
Q ss_pred ecCCC-CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC--eEEeeecccccc
Q 005236 463 EFMPN-KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGLARAF 539 (706)
Q Consensus 463 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfgla~~~ 539 (706)
|-+++ .+|.+++.+.. ....+...+..++.++++.++-||..+ +.|+|+.+.||+++.++. ++++||.-++..
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 97764 58988885432 234677778899999999999999998 999999999999987777 999999987753
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.7e-06 Score=84.38 Aligned_cols=140 Identities=17% Similarity=0.190 Sum_probs=86.2
Q ss_pred ceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcc--eeeeEeEEEeCCeeEEEEecCCCCC-
Q 005236 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRN--LVKLLGCCIHGEEKLLIYEFMPNKS- 469 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gs- 469 (706)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+.+....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 68999999999984 24567888876533 3345788999999886444 4667777777777889999999974
Q ss_pred hhhhhh--------------c----ccc--cCCCCHHHHH-HHHH----------HHHH-HHHHHHh-CCCCceEecccC
Q 005236 470 LDSFIF--------------D----QER--CKLLDWSKRF-HIIC----------GTAR-GLLYLHQ-DSRLRIIHRDLK 516 (706)
Q Consensus 470 L~~~l~--------------~----~~~--~~~l~~~~~~-~i~~----------~ia~-~l~~LH~-~~~~~ivH~Dik 516 (706)
+...+. + -.. .......... ++.. .+.. ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 221110 0 000 0001111100 0000 0011 1122221 123457999999
Q ss_pred CCcEEEcCCCCeEEeeeccccc
Q 005236 517 ASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 517 p~Nill~~~~~~kl~Dfgla~~ 538 (706)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999988 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=6.3e-08 Score=105.55 Aligned_cols=152 Identities=17% Similarity=0.258 Sum_probs=97.7
Q ss_pred HHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC------cc-cccccccccCccCccccc
Q 005236 492 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET------EG-NTNRVVGTYGYMAPEYAS 564 (706)
Q Consensus 492 ~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~------~~-~~~~~~gt~~y~aPE~~~ 564 (706)
+.+++.||.|+|... .+||++|.|++|.++..+..||+.|+.+........ .. ..........|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345669999999865 699999999999999999999999999876543111 00 111123456899999999
Q ss_pred cCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhc
Q 005236 565 DGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCV 643 (706)
Q Consensus 565 ~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl 643 (706)
....+.++|+||+|+++|-+.. |+.-+.............. ..+....... .... . ++.+=+...+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~-----~~~~~~~~~s----~~~p-~---el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN-----LLNAGAFGYS----NNLP-S---ELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc-----cccccccccc----ccCc-H---HHHHHHHHHh
Confidence 9899999999999999999995 4444332221111111100 0000000000 0111 1 2233445789
Q ss_pred CCCCCCCCChhHHHH
Q 005236 644 QQYPEDRPCMPSVIL 658 (706)
Q Consensus 644 ~~~p~~RPt~~ev~~ 658 (706)
..++.-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998877753
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.8e-06 Score=81.78 Aligned_cols=138 Identities=15% Similarity=0.138 Sum_probs=93.6
Q ss_pred hccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHH---------HHHHHHHHhhcCC---cceeeeEeEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKE---------LKNEIILFSKLQH---RNLVKLLGCC 452 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h---~niv~l~~~~ 452 (706)
...+|.+.+++-......|.+... +|+.+++|..+.......+. ..+++..+.+++. ..+..++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 346888888888888888888776 56889999876533322222 2234444444432 2233333332
Q ss_pred Ee-----CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC
Q 005236 453 IH-----GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 527 (706)
Q Consensus 453 ~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~ 527 (706)
.. ....+++|||++|..|.++.. ++. .++..+++++.-||..| ++|+|.+|.|+++.+++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 22 234568999999998876541 221 25566788899999998 99999999999998655
Q ss_pred eEEeeeccccc
Q 005236 528 PKISDFGLARA 538 (706)
Q Consensus 528 ~kl~Dfgla~~ 538 (706)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.40 E-value=5.3e-07 Score=73.10 Aligned_cols=72 Identities=40% Similarity=0.804 Sum_probs=57.7
Q ss_pred CceEEeeccCCCCCCccccccccCHhHHHHHHhh-cCccccccccccCCCCceeeeee-cccccccccCCCCccEEEE
Q 005236 225 DGFIKFTAMKLPDATPSWVSKSMNLKECREKCLE-NSSCMAYTNSDIRGGGSGCAMWF-GELIDMRDFPDGGQDLYIR 300 (706)
Q Consensus 225 ~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-~CsC~a~~~~~~~~~~~~c~~~~-~~l~d~~~~~~~~~dlylr 300 (706)
..|++++++.+++..... ....++++|++.|++ +|+|.||.|.+ ++.+|.+|. +.+.+....+..+.++|.+
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEEe
Confidence 569999999999765532 457899999999999 99999999975 457899998 8888777555556667665
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.24 E-value=8.8e-06 Score=81.33 Aligned_cols=144 Identities=21% Similarity=0.193 Sum_probs=86.4
Q ss_pred cceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCc--ceeeeEeEEEeC---CeeEEEEecCC
Q 005236 392 NKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHR--NLVKLLGCCIHG---EEKLLIYEFMP 466 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lV~e~~~ 466 (706)
++.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++...... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3679999999999999977 69999987554 4556788899888888533 356666654333 34689999999
Q ss_pred CCChhh----------------hhh---ccc-ccCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 005236 467 NKSLDS----------------FIF---DQE-RCKLLDWSK---------RFHI------------ICGTAR-GLLYLHQ 504 (706)
Q Consensus 467 ~gsL~~----------------~l~---~~~-~~~~l~~~~---------~~~i------------~~~ia~-~l~~LH~ 504 (706)
+..+.. .+. ... ......... .... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 998877 111 110 000011100 0000 111222 2333332
Q ss_pred ----CCCCceEecccCCCcEEEc-CCCCeEEeeeccccc
Q 005236 505 ----DSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARA 538 (706)
Q Consensus 505 ----~~~~~ivH~Dikp~Nill~-~~~~~kl~Dfgla~~ 538 (706)
.....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2345699999999999999 666668999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=8.2e-06 Score=89.24 Aligned_cols=138 Identities=15% Similarity=0.200 Sum_probs=88.1
Q ss_pred ceeccCCceeEEEEEeCCCcEEEEEEcCccchhh-------------------------------HHH------HHHHHH
Q 005236 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQG-------------------------------LKE------LKNEII 435 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~~------~~~E~~ 435 (706)
+.||.-+.|.||+|++++|+.||||+-+..-+.. .+. |.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 7899999999999999999999999976532211 011 233333
Q ss_pred HHh----hcCCcc------eeeeEeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHH-HHh
Q 005236 436 LFS----KLQHRN------LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLY-LHQ 504 (706)
Q Consensus 436 ~l~----~l~h~n------iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~-LH~ 504 (706)
-.. .+.|-+ |.+++-- -...+.|+||||+|.-+.+.-.-.. ..++... ++..+.++... +-.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~---i~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDK--RGISPHD---ILNKLVEAYLEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHH--cCCCHHH---HHHHHHHHHHHHHHh
Confidence 222 233444 3333222 2347899999999998876542111 1244443 33333333222 222
Q ss_pred CCCCceEecccCCCcEEEcC----CCCeEEeeeccccccC
Q 005236 505 DSRLRIIHRDLKASNVLLDQ----DMNPKISDFGLARAFG 540 (706)
Q Consensus 505 ~~~~~ivH~Dikp~Nill~~----~~~~kl~Dfgla~~~~ 540 (706)
.| ++|+|-+|.||+++. ++.+.+.|||+...+.
T Consensus 320 ~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cC---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 34 999999999999994 6789999999988753
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.8e-05 Score=79.78 Aligned_cols=141 Identities=15% Similarity=0.119 Sum_probs=86.3
Q ss_pred eeccCCc-eeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCeeEEEEecCCCCChh
Q 005236 394 KLGEGGF-GPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKLLIYEFMPNKSLD 471 (706)
Q Consensus 394 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 471 (706)
.|..|.. ..||+.... +..++||+..... ...+.+|+.++..+. +--+.+++.+....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 789998765 4678888875543 345677888888874 344567777776666789999999998876
Q ss_pred hhhh-------------------cccc-cCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----C
Q 005236 472 SFIF-------------------DQER-CKLLD--WSKRFHIIC--------------------GTARGLLYLHQ----D 505 (706)
Q Consensus 472 ~~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------~ia~~l~~LH~----~ 505 (706)
.... .... ..... ....+.... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4421 0000 00000 000000000 01111222211 1
Q ss_pred CCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 506 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 506 ~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
....++|+|+.|.|||++++....|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234599999999999999988889999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.15 E-value=9.2e-06 Score=77.86 Aligned_cols=105 Identities=22% Similarity=0.219 Sum_probs=83.7
Q ss_pred HHHHHHHhhcCC-cceeeeEeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 005236 431 KNEIILFSKLQH-RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLR 509 (706)
Q Consensus 431 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ 509 (706)
..|..+++.+++ +++++++|.| ..++|.||...+++...-..-...-..+|..+.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999976 6999999999 45789999998766422100011123689999999999999999999865555
Q ss_pred eEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 510 IIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 510 ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
+.-.|++|+|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999877654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=4.9e-07 Score=97.49 Aligned_cols=190 Identities=18% Similarity=0.157 Sum_probs=134.6
Q ss_pred HhccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcc-eeeeEeEEEeCCeeEEEE
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRN-LVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~ 462 (706)
..+.-+......+++++++++|.+-...+...++.+... ....-++++|.+++||| .++.++-+..++...+++
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 334445555778999999999988755555556655332 45567899999999999 666666666677888999
Q ss_pred ecCCCC-ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 463 EFMPNK-SLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 463 e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
+++..+ +-..-+...+ -.+.......+...-++++++||+.. -+|+| ||+..+ +..|..||+....+..
T Consensus 314 ~i~s~~rs~~~~~~~se--~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 314 RICSTGRSSALEMTVSE--IALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTR 383 (829)
T ss_pred hhhcCCccccccCChhh--Hhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCc
Confidence 999877 2211110000 01112223345556677899999764 48888 777665 6789999999876643
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNR 591 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~ 591 (706)
.. ..+...+++.++|||++....+..+.|+|++|+-..++--|-+|-
T Consensus 384 ~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 384 TM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 22 334467899999999999999999999999999878887777663
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=98.07 E-value=5e-06 Score=59.06 Aligned_cols=44 Identities=50% Similarity=0.727 Sum_probs=39.9
Q ss_pred CCCCCCCCCCCcccCCCCCCcCCCCCCC--CCCCcceeEeeeeccC
Q 005236 663 EIVLPQPKQPGYLADRKSTRLDSSLSMP--ESSSTNTITISELEGR 706 (706)
Q Consensus 663 ~~~~~~p~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 706 (706)
...+|+|++|+|+..+...+..++++.. +.+++|+||+|.|++|
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 4679999999999999888888888776 8999999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.00 E-value=7.3e-05 Score=72.86 Aligned_cols=150 Identities=19% Similarity=0.221 Sum_probs=94.5
Q ss_pred HHHHHHhccCCCccc---eeccCCceeEEEEEeCCCcEEEEEEcCccchhh-------------------HH-----HHH
Q 005236 379 LATIANATDNFSINK---KLGEGGFGPVYKGTLADEQEIAVKRLSKISEQG-------------------LK-----ELK 431 (706)
Q Consensus 379 ~~~~~~~~~~~~~~~---~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~-----~~~ 431 (706)
...+....+...+.+ .|..|--+.||+|...++..+|||+........ .+ -..
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~ 116 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR 116 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence 444455555555544 456777889999998889999999875421110 00 123
Q ss_pred HHHHHHhhcC--CcceeeeEeEEEeCCeeEEEEecCCCCCh-hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 005236 432 NEIILFSKLQ--HRNLVKLLGCCIHGEEKLLIYEFMPNKSL-DSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRL 508 (706)
Q Consensus 432 ~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~ 508 (706)
+|+.-|.++. +-.+.+-+++ ..-.|||||+...-+ .-.|.+- .+...+...+..++++.+.-|-...
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 4555555553 2223333333 245799999975421 1111111 1222245667777888888777622
Q ss_pred ceEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 509 RIIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 509 ~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
.+||+||..-|||+. ++.+.|+|||.|...
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECcccccc
Confidence 399999999999999 899999999988764
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.0001 Score=87.54 Aligned_cols=79 Identities=14% Similarity=0.312 Sum_probs=58.5
Q ss_pred cceeccCCceeEEEEEeCCC---cEEEEEEcCccc-hhhHHHHHHHHHHHhhcC-Ccce--eeeEeEEEeC---CeeEEE
Q 005236 392 NKKLGEGGFGPVYKGTLADE---QEIAVKRLSKIS-EQGLKELKNEIILFSKLQ-HRNL--VKLLGCCIHG---EEKLLI 461 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lV 461 (706)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+.+++.+. |+++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 47889999999999887554 467888764322 223456889999999995 6665 7788887664 357899
Q ss_pred EecCCCCCh
Q 005236 462 YEFMPNKSL 470 (706)
Q Consensus 462 ~e~~~~gsL 470 (706)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.93 E-value=7.3e-05 Score=74.94 Aligned_cols=73 Identities=14% Similarity=0.240 Sum_probs=46.0
Q ss_pred ceeccCCce-eEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCc---ceeeeEeEEEeC---CeeEEEEecC
Q 005236 393 KKLGEGGFG-PVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHR---NLVKLLGCCIHG---EEKLLIYEFM 465 (706)
Q Consensus 393 ~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lV~e~~ 465 (706)
+.|+.|+.. .||+. +..+++|..+... ....+..|..++..+... -+.+.++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777776 58875 2357777654322 245788899998887532 234444433222 1348899999
Q ss_pred CCCChh
Q 005236 466 PNKSLD 471 (706)
Q Consensus 466 ~~gsL~ 471 (706)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 998774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00015 Score=66.90 Aligned_cols=129 Identities=21% Similarity=0.255 Sum_probs=90.3
Q ss_pred CccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCccee-eeEeEEEeCCeeEEEEecCCCC
Q 005236 390 SINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV-KLLGCCIHGEEKLLIYEFMPNK 468 (706)
Q Consensus 390 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~g 468 (706)
...+.|++|++|.||+|.+.++ .+|+|+-...+ ....++.|++++..++-.++- +++.+. .-.+.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGG-EVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeeccCc-eEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 4458899999999999999654 88888765433 346889999999999866653 344442 234459999998
Q ss_pred ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC-CCcEEEcCCCCeEEeeeccccc
Q 005236 469 SLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK-ASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 469 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik-p~Nill~~~~~~kl~Dfgla~~ 538 (706)
.|.++-... +. +-+..+++.---|...+ |-|..|. |..++|-.++.+.|+||..|..
T Consensus 98 ~L~~~~~~~------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 887654211 11 22334555545555555 9999985 6666666666999999999874
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00019 Score=71.83 Aligned_cols=141 Identities=21% Similarity=0.256 Sum_probs=82.5
Q ss_pred ceeccCCceeEEEEEeCC--CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcce-eeeEeEEEeCCeeEEEEecCCCCC
Q 005236 393 KKLGEGGFGPVYKGTLAD--EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL-VKLLGCCIHGEEKLLIYEFMPNKS 469 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~gs 469 (706)
+.|..|-...+|+....+ ++.+++|........ .-....|+.++..+...++ +++++.+. ..+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 577888889999998764 678889976543221 1233468888888854444 44444322 247999999987
Q ss_pred hhhh-------h----------hccccc--------CCCC-HHHHHHHHH----------------------HHH---HH
Q 005236 470 LDSF-------I----------FDQERC--------KLLD-WSKRFHIIC----------------------GTA---RG 498 (706)
Q Consensus 470 L~~~-------l----------~~~~~~--------~~l~-~~~~~~i~~----------------------~ia---~~ 498 (706)
+... + +..... .... +..+..+.. .+. ..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6422 1 110100 0111 122112111 111 11
Q ss_pred HH-HHHhC-CCCceEecccCCCcEEEcC-CCCeEEeeeccccc
Q 005236 499 LL-YLHQD-SRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARA 538 (706)
Q Consensus 499 l~-~LH~~-~~~~ivH~Dikp~Nill~~-~~~~kl~Dfgla~~ 538 (706)
|. .+... ....++|+|+.+.|||+++ ++.+.|+||..|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 11 11111 2346999999999999998 57899999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00028 Score=67.99 Aligned_cols=131 Identities=16% Similarity=0.282 Sum_probs=90.7
Q ss_pred cceeccCCceeEEEEEeCCCcEEEEEEcCccc----------------hhhHHHHHHHHHHHhhcC------CcceeeeE
Q 005236 392 NKKLGEGGFGPVYKGTLADEQEIAVKRLSKIS----------------EQGLKELKNEIILFSKLQ------HRNLVKLL 449 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~ 449 (706)
...||+|+.-.||. +++.....||+..... ....++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46899999999995 4555667888775544 223456667777666655 78899999
Q ss_pred eEEEeCCeeEEEEecCCC------CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc
Q 005236 450 GCCIHGEEKLLIYEFMPN------KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 523 (706)
Q Consensus 450 ~~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~ 523 (706)
|...+....-+|+|.+.+ -+|.+++.+. .++. ...+. +-+-..||-+++ |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999999999998743 3577777332 2444 33333 334445666555 99999999999996
Q ss_pred CCC----CeEEee-ecc
Q 005236 524 QDM----NPKISD-FGL 535 (706)
Q Consensus 524 ~~~----~~kl~D-fgl 535 (706)
... .+.|+| ||-
T Consensus 153 ~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGE 169 (199)
T ss_pred ecCCCceEEEEEeCCCC
Confidence 432 577777 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00014 Score=73.91 Aligned_cols=139 Identities=17% Similarity=0.129 Sum_probs=79.7
Q ss_pred eeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcce-eeeEeEEEeCCeeEEEEecCCCCChhh
Q 005236 394 KLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL-VKLLGCCIHGEEKLLIYEFMPNKSLDS 472 (706)
Q Consensus 394 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~gsL~~ 472 (706)
.+..|-...+|+... +++.+++|..........-...+|..+++.+....+ .+++... ...+||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 456688889998874 566888887654322211134678888888864433 3344332 2368999999977643
Q ss_pred h-----------------hhcccc-cCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCceEecccCCCc
Q 005236 473 F-----------------IFDQER-CKLLDWSKR-FHIICG---------TARGLLYLHQD-----SRLRIIHRDLKASN 519 (706)
Q Consensus 473 ~-----------------l~~~~~-~~~l~~~~~-~~i~~~---------ia~~l~~LH~~-----~~~~ivH~Dikp~N 519 (706)
- |+.... ...++.... ..+..+ +...+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 111110 011121111 111111 11112222211 13458999999999
Q ss_pred EEEcCCCCeEEeeeccccc
Q 005236 520 VLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 520 ill~~~~~~kl~Dfgla~~ 538 (706)
|++++++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00039 Score=72.17 Aligned_cols=78 Identities=14% Similarity=0.094 Sum_probs=57.1
Q ss_pred CccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCC---cceeeeEeEEEeC---CeeEEEEe
Q 005236 390 SINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQH---RNLVKLLGCCIHG---EEKLLIYE 463 (706)
Q Consensus 390 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lV~e 463 (706)
.-.+.||.|..+.||+....++ .+++|..+... ....+..|...++.|.- ..+.++++.+..+ +..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3347899999999999877665 46666643211 23578899999988853 3578888877543 56899999
Q ss_pred cCCCCCh
Q 005236 464 FMPNKSL 470 (706)
Q Consensus 464 ~~~~gsL 470 (706)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00045 Score=73.80 Aligned_cols=75 Identities=13% Similarity=0.180 Sum_probs=54.8
Q ss_pred ceeccCCceeEEEEEeCCC-cEEEEEEcCcc-------chhhHHHHHHHHHHHhhcC---CcceeeeEeEEEeCCeeEEE
Q 005236 393 KKLGEGGFGPVYKGTLADE-QEIAVKRLSKI-------SEQGLKELKNEIILFSKLQ---HRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV 461 (706)
+.||.|.+..||++...+| +.++||.-... .+...+.+..|.+.|..+. -.++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6899999999999999877 58999974321 1234567777888887763 2456667766 44667999
Q ss_pred EecCCCCC
Q 005236 462 YEFMPNKS 469 (706)
Q Consensus 462 ~e~~~~gs 469 (706)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00051 Score=79.87 Aligned_cols=200 Identities=20% Similarity=0.187 Sum_probs=137.4
Q ss_pred HHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeE----EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHH
Q 005236 427 LKELKNEIILFSKLQHRNLVKLLGCCIHGEEKL----LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL 502 (706)
Q Consensus 427 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L 502 (706)
......|...+.++.|+|++.++.+..++...- +..|++..-++...+.. ...++....+.+..++.+||+|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHH
Confidence 334556777888999999999999987654433 44577888788777743 34578888888999999999999
Q ss_pred HhCCCCceEecccCCC---cEEEcCCCCeEEe--eeccccccCCCCCcccccccccccCccCccccccCCCCc--chhhH
Q 005236 503 HQDSRLRIIHRDLKAS---NVLLDQDMNPKIS--DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSV--KSDVF 575 (706)
Q Consensus 503 H~~~~~~ivH~Dikp~---Nill~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--~sDv~ 575 (706)
|+.. ..|.-+..+ +--++.++...++ ||+.++.+....... ...-+..+.+||......+.. ..|+|
T Consensus 303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHH
Confidence 9985 666555555 5566777778877 999888764322211 123355678888877665554 47999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhH
Q 005236 576 SFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPS 655 (706)
Q Consensus 576 SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~e 655 (706)
.+|..+..+..|..+..... .+..+++..... ...+....|+..++++|++..+
T Consensus 377 ~lgll~~~~~~~~~i~~~~~------------------~~~~~l~~~~~~--------~~~d~~~~~~~~~~~~Rl~~~~ 430 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKSA------------------VPVSLLDVLSTS--------ELLDALPKCLDEDSEERLSALE 430 (1351)
T ss_pred HHHHHHhhhhhcCccccccc------------------chhhhhccccch--------hhhhhhhhhcchhhhhccchhh
Confidence 99999999999877632110 111111111100 2234566899999999999999
Q ss_pred HHHHhc
Q 005236 656 VILMLG 661 (706)
Q Consensus 656 v~~~L~ 661 (706)
++...-
T Consensus 431 ll~~~f 436 (1351)
T KOG1035|consen 431 LLTHPF 436 (1351)
T ss_pred hhhchh
Confidence 987653
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00059 Score=70.97 Aligned_cols=143 Identities=20% Similarity=0.191 Sum_probs=86.7
Q ss_pred cceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcc--eeeeEeE------EEeCCeeEEEEe
Q 005236 392 NKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRN--LVKLLGC------CIHGEEKLLIYE 463 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~e 463 (706)
.+.|..|....+|+....+ ..+++|+... ...+.+..|+.++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4677788888999987644 4688888754 23456777888888775433 4444431 123445689999
Q ss_pred cCCCCChhh----hh----------hccc-c-------cCCCCHHHHH----------HHHHHHHHHHHHHHh----CCC
Q 005236 464 FMPNKSLDS----FI----------FDQE-R-------CKLLDWSKRF----------HIICGTARGLLYLHQ----DSR 507 (706)
Q Consensus 464 ~~~~gsL~~----~l----------~~~~-~-------~~~l~~~~~~----------~i~~~ia~~l~~LH~----~~~ 507 (706)
|++|..+.. .+ +... . .....|.... .....+..++.++.. .-+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999987643 11 1000 0 0011221111 011123344455543 123
Q ss_pred CceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 508 LRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 508 ~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
..++|+|+.|.||++++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4599999999999999988789999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0013 Score=62.87 Aligned_cols=125 Identities=26% Similarity=0.362 Sum_probs=89.7
Q ss_pred cCCCccceeccCCc-eeEEEEEeCCCcEEEEEEcCc---cch------------------hhHHHHHHHHHHHhhcC---
Q 005236 387 DNFSINKKLGEGGF-GPVYKGTLADEQEIAVKRLSK---ISE------------------QGLKELKNEIILFSKLQ--- 441 (706)
Q Consensus 387 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 441 (706)
.+++..+.||.|.- |.||++++ +|+.+|+|.+.. ... ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78899999999999 99999999 566999999321 000 11234778998888875
Q ss_pred Ccce--eeeEeEEEeC------------------CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHH
Q 005236 442 HRNL--VKLLGCCIHG------------------EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLY 501 (706)
Q Consensus 442 h~ni--v~l~~~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~ 501 (706)
+.++ |+.+|+..-. ....||.||++... .....-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence 4456 8888887322 12357788775533 1112345678888899
Q ss_pred HHhCCCCceEecccCCCcEEEcCCCCeEEeeeccc
Q 005236 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 536 (706)
Q Consensus 502 LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla 536 (706)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99888 999999999986 3489999864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00076 Score=70.37 Aligned_cols=141 Identities=26% Similarity=0.352 Sum_probs=84.2
Q ss_pred ceeccCCceeEEEEEeCC-------CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcce-eeeEeEEEeCCeeEEEEec
Q 005236 393 KKLGEGGFGPVYKGTLAD-------EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL-VKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~ 464 (706)
+.|..|-...+|+....+ ++.+++|...... ........|..++..+....+ .++++++. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 566677778999988765 4788889865433 223455778888887754333 34555543 2358999
Q ss_pred CCCCChhhhh-----------------hccccc--C----CC--CHHHHHH--------------------------HHH
Q 005236 465 MPNKSLDSFI-----------------FDQERC--K----LL--DWSKRFH--------------------------IIC 493 (706)
Q Consensus 465 ~~~gsL~~~l-----------------~~~~~~--~----~l--~~~~~~~--------------------------i~~ 493 (706)
++|..+.... +..... . .. -+..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9988775321 111100 0 00 0111111 111
Q ss_pred HHHHHHHHHHh------CCCCceEecccCCCcEEEcCC----CCeEEeeeccccc
Q 005236 494 GTARGLLYLHQ------DSRLRIIHRDLKASNVLLDQD----MNPKISDFGLARA 538 (706)
Q Consensus 494 ~ia~~l~~LH~------~~~~~ivH~Dikp~Nill~~~----~~~kl~Dfgla~~ 538 (706)
.+.+.+..|.. ..+..++|+|+.|.|||++++ +.++++||..|..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 235579999999999999985 8899999998854
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0053 Score=64.59 Aligned_cols=142 Identities=20% Similarity=0.214 Sum_probs=77.9
Q ss_pred ceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcc--eeeeEe------EEEeCCeeEEEEec
Q 005236 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRN--LVKLLG------CCIHGEEKLLIYEF 464 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lV~e~ 464 (706)
+.|+.|....+|+....+| .+++|+..... .+.+..|+.++..|...+ +.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 5677788889999887655 68889875222 233444555555553222 223332 12234567899999
Q ss_pred CCCCChhh-----------hh---hcccc--------cCCCCH-HHHHH------------HHH-HHHHHHHHHHhC---
Q 005236 465 MPNKSLDS-----------FI---FDQER--------CKLLDW-SKRFH------------IIC-GTARGLLYLHQD--- 505 (706)
Q Consensus 465 ~~~gsL~~-----------~l---~~~~~--------~~~l~~-~~~~~------------i~~-~ia~~l~~LH~~--- 505 (706)
++|..+.. .| +.... ...+.| ..... .+. .+...+..+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99975421 11 11000 001111 11111 111 111222333211
Q ss_pred -CCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 506 -SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 506 -~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
-+..++|+|++|.||+++.+...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234699999999999999776668999998753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0036 Score=64.16 Aligned_cols=31 Identities=26% Similarity=0.528 Sum_probs=26.2
Q ss_pred CceEecccCCCcEEEcCCCC-eEEeeeccccc
Q 005236 508 LRIIHRDLKASNVLLDQDMN-PKISDFGLARA 538 (706)
Q Consensus 508 ~~ivH~Dikp~Nill~~~~~-~kl~Dfgla~~ 538 (706)
..++|+|++|.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999998565 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0038 Score=66.26 Aligned_cols=141 Identities=18% Similarity=0.269 Sum_probs=82.8
Q ss_pred ceeccCCceeEEEEEeCC-----CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcce-eeeEeEEEeCCeeEEEEecCC
Q 005236 393 KKLGEGGFGPVYKGTLAD-----EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL-VKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~ 466 (706)
+.|-.|-...+|+....+ ++.+++|............ ..|..++..+...++ .++++.+..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 456567788999987533 3678888876544333333 678888888864444 3455555332 5899998
Q ss_pred CCChhhh-----------------hhccc--c-cCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 005236 467 NKSLDSF-----------------IFDQE--R-CKLLDWSKRFHIICGT-----------------ARGLLYL----HQ- 504 (706)
Q Consensus 467 ~gsL~~~-----------------l~~~~--~-~~~l~~~~~~~i~~~i-----------------a~~l~~L----H~- 504 (706)
+.+|... +|... . .....+.++.++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8777522 11111 0 0011223332332211 1111122 21
Q ss_pred CCCCceEecccCCCcEEEcC-CCCeEEeeeccccc
Q 005236 505 DSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARA 538 (706)
Q Consensus 505 ~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfgla~~ 538 (706)
..+..++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22446999999999999986 47899999998864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0062 Score=63.66 Aligned_cols=144 Identities=24% Similarity=0.219 Sum_probs=82.6
Q ss_pred cceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcc--eeeeEeE------EEeCCeeEEEEe
Q 005236 392 NKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRN--LVKLLGC------CIHGEEKLLIYE 463 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~e 463 (706)
.+.++.|.-..+|+....++ .+++|+..... ..+.+..|+.++..|.... +.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876545 67788765421 1234556677776664322 3343331 112345689999
Q ss_pred cCCCCChhhh--------------hhccccc---------CCCCHHHHH------------HHHHHHHHHHHHHHh----
Q 005236 464 FMPNKSLDSF--------------IFDQERC---------KLLDWSKRF------------HIICGTARGLLYLHQ---- 504 (706)
Q Consensus 464 ~~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~~ia~~l~~LH~---- 504 (706)
|++|..+... ++..... ....|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998654211 1110000 001111110 011123334555542
Q ss_pred CCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 505 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 505 ~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
..+..++|+|+++.||++++++...|+||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 2235699999999999999988778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.00093 Score=67.42 Aligned_cols=136 Identities=15% Similarity=0.173 Sum_probs=94.3
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcC--ccc------------------hh--hHHHHHHHHHHHhhcCC-c
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLS--KIS------------------EQ--GLKELKNEIILFSKLQH-R 443 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~------------------~~--~~~~~~~E~~~l~~l~h-~ 443 (706)
--+.+.++||-|--+-||.+-..+|++.++|.-+ ..+ .. ..-...+|...|+.|.. -
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3467889999999999999999999999888421 110 00 01234578888888853 2
Q ss_pred -ceeeeEeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE
Q 005236 444 -NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 522 (706)
Q Consensus 444 -niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill 522 (706)
-+.+.++ .+..++|||++.+-.|...-+ ..+...+. ..+..-+.-|..+| +||+|..-=||+|
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly---~~lm~~Iv~la~~G---lIHgDFNEFNimv 235 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLY---DDLMGLIVRLANHG---LIHGDFNEFNIMV 235 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeee------cCChHHHH---HHHHHHHHHHHHcC---ceecccchheeEE
Confidence 2333443 345689999999988865431 12333333 33444455667777 9999999999999
Q ss_pred cCCCCeEEeeeccccc
Q 005236 523 DQDMNPKISDFGLARA 538 (706)
Q Consensus 523 ~~~~~~kl~Dfgla~~ 538 (706)
++++.++++||-....
T Consensus 236 ~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMVS 251 (465)
T ss_pred ecCCCEEEeechHhhc
Confidence 9999999999986543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0073 Score=62.38 Aligned_cols=139 Identities=15% Similarity=0.217 Sum_probs=83.5
Q ss_pred ccceeccCCceeEEEEEeCCCcEEEEEEcC-ccchhhHHHHHHHHHHHhhcCC--cceeeeEeEEEeCC--eeEEEEecC
Q 005236 391 INKKLGEGGFGPVYKGTLADEQEIAVKRLS-KISEQGLKELKNEIILFSKLQH--RNLVKLLGCCIHGE--EKLLIYEFM 465 (706)
Q Consensus 391 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lV~e~~ 465 (706)
+.+++..|.--.+|..... ++++++.+-. ...........+|+.+++.+.- .-..+.+++|.++. ..+.||+|+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 3344544444445554443 7778887321 1233345566778888887753 23455667777666 669999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHH-HHHHHH---------------------------------------------
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIIC-GTARGL--------------------------------------------- 499 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~-~ia~~l--------------------------------------------- 499 (706)
+|..+...+.... .. .+++. .+++.|
T Consensus 108 eGe~~~~~~~~~~------~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 108 EGEVVWSALPPES------LG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred cceeccCcCCccc------ch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 9854333221100 00 01111 333333
Q ss_pred -----HHHHhC-----CCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 500 -----LYLHQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 500 -----~~LH~~-----~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
.+|+.. ++..++|+|+++.||+++.+.-+-++||+++..
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 333322 345799999999999999999999999999875
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.01 Score=60.92 Aligned_cols=75 Identities=19% Similarity=0.221 Sum_probs=48.8
Q ss_pred CccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcC---CcceeeeEeEEEeCCeeEEEEecCC
Q 005236 390 SINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ---HRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 390 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
+-.+.|+.|.-..+|+.. .+++.+.||.-. ......|..|..-|+.|. --.+.+.+++....+..+|||||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 334788989999999987 577889999865 333456788888888773 4457788888888888899999998
Q ss_pred CC
Q 005236 467 NK 468 (706)
Q Consensus 467 ~g 468 (706)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 77
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.01 Score=62.09 Aligned_cols=74 Identities=12% Similarity=0.149 Sum_probs=49.7
Q ss_pred ceeccCCceeEEEEEeCCC-cEEEEEEcCc-------cchhhHHHHHHHHHHHhhcC--Ccc-eeeeEeEEEeCCeeEEE
Q 005236 393 KKLGEGGFGPVYKGTLADE-QEIAVKRLSK-------ISEQGLKELKNEIILFSKLQ--HRN-LVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~lV 461 (706)
+.||.|....||++...++ +.|+||.-.. ..+...++..-|...|+... -|. +++++.+ +.+...+|
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 3589999999999998654 5899996422 12334556667777776653 343 4445544 55667799
Q ss_pred EecCCCC
Q 005236 462 YEFMPNK 468 (706)
Q Consensus 462 ~e~~~~g 468 (706)
||+++..
T Consensus 79 MEdL~~~ 85 (370)
T TIGR01767 79 MEDLSHH 85 (370)
T ss_pred HhhCccc
Confidence 9999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0012 Score=52.48 Aligned_cols=49 Identities=16% Similarity=0.359 Sum_probs=36.0
Q ss_pred eeccCCCCCCccccccccCHhHHHHHHhhcCccccccccccCCCCceeeeeec
Q 005236 230 FTAMKLPDATPSWVSKSMNLKECREKCLENSSCMAYTNSDIRGGGSGCAMWFG 282 (706)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~~~~c~~~~~ 282 (706)
+.++.++.+..... ...+.++|+..|+.+|+|.||.|.. +...|.++..
T Consensus 9 ~~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~ 57 (73)
T cd01100 9 GSNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSS 57 (73)
T ss_pred cCCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccC
Confidence 35667766555433 3679999999999999999999974 2456777644
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.019 Score=61.24 Aligned_cols=73 Identities=11% Similarity=0.095 Sum_probs=50.3
Q ss_pred cceeccCCceeEEEEEeCCCcEEEEEEcCcc----c---hhhHHHHHHHHHHHhhcC---CcceeeeEeEEEeCCeeEEE
Q 005236 392 NKKLGEGGFGPVYKGTLADEQEIAVKRLSKI----S---EQGLKELKNEIILFSKLQ---HRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV 461 (706)
.+.||.|....||+.... ++.++||.-... . +....+-..|+..|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 478999999999998874 557999975421 1 123444455566665553 246777888865 556888
Q ss_pred EecCCC
Q 005236 462 YEFMPN 467 (706)
Q Consensus 462 ~e~~~~ 467 (706)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.0015 Score=77.70 Aligned_cols=162 Identities=14% Similarity=-0.021 Sum_probs=114.7
Q ss_pred HHHHHHHHHHhhcCCcceeeeEeEEEe--CCeeEEEEecCCCCChhhhhhcccc-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 005236 428 KELKNEIILFSKLQHRNLVKLLGCCIH--GEEKLLIYEFMPNKSLDSFIFDQER-CKLLDWSKRFHIICGTARGLLYLHQ 504 (706)
Q Consensus 428 ~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~ 504 (706)
+....|....+...|+++.....-... ..+.+.+++|+..|.+.+.|-.... ...++...+...-.+......-.|.
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 344556666677789998776554432 3466899999999999998865432 2333333333333332555555554
Q ss_pred CC--CCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHH
Q 005236 505 DS--RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLL 582 (706)
Q Consensus 505 ~~--~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ 582 (706)
.. ....+|+++|+-|.+|..+..+|+.++|+.+...... .......+++-|++|+....-.++.++|+|..|+.+|
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 32 2347999999999999999999999999998432221 1222356788899999998889999999999999999
Q ss_pred HHHhCCCCC
Q 005236 583 EIVSGKKNR 591 (706)
Q Consensus 583 elltG~~p~ 591 (706)
+.--|..++
T Consensus 1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred HHhcccHHH
Confidence 998887764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.01 Score=62.88 Aligned_cols=74 Identities=12% Similarity=0.129 Sum_probs=51.3
Q ss_pred cceeccCCceeEEEEEeCC-CcEEEEEEcCc------cchhhHHHHHHHHHHHhhcC--Ccc-eeeeEeEEEeCCeeEEE
Q 005236 392 NKKLGEGGFGPVYKGTLAD-EQEIAVKRLSK------ISEQGLKELKNEIILFSKLQ--HRN-LVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~lV 461 (706)
.+.||.|.-..||++.+.. ++.|+||.-.. ..+-..++..-|.+.|+... -|. +++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4789999999999999843 56799986421 22445667777888877663 343 4555544 55667789
Q ss_pred EecCCC
Q 005236 462 YEFMPN 467 (706)
Q Consensus 462 ~e~~~~ 467 (706)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.029 Score=59.17 Aligned_cols=141 Identities=17% Similarity=0.243 Sum_probs=80.6
Q ss_pred ceeccCCceeEEEEEeCC----CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcce-eeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLAD----EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL-VKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~ 467 (706)
+.|..|-...+|+....+ +..|++|......... -.-.+|..+++.+..-++ .++++++. .. +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 455557778899887543 2378888875533322 223568888888865555 35565552 22 58999988
Q ss_pred CChhhh-------h----------hcccc---cCCCCHHHHHHHHHHH----------------------HH---HHHHH
Q 005236 468 KSLDSF-------I----------FDQER---CKLLDWSKRFHIICGT----------------------AR---GLLYL 502 (706)
Q Consensus 468 gsL~~~-------l----------~~~~~---~~~l~~~~~~~i~~~i----------------------a~---~l~~L 502 (706)
.+|..- + |.... ....-|..+.++..++ .+ .+..+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 776321 1 11110 0011233322222221 11 11111
Q ss_pred H-h-CCCCceEecccCCCcEEEcC-CCCeEEeeeccccc
Q 005236 503 H-Q-DSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARA 538 (706)
Q Consensus 503 H-~-~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfgla~~ 538 (706)
. . ..+..+.|.|+.+.|||+++ ++.++++||..|-.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 1 12345899999999999975 57899999998854
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.031 Score=57.74 Aligned_cols=140 Identities=22% Similarity=0.233 Sum_probs=93.1
Q ss_pred ccceeccCCceeEEEEEeCCCcEEEEEEcCcc-----ch--------------------hhHH-HHHHHHHHHhhcCCcc
Q 005236 391 INKKLGEGGFGPVYKGTLADEQEIAVKRLSKI-----SE--------------------QGLK-ELKNEIILFSKLQHRN 444 (706)
Q Consensus 391 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-----~~--------------------~~~~-~~~~E~~~l~~l~h~n 444 (706)
+.-.|..|--+.||.++..+|..+|||+.+.. .. .-.+ -...|++-|.+|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 44678899999999999999999999986421 00 0011 1345777777776554
Q ss_pred eeeeEeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC
Q 005236 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ 524 (706)
Q Consensus 445 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~ 524 (706)
|.----... ....|||+|+....-.. ..-+--.++...+..+-.|++.-|.-|-..+ .+||.||.--|+|+ .
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~a---PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-h 299 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAA---PKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-H 299 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcC---cccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-E
Confidence 432111111 12368999996432211 1111123556677777788888888888877 49999999999998 4
Q ss_pred CCCeEEeeeccccc
Q 005236 525 DMNPKISDFGLARA 538 (706)
Q Consensus 525 ~~~~kl~Dfgla~~ 538 (706)
+|.+.|+|-+.+..
T Consensus 300 dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVE 313 (520)
T ss_pred CCEEEEEEcccccc
Confidence 57899999887654
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.012 Score=57.79 Aligned_cols=31 Identities=35% Similarity=0.543 Sum_probs=22.3
Q ss_pred CceEecccCCCcEEE-cCCCCeEEeeeccccc
Q 005236 508 LRIIHRDLKASNVLL-DQDMNPKISDFGLARA 538 (706)
Q Consensus 508 ~~ivH~Dikp~Nill-~~~~~~kl~Dfgla~~ 538 (706)
..+.|.|+.|.|||+ +.++.++|+||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 458999999999999 8999999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.029 Score=49.20 Aligned_cols=37 Identities=19% Similarity=0.234 Sum_probs=22.0
Q ss_pred cCCCCCCCCCceEEEEeeCCCcceEEeeCCceeeeeCC
Q 005236 61 WKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFYRSGP 98 (706)
Q Consensus 61 w~s~~dps~G~fsl~~~~~g~~~~~~~~~~~~yw~sg~ 98 (706)
|.|....+.+.+.+.|+++|+..++--+ +.+.|.|..
T Consensus 78 W~S~~~~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~ 114 (116)
T cd00028 78 WSSNTTRVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFD 114 (116)
T ss_pred EEecccCCCCceEEEEeCCCCEEEECCC-CCEEEcCCC
Confidence 4444433456778888888875544322 456776653
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.037 Score=53.16 Aligned_cols=139 Identities=14% Similarity=0.141 Sum_probs=88.5
Q ss_pred EEEEEEcCccchh-hHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHH
Q 005236 413 EIAVKRLSKISEQ-GLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI 491 (706)
Q Consensus 413 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i 491 (706)
...+|++....-. ...-+..+..++++++ .|++|..- .....-++.|+|..-.. .. ..+
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~----~N~ 146 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NF----SNF 146 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------ch----hHH
Confidence 4567776554433 4456788888988875 57777632 34455688998833111 11 112
Q ss_pred HHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcc
Q 005236 492 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVK 571 (706)
Q Consensus 492 ~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~ 571 (706)
+..=+++|.-.|+.+ ...+|+|-.|+||+-|..|.+||.|-+..-. .+..|.-- .....|++
T Consensus 147 i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~---~Y~~lT~~ 208 (308)
T PF07387_consen 147 ITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNI---EYESLTQE 208 (308)
T ss_pred HHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEee---eccccChH
Confidence 222256788888553 3699999999999999999999999664321 11122221 12345778
Q ss_pred hhhHHHHHHHHHHHhCCC
Q 005236 572 SDVFSFGILLLEIVSGKK 589 (706)
Q Consensus 572 sDv~SlGvil~elltG~~ 589 (706)
+.+=+|=.-++++.....
T Consensus 209 aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 209 AEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred HHHHHHHHHHHHHHHHHh
Confidence 888888888888876543
|
The function of this family is unknown. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.12 Score=54.12 Aligned_cols=30 Identities=23% Similarity=0.333 Sum_probs=25.9
Q ss_pred CceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 508 LRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 508 ~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
..++|+|+++.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 46899999999999988 6789999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 706 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-52 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-50 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-39 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-39 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-35 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-23 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-23 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-22 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-22 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-22 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-22 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-21 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-21 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-21 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-20 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-20 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-20 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-18 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-18 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-17 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-17 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-17 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-17 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-17 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-17 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-17 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-17 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-17 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-17 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-17 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-17 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-17 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-17 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-17 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-17 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-17 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-17 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-17 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-17 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-17 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-16 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-16 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-16 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-16 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-16 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-16 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-16 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-16 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-14 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 706 | |||
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-141 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-137 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-122 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 7e-93 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-76 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-64 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-62 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-60 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-60 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-60 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-58 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-58 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 6e-58 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 7e-55 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-52 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-52 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-51 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-50 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 5e-49 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 6e-46 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-45 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-45 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 3e-45 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-45 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 4e-45 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 5e-45 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 8e-45 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-44 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-44 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-44 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-44 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 3e-44 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 5e-44 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 6e-44 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 8e-44 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-43 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-43 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-43 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-43 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-43 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-43 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-43 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 3e-43 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 3e-43 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 5e-43 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-43 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 6e-43 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 7e-43 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 7e-43 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 7e-43 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 7e-43 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 8e-43 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-42 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-42 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-42 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 3e-42 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 3e-42 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-42 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 4e-42 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 6e-42 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 6e-42 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 8e-42 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 9e-42 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 9e-42 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-41 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-41 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-41 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 3e-41 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 5e-41 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 7e-41 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-40 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-40 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 8e-40 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-39 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 7e-39 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-38 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-38 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-38 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-38 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 4e-38 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-37 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-37 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 4e-36 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 4e-36 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 6e-36 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-35 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-35 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 3e-35 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 4e-35 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 6e-35 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-34 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-34 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-34 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-34 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 4e-34 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-34 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 5e-34 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-33 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-33 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-33 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-33 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 5e-33 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 5e-33 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-32 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-32 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 7e-32 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-31 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-31 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-31 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 4e-31 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-30 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 3e-30 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-29 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-29 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-29 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 7e-29 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-28 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-28 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-28 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 6e-28 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 8e-28 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 8e-28 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 8e-28 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 9e-28 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-27 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-27 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-27 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-27 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-27 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-27 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-27 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-27 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 4e-27 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 6e-27 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 6e-27 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 9e-27 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-26 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-26 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-26 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 4e-26 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 7e-26 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 8e-26 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 8e-26 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 9e-26 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-25 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-25 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-25 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-25 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 5e-25 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 5e-25 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 6e-25 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-24 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-24 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-24 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 3e-24 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-24 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 4e-24 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 4e-24 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 5e-24 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 8e-24 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 9e-24 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-23 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 1e-23 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-23 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-23 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-23 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-23 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-23 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-23 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-23 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 5e-23 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 5e-23 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 5e-23 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 6e-23 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-22 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-22 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-22 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-22 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-22 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 9e-22 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-21 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-21 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-21 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-21 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 5e-21 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 6e-21 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 5e-20 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 5e-20 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-20 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 7e-20 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 2e-19 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-19 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-19 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-19 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-19 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 5e-19 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 6e-19 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-13 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-18 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-18 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-18 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-18 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-18 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-18 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-18 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-18 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 4e-18 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 5e-18 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 7e-18 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-17 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-17 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-17 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-17 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 2e-17 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-17 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-17 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 3e-17 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 6e-16 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-15 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 6e-15 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 9e-15 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-14 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-12 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-11 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 2e-10 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-10 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 3e-09 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 5e-09 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 8e-09 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 8e-09 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 9e-09 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 3e-08 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 4e-08 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-07 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-06 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 4e-06 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 4e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-04 |
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 415 bits (1069), Expect = e-141
Identities = 102/309 (33%), Positives = 160/309 (51%), Gaps = 22/309 (7%)
Query: 366 EDQNIDL---DLPLFELATIANATDNFS------INKKLGEGGFGPVYKGTLADEQEIAV 416
E++++++ F + N T+NF K+GEGGFG VYKG + + +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 417 KRLSKI----SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDS 472
K+L+ + +E+ ++ EI + +K QH NLV+LLG G++ L+Y +MPN SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 473 FIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 532
+ + L W R I G A G+ +LH++ IHRD+K++N+LLD+ KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 533 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRG 592
FGLARA T+R+VGT YMAPE G+ + KSD++SFG++LLEI++G
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 593 FYHSDNKLNLIRHAWKLWNEGMP-SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
+ L+ ++ +E ID D + V + C+ + RP
Sbjct: 236 EHREPQ--LLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 652 CMPSVILML 660
+ V +L
Sbjct: 293 DIKKVQQLL 301
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 403 bits (1039), Expect = e-137
Identities = 119/306 (38%), Positives = 176/306 (57%), Gaps = 6/306 (1%)
Query: 366 EDQNIDLDLP-LFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISE 424
ED + L F L + A+DNFS LG GGFG VYKG LAD +AVKRL +
Sbjct: 8 EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT 67
Query: 425 QGLK-ELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKL- 482
QG + + + E+ + S HRNL++L G C+ E+LL+Y +M N S+ S + ++ +
Sbjct: 68 QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 127
Query: 483 LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542
LDW KR I G+ARGL YLH +IIHRD+KA+N+LLD++ + DFGLA+
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
Query: 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN--RGFYHSDNKL 600
+T T V GT G++APEY S G+ S K+DVF +G++LLE+++G++ +D+ +
Sbjct: 188 DTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 601 NLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
L+ L E L+D + ++ EV + I + LLC Q P +RP M V+ ML
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
Query: 661 GSEIVL 666
+ +
Sbjct: 307 EGDGLA 312
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 366 bits (942), Expect = e-122
Identities = 103/308 (33%), Positives = 160/308 (51%), Gaps = 6/308 (1%)
Query: 355 NRNNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEI 414
N + + + + L + AT+NF +G G FG VYKG L D ++
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 415 AVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI 474
A+KR + S QG++E + EI S +H +LV L+G C E +LIY++M N +L +
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 475 FDQERCKL-LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 533
+ + + + W +R I G ARGL YLH + IIHRD+K+ N+LLD++ PKI+DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183
Query: 534 GLARAF-GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRG 592
G+++ D+T +T V GT GY+ PEY G+ + KSDV+SFG++L E++ +
Sbjct: 184 GISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 593 FYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPC 652
+NL A + N G Q++D D + + + C+ EDRP
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 653 MPSVILML 660
M V+ L
Sbjct: 303 MGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 7e-93
Identities = 74/323 (22%), Positives = 128/323 (39%), Gaps = 33/323 (10%)
Query: 360 GTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRL 419
G + +DL ++ + + G FG V+K L + +AVK
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSM-----PLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF 55
Query: 420 SKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE----EKLLIYEFMPNKSLDSFIF 475
+Q + + E+ ++H N+++ +G G + LI F SL F+
Sbjct: 56 PIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL- 113
Query: 476 DQERCKLLDWSKRFHIICGTARGLLYLHQD-------SRLRIIHRDLKASNVLLDQDMNP 528
+ ++ W++ HI ARGL YLH+D + I HRD+K+ NVLL ++
Sbjct: 114 ---KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170
Query: 529 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-----QFSVKSDVFSFGILLLE 583
I+DFGLA F ++ G+T+ VGT YMAPE ++ D+++ G++L E
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230
Query: 584 IVSGKKNRGFYHSDNKLNLIRHAWKLWN-EGMPS----QLIDACFKDSFNLAEVIRCI-H 637
+ S + L + + E M + +D + + +
Sbjct: 231 LASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCE 290
Query: 638 IGLLCVQQYPEDRPCMPSVILML 660
C E R V +
Sbjct: 291 TIEECWDHDAEARLSAGCVGERI 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 1e-76
Identities = 73/322 (22%), Positives = 121/322 (37%), Gaps = 42/322 (13%)
Query: 385 ATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRN 444
DN + + +G G +G VYKG+L DE+ +AVK S + Q K I ++H N
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDN 68
Query: 445 LVKLLGCCIHGE-----EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGL 499
+ + + E LL+ E+ PN SL ++ DW + RGL
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGL 124
Query: 500 LYLHQD------SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG------DETEGN 547
YLH + + I HRDL + NVL+ D ISDFGL+ G E +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 548 TNRVVGTYGYMAPEYASD-------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKL 600
VGT YMAPE + D+++ G++ EI + S +
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 601 NLIRHAWKLWNEGMPSQLIDA-CFK-------DSFNLAEVIRCIHIGLL--CVQQYPEDR 650
+ ++ N + + +++ + + C Q E R
Sbjct: 245 QMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303
Query: 651 PCMPSVILMLGSEIVLPQPKQP 672
+ +E+++ +
Sbjct: 304 LTAQXAEERM-AELMMIWERNK 324
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 2e-64
Identities = 71/287 (24%), Positives = 130/287 (45%), Gaps = 23/287 (8%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRL--SKISEQGLKELKNEIILFSKLQHRN 444
+ +I +K+G G FG V++ ++AVK L + + E E+ + +L+H N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ 504
+V +G ++ E++ SL + + LD +R + A+G+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 505 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS 564
I+HR+LK+ N+L+D+ K+ DFGL+R T ++ GT +MAPE
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGTPEWMAPEVLR 212
Query: 565 DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624
D + KSDV+SFG++L E+ + ++ + LN + + + ++
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQ---PWG---NLNPAQVVAAVGFKCKRLEIPRNLNP 266
Query: 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS--EIVLPQP 669
+A +I C P RP +++ +L + +P P
Sbjct: 267 Q---VAAIIE------GCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 1e-62
Identities = 74/288 (25%), Positives = 122/288 (42%), Gaps = 26/288 (9%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
+ + +G G FG V K +++A+K++ SE K E+ S++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRA-KDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
KL G C+ L+ E+ SL + + E + ++G+ YLH
Sbjct: 65 KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 507 RLRIIHRDLKASNVLLDQDMN-PKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD 565
+IHRDLK N+LL KI DFG A + + + G+ +MAPE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 566 GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625
+S K DVFS+GI+L E+++ +K + + R W + N P LI K
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PF-DEIGGPAFRIMWAVHNGTRPP-LIKNLPKP 232
Query: 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS-EIVLPQPKQP 672
+ ++ C + P RP M ++ ++ P +P
Sbjct: 233 ---IESLMTR------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 2e-60
Identities = 72/289 (24%), Positives = 135/289 (46%), Gaps = 38/289 (13%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQG-------LKELKNEIILFS 438
+ K++G+GGFG V+KG + D+ +A+K L +G +E + E+ + S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 439 KLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARG 498
L H N+VKL G ++ EF+P L + D+ + WS + ++ A G
Sbjct: 79 NLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALG 134
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLARAFGGDETEGNTNRVVG 553
+ Y+ I+HRDL++ N+ L + K++DFGL++ ++ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 554 TYGYMAPE--YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWN 611
+ +MAPE A + ++ K+D +SF ++L I++G+ + + I+ +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PF-DEYSYGKIKFINMIRE 244
Query: 612 EGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
EG+ + + C L VI LC P+ RP ++ L
Sbjct: 245 EGLRPTIPEDCPPR---LRNVIE------LCWSGDPKKRPHFSYIVKEL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 2e-60
Identities = 75/282 (26%), Positives = 129/282 (45%), Gaps = 36/282 (12%)
Query: 391 INKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQ----GLKELKNEIILFSKLQHRNLV 446
+ + +G GGFG VY+ E+AVK ++ ++ ++ E LF+ L+H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
L G C+ L+ EF L+ + K + + ARG+ YLH ++
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 507 RLRIIHRDLKASNVLLDQDMNP--------KISDFGLARAFGGDETEGNTNRVVGTYGYM 558
+ IIHRDLK+SN+L+ Q + KI+DFGLAR + G Y +M
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWM 181
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618
APE FS SDV+S+G+LL E+++G+ + ++ + A+ + + +
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEV---PFRG---IDGLAVAYGVAMNKLALPI 235
Query: 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
C + A+++ C P RP +++ L
Sbjct: 236 PSTCPEP---FAKLME------DCWNPDPHSRPSFTNILDQL 268
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-60
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL 445
+ + LG+G FG K T + + +K L + E+ + E+ + L+H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD 505
+K +G + I E++ +L I + WS+R A G+ YLH
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHS- 126
Query: 506 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR------------VVG 553
+ IIHRDL + N L+ ++ N ++DFGLAR ++T+ R VVG
Sbjct: 127 --MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 554 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 589
+MAPE + + K DVFSFGI+L EI+
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 1e-58
Identities = 78/316 (24%), Positives = 143/316 (45%), Gaps = 44/316 (13%)
Query: 353 RENRNNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQ 412
+ ++ G+ +D I ++ ++ +++G G FG VYKG
Sbjct: 4 GHHHHHHGSRDAADDWEIPDG----QI----------TVGQRIGSGSFGTVYKGKW--HG 47
Query: 413 EIAVKRL--SKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKL-LIYEFMPNKS 469
++AVK L + + Q L+ KNE+ + K +H N++ +G +L ++ ++ S
Sbjct: 48 DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST--APQLAIVTQWCEGSS 105
Query: 470 LDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 529
L + E + K I TARG+ YLH IIHRDLK++N+ L +D K
Sbjct: 106 LYHHLHASET--KFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVK 160
Query: 530 ISDFGLARAFGGDETEGNTNRVVGTYGYMAPE---YASDGQFSVKSDVFSFGILLLEIVS 586
I DFGLA ++ G+ +MAPE +S +SDV++FGI+L E+++
Sbjct: 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220
Query: 587 GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI--DACFKDSFNLAEVIRCIHIGLLCVQ 644
G+ + + +N+ +I + P C K + ++ C++
Sbjct: 221 GQ--LPYSNINNRDQIIEMVGR--GSLSPDLSKVRSNCPKR---MKRLMA------ECLK 267
Query: 645 QYPEDRPCMPSVILML 660
+ ++RP P ++ +
Sbjct: 268 KKRDERPSFPRILAEI 283
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 6e-58
Identities = 59/281 (20%), Positives = 117/281 (41%), Gaps = 32/281 (11%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRL--SKISEQGLKELKNEIILFSKLQHRN 444
+ KL E G ++KG +I VK L S + ++ E H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 445 LVKLLGCCIHGEEKLL--IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL 502
++ +LG C I +MP SL + + + ++D S+ ARG+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFL 127
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE- 561
H L I L + +V++D+DM +IS + +F + + ++APE
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEA 179
Query: 562 --YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619
+ +D++SF +LL E+V+ + + L+ + K+ EG+ +
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREV---PFA---DLSNMEIGMKVALEGLRPTIP 233
Query: 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
S +++++++ +C+ + P RP ++ +L
Sbjct: 234 PGI---SPHVSKLMK------ICMNEDPAKRPKFDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 7e-55
Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 37/284 (13%)
Query: 391 INKKLGEGGFGPVYKGTLADEQEIAVKRL--SKISEQGLKELKNEIILFSKLQHRNLVKL 448
I + +G+G FG VY G E+A++ + + +E LK K E++ + + +H N+V
Sbjct: 37 IGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 449 LGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRL 508
+G C+ +I ++L S + D + +LD +K I +G+ YLH
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHA---K 149
Query: 509 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR---VVGTYGYMAPE---- 561
I+H+DLK+ NV D + I+DFGL G + ++ G ++APE
Sbjct: 150 GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 562 -----YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616
FS SDVF+ G + E+ + + + + W++ P+
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP---FKT---QPAEAIIWQMGTGMKPN 262
Query: 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
K+ +++++ C E+RP ++ ML
Sbjct: 263 LSQIGMGKE---ISDILL------FCWAFEQEERPTFTKLMDML 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-52
Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 26/237 (10%)
Query: 373 DLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKN 432
LPL TIA + K++G+G +G V+ G +++AVK E +
Sbjct: 26 GLPLLVQRTIA---KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA-SWFRET 80
Query: 433 EIILFSKLQHRNLVKLLGCCIHGEEK----LLIYEFMPNKSLDSFIFDQERCKLLDWSKR 488
EI ++H N++ + I G LI ++ N SL ++ + LD
Sbjct: 81 EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSM 136
Query: 489 FHIICGTARGLLYLHQDSRLR-----IIHRDLKASNVLLDQDMNPKISDFGLARAF--GG 541
+ + GL +LH + I HRDLK+ N+L+ ++ I+D GLA F
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196
Query: 542 DETEGNTNRVVGTYGYMAPE------YASDGQFSVKSDVFSFGILLLEIVSGKKNRG 592
+E + N VGT YM PE + Q + +D++SFG++L E+ + G
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 4e-52
Identities = 56/231 (24%), Positives = 101/231 (43%), Gaps = 30/231 (12%)
Query: 381 TIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNE--IILFS 438
T+A + ++ + +G+G +G V++G+ + +AVK S + K E +
Sbjct: 5 TVA---RDITLLECVGKGRYGEVWRGSW-QGENVAVK---IFSSRDEKSWFRETELYNTV 57
Query: 439 KLQHRNLVKLLGCCIHGEEK----LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICG 494
L+H N++ + + LI + SL ++ + LD I+
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLS 113
Query: 495 TARGLLYLHQDSRLR-----IIHRDLKASNVLLDQDMNPKISDFGLAR--AFGGDETEGN 547
A GL +LH + I HRDLK+ N+L+ ++ I+D GLA + ++ +
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 548 TNRVVGTYGYMAPE------YASDGQFSVKSDVFSFGILLLEIVSGKKNRG 592
N VGT YMAPE + D+++FG++L E+ + G
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 3e-50
Identities = 61/239 (25%), Positives = 102/239 (42%), Gaps = 28/239 (11%)
Query: 374 LPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQG-LKELKN 432
LPL TIA + + +G+G FG V++G +E+AVK S E+ +E
Sbjct: 32 LPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREA-- 85
Query: 433 EIILFSKLQHRNLVKLLGCCIHGEEK----LLIYEFMPNKSLDSFIFDQERCKLLDWSKR 488
EI L+H N++ + L+ ++ + SL ++ +
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGM 141
Query: 489 FHIICGTARGLLYLHQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GG 541
+ TA GL +LH + + I HRDLK+ N+L+ ++ I+D GLA
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201
Query: 542 DETEGNTNRVVGTYGYMAPE------YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 594
D + N VGT YMAPE + ++D+++ G++ EI G +
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 5e-49
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRL-SKISEQGLKELKNEIILFSKLQHRN 444
++ + +++G G FG V+ G L AD +AVK + + E + + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ 504
+V+L+G C + ++ E + +F+ + L ++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 505 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY----MAP 560
IHRDL A N L+ + KISDFG++R +E +G G AP
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAP 284
Query: 561 EYASDGQFSVKSDVFSFGILLLEIVS 586
E + G++S +SDV+SFGILL E S
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFS 310
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-46
Identities = 64/224 (28%), Positives = 107/224 (47%), Gaps = 32/224 (14%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL------ADEQEIAVKRLSKISEQGLKELKNEIILFSKL 440
+ + ++LGEG FG V+ D+ +AVK L + K+ + E L + L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 441 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSF-------------IFDQERCKLLDWSK 487
QH ++VK G C G+ ++++E+M + L+ F ++ L S+
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 488 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547
HI A G++YL + +HRDL N L+ ++ KI DFG++R D +
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTD 187
Query: 548 TNRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
R VG + +M PE +F+ +SDV+SFG++L EI +
Sbjct: 188 YYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 31/223 (13%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL------ADEQEIAVKRLSKISEQGLKELKNEIILFSKL 440
+ + +LGEG FG V+ D+ +AVK L + SE ++ + E L + L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 441 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSF------------IFDQERCKLLDWSKR 488
QH+++V+ G C G L+++E+M + L+ F + L +
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 489 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 548
+ A G++YL + L +HRDL N L+ Q + KI DFG++R D +
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDY 213
Query: 549 NRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
R VG +M PE +F+ +SDV+SFG++L EI +
Sbjct: 214 YR-VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 2e-45
Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
+ ++ K+LG G FG V G + ++AVK + K E E KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
K G C ++ E++ N L +++ + K L+ S+ + G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMAPEYA 563
+ IHRDL A N L+D+D+ K+SDFG+ R D+ VGT + APE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV----SSVGTKFPVKWSAPEVF 177
Query: 564 SDGQFSVKSDVFSFGILLLEIVS 586
++S KSDV++FGIL+ E+ S
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFS 200
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-45
Identities = 75/281 (26%), Positives = 122/281 (43%), Gaps = 29/281 (10%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQE-----IAVKRLSKISEQGLKELKNEIILFSKLQ 441
+ ++LG+G FG V Q+ +AVK+L +E+ L++ + EI + LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 442 HRNLVKLLGCCIHGEEK--LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGL 499
H N+VK G C + LI E++P SL ++ Q+ + +D K +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG--- 556
YL R IHRDL N+L++ + KI DFGL + D+ V G
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY----YKVKEPGESP 211
Query: 557 --YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM 614
+ APE ++ +FSV SDV+SFG++L E+ + + ++ + M
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ----GQM 267
Query: 615 PSQLIDACFKDSFNLAEVIRC---IH-IGLLCVQQYPEDRP 651
+ K++ L C I+ I C RP
Sbjct: 268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 308
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-45
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
+ + K+LG G FG V G + ++A+K + K E E + L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+L G C +I E+M N L +++ +E + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMAPEYA 563
+ +HRDL A N L++ K+SDFGL+R DE VG+ + PE
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT----SSVGSKFPVRWSPPEVL 193
Query: 564 SDGQFSVKSDVFSFGILLLEIVS 586
+FS KSD+++FG+L+ EI S
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-45
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 13/203 (6%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
+ +++G G FG V+ G ++ ++A+K + + ++ E + KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+L G C+ L+ EFM + L ++ + + L + G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMAPEYA 563
+IHRDL A N L+ ++ K+SDFG+ R D+ GT + +PE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT----SSTGTKFPVKWASPEVF 177
Query: 564 SDGQFSVKSDVFSFGILLLEIVS 586
S ++S KSDV+SFG+L+ E+ S
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-45
Identities = 76/290 (26%), Positives = 125/290 (43%), Gaps = 29/290 (10%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQE-----IAVKRLSKISEQGLKELKNEIILFSKLQ 441
+ ++LG+G FG V Q+ +AVK+L +E+ L++ + EI + LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 442 HRNLVKLLGCCIHGEEK--LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGL 499
H N+VK G C + LI E++P SL ++ Q+ + +D K +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG--- 556
YL R IHRDL N+L++ + KI DFGL + D+ V G
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF----FKVKEPGESP 180
Query: 557 --YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM 614
+ APE ++ +FSV SDV+SFG++L E+ + + ++ + M
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ----GQM 236
Query: 615 PSQLIDACFKDSFNLAEVIRC---IH-IGLLCVQQYPEDRPCMPSVILML 660
+ K++ L C I+ I C RP + L +
Sbjct: 237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 8e-45
Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 390 SINKKLGEGGFGPVYKGTLAD----EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRN 444
N+ +G G FG VY GTL D + AVK L++I + + E I+ H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 445 LVKLLGCCIHGEEKLL-IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH 503
++ LLG C+ E L + +M + L +FI + A+G+ YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 144
Query: 504 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG------Y 557
+ + +HRDL A N +LD+ K++DFGLAR D + V G +
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKW 198
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVS 586
MA E +F+ KSDV+SFG+LL E+++
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 27/219 (12%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSKI-SEQGLKELKNEIILFSK 439
+ +++++LG+G FG VY+G E +A+K +++ S + E NE + +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSF-------IFDQERCKLLDWSKRFHII 492
++V+LLG G+ L+I E M L S+ + + SK +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 552
A G+ YL + + +HRDL A N ++ +D KI DFG+ R D E + R
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR-K 196
Query: 553 GTYGY-----MAPEYASDGQFSVKSDVFSFGILLLEIVS 586
G G M+PE DG F+ SDV+SFG++L EI +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 70/202 (34%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
+ + ++LG G FG V+ G ++AVK L K E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+L E +I E+M N SL F+ KL +K + A G+ ++
Sbjct: 72 RLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFI---E 126
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY--MAPEYAS 564
IHRDL+A+N+L+ ++ KI+DFGLAR +E T R + APE +
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 183
Query: 565 DGQFSVKSDVFSFGILLLEIVS 586
G F++KSDV+SFGILL EIV+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL 445
+ ++ KLG G +G VY+G +AVK L K ++E E + +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD 505
V+LLG C +I EFM +L ++ + R + + ++ + + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYL--- 127
Query: 506 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN-----RVVGTYGYMAP 560
+ IHRDL A N L+ ++ K++DFGL+R GD + + + AP
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAP 181
Query: 561 EYASDGQFSVKSDVFSFGILLLEIVS 586
E + +FS+KSDV++FG+LL EI +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 76/338 (22%), Positives = 126/338 (37%), Gaps = 69/338 (20%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL-----ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ 441
+ +LG+G FG V +AVK+L ++ + EI + L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 442 HRNLVKLLGCCIHGEEK--LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGL 499
+VK G + L+ E++P+ L F+ Q LD S+ +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG--- 556
YL R +HRDL A N+L++ + + KI+DFGLA+ D+ VV G
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY----YVVREPGQSP 193
Query: 557 --YMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEG 613
+ APE SD FS +SDV+SFG++L E+ + K+ +
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS-------------------CSPS 234
Query: 614 MPSQLIDACFKDSFNLAEVIRCIHIG-----------------LLCVQQYPEDRPCMPSV 656
+ C +D L+ ++ + G LC P+DRP ++
Sbjct: 235 AEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294
Query: 657 ILMLGSEIVLPQPKQPGYLADRKSTRLDSSLSMPESSS 694
L + + + + PE
Sbjct: 295 GPQLDM-----------LWSGSRGCETHAFTAHPEGKH 321
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-44
Identities = 70/202 (34%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
++ + KKLG G FG V+ T ++AVK + K ++ E + LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
KL E +I EFM SL F+ E K A G+ ++
Sbjct: 247 KLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY--MAPEYAS 564
+ IHRDL+A+N+L+ + KI+DFGLAR +E T R + APE +
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAIN 358
Query: 565 DGQFSVKSDVFSFGILLLEIVS 586
G F++KSDV+SFGILL+EIV+
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVT 380
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 5e-44
Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQE-----IAVKRLSK-ISEQGLKELKNEIILFSKL 440
F K LG G FG VYKG E E +A+K L + S + KE+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 441 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLL 500
+ ++ +LLG C+ LI + MP L ++ +E + + A+G+
Sbjct: 75 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 501 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG---- 556
YL R++HRDL A NVL+ + KI+DFGLA+ G +E E + G
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPI 183
Query: 557 -YMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKK 589
+MA E ++ +SDV+S+G+ + E+++ G K
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 6e-44
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 33/217 (15%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL----ADEQEIAVKRL-SKISEQGLKELKNEIILFSKLQ 441
I K +G G G V G L + +A+K L + +E+ ++ +E + +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLY 501
H N+++L G G +++ E+M N SLD+F+ + + ++ G G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY---- 557
L S L +HRDL A NVL+D ++ K+SDFGL+R D
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTT 212
Query: 558 --------MAPEYASDGQFSVKSDVFSFGILLLEIVS 586
APE + FS SDV+SFG+++ E+++
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 8e-44
Identities = 64/213 (30%), Positives = 90/213 (42%), Gaps = 24/213 (11%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQE-----IAVKRL-SKISEQGLKELKNEIILFSKL 440
+ LGEG FG V + +AVK L + Q K EI + L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 441 QHRNLVKLLGCCIHGEEK--LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARG 498
H +++K GCC L+ E++P SL ++ + ++ G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG-- 556
+ YLH IHRDL A NVLLD D KI DFGLA+A V G
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY----YRVREDGDS 199
Query: 557 ---YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+ APE + +F SDV+SFG+ L E+++
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-43
Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 7/201 (3%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL 445
+ ++ KLG G +G VY+G +AVK L K ++E E + +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD 505
V+LLG C +I EFM +L ++ + R + + ++ + + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYL--- 334
Query: 506 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD 565
+ IHR+L A N L+ ++ K++DFGL+R GD + + APE +
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393
Query: 566 GQFSVKSDVFSFGILLLEIVS 586
+FS+KSDV++FG+LL EI +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 391 INKKLGEGGFGPVYKGTLAD----EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNL 445
++ +G+G FG VY G D + A+K LS+I Q ++ E +L L H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 446 VKLLGCCIHGEE-KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ 504
+ L+G + E ++ +M + L FI + + ARG+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYL-- 140
Query: 505 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG------YM 558
+ + +HRDL A N +LD+ K++DFGLAR D + V +
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLAR----DILDREYYSVQQHRHARLPVKWT 195
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVS 586
A E +F+ KSDV+SFG+LL E+++
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
+ + +G+G FG V G ++AVK + + + E + ++L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRG-NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77
Query: 447 KLLGCCIHGEEKLLI-YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD 505
+LLG + + L I E+M SL ++ + R +L + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 506 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG------YMA 559
+HRDL A NVL+ +D K+SDFGL + + + + A
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASST-------QDTGKLPVKWTA 182
Query: 560 PEYASDGQFSVKSDVFSFGILLLEIVS 586
PE + +FS KSDV+SFGILL EI S
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 66/223 (29%), Positives = 101/223 (45%), Gaps = 34/223 (15%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL---ADEQEIAVKRL-SKISEQGLKELKNEIILFSKL-Q 441
++ +GEG FG V K + + A+KR+ S+ ++ E+ + KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSF-------------IFDQERCKLLDWSKR 488
H N++ LLG C H L E+ P+ +L F L +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 489 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 548
H ARG+ YL S+ + IHRDL A N+L+ ++ KI+DFGL+R G + T
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 199
Query: 549 N-----RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
R +MA E + ++ SDV+S+G+LL EIVS
Sbjct: 200 MGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 390 SINKKLGEGGFGPVYKGTLAD----EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRN 444
N+ +G G FG VY GTL D + AVK L++I + + E I+ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 445 LVKLLGCCIHGEEKLL-IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH 503
++ LLG C+ E L + +M + L +FI + A+G+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL- 208
Query: 504 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG------Y 557
+ + +HRDL A N +LD+ K++DFGLAR D + + V G +
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKW 262
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVS 586
MA E +F+ KSDV+SFG+LL E+++
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 68/296 (22%), Positives = 111/296 (37%), Gaps = 59/296 (19%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQE-----IAVKRL-SKISEQGLKELKNEIILFSKL 440
+ LGEG FG V E + +AVK L + + +LK EI + L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 441 QHRNLVKLLGCCIHGEEK--LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARG 498
H N+VK G C LI EF+P+ SL ++ + ++ ++ +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG-- 556
+ YL + +HRDL A NVL++ + KI DFGL +A D+ V
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY----YTVKDDRDS 191
Query: 557 ---YMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNE 612
+ APE +F + SDV+SFG+ L E+++ + + + L +
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS------SPMALFLKMIGPTHG 245
Query: 613 GMPSQLIDACFKDSFNLAEVIRCIHIG-----------------LLCVQQYPEDRP 651
M ++ + G C + P +R
Sbjct: 246 QMTVT-------------RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRT 288
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 70/233 (30%), Positives = 106/233 (45%), Gaps = 41/233 (17%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSKI-SEQGLKELKNEIILFSK 439
N + K LGEG FG V K T +AVK L + S L++L +E + +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSF-------------IFDQERCKLLDWS 486
+ H +++KL G C LLI E+ SL F LD
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 487 KRFHIICGT--------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538
+ G ++G+ YL + ++++HRDL A N+L+ + KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR- 198
Query: 539 FGGDETEGNTNRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
D E ++ + G +MA E D ++ +SDV+SFG+LL EIV+
Sbjct: 199 ---DVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 27/219 (12%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD----EQEIAVKRLSK--ISEQGLKELKNEIILFSKL 440
+ + K LGEG FG V +G L ++AVK + S++ ++E +E
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 441 QHRNLVKLLGCCIHGE-----EKLLIYEFMPNKSLDSFI---FDQERCKLLDWSKRFHII 492
H N+++LLG CI + ++I FM L +++ + K + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 552
A G+ YL S +HRDL A N +L DM ++DFGL++ G+ R
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYR-Q 205
Query: 553 GTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
G ++A E +D ++ KSDV++FG+ + EI +
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 36/228 (15%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD--------EQEIAVKRLSKI-SEQGLKELKNEIILF 437
D ++ K LGEG FG V +AVK L +E+ L +L +E+ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 438 SKL-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSF-------------IFDQERCKLL 483
+ +H+N++ LLG C +I E+ +L + ++ + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 484 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543
+ ARG+ YL + + IHRDL A NVL+ ++ KI+DFGLAR D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 207
Query: 544 TEGNTNRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+ + T G +MAPE D ++ +SDV+SFG+L+ EI +
Sbjct: 208 NNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-43
Identities = 67/219 (30%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL------ADEQEIAVKRLSKI-SEQGLKELKNEIILFSK 439
N ++ + LG G FG VY+G + ++AVK L ++ SEQ + E ++ SK
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI----FDQERCKLLDWSKRFHIICGT 495
H+N+V+ +G + + ++ E M L SF+ + L H+
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTNRVV 552
A G YL IHRD+ A N LL KI DFG+AR D + R
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYR-K 201
Query: 553 GTYGY-----MAPEYASDGQFSVKSDVFSFGILLLEIVS 586
G M PE +G F+ K+D +SFG+LL EI S
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 5e-43
Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
+ + +G+G FG V G ++AVK + + + E + ++L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRG-NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249
Query: 447 KLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD 505
+LLG + + L ++ E+M SL ++ + R +L + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 506 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY--MAPEYA 563
+HRDL A NVL+ +D K+SDFGL + E ++ + G APE
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEAL 358
Query: 564 SDGQFSVKSDVFSFGILLLEIVS 586
+ +FS KSDV+SFGILL EI S
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYS 381
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-43
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 33/225 (14%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSKI-SEQGLKELKNEIILFSK 439
++LGE FG VYKG L Q +A+K L +E ++E +L ++
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSF-------------IFDQERCKLLDWS 486
LQH N+V LLG + +I+ + + L F D+ L+
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 487 KRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546
H++ A G+ YL S ++H+DL NVL+ +N KISD GL R +
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAA 181
Query: 547 NTNRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+ + + +MAPE G+FS+ SD++S+G++L E+ S
Sbjct: 182 DYYK-LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-43
Identities = 83/341 (24%), Positives = 143/341 (41%), Gaps = 72/341 (21%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL----ADEQEIAVKRLSK-ISEQGLKELKNEIILFSKLQ 441
N SI+K +G G FG V G L E +A+K L +E+ ++ E + +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLY 501
H N+++L G + +++ E+M N SLDSF+ ++ + ++ G A G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG----- 556
L S + +HRDL A N+L++ ++ K+SDFGL R D T G
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA-----AYTTRGGKIPI 214
Query: 557 -YMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGM 614
+ +PE + +F+ SDV+S+GI+L E++S G++ Y M
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP---Y-----------------WEM 254
Query: 615 PSQLIDACFKDSFNLAEVIRCIHIG-----------------LLCVQQYPEDRPCMPSVI 657
+Q +VI+ + G L C Q+ +RP ++
Sbjct: 255 SNQ-------------DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 658 LMLGSEIVLPQPKQPGYLADRKSTRLDSSLSMPESSSTNTI 698
+L I P + A + + L S + ++ T
Sbjct: 302 SILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTT 342
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-43
Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQE-----IAVKRL-SKISEQGLKELKNEIILFSKL 440
K LG G FG V+KG E E + +K + K Q + + + ++ L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 441 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERC----KLLDWSKRFHIICGTA 496
H ++V+LLG C G L+ +++P SL + LL+W A
Sbjct: 73 DHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG------VQIA 125
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
+G+ YL ++HR+L A NVLL +++DFG+A D+ + ++ +
Sbjct: 126 KGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ-----LLYSEA 177
Query: 557 -----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+MA E G+++ +SDV+S+G+ + E+++
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-43
Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD----EQEIAVKRLSK--ISEQGLKELKNEIILFSKL 440
F++ + LG+G FG V + L ++AVK L I+ ++E E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 441 QHRNLVKLLGCCIHGEEK------LLIYEFMPNKSLDSFIFD---QERCKLLDWSKRFHI 491
H ++ KL+G + K ++I FM + L +F+ E L
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 492 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 551
+ A G+ YL S IHRDL A N +L +DM ++DFGL+R G+ R
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYR- 194
Query: 552 VGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
G ++A E +D ++V SDV++FG+ + EI++
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-43
Identities = 67/219 (30%), Positives = 97/219 (44%), Gaps = 27/219 (12%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL------ADEQEIAVKRLSKI-SEQGLKELKNEIILFSK 439
N ++ + LG G FG VY+G + ++AVK L ++ SEQ + E ++ SK
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI----FDQERCKLLDWSKRFHIICGT 495
H+N+V+ +G + + ++ E M L SF+ + L H+
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTNRVV 552
A G YL IHRD+ A N LL KI DFG+AR D R
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYR-K 242
Query: 553 GTYGY-----MAPEYASDGQFSVKSDVFSFGILLLEIVS 586
G M PE +G F+ K+D +SFG+LL EI S
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 8e-43
Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 14/208 (6%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL-----ADEQEIAVKRLSK-ISEQGLKELKNEIILFSKL 440
+ K +G G FG VYKG L E +A+K L +E+ + E + +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 441 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLL 500
H N+++L G + ++I E+M N +LD F+ +E+ + ++ G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 501 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY--M 558
YL + + +HRDL A N+L++ ++ K+SDFGL+R D+ E G
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWT 217
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVS 586
APE S +F+ SDV+SFGI++ E+++
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 36/228 (15%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD--------EQEIAVKRL-SKISEQGLKELKNEIILF 437
D ++ K LGEG FG V +AVK L +E+ L +L +E+ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 438 SKL-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSF-------------IFDQERCKLL 483
+ +H+N++ LLG C +I E+ +L + ++ + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 484 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543
+ ARG+ YL + + IHRDL A NVL+ ++ KI+DFGLAR D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 253
Query: 544 TEGNTNRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+ + T G +MAPE D ++ +SDV+SFG+L+ EI +
Sbjct: 254 NNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 41/233 (17%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSKI-SEQGLKELKNEIILFSK 439
+N + +GEG FG V++ +AVK L + S + + E L ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSF---------------------IFDQE 478
+ N+VKLLG C G+ L++E+M L+ F
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 479 RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538
L +++ I A G+ YL S + +HRDL N L+ ++M KI+DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR- 222
Query: 539 FGGDETEGNTNRVVGTYGY-----MAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+ + + M PE +++ +SDV+++G++L EI S
Sbjct: 223 ---NIYSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-42
Identities = 64/200 (32%), Positives = 103/200 (51%), Gaps = 7/200 (3%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
++ + KLG+G FG V+ GT +A+K L K + E + KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+L E ++ E+M SL F+ + K L + + A G+ Y+
Sbjct: 243 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYV---E 297
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 566
R+ +HRDL+A+N+L+ +++ K++DFGLAR +E + APE A G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356
Query: 567 QFSVKSDVFSFGILLLEIVS 586
+F++KSDV+SFGILL E+ +
Sbjct: 357 RFTIKSDVWSFGILLTELTT 376
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-42
Identities = 66/229 (28%), Positives = 93/229 (40%), Gaps = 38/229 (16%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSKI-SEQGLKELKNEIILFSK 439
+ S K LG G FG V + T +AVK L + L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 440 L-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSF---------------IFDQERCKLL 483
L H N+V LLG C G L+I E+ L +F ++ L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 484 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGD 542
D A+G+ +L + IHRDL A N+LL KI DFGLAR
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 543 ETEGNTN-----RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
N + +MAPE + ++ +SDV+S+GI L E+ S
Sbjct: 200 NYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQE-----IAVKRL-SKISEQGLKELKNEIILFSKL 440
F K LG G FG VYKG E E +A+K L S + KE+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 441 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLL 500
+ ++ +LLG C+ LI + MP L ++ +E + + A+G+
Sbjct: 75 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 501 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG---- 556
YL R++HRDL A NVL+ + KI+DFGLA+ G +E E + G
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPI 183
Query: 557 -YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+MA E ++ +SDV+S+G+ + E+++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 3e-42
Identities = 64/200 (32%), Positives = 103/200 (51%), Gaps = 7/200 (3%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
++ + KLG+G FG V+ GT +A+K L K + E + KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+L E ++ E+M SL F+ + K L + + A G+ Y+
Sbjct: 326 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYV---E 380
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 566
R+ +HRDL+A+N+L+ +++ K++DFGLAR +E + APE A G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439
Query: 567 QFSVKSDVFSFGILLLEIVS 586
+F++KSDV+SFGILL E+ +
Sbjct: 440 RFTIKSDVWSFGILLTELTT 459
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 75/224 (33%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRL-SKISEQGLKELKNEIILFSK 439
+N K LG G FG V + T ++AVK L S + L +E+ + S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 440 L-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKR---------- 488
L QH N+V LLG C HG L+I E+ L +F+ + R D +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 489 -FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547
H A+G+ +L + IHRD+ A NVLL KI DFGLAR D +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDS 218
Query: 548 TNRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
V +MAPE D ++V+SDV+S+GILL EI S
Sbjct: 219 NYI-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-42
Identities = 55/268 (20%), Positives = 120/268 (44%), Gaps = 25/268 (9%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVK--RLSKISEQGLKELKNEIILFSKLQHR 443
+ + +K+GEG FG D ++ +K +S++S + +E + E+ + + ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 444 NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH 503
N+V+ ++ ++ L I + ++ L + L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 504 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 563
+I+HRD+K+ N+ L +D ++ DFG+AR +GT Y++PE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 564 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623
+ ++ KSD+++ G +L E+ + K + + + NL+ K+ + P + +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA---FEAGSMKNLVL---KIISGSFPP--VSLHY 249
Query: 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
S++L ++ ++ P DRP
Sbjct: 250 --SYDLRSLVS------QLFKRNPRDRP 269
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-42
Identities = 50/222 (22%), Positives = 95/222 (42%), Gaps = 38/222 (17%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL--------ADEQEIAVKRLSKISEQGLKELKNEIILFS 438
++ N+ LG+G F ++KG E E+ +K L K + + S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 439 KLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARG 498
KL H++LV G C+ G+E +L+ EF+ SLD+++ ++ ++ + + A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNP--------KISDFGLARAFGGDETEGNTNR 550
+ +L +IH ++ A N+LL ++ + K+SD G++ +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 551 VVGTYGY-----MAPEYASDG-QFSVKSDVFSFGILLLEIVS 586
+ PE + ++ +D +SFG L EI S
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 8e-42
Identities = 69/288 (23%), Positives = 120/288 (41%), Gaps = 49/288 (17%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL 445
+F + +G GGFG V+K D + +KR+ +E + + E+ +KL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66
Query: 446 VKLLGC---------------CIHGEEKLLIY-EFMPNKSLDSFIFDQERCKLLDWSKRF 489
V GC + L I EF +L+ +I ++ R + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 490 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 549
+ +G+ Y+H ++I+RDLK SN+ L KI DFGL + + +G
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRT 179
Query: 550 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKL 609
R GT YM+PE S + + D+++ G++L E++ + + +R
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--AFETSKFFTDLRD---- 233
Query: 610 WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI 657
+I F +++ LL + PEDRP ++
Sbjct: 234 -------GIISDIF--DKKEKTLLQ----KLLSKK--PEDRPNTSEIL 266
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 9e-42
Identities = 63/227 (27%), Positives = 97/227 (42%), Gaps = 35/227 (15%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRL-SKISEQGLKELKNEIILFSK 439
D + K LG G FG V + + +AVK L + + L +E+ +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 440 L-QHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGT-- 495
+ H N+V LLG C L +I EF +L +++ + + +
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 496 -----------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544
A+G+ +L + + IHRDL A N+LL + KI DFGLAR D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIY 199
Query: 545 EGNTNRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+ +MAPE D ++++SDV+SFG+LL EI S
Sbjct: 200 KDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 9e-42
Identities = 69/233 (29%), Positives = 102/233 (43%), Gaps = 41/233 (17%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRL-SKISEQGLKELKNEIILFSK 439
+N K LG G FG V T ++AVK L K + L +E+ + ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 440 L-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSF-----------IFDQERCKLLDWSK 487
L H N+V LLG C LI+E+ L ++ + E K L+ +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 488 RFHIICGT---------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538
+++ A+G+ +L +HRDL A NVL+ KI DFGLAR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR- 220
Query: 539 FGGDETEGNTNRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
D + V +MAPE +G +++KSDV+S+GILL EI S
Sbjct: 221 ---DIMSDSNYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 70/229 (30%), Positives = 106/229 (46%), Gaps = 38/229 (16%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD--------EQEIAVKRLSKI-SEQGLKELKNEIILF 437
D + K LGEG FG V ++AVK L +E+ L +L +E+ +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 438 SKL-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGT- 495
+ +H+N++ LLG C +I E+ +L ++ R L++S
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQ 187
Query: 496 -------------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542
ARG+ YL + + IHRDL A NVL+ +D KI+DFGLAR D
Sbjct: 188 LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----D 240
Query: 543 ETEGNTNRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+ + T G +MAPE D ++ +SDV+SFG+LL EI +
Sbjct: 241 IHHIDYYK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 58/214 (27%), Positives = 87/214 (40%), Gaps = 26/214 (12%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL----ADEQEIAVKRL---SKISEQGLKELKNEIILFSK 439
+ + +KLG+G FG V +G +AVK L + + + E+
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQER----CKLLDWSKRFHIICGT 495
L HRNL++L G + ++ E P SL + + L ++
Sbjct: 78 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA------VQV 130
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT- 554
A G+ YL R IHRDL A N+LL KI DFGL RA ++
Sbjct: 131 AEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRK 185
Query: 555 --YGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+ + APE FS SD + FG+ L E+ +
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-41
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 22/210 (10%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD----EQEIAVKRLSK-ISEQGLKELKNEIILFSKLQ 441
+ + + +GEG FG V++G +A+K S+ ++ E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLY 501
H ++VKL+G +I E L SF+ Q R LD + + L Y
Sbjct: 75 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG----- 556
L R +HRD+ A NVL+ + K+ DFGL+R + G
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIK 182
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+MAPE + +F+ SDV+ FG+ + EI+
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 65/289 (22%), Positives = 113/289 (39%), Gaps = 45/289 (15%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLS-KISEQGLKELKNEIILFSKLQHRN 444
+F + LG GGFG V++ D+ A+KR+ E +++ E+ +KL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 445 LVKLLGCCIHGEE---------KLLIY---EFMPNKSLDSFIFDQERCKLLDWSKRFHII 492
+V+ + K+ +Y + ++L ++ + + + S HI
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV- 551
A + +LH ++HRDLK SN+ D K+ DFGL A DE E
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 552 ---------VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNL 602
VGT YM+PE +S K D+FS G++L E++ F ++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPFSTQMERVRT 236
Query: 603 IRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
+ L + +++ +L P +RP
Sbjct: 237 LTDV----RNLKFPPLFTQKYPC---EYVMVQ----DMLSPS--PMERP 272
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-41
Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL----ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQ 441
++ +N+ LGEG FG VY+G ++ +AVK K + ++ +E ++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLY 501
H ++VKL+G E +I E P L ++ + L + + Y
Sbjct: 72 HPHIVKLIGIIE-EEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYM 558
L + +HRD+ N+L+ K+ DFGL+R ++ + T +M
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY----KASVTRLPIKWM 181
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVS 586
+PE + +F+ SDV+ F + + EI+S
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-41
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 33/212 (15%)
Query: 391 INKKLGEGGFGPVYKGTL---ADEQEIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLV 446
+ +LG G FG V +G + ++A+K L + + +E+ E + +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+L+G C E +L+ E L F+ + + + S ++ + G+ YL
Sbjct: 74 RLIGVCQ-AEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY--------- 557
+HRDL A NVLL KISDFGL++A G D++ Y
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-----------YTARSAGKWP 176
Query: 558 ---MAPEYASDGQFSVKSDVFSFGILLLEIVS 586
APE + +FS +SDV+S+G+ + E +S
Sbjct: 177 LKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 392 NKKLGEGGFGPVYKGTL---ADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLV 446
+K+LG G FG V KG + +AVK L EL E + +L + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+++G C E +L+ E L+ ++ ++ + + ++ + G+ YL
Sbjct: 82 RMIGICE-AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---E 134
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG------YMAP 560
+HRDL A NVLL KISDFGL++A DE + AP
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAP 189
Query: 561 EYASDGQFSVKSDVFSFGILLLEIVS 586
E + +FS KSDV+SFG+L+ E S
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 61/269 (22%), Positives = 117/269 (43%), Gaps = 31/269 (11%)
Query: 391 INKKLGEGGFGPVYKGTLADE-QEIAVK--RLSKISEQGLKELKNEIILFSKLQHRNLVK 447
+ ++G G F VYKG + E+A + K+++ + K E + LQH N+V+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 448 LLGCCIH---GEEKLLIY-EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH 503
G++ +++ E M + +L +++ +R K++ +GL +LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 504 QDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562
+ IIHRDLK N+ + + KI D GLA + V+GT +MAPE
Sbjct: 147 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEM 201
Query: 563 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622
+ + DV++FG+ +LE+ + + + ++ ++ G+ D
Sbjct: 202 YEEK-YDESVDVYAFGMCMLEMATSE------YPYSECQNAAQIYRRVTSGVKPASFDKV 254
Query: 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
+ E+I C++Q ++R
Sbjct: 255 A--IPEVKEIIE------GCIRQNKDERY 275
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 8e-40
Identities = 71/272 (26%), Positives = 119/272 (43%), Gaps = 27/272 (9%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRL---SKISEQGLKELKNEIILFSKLQH 442
NF I KK+G G F VY+ L D +A+K++ + + + EI L +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 443 RNLVKLLGCCIHGEEKLLIY-EFMPNKSLDSFIFDQ-ERCKLLDWSKRFHIICGTARGLL 500
N++K I + +L I E L I ++ +L+ + L
Sbjct: 92 PNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 501 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 560
++H R++HRD+K +NV + K+ D GL R F T ++ +VGT YM+P
Sbjct: 151 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSP 205
Query: 561 EYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY-HSDNKLNLIRHAWKLWNEGMPSQLI 619
E + ++ KSD++S G LL E+ + + FY N +L + + L
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMNLYSLCKKI----EQCDYPPLP 259
Query: 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
+ S L +++ +C+ PE RP
Sbjct: 260 SDHY--SEELRQLVN------MCINPDPEKRP 283
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 66/307 (21%), Positives = 119/307 (38%), Gaps = 46/307 (14%)
Query: 388 NFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
++ +KLGEGGF V L D A+KR+ +Q +E + E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 447 KLLGCCI----HGEEKLLIYEFMPNKSLDSFIFD-QERCKLLDWSKRFHIICGTARGLLY 501
+L+ C+ E L+ F +L + I +++ L + ++ G RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV-------GT 554
+H HRDLK +N+LL + P + D G + T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 555 YGYMAPE------YASDGQFSVKSDVFSFGILLLEIVSGKK--NRGFYHSDNKLNLIRHA 606
Y APE + + ++DV+S G +L ++ G+ + F D+ +++
Sbjct: 207 ISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263
Query: 607 WKL-WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665
+ + S L ++ ++ V P RP +P ++ L +
Sbjct: 264 LSIPQSPRHSSALWQ-----------LLN----SMMTVD--PHQRPHIPLLLSQL-EALQ 305
Query: 666 LPQPKQP 672
P P Q
Sbjct: 306 PPAPGQH 312
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-39
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 10/210 (4%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVK--RLSKISEQGLKELKNEIILFSKLQHR 443
+++ + +G G +G K +D + + K ++E + L +E+ L +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 444 NLVKLLGCCIHGEEKLL--IYEFMPNKSLDSFIFDQERCK-LLDWSKRFHIICGTARGLL 500
N+V+ I L + E+ L S I + + LD ++ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 501 YLHQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
H+ D ++HRDLK +NV LD N K+ DFGLAR D + T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVSGK 588
+PE + ++ KSD++S G LL E+ +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 1e-38
Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 391 INKKLGEGGFGPVYKGTLADEQE---IAVKRL-SKISEQGLKELKNEIILFSKLQHRNLV 446
+ +LG G FG V +G ++ +A+K L + +E+ E + +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+L+G C E +L+ E L F+ + + + S ++ + G+ YL
Sbjct: 400 RLIGVCQ-AEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMAPEYA 563
+HR+L A NVLL KISDFGL++A G D++ + APE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECI 511
Query: 564 SDGQFSVKSDVFSFGILLLEIVS 586
+ +FS +SDV+S+G+ + E +S
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALS 534
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-38
Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD----EQEIAVKRL-SKISEQGLKELKNEIILFSKLQ 441
+ + + +GEG FG V++G +A+K + S+ ++ E + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLY 501
H ++VKL+G +I E L SF+ Q R LD + + L Y
Sbjct: 450 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 561
L R +HRD+ A NVL+ + K+ DFGL+R + + +MAPE
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPE 562
Query: 562 YASDGQFSVKSDVFSFGILLLEIVS 586
+ +F+ SDV+ FG+ + EI+
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILM 587
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 25/233 (10%)
Query: 388 NFSINKKLGEGGFGPVYKGTLADEQEIAVKR--LSKISEQGLKELKNEIILFSKLQHRNL 445
+SI K++G GG V++ +Q A+K L + Q L +NEI +KLQ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 446 --VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH 503
++L I + ++ E N L+S++ ++ +D +R + +H
Sbjct: 89 KIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIH 144
Query: 504 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-- 561
Q I+H DLK +N L+ D K+ DFG+A D T + VGT YM PE
Sbjct: 145 Q---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 562 ---------YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRH 605
S + S KSDV+S G +L + GK F N+++ +
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKLHA 251
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 72/299 (24%), Positives = 121/299 (40%), Gaps = 60/299 (20%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRN 444
+F LG+G FG V K D + A+K++ +E+ L + +E++L + L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 445 LVKLLGC----------CIHGEEKLLIY---EFMPNKSLDSFIFDQ----ERCKLLDWSK 487
+V+ ++K ++ E+ N +L I + +R +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL-- 121
Query: 488 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF-------- 539
F I L Y+H IIHRDLK N+ +D+ N KI DFGLA+
Sbjct: 122 -FRQIL---EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 540 ----GGDETEGNTNRVVGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 594
+ N +GT Y+A E G ++ K D++S GI+ E++ F
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-----PFS 229
Query: 595 HSDNKLNLIRHAWKLWNE--GMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
++N+++ KL + P D K ++IR L+ P RP
Sbjct: 230 TGMERVNILK---KLRSVSIEFPPDFDDNKMKV---EKKIIRL----LIDHD--PNKRP 276
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 393 KKLGEGGFGPVYKGTLADEQE-IAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGC 451
LG+G +G VY G Q IA+K + + + + L EI L L+H+N+V+ LG
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 452 CIHGEEKLLIY-EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTAR----GLLYLHQDS 506
+ I+ E +P SL + + + + L ++ I + GL YLH +
Sbjct: 88 FSE-NGFIKIFMEQVPGGSLSALL--RSKWGPLKDNE--QTIGFYTKQILEGLKYLHDN- 141
Query: 507 RLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE--YA 563
+I+HRD+K NVL++ KISDFG ++ G T GT YMAPE
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDK 197
Query: 564 SDGQFSVKSDVFSFGILLLEIVSGK 588
+ +D++S G ++E+ +GK
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGK 222
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-37
Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 25/233 (10%)
Query: 388 NFSINKKLGEGGFGPVYKGTLADEQEIAVKR--LSKISEQGLKELKNEIILFSKLQHRNL 445
+SI K++G GG V++ +Q A+K L + Q L +NEI +KLQ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 446 --VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH 503
++L I + ++ E N L+S++ ++ +D +R + +H
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIH 172
Query: 504 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-- 561
Q I+H DLK +N L+ D K+ DFG+A D T + VG YM PE
Sbjct: 173 Q---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 562 ---------YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRH 605
S + S KSDV+S G +L + GK F N+++ +
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHA 279
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 25/233 (10%)
Query: 388 NFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNL 445
+SI K++G GG V++ +Q A+K ++ Q L +NEI +KLQ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 446 --VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH 503
++L I + ++ E N L+S++ ++ +D +R + +H
Sbjct: 70 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIH 125
Query: 504 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-- 561
Q I+H DLK +N L+ D K+ DFG+A D T + VGT YM PE
Sbjct: 126 Q---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 562 ---------YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRH 605
S + S KSDV+S G +L + GK F N+++ +
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKLHA 232
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 67/214 (31%), Positives = 110/214 (51%), Gaps = 10/214 (4%)
Query: 376 LFELATIANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEI 434
L E + + F + +KLGEG +G VYK Q +A+K++ E L+E+ EI
Sbjct: 18 LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEI 75
Query: 435 ILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICG 494
+ + ++VK G + ++ E+ S+ I + R K L + I+
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQS 133
Query: 495 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 554
T +GL YLH R IHRD+KA N+LL+ + + K++DFG+A +T N V+GT
Sbjct: 134 TLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDTMAKRNTVIGT 188
Query: 555 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
+MAPE + ++ +D++S GI +E+ GK
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 55/217 (25%), Positives = 116/217 (53%), Gaps = 16/217 (7%)
Query: 376 LFELATIANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEI 434
L + ++ + ++ +K+G+G G VY +A QE+A+++++ + + + NEI
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 435 ILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI--I 492
++ + ++ N+V L + G+E ++ E++ SL + + I +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCM----DEGQIAAV 121
Query: 493 C-GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 551
C + L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ +T +
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--M 176
Query: 552 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
VGT +MAPE + + K D++S GI+ +E++ G+
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 63/269 (23%), Positives = 97/269 (36%), Gaps = 32/269 (11%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--ISEQGLKELKNEIILFSKL-QH 442
+F +LG G +G V+K D + AVKR + E+ K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL 502
V+L G L E SL + L ++ + + T L +L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562
H ++H D+K +N+ L K+ DFGL G T G G YMAPE
Sbjct: 174 HS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPE- 226
Query: 563 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622
G + +DVFS G+ +LE+ + H +R + L
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNME---LPHGGEGWQQLRQ--GYLPPEFTAGL---- 277
Query: 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
S L V+ + ++ P+ R
Sbjct: 278 ---SSELRSVLV------MMLEPDPKLRA 297
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 60/258 (23%), Positives = 102/258 (39%), Gaps = 30/258 (11%)
Query: 339 KSRRNIVVNIARYFRENRNNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEG 398
K+ + + R E +N G + + +D + + ++G G
Sbjct: 18 KTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYE--------YREEVHWMTHQPRVGRG 69
Query: 399 GFGPVYKGTLADEQE-IAVK--RLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG 455
FG V++ AVK RL + E++ + L +V L G G
Sbjct: 70 SFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREG 122
Query: 456 EEKLLIY-EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRD 514
+ I+ E + SL I ++ L + + + GL YLH RI+H D
Sbjct: 123 -PWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGD 175
Query: 515 LKASNVLLDQDMNP-KISDFGLAR---AFGGDETEGNTNRVVGTYGYMAPEYASDGQFSV 570
+KA NVLL D + + DFG A G ++ + + GT +MAPE
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235
Query: 571 KSDVFSFGILLLEIVSGK 588
K D++S ++L +++G
Sbjct: 236 KVDIWSSCCMMLHMLNGC 253
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 61/239 (25%), Positives = 108/239 (45%), Gaps = 16/239 (6%)
Query: 354 ENRNNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADEQ 412
+ Q + L + + K+GEG G V +
Sbjct: 12 DLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGR 71
Query: 413 EIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDS 472
++AVK + +Q + L NE+++ QH N+V++ + GEE ++ EF+ +L
Sbjct: 72 QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD 131
Query: 473 FIFDQERCKLLDWSKRFHI--IC-GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 529
+ + +L I +C + L YLH +IHRD+K+ ++LL D K
Sbjct: 132 IV---SQVRL----NEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVK 181
Query: 530 ISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
+SDFG D + + +VGT +MAPE S ++ + D++S GI+++E+V G+
Sbjct: 182 LSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 13/217 (5%)
Query: 378 ELATIANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIIL 436
+ + + + I +LG+G FG VYK A K + SE+ L++ EI +
Sbjct: 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEI 69
Query: 437 FSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA 496
+ H +VKLLG H + ++ EF P ++D+ + E + L + +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQML 127
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
L +LH RIIHRDLKA NVL+ + + +++DFG++ +T + +GT
Sbjct: 128 EALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKRDSFIGTPY 182
Query: 557 YMAPE-----YASDGQFSVKSDVFSFGILLLEIVSGK 588
+MAPE D + K+D++S GI L+E+ +
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRL-SKISEQGLKELKNEI-ILFSKLQHR 443
D+ +LG G +G V K +I AVKR+ + ++ Q K L ++ I +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 444 NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRF------HIICGTAR 497
V G + + E M + SLD F +++D + I +
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 557
L +LH S+L +IHRD+K SNVL++ K+ DFG++ G + + G Y
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDIDAGCKPY 175
Query: 558 MAPE----YASDGQFSVKSDVFSFGILLLEIVSGK 588
MAPE + +SVKSD++S GI ++E+ +
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-35
Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLS-KISEQGLKELKNEIILFSKLQHRN 444
D+F +LG G G V+K + + A K + +I ++ E+ + +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRF------HIICGTARG 498
+V G E + E M SLD ++L + R + +G
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLD---------QVLKKAGRIPEQILGKVSIAVIKG 143
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
L YL + +I+HRD+K SN+L++ K+ DFG++ ++ N+ VGT YM
Sbjct: 144 LTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--VGTRSYM 197
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVSGK 588
+PE +SV+SD++S G+ L+E+ G+
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 48/222 (21%), Positives = 86/222 (38%), Gaps = 24/222 (10%)
Query: 384 NATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKE-LKNEIILFSKLQ 441
+ + ++ LG+G V++G A+K + IS + E + KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 442 HRNLVKLLGCCIHGEEKLLIY---EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARG 498
H+N+VKL EF P SL + + + L S+ ++ G
Sbjct: 66 HKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 499 LLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGDETEGNTNRVVGT 554
+ +L + I+HR++K N++ D K++DFG AR DE + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGT 178
Query: 555 YGYMAPE--------YASDGQFSVKSDVFSFGILLLEIVSGK 588
Y+ P+ ++ D++S G+ +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--ISEQGLKE-LKNEIILFSKLQH 442
+ + LG+GGF ++ + ++ A K + K + + +E + EI + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 443 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI--ICGTARGL 499
+++V G + + ++ E +SL + R L + R+++ I G
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVL---GC 154
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 559
YLH+ R+IHRDLK N+ L++D+ KI DFGLA D + GT Y+A
Sbjct: 155 QYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIA 209
Query: 560 PEYASDGQFSVKSDVFSFGILLLEIVSGK 588
PE S S + DV+S G ++ ++ GK
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 61/208 (29%), Positives = 110/208 (52%), Gaps = 11/208 (5%)
Query: 383 ANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLS-KISEQGLKELKNEIILFSKL 440
A+ + F+ +K+G+G FG V+KG ++ +A+K + + +E +++++ EI + S+
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 441 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLL 500
+ K G + + +I E++ S D LD ++ I+ +GL
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLD 133
Query: 501 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 560
YLH + + IHRD+KA+NVLL + K++DFG+A +T+ N VGT +MAP
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAP 188
Query: 561 EYASDGQFSVKSDVFSFGILLLEIVSGK 588
E + K+D++S GI +E+ G+
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--ISEQGLKE-LKNEIILFSKLQH 442
+ + LG+GGF ++ + ++ A K + K + + +E + EI + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 443 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI--ICGTARGL 499
+++V G + + ++ E +SL + R L + R+++ I G
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVL---GC 128
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 559
YLH R R+IHRDLK N+ L++D+ KI DFGLA D + GT Y+A
Sbjct: 129 QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIA 183
Query: 560 PEYASDGQFSVKSDVFSFGILLLEIVSGK 588
PE S S + DV+S G ++ ++ GK
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 59/207 (28%), Positives = 110/207 (53%), Gaps = 13/207 (6%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--ISEQGLKE-LKNEIILFSKLQH 442
++F + LG+G F VY+ + E+A+K + K + + G+ + ++NE+ + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 443 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLY 501
++++L + L+ E N ++ ++ + R K ++ H + G+LY
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLY 127
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 561
LH I+HRDL SN+LL ++MN KI+DFGLA + T + GT Y++PE
Sbjct: 128 LH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPE 182
Query: 562 YASDGQFSVKSDVFSFGILLLEIVSGK 588
A+ ++SDV+S G + ++ G+
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 66/223 (29%), Positives = 106/223 (47%), Gaps = 19/223 (8%)
Query: 373 DLPLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLS---KISEQGLK 428
D + EL + FS +++G G FG VY + + + +A+K++S K S + +
Sbjct: 40 DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 99
Query: 429 ELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKR 488
++ E+ KL+H N ++ GC + L+ E+ + D + K L +
Sbjct: 100 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEI 156
Query: 489 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 548
+ G +GL YLH +IHRD+KA N+LL + K+ DFG A N+
Sbjct: 157 AAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS 209
Query: 549 NRVVGTYGYMAPE---YASDGQFSVKSDVFSFGILLLEIVSGK 588
VGT +MAPE +GQ+ K DV+S GI +E+ K
Sbjct: 210 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRL-SKISEQGLKELKNEI-ILFSKLQHR 443
++ ++G G +G V K +I AVKR+ S + E+ K+L ++ ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 444 NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRF------HIICGTAR 497
+V+ G + + E M + S D F I T +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVL----DDVIPEEILGKITLATVK 136
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 557
L +L L+IIHRD+K SN+LLD+ N K+ DFG++ ++ T G Y
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTR-DAGCRPY 191
Query: 558 MAPE----YASDGQFSVKSDVFSFGILLLEIVSGK 588
MAPE AS + V+SDV+S GI L E+ +G+
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 48/222 (21%), Positives = 86/222 (38%), Gaps = 24/222 (10%)
Query: 384 NATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKE-LKNEIILFSKLQ 441
+ + ++ LG+G V++G A+K + IS + E + KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 442 HRNLVKLLGCCIHGEEKLLIY---EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARG 498
H+N+VKL EF P SL + + + L S+ ++ G
Sbjct: 66 HKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 499 LLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGDETEGNTNRVVGT 554
+ +L + I+HR++K N++ D K++DFG AR DE + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGT 178
Query: 555 YGYMAPE--------YASDGQFSVKSDVFSFGILLLEIVSGK 588
Y+ P+ ++ D++S G+ +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 58/312 (18%), Positives = 113/312 (36%), Gaps = 58/312 (18%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKR--LSKISEQGLKELKNEIILFSKL-Q 441
T F +K+G G FG V+K D A+KR + E+ + L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 442 HRNLVKLLGCCIHGEEKLLIY-EFMPNKSLDSFIFDQER-CKLLDWSKRFHIICGTARGL 499
H ++V+ + +LI E+ SL I + R ++ ++ RGL
Sbjct: 70 HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNP-------------------KISDFGLARAFG 540
Y+H ++H D+K SN+ + + P KI D G
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 541 GDETEGNTNRVVGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK 599
+ E G ++A E + K+D+F+ + ++ + + ++
Sbjct: 186 SPQVE------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP---LPRNGDQ 236
Query: 600 LNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659
+ IR +G ++ S E+++ + + PE R PS + +
Sbjct: 237 WHEIR-------QGRLPRIPQVL---SQEFTELLK------VMIHPDPERR---PSAMAL 277
Query: 660 LGSEIVLPQPKQ 671
+ ++L ++
Sbjct: 278 VKHSVLLSASRK 289
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 68/334 (20%), Positives = 117/334 (35%), Gaps = 90/334 (26%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLS-KISEQGLKELKNEIILFSKLQHRN 444
+F + +G GGFG V++ D+ A+KR+ E +++ E+ +KL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 445 LVKLLGCCIHG----------------------------------EEKLL-------IYE 463
+V+ + + + +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 464 FMPNKSLDSFIFDQ-ERCK---LLDWSKR------------FHIICGTARGLLYLHQDSR 507
+ S +++ Q + C+ L DW R HI A + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182
Query: 508 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN----------RVVGTYGY 557
++HRDLK SN+ D K+ DFGL A DE E VGT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617
M+PE +S K D+FS G++L E++ F ++ +I + N P
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLY-----SFSTQMERVRIIT---DVRNLKFPLL 294
Query: 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
+ +++ + P +RP
Sbjct: 295 FT----QKYPQEHMMVQ------DMLSPSPTERP 318
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 53/223 (23%), Positives = 86/223 (38%), Gaps = 23/223 (10%)
Query: 388 NFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-HRNL 445
+ + L EGGF VY+ + +E A+KRL E+ + + E+ KL H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 446 VKLLGCCI-------HGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARG 498
V+ G+ + L+ + L F+ E L I T R
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR-------- 550
+ ++H+ + IIHRDLK N+LL K+ DFG A + +
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 551 --VVGTYGYMAPE---YASDGQFSVKSDVFSFGILLLEIVSGK 588
T Y PE S+ K D+++ G +L + +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 20/225 (8%)
Query: 377 FELATIANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEII 435
+L+ + + F + + +G G +G VYKG + Q A+K + ++ +E+K EI
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEIN 72
Query: 436 LFSKL-QHRNLVKLLGCCIHG-----EEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKR 488
+ K HRN+ G I +++L L+ EF S+ + + L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWI 131
Query: 489 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 548
+I RGL +LHQ ++IHRD+K NVLL ++ K+ DFG++ D T G
Sbjct: 132 AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRR 186
Query: 549 NRVVGTYGYMAPE-----YASDGQFSVKSDVFSFGILLLEIVSGK 588
N +GT +MAPE D + KSD++S GI +E+ G
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-32
Identities = 59/282 (20%), Positives = 107/282 (37%), Gaps = 38/282 (13%)
Query: 388 NFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLV 446
+F LG G G + + D +++AVKR+ + E+ L + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 447 KLLGCCIHGEEKLLIY---EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH 503
+ +++ Y E +L ++ +++ + ++ T GL +LH
Sbjct: 82 RYFCTE---KDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLH 135
Query: 504 QDSRLRIIHRDLKASNVLL-----DQDMNPKISDFGLARAFGGDETE-GNTNRVVGTYGY 557
L I+HRDLK N+L+ + ISDFGL + + V GT G+
Sbjct: 136 S---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 558 MAPEY---ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM 614
+APE + D+FS G + ++S F S + I +
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS-HPFGKSLQRQANILLGACSLDCLH 251
Query: 615 PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSV 656
P + D ++ +I + P+ RP V
Sbjct: 252 PEKHEDVIARE------LIEK------MIAMDPQKRPSAKHV 281
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 132 bits (332), Expect = 3e-32
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 17/214 (7%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKE-LKNEIILFSKLQHR 443
+ + ++LG GGFG V + +++A+K+ + +E EI + KL H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 444 NLVKLL------GCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTAR 497
N+V + LL E+ L ++ E C L ++ +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTNRVVGT 554
L YLH+ RIIHRDLK N++L Q + KI D G A+ E VGT
Sbjct: 133 ALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGT 186
Query: 555 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
Y+APE +++V D +SFG L E ++G
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADE----QEIAVKRLSK--ISEQGLKE-LKNEIILFSK 439
++F I + LG+G FG VY LA E +A+K L K + + G++ L+ E+ + S
Sbjct: 9 EDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 65
Query: 440 LQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARG 498
L+H N+++L G H ++ LI E+ P ++ + ++ D + I A
Sbjct: 66 LRHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANA 121
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV-GTYGY 557
L Y H R+IHRD+K N+LL KI+DFG + + + GT Y
Sbjct: 122 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV-----HAPSSRRTDLCGTLDY 173
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
+ PE K D++S G+L E + GK
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 37/257 (14%), Positives = 75/257 (29%), Gaps = 25/257 (9%)
Query: 386 TDNFSINKKLGEGGFGPVYKGTLADE------QEIAVKRLSKISEQGLKELKNEIILFSK 439
+ ++ LGEG F VY+ T D Q+ +K + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI--FDQERCKLLDWSKRFHIICGTAR 497
+K + +L+ E +L + I + K++
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLL-----------DQDMNPKISDFGLARAFGGDETEG 546
+ +H IIH D+K N +L D + D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHA 606
T G+ E S+ ++ + D F + ++ G ++
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM--KVKNEGGECKPEGL 298
Query: 607 WK-LWNEGMPSQLIDAC 622
++ L + M ++
Sbjct: 299 FRRLPHLDMWNEFFHVM 315
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 52/246 (21%), Positives = 103/246 (41%), Gaps = 41/246 (16%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADE--QEIAVKRLSK-----------------ISEQGL 427
+++ I + L +G F + L ++ + A+K+ K +
Sbjct: 31 NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 428 KELKNEIILFSKLQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWS 486
+ KNE+ + + +++ + G I +++ +IYE+M N S+ F +++
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYT 145
Query: 487 KRF------HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540
II Y+H + I HRD+K SN+L+D++ K+SDFG +
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM- 202
Query: 541 GDETEGNTNRVVGTYGYMAPE-YASDGQFS-VKSDVFSFGILLLEIVSGKKNRGFYHSDN 598
+ GTY +M PE ++++ ++ K D++S GI L + F +
Sbjct: 203 ---VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP--FSLKIS 257
Query: 599 KLNLIR 604
+ L
Sbjct: 258 LVELFN 263
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 48/210 (22%), Positives = 92/210 (43%), Gaps = 16/210 (7%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRL-SKISEQGLKELKNEI-ILFSKLQHR 443
++ ++G G G V+K IAVK++ +++ K + ++ ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 444 NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH 503
+V+ G I + + E M + + + + + L YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAEKLK--KRMQGPIPERILGKMTVAIVKALYYLK 141
Query: 504 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-- 561
+ +IHRD+K SN+LLD+ K+ DFG++ G + +R G YMAPE
Sbjct: 142 --EKHGVIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKDRSAGCAAYMAPERI 196
Query: 562 ---YASDGQFSVKSDVFSFGILLLEIVSGK 588
+ + +++DV+S GI L+E+ +G+
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 4e-31
Identities = 43/225 (19%), Positives = 80/225 (35%), Gaps = 22/225 (9%)
Query: 379 LATIANATDNFSINKKLGEG--GFGPVYKGT-LADEQEIAVKR--LSKISEQGLKELKNE 433
+++ + + +G+G V + + V+R L S + + L+ E
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 434 IILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI-- 491
+ + H N+V I E ++ FM S I + I
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM----NELAIAY 132
Query: 492 IC-GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-- 548
I G + L Y+H +HR +KAS++L+ D +S +
Sbjct: 133 ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189
Query: 549 ---NRVVGTYGYMAPE--YASDGQFSVKSDVFSFGILLLEIVSGK 588
V +++PE + + KSD++S GI E+ +G
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 14/216 (6%)
Query: 384 NATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLS-KISEQGLKELKNEIILFSKLQ 441
D++ + + +G G V ++++A+KR++ + + + EL EI S+
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSL-----DSFIFDQERCKLLDWSKRFHIICGTA 496
H N+V + +E L+ + + S+ + + +LD S I+
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL-ARAFGGDETEGNTNR--VVG 553
GL YLH++ IHRD+KA N+LL +D + +I+DFG+ A G + N R VG
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 554 TYGYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 588
T +MAPE + K+D++SFGI +E+ +G
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 391 INKKLGEGGFGPVYKGTLADEQ---EIAVKRLS---KISEQGLKELKNEIILFSKLQHRN 444
I KLG GG VY D ++A+K + + E+ LK + E+ S+L H+N
Sbjct: 15 IVDKLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 445 LVKLLGCCIH--GEEKLLIY---EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGL 499
+V + EE Y E++ +L +I L + G+
Sbjct: 73 IVS-----MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGI 124
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 559
+ H +RI+HRD+K N+L+D + KI DFG+A+A + + TN V+GT Y +
Sbjct: 125 KHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFS 180
Query: 560 PEYASDGQFSVKSDVFSFGILLLEIVSGK 588
PE A +D++S GI+L E++ G+
Sbjct: 181 PEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADE----QEIAVKRLSK--ISEQGLKE-LKNEIILFSK 439
D+F I + LG+G FG VY LA E +A+K L K + ++G++ L+ EI + S
Sbjct: 14 DDFDIGRPLGKGKFGNVY---LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 440 LQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARG 498
L+H N++++ H +++ L+ EF P L + Q+ + + + A
Sbjct: 71 LRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSAT-FMEELADA 126
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-TNRVVGTYGY 557
L Y H ++IHRD+K N+L+ KI+DFG + + GT Y
Sbjct: 127 LHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSV-----HAPSLRRRTMCGTLDY 178
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
+ PE K D++ G+L E + G
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 391 INKKLGEGGFGPVYKGTLADEQ---EIAVKRLSK--ISEQGLKE-LKNEIILFSKLQHRN 444
+ + +G GG G VY+ D +A+K +S+ S+ + ++ E +LQ +
Sbjct: 38 LRRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 445 LVKLLGCCIH--GEEKLLIY---EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGL 499
+V IH GE +Y + L + + Q L + I+ L
Sbjct: 96 VVP-----IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSAL 147
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 559
H HRD+K N+L+ D + DFG+A A DE VGT YMA
Sbjct: 148 DAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGTLYYMA 203
Query: 560 PEYASDGQFSVKSDVFSFGILLLEIVSGK 588
PE S+ + ++D+++ +L E ++G
Sbjct: 204 PERFSESHATYRADIYALTCVLYECLTGS 232
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-29
Identities = 68/265 (25%), Positives = 110/265 (41%), Gaps = 42/265 (15%)
Query: 353 RENRNNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADE 411
+ ++ G E ++ +F + + ++ + KKLG G +G V
Sbjct: 3 HHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTH 62
Query: 412 QEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKS 469
E A+K + K +S +L E+ + L H N++KL E+K Y M
Sbjct: 63 VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF---EDKRNYYLVM---- 115
Query: 470 LDSFIFDQERCK---LLDW---SKRF------HIICGTARGLLYLHQDSRLRIIHRDLKA 517
E K L D +F II G+ YLH+ I+HRDLK
Sbjct: 116 --------ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKP 164
Query: 518 SNVLL---DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDV 574
N+LL ++D KI DFGL+ F + +GT Y+APE ++ K DV
Sbjct: 165 ENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPE-VLRKKYDEKCDV 220
Query: 575 FSFGILLLEIVSGKKNRGFYHSDNK 599
+S G++L +++G F ++
Sbjct: 221 WSIGVILFILLAGY--PPFGGQTDQ 243
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 33/314 (10%), Positives = 69/314 (21%), Gaps = 51/314 (16%)
Query: 373 DLPLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK---ISEQGLK 428
+ + ++ + + L G V+ + ++ A+K + S L+
Sbjct: 48 NAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELE 107
Query: 429 ELKNEIILFSKLQHRNLVKLLGCC--------------------------IHGEEKLLIY 462
L ++L + + LL+
Sbjct: 108 RLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLM 167
Query: 463 EFMP---NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 519
+ F + R L ++H N
Sbjct: 168 PAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDN 224
Query: 520 VLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY--ASDGQFSVKSDVFSF 577
+ + D + D G Y E+ AS F+ + +
Sbjct: 225 LFIMPDGRLMLGDVSALWKVGTRGPA-----SSVPVTYAPREFLNASTATFTHALNAWQL 279
Query: 578 GILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIH 637
G+ + + F + L G S +C + +I
Sbjct: 280 GLSIYRVWCLF--LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG--- 334
Query: 638 IGLLCVQQYPEDRP 651
L R
Sbjct: 335 -RFLNFD--RRRRL 345
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 57/229 (24%), Positives = 89/229 (38%), Gaps = 36/229 (15%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEI-ILFSKLQHRNL 445
+ K LG G G V + +AVKR+ EI +L H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 446 VKLLGCCIHGEEKL-LIYEFMPNKSLDSFI----FDQERCKLLDWSKRFHIICGTARGLL 500
++ C + L + E N +L + E KL ++ A G+
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 501 YLHQDSRLRIIHRDLKASNVLLD-------------QDMNPKISDFGLARAFGGDET--E 545
+LH L+IIHRDLK N+L+ +++ ISDFGL + ++
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 546 GNTNRVVGTYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSG 587
N N GT G+ APE + + + D+FS G + I+S
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 49/390 (12%), Positives = 95/390 (24%), Gaps = 70/390 (17%)
Query: 353 RENRNNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADE 411
+ + P + + LG+ + T
Sbjct: 44 TSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETG 103
Query: 412 QEIAVKRLSK---ISEQGLKELKNEIILFSKLQ----------------------HRNLV 446
+ V +K++K E++ L+
Sbjct: 104 ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 163
Query: 447 KLLGCCIHGEEKLLIYEF--MPNKSLDSFIF------DQERCKLLDWSKRFHIICGTARG 498
K++ + + ++ F P + F K L R + R
Sbjct: 164 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 223
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
L LH ++H L+ +++LDQ ++ F G R
Sbjct: 224 LASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD-GASAVSPIGRGFAPPETT 279
Query: 559 APE-----YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG 613
A + D ++ G+ + I
Sbjct: 280 AERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD--LPNTDDA---------------- 321
Query: 614 MPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLPQ--PKQ 671
+ F+ N+ + +R + G L EDR + E + +
Sbjct: 322 -ALGGSEWIFRSCKNIPQPVRALLEGFLRYP--KEDRLLPLQAMETPEYEQLRTELSAAL 378
Query: 672 PGYLADRKSTRLD----SSLSMPESSSTNT 697
P Y D + TR S S P+ +
Sbjct: 379 PLYQTDGEPTREGGAPPSGTSQPDEAGAAE 408
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNEIILFSKLQH 442
++F K LGEG F V A+K L K I E + + E + S+L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 443 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFI-----FDQERCKLLDWSKRFH---IIC 493
VKL +EKL + N L +I FD+ RF+ I+
Sbjct: 90 PFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAEIVS 141
Query: 494 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 553
L YLH IIHRDLK N+LL++DM+ +I+DFG A+ + + N VG
Sbjct: 142 A----LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 554 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
T Y++PE ++ SD+++ G ++ ++V+G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 70/221 (31%), Positives = 114/221 (51%), Gaps = 32/221 (14%)
Query: 384 NATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQG-----LKELKNEIILF 437
+++ F +KLG G + VYKG +A+K + SE+G ++E I L
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLM 57
Query: 438 SKLQHRNLVKLLGCCIHGEEKL-LIYEFMPN--KSLDSFIFDQERCKLLDWSKRFHIICG 494
+L+H N+V+L IH E KL L++EFM N K + L+ + +
Sbjct: 58 KELKHENIVRLY-DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 495 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 554
+GL + H++ +I+HRDLK N+L+++ K+ DFGLARAF G ++ VV T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-T 171
Query: 555 YGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 588
Y AP+ Y++ S+ D++S G +L E+++GK
Sbjct: 172 LWYRAPDVLMGSRTYST----SI--DIWSCGCILAEMITGK 206
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-28
Identities = 63/264 (23%), Positives = 108/264 (40%), Gaps = 51/264 (19%)
Query: 353 RENRNNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADE 411
+ ++ + Q I ++ ++ +++ +KLG G +G V
Sbjct: 2 HHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61
Query: 412 QEIAVKRLSK-------------ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEK 458
E A+K + K E+ +E+ NEI L L H N++KL E+K
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF---EDK 118
Query: 459 LLIYEFMPNKSLDSFIFDQERCK---LLDW---SKRF------HIICGTARGLLYLHQDS 506
Y E + L + +F +I+ G+ YLH+
Sbjct: 119 KYFYLVT------------EFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK-- 164
Query: 507 RLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 563
I+HRD+K N+LL + +N KI DFGL+ F D +GT Y+APE
Sbjct: 165 -HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPE-V 219
Query: 564 SDGQFSVKSDVFSFGILLLEIVSG 587
+++ K DV+S G+++ ++ G
Sbjct: 220 LKKKYNEKCDVWSCGVIMYILLCG 243
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 43/221 (19%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQG-----LKELKNEIILFSKL 440
+ + KLGEG + VYKG + A+K + E+G ++E+ L L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 441 QHRNLVKLLGCCIHGEEKL-LIYEFMPN---KSLDS--FIFDQERCKLLDWSKRFHIICG 494
+H N+V L IH E+ L L++E++ + LD I + KL +
Sbjct: 58 KHANIVTLH-DIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ-------- 108
Query: 495 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 554
RGL Y H+ +++HRDLK N+L+++ K++DFGLARA T+ N VV T
Sbjct: 109 LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-T 163
Query: 555 YGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 588
Y P+ Y S + D++ G + E+ +G+
Sbjct: 164 LWYRPPDILLGSTDY------STQIDMWGVGCIFYEMATGR 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 42/221 (19%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQGLKELKN-----EIILFSKL 440
+ + K+GEG +G V+K D +I A+K K E + EI + +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQL 59
Query: 441 QHRNLVKLLGCCIHGEEKL-LIYEFMPN---KSLDSF--IFDQERCKLLDWSKRFHIICG 494
+H NLV LL + +L L++E+ + LD + + K + W
Sbjct: 60 KHPNLVNLL-EVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ-------- 110
Query: 495 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 554
T + + + H+ IHRD+K N+L+ + K+ DFG AR ++ + V T
Sbjct: 111 TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-T 165
Query: 555 YGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 588
Y +PE Y V DV++ G + E++SG
Sbjct: 166 RWYRSPELLVGDTQYGP----PV--DVWAIGCVFAELLSGV 200
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 72/221 (32%), Positives = 112/221 (50%), Gaps = 43/221 (19%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQ------GLKELKNEIILFSKL 440
+ + +K+GEG +G VYK + + +A+KR+ +E ++E I L +L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIRE----ISLLKEL 76
Query: 441 QHRNLVKLLGCCIHGEEKL-LIYEFMPN---KSLDSF--IFDQERCKLLDWSKRFHIICG 494
H N+V L+ IH E L L++EFM K LD + K+ + +
Sbjct: 77 HHPNIVSLI-DVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIY-----LYQLL- 129
Query: 495 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 554
RG+ + HQ RI+HRDLK N+L++ D K++DFGLARAF G T+ VV T
Sbjct: 130 --RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-T 182
Query: 555 YGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 588
Y AP+ Y++ SV D++S G + E+++GK
Sbjct: 183 LWYRAPDVLMGSKKYST----SV--DIWSIGCIFAEMITGK 217
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 68/221 (30%), Positives = 98/221 (44%), Gaps = 41/221 (18%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK---ISEQGLKELKNEIILFSKLQ 441
+D + + LG+G FG V QE AVK +SK + + L E+ L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCK---LLDW---SKRF------ 489
H N++KL E+K Y E L D KRF
Sbjct: 85 HPNIMKLYEFF---EDKGYFYLVG------------EVYTGGELFDEIISRKRFSEVDAA 129
Query: 490 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEG 546
II G+ Y+H+ +I+HRDLK N+LL +D N +I DFGL+ F +
Sbjct: 130 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-- 184
Query: 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 587
+GT Y+APE G + K DV+S G++L ++SG
Sbjct: 185 -MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 23/211 (10%)
Query: 391 INKKLGEGGFGPVYKGTLADEQ---EIAVK----RLSKISEQGLKELKNEIILFSKLQHR 443
+ + LG GG V+ D + ++AVK L++ + E + L H
Sbjct: 16 LGEILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHP 72
Query: 444 NLVKLL--GCCIHGEEKLLIY---EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARG 498
+V + G L Y E++ +L + + + + +I +
Sbjct: 73 AIVAVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQA 128
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE-TEGNTNRVVGTYGY 557
L + H + IIHRD+K +N+++ K+ DFG+ARA + T V+GT Y
Sbjct: 129 LNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
++PE A +SDV+S G +L E+++G+
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKN-----EIILFSKL 440
+ LGEG F VYK Q +A+K++ K+ N EI L +L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 441 QHRNLVKLLGCCIHGEEKL-LIYEFMPN---KSLDS--FIFDQERCKLLDWSKRFHIICG 494
H N++ LL + + L+++FM + + K
Sbjct: 70 SHPNIIGLLDA-FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM-------- 120
Query: 495 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 554
T +GL YLHQ I+HRDLK +N+LLD++ K++DFGLA++F G T++VV T
Sbjct: 121 TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-T 175
Query: 555 YGYMAPE--YASDGQFSVKSDVFSFGILLLEIVSGK 588
Y APE + + + V D+++ G +L E++
Sbjct: 176 RWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRV 210
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNEIILFSKLQH 442
D F + LG GGFG V+ + ++ A K+L+K +G + E + +K+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 443 RNLVKLLGCCIHGEEKL-LIYEFMP---------NKSLDSFIFDQERCKLLDWSKRF--- 489
R +V L + L L+ M N D+ F + R F
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA-------IFYTA 296
Query: 490 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 549
I+ G L +LHQ II+RDLK NVLLD D N +ISD GLA +T+ T
Sbjct: 297 QIVSG----LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TK 347
Query: 550 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
GT G+MAPE ++ D F+ G+ L E+++ +
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 67/220 (30%), Positives = 98/220 (44%), Gaps = 40/220 (18%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQH 442
+ ++I LG+G FG V K +QE AVK ++K + + E+ L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCK---LLDW---SKRF------H 490
N++KL E+ Y E L D KRF
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVG------------ELYTGGELFDEIIKRKRFSEHDAAR 125
Query: 491 IICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGN 547
II G+ Y+H+ I+HRDLK N+LL ++D + KI DFGL+ F +
Sbjct: 126 IIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--- 179
Query: 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 587
+GT Y+APE G + K DV+S G++L ++SG
Sbjct: 180 MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 40/222 (18%)
Query: 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL 445
++ K +G G FG V++ L + E+A+K++ + +EL+ + ++H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNV 94
Query: 446 VKLLGCCIH------GEEKL-LIYEFMP---NKSLDSF-----IFDQERCKLLDWSKRFH 490
V L + E L L+ E++P ++ + KL +
Sbjct: 95 VDLK-AFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLY----MYQ 149
Query: 491 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTN 549
++ R L Y+H + I HRD+K N+LLD K+ DFG A+ E N +
Sbjct: 150 LL----RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVS 200
Query: 550 RVVGTYGYMAPEY---ASDGQFSVKSDVFSFGILLLEIVSGK 588
+ Y Y APE A+ ++ D++S G ++ E++ G+
Sbjct: 201 YICSRY-YRAPELIFGAT--NYTTNIDIWSTGCVMAELMQGQ 239
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 30/241 (12%), Positives = 65/241 (26%), Gaps = 54/241 (22%)
Query: 393 KKLGEGGFGPVYKGT-LADEQEIAVKRLSK---ISEQGLKELKNEIILFSKLQ------- 441
LG+ + T + V +K++K E++ L+
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 442 ------------------HRNLVKLLGCCIHGEEK--LLIYEFMPNKSLDSF--IFD-QE 478
+ ++++ +Y M + +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 479 RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538
K L R + R L LH ++H L+ +++LDQ ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 539 FGGDETEGNTNRVVGTYGYMAPEYASD-----------GQFSVKSDVFSFGILLLEIVSG 587
G + G+ PE + + D ++ G+++ I
Sbjct: 256 DGARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 588 K 588
Sbjct: 310 D 310
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 54/188 (28%), Positives = 91/188 (48%), Gaps = 31/188 (16%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQ------GLKELKNEIILFSK 439
+ +K+GEG +G V+K + +A+KR+ + L+E+ L +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKE 57
Query: 440 LQHRNLVKLLGCCIHGEEKL-LIYEFMPN---KSLDS--FIFDQERCKLLDWSKRFHIIC 493
L+H+N+V+L +H ++KL L++EF K DS D E K +
Sbjct: 58 LKHKNIVRLH-DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLL 111
Query: 494 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 553
+GL + H ++HRDLK N+L++++ K+++FGLARAF G + VV
Sbjct: 112 ---KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV- 163
Query: 554 TYGYMAPE 561
T Y P+
Sbjct: 164 TLWYRPPD 171
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-27
Identities = 38/211 (18%), Positives = 79/211 (37%), Gaps = 34/211 (16%)
Query: 391 INKKLGEGGFGPVYKG--TLADEQEIAVKRLSKISEQGLKE-LKNEIILFSKLQHRNLVK 447
+ + GG G +Y + + + +K L + + E +++ H ++V+
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 448 LLGCCIH--GEE-----KLLIY---EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTAR 497
I E + Y E++ +SL ++ L ++ +
Sbjct: 144 -----IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQK---LPVAEAIAYLLEILP 193
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 557
L YLH + +++ DLK N++L ++ K+ D G + GT G+
Sbjct: 194 ALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGF 243
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
APE +V +D+++ G L +
Sbjct: 244 QAPEIVR-TGPTVATDIYTVGRTLAALTLDL 273
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 43/221 (19%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKE------LKNEIILFSKL 440
+ + +K+GEG +G VYK + A+K++ E E ++ EI + +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIR-EISILKEL 57
Query: 441 QHRNLVKLLGCCIHGEEKL-LIYEFMPN---KSLDS--FIFDQERCKLLDWSKRFHIICG 494
+H N+VKL IH +++L L++E + K LD + K
Sbjct: 58 KHSNIVKLY-DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ-------- 108
Query: 495 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 554
G+ Y H R++HRDLK N+L++++ KI+DFGLARAF G T+ +V T
Sbjct: 109 LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-T 163
Query: 555 YGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 588
Y AP+ Y++ ++ D++S G + E+V+G
Sbjct: 164 LWYRAPDVLMGSKKYST----TI--DIWSVGCIFAEMVNGT 198
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-27
Identities = 65/217 (29%), Positives = 96/217 (44%), Gaps = 33/217 (15%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNEIILFSKLQH 442
+ F + LG+GGFG V + ++ A K+L K +G NE + K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 443 RNLVKLLGCCIHGEEKL-LIYEFMPNKSL-------DSFIFDQERCKLLDWSKRF---HI 491
R +V L ++ L L+ M L F + R F I
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA-------VFYAAEI 295
Query: 492 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 551
CG L LH R RI++RDLK N+LLD + +ISD GLA +T
Sbjct: 296 CCG----LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGR 345
Query: 552 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
VGT GYMAPE + +++ D ++ G LL E+++G+
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 67/218 (30%), Positives = 94/218 (43%), Gaps = 44/218 (20%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQH 442
+ ++I LG+G FG V K +QE AVK ++K + + E+ L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCK---LLDW---SKRF------H 490
N++KL E+ Y E L D KRF
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVG------------ELYTGGELFDEIIKRKRFSEHDAAR 125
Query: 491 IICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGN 547
II G+ Y+H+ I+HRDLK N+LL ++D + KI DFGL+ F +
Sbjct: 126 IIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--- 179
Query: 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 581
+GT Y+APE G + K DV+S G ILL
Sbjct: 180 MKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILL 216
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 42/221 (19%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQGLKELKN-----EIILFSKL 440
+ + +GEG +G V K D I A+K K E ++ EI L +L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQL 81
Query: 441 QHRNLVKLLGCCIHGEEKL-LIYEFMPN---KSLDSF--IFDQERCKLLDWSKRFHIICG 494
+H NLV LL +++ L++EF+ + L+ F D + + +
Sbjct: 82 RHENLVNLL-EVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ-------- 132
Query: 495 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 554
G+ + H IIHRD+K N+L+ Q K+ DFG AR E + V T
Sbjct: 133 IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-T 187
Query: 555 YGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 588
Y APE Y +V DV++ G L+ E+ G+
Sbjct: 188 RWYRAPELLVGDVKYGK----AV--DVWAIGCLVTEMFMGE 222
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-26
Identities = 69/221 (31%), Positives = 103/221 (46%), Gaps = 40/221 (18%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNE-IIL--FSK 439
++FS+++ +G GGFG VY AD ++ A+K L K +QG NE I+L S
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 440 LQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFI-----FDQERCKLLDWSKRFH--- 490
+V + H +KL I + M L + F + RF+
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-------RFYAAE 300
Query: 491 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 550
II G L ++H +++RDLK +N+LLD+ + +ISD GLA F +
Sbjct: 301 IILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---- 349
Query: 551 VVGTYGYMAPEYASDGQ---FSVKSDVFSFGILLLEIVSGK 588
VGT+GYMAPE G S D FS G +L +++ G
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 56/259 (21%), Positives = 92/259 (35%), Gaps = 67/259 (25%)
Query: 388 NFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--------ISEQGLKELKNEIILFS 438
+S LG G FG V+ +E+ VK + K I + L ++ EI + S
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 439 KLQHRNLVKLLGCCIHGEEKLLIYEFMPNKS--------------LDSFIFDQERCKLLD 484
+++H N++K+ + N+ L +FI R
Sbjct: 85 RVEHANIIKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL 131
Query: 485 WSKRFH-IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543
S F ++ YL IIHRD+K N+++ +D K+ DFG A E
Sbjct: 132 ASYIFRQLVSAVG----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---E 181
Query: 544 TEGNTNRVVGTYGYMAPEYAS----DGQFSVKSDVFSFGILLLEIVSG--------KKNR 591
GT Y APE G + +++S G+ L +V +
Sbjct: 182 RGKLFYTFCGTIEYCAPEVLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFCELEETVE 238
Query: 592 GFYH-----SDNKLNLIRH 605
H S ++L+
Sbjct: 239 AAIHPPYLVSKELMSLVSG 257
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-26
Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 25/241 (10%)
Query: 353 RENRNNRGTEQKNEDQNIDLDLPLFELATIANATDNFS----INKKLGEGGFGPVYKGT- 407
+ +GT N D + + + D+ I+++LG G FG V++ T
Sbjct: 119 GKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTE 178
Query: 408 LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 467
A A K + E + ++ EI S L+H LV L E ++IYEFM
Sbjct: 179 RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238
Query: 468 KSLDSFIFD---QERCKL--LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 522
L F+ E K+ + + +C GL ++H+ +H DLK N++
Sbjct: 239 GEL----FEKVADEHNKMSEDEAVEYMRQVCK---GLCHMHE---NNYVHLDLKPENIMF 288
Query: 523 DQDMNP--KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGIL 580
+ K+ DFGL + + GT + APE A +D++S G+L
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345
Query: 581 L 581
Sbjct: 346 S 346
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 71/251 (28%), Positives = 104/251 (41%), Gaps = 45/251 (17%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKE-LKNEIILFSKLQHRN 444
+++ + + LGEG +G V E+ +AVK + E +K EI + L H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 445 LVKLLGCCIHGEEKLLIY---EFMPNKSLDSFIFDQERCKLLDWSKRFH-IICGTARGLL 500
+VK G H E + Y E+ L I D + FH ++ G
Sbjct: 67 VVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 501 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 560
YLH + I HRD+K N+LLD+ N KISDFGLA F + E N++ GT Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 561 EYAS----DGQFSVKSDVFSFGILLLEIVSG----------------KKNRGFYH----- 595
E + DV+S GI+L +++G K + Y
Sbjct: 177 ELLKRREFHAE---PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233
Query: 596 -SDNKLNLIRH 605
L L+
Sbjct: 234 IDSAPLALLHK 244
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 388 NFSINKKLGEGGFGPVYKGT-LADEQEIAVKRL--SKISEQGLKELKNEIILFSKLQHRN 444
N+ + K +G+G F V + +E+A+K + ++++ L++L E+ + L H N
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 445 LVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFH-IICGTARGLLYL 502
+VKL I E+ L LI E+ + ++ R K + +F I+ Y
Sbjct: 76 IVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YC 130
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562
H + RI+HRDLKA N+LLD DMN KI+DFG + F + G Y APE
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPEL 184
Query: 563 AS----DGQFSVKSDVFSFGILLLEIVSGK 588
DG + DV+S G++L +VSG
Sbjct: 185 FQGKKYDGP---EVDVWSLGVILYTLVSGS 211
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 52/228 (22%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKE------LKNEIILFSK 439
D + KLGEG +G VYK + +A+KR+ E +E ++ E+ L +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE---EEGVPGTAIR-EVSLLKE 89
Query: 440 LQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRF---HIICGT 495
LQHRN+++L IH +L LI+E+ + + K +D + I
Sbjct: 90 LQHRNIIELK-SVIHHNHRLHLIFEYA----------ENDLKKYMDKNPDVSMRVIKSFL 138
Query: 496 A---RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-----KISDFGLARAFGGDETEGN 547
G+ + H R +HRDLK N+LL KI DFGLARAF G
Sbjct: 139 YQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194
Query: 548 TNRVVGTYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 588
T+ ++ T Y PE Y++ SV D++S + E++
Sbjct: 195 THEII-TLWYRPPEILLGSRHYST----SV--DIWSIACIWAEMLMKT 235
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 50/215 (23%), Positives = 83/215 (38%), Gaps = 38/215 (17%)
Query: 383 ANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ 441
+ +++ +G G +G V A K++ K + + K EI + L
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCK---LLDW---SKRF------ 489
H N+++L E+ IY M E C L + + F
Sbjct: 65 HPNIIRLYETF---EDNTDIYLVM------------ELCTGGELFERVVHKRVFRESDAA 109
Query: 490 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEG 546
I+ + Y H+ L + HRDLK N L D K+ DFGLA F +
Sbjct: 110 RIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-- 164
Query: 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 581
VGT Y++P+ +G + + D +S G+++
Sbjct: 165 -MRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 388 NFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK----ISEQGLKELKNEIILFSKLQH 442
+ + LGEG +G V + AVK L K G +K EI L +L+H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 443 RNLVKLLGCCIHGEEKLLIY---EFMPNKSLDSFIFD---QERCKLLDWSKRFH-IICGT 495
+N+++L+ ++ EEK +Y E+ + + D ++R + F +I G
Sbjct: 66 KNVIQLVDV-LYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 555
YLH I+H+D+K N+LL KIS G+A A + G+
Sbjct: 123 E----YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 556 GYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGK 588
+ PE A+ G K D++S G+ L I +G
Sbjct: 176 AFQPPEIANGLDTFSGF---KVDIWSAGVTLYNITTGL 210
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 53/207 (25%), Positives = 85/207 (41%), Gaps = 21/207 (10%)
Query: 383 ANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ 441
+ D + I ++LG G FG V++ A + K ++ +KNEI + ++L
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106
Query: 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFD---QERCKL--LDWSKRFHIICGTA 496
H L+ L E +LI EF+ L FD E K+ + C
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACE-- 160
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTNRVVGT 554
GL ++H+ I+H D+K N++ + KI DFGLA DE T
Sbjct: 161 -GLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTAT 213
Query: 555 YGYMAPEYASDGQFSVKSDVFSFGILL 581
+ APE +D+++ G+L
Sbjct: 214 AEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 71/251 (28%), Positives = 104/251 (41%), Gaps = 45/251 (17%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKE-LKNEIILFSKLQHRN 444
+++ + + LGEG +G V E+ +AVK + E +K EI + L H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 445 LVKLLGCCIHGEEKLLIY---EFMPNKSLDSFIFDQERCKLLDWSKRFH-IICGTARGLL 500
+VK G H E + Y E+ L I D + FH ++ G
Sbjct: 67 VVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 501 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 560
YLH + I HRD+K N+LLD+ N KISDFGLA F + E N++ GT Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 561 EYAS----DGQFSVKSDVFSFGILLLEIVSG----------------KKNRGFYH----- 595
E + DV+S GI+L +++G K + Y
Sbjct: 177 ELLKRREFHAE---PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233
Query: 596 -SDNKLNLIRH 605
L L+
Sbjct: 234 IDSAPLALLHK 244
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 5e-25
Identities = 55/216 (25%), Positives = 83/216 (38%), Gaps = 42/216 (19%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRN 444
F + LG G F V+ + A+K + K L+NEI + K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCK---LLDW---SKRF------HII 492
+V L E Y M + L D + +I
Sbjct: 68 IVTLEDIY---ESTTHYYLVM------------QLVSGGELFDRILERGVYTEKDASLVI 112
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTN 549
+ YLH+ I+HRDLK N+L +++ I+DFGL++ G +
Sbjct: 113 QQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMS 165
Query: 550 RVVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 581
GT GY+APE + +S D +S G ILL
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 54/264 (20%), Positives = 93/264 (35%), Gaps = 51/264 (19%)
Query: 349 ARYFRENRNNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGT- 407
A + N + Q++ + L + A + +G G V +
Sbjct: 56 AEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVH 115
Query: 408 LADEQEIAVKRLSK--------ISEQGLKELKNEI-ILFSKLQHRNLVKLLGCCIHGEEK 458
A E AVK + E+ + + E IL H +++ L+ E
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---ESS 172
Query: 459 LLIY---EFMPNKSLDSFIFD--------QERCKLLDWSKRFHIICGTARGLLYLHQDSR 507
++ + M L FD E+ + + + +LH
Sbjct: 173 SFMFLVFDLMRKGEL----FDYLTEKVALSEK----ETRSIMRSLLE---AVSFLHA--- 218
Query: 508 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE------ 561
I+HRDLK N+LLD +M ++SDFG + E + GT GY+APE
Sbjct: 219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSM 275
Query: 562 YASDGQFSVKSDVFSFG----ILL 581
+ + + D+++ G LL
Sbjct: 276 DETHPGYGKEVDLWACGVILFTLL 299
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 54/216 (25%), Positives = 83/216 (38%), Gaps = 35/216 (16%)
Query: 383 ANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKE-LKNEIILFSKL 440
D F +KLG G FG V+ + E +K ++K Q E ++ EI + L
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 441 QHRNLVKLLGCCIHGEEKLLIY------------EFMPNKSLDSFIFDQERCKLLDWSKR 488
H N++K+ E+ +Y E + + + L
Sbjct: 78 DHPNIIKIFEVF---EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL----- 129
Query: 489 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETE 545
+ L Y H ++H+DLK N+L KI DFGLA F DE
Sbjct: 130 MKQMMN---ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH- 182
Query: 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 581
+ GT YMAPE + K D++S G+++
Sbjct: 183 --STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 39/222 (17%)
Query: 386 TDNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQGLKELKNEIILFSKLQHRN 444
+++ K +G G FG VY+ L D E+ A+K++ + +EL+ + KL H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCN 108
Query: 445 LVKLLGCCIHGEEKL------LIYEFMPNKSLDSFI--FDQERCKLLDWSKRFHI--ICG 494
+V+L EK L+ +++P +++ + + + L + ++ +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 166
Query: 495 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTNRVVG 553
R L Y+H I HRD+K N+LLD D K+ DFG A+ E N + +
Sbjct: 167 --RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICS 219
Query: 554 TYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 588
Y Y APE Y + DV+S G +L E++ G+
Sbjct: 220 RY-YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 48/252 (19%), Positives = 86/252 (34%), Gaps = 52/252 (20%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVK-----RLSKISEQGLKELKNEIILFSK 439
+ + +G+G +G V A+K ++ +I+ + ++ +K E+ L K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 440 LQHRNLVKLLGC-----CIH--------GE------------------EKLLIYEFMPNK 468
L H N+ +L I G + + +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 469 SLDSFIFDQERCKLLDWSKRF------HIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 522
+ I +I+ L YLH I HRD+K N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201
Query: 523 --DQDMNPKISDFGLARAFGGDETEGNT--NRVVGTYGYMAPE--YASDGQFSVKSDVFS 576
++ K+ DFGL++ F GT ++APE ++ + K D +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 577 FGILLLEIVSGK 588
G+LL ++ G
Sbjct: 262 AGVLLHLLLMGA 273
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 61/237 (25%), Positives = 90/237 (37%), Gaps = 41/237 (17%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVK-----RLSKISEQGLKELKNEIILFSK 439
D + + + +G+G F V + Q+ AVK + + ++LK E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 440 LQHRNLVKLLGCCIHGEEKLLIY---EFMPNKSLDSFIFDQERCKLLDWSKRF------H 490
L+H ++V+LL ++Y EFM L E K D + H
Sbjct: 83 LKHPHIVELLETY---SSDGMLYMVFEFMDGADL----CF-EIVKRADAGFVYSEAVASH 134
Query: 491 IICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGN 547
+ L Y H IIHRD+K VLL + K+ FG+A G
Sbjct: 135 YMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG 191
Query: 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFG----ILLLEIVSGKKNRGFYHSDNKL 600
VGT +MAPE + DV+ G ILL SG FY + +L
Sbjct: 192 G--RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILL----SGC--LPFYGTKERL 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 383 ANATDNFSINKK--LGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSK 439
++++K LG G FG V+K A ++A K + + +E+KNEI + ++
Sbjct: 83 GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQ 142
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFD---QERCKL--LDWSKRFHIICG 494
L H NL++L + +L+ E++ L FD E L LD IC
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICE 198
Query: 495 TARGLLYLHQDSRLRIIHRDLKASNVLL-DQDMNP-KISDFGLARAFGGDETEGNTNRVV 552
G+ ++HQ + I+H DLK N+L ++D KI DFGLAR + E
Sbjct: 199 ---GIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNF 249
Query: 553 GTYGYMAPEYASDGQFSVKSDVFSFG----ILL 581
GT ++APE + S +D++S G +LL
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 49/185 (26%), Positives = 82/185 (44%), Gaps = 18/185 (9%)
Query: 391 INKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGL-KELKNEIILFSKLQHRNLVKLL 449
K+G G +G VYK D ++ L +I G+ EI L +L+H N++ L
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQ 84
Query: 450 GCCI-HGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRF------HIICGTARGLLY 501
+ H + K+ L++++ L I K + ++ G+ Y
Sbjct: 85 KVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLARAFGG-DETEGNTNRVVGTYG 556
LH + ++HRDLK +N+L+ + KI+D G AR F + + + VV T+
Sbjct: 144 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 200
Query: 557 YMAPE 561
Y APE
Sbjct: 201 YRAPE 205
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 56/260 (21%), Positives = 98/260 (37%), Gaps = 67/260 (25%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK------ISEQGLKELKNEIILFSK 439
+ + LG GGFG VY G ++D +A+K + K + E++L K
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 440 LQHR--NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCK----LLDW-------- 485
+ +++L ++ DSF+ ER + L D+
Sbjct: 103 VSSGFSGVIRL-------------LDWFERP--DSFVLILERPEPVQDLFDFITERGALQ 147
Query: 486 ---SKRF--HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAF 539
++ F ++ + + H ++HRD+K N+L+D + K+ DFG
Sbjct: 148 EELARSFFWQVLEA----VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200
Query: 540 GGDETEGNTNRVVGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSG--------KKN 590
+ GT Y PE+ ++ + V+S GILL ++V G +
Sbjct: 201 ----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 256
Query: 591 RGFYH-----SDNKLNLIRH 605
RG S +LIR
Sbjct: 257 RGQVFFRQRVSSECQHLIRW 276
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 50/229 (21%)
Query: 387 DNFSINKKLGEGGFGPVYKG--TLADEQEIAVKRLSKISEQG------------LKELKN 432
+ ++GEG +G V+K + +A+KR+ + + L+ L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 433 EIILFSKLQHRNLVKLL----GCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSK 487
+H N+V+L E KL L++E + DQ+ LD
Sbjct: 71 F-------EHPNVVRLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVP 113
Query: 488 RFHIICGTA--------RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539
+ T RGL +LH R++HRDLK N+L+ K++DFGLAR +
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 540 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
T+ VV T Y APE ++ D++S G + E+ K
Sbjct: 171 SFQMAL--TSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 41/217 (18%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQH 442
+DN+ + ++LG+G F V + E A K ++ +S + ++L+ E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 443 RNLVKLLGCCIHGEEKLLIY---EFMPNKSLDSFIFDQ--------ERCKLLDWSKRFHI 491
N+V+L +E+ Y + + L F+ E D S
Sbjct: 65 PNIVRLHDSI---QEESFHYLVFDLVTGGEL----FEDIVAREFYSEA----DASHCIQQ 113
Query: 492 ICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNT 548
I + Y H I+HR+LK N+LL + K++DFGLA E
Sbjct: 114 ILE---SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---W 164
Query: 549 NRVVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 581
+ GT GY++PE +S D+++ G ILL
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 46/206 (22%), Positives = 83/206 (40%), Gaps = 22/206 (10%)
Query: 384 NATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQH 442
+ + I + LG G FG V++ + ++ K + +K EI + + +H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFD---QERCKL--LDWSKRFHIICGTAR 497
RN++ L EE ++I+EF+ + F+ +L + H +C
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCE--- 113
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTNRVVGTY 555
L +LH I H D++ N++ + KI +FG AR + +
Sbjct: 114 ALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAP 167
Query: 556 GYMAPEYASDGQFSVKSDVFSFGILL 581
Y APE S +D++S G L+
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 60/233 (25%), Positives = 95/233 (40%), Gaps = 52/233 (22%)
Query: 385 ATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQG---------------LK 428
AT + ++G G +G VYK +A+K + + G L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 429 ELKNEIILFSKLQHRNLVKLLGCCIH----GEEKL-LIYEFMPNKSLDSFIFDQERCKLL 483
L+ +H N+V+L+ C E K+ L++E + DQ+ L
Sbjct: 67 RLEAF-------EHPNVVRLMDVCATSRTDREIKVTLVFEHV----------DQDLRTYL 109
Query: 484 DWSKRFHIICGTA--------RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 535
D + + T RGL +LH + I+HRDLK N+L+ K++DFGL
Sbjct: 110 DKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL 166
Query: 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
AR + T VV T Y APE ++ D++S G + E+ K
Sbjct: 167 ARIYSYQMA--LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 25/211 (11%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--------ISEQGLKELKNEIIL 436
D + ++K LG G G V +++A++ +SK ++ EI +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 437 FSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA 496
KL H ++K+ E+ ++ E M L + +R K F+ +
Sbjct: 194 LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL-- 250
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTNRVVG 553
+ YLH+ IIHRDLK NVLL ++D KI+DFG ++ G + G
Sbjct: 251 -AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCG 303
Query: 554 TYGYMAPE---YASDGQFSVKSDVFSFGILL 581
T Y+APE ++ D +S G++L
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 53/221 (23%), Positives = 85/221 (38%), Gaps = 42/221 (19%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKE---------LKNEI- 434
+N+ + LG G V + +E AVK + E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 435 ILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQ--------ERCKLLDWS 486
IL H N+++L L+++ M L FD E+ +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEK----ETR 127
Query: 487 KRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546
K + + LH+ L I+HRDLK N+LLD DMN K++DFG + E
Sbjct: 128 KIMRALLE---VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-- 179
Query: 547 NTNRVVGTYGYMAPE------YASDGQFSVKSDVFSFGILL 581
V GT Y+APE + + + D++S G+++
Sbjct: 180 -LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 49/230 (21%), Positives = 92/230 (40%), Gaps = 45/230 (19%)
Query: 384 NATDNFSINKKLGEGGFGPVYKGTLADEQE-IAVKRLSKISEQGLKELKN----EIILFS 438
D F + + G+G FG V G +A+K K+ + +N + +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK---KVIQD--PRFRNRELQIMQDLA 74
Query: 439 KLQHRNLVKLLGCCIHGEEK-------LLIYEFMP---NKSLDSFIFDQERCKLLDWSKR 488
L H N+V+L E+ ++ E++P ++ ++ + + +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYY--RRQVAPPPILIK 132
Query: 489 FHI--ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETE 545
+ + R + LH S + + HRD+K NVL+++ K+ DFG A+ E
Sbjct: 133 VFLFQLI---RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP- 187
Query: 546 GNTNRVVGTYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 588
N + Y Y APE Y + D++S G + E++ G+
Sbjct: 188 -NVAYICSRY-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 64/237 (27%), Positives = 101/237 (42%), Gaps = 62/237 (26%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQGLKE------LKNEIILFSK 439
+ K+G+G FG V+K + A+K++ +E KE L+ EI +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITALR-EIKILQL 72
Query: 440 LQHRNLVKLLGCCIHGEEKL--------LIYEFMPN---KSLDS--FIFDQERCK----- 481
L+H N+V L+ C L+++F + L + F K
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 482 LLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541
LL GL Y+H++ +I+HRD+KA+NVL+ +D K++DFGLARAF
Sbjct: 133 LL-------------NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSL 176
Query: 542 DETEGN---TNRVVGTYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 588
+ TNRVV T Y PE Y D++ G ++ E+ +
Sbjct: 177 AKNSQPNRYTNRVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 48/210 (22%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 383 ANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK------ISEQGLKELKNEII 435
+ D++ + ++LG G F V K +E A K + K +E++ E+
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 436 LFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGT 495
+ +++H N++ L + + +LI E + L F+ ++E + ++ I
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD- 119
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGDETEGNTNRV 551
G+ YLH RI H DLK N++L + K+ DFG+A +
Sbjct: 120 --GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNI 171
Query: 552 VGTYGYMAPEYASDGQFSVKSDVFSFGILL 581
GT ++APE + +++D++S G++
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 43/218 (19%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQH 442
+DN+ + ++LG+G F V + E A K ++ +S + ++L+ E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCK---LLDW---SKRF------H 490
N+V+L +E+ Y + L + + + H
Sbjct: 88 PNIVRLHDSI---QEESFHYLVF------------DLVTGGELFEDIVAREFYSEADASH 132
Query: 491 IICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGN 547
I + Y H I+HR+LK N+LL + K++DFGLA E
Sbjct: 133 CIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--- 186
Query: 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 581
+ GT GY++PE +S D+++ G ILL
Sbjct: 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 60/238 (25%), Positives = 104/238 (43%), Gaps = 51/238 (21%)
Query: 388 NFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK------------------------- 421
+++ ++G+G +G V D A+K LSK
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 422 -ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY---EFMPNKSLDSFIFDQ 477
++++ EI + KL H N+VKL+ + + +Y E + + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEV 128
Query: 478 ERCKLL--DWSKRFH--IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 533
K L D ++ + +I G + YLH +IIHRD+K SN+L+ +D + KI+DF
Sbjct: 129 PTLKPLSEDQARFYFQDLIKG----IEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 534 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSV---KSDVFSFGILLLEIVSGK 588
G++ F G + + VGT +MAPE S+ + DV++ G+ L V G+
Sbjct: 182 GVSNEFKGSDALLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--------ISEQGLKELKNEIIL 436
D + ++K LG G G V +++A+K +SK ++ EI +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 437 FSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFD--------QERCKLLDWSKR 488
KL H ++K+ E+ ++ E M L FD +E
Sbjct: 69 LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGEL----FDKVVGNKRLKEA----TCKLY 119
Query: 489 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETE 545
F+ + + YLH IIHRDLK NVLL ++D KI+DFG ++ G
Sbjct: 120 FYQMLL---AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL- 172
Query: 546 GNTNRVVGTYGYMAPE---YASDGQFSVKSDVFSFGILL 581
+ GT Y+APE ++ D +S G++L
Sbjct: 173 --MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 54/262 (20%), Positives = 96/262 (36%), Gaps = 69/262 (26%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK------ISEQGLKELKNEI----I 435
+ + LG+GGFG V+ G L D ++A+K + + E+
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 436 LFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCK----LLDW------ 485
+ + H +++L ++ + + F+ ER L D+
Sbjct: 91 VGAGGGHPGVIRL-------------LDWFETQ--EGFMLVLERPLPAQDLFDYITEKGP 135
Query: 486 -----SKRF--HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLAR 537
S+ F ++ + + H ++HRD+K N+L+D K+ DFG
Sbjct: 136 LGEGPSRCFFGQVVAA----IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGA 188
Query: 538 AFGGDETEGNTNRVVGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSG--------K 588
+ GT Y PE+ S Q+ + + V+S GILL ++V G +
Sbjct: 189 LL----HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE 244
Query: 589 KNRGFYH-----SDNKLNLIRH 605
H S + LIR
Sbjct: 245 ILEAELHFPAHVSPDCCALIRR 266
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-23
Identities = 51/224 (22%), Positives = 93/224 (41%), Gaps = 42/224 (18%)
Query: 380 ATIANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--ISEQGLKELKNEIIL 436
T T+ + + ++LG+G F V + + QE A ++ +S + ++L+ E +
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 437 FSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCK---LLDW---SKRF- 489
L+H N+V+L E+ Y + L + + +
Sbjct: 64 CRLLKHPNIVRLHDSI---SEEGHHYLIF------------DLVTGGELFEDIVAREYYS 108
Query: 490 -----HIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGG 541
H I +L+ HQ + ++HR+LK N+LL + K++DFGLA G
Sbjct: 109 EADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
Query: 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 581
++ GT GY++PE + D+++ G ILL
Sbjct: 166 EQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 384 NATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK------ISEQGLKELKNEIIL 436
N D + ++LG G F V K + + A K + K ++++ E+ +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 437 FSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA 496
++QH N++ L + + +LI E + L F+ ++E + ++ I
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN-- 125
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGDETEGNTNRVV 552
G+ YLH L+I H DLK N++L KI DFGLA +
Sbjct: 126 -GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 553 GTYGYMAPEYASDGQFSVKSDVFSFGILL 581
GT ++APE + +++D++S G++
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 20/210 (9%)
Query: 383 ANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK------ISEQGLKELKNEII 435
D + I ++LG G F V K + E A K + K +E++ E+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 436 LFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGT 495
+ ++ H N++ L + + +LI E + L F+ +E + + I
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD- 126
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLARAFGGDETEGNTNRV 551
G+ YLH +I H DLK N++L P K+ DFGLA +
Sbjct: 127 --GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNI 178
Query: 552 VGTYGYMAPEYASDGQFSVKSDVFSFGILL 581
GT ++APE + +++D++S G++
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 20/210 (9%)
Query: 383 ANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKIS------EQGLKELKNEII 435
D + I ++LG G F V K + E A K + K +E++ E+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 436 LFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGT 495
+ ++ H N++ L + + +LI E + L F+ +E + + I
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD- 126
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGDETEGNTNRV 551
G+ YLH +I H DLK N++L + K+ DFGLA +
Sbjct: 127 --GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNI 178
Query: 552 VGTYGYMAPEYASDGQFSVKSDVFSFGILL 581
GT ++APE + +++D++S G++
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 56/216 (25%), Positives = 85/216 (39%), Gaps = 43/216 (19%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRN 444
+D F + +LG G VY+ ++ A+K L K ++ K ++ EI + +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCK---LLDW---SKRF------HII 492
++KL E I + E L D + +
Sbjct: 110 IIKLKEIF---ETPTEISLVL------------ELVTGGELFDRIVEKGYYSERDAADAV 154
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTN 549
+ YLH+ I+HRDLK N+L D KI+DFGL++
Sbjct: 155 KQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MK 208
Query: 550 RVVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 581
V GT GY APE + + D++S G ILL
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILL 244
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 40/213 (18%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRN 444
TD + + + +G G + + A E AVK + K +E++ IL QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCK---LLDW---SKRF------HII 492
++ L ++ +Y E K LLD K F ++
Sbjct: 78 IITLKDVY---DDGKYVYVVT------------ELMKGGELLDKILRQKFFSEREASAVL 122
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLL-DQDMNP---KISDFGLARAFGGDETEGNT 548
+ + YLH ++HRDLK SN+L D+ NP +I DFG A+ + T
Sbjct: 123 FTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 549 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 581
T ++APE + D++S G+LL
Sbjct: 180 --PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 388 NFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--ISEQGLKE-LKNEIILFSKLQHR 443
++ + LG G FG V G ++AVK L++ I + +K EI +H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 444 NLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFH-IICGTARGLLY 501
+++KL I ++ E++ L +I R + ++ + F I+ Y
Sbjct: 72 HIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----Y 126
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTNRVVGTYGYM 558
H R ++HRDLK NVLLD MN KI+DFGL+ E T G+ Y
Sbjct: 127 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SCGSPNYA 177
Query: 559 APEYAS----DGQFSVKSDVFSFGILLLEIVSGK 588
APE S G + D++S G++L ++ G
Sbjct: 178 APEVISGRLYAGP---EVDIWSCGVILYALLCGT 208
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 55/220 (25%), Positives = 85/220 (38%), Gaps = 38/220 (17%)
Query: 386 TDNFSINKK-LGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-H 442
D + + + LGEG V L QE AVK + K + E+ + + Q H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQ--------ERCKLLDWSKRFHIICG 494
RN+++L+ + L++E M S+ E + S +
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNEL----EASVVVQDVAS 122
Query: 495 TARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF--GGDETEGNTN 549
L +LH I HRDLK N+L +Q KI DF L GD + +T
Sbjct: 123 ---ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 550 R---VVGTYGYMAPE-----YASDGQFSVKSDVFSFGILL 581
G+ YMAPE + + D++S G++L
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 19/229 (8%)
Query: 363 QKNEDQNIDLDLPLFELATIANATDNFSINKK-LGEGGFGPVYKGT-LADEQEIAVKRLS 420
+ +DL ++ N + + + K LG G F V + + QE A K L
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 421 K--ISEQGLKELKNEIILFSKLQHR-NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQ 477
K + E+ +EI + + ++ L + E +LI E+ + S +
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE 123
Query: 478 ERCKL--LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISD 532
+ D + I G+ YLHQ I+H DLK N+LL + KI D
Sbjct: 124 LAEMVSENDVIRLIKQILE---GVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 533 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 581
FG++R G ++GT Y+APE + + +D+++ GI+
Sbjct: 178 FGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 9e-22
Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 35/212 (16%)
Query: 386 TDNFSINKK-LGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEI-ILFSKLQH 442
TD++ ++K+ LG G G V + Q+ A+K L + + E+ +
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGG 81
Query: 443 RNLVKLLGCC---IHGEEKL-LIYEFMPNKSLDSFIFD--QERCKLL----DWSKRFHII 492
++V +L HG+ L +I E M L F QER + ++ I
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEIMRDI 137
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTN 549
+ +LH I HRD+K N+L ++D K++DFG A+ T+
Sbjct: 138 GT---AIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQ 187
Query: 550 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 581
T Y+APE ++ D++S G+++
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNEIILFSKLQH 442
D+F I + +G+G FG V D +++ A+K ++K + ++ + E+ + L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 443 RNLVKLLGCCIHGEEKL-LIYEFMPNKSL-----DSFIFDQERCKLLDWSKRFHIICGTA 496
LV L EE + ++ + + L + F +E KL IC
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF--------ICELV 125
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
L YL RIIHRD+K N+LLD+ + I+DF +A + + GT
Sbjct: 126 MALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKP 179
Query: 557 YMAPE-YASDGQ----FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK 599
YMAPE ++S F+V D +S G+ E++ G+ R ++ +
Sbjct: 180 YMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGR--RPYHIRSST 223
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 27/215 (12%)
Query: 384 NATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ- 441
D++ + +KLG G + V++ + + +++ VK L + + K++K EI + L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRG 89
Query: 442 HRNLVKLLGCCIHGEEK---LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI--ICGTA 496
N++ L + L++E + N L D+ RF++ I
Sbjct: 90 GPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEIL--- 140
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGDETEGNTNRVVGTY 555
+ L Y H S I+HRD+K NV++D + ++ D+GLA + RV Y
Sbjct: 141 KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY 195
Query: 556 GYMAPEYASDGQFSVKS-DVFSFGILLLEIVSGKK 589
+ PE D Q S D++S G +L ++ K+
Sbjct: 196 -FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 53/225 (23%)
Query: 388 NFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--ISEQGLKE-LKNEIILFSKLQHR 443
+ I + LGEG FG V T +Q++A+K +S+ + + + ++ EI L+H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 444 NLVKLLGCCIHGEEKLLIYEFMPNKS------------LDSFIFDQERCKLLDWSKRFH- 490
+++KL Y+ + + L +I +++R + + F
Sbjct: 70 HIIKL-------------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQ 116
Query: 491 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGN 547
IIC Y H R +I+HRDLK N+LLD ++N KI+DFGL+ T
Sbjct: 117 IICAIE----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT--- 166
Query: 548 TNRVVGTYGYMAPEYAS----DGQFSVKSDVFSFGILLLEIVSGK 588
G+ Y APE + G + DV+S GI+L ++ G+
Sbjct: 167 ---SCGSPNYAAPEVINGKLYAGP---EVDVWSCGIVLYVMLVGR 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 5e-21
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 388 NFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--ISEQGLKE-LKNEIILFSKLQHR 443
++ + LG G FG V G ++AVK L++ I + ++ EI +H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 444 NLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFH-IICGTARGLLY 501
+++KL I + ++ E++ L +I R + + F I+ G Y
Sbjct: 77 HIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----Y 131
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTNRVVGTYGYM 558
H R ++HRDLK NVLLD MN KI+DFGL+ E T G+ Y
Sbjct: 132 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SCGSPNYA 182
Query: 559 APEYAS----DGQFSVKSDVFSFGILLLEIVSGK 588
APE S G + D++S G++L ++ G
Sbjct: 183 APEVISGRLYAGP---EVDIWSSGVILYALLCGT 213
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 53/203 (26%), Positives = 83/203 (40%), Gaps = 32/203 (15%)
Query: 392 NKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-HRNLVKLL 449
+K LGEG F K Q AVK +SK + + EI + H N+VKL
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLH 72
Query: 450 GCCIHGEEKLLIYEFMPNKSLDSFIFD--QERCKLLDWSKRF------HIICGTARGLLY 501
L+ E + L F+ +++ K F +I+ + +
Sbjct: 73 EVFHDQLHTFLVMELLNGGEL----FERIKKK-------KHFSETEASYIMRKLVSAVSH 121
Query: 502 LHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
+H + ++HRDLK N+L + ++ KI DFG AR D T T Y
Sbjct: 122 MHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYA 176
Query: 559 APEYASDGQFSVKSDVFSFGILL 581
APE + + D++S G++L
Sbjct: 177 APELLNQNGYDESCDLWSLGVIL 199
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 5e-20
Identities = 43/206 (20%), Positives = 84/206 (40%), Gaps = 33/206 (16%)
Query: 391 INKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEI-ILFSKLQHRNLVKL 448
++ LG G G V + +++ A+K L + + E+ + + Q ++V++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 120
Query: 449 LGCC---IHGEEKL-LIYEFMPNKSLDSFIFD--QERCKLL----DWSKRFHIICGTARG 498
+ G + L ++ E + L F Q+R + S+ I
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEA--- 173
Query: 499 LLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 555
+ YLH + I HRD+K N+L + K++DFG A+ + T
Sbjct: 174 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTP 227
Query: 556 GYMAPEYASDGQFSVKSDVFSFGILL 581
Y+APE ++ D++S G+++
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 32/217 (14%)
Query: 387 DNFSINKKLGEGGFGPVY---KGTLADEQEI-AVKRLSK--ISEQGLKELKNEIILFSKL 440
F + K LG+G FG V+ K + +D +++ A+K L K + + K E + ++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 441 QHRNLVKLLGCCIHGEEKL-LIYEFMPNKSL-----DSFIFDQERCKLLDWSKRFH---I 491
H +VKL E KL LI +F+ L +F +E +F+ +
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-------KFYLAEL 135
Query: 492 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 551
L +LH L II+RDLK N+LLD++ + K++DFGL++ E + +
Sbjct: 136 ALA----LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--F 186
Query: 552 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
GT YMAPE + + +D +SFG+L+ E+++G
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 24/213 (11%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQH 442
+ +G G +G V +++A+K+LS+ SE K E++L +QH
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 443 RNLVKLLGCCIHGEEKL------LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA 496
N++ LL L+ FM L + K + ++ ++
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GLKFSEEKIQY-LVYQML 136
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
+GL Y+H ++HRDLK N+ +++D KI DFGLAR + T V T
Sbjct: 137 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YVVTRW 188
Query: 557 YMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK 588
Y APE S ++ D++S G ++ E+++GK
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 35/224 (15%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQGLKEL---KNEIILFSKLQH 442
D F K LG G FG V + A+K L K LK++ NE + +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 443 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFI-----FDQERCKLLDWSKRF---HIIC 493
LVKL L ++ E++ + S + F + RF I+
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-------RFYAAQIVL 152
Query: 494 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 553
YLH L +I+RDLK N+L+DQ +++DFG A+ +G T + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCG 200
Query: 554 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSD 597
T +APE ++ D ++ G+L+ E+ +G F+
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP--FFADQ 242
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 48/216 (22%), Positives = 90/216 (41%), Gaps = 25/216 (11%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNEIILFSKLQH 442
D+F I K +G G F V + ++ A+K ++K + + + E +
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 443 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFH---IICGTARG 498
R + +L E L L+ E+ L + + + + RF+ I+
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA---- 174
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
+ +H+ L +HRD+K N+LLD+ + +++DFG D T + VGT Y+
Sbjct: 175 IDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYL 230
Query: 559 APE-------YASDGQFSVKSDVFSFGILLLEIVSG 587
+PE G + + D ++ G+ E+ G
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 32/214 (14%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKE-LKNEIILFSKLQHRN 444
D + K +G G FG ++ +AVK + + + E ++ EII L+H N
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPN 77
Query: 445 LVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFH-IICGTARGLLYL 502
+V+ I L +I E+ L I + R + F ++ G + Y
Sbjct: 78 IVRFKEV-ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS----YC 132
Query: 503 HQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLARAFGGDE---TEGNTNRVVGTYGY 557
H ++I HRDLK N LLD KI DFG +++ + VGT Y
Sbjct: 133 H---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS------TVGTPAY 183
Query: 558 MAPEYAS----DGQFSVKSDVFSFGILLLEIVSG 587
+APE DG+ +DV+S G+ L ++ G
Sbjct: 184 IAPEVLLRQEYDGK---IADVWSCGVTLYVMLVG 214
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 52/240 (21%), Positives = 102/240 (42%), Gaps = 24/240 (10%)
Query: 362 EQKNEDQNIDLDLPLFELATIANAT-DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRL 419
+KN + ++ P ++F I K +G G FG V L + ++ A+K L
Sbjct: 48 REKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKIL 107
Query: 420 SKISEQGLKEL---KNEIILFSKLQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFIF 475
+K E + E + + + L + L L+ ++ L + +
Sbjct: 108 NKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLS 166
Query: 476 DQERCKLLDWSKRFH---IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 532
E + + RF+ ++ + +HQ L +HRD+K N+L+D + + +++D
Sbjct: 167 KFEDRLPEEMA-RFYLAEMVIA----IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLAD 218
Query: 533 FGLARAFGGDETEGNTNRVVGTYGYMAPE-----YASDGQFSVKSDVFSFGILLLEIVSG 587
FG D T ++ VGT Y++PE G++ + D +S G+ + E++ G
Sbjct: 219 FGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNEIILFSKLQH 442
+ F K LG+G FG V A+K L K +++ + E + +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 443 RNLVKLLGCCIHGEEKL-LIYEFMPNKSL-----DSFIFDQERCKLLDWSKRFHIICGTA 496
L L ++L + E+ L +F ++R RF+
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RFYGAE-IV 258
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
L YLH S +++RDLK N++LD+D + KI+DFGL + D T GT
Sbjct: 259 SALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPE 314
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
Y+APE D + D + G+++ E++ G+
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 33/214 (15%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQGLKEL---KNEIILFSKLQH 442
+F I + LG G FG V+ A+K L K LK++ +E ++ S + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 443 RNLVKLLGCCIHGEEKL-LIYEFMPNKSLDSFI-----FDQERCKLLDWSKRFH---IIC 493
++++ G +++ +I +++ L S + F +F+ +
Sbjct: 66 PFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-------KFYAAEVCL 117
Query: 494 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 553
L YLH II+RDLK N+LLD++ + KI+DFG A+ T + G
Sbjct: 118 A----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCG 165
Query: 554 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 587
T Y+APE S ++ D +SFGIL+ E+++G
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 50/251 (19%), Positives = 97/251 (38%), Gaps = 61/251 (24%)
Query: 384 NATDNFSINKKLGEGGFGPVYKGTLADEQE-IAVKRLSKISEQGLKELKNEIILFSKLQH 442
++ +S+ K LG G FG V + + + A+K++ + +EL + L H
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDH 59
Query: 443 RNLVKLLGCCIHGEEKL---------------------------------------LIYE 463
N++KL+ + +I E
Sbjct: 60 VNIIKLV-DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 464 FMPNKSLDSFI--FDQERCKLLDWSKRFHI--ICGTARGLLYLHQDSRLRIIHRDLKASN 519
++P +L + F + + +I + R + ++H L I HRD+K N
Sbjct: 119 YVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF---RAVGFIHS---LGICHRDIKPQN 171
Query: 520 VLLDQDMNP-KISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-YASDGQFSVKSDVFSF 577
+L++ N K+ DFG A+ +E + + + Y APE +++ D++S
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSI 228
Query: 578 GILLLEIVSGK 588
G + E++ GK
Sbjct: 229 GCVFGELILGK 239
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.1 bits (218), Expect = 6e-19
Identities = 38/95 (40%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT- 554
A+G+ +L + + IHRDL A N+LL + KI DFGLAR D + G
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGDA 255
Query: 555 ---YGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 586
+MAPE D ++++SDV+SFG+LL EI S
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 37/160 (23%), Positives = 61/160 (38%), Gaps = 19/160 (11%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL------ADEQEIAVKRL-SKISEQGLKELKNEIILFSK 439
D + K LG G FG V + A + +AVK L + + L +E+ +
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 440 L-QHRNLVKLLGCCI-HGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTAR 497
+ H N+V LLG C G ++I EF +L +++ SKR + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537
G + + I DLK + + S F +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 1e-18
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQH 442
+ K +G G G V ++ +A+K+LS+ ++ K E++L + H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 443 RNLVKLL------GCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA 496
+N++ LL ++ L+ E M L I + +L + ++
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI----QMELDHERMSY-LLYQML 174
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
G+ +LH IIHRDLK SN+++ D KI DFGLAR + T VV T
Sbjct: 175 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV-TRY 228
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
Y APE + D++S G ++ E+V K
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 387 DNFSINKKLGEGGFGPVY---KGTLADEQEI-AVKRLSK---ISEQGLKE-LKNEIILFS 438
+ F + + LG+GG+G V+ K T A+ +I A+K L K + K E +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 439 KLQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSL-----DSFIFDQERCKLLDWSKRF--- 489
+++H +V L+ KL LI E++ L IF ++ F
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-------CFYLA 128
Query: 490 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 549
I L +LHQ II+RDLK N++L+ + K++DFGL + D T +T
Sbjct: 129 EISMA----LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT- 180
Query: 550 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
GT YMAPE + D +S G L+ ++++G
Sbjct: 181 -FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 25/216 (11%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGL-KELKNEIILFSKLQHR 443
++ +GEG +G V ++ +A+K++S Q + EI + + +H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 444 NLVKLLGCCIHGEEKL-----LIYEFMP---NKSLDSFIFDQERCKLLDWSKRFHIICGT 495
N++ + + ++ + M K L + + + +
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC--------YFLYQI 137
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN--TNRVVG 553
RGL Y+H S ++HRDLK SN+LL+ + KI DFGLAR D T V
Sbjct: 138 LRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA- 193
Query: 554 TYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK 588
T Y APE + ++ D++S G +L E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 24/212 (11%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNEIILFSKLQH 442
++F K LG+G FG V A+K L K I++ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 443 RNLVKLLGCCIHGEEKL-LIYEFMPNKSL-----DSFIFDQERCKLLDWSKRFHIICGTA 496
L L ++L + E+ L +F +ER RF+
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-------RFYGAE-IV 115
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
L YLH +++RD+K N++LD+D + KI+DFGL + D T GT
Sbjct: 116 SALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPE 170
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
Y+APE D + D + G+++ E++ G+
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQH 442
+ K +G G G V E+ +A+K+LS+ ++ K E++L + H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 443 RNLVKLL------GCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA 496
+N++ LL ++ ++ E M +L I + +L + ++
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMELDHERMSY-LLYQML 137
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
G+ +LH IIHRDLK SN+++ D KI DFGLAR + T VV T
Sbjct: 138 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV-TRY 191
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
Y APE + D++S G ++ E++ G
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 55/222 (24%), Positives = 88/222 (39%), Gaps = 30/222 (13%)
Query: 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELK-----------NEI 434
+++ + + G +G V G ++ +A+KR+ G EI
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 435 ILFSKLQHRNLVKLLGCCIHGEEKL-----LIYEFMPNKSLDSFIFDQERCKLLDWSKRF 489
L + H N++ L +H EE L+ E M L I DQ R + ++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ-RIVISPQHIQY 138
Query: 490 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGN 547
+ GL LH+ ++HRDL N+LL + + I DF LAR D T
Sbjct: 139 -FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH-- 192
Query: 548 TNRVVGTYGYMAPEY-ASDGQFSVKSDVFSFGILLLEIVSGK 588
V Y APE F+ D++S G ++ E+ + K
Sbjct: 193 ---YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNE-IILFSKLQ 441
+F K +G+G FG V E+ AVK L K + ++ K + +E +L ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 442 HRNLVKLLGCCIHGEEKL-LIYEFMPNKSL-----DSFIFDQERCKLLDWSKRF---HII 492
H LV L +KL + +++ L F + R RF I
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-------RFYAAEIA 149
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 552
L YLH L I++RDLK N+LLD + ++DFGL + E T+
Sbjct: 150 SA----LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFC 200
Query: 553 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
GT Y+APE + D + G +L E++ G
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 3e-18
Identities = 46/193 (23%), Positives = 86/193 (44%), Gaps = 21/193 (10%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGL--KELKNEIILFSKLQH 442
D + I +G G +G V + +++ +A+K++ ++ E + K + EI + ++L H
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNH 111
Query: 443 RNLVKLLGCCI-HGEEKL----LIYEFMP---NKSLDSFIFDQERCKLLDWSKRFHIICG 494
++VK+L I EK ++ E K + + L + + ++
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV------YLTELHIKT-LLYN 164
Query: 495 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 554
G+ Y+H S I+HRDLK +N L++QD + K+ DFGLAR E + +
Sbjct: 165 LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 555 YGYMAPEYASDGQ 567
M +
Sbjct: 222 EDDMNLVTFPHTK 234
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 32/217 (14%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNEIILFSKLQH 442
+++ + K +G G FG V +++ A+K LSK I E + +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 443 RNLVKLLGCCIHGEEKL-LIYEFMPN----KSLDSFIFDQERCKLLDWSKRFH---IICG 494
+V+L + L ++ E+MP + ++ ++ RF+ ++
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-------RFYTAEVVLA 180
Query: 495 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 554
L +H + IHRD+K N+LLD+ + K++DFG + + VGT
Sbjct: 181 ----LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGT 232
Query: 555 YGYMAPE----YASDGQFSVKSDVFSFGILLLEIVSG 587
Y++PE DG + + D +S G+ L E++ G
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQH 442
+ + +G G +G V ++A+K+L + SE K E+ L ++H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 443 RNLVKLLGCCIHGEEKL------LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA 496
N++ LL E L+ FM L + + KL + +F ++
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQF-LVYQML 138
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
+GL Y+H IIHRDLK N+ +++D KI DFGLAR + T V T
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG-----YVVTRW 190
Query: 557 YMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK 588
Y APE + +++ D++S G ++ E+++GK
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 40/224 (17%)
Query: 387 DNFSINKKLGEGGFGPVY---KGTLADEQEI-AVKRLSK---ISEQGLKE-LKNE-IILF 437
+NF + K LG G +G V+ K + D ++ A+K L K + + E + E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 438 SKLQHRNLVKLLGCCIHGEEKL-LIYEFMPNKSL-----DSFIFDQERCKLLDWSKRFH- 490
Q LV L E KL LI +++ L F + + +
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-------QIYV 165
Query: 491 --IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 548
I+ L +LH+ L II+RD+K N+LLD + + ++DFGL++ F DETE
Sbjct: 166 GEIVLA----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-A 217
Query: 549 NRVVGTYGYMAPEYASDGQ----FSVKSDVFSFGILLLEIVSGK 588
GT YMAP+ G +V D +S G+L+ E+++G
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 1e-17
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNE-IILFSKLQ 441
+F+ LG+G FG V E+ AVK L K I + ++ E +L +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 442 HRNLVKLLGCCIHGEEKL-LIYEFMPNKSL-----DSFIFDQERCKLLDWSKRFHIICGT 495
L +L C ++L + E++ L F + F+
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAE-I 451
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGDETEGNTNRVVGT 554
A GL +L II+RDLK NV+LD + + KI+DFG+ + T T GT
Sbjct: 452 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGT 505
Query: 555 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
Y+APE + + D ++FG+LL E+++G+
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 33/217 (15%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNE-IILFSKLQ 441
+F+ LG+G FG V E+ AVK L K I + ++ E +L +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 442 HRNLVKLLGCCIHGEEKL-LIYEFMPNKSL-----DSFIFDQERCKLLDWSKRFH---II 492
L +L C ++L + E++ L F + F+ I
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAEIA 131
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGDETEGNTNRV 551
G L +L II+RDLK NV+LD + + KI+DFG+ + T T
Sbjct: 132 IG----LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTF 181
Query: 552 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
GT Y+APE + + D ++FG+LL E+++G+
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQH 442
+ + +G G +G V +AVK+LS+ S K E+ L ++H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 443 RNLVKLL------GCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA 496
N++ LL + L+ M L++ + Q KL D +F +I
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQ---KLTDDHVQF-LIYQIL 142
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
RGL Y+H IIHRDLK SN+ +++D KI DFGLAR + T V T
Sbjct: 143 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG-----YVATRW 194
Query: 557 YMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK 588
Y APE + ++ D++S G ++ E+++G+
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 33/217 (15%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNE-IILFSKLQ 441
+F + + +G G + V L I A+K + K ++ + ++ E +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 442 HRNLVKLLGCCIHGEEKL-LIYEFMPNKSL-----DSFIFDQERCKLLDWSKRFH---II 492
H LV L C E +L + E++ L +E RF+ I
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAEIS 120
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF-GGDETEGNTNRV 551
L YLH+ II+RDLK NVLLD + + K++D+G+ + +T T+
Sbjct: 121 LA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTF 170
Query: 552 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
GT Y+APE + D ++ G+L+ E+++G+
Sbjct: 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNE-IILFSKLQ 441
DNF + LG+G FG V + + ++ AVK L K + + ++ E IL
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 442 HRNLVKLLGCCIHGEEKL-LIYEFMPNKSL-----DSFIFDQERCKLLDWSKRFHIICGT 495
H L +L CC ++L + EF+ L S FD+ R RF+
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-------RFYAAE-I 133
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 555
L++LH II+RDLK NVLLD + + K++DFG+ + + T GT
Sbjct: 134 ISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTP 188
Query: 556 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
Y+APE + + D ++ G+LL E++ G
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 40/228 (17%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKN---EIILFSKLQ 441
+ K LG GG G V+ ++ +A+K KI + +K+ EI + +L
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLD 66
Query: 442 HRNLVKLL----------GCCIHGEEKL----LIYEFMP---NKSLDSFIFDQERCKLLD 484
H N+VK+ + +L ++ E+M L+ +E +L
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-- 124
Query: 485 WSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGDE 543
+ RGL Y+H + ++HRDLK +N+ ++ +D+ KI DFGLAR
Sbjct: 125 ------FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
Query: 544 TEGN--TNRVVGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 588
+ + +V T Y +P S ++ D+++ G + E+++GK
Sbjct: 176 SHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNE-IILFSKLQ 441
++F ++K LG+G FG V+ + A+K L K + + ++ E +L +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 442 HRNLVKLLGCCIHGEEKL-LIYEFMPNKSL-----DSFIFDQERCKLLDWSKRFHIICGT 495
H L + C +E L + E++ L FD R F+
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-------TFYAAE-I 127
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF-GGDETEGNTNRVVGT 554
GL +LH I++RDLK N+LLD+D + KI+DFG+ + GD TN GT
Sbjct: 128 ILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGT 181
Query: 555 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 587
Y+APE +++ D +SFG+LL E++ G
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSK---ISEQGLKELKNE-IILFSKLQ 441
+F + + +G G + V L I A++ + K ++ + ++ E +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 442 HRNLVKLLGCCIHGEEKL-LIYEFMPNKSL-----DSFIFDQERCKLLDWSKRFH---II 492
H LV L C E +L + E++ L +E RF+ I
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAEIS 163
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 552
L YLH+ II+RDLK NVLLD + + K++D+G+ + T+
Sbjct: 164 LA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFC 214
Query: 553 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
GT Y+APE + D ++ G+L+ E+++G+
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 30/222 (13%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGL-KELKNEIILFSKLQHR 443
+ +F + LGEG +G V T + +A+K++ + EI + +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 444 NLVKLL-----GCCIHGEEKLLIYEFMP---NKSLDSFIFDQERCKLLDWSKRFHIICGT 495
N++ + + E +I E M ++ + + + + + + I T
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ--------YFIYQT 121
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV---- 551
R + LH + +IHRDLK SN+L++ + + K+ DFGLAR + +
Sbjct: 122 LRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 552 ----VGTYGYMAPEY-ASDGQFSVKSDVFSFGILLLEIVSGK 588
V T Y APE + ++S DV+S G +L E+ +
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 23/194 (11%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGL--KELKNEIILFSKLQH 442
DN+ I +G G +G VY E+ +A+K+++++ E + K + EI + ++L+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 443 RNLVKLLGCCI-----HGEEKLLIYEFMP---NKSLDSFI-FDQERCKLLDWSKRFHIIC 493
+++L I +E ++ E K + I +E K I+
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIK--------TILY 136
Query: 494 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 553
G ++H IIHRDLK +N LL+QD + K+ DFGLAR ++ N +
Sbjct: 137 NLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 554 TYGYMAPEYASDGQ 567
Q
Sbjct: 194 NEEPGPHNKNLKKQ 207
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 37/177 (20%), Positives = 70/177 (39%), Gaps = 30/177 (16%)
Query: 375 PLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNE 433
++ A D ++ LG G G V + +++ A+K L + + E
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE 60
Query: 434 I-ILFSKLQHRNLVKLLGCC---IHGEEKL-LIYEFMPNKSLDSFIFD--QERCKLL--- 483
+ + + Q ++V+++ G + L ++ E + L F Q+R
Sbjct: 61 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTE 116
Query: 484 -DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLA 536
+ S+ I + YLH + I HRD+K N+L + K++DFG A
Sbjct: 117 REASEIMKSIGEA---IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 75.3 bits (184), Expect = 9e-15
Identities = 38/202 (18%), Positives = 65/202 (32%), Gaps = 52/202 (25%)
Query: 385 ATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRL--------SKISEQGLKELKNEIIL 436
T+ +K+GEG FG V++ AD +A+K + + ++ +E+ EII+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 437 FSKLQ---------HRNLVKLLGCCI-----------------------------HGEEK 458
+L + L +++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 518
L I +D +Q R KL + I+ L LR HRDL
Sbjct: 137 LFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWG 191
Query: 519 NVLLDQDMNPKISDFGLARAFG 540
NVLL + K+ ++
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSST 213
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 56/232 (24%), Positives = 107/232 (46%), Gaps = 40/232 (17%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGL--KELKNEIILFSKLQ- 441
+ + KKLG+G +G V+K + +AVK++ + + EI++ ++L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 442 HRNLVKLLGCCI--HGEEKLLIYEFMP---NKSLDSFIFDQERCKLLDWSKRFHIICGTA 496
H N+V LL + + L++++M + + + I + + +++
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQ--------YVVYQLI 119
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV----- 551
+ + YLH S ++HRD+K SN+LL+ + + K++DFGL+R+F N +
Sbjct: 120 KVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 552 --------------VGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK 588
V T Y APE +++ D++S G +L EI+ GK
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 23/201 (11%), Positives = 53/201 (26%), Gaps = 45/201 (22%)
Query: 394 KLGEGGFGPVYKGTLADEQ---EIAVKRL---SKISEQGLKELKNEIILFSKLQHRNLVK 447
G ++ D ++A+ + + + L+E + + S++ + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 448 LLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSR 507
+L L++ E++ SL + A H R
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA--DTS---PSPVGAIRAMQSLAAAADAAH---R 147
Query: 508 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ 567
+ S V + D G V+ M
Sbjct: 148 AGVALSIDHPSRVRVSID--------GDV--------------VLAYPATMPDA------ 179
Query: 568 FSVKSDVFSFGILLLEIVSGK 588
+ + D+ G L ++ +
Sbjct: 180 -NPQDDIRGIGASLYALLVNR 199
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 42/225 (18%)
Query: 391 INKKLGEGGFGPVYKGT-LADEQEIAVKRL---SKISEQGLKELK-------NEIILFSK 439
+ +KLG G F V+ + + +A+K + +E E+K +
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 440 LQHRNLVKLLGCCIH-GEEKL---LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI--IC 493
+ +++KLL H G + +++E + ++L + I E + + +
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-------HRGIPLIYVK 134
Query: 494 GTAR----GLLYLHQDSRLRIIHRDLKASNVLLDQDMNP------KISDFGLARAFGGDE 543
++ GL Y+H R IIH D+K NVL++ +P KI+D G A
Sbjct: 135 QISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----WY 188
Query: 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
E TN + T Y +PE + +D++S L+ E+++G
Sbjct: 189 DEHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 38/233 (16%), Positives = 82/233 (35%), Gaps = 31/233 (13%)
Query: 354 ENRNNRGTEQKNEDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQE 413
+ ++ + P ++ + + + KK+G GGFG +Y ++ E
Sbjct: 5 HHHSSGVDLGTENLYFQSMPFPEGKVLDDMEG-NQWVLGKKIGSGGFGLIYLAFPTNKPE 63
Query: 414 IAVKRLSKISEQGLKELKNEIILFSKLQHRNLV----KLLGCCIHGEEKLLIYEFMPNKS 469
+ + K+ Q L +E+ + ++ ++ + + G K
Sbjct: 64 KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKG 123
Query: 470 LDSFIFDQERC-----KLLDWSKRFHI--ICGTARGLL----YLHQDSRLRIIHRDLKAS 518
ER K+ + F + +L Y+H++ +H D+KA+
Sbjct: 124 RSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAA 180
Query: 519 NVLLDQDMNPKI--SDFGLARAFGGDET-----EGNTNRVVGTYGYMAPEYAS 564
N+LL ++ +D+GL+ + + E GT E+ S
Sbjct: 181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGT-----IEFTS 228
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 39/164 (23%), Positives = 74/164 (45%), Gaps = 25/164 (15%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQH-RN 444
+ + + +K+G G FG +Y GT +A +E+A+K ++ L E ++ +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI--ICGTARGLL-- 500
+ + C G+ +++ E + SL+ C S++F + + A ++
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLF---NFC-----SRKFSLKTVLLLADQMISR 117
Query: 501 --YLHQDSRLRIIHRDLKASNVLLDQDMNPK---ISDFGLARAF 539
Y+H + IHRD+K N L+ I DFGLA+ +
Sbjct: 118 IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 37/164 (22%), Positives = 73/164 (44%), Gaps = 25/164 (15%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL 445
+ F + +K+G G FG +Y GT + +E+A+K + ++ L E ++ LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTG 64
Query: 446 V-KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI--ICGTARGLL-- 500
+ + + G+ +L+ + + SL+ C S++ + + A ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLF---NFC-----SRKLSLKTVLMLADQMINR 115
Query: 501 --YLHQDSRLRIIHRDLKASNVLLDQDMNPK---ISDFGLARAF 539
++H S +HRD+K N L+ I DFGLA+ +
Sbjct: 116 VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 54/226 (23%)
Query: 389 FSINKKLGEGGFGPVYKGT-LADEQEIAVKRL---SKISEQGLKELKNEIILFSKLQHR- 443
+ + K +G+G FG V K Q +A+K + + Q +E++ IL L+ +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR---IL-EHLRKQD 154
Query: 444 -----NLVKLLGC-------CIHGEEKLL---IYEFMPNKSLDSFIFDQERCKLLDWSKR 488
N++ +L C+ E LL +YE + F R
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSLPLVR--------- 203
Query: 489 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEG 546
+ L LH + RIIH DLK N+LL Q K+ DFG + +
Sbjct: 204 -KFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CY------- 251
Query: 547 NTNRVVGTY----GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
++ V TY Y APE ++ + D++S G +L E+++G
Sbjct: 252 -EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 39/212 (18%), Positives = 72/212 (33%), Gaps = 53/212 (25%)
Query: 388 NFSINKKLGEGGFGPVYKGTLADEQEIAVKRLS--KISEQGLKELKNEIILFSKLQHRNL 445
+ + +G+GGFG +Y + + + K+ L E+ + +
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 446 V---------------KLLGCCIHGEEKLLIYEFMP----NKSLDSFIFDQERCKLLDW- 485
+ K G +H + Y FM L K+ +
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKS-YRFMIMDRFGSDLQ---------KIYEAN 145
Query: 486 SKRFHI--ICGTARGLL----YLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLAR 537
+KRF + + +L Y+H+ +H D+KASN+LL+ ++ D+GLA
Sbjct: 146 AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
Query: 538 AFGGDET-----EGNTNRVVGTYGYMAPEYAS 564
+ + GT E+ S
Sbjct: 203 RYCPEGVHKAYAADPKRCHDGT-----IEFTS 229
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 33/166 (19%), Positives = 79/166 (47%), Gaps = 27/166 (16%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQH-RN 444
++ + +++GEG FG +++GT L + Q++A+K + S+ L++E + L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTG 67
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI--ICGTARGLL-- 500
+ + G +L+ + + SL+ + + C ++F + + A+ +L
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLEDLL---DLC-----GRKFSVKTVAMAAKQMLAR 118
Query: 501 --YLHQDSRLRIIHRDLKASNVLLDQDMNPK-----ISDFGLARAF 539
+H+ S +++RD+K N L+ + + + DFG+ + +
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 49/227 (21%), Positives = 82/227 (36%), Gaps = 48/227 (21%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVK---RLSKISEQGLKELKNEIILFSKLQ 441
D + I+ +G+G FG V K +++ +A+K Q E++ +L +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR---LL-ELMN 108
Query: 442 HR------NLVKLLGCCIHGE------EKLLI--YEFMPNKSLDSFIFDQERCKLLDWSK 487
+V L + E L Y+ + N + + R
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTR-------- 160
Query: 488 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETE 545
LL+L L IIH DLK N+LL KI DFG + G
Sbjct: 161 --KFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQR-- 214
Query: 546 GNTNRVVGTY----GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
+ Y Y +PE + + D++S G +L+E+ +G+
Sbjct: 215 ------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 40/165 (24%), Positives = 71/165 (43%), Gaps = 27/165 (16%)
Query: 388 NFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQH-RNL 445
NF + KK+G G FG + G L + +A+K S +L E + +L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGI 67
Query: 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHI--ICGTARGLL--- 500
++ G+ ++ E + SL+ +FD C + F + + A L+
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLED-LFDL--C-----DRTFSLKTVLMIAIQLISRM 118
Query: 501 -YLHQDSRLRIIHRDLKASNVLLDQDMNPK-----ISDFGLARAF 539
Y+H + +I+RD+K N L+ + N I DF LA+ +
Sbjct: 119 EYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 33/208 (15%), Positives = 71/208 (34%), Gaps = 45/208 (21%)
Query: 388 NFSINKKLGEGGFGPVYKGT---------LADEQEIAVKRLSKISEQGLKELK------- 431
+ + G +Y+ +Q+ ++K L + E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAK 101
Query: 432 -NEIILFSKLQHRNLV---KLLGCCIHGEEKLLIYEFMP----NKSLDSFIFDQERCKLL 483
++ + KL L+ +G +H ++ Y F+ +SL S D +L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQS-ALDVSPKHVL 156
Query: 484 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLARAFGG 541
+ C L +LH++ +H ++ A N+ +D + ++ + +G A +
Sbjct: 157 SERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 542 DET-----EGNTNRVVGTYGYMAPEYAS 564
EG+ + G E+ S
Sbjct: 214 SGKHVAYVEGSRSPHEGD-----LEFIS 236
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 55/279 (19%), Positives = 93/279 (33%), Gaps = 100/279 (35%)
Query: 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQE---IAVKRLSKISEQGLKELKNEIILFSKLQ 441
+ + +KLG G F V+ L+ D Q +A+K + K +E + +EI L ++
Sbjct: 36 NGRYHVIRKLGWGHFSTVW---LSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVR 91
Query: 442 --------HRNLVKLLGC-CIHGEE---KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRF 489
+V+LL I G +++E + LL W +
Sbjct: 92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-------------GHHLLKWIIKS 138
Query: 490 -----------HIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---------------- 522
II +GL YLH ++ RIIH D+K N+LL
Sbjct: 139 NYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATE 196
Query: 523 ---------------------------------DQDMNPKISDFGLARAFGGDETEGNTN 549
+ + KI+D G A TE
Sbjct: 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE---- 252
Query: 550 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
+ T Y + E ++ +D++S + E+ +G
Sbjct: 253 -DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 51/243 (20%), Positives = 85/243 (34%), Gaps = 64/243 (26%)
Query: 386 TDNFSINKKLGEGGFGPVYKG--TLADEQEIAVK---RLSKISEQGLKELKNEIILFSKL 440
+ + I LGEG FG V + + ++A+K + K E E+ +L K+
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN---VL-KKI 73
Query: 441 QHR------NLVKLLGC-------CIHGEEKLL---IYEFMPNKSLDSFIFDQERCKLLD 484
+ + V + CI E LL +EF+ + + R
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENNFQPYPLPHVR----- 126
Query: 485 WSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP---------------- 528
H+ L +LH ++ H DLK N+L
Sbjct: 127 -----HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN 178
Query: 529 ---KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIV 585
+++DFG A F + + +V T Y PE + ++ DV+S G +L E
Sbjct: 179 TSIRVADFGSA-TFDHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233
Query: 586 SGK 588
G
Sbjct: 234 RGF 236
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 55/236 (23%), Positives = 86/236 (36%), Gaps = 56/236 (23%)
Query: 389 FSINKKLGEGGFGPVYKG--TLADEQEIAVK---RLSKISEQGLKELKNEIILFSKLQHR 443
+ I LGEG FG V + A + +AVK + + E E++ +L L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ---VL-EHLNTT 71
Query: 444 ------NLVKLLGC-------CIHGEEKLL---IYEFMPNKSLDSFIFDQERCKLLDWSK 487
V++L CI E LL Y+F+ F D R
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENGFLPFRLDHIR-------- 121
Query: 488 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA--------- 538
+ + + +LH ++ H DLK N+L Q + + + R
Sbjct: 122 --KMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 539 ----FGG--DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
FG + E + + +V T Y APE +S DV+S G +L+E G
Sbjct: 177 KVVDFGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 54/239 (22%), Positives = 88/239 (36%), Gaps = 58/239 (24%)
Query: 389 FSINKKLGEGGFGPVYKGT-LADEQEIAVK---RLSKISEQGLKELKNEIILFSKLQHR- 443
F + +K+G+G FG V + +++ AVK + K + E IL K+Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD---IL-KKIQNDD 92
Query: 444 ----NLVKLLGC-------CIHGEEKLL---IYEFMPNKSLDSFIFDQERCKLLDWSKRF 489
N+VK G C+ E L +YE + + + F + +
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNNYNGFHIEDIK---------- 140
Query: 490 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 549
+ L YL ++ + H DLK N+LLD K G T
Sbjct: 141 LYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 550 R--------------------VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
++ T Y APE + + V SD++SFG +L E+ +G
Sbjct: 198 STGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 3e-04
Identities = 85/624 (13%), Positives = 162/624 (25%), Gaps = 183/624 (29%)
Query: 40 LLPGMKLGWDLK--TGLERRITSWKSPDD----PSPGNFT----WAVERQDNPELIMWKG 89
+D K + + I S + D + T W + + +
Sbjct: 25 FEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQE------EM 78
Query: 90 SRKFYRSG-----PWNGLRFSAATLRQNPVFNFSFVSSEDELYYTFDLIDKAVFSRIVMN 144
+KF + RQ + ++ D LY + K SR+
Sbjct: 79 VQKFVEEVLRINYKFLMSPIKTEQ-RQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPY 137
Query: 145 QTLYLRQRFTWKKATQNWELQLNVPRDLCDTYALCGDYGI---CIISDLPVCQCLKGFKP 201
L + L+L +++ + G G + D VC K +
Sbjct: 138 LKL------------RQALLELRPAKNV----LIDGVLGSGKTWVALD--VCLSYK-VQC 178
Query: 202 KSRGYVDW-SQG-CVRDKSL-------------NY-SREDGFIK---------------F 230
K + W + C +++ N+ SR D
Sbjct: 179 KMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLL 238
Query: 231 TAMKLP-------DATPSWVSKSMNLKECREKCL---ENSSCMAYTNSDIRGGGSGCAMW 280
+ + + + NL C K L +D + +
Sbjct: 239 KSKPYENCLLVLLNVQNAKAWNAFNLS-C--KILLTTRFKQ-----VTDFLSAATTTHI- 289
Query: 281 FGELIDMRD-F-PDGGQDL---YIRMSASELGAKGEP--TTKIVLIVISTAALLAVVIAA 333
L PD + L Y+ +L P +S +IA
Sbjct: 290 --SLDHHSMTLTPDEVKSLLLKYLDCRPQDL-----PREVLTTNPRRLS-------IIAE 335
Query: 334 GYLIHKSRRNIVVNIARYFRENRNNRGT---EQKNEDQNIDLDLPLFELATIANATDNFS 390
+ + ++ ++ T E +F+ ++ F
Sbjct: 336 SIRDGLATWD-------NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV------FP 382
Query: 391 INKKLGEGGFGPVYKGTLADEQEIAVKRLSKIS--EQGLKELKNEI--ILFSKLQHRNLV 446
+ + ++ + + + V +L K S E+ KE I I
Sbjct: 383 PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENE 442
Query: 447 KLLGCCIHGEEKLLI--YEF--------MPNKSLDSFIFDQERCKLLDWSKRFHIICGTA 496
L H + ++ Y + LD + + HI G
Sbjct: 443 YAL----H---RSIVDHYNIPKTFDSDDLIPPYLDQYFY-------------SHI--G-- 478
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAFGGDETEGNTNRVVGTY 555
+ H + R V LD + KI A G NT + + Y
Sbjct: 479 ----H-HL-KNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSIL--NTLQQLKFY 530
Query: 556 -GYMAPEYASDGQFSVK-SDVFSF 577
Y+ +D ++ + + F
Sbjct: 531 KPYICD---NDPKYERLVNAILDF 551
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 706 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.85 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.1 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 98.94 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 98.93 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 98.93 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.9 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.48 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.45 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.4 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.34 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.29 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.02 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.77 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.71 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.69 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 97.6 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 97.48 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 97.46 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 97.45 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.44 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 97.41 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.39 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 97.37 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.33 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.27 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.24 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.22 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 97.2 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.19 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 97.19 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 97.14 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 97.14 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.01 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 96.96 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 96.83 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.73 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 96.68 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.65 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.3 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 96.25 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 96.11 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.84 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 95.26 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 94.48 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.75 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 89.29 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.72 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.95 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.85 | |
| 1b9w_A | 95 | Protein (merozoite surface protein 1); MSP-1, cand | 81.13 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=445.86 Aligned_cols=261 Identities=27% Similarity=0.423 Sum_probs=207.7
Q ss_pred cCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+.++++++|||||+++++|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56788899999999999999864 367899999988777788899999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhcccc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCe
Q 005236 461 IYEFMPNKSLDSFIFDQER------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 528 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 528 (706)
|||||++|+|.++|+.... ...++|.++++|+.|||+||+|||+.+ ||||||||+||||++++++
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999975421 245899999999999999999999987 9999999999999999999
Q ss_pred EEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHH
Q 005236 529 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAW 607 (706)
Q Consensus 529 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 607 (706)
||+|||+|+.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||..... .+.+....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i~ 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDCIT 274 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHHHHH
Confidence 9999999997754444444445679999999999999999999999999999999999 8999864322 22222221
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCCC
Q 005236 608 KLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVL 666 (706)
Q Consensus 608 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~~ 666 (706)
.+....... ..+ ..+.+|+.+||+.||++||||+||++.|+.+...
T Consensus 275 ----~g~~~~~p~-----~~~----~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 275 ----QGRELERPR-----ACP----PEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ----HTCCCCCCT-----TCC----HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----cCCCCCCcc-----ccc----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 111111111 111 2466799999999999999999999999987543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-54 Score=441.46 Aligned_cols=258 Identities=28% Similarity=0.456 Sum_probs=213.4
Q ss_pred cCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+.++++++|||||+++++|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57888999999999999999864 367899999988777778899999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhccc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEE
Q 005236 461 IYEFMPNKSLDSFIFDQE----------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 530 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 530 (706)
|||||++|+|.++|+... ....++|..+++|+.|||+||+|||+++ |+||||||+||||++++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 2356999999999999999999999987 999999999999999999999
Q ss_pred eeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHH
Q 005236 531 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKL 609 (706)
Q Consensus 531 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 609 (706)
+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||..... .+......
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i~-- 244 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECIT-- 244 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHH--
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH--
Confidence 99999997654433333444679999999999999999999999999999999999 8999864332 22222221
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 610 WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 610 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.+....... .. ...+.+|+.+||+.||++||||+||++.|+.+
T Consensus 245 --~~~~~~~p~-----~~----~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 245 --QGRVLQRPR-----TC----PQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp --HTCCCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --cCCCCCCCc-----cc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 222111111 11 12466899999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=432.46 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=201.1
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
+++++.++||+|+||+||+|++++ .||||+++. ......+.|.+|+.++++++|||||++++++.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 678899999999999999999754 599999864 345667889999999999999999999998854 578999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
|++|+|.++|+... ..+++..+++|+.|||+||+|||+++ ||||||||+||||++++++||+|||+|+.......
T Consensus 113 ~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 99999999996543 45899999999999999999999987 99999999999999999999999999987654333
Q ss_pred cccccccccccCccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
.......+||+.|||||++.+ ..|+.++|||||||+||||+||+.||...... .............+....+..
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~- 264 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGYASPDLSKLYK- 264 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTCCCCCSTTSCT-
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCCcccccc-
Confidence 334455789999999999964 46899999999999999999999998543221 111111111111111111111
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.. ...+.+|+.+||+.||++||||.||++.|+.+
T Consensus 265 ----~~----~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 265 ----NC----PKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp ----TS----CHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ----cc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 13466789999999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-53 Score=436.81 Aligned_cols=258 Identities=27% Similarity=0.426 Sum_probs=210.8
Q ss_pred cCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 459 (706)
+++++.++||+|+||+||+|++. +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677899999999999999863 4678999999753 3344678999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC
Q 005236 460 LIYEFMPNKSLDSFIFDQE-------------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 526 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 526 (706)
+|||||++|+|.++|.... ....++|..+++|+.|||+||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999996532 1245899999999999999999999988 99999999999999999
Q ss_pred CeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHH
Q 005236 527 NPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRH 605 (706)
Q Consensus 527 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 605 (706)
++||+|||+|+.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||..... .+.+..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVEM 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHHH
Confidence 999999999997654443334445689999999999999999999999999999999999 8999764332 222222
Q ss_pred HHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 606 AWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 606 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
+..+......+ .. ...+.+|+.+||+.||.+||||+||++.|+..
T Consensus 260 ----i~~~~~~~~p~-----~~----~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 ----IRNRQVLPCPD-----DC----PAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ----HHTTCCCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----HHcCCCCCCcc-----cc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 22222222111 11 13466899999999999999999999999854
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=425.68 Aligned_cols=250 Identities=21% Similarity=0.349 Sum_probs=201.0
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
++|++.++||+|+||+||+|+.. +++.||||++.. ......+.+.+|+.++++++|||||++++++.+.+..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999984 589999999864 345567789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
||++|+|.++|.... ...+++..++.|+.||+.||+|||+++ |+||||||+||||++++++||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp CCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred CCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 999999999996543 345788899999999999999999998 999999999999999999999999999875321
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
.......+||+.|||||++.+..|+.++|||||||+||||++|+.||.... ....... ..... ...+.
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~---i~~~~-~~~~~---- 246 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS---MKNLVLK---IISGS-FPPVS---- 246 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHH---HHHTC-CCCCC----
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHH---HHcCC-CCCCC----
Confidence 112334679999999999999999999999999999999999999985422 2222222 22221 11111
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
...+ ..+.+|+.+||+.||.+|||++|+++
T Consensus 247 -~~~s----~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 247 -LHYS----YDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -ccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 24567899999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=422.90 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=206.3
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
+.|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999985 58999999997655555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++|+|.+++.+ ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 224 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 224 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence 99999999854 34899999999999999999999998 9999999999999999999999999999864332
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||.... ......... ......+.. + .
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~----~~~~~~~~~--~-~ 294 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIR----DNLPPRLKN--L-H 294 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHH----HSSCCCCSC--G-G
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHH----cCCCCCCCc--c-c
Confidence 22344789999999999999999999999999999999999999985422 222222221 111111100 0 0
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
..+ ..+.+|+.+||+.||++|||++|+++
T Consensus 295 ~~s----~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 295 KVS----PSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCC----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 24567899999999999999999876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=421.62 Aligned_cols=248 Identities=25% Similarity=0.323 Sum_probs=207.9
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.++||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999984 5889999999653 2344678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|.++|.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999654 35899999999999999999999998 999999999999999999999999999987655
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
.........+||+.|||||++.+..|+.++||||+||+||||++|+.||.... ......... .. .. .+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~---~~-~~-~~---- 253 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EGLIFAKII---KL-EY-DF---- 253 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH---HT-CC-CC----
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHH---cC-CC-CC----
Confidence 44445556789999999999999999999999999999999999999985422 222222221 11 11 01
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI 657 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~ 657 (706)
....+ ..+.+|+.+||+.||.+|||++|++
T Consensus 254 -p~~~s----~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 -PEKFF----PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -CTTCC----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -CcccC----HHHHHHHHHHccCCHhHCcChHHHc
Confidence 01112 2456799999999999999999963
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=426.22 Aligned_cols=268 Identities=28% Similarity=0.410 Sum_probs=215.5
Q ss_pred HHHHHHhccCCCccceeccCCceeEEEEEeCC------CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCC-cceeeeEe
Q 005236 379 LATIANATDNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQH-RNLVKLLG 450 (706)
Q Consensus 379 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~l~~ 450 (706)
..+.....++|++.++||+|+||+||+|++.. ++.||||++... .....+.|.+|+.++.+++| ||||++++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 34444456889999999999999999998643 357999999763 34456789999999999965 89999999
Q ss_pred EEEeC-CeeEEEEecCCCCChhhhhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 005236 451 CCIHG-EEKLLIYEFMPNKSLDSFIFDQER-------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 516 (706)
Q Consensus 451 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik 516 (706)
+|.+. +..++|||||++|+|.++|+.... ...+++..++.++.|||+||+|||+++ |||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccC
Confidence 99764 568999999999999999975432 245899999999999999999999988 9999999
Q ss_pred CCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 005236 517 ASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYH 595 (706)
Q Consensus 517 p~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~ 595 (706)
|+||||++++.+||+|||+|+.+..+..........||+.|||||++.+..|+.++|||||||+||||+| |+.||....
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999998765554444555789999999999999999999999999999999998 899986433
Q ss_pred CCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 596 SDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
... .... .+..+......+ ..+ ..+.+++.+||+.||.+|||++||++.|+.+.
T Consensus 293 ~~~--~~~~----~i~~g~~~~~p~-----~~~----~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 293 IDE--EFCR----RLKEGTRMRAPD-----YTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp CSH--HHHH----HHHHTCCCCCCT-----TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH--HHHH----HHHcCCCCCCCc-----cCC----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 221 1111 122222111111 111 24667899999999999999999999998653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=418.05 Aligned_cols=252 Identities=23% Similarity=0.269 Sum_probs=203.1
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
.+.|++.++||+|+||.||+|++. .|+.||||+++.... ..+|+.++++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888899999999999999985 589999999865321 24699999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-CeEEeeeccccccCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFGGDE 543 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfgla~~~~~~~ 543 (706)
|+||+|.++|.+. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.+..+.
T Consensus 132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999654 35899999999999999999999988 99999999999999988 69999999999875432
Q ss_pred Ccc---cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC-cccc
Q 005236 544 TEG---NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP-SQLI 619 (706)
Q Consensus 544 ~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 619 (706)
... .....+||+.|||||++.+..++.++|||||||+||||++|+.||...........+. ..... .++.
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~~~~~~~~~ 279 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA------SEPPPIREIP 279 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH------HSCCGGGGSC
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------cCCCCchhcC
Confidence 211 2234679999999999999999999999999999999999999987544433322221 11111 1111
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
...+ ..+.+++.+||+.||.+|||+.||++.|...
T Consensus 280 -----~~~s----~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 280 -----PSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp -----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----ccCC----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1111 2456788999999999999999999887643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=416.84 Aligned_cols=268 Identities=23% Similarity=0.277 Sum_probs=200.9
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC----eeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE----EKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 462 (706)
++|.+.++||+|+||+||+|++ .|+.||||++...... ...++.|+..+.+++|||||++++++.+.+ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4678889999999999999998 5889999999654322 223345666778899999999999998764 579999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
|||++|+|.++|+.. .++|..+++++.|+++||+|||++ ..++|+||||||+||||++++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999643 489999999999999999999986 13359999999999999999999999999998
Q ss_pred ccCCCCCc--ccccccccccCccCccccccC------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc--------hh
Q 005236 538 AFGGDETE--GNTNRVVGTYGYMAPEYASDG------QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK--------LN 601 (706)
Q Consensus 538 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~--------~~ 601 (706)
........ ......+||+.|||||++.+. .++.++|||||||+||||+||+.|+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76443222 223346799999999999764 467899999999999999999887643221110 01
Q ss_pred HHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 602 LIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
..............+.-+.. ...+.+....+.+++.+||+.||++||||.||++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCc---cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11122222222222111111 112234556678899999999999999999999999865
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=404.71 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=196.5
Q ss_pred CccceeccCCceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEe----CCeeEEEE
Q 005236 390 SINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIH----GEEKLLIY 462 (706)
Q Consensus 390 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 462 (706)
++.++||+|+||+||+|++. .++.||||++.. ......+.|.+|+.++++++|||||++++++.+ +...+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 66788999999999999985 488999999864 345556789999999999999999999999875 34579999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc-CCCCeEEeeeccccccCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGG 541 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~Dfgla~~~~~ 541 (706)
|||++|+|.++|.+. ..+++..+..++.||+.||+|||+++ .+|+||||||+||||+ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999653 45899999999999999999999875 3599999999999998 479999999999986432
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
......+||+.|||||++.+ .|+.++|||||||+||||+||+.||..... ... .......+..+..++.
T Consensus 185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~----~~~~i~~~~~~~~~~~ 253 (290)
T 3fpq_A 185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQ----IYRRVTSGVKPASFDK 253 (290)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHH----HHHHHTTTCCCGGGGG
T ss_pred ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHH----HHHHHHcCCCCCCCCc
Confidence 22334689999999998865 699999999999999999999999853221 111 1122222222111111
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
... ..+.+|+.+||+.||.+|||++|+++
T Consensus 254 ----~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 254 ----VAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----CCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----cCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 13567899999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=423.72 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=206.6
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
+.|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 57999999999999999999985 58999999997655555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+.+....
T Consensus 231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-- 301 (423)
T 4fie_A 231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 301 (423)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence 99999999854 34899999999999999999999998 9999999999999999999999999999864332
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||... .......... ......+.. + .
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~----~~~~~~~~~--~-~ 371 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIR----DNLPPRLKN--L-H 371 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHH----HSCCCCCSC--T-T
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHH----cCCCCCCcc--c-c
Confidence 2234578999999999999999999999999999999999999998532 2222222221 111111100 0 0
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
..+ ..+.+|+.+||+.||.+|||++|+++
T Consensus 372 ~~s----~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 372 KVS----PSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCC----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 24567899999999999999999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=402.48 Aligned_cols=246 Identities=24% Similarity=0.369 Sum_probs=188.7
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 368999999999999999999974 5899999998653 233456799999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+ +|+|.++|.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||++++++||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EeCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9999 68999998654 35899999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCcccccccccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.. .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||... ......... ...... + .
T Consensus 165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~~~~~~i----~~~~~~-~-p 232 (275)
T 3hyh_A 165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIPVLFKNI----SNGVYT-L-P 232 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH----HHTCCC-C-C
T ss_pred CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHH----HcCCCC-C-C
Confidence 22 2234689999999999998876 57999999999999999999998532 222222221 111110 0 0
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
...+ ..+.+++.+||+.||++|||++|+++
T Consensus 233 ----~~~s----~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 233 ----KFLS----PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ----TTSC----HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CCCC----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1112 24567899999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=410.65 Aligned_cols=247 Identities=24% Similarity=0.296 Sum_probs=193.9
Q ss_pred cCCCccceeccCCceeEEEEEeC----CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA----DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
++|++.++||+|+||+||+|+.. .++.||||++.+. .......+.+|+.++++++|||||++++++.+.+..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999862 3678999998653 22334568889999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||++||+|.++|.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999654 35899999999999999999999998 9999999999999999999999999998653
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
... ......+||+.|||||++.+..++.++|||||||+||||++|+.||.... ......... .. .. .+
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~---~~-~~-~~-- 245 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD---RKETMTMIL---KA-KL-GM-- 245 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH---HC-CC-CC--
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC---HHHHHHHHH---cC-CC-CC--
Confidence 322 22334689999999999999999999999999999999999999985422 222222221 11 11 00
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCCh-----hHHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCM-----PSVIL 658 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~-----~ev~~ 658 (706)
....+ ..+.+++.+||+.||++|||+ +|+++
T Consensus 246 ---p~~~s----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 246 ---PQFLS----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ---CTTSC----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ---CCcCC----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 01112 245678999999999999985 56653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=400.00 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=190.8
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC--------
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE-------- 456 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 456 (706)
++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+.++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999984 5889999998653 3445578999999999999999999999987654
Q ss_pred ----eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEee
Q 005236 457 ----EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 532 (706)
Q Consensus 457 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 532 (706)
..++||||+++|+|.+++.........++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999977665566777888999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCCCcc----------cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhH
Q 005236 533 FGLARAFGGDETEG----------NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNL 602 (706)
Q Consensus 533 fgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~ 602 (706)
||+|+.+....... .....+||+.|||||++.+..|+.++|||||||++|||++ ||.. ..+.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~-----~~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-----QMER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS-----HHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC-----ccHH
Confidence 99999875432211 1233579999999999999999999999999999999996 5431 1111
Q ss_pred HHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 603 IRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 603 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.... ........+.... .....+.+++.+||+.||.+|||+.|+++
T Consensus 234 ~~~~-~~~~~~~~p~~~~---------~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTL-TDVRNLKFPPLFT---------QKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHH-HHHHTTCCCHHHH---------HHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH-HHHhcCCCCCCCc---------ccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 1112222221111 11123456889999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=388.34 Aligned_cols=285 Identities=35% Similarity=0.596 Sum_probs=245.6
Q ss_pred HHHHHHhccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCee
Q 005236 379 LATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 379 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 458 (706)
+.++...+++|++.+.||+|+||.||+|++.+++.||||++........+.+.+|+.++++++||||+++++++.+.+..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 33445577899999999999999999999988999999999876666778899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhcccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQER-CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999965432 235899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
...............||+.|+|||++.+..++.++||||||+++|||++|+.||......+......+.......+....
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 75433333333445689999999999999999999999999999999999999977666666666666555555666667
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCCC
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVL 666 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~~ 666 (706)
++++.+...........+.+++.+||+.||++|||++||++.|+.+..+
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 7777776677778888899999999999999999999999999876443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=393.79 Aligned_cols=261 Identities=20% Similarity=0.317 Sum_probs=200.4
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEe------CCe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIH------GEE 457 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 457 (706)
++|++.++||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.+|++++|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 68999999999999999999984 5899999999653 34456778899999999999999999998764 357
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.|+|||||+ |+|.++|... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 6799998543 45899999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCC--cccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC
Q 005236 538 AFGGDET--EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM 614 (706)
Q Consensus 538 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 614 (706)
.+..... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||..... ...............
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~---~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY---VHQLQLIMMVLGTPS 283 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCCCC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCCCC
Confidence 7643322 2233457899999999998875 569999999999999999999999864332 222222222111111
Q ss_pred Ccccccc------------cc-cCcCCHHH-----HHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 615 PSQLIDA------------CF-KDSFNLAE-----VIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 615 ~~~~~d~------------~~-~~~~~~~~-----~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
. ..... .. .....+.. ...+.+|+.+||+.||.+|||++|+++
T Consensus 284 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 284 P-AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp G-GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred h-HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 00000 00 00111111 124678999999999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=382.86 Aligned_cols=198 Identities=25% Similarity=0.395 Sum_probs=170.0
Q ss_pred HhccCCCccceeccCCceeEEEEEeC----CCcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCee
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTLA----DEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 458 (706)
...+.|++.++||+|+||+||+|+.+ .++.||||++.... ....+.+|+.+++.+ +|||||++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45678999999999999999999863 46789999986543 345678999999998 699999999999999999
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-CCeEEeeecccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLAR 537 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfgla~ 537 (706)
++||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999983 3889999999999999999999998 9999999999999877 799999999998
Q ss_pred ccCCCCCc--------------------------ccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCC
Q 005236 538 AFGGDETE--------------------------GNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKN 590 (706)
Q Consensus 538 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p 590 (706)
........ ......+||+.|||||++.+. .++.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65432111 012235799999999999875 589999999999999999999999
Q ss_pred CC
Q 005236 591 RG 592 (706)
Q Consensus 591 ~~ 592 (706)
|.
T Consensus 247 f~ 248 (361)
T 4f9c_A 247 FY 248 (361)
T ss_dssp SS
T ss_pred CC
Confidence 74
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=377.99 Aligned_cols=289 Identities=40% Similarity=0.669 Sum_probs=243.3
Q ss_pred CCcccHHHHHHhccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccch-hhHHHHHHHHHHHhhcCCcceeeeEeEE
Q 005236 374 LPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISE-QGLKELKNEIILFSKLQHRNLVKLLGCC 452 (706)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~ 452 (706)
...+++.++....++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|+.++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 445788899999999999999999999999999988899999999875432 2234689999999999999999999999
Q ss_pred EeCCeeEEEEecCCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEe
Q 005236 453 IHGEEKLLIYEFMPNKSLDSFIFDQE-RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 531 (706)
Q Consensus 453 ~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 531 (706)
......++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+....+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997654 23458999999999999999999999822239999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCC--CCCCchhHHHHHHHH
Q 005236 532 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY--HSDNKLNLIRHAWKL 609 (706)
Q Consensus 532 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~--~~~~~~~~~~~~~~~ 609 (706)
|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||... ..........+....
T Consensus 177 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999987643322 2233356999999999999999999999999999999999999998532 222333445555555
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 610 WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 610 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
........+.+..+...........+.+++.+||+.||.+|||++||+++|++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 566666777777777778888888999999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=406.26 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=207.4
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
.++|++.++||+|+||.||+|+.+ +|+.||||++........+.+.+|+.+|+.++|||||++++++.+....++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999985 5899999999776666778899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC--CCeEEeeeccccccCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLARAFGGD 542 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~--~~~kl~Dfgla~~~~~~ 542 (706)
|++|+|.++|... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999999543 245889999999999999999999998 9999999999999854 89999999999987433
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ........ .... .+.+..
T Consensus 311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~---~~~~~~i~----~~~~-~~~~~~ 379 (573)
T 3uto_A 311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVK----SCDW-NMDDSA 379 (573)
T ss_dssp S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHH----TTCC-CCCSGG
T ss_pred C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHH----hCCC-CCCccc
Confidence 2 23346799999999999999999999999999999999999999854322 22222111 1111 000111
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+ ...+ ..+.+|+.+||+.||.+|||+.|+++
T Consensus 380 ~-~~~s----~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 380 F-SGIS----EDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp G-TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c-cCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1111 24567899999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=396.96 Aligned_cols=249 Identities=25% Similarity=0.307 Sum_probs=197.7
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHH---HHHHHHHhhcCCcceeeeEeEEEeCCee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKEL---KNEIILFSKLQHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~ 458 (706)
.++|++.++||+|+||.||+|+.. +|+.||||++.+.. ......+ +.++.+++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 368999999999999999999985 58899999986521 1222233 3446677788999999999999999999
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
|+||||++||+|.++|.+. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999999654 35899999999999999999999988 99999999999999999999999999997
Q ss_pred cCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
+... .....+||+.|||||++.. ..|+.++|||||||+||||++|+.||......+.......... .....+.
T Consensus 342 ~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~--~~~~~p~ 415 (689)
T 3v5w_A 342 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPD 415 (689)
T ss_dssp CSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH--CCCCCCT
T ss_pred cCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC--CCCCCCc
Confidence 6433 2334689999999999975 5799999999999999999999999865433332222211111 0111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCC-----hhHHHH
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPC-----MPSVIL 658 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~ev~~ 658 (706)
..+ ..+.+|+..||+.||.+|++ ++||.+
T Consensus 416 --------~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 416 --------SFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --------TSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --------cCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 112 24568999999999999998 566653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.06 Aligned_cols=284 Identities=35% Similarity=0.551 Sum_probs=229.4
Q ss_pred CCCcccHHHHHHhccCCCcc------ceeccCCceeEEEEEeCCCcEEEEEEcCcc----chhhHHHHHHHHHHHhhcCC
Q 005236 373 DLPLFELATIANATDNFSIN------KKLGEGGFGPVYKGTLADEQEIAVKRLSKI----SEQGLKELKNEIILFSKLQH 442 (706)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h 442 (706)
....|.+.++..++++|... +.||+|+||.||+|+. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34567888899999888776 8999999999999987 6789999998642 23446789999999999999
Q ss_pred cceeeeEeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE
Q 005236 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 522 (706)
Q Consensus 443 ~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill 522 (706)
|||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999976555567999999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhH
Q 005236 523 DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNL 602 (706)
Q Consensus 523 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~ 602 (706)
++++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||...........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 9999999999999987654333333344678999999998865 589999999999999999999999876544433332
Q ss_pred HHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 603 IRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 603 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
+...... ........++..+. .........+.+++..||+.+|.+|||+.+|++.|+.+
T Consensus 246 ~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 246 IKEEIED-EEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHHT-TSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHhhh-hhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 2221111 11112233333222 23445566788999999999999999999999999865
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=362.11 Aligned_cols=266 Identities=26% Similarity=0.425 Sum_probs=204.2
Q ss_pred hccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
..++|++.++||+|+||.||+|+. .++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 347899999999999999999987 5788999998653 3455678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++++|.+++........+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999999976554455899999999999999999999874 24999999999999999999999999999864322
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......... ......+.
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~~~---~~~~~~~~--- 261 (309)
T 3p86_A 193 F--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAVGF---KCKRLEIP--- 261 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHHH---SCCCCCCC---
T ss_pred c--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh---cCCCCCCC---
Confidence 1 122345789999999999999999999999999999999999999864322 111111111 11111111
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCCCCCC
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLPQP 669 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~~~~p 669 (706)
...+ ..+.+++.+||+.+|.+|||+++|++.|+.+.....|
T Consensus 262 --~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 262 --RNLN----PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp --TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred --ccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 1111 2456789999999999999999999999987544333
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=367.64 Aligned_cols=259 Identities=28% Similarity=0.425 Sum_probs=211.3
Q ss_pred ccCCCccceeccCCceeEEEEEeC--------CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeC
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA--------DEQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHG 455 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 455 (706)
.++|++.+.||+|+||.||+|+.. .+..||||++... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999862 3457999999754 445567899999999999 899999999999999
Q ss_pred CeeEEEEecCCCCChhhhhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE
Q 005236 456 EEKLLIYEFMPNKSLDSFIFDQER-------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 522 (706)
Q Consensus 456 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill 522 (706)
+..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999975432 235789999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchh
Q 005236 523 DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLN 601 (706)
Q Consensus 523 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~ 601 (706)
+.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 9999999999999997654443333444567889999999999999999999999999999999 99997643322 2
Q ss_pred HHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 602 LIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
..... ..+....... .. ...+.+++..||+.+|.+||++.|+++.|+.+
T Consensus 314 ~~~~~----~~~~~~~~~~-----~~----~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 314 LFKLL----KEGHRMDKPA-----NC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HHHHH----HTTCCCCCCT-----TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHH----hcCCCCCCCC-----CC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22111 1111111110 11 12466789999999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=360.51 Aligned_cols=256 Identities=28% Similarity=0.422 Sum_probs=209.9
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
++|.+.++||+|+||.||+|+.. +++.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 67899999999999999999985 58899999998777778889999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 999999999653 245899999999999999999999998 999999999999999999999999999876433221
Q ss_pred c------------cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCch--hHHHHHHHHhh
Q 005236 546 G------------NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKL--NLIRHAWKLWN 611 (706)
Q Consensus 546 ~------------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~--~~~~~~~~~~~ 611 (706)
. ......||+.|+|||++.+..++.++||||||+++|||++|..|+......... .........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-- 242 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR-- 242 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH--
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc--
Confidence 1 111357999999999999999999999999999999999999987654332211 111111111
Q ss_pred cCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 612 EGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 612 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
..... .+ ..+.+++.+||+.||++|||++||++.|+.+
T Consensus 243 -~~~~~---------~~----~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 243 -YCPPN---------CP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp -TCCTT---------CC----TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cCCCC---------CC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00100 00 1355788899999999999999999999876
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=364.12 Aligned_cols=265 Identities=26% Similarity=0.378 Sum_probs=208.1
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC----eeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE----EKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 462 (706)
++|++.++||+|+||.||+|+.. ++.||||++..... ....+..|+.++++++||||+++++++.+.. ..++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 68999999999999999999885 78999999965433 3445667999999999999999999998754 369999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCceEecccCCCcEEEcCCCCeEEee
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD----------SRLRIIHRDLKASNVLLDQDMNPKISD 532 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~----------~~~~ivH~Dikp~Nill~~~~~~kl~D 532 (706)
||+++|+|.+++... .+++..++.++.||+.||+|||+. + |+||||||+|||++.++.+||+|
T Consensus 102 e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECC
T ss_pred ecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEcc
Confidence 999999999999543 389999999999999999999987 6 99999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccCccCccccccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHH----
Q 005236 533 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-----QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLI---- 603 (706)
Q Consensus 533 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~---- 603 (706)
||+++.+.............||+.|+|||++.+. .++.++||||||+++|||++|+.||............
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999887654444344446799999999999863 5667899999999999999999998654332221111
Q ss_pred -----HHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 604 -----RHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 604 -----~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
...............+...+. .......+.+++.+||+.||++|||++||++.|+.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQ---KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGG---SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCcccccc---ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111111111111111111 123445678899999999999999999999999865
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=351.58 Aligned_cols=251 Identities=23% Similarity=0.404 Sum_probs=205.9
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
.++|++.++||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999997 56889999998765555567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999543 4889999999999999999999998 99999999999999999999999999987643322
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...... ............
T Consensus 172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~---~~~~~~~~~~~~---- 239 (297)
T 3fxz_A 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYL---IATNGTPELQNP---- 239 (297)
T ss_dssp --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHH---HHHHCSCCCSCG----
T ss_pred --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH---HHhCCCCCCCCc----
Confidence 23345799999999999999999999999999999999999999854221 111111 111111110000
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
... ...+.+++.+||+.||.+|||++|+++.
T Consensus 240 ~~~----~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 240 EKL----SAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GGS----CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccc----CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011 1245678999999999999999999863
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=357.90 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=207.4
Q ss_pred ccCCCccceeccCCceeEEEEEeC----CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA----DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
.++|++.+.||+|+||.||+|++. .+..||||++... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 367899999999999999999984 3456999999763 45556789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 128 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999995432 45899999999999999999999988 9999999999999999999999999999865
Q ss_pred CCCCcc-cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 541 GDETEG-NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 541 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ........ .......
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~----~~~~~~~ 275 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISSVE----EGYRLPA 275 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHH----TTCCCCC
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH----cCCCCCC
Confidence 432221 2223456788999999999999999999999999999999 9999754322 12221111 1111110
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCCC
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVL 666 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~~ 666 (706)
. ... ...+.+++..||+.||.+|||+.+|++.|+.+...
T Consensus 276 ~-----~~~----~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 276 P-----MGC----PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp C-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred C-----CCc----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 0 011 12466789999999999999999999999987543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=358.55 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=204.8
Q ss_pred hccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
..++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346899999999999999999998 56899999998653 445567889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999999654 34889999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCcccccccccccCccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.. ......||+.|+|||++.+..++ .++|||||||++|||++|+.||..... ....... . .+... +
T Consensus 167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i---~-~~~~~-~-- 233 (328)
T 3fe3_A 167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL---KELRERV---L-RGKYR-I-- 233 (328)
T ss_dssp SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH---H-HCCCC-C--
T ss_pred CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH---HHHHHHH---H-hCCCC-C--
Confidence 22 23446799999999999988875 799999999999999999999854321 1111111 1 11110 0
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.... ...+.+++.+||+.||.+|||++|+++.
T Consensus 234 ---p~~~----s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 ---PFYM----STDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---CTTS----CHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---CCCC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0011 1245678899999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=354.34 Aligned_cols=263 Identities=24% Similarity=0.356 Sum_probs=211.1
Q ss_pred CCcccHHHHHHhccC----------CCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCC
Q 005236 374 LPLFELATIANATDN----------FSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQH 442 (706)
Q Consensus 374 ~~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 442 (706)
.+.++..++..+++. |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 345666666666543 677789999999999999986 689999999976666667889999999999999
Q ss_pred cceeeeEeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE
Q 005236 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 522 (706)
Q Consensus 443 ~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill 522 (706)
|||+++++++...+..++||||+++++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll 174 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL 174 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999853 34899999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhH
Q 005236 523 DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNL 602 (706)
Q Consensus 523 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~ 602 (706)
+.++.+||+|||++..+..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ....
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~---~~~~ 249 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS---PVQA 249 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHH
T ss_pred CCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHH
Confidence 9999999999999987643322 2234579999999999999999999999999999999999999975322 1122
Q ss_pred HHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 603 IRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 603 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.... .......+... ...+ ..+.+++.+||+.||++|||++|+++.
T Consensus 250 ~~~~----~~~~~~~~~~~---~~~~----~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 MKRL----RDSPPPKLKNS---HKVS----PVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHH----HHSSCCCCTTG---GGSC----HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHH----hcCCCCCcCcc---ccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2111 11111111100 0111 245678899999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=363.74 Aligned_cols=269 Identities=29% Similarity=0.410 Sum_probs=215.7
Q ss_pred hccCCCccceeccCCceeEEEEEeC--------CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEe
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA--------DEQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIH 454 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 454 (706)
..++|.+.++||+|+||.||+|+.. .+..||||++... .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3478999999999999999999862 2357999998653 455567899999999999 99999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEE
Q 005236 455 GEEKLLIYEFMPNKSLDSFIFDQER-------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 521 (706)
Q Consensus 455 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nil 521 (706)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999975432 235899999999999999999999988 999999999999
Q ss_pred EcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCch
Q 005236 522 LDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKL 600 (706)
Q Consensus 522 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~ 600 (706)
|++++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... .
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---~ 300 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---E 300 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---H
Confidence 99999999999999987754443334444567899999999999999999999999999999999 9998753321 1
Q ss_pred hHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCCCCCCCCC
Q 005236 601 NLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLPQPKQP 672 (706)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~~~~p~~p 672 (706)
... ..+.......... .. ...+.+++.+||+.+|.+|||++||++.|+.+.........
T Consensus 301 ~~~----~~~~~~~~~~~~~-----~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 359 (382)
T 3tt0_A 301 ELF----KLLKEGHRMDKPS-----NC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM 359 (382)
T ss_dssp HHH----HHHHTTCCCCCCS-----SC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred HHH----HHHHcCCCCCCCc-----cC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence 111 1222221111111 11 12466789999999999999999999999987544433333
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.54 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=207.5
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.++|.+.+.||+|+||.||+|++. +++.||||++... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 468899999999999999999986 6889999998753 33445678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 999999999996532 35889999999999999999999998 9999999999999999999999999998754322
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
.........+++.|+|||.+....++.++||||||+++|||++ |+.||..... ..... ....+.......
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~~----~~~~~~~~~~~~-- 338 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTRE----FVEKGGRLPCPE-- 338 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHHH----HHHTTCCCCCCT--
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHHcCCCCCCCC--
Confidence 2222222346788999999999999999999999999999998 9988754322 11111 111111111100
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.. ...+.+++.+||+.||.+|||+++|++.|+.+
T Consensus 339 ---~~----~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 339 ---LC----PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp ---TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 11 12456789999999999999999999999865
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=362.22 Aligned_cols=259 Identities=29% Similarity=0.435 Sum_probs=207.7
Q ss_pred ccCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 458 (706)
.++|++.++||+|+||.||+|++. .++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367999999999999999999853 3668999999653 455566889999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhccc----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC---CeEEe
Q 005236 459 LLIYEFMPNKSLDSFIFDQE----RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKIS 531 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl~ 531 (706)
++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997543 2245889999999999999999999998 99999999999999555 59999
Q ss_pred eeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHh
Q 005236 532 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLW 610 (706)
Q Consensus 532 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 610 (706)
|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... ....... .
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~---~~~~~~~----i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEF----V 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHH----H
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH----H
Confidence 9999986533333333344568999999999999999999999999999999998 999875422 1122211 1
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 611 NEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 611 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.......... .. ...+.+++..||+.+|.+|||+.+|++.|+.+
T Consensus 300 ~~~~~~~~~~-----~~----~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 300 TSGGRMDPPK-----NC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HTTCCCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCCCCCCc-----cC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111111111 11 12466789999999999999999999999765
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=360.22 Aligned_cols=257 Identities=28% Similarity=0.441 Sum_probs=196.3
Q ss_pred cCCCccceeccCCceeEEEEEeC----CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA----DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
++|++.+.||+|+||.||+|++. .+..||||++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 58999999999999999999875 4778999999753 455567899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 125 ~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 125 TEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 9999999999999653 245899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCcc-cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 542 DETEG-NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 542 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
..... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ...............
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i~~~~~~~~----- 271 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAVDEGYRLPP----- 271 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHHHTTEECCC-----
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCC-----
Confidence 32211 1222345788999999999999999999999999999998 9999754321 122211111110000
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
.......+.+++.+||+.+|.+||++.+|+++|+.+.
T Consensus 272 --------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 272 --------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp --------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 0011235668999999999999999999999998763
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=349.79 Aligned_cols=264 Identities=26% Similarity=0.409 Sum_probs=205.1
Q ss_pred ccCCCccceeccCCceeEEEEEe-----CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC--Cee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-----ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--EEK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 458 (706)
.++|++.++||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36899999999999999999984 35789999999887777788999999999999999999999998654 468
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 99999999999999996543 34899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCc-ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC---------CCchhHHHHHHH
Q 005236 539 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHS---------DNKLNLIRHAWK 608 (706)
Q Consensus 539 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~---------~~~~~~~~~~~~ 608 (706)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+..... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6443221 122334577889999999999999999999999999999999988653211 000111111112
Q ss_pred HhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 609 LWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 609 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
...........+ .. ...+.+++..||+.||.+|||++||++.|+.+
T Consensus 244 ~~~~~~~~~~~~-----~~----~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 244 LLKNNGRLPRPD-----GC----PDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHTTCCCCCCT-----TC----CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccCcCCCCc-----Cc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 222211111111 11 13466789999999999999999999999865
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=361.33 Aligned_cols=269 Identities=29% Similarity=0.426 Sum_probs=213.3
Q ss_pred ccHHHHHHhccCCCccceeccCCceeEEEEEe------CCCcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeee
Q 005236 377 FELATIANATDNFSINKKLGEGGFGPVYKGTL------ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKL 448 (706)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l 448 (706)
+.........++|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34455556678999999999999999999974 34678999999763 444567899999999999 79999999
Q ss_pred EeEEEeCCe-eEEEEecCCCCChhhhhhcccc------------------------------------------------
Q 005236 449 LGCCIHGEE-KLLIYEFMPNKSLDSFIFDQER------------------------------------------------ 479 (706)
Q Consensus 449 ~~~~~~~~~-~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------ 479 (706)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999975432
Q ss_pred ---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 480 ---------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 480 ---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122889999999999999999999998 99999999999999999999999999987654443
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
........||+.|+|||++.+..++.++||||||+++|||++ |+.||....... ..... ...........
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~----~~~~~~~~~~~--- 319 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRR----LKEGTRMRAPD--- 319 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHH----HHHTCCCCCCT---
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHH----HHcCCCCCCCC---
Confidence 334445678999999999999999999999999999999998 999975433221 11111 11111111111
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
..+ ..+.+++..||+.+|.+|||++||++.|+.+
T Consensus 320 --~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 320 --YTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp --TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111 2466788999999999999999999999865
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=351.17 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=201.7
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999985 68899999985432 2334678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999998543 34899999999999999999999988 9999999999999999999999999998764333
Q ss_pred CcccccccccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
.........||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... ...+ ...... ..+
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~-----~~~~~~--~~~- 230 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW-----KEKKTY--LNP- 230 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHH-----HTTCTT--STT-
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHH-----hccccc--CCc-
Confidence 3333345679999999999988776 78999999999999999999998654332211 1111 111100 000
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. ...+ ..+.+++.+||+.||.+|||++|+++.
T Consensus 231 ~-~~~~----~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 W-KKID----SAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp G-GGSC----HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c-ccCC----HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 0111 235578899999999999999999865
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=346.29 Aligned_cols=272 Identities=20% Similarity=0.272 Sum_probs=214.3
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC--eeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE--EKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV 461 (706)
.++|++.++||+|+||.||+|+... ++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 3679999999999999999999864 8899999987533 344677889999999999999999999998765 77999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE----cCCCCeEEeeecccc
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLAR 537 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~~kl~Dfgla~ 537 (706)
|||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999987665556999999999999999999999998 9999999999999 788889999999998
Q ss_pred ccCCCCCcccccccccccCccCccccc--------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc-hhHHHHHHH
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYAS--------DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK-LNLIRHAWK 608 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~-~~~~~~~~~ 608 (706)
.+.... ......||+.|+|||++. +..++.++||||||+++|||++|+.||........ .........
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 764332 222356899999999986 57899999999999999999999999865443222 222222222
Q ss_pred HhhcCCCccccc-----------ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 609 LWNEGMPSQLID-----------ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 609 ~~~~~~~~~~~d-----------~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.........+.. ..............+.+++..||+.||++|||++|+++.....
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 111111111000 0011123344555677899999999999999999999988754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=354.86 Aligned_cols=255 Identities=26% Similarity=0.414 Sum_probs=199.6
Q ss_pred cCCCccceeccCCceeEEEEEeCC-Cc----EEEEEEcCc-cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQ----EIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
++|++.++||+|+||.||+|++.. ++ +||+|.+.. ......+.+.+|+.++++++||||+++++++.++. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 579999999999999999999743 33 368888754 33455678999999999999999999999998754 789
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 94 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 999999999999996543 45899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ..... .........
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~----~~~~~~~~~ 241 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL----EKGERLPQP 241 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTTCCCCCC
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHHH----HcCCCCCCC
Confidence 5444434444567889999999999999999999999999999999 999986543322 11111 111110000
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
......+.+++.+||+.+|.+||++.||++.|+.+
T Consensus 242 ---------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 242 ---------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ---------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred ---------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 01122466789999999999999999999999765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=341.63 Aligned_cols=257 Identities=28% Similarity=0.417 Sum_probs=209.1
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
.++|++.+.||+|+||.||+|+..++..||||++.... ...+++.+|+.++.+++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46899999999999999999999888899999986533 23467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 9999999996542 35899999999999999999999988 999999999999999999999999999876443222
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ...... ........ .
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~----~~~~~~~~-~---- 227 (268)
T 3sxs_A 161 -SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS---EVVLKV----SQGHRLYR-P---- 227 (268)
T ss_dssp -ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHH----HTTCCCCC-C----
T ss_pred -cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH---HHHHHH----HcCCCCCC-C----
Confidence 2223456778999999999899999999999999999999 99997543221 111111 11111000 0
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
...+ ..+.+++..||+.+|.+|||++|+++.|+.+.+
T Consensus 228 ~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 228 HLAS----DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TTSC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CcCh----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 0111 246678999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=344.52 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=207.0
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
++|++.+.||+|+||.||+|+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5789999999999999999999889999999996533 234678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 89 ~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 162 (269)
T 4hcu_A 89 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 162 (269)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred CCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence 999999995433 45899999999999999999999998 99999999999999999999999999987543221 1
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ........ ...... .. .
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~~~~~~----~~~~~~-~~----~ 230 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDIS----TGFRLY-KP----R 230 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHH----TTCCCC-CC----T
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHh----cCccCC-CC----C
Confidence 2223456788999999999999999999999999999999 8999754222 12221111 111100 00 0
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.. ...+.+++..||+.+|++|||++|+++.|+.+
T Consensus 231 ~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 231 LA----STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cC----CHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 11 12466788999999999999999999999865
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=350.97 Aligned_cols=253 Identities=24% Similarity=0.359 Sum_probs=200.9
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe------
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEE------ 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 457 (706)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999986 6899999998643 33456789999999999999999999999876542
Q ss_pred ---------------------------------------------------eEEEEecCCCCChhhhhhcccccCCCCHH
Q 005236 458 ---------------------------------------------------KLLIYEFMPNKSLDSFIFDQERCKLLDWS 486 (706)
Q Consensus 458 ---------------------------------------------------~~lV~e~~~~gsL~~~l~~~~~~~~l~~~ 486 (706)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 79999999999999999877666667888
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc----------ccccccccccC
Q 005236 487 KRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE----------GNTNRVVGTYG 556 (706)
Q Consensus 487 ~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt~~ 556 (706)
.++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999988 999999999999999999999999999987543211 12233579999
Q ss_pred ccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHH
Q 005236 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCI 636 (706)
Q Consensus 557 y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 636 (706)
|+|||++.+..++.++||||||+++|||++|..|+. .. ................. .....+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~-~~~~~~~~~~~~~~~~~---------~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ER-VRIITDVRNLKFPLLFT---------QKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HH-HHHHHHHHTTCCCHHHH---------HHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HH-HHHHHHhhccCCCcccc---------cCChhHH
Confidence 999999999999999999999999999999876621 11 11111111222111111 1122456
Q ss_pred HHHHHhcCCCCCCCCChhHHHHH
Q 005236 637 HIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 637 ~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
+++.+||+.||.+|||++|+++.
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 78999999999999999999863
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=344.70 Aligned_cols=261 Identities=25% Similarity=0.368 Sum_probs=205.7
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc---cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK---ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|++.+.||+|+||.||+|+.. .++.||+|++.. ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999974 588999998843 3445567899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999654 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ............. ....
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~-~~~~- 234 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDSVP-NVTT- 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSCCC-CHHH-
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhccCC-Ccch-
Confidence 221 223345799999999999999999999999999999999999999754221 1111122222111 1100
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCC-ChhHHHHHhcCCCC
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRP-CMPSVILMLGSEIV 665 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-t~~ev~~~L~~~~~ 665 (706)
...... ...+.+++.+||+.||.+|| +++++.+.|+....
T Consensus 235 ~~~~~~----~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 235 DVRKDI----PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HSCTTS----CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred hcccCC----CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 011111 12466789999999999999 99999999987644
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=356.86 Aligned_cols=265 Identities=26% Similarity=0.420 Sum_probs=212.9
Q ss_pred HHHhccCCCccceeccCCceeEEEEEeCC------CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEe
Q 005236 382 IANATDNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIH 454 (706)
Q Consensus 382 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 454 (706)
+....++|++.+.||+|+||.||+|+..+ ++.||||++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 34456899999999999999999999853 478999999764 44456789999999999999999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhhcccc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEec
Q 005236 455 GEEKLLIYEFMPNKSLDSFIFDQER---------------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHR 513 (706)
Q Consensus 455 ~~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~ 513 (706)
.+..++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 9999999999999999999975321 256899999999999999999999998 9999
Q ss_pred ccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCC
Q 005236 514 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRG 592 (706)
Q Consensus 514 Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~ 592 (706)
||||+|||++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999987643332233334568899999999999999999999999999999999 999975
Q ss_pred CCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 593 FYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
.... ..... ....+......+ ..+ ..+.+++..||+.+|.+||++.+|++.|+.+..
T Consensus 279 ~~~~---~~~~~----~~~~~~~~~~~~-----~~~----~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 279 GMAH---EEVIY----YVRDGNILACPE-----NCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TSCH---HHHHH----HHHTTCCCCCCT-----TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCh---HHHHH----HHhCCCcCCCCC-----CCC----HHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 3221 11111 111222111111 111 246678999999999999999999999998744
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=346.59 Aligned_cols=264 Identities=27% Similarity=0.440 Sum_probs=202.4
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
++|++.+.||+|+||.||+|+.. ++.||||++... ...+.+.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 57889999999999999999985 678999998643 34578999999999999999999999876 45899999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC-eEEeeeccccccCCCCCc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-PKISDFGLARAFGGDETE 545 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-~kl~Dfgla~~~~~~~~~ 545 (706)
+++|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999977655556889999999999999999999943234999999999999998887 799999999765322
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..+ .+... .........
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~--~~~~~-~~~~~~~~~----- 227 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRI--MWAVH-NGTRPPLIK----- 227 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH--HHH--HHHHH-TTCCCCCBT-----
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH--HHH--HHHHh-cCCCCCccc-----
Confidence 223468999999999999999999999999999999999999986433221 111 11111 111111111
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC-CCCCCCCCCc
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI-VLPQPKQPGY 674 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~-~~~~p~~p~~ 674 (706)
..+ ..+.+++.+||+.+|.+|||++||++.|+.+. ..+.+..|..
T Consensus 228 ~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~ 273 (307)
T 2eva_A 228 NLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273 (307)
T ss_dssp TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCC
T ss_pred ccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccc
Confidence 111 24567899999999999999999999998763 3444444433
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=354.16 Aligned_cols=249 Identities=21% Similarity=0.265 Sum_probs=203.1
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|++.+.||+|+||.||+++.. +++.||||++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 368999999999999999999985 5889999998653 233467789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999998643 35889999999999999999999988 99999999999999999999999999986432
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ........ ... ... +
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i---~~~-~~~-~--- 224 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELI---LME-EIR-F--- 224 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH---HHC-CCC-C---
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HHHHHHHH---HcC-CCC-C---
Confidence 22 22334679999999999999999999999999999999999999975322 11111111 111 110 0
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCC-----ChhHHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRP-----CMPSVILM 659 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~~ 659 (706)
....+ ..+.+++..||+.||.+|| +++||++.
T Consensus 225 --p~~~s----~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 --PRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCC----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 01111 2456788999999999999 89998753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=368.89 Aligned_cols=259 Identities=31% Similarity=0.449 Sum_probs=209.2
Q ss_pred HhccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
...++|.+.++||+|+||.||+|+++++..||||++.... ...+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 3457899999999999999999999888999999997543 34678999999999999999999999986 667899999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 263 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred ecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999999996542 235788999999999999999999988 9999999999999999999999999998764321
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
.. ......+|+.|+|||++....++.++||||||++||||++ |+.||..... .+.............+
T Consensus 339 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~~~~------- 407 (454)
T 1qcf_A 339 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALERGYRMPRP------- 407 (454)
T ss_dssp HH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHHTCCCCCC-------
T ss_pred ee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCC-------
Confidence 11 1222446789999999999999999999999999999999 9999754322 2222221111111110
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
... ...+.+++.+||+.||.+|||+++|++.|+.+..
T Consensus 408 --~~~----~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 408 --ENC----PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp --TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred --CCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 011 1246678999999999999999999999998744
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=353.24 Aligned_cols=262 Identities=24% Similarity=0.400 Sum_probs=194.0
Q ss_pred hccCCCccceeccCCceeEEEEEeCCCc----EEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCee
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLADEQ----EIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 458 (706)
..++|++.+.||+|+||.||+|++.... .||||++... .....+.+.+|+.++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 3468999999999999999999975532 7999998653 345567899999999999999999999999877655
Q ss_pred ------EEEEecCCCCChhhhhhcccc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeE
Q 005236 459 ------LLIYEFMPNKSLDSFIFDQER---CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 529 (706)
Q Consensus 459 ------~lV~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 529 (706)
++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 999999999999999965432 225899999999999999999999998 99999999999999999999
Q ss_pred EeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHH
Q 005236 530 ISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWK 608 (706)
Q Consensus 530 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~ 608 (706)
|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .......
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~- 253 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYNYLI- 253 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHH-
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHHHHh-
Confidence 999999987654433333334567889999999999999999999999999999999 89987643322 2221111
Q ss_pred HhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 609 LWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 609 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
......... .. ...+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 254 ---~~~~~~~~~-----~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 254 ---GGNRLKQPP-----EC----MEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp ---TTCCCCCCT-----TC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cCCCCCCCC-----cc----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111111100 11 1246689999999999999999999999987743
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.68 Aligned_cols=263 Identities=26% Similarity=0.335 Sum_probs=203.0
Q ss_pred hccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
..++|++.++||+|+||.||+|+..+++.||||++... .....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 34789999999999999999999988999999998653 2233567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++ +|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99985 7887775432 45889999999999999999999988 999999999999999999999999999876422
Q ss_pred CCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc---
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL--- 618 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 618 (706)
. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+.. ..........
T Consensus 173 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~ 247 (311)
T 3niz_A 173 V--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS---ILGTPNPREWPQV 247 (311)
T ss_dssp C--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHH---HHCCCCTTTSGGG
T ss_pred c--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH---HHCCCChHHhhhh
Confidence 2 12233568999999999876 5689999999999999999999999876554443332222 2211111110
Q ss_pred ccc------c--ccCcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 619 IDA------C--FKDSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 619 ~d~------~--~~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.+. . ........ ....+.+++.+||+.||.+|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 0 00000111 1124678999999999999999999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=356.27 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=201.3
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcE----EEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQE----IAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
++|++.+.||+|+||.||+|++.. ++. ||+|.+... .....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 579999999999999999999743 443 788877543 2333456788999999999999999999885 567899
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999999654 245888999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
............+|..|+|||++.+..++.++||||||+++|||++ |+.||....... ........ .........
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~-~~~~~~~~~ 242 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDLLEKG-ERLAQPQIC 242 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHHHHTT-CBCCCCTTB
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHHHHcC-CCCCCCCcC
Confidence 5544444445678889999999999999999999999999999999 999986543222 11111111 011111111
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
. ..+.+++..||+.+|.+||+++||++.|+.+.
T Consensus 243 ~------------~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 243 T------------IDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp C------------TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred c------------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 12446888999999999999999999998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.19 Aligned_cols=259 Identities=30% Similarity=0.440 Sum_probs=210.9
Q ss_pred ccCCCccceeccCCceeEEEEEe------CCCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL------ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 458 (706)
.++|.+.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46899999999999999999986 23578999998753 455567899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhcccc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCC
Q 005236 459 LLIYEFMPNKSLDSFIFDQER---------------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKA 517 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp 517 (706)
++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999976432 134789999999999999999999988 99999999
Q ss_pred CcEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCC
Q 005236 518 SNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHS 596 (706)
Q Consensus 518 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~ 596 (706)
+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654443333344567889999999999999999999999999999999 9999764333
Q ss_pred CCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 597 DNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.. ..... .......... .. ...+.+++.+||+.||.+||++.||++.|+.+
T Consensus 259 ~~---~~~~~----~~~~~~~~~~-----~~----~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 259 ER---LFNLL----KTGHRMERPD-----NC----SEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GG---HHHHH----HTTCCCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---HHHHh----hcCCcCCCCc-----cC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 21 21111 1111111111 11 12466789999999999999999999999865
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=356.34 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=203.0
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccch------hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISE------QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 458 (706)
.+.|.+.+.||+|+||.||+++.. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 468999999999999999999985 588999999865322 1357899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC----CeEEeeec
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFG 534 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~Dfg 534 (706)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 9999999999999999543 35899999999999999999999998 99999999999998877 79999999
Q ss_pred cccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC
Q 005236 535 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM 614 (706)
Q Consensus 535 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 614 (706)
+++.+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ........ ....
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~---~~~~~~~i----~~~~ 234 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANI----TAVS 234 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHH----HTTC
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH----HhcC
Confidence 998764322 2234579999999999999999999999999999999999999985422 11221111 1111
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 615 PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 615 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
. .+ ++......+ ..+.+++..||+.||.+|||+.|+++
T Consensus 235 ~-~~-~~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 Y-DF-DEEFFSQTS----ELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C-CC-CHHHHTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C-CC-CchhccCCC----HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 00 000001111 24567899999999999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=345.53 Aligned_cols=261 Identities=23% Similarity=0.320 Sum_probs=200.0
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhh--cCCcceeeeEeEEEeC----CeeE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSK--LQHRNLVKLLGCCIHG----EEKL 459 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~ 459 (706)
.++|++.+.||+|+||.||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999998 6889999998653 33455566666665 7999999999997653 4578
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecccCCCcEEEcCCCCeEEe
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH--------QDSRLRIIHRDLKASNVLLDQDMNPKIS 531 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~Dikp~Nill~~~~~~kl~ 531 (706)
+||||+++|+|.+++.. ..+++..+++++.||+.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 99999999999999943 35899999999999999999999 666 9999999999999999999999
Q ss_pred eeccccccCCCCCcc--cccccccccCccCccccccC------CCCcchhhHHHHHHHHHHHhC----------CCCCCC
Q 005236 532 DFGLARAFGGDETEG--NTNRVVGTYGYMAPEYASDG------QFSVKSDVFSFGILLLEIVSG----------KKNRGF 593 (706)
Q Consensus 532 Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDv~SlGvil~elltG----------~~p~~~ 593 (706)
|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999998764332221 22334799999999999876 456799999999999999999 777654
Q ss_pred CCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 594 YHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
............. ..........+.. ..........+.+++.+||+.||.+|||++||++.|+.
T Consensus 236 ~~~~~~~~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 236 VVPNDPSFEDMRK-VVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TSCSSCCHHHHHH-HHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cCCCCcchhhhhH-HHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 4333222111111 1111111111111 11122345567889999999999999999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=351.27 Aligned_cols=252 Identities=21% Similarity=0.283 Sum_probs=203.7
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
.++|++.+.||+|+||.||+++.. +++.+|+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 478999999999999999999985 4788999998643 34456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC--CCCeEEeeeccccccCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLARAFGGD 542 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~--~~~~kl~Dfgla~~~~~~ 542 (706)
+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999999543 235899999999999999999999998 999999999999997 789999999999876432
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........ ..... .....
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~---~~~~~--~~~~~ 226 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIM---NAEYT--FDEEA 226 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHH---HTCCC--CCHHH
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHH---cCCCC--CChhh
Confidence 2 22345789999999999998899999999999999999999999854221 12221111 11110 00000
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
+ ... ...+.+++.+||+.||.+|||+.|+++.
T Consensus 227 ~-~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 227 F-KEI----SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp H-TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred h-ccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 011 1246688999999999999999999873
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=343.06 Aligned_cols=261 Identities=15% Similarity=0.215 Sum_probs=211.4
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999997 568899999985432 234678899999999 79999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC-----eEEeeeccccc
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKISDFGLARA 538 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-----~kl~Dfgla~~ 538 (706)
|+ +++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 999999996542 35899999999999999999999988 999999999999988776 99999999987
Q ss_pred cCCCCCc-----ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC
Q 005236 539 FGGDETE-----GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG 613 (706)
Q Consensus 539 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 613 (706)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6543221 12334679999999999999999999999999999999999999987655444444333332222222
Q ss_pred CCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 614 MPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 614 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
....+.. ..+ ..+.+++..||+.+|.+||++++|++.|+.+
T Consensus 241 ~~~~~~~-----~~~----~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 241 PLRELCA-----GFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp CHHHHTT-----TSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cHHHHHh-----hCc----HHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 2111111 111 2466789999999999999999999999876
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=349.46 Aligned_cols=260 Identities=18% Similarity=0.209 Sum_probs=209.3
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++++ +||||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36899999999999999999997 5688999999864322 24688999999999 99999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC-----eEEeeeccccc
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKISDFGLARA 538 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-----~kl~Dfgla~~ 538 (706)
|+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999999653 246899999999999999999999998 999999999999999887 99999999997
Q ss_pred cCCCCCcc-----cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC
Q 005236 539 FGGDETEG-----NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG 613 (706)
Q Consensus 539 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 613 (706)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 64432211 1234679999999999999999999999999999999999999987655444433333322211111
Q ss_pred CCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 614 MPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 614 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
....+ .... ..+.+++..||+.+|.+||++++|++.|+.+
T Consensus 240 ~~~~~-----~~~~-----p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 240 PIEVL-----CENF-----PEMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp CHHHH-----TTTC-----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CHHHH-----hccC-----hHHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 11100 0001 1567789999999999999999999999644
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.69 Aligned_cols=259 Identities=18% Similarity=0.211 Sum_probs=204.7
Q ss_pred HHHHHhccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC
Q 005236 380 ATIANATDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHG 455 (706)
Q Consensus 380 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 455 (706)
..+....++|++.++||+|+||.||+|+... ++.||+|++.+.. ....+.+.+|+.+++.++|||||++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3444556899999999999999999999864 7899999986521 12234578999999999999999999999999
Q ss_pred CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecc
Q 005236 456 EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 535 (706)
Q Consensus 456 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgl 535 (706)
...++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 9999999999999999998542 4789999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccCccCccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ----FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWN 611 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 611 (706)
++....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... .............
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~ 290 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYSKIMNHKN 290 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTHHH
T ss_pred eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC---hhhHHHHHHhccc
Confidence 987643321 1233468999999999998765 8899999999999999999999985432 2222222211110
Q ss_pred cCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCC--CCChhHHHHH
Q 005236 612 EGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPED--RPCMPSVILM 659 (706)
Q Consensus 612 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--RPt~~ev~~~ 659 (706)
....+.. ...+ ..+.+++..||+.+|.+ ||+++||++.
T Consensus 291 ~~~~p~~------~~~s----~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 SLTFPDD------NDIS----KEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HCCCCTT------CCCC----HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cccCCCc------cccc----HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1111100 0111 24567889999999988 9999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=362.48 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=202.5
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
..++|++.++||+|+||.||++... +++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4568999999999999999999874 5889999998643 344567889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc---CCCCeEEeeeccccc
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARA 538 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~~kl~Dfgla~~ 538 (706)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999998654 34899999999999999999999998 99999999999998 568899999999987
Q ss_pred cCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ......... .+... .
T Consensus 163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~~~i~----~~~~~-~ 232 (444)
T 3soa_A 163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIK----AGAYD-F 232 (444)
T ss_dssp CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHH----HTCCC-C
T ss_pred ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHH----hCCCC-C
Confidence 643322 2233679999999999999999999999999999999999999975322 122222111 11110 0
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
..+.+. ..+ ..+.+++..||+.||.+|||+.|+++.
T Consensus 233 ~~~~~~-~~s----~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 PSPEWD-TVT----PEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CTTTTT-TSC----HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred Cccccc-cCC----HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000 111 245678999999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=353.83 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=196.9
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 460 (706)
.++|++.++||+|+||.||+|+.+. ++.||||++.+. .....+.+..|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4689999999999999999999854 778999998653 223345688899999887 89999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999999654 34899999999999999999999998 9999999999999999999999999998632
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc--hhHHHHHHHHhhcCCCccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK--LNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 618 (706)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........+........ +
T Consensus 205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-~ 281 (396)
T 4dc2_A 205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-I 281 (396)
T ss_dssp CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC-C
T ss_pred cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC-C
Confidence 21 1233446899999999999999999999999999999999999999864322111 11111111111111110 0
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCCh
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCM 653 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 653 (706)
....+ ..+.+++..||+.||.+||++
T Consensus 282 -----p~~~s----~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 282 -----PRSLS----VKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CTTSC----HHHHHHHHHHTCSCTTTSTTC
T ss_pred -----CCcCC----HHHHHHHHHHhcCCHhHcCCC
Confidence 01111 245678999999999999996
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=369.02 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=210.1
Q ss_pred hccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
..++|++.++||+|+||.||+|++.. +..||||++.... ...+.|.+|+.++++++||||+++++++.+....++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34678899999999999999999865 7899999996543 346789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999996533 245889999999999999999999998 9999999999999999999999999998764332
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
.. ......+++.|+|||++....++.++||||||++||||++ |+.||...... ...... ..........
T Consensus 373 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~~----~~~~~~~~~~-- 442 (495)
T 1opk_A 373 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL----EKDYRMERPE-- 442 (495)
T ss_dssp EE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH----HTTCCCCCCT--
T ss_pred ee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCCCCCCC--
Confidence 21 2223456789999999999999999999999999999999 88887643322 222111 1111111100
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
.. ...+.+++.+||+.+|.+|||+.+|++.|+.+.
T Consensus 443 ---~~----~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 443 ---GC----PEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ---TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ---CC----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11 134667899999999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.91 Aligned_cols=263 Identities=30% Similarity=0.433 Sum_probs=208.6
Q ss_pred hccCCCccceeccCCceeEEEEEe------CCCcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCC
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTL------ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGE 456 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 456 (706)
..++|.+.+.||+|+||.||+|+. ..+..||||++... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 447899999999999999999986 23568999998753 334457899999999999 8999999999999999
Q ss_pred eeEEEEecCCCCChhhhhhccccc--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERC--------------------KLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 516 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik 516 (706)
..++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999754321 34789999999999999999999988 9999999
Q ss_pred CCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 005236 517 ASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYH 595 (706)
Q Consensus 517 p~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~ 595 (706)
|+|||++.++.+||+|||++..+.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654433333344567889999999999999999999999999999998 999986543
Q ss_pred CCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 596 SDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
.... .. ............ ... ...+.+++..||+.||.+|||+.||++.|+....
T Consensus 280 ~~~~---~~---~~~~~~~~~~~~-----~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 280 VDAN---FY---KLIQNGFKMDQP-----FYA----TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CSHH---HH---HHHHTTCCCCCC-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cHHH---HH---HHHhcCCCCCCC-----CCC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 3211 11 111111111110 011 1346678999999999999999999999987633
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=350.11 Aligned_cols=251 Identities=21% Similarity=0.306 Sum_probs=202.7
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccch------hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISE------QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 459 (706)
+.|.+.+.||+|+||.||+++.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 57999999999999999999985 588999999865322 23678999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC----CeEEeeecc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFGL 535 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~Dfgl 535 (706)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 999999999999999543 45899999999999999999999988 99999999999999888 899999999
Q ss_pred ccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
++.+.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .......... .....
T Consensus 165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~-~~~~~ 237 (326)
T 2y0a_A 165 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANVSAV-NYEFE 237 (326)
T ss_dssp CEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHT-CCCCC
T ss_pred CeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HHHHHHHHhc-CCCcC
Confidence 98764322 22335799999999999999999999999999999999999999753221 1111111110 01111
Q ss_pred cccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 616 SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 616 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
... . ...+ ..+.+++..||+.||.+|||++|+++.
T Consensus 238 ~~~----~-~~~~----~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 238 DEY----F-SNTS----ALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHH----H-TTSC----HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccc----c-ccCC----HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 110 0 0111 245678999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=365.17 Aligned_cols=258 Identities=27% Similarity=0.433 Sum_probs=203.2
Q ss_pred hccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
..++|++.++||+|+||.||+|+++++..||||++.... ...+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 346789999999999999999999888899999997543 335789999999999999999999999865 678999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 99999999996432 245889999999999999999999988 99999999999999999999999999987643221
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
. ......++..|+|||++....++.++||||||+++|||++ |+.||..... .+..... ..+......
T Consensus 336 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i----~~~~~~~~~---- 403 (452)
T 1fmk_A 336 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQV----ERGYRMPCP---- 403 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHH----HTTCCCCCC----
T ss_pred e-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCCCCCCC----
Confidence 1 1223456789999999999999999999999999999999 8998754322 1222111 111111110
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
... ...+.+++.+||+.+|++|||+++|++.|+....
T Consensus 404 -~~~----~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 404 -PEC----PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp -TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 011 1246678999999999999999999999998744
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=361.04 Aligned_cols=263 Identities=17% Similarity=0.205 Sum_probs=206.1
Q ss_pred HHHHHHhccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEe
Q 005236 379 LATIANATDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIH 454 (706)
Q Consensus 379 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 454 (706)
+.++....++|++.++||+|+||.||+|+... ++.||||++.+.. ....+.+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34445566899999999999999999999865 7889999986522 1223348899999999999999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeec
Q 005236 455 GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 534 (706)
Q Consensus 455 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 534 (706)
.+..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999999653 245899999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH
Q 005236 535 LARAFGGDETEGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKL 609 (706)
Q Consensus 535 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 609 (706)
+++.+...... .....+||+.|+|||++. ...++.++|||||||++|||++|+.||..... ..........
T Consensus 221 la~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~ 296 (437)
T 4aw2_A 221 SCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMNH 296 (437)
T ss_dssp TCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTH
T ss_pred hhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---hHHHHhhhhc
Confidence 99876433221 223367999999999997 56789999999999999999999999864322 2222222111
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCC--CCChhHHHHH
Q 005236 610 WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPED--RPCMPSVILM 659 (706)
Q Consensus 610 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--RPt~~ev~~~ 659 (706)
......+.... ..+ ..+.+++.+||+.+|.+ ||+++|+++.
T Consensus 297 ~~~~~~p~~~~-----~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 297 KERFQFPTQVT-----DVS----ENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHCCCCSSCC-----CSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccccCCcccc-----cCC----HHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11111111100 111 24567888999888888 9999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=356.71 Aligned_cols=247 Identities=25% Similarity=0.336 Sum_probs=197.8
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 460 (706)
.++|++.++||+|+||.||+|+.. +++.||||++.+. .....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999985 4889999998653 334456788999999988 79999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999999654 34899999999999999999999998 9999999999999999999999999998642
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC-Ccccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM-PSQLI 619 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 619 (706)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .... .+.
T Consensus 176 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~---~~~~~~p~-- 245 (353)
T 3txo_A 176 CN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---DDLFEAIL---NDEVVYPT-- 245 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH---HCCCCCCT--
T ss_pred cC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH---HHHHHHHH---cCCCCCCC--
Confidence 22 1233446799999999999999999999999999999999999999854322 22221111 1111 111
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCCh------hHHHH
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCM------PSVIL 658 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~------~ev~~ 658 (706)
..+ ..+.+++..||+.||.+||++ +|+++
T Consensus 246 ------~~~----~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 246 ------WLH----EDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ------TSC----HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ------CCC----HHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111 245678899999999999998 66664
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=348.72 Aligned_cols=253 Identities=23% Similarity=0.287 Sum_probs=201.8
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc-----hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS-----EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 57999999999999999999984 58899999985421 1246789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC---eEEeeeccc
Q 005236 461 IYEFMPNKSLDSFIFDQE-RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLA 536 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---~kl~Dfgla 536 (706)
||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999998886543 2345899999999999999999999998 999999999999987655 999999999
Q ss_pred cccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc
Q 005236 537 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616 (706)
Q Consensus 537 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (706)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ........ ......
T Consensus 181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~i----~~~~~~ 250 (351)
T 3c0i_A 181 IQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLFEGI----IKGKYK 250 (351)
T ss_dssp EECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS----HHHHHHHH----HHTCCC
T ss_pred eEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc----HHHHHHHH----HcCCCC
Confidence 87644322 223457999999999999999999999999999999999999998542 11111111 111110
Q ss_pred ccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 617 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
..+......+ ..+.+++.+||+.||.+|||+.|+++
T Consensus 251 --~~~~~~~~~s----~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 --MNPRQWSHIS----ESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCHHHHTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCccccccCC----HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000001111 24567899999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=352.34 Aligned_cols=271 Identities=23% Similarity=0.337 Sum_probs=200.1
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe----
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEE---- 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 457 (706)
.++|++.+.||+|+||.||+++. .+++.||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 47899999999999999999997 56889999998653 33445688999999999999999999999876654
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 39999999999999999653 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCc-ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc
Q 005236 538 AFGGDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616 (706)
Q Consensus 538 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (706)
.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .. ............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~---~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VS---VAYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HH---HHHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HH---HHHHHhcCCCCC
Confidence 76433221 223345789999999999999999999999999999999999999854221 11 111122221111
Q ss_pred ccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHH-HHhcCCCCCCCCCCCCcc
Q 005236 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI-LMLGSEIVLPQPKQPGYL 675 (706)
Q Consensus 617 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~-~~L~~~~~~~~p~~p~~~ 675 (706)
.. ......+ ..+.+++.+||+.||.+||+..+++ ..|........|..|...
T Consensus 239 ~~---~~~~~~~----~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~~~ 291 (311)
T 3ork_A 239 PS---ARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVL 291 (311)
T ss_dssp HH---HHSTTCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCCCC
T ss_pred cc---cccCCCC----HHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCccc
Confidence 00 0001111 2456788999999999999766554 455444333334444443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=344.43 Aligned_cols=260 Identities=29% Similarity=0.417 Sum_probs=210.4
Q ss_pred ccCCCccceeccCCceeEEEEEe------CCCcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL------ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEE 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 457 (706)
.++|++.+.||+|+||.||+|+. ..++.||||++... .....+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999985 34678999998754 334567899999999999 99999999999999999
Q ss_pred eEEEEecCCCCChhhhhhcccc---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE
Q 005236 458 KLLIYEFMPNKSLDSFIFDQER---------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 522 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill 522 (706)
.++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999975432 124899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchh
Q 005236 523 DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLN 601 (706)
Q Consensus 523 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~ 601 (706)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence 9999999999999988755443333344567889999999999999999999999999999999 9999764432211
Q ss_pred HHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 602 LIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
...... ....... . ... ...+.+++.+||+.||.+|||+.||++.|+..
T Consensus 257 ~~~~~~----~~~~~~~-~----~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 257 FYKMIK----EGFRMLS-P----EHA----PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp HHHHHH----HTCCCCC-C----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhc----cCCCCCC-c----ccC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111111 1111000 0 011 12466789999999999999999999999865
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=355.46 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=205.4
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999985 5889999998776666667899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC--CCCeEEeeeccccccCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLARAFGGD 542 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~--~~~~kl~Dfgla~~~~~~ 542 (706)
+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 130 ~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 99999999985432 35889999999999999999999998 999999999999974 578999999999876433
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... .........
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~i~~~-~~~~~~~~~--- 274 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRC-DWEFDEDAF--- 274 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHC-CCCCCSSTT---
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---HHHHHHHHHhC-CCCCCcccc---
Confidence 2 2233578999999999999999999999999999999999999985422 12222211111 000000110
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
...+ ..+.+++..||+.||.+|||+.|+++.
T Consensus 275 --~~~s----~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 275 --SSVS----PEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --ccCC----HHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111 246689999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=340.47 Aligned_cols=260 Identities=28% Similarity=0.448 Sum_probs=194.6
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.++|++.++||+|+||.||+|+... .||||++.. ......+.+.+|+.++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4689999999999999999998754 599999864 3455667899999999999999999999965 5667899999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 99999999999543 245899999999999999999999988 9999999999999999999999999998764333
Q ss_pred CcccccccccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.........||+.|+|||.+. ...++.++||||||+++|||++|+.||...... ..................+.
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~- 251 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVGRGSLSPDLSKVR- 251 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHHHHTSCCCCTTSSC-
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHhcccccCcchhhcc-
Confidence 333334467999999999986 667899999999999999999999998543221 11111111111111111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
... ...+.+++..||+.+|.+|||+.+|++.|+.+.
T Consensus 252 ----~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 252 ----SNC----PKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp ----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----ccC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111 135668899999999999999999999998763
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=347.72 Aligned_cols=262 Identities=27% Similarity=0.421 Sum_probs=210.4
Q ss_pred hccCCCccceeccCCceeEEEEEeC--------CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEe
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA--------DEQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIH 454 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 454 (706)
..++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3478999999999999999999863 4678999999753 445567899999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEE
Q 005236 455 GEEKLLIYEFMPNKSLDSFIFDQER-------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 521 (706)
Q Consensus 455 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nil 521 (706)
.+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999975432 234889999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCch
Q 005236 522 LDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKL 600 (706)
Q Consensus 522 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~ 600 (706)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... .
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~ 266 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---E 266 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---H
Confidence 99999999999999987654433333344567889999999999999999999999999999999 9998754321 1
Q ss_pred hHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 601 NLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
..... .......... ... ...+.+++.+||+.+|.+|||+.||++.|+.+..
T Consensus 267 ~~~~~----~~~~~~~~~~-----~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 267 ELFKL----LKEGHRMDKP-----ANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHH----HHHTCCCCCC-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHH----HhcCCCCCCC-----ccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11111 1111111111 111 1246678899999999999999999999987743
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=349.46 Aligned_cols=265 Identities=26% Similarity=0.361 Sum_probs=209.7
Q ss_pred cCCCccceeccCCceeEEEEEe-----CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEe--CCeeE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-----ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIH--GEEKL 459 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 459 (706)
++|++.++||+|+||.||+++. ..++.||||++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6899999999999999999984 4578999999988777777889999999999999999999999874 45689
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
+||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999999999996533 35899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCc-ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC--------CchhHHHHHHHHh
Q 005236 540 GGDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSD--------NKLNLIRHAWKLW 610 (706)
Q Consensus 540 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~--------~~~~~~~~~~~~~ 610 (706)
...... .......+|+.|+|||++.+..++.++||||||+++|||++|+.|+...... .............
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 433221 1233356888899999999999999999999999999999999986432110 0001111111121
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 611 NEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 611 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
........ .......+.+++..||+.||.+|||++||++.|+.+..
T Consensus 258 ~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 258 EEGQRLPA---------PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hcccCCCC---------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 12111111 01112346678999999999999999999999987743
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=340.42 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=204.5
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
.++|++.+.||+|+||.||++...++..||||++..... ..+++.+|+.++.+++||||+++++++.+....++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 468999999999999999999999888999999975432 3467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 175 (283)
T 3gen_A 102 ANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 175 (283)
T ss_dssp TTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred CCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence 9999999996532 35899999999999999999999988 99999999999999999999999999987643211
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ....... ....... .
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~----~~~~~~~-~---- 243 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHIA----QGLRLYR-P---- 243 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHH----TTCCCCC-C----
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHHHHh----cccCCCC-C----
Confidence 12223456788999999999999999999999999999998 99997543321 1111111 1111000 0
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
... ...+.+++.+||+.+|.+|||++|+++.|+.+
T Consensus 244 ~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 244 HLA----SEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 011 12466789999999999999999999999764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=336.18 Aligned_cols=253 Identities=30% Similarity=0.480 Sum_probs=195.1
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccc----hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKIS----EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|++.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 368999999999999999999985 7899999986532 23357889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC--------CCCeEEeee
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--------DMNPKISDF 533 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~--------~~~~kl~Df 533 (706)
|||+++++|.+++.. ..+++..++.++.|++.||+|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999999843 35899999999999999999999987556899999999999986 778999999
Q ss_pred ccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC
Q 005236 534 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG 613 (706)
Q Consensus 534 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 613 (706)
|+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ... ........
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~---~~~~~~~~ 230 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAV---AYGVAMNK 230 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---HHH---HHHHHTSC
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHH---HHhhhcCC
Confidence 9998654322 2235689999999999999999999999999999999999999854221 111 11111111
Q ss_pred CCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 614 MPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 614 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
....... .. ...+.+++.+||+.+|.+|||+.|+++.|+.
T Consensus 231 ~~~~~~~-----~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 LALPIPS-----TC----PEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCCc-----cc----CHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111111 11 1246678999999999999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=353.45 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=202.8
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
.++|++.+.||+|+||.||+|+.. +++.||+|++.. ......+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 468999999999999999999985 588999999864 34455678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC---CeEEeeecccccc
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLARAF 539 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl~Dfgla~~~ 539 (706)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 108 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 999999999998543 35889999999999999999999998 99999999999998654 5999999999876
Q ss_pred CCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 540 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 540 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......... .+... ..
T Consensus 182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~~~i~----~~~~~-~~ 250 (362)
T 2bdw_A 182 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIK----AGAYD-YP 250 (362)
T ss_dssp TTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH----HTCCC-CC
T ss_pred cCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHH----hCCCC-CC
Confidence 4322 2233579999999999999999999999999999999999999975322 112221111 11110 00
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+.+ ...+ ..+.+++.+||+.||.+|||+.|+++.
T Consensus 251 ~~~~-~~~~----~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 SPEW-DTVT----PEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TTGG-GGSC----HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccc-cCCC----HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 0111 245678999999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=348.87 Aligned_cols=264 Identities=27% Similarity=0.438 Sum_probs=211.4
Q ss_pred HHhccCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC
Q 005236 383 ANATDNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG 455 (706)
Q Consensus 383 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 455 (706)
....++|++.+.||+|+||.||+|+.. .++.||||++... .......+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345578999999999999999999864 3678999999753 344556789999999999999999999999999
Q ss_pred CeeEEEEecCCCCChhhhhhcccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCe
Q 005236 456 EEKLLIYEFMPNKSLDSFIFDQER-------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 528 (706)
Q Consensus 456 ~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 528 (706)
+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence 999999999999999999965322 245789999999999999999999998 9999999999999999999
Q ss_pred EEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHH
Q 005236 529 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAW 607 (706)
Q Consensus 529 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 607 (706)
||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+..... ......
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~-- 252 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRF-- 252 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHHH--
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHHHHH--
Confidence 9999999987643332223334567889999999999999999999999999999999 8888754221 111111
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 608 KLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 608 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
........... .. ...+.+++.+||+.+|.+|||+.|+++.|+....
T Consensus 253 --~~~~~~~~~~~-----~~----~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 253 --VMEGGLLDKPD-----NC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --HHTTCCCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --HHcCCcCCCCC-----CC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111111111 11 1245678999999999999999999999997644
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=344.55 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=198.6
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 461 (706)
++|++.+.||+|+||.||+++.. +++.||||++.+. .....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999985 4789999998653 344567788999999988 899999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999999653 34899999999999999999999998 99999999999999999999999999986422
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc--hhHHHHHHHHhhcCCCcccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK--LNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 619 (706)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..........+...... +
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-~- 238 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-I- 238 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-C-
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-C-
Confidence 21 223346799999999999999999999999999999999999999864322111 01111111111111111 0
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCCh
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCM 653 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 653 (706)
....+ ..+.+++.+||+.||.+||++
T Consensus 239 ----p~~~s----~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 239 ----PRSLS----VKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----CTTSC----HHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CCCCC----HHHHHHHHHHhcCCHhHCCCC
Confidence 01111 245678899999999999996
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=359.58 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=203.8
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC-eeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE-EKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~ 464 (706)
.++|++.++||+|+||.||+|... ++.||||+++... ..+.+.+|+.++++++||||+++++++.+.. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467899999999999999999985 6799999997543 4578999999999999999999999988765 78999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 99999999997543 244789999999999999999999998 999999999999999999999999999864321
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+. ..... .+......+
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~~i~----~~~~~~~p~--- 409 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVE----KGYKMDAPD--- 409 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HHHHH----TTCCCCCCT---
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH----cCCCCCCCC---
Confidence 122357889999999999999999999999999999998 9999865443322 21111 111111111
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.. ...+.+++..||+.||.+|||+.+|++.|+.+
T Consensus 410 --~~----~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 410 --GC----PPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp --TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --cC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 12466789999999999999999999999865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=352.98 Aligned_cols=249 Identities=25% Similarity=0.349 Sum_probs=201.4
Q ss_pred HhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCee
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 458 (706)
...++|.+.+.||+|+||.||+|+.+ +++.||||++++.. ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34579999999999999999999985 58899999986532 33456788899999887 899999999999999999
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999999653 34889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... .....+.
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~--~~~~~p~- 239 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSIRM--DNPFYPR- 239 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH--CCCCCCT-
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHh--CCCCCCc-
Confidence 43221 223446799999999999999999999999999999999999999854221 122211111 0111111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChh-HHH
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMP-SVI 657 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~-ev~ 657 (706)
..+ ..+.+++..||+.||.+||++. +|+
T Consensus 240 -------~~s----~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 240 -------WLE----KEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -------TSC----HHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -------ccC----HHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111 2456789999999999999998 665
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=345.97 Aligned_cols=245 Identities=24% Similarity=0.338 Sum_probs=201.8
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|++.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999985 58899999986532 23456788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999999653 34889999999999999999999988 99999999999999999999999999987532
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ....... ....... +
T Consensus 159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~---i~~~~~~--~--- 222 (318)
T 1fot_A 159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKTYEK---ILNAELR--F--- 222 (318)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHH---HHHCCCC--C---
T ss_pred -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHH---HHhCCCC--C---
Confidence 2234679999999999999999999999999999999999999985322 1121111 1111110 0
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCC-----ChhHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRP-----CMPSVIL 658 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~ 658 (706)
....+ ..+.+++.+||+.||.+|| +++||++
T Consensus 223 --p~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 223 --PPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --CTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCC----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 01111 2456788999999999999 8888874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=342.70 Aligned_cols=261 Identities=24% Similarity=0.349 Sum_probs=198.6
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
++|++.++||+|+||.||+|+...++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999999889999999986532 23346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++ +|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 986 8988885432 45889999999999999999999988 99999999999999999999999999987643211
Q ss_pred cccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc---cc--
Q 005236 545 EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS---QL-- 618 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-- 618 (706)
......||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ................. ..
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHHCCCChhhchhhhc
Confidence 22235689999999999764 589999999999999999999999854322 22222222221111100 00
Q ss_pred ---cccccc-------CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 619 ---IDACFK-------DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 619 ---~d~~~~-------~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.++... ..........+.+++.+||+.||.+|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0000001124568999999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=349.25 Aligned_cols=249 Identities=23% Similarity=0.359 Sum_probs=202.5
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.+.||+|+||.||+++... ++.||+|++... .....+.+.+|+.+++.++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 689999999999999999999854 788999998653 2334578889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++++||+|||+++.+...
T Consensus 95 e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 999999999999653 34899999999999999999999998 999999999999999999999999999876432
Q ss_pred CCcccccccccccCccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||.................. ....+.
T Consensus 169 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~p~-- 241 (384)
T 4fr4_A 169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT--VVTYPS-- 241 (384)
T ss_dssp ---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC--CCCCCT--
T ss_pred ---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc--ccCCCC--
Confidence 22334679999999999974 46899999999999999999999998654443333222221111 000111
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCC-hhHHHH
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPC-MPSVIL 658 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-~~ev~~ 658 (706)
..+ ..+.+++..||+.||.+||+ +++|..
T Consensus 242 ------~~s----~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 242 ------AWS----QEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------TSC----HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------cCC----HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111 24667899999999999999 677664
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=343.53 Aligned_cols=251 Identities=23% Similarity=0.390 Sum_probs=202.8
Q ss_pred cCCCccceeccCCceeEEEEEeCC-C-------cEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCee
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-E-------QEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 458 (706)
++|.+.+.||+|+||.||+|+... + ..||+|++........+.+.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 679999999999999999998754 2 46999999877777778999999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC--------eEE
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--------PKI 530 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~--------~kl 530 (706)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999996543 34889999999999999999999998 999999999999998887 999
Q ss_pred eeeccccccCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH
Q 005236 531 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKL 609 (706)
Q Consensus 531 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 609 (706)
+|||++..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|..|+... ......... ..
T Consensus 163 ~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~--~~~~~~~~~-~~- 232 (289)
T 4fvq_A 163 SDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA--LDSQRKLQF-YE- 232 (289)
T ss_dssp CCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT--SCHHHHHHH-HH-
T ss_pred ccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc--cchHHHHHH-hh-
Confidence 99999875421 223568899999999987 77999999999999999999966553221 111111111 11
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 610 WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 610 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
.......... ..+.+++..||+.||.+|||++|+++.|+.+..
T Consensus 233 -~~~~~~~~~~------------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 -DRHQLPAPKA------------AELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp -TTCCCCCCSS------------CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred -ccCCCCCCCC------------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111111111 134578889999999999999999999997644
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=337.49 Aligned_cols=255 Identities=27% Similarity=0.520 Sum_probs=200.4
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchh-------hHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQ-------GLKELKNEIILFSKLQHRNLVKLLGCCIHGEE 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 457 (706)
.++|++.+.||+|+||.||+|++ .+++.||||++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36899999999999999999998 46889999998643221 1267899999999999999999999985544
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC-----eEEee
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKISD 532 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-----~kl~D 532 (706)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 79999999999999886533 46899999999999999999999875 34999999999999988876 99999
Q ss_pred eccccccCCCCCcccccccccccCccCcccc--ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 005236 533 FGLARAFGGDETEGNTNRVVGTYGYMAPEYA--SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLW 610 (706)
Q Consensus 533 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 610 (706)
||+++.... ......||+.|+|||++ ....++.++||||||+++|||++|+.||........ ..... ..
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~---~~ 243 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINM---IR 243 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHHHH---HH
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHHHH---Hh
Confidence 999985422 22335789999999998 445678999999999999999999999865433221 11111 11
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 611 NEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 611 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.......+.. .. ...+.+++..||+.||.+|||++||++.|+.+
T Consensus 244 ~~~~~~~~~~-----~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEGLRPTIPE-----DC----PPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSCCCCCCCT-----TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccCCCCCCCc-----cc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111111111 11 12466789999999999999999999999753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=336.80 Aligned_cols=262 Identities=22% Similarity=0.293 Sum_probs=199.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
++|++.++||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999985 5889999998643 33445788899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9986 555554332 245899999999999999999999998 9999999999999999999999999998764322
Q ss_pred CcccccccccccCccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc---c
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL---I 619 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 619 (706)
.......||+.|+|||++.+.. ++.++||||||+++|||++|..|+.. ....................... .
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~--~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC--CCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 2223357899999999998765 89999999999999999999888532 22222333333322221111100 0
Q ss_pred ---ccc---------ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 620 ---DAC---------FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 620 ---d~~---------~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+.. ............+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 000000011234568999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.54 Aligned_cols=252 Identities=27% Similarity=0.361 Sum_probs=196.3
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCC--cceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQH--RNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV 461 (706)
.++|++.+.||+|+||.||++...+++.||||++.. ......+.+.+|+.++.+++| |||+++++++.+....++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 467999999999999999999998899999999854 345556789999999999986 9999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|| +.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 88 ~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 5688999999653 35889999999999999999999998 99999999999997 67899999999987654
Q ss_pred CCCcccccccccccCccCcccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASD-----------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLW 610 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 610 (706)
...........||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .........
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~ 234 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII 234 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHh
Confidence 433333445679999999999865 6789999999999999999999999853221 112222222
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 611 NEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 611 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.........+ .. ...+.+++..||+.||.+|||+.|+++.
T Consensus 235 ~~~~~~~~~~-----~~----~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 DPNHEIEFPD-----IP----EKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CTTSCCCCCC-----CS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCcccCCcc-----cC----CHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111111111 11 1245678999999999999999999865
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=349.63 Aligned_cols=244 Identities=22% Similarity=0.247 Sum_probs=201.8
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999985 58899999986532 234577889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999654 34889999999999999999999988 999999999999999999999999999876432
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.... ......... .+... +
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~----~~~~~-~---- 257 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYEKIV----SGKVR-F---- 257 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH----HCCCC-C----
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC---HHHHHHHHH----cCCCC-C----
Confidence 234679999999999999999999999999999999999999985322 112211111 11110 0
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCC-----hhHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPC-----MPSVIL 658 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~ev~~ 658 (706)
....+ ..+.+++.+||+.||.+||+ ++||++
T Consensus 258 -p~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 258 -PSHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CTTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCC----HHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 01111 24567899999999999998 888875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=337.67 Aligned_cols=249 Identities=26% Similarity=0.369 Sum_probs=193.7
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccch--------------------------hhHHHHHHHHHHHh
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISE--------------------------QGLKELKNEIILFS 438 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 438 (706)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999974 578999999864321 12356889999999
Q ss_pred hcCCcceeeeEeEEEe--CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 005236 439 KLQHRNLVKLLGCCIH--GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 516 (706)
Q Consensus 439 ~l~h~niv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik 516 (706)
+++||||+++++++.+ ....++||||+++++|.+++. ...+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 568899999999999988763 245899999999999999999999998 9999999
Q ss_pred CCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCC
Q 005236 517 ASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ---FSVKSDVFSFGILLLEIVSGKKNRGF 593 (706)
Q Consensus 517 p~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDv~SlGvil~elltG~~p~~~ 593 (706)
|+|||++.++.+||+|||+++.+..... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987643321 223357999999999997765 47889999999999999999999753
Q ss_pred CCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 594 YHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.. ....... ....... ... ....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~---~~~~~~~----~~~~~~~-~~~---~~~~~----~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ER---IMCLHSK----IKSQALE-FPD---QPDIA----EDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SS---HHHHHHH----HHHCCCC-CCS---SSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cc---HHHHHHH----HhcccCC-CCC---ccccC----HHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 21 1111111 1111110 000 01111 24667899999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=344.99 Aligned_cols=260 Identities=25% Similarity=0.357 Sum_probs=188.6
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 368999999999999999999985 58899999986533 2334678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 464 FMPNKSLDSFIFDQE---RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
|++ ++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999986532 1235889999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC---CCc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG---MPS 616 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 616 (706)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ............. ...
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCTTTCG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhHhh
Confidence 3221 2233578999999999976 46899999999999999999999998643322 2222222211110 000
Q ss_pred c---------------------cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 617 Q---------------------LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 617 ~---------------------~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
. .+.+...... ...+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPL----DGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCC----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccC----CHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0000001111 125678999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=350.87 Aligned_cols=267 Identities=18% Similarity=0.227 Sum_probs=205.0
Q ss_pred hccCCCccceeccCCceeEEEEEeCC------CcEEEEEEcCccchhhH-----------HHHHHHHHHHhhcCCcceee
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSKISEQGL-----------KELKNEIILFSKLQHRNLVK 447 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~ 447 (706)
..++|++.++||+|+||.||+|++.. ++.||||++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998865 47899999865432211 12345666778889999999
Q ss_pred eEeEEEeC----CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc
Q 005236 448 LLGCCIHG----EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 523 (706)
Q Consensus 448 l~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~ 523 (706)
+++++... ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999875 4579999999 99999999653 245899999999999999999999998 99999999999999
Q ss_pred --CCCCeEEeeeccccccCCCCCcc-----cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 005236 524 --QDMNPKISDFGLARAFGGDETEG-----NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHS 596 (706)
Q Consensus 524 --~~~~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~ 596 (706)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998764322111 11334599999999999999999999999999999999999999864332
Q ss_pred CCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 597 DNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.. .......... ......+++.++....-. ..+.+++..||+.+|.+||++++|++.|+.+
T Consensus 267 ~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 267 DP--KYVRDSKIRY-RENIASLMDKCFPAANAP---GEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp CH--HHHHHHHHHH-HHCHHHHHHHHSCTTCCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CH--HHHHHHHHHh-hhhHHHHHHHhcccccCH---HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 21 1222111111 122334444443222111 2456788899999999999999999999866
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=352.10 Aligned_cols=246 Identities=24% Similarity=0.286 Sum_probs=195.1
Q ss_pred cceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCCCCh
Q 005236 392 NKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSL 470 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 470 (706)
.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 578999999999999974 5889999999876666778899999999999999999999999999999999999999999
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE--cCCCCeEEeeeccccccCCCCCcccc
Q 005236 471 DSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL--DQDMNPKISDFGLARAFGGDETEGNT 548 (706)
Q Consensus 471 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill--~~~~~~kl~Dfgla~~~~~~~~~~~~ 548 (706)
.+++.... ..+++..++.++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+..... .
T Consensus 174 ~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~ 245 (373)
T 2x4f_A 174 FDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L 245 (373)
T ss_dssp HHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence 99886432 35889999999999999999999988 9999999999999 6778999999999987643322 2
Q ss_pred cccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCC
Q 005236 549 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFN 628 (706)
Q Consensus 549 ~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 628 (706)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ ..... +....+ ...+
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~---~~~~~--~~~~~~-~~~~ 316 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---AETLNNIL---ACRWD--LEDEEF-QDIS 316 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHH---HTCCC--SCSGGG-TTSC
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH---hccCC--CChhhh-ccCC
Confidence 235699999999999999999999999999999999999999854321 12221111 11110 001111 1111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 629 LAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 629 ~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
..+.+++.+||+.||.+|||++|+++
T Consensus 317 ----~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 317 ----EEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 24667899999999999999999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=353.85 Aligned_cols=207 Identities=27% Similarity=0.335 Sum_probs=179.3
Q ss_pred ccHHHHHHhccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-----CcceeeeEe
Q 005236 377 FELATIANATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-----HRNLVKLLG 450 (706)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~ 450 (706)
+.+.+.....++|.+.++||+|+||.||+|+. .+++.||||++.. .....+.+..|+.+++.++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 44444455668999999999999999999998 4588999999864 3344567788999999997 999999999
Q ss_pred EEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC------
Q 005236 451 CCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ------ 524 (706)
Q Consensus 451 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~------ 524 (706)
++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccc
Confidence 999999999999999 999999996543 235889999999999999999999988 999999999999976
Q ss_pred -------------------CCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHH
Q 005236 525 -------------------DMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIV 585 (706)
Q Consensus 525 -------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ell 585 (706)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 889999999999864322 22357899999999999999999999999999999999
Q ss_pred hCCCCCCCC
Q 005236 586 SGKKNRGFY 594 (706)
Q Consensus 586 tG~~p~~~~ 594 (706)
+|+.||...
T Consensus 254 ~g~~pf~~~ 262 (360)
T 3llt_A 254 TGSLLFRTH 262 (360)
T ss_dssp HSSCSCCCS
T ss_pred HCCCCCCCC
Confidence 999998643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=336.56 Aligned_cols=255 Identities=31% Similarity=0.465 Sum_probs=205.4
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
.++|++.+.||+|+||.||+|+..+++.||||++.... ...+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 36899999999999999999999888899999986533 34578999999999999999999999976 55689999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 9999999996432 235889999999999999999999998 999999999999999999999999999876433221
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....... ........ .
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~----~~~~~~~~-~---- 232 (279)
T 1qpc_A 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNL----ERGYRMVR-P---- 232 (279)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHH----HTTCCCCC-C----
T ss_pred -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHHHH----hcccCCCC-c----
Confidence 2223456789999999998999999999999999999999 8888754221 1222111 11111110 0
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
... ...+.+++..||+.+|++|||+.+|++.|+..
T Consensus 233 ~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 233 DNC----PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccc----cHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 111 12466789999999999999999999999876
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=356.93 Aligned_cols=262 Identities=18% Similarity=0.199 Sum_probs=204.4
Q ss_pred HHHHHHhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEe
Q 005236 379 LATIANATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIH 454 (706)
Q Consensus 379 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 454 (706)
+.+.....++|++.++||+|+||.||+++.+ +++.||||++.+.. ....+.+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3344455689999999999999999999985 58999999986532 2234468899999999999999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeec
Q 005236 455 GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 534 (706)
Q Consensus 455 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 534 (706)
.+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 999999999999999999996532 35889999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccCccCccccc-------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 005236 535 LARAFGGDETEGNTNRVVGTYGYMAPEYAS-------DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAW 607 (706)
Q Consensus 535 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 607 (706)
+++.+..... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||..... ........
T Consensus 208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~ 283 (412)
T 2vd5_A 208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST---AETYGKIV 283 (412)
T ss_dssp TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHH
T ss_pred hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH---HHHHHHHH
Confidence 9987643322 1223457999999999997 35789999999999999999999999854322 22222211
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCC---CChhHHHHH
Q 005236 608 KLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDR---PCMPSVILM 659 (706)
Q Consensus 608 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R---Pt~~ev~~~ 659 (706)
........+. .....+ ..+.+++.+||+ +|.+| |+++|+++.
T Consensus 284 ~~~~~~~~p~-----~~~~~s----~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 284 HYKEHLSLPL-----VDEGVP----EEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp THHHHCCCC---------CCC----HHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred hcccCcCCCc-----cccCCC----HHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1100111110 001111 245678899999 99998 688888753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=345.77 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=192.9
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
.++|++.++||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999986 68899999986533 2236788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC--eEEeeeccccccCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGLARAFGGD 542 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfgla~~~~~~ 542 (706)
+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999999653 34899999999999999999999988 999999999999987775 999999999753221
Q ss_pred CCcccccccccccCccCccccccCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVK-SDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
.......||+.|+|||++.+..++.+ +||||||+++|||++|+.||............ .......... +..
T Consensus 172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~~~~~~~~~--~~~- 243 (361)
T 3uc3_A 172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT--IQRILSVKYS--IPD- 243 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH--HHHHHTTCCC--CCT-
T ss_pred ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH--HHHHhcCCCC--CCC-
Confidence 12233579999999999988888766 89999999999999999998654333222221 1111111110 000
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. ... ...+.+++.+||+.||.+|||++|+++.
T Consensus 244 ~--~~~----s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 D--IRI----SPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp T--SCC----CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred c--CCC----CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0 001 1245679999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=340.51 Aligned_cols=263 Identities=25% Similarity=0.371 Sum_probs=204.5
Q ss_pred cCCCccceeccCCceeEEEEEe-----CCCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC--Cee
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-----ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--EEK 458 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 458 (706)
+.|++.++||+|+||.||+|++ ..++.||||++... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5689999999999999999983 45889999998753 334567899999999999999999999999876 668
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 99999999999999995433 45899999999999999999999998 99999999999999999999999999988
Q ss_pred cCCCCCc-ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------CCCchhHHHHHHHH
Q 005236 539 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH--------SDNKLNLIRHAWKL 609 (706)
Q Consensus 539 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~--------~~~~~~~~~~~~~~ 609 (706)
....... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.... ..............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 6543321 22334568889999999999999999999999999999999998853210 00111111111122
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 610 WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 610 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
........... .. ...+.+++.+||+.||.+|||++||++.|+.+
T Consensus 256 ~~~~~~~~~~~-----~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 256 LKEGKRLPCPP-----NC----PDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHTTCCCCCCT-----TC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhccCCCCCCC-----CC----CHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 21211111100 11 13466899999999999999999999999764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=349.76 Aligned_cols=262 Identities=19% Similarity=0.242 Sum_probs=199.8
Q ss_pred HHHhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-----chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC
Q 005236 382 IANATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-----SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG 455 (706)
Q Consensus 382 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 455 (706)
+....++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3455678999999999999999999984 5788999998643 344567899999999999999999999999999
Q ss_pred CeeEEEEecCCCCChhhhhhcccc-------------------------------------cCCCCHHHHHHHHHHHHHH
Q 005236 456 EEKLLIYEFMPNKSLDSFIFDQER-------------------------------------CKLLDWSKRFHIICGTARG 498 (706)
Q Consensus 456 ~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~ia~~ 498 (706)
+..++||||+++|+|.+++..... ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999852110 1123567788899999999
Q ss_pred HHHHHhCCCCceEecccCCCcEEEcCCC--CeEEeeeccccccCCCCC--cccccccccccCccCcccccc--CCCCcch
Q 005236 499 LLYLHQDSRLRIIHRDLKASNVLLDQDM--NPKISDFGLARAFGGDET--EGNTNRVVGTYGYMAPEYASD--GQFSVKS 572 (706)
Q Consensus 499 l~~LH~~~~~~ivH~Dikp~Nill~~~~--~~kl~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~s~~s 572 (706)
|+|||+.+ |+||||||+|||++.++ .+||+|||+++.+..... ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 899999999987533211 112334679999999999975 6789999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 005236 573 DVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPC 652 (706)
Q Consensus 573 Dv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt 652 (706)
||||||+++|||++|+.||..... ..... .......... .+... ..+ ..+.+++..||+.+|.+||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~---~~~~~---~~~~~~~~~~--~~~~~-~~~----~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVND---ADTIS---QVLNKKLCFE--NPNYN-VLS----PLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHCCCCTT--SGGGG-GSC----HHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCh---HHHHH---HHHhcccccC--Ccccc-cCC----HHHHHHHHHHcCCChhHCCC
Confidence 999999999999999999754322 11111 1211111110 01100 111 24567899999999999999
Q ss_pred hhHHHHH
Q 005236 653 MPSVILM 659 (706)
Q Consensus 653 ~~ev~~~ 659 (706)
+.|+++.
T Consensus 325 ~~~~l~h 331 (345)
T 3hko_A 325 AMRALQH 331 (345)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999873
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=337.04 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=194.2
Q ss_pred ccCCCccceeccCCceeEEEEEeCC----CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD----EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
.++|++.+.||+|+||.||+|+... +..||+|++... .....+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 3689999999999999999998743 456999998653 445567899999999999999999999997 4567899
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 999999999999996432 35889999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
..... ......+|+.|+|||++....++.++||||||+++|||++ |+.||......+ ...... ......+.
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~i~----~~~~~~~~ 239 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIE----NGERLPMP 239 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHH----TTCCCCCC
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHHHH----cCCCCCCC
Confidence 33221 2223456789999999999999999999999999999997 899976433222 221111 11111111
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
... ...+.+++..||+.||.+|||+.||++.|+.+
T Consensus 240 -----~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 240 -----PNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111 12456789999999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=344.01 Aligned_cols=266 Identities=17% Similarity=0.221 Sum_probs=200.0
Q ss_pred ccCCCccceeccCCceeEEEEEeC----CCcEEEEEEcCccchh-----------hHHHHHHHHHHHhhcCCcceeeeEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA----DEQEIAVKRLSKISEQ-----------GLKELKNEIILFSKLQHRNLVKLLG 450 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 450 (706)
.++|.+.+.||+|+||.||+|+.. .+..+|||++...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 368999999999999999999985 5778999998653221 1134667888999999999999999
Q ss_pred EEEe----CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC
Q 005236 451 CCIH----GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 526 (706)
Q Consensus 451 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 526 (706)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67889999999 999999996543 6899999999999999999999998 99999999999999887
Q ss_pred --CeEEeeeccccccCCCCCc-----ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc
Q 005236 527 --NPKISDFGLARAFGGDETE-----GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK 599 (706)
Q Consensus 527 --~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~ 599 (706)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP- 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence 9999999999876432211 11234579999999999999999999999999999999999999985322211
Q ss_pred hhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 600 LNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
.................+......... ...+.+++..||+.+|.+||++++|++.|+...
T Consensus 268 -~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 268 -VAVQTAKTNLLDELPQSVLKWAPSGSS----CCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp -HHHHHHHHHHHHTTTHHHHHHSCTTSC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred -HHHHHHHHhhcccccHHHHhhcccccc----HHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 112222222222222211110000011 124667889999999999999999999999863
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=343.04 Aligned_cols=267 Identities=29% Similarity=0.420 Sum_probs=212.1
Q ss_pred HHHHHHhccCCCccceeccCCceeEEEEEe------CCCcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEe
Q 005236 379 LATIANATDNFSINKKLGEGGFGPVYKGTL------ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLG 450 (706)
Q Consensus 379 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 450 (706)
........++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 344445568999999999999999999984 34678999998753 344567899999999999 7999999999
Q ss_pred EEEeCC-eeEEEEecCCCCChhhhhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 005236 451 CCIHGE-EKLLIYEFMPNKSLDSFIFDQER-------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 516 (706)
Q Consensus 451 ~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik 516 (706)
++...+ ..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCc
Confidence 988755 58999999999999999975432 123788999999999999999999988 9999999
Q ss_pred CCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 005236 517 ASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYH 595 (706)
Q Consensus 517 p~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~ 595 (706)
|+||+++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999987654433333444668899999999999999999999999999999998 999975433
Q ss_pred CCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 596 SDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
... ..... ........... ..+ ..+.+++.+||+.+|.+|||+.||++.|+.+
T Consensus 256 ~~~--~~~~~----~~~~~~~~~~~-----~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 256 IDE--EFCRR----LKEGTRMRAPD-----YTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CSH--HHHHH----HHHTCCCCCCT-----TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhH--HHHHH----hccCccCCCCC-----CCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 221 11111 11111111111 111 2466788999999999999999999999865
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=345.82 Aligned_cols=263 Identities=31% Similarity=0.418 Sum_probs=209.9
Q ss_pred HHhccCCCccceeccCCceeEEEEEeCC------CcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEe
Q 005236 383 ANATDNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIH 454 (706)
Q Consensus 383 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 454 (706)
....++|.+.+.||+|+||.||+|+... .+.||+|.+... .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3445789999999999999999999743 247999998754 344567899999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhhcccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc
Q 005236 455 GEEKLLIYEFMPNKSLDSFIFDQER-----------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 523 (706)
Q Consensus 455 ~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~ 523 (706)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence 9999999999999999999975432 245789999999999999999999988 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhH
Q 005236 524 QDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNL 602 (706)
Q Consensus 524 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~ 602 (706)
.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..||........ .
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~ 276 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--F 276 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--H
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--H
Confidence 999999999999987644333333334567889999999999999999999999999999999 8888754332211 1
Q ss_pred HHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 603 IRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 603 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
... .......... ... ...+.+++..||+.+|.+|||++||++.|+..
T Consensus 277 ~~~----~~~~~~~~~~-----~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 277 YKL----VKDGYQMAQP-----AFA----PKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHH----HHHTCCCCCC-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH----HhcCCCCCCC-----CCC----CHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 111 1111111000 001 12456789999999999999999999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=350.25 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=200.0
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999997 568899999986432 22245789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+ +|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 78898888654 34899999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCcccccccccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.. ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...........+ .... .
T Consensus 161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-------~~~~-~---- 225 (336)
T 3h4j_B 161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-------NSCV-Y---- 225 (336)
T ss_dssp SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-------CSSC-C----
T ss_pred Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-------HcCC-C----
Confidence 22 2234579999999999988776 78999999999999999999998643322211100 0000 0
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+....+ ..+.+++.+||+.||.+|||++|+++.
T Consensus 226 -~~p~~~s----~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 226 -VMPDFLS----PGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -CCCTTSC----HHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -CCcccCC----HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0011111 245678999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.30 Aligned_cols=206 Identities=20% Similarity=0.266 Sum_probs=178.3
Q ss_pred ccCCCccceeccC--CceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 386 TDNFSINKKLGEG--GFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 386 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
.++|++.++||+| +||.||+|+.. +++.||||++... .....+.+.+|+.++++++|||||++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3689999999999 99999999986 5889999998653 34556788899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999996542 245899999999999999999999998 9999999999999999999999999987542
Q ss_pred CCCC-----cccccccccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 005236 541 GDET-----EGNTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFYH 595 (706)
Q Consensus 541 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvil~elltG~~p~~~~~ 595 (706)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2111 112223478999999999987 679999999999999999999999986543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.51 Aligned_cols=262 Identities=27% Similarity=0.363 Sum_probs=204.5
Q ss_pred cCC-CccceeccCCceeEEEEEe-----CCCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC--Ce
Q 005236 387 DNF-SINKKLGEGGFGPVYKGTL-----ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--EE 457 (706)
Q Consensus 387 ~~~-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 457 (706)
++| ++.++||+|+||.||++.. .+++.||||++... .....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344 8999999999999988864 25788999999764 345567899999999999999999999999884 57
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.++||||+++++|.+++... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 89999999999999999543 3899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCc-ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC--------CchhHHHHHHH
Q 005236 538 AFGGDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSD--------NKLNLIRHAWK 608 (706)
Q Consensus 538 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~--------~~~~~~~~~~~ 608 (706)
........ .......+|..|+|||++.+..++.++||||||+++|||++|+.|+...... ...........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 86543221 1233356788899999999999999999999999999999999997532110 00001111111
Q ss_pred HhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 609 LWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 609 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
............ . ....+.+++.+||+.||.+|||++||++.|+.+.
T Consensus 263 ~~~~~~~~~~~~-----~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 263 LLERGERLPRPD-----K----CPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHHTTCCCCCCT-----T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcccCCCCCc-----c----ccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111111111111 1 1235678899999999999999999999998763
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=334.83 Aligned_cols=254 Identities=26% Similarity=0.424 Sum_probs=206.5
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
++|++.+.||+|+||.||+|+..+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 57899999999999999999998888999999975432 34678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++....... .
T Consensus 87 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 160 (267)
T 3t9t_A 87 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 160 (267)
T ss_dssp TCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred CCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-c
Confidence 999999996532 45889999999999999999999998 99999999999999999999999999987543211 1
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ....... ....... .. .
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~i----~~~~~~~-~~----~ 228 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDI----STGFRLY-KP----R 228 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH----HTTCCCC-CC----T
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---HHHHHHH----hcCCcCC-CC----c
Confidence 2223456788999999999999999999999999999999 8988754221 1111111 1111100 00 0
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.. ...+.+++.+||+.+|.+||+++++++.|+.+
T Consensus 229 ~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 229 LA----STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cC----cHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 12456789999999999999999999999865
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=346.10 Aligned_cols=248 Identities=23% Similarity=0.284 Sum_probs=191.4
Q ss_pred ccCCCccceeccCCceeEEEEEe----CCCcEEEEEEcCccc----hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL----ADEQEIAVKRLSKIS----EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEE 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 457 (706)
.++|++.+.||+|+||.||+++. ..++.||+|++.+.. ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36899999999999999999987 468899999987532 2345668899999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999999643 34788999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ........... ......
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~--~~~~p~ 242 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN---RKKTIDKILKC--KLNLPP 242 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHT--CCCCCT
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhC--CCCCCC
Confidence 643221 12234579999999999999999999999999999999999999985422 12222221111 001111
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCC-----ChhHHHH
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP-----CMPSVIL 658 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~ 658 (706)
..+ ..+.+++.+||+.||.+|| ++.|+++
T Consensus 243 --------~~~----~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 243 --------YLT----QEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --------TSC----HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --------CCC----HHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 111 2456788999999999999 6677765
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=334.22 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=202.6
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
.++|++.+.||+|+||.||+|... +++.||+|++.. ......+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999985 488999999854 34455678899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC---eEEeeecccccc
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLARAF 539 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---~kl~Dfgla~~~ 539 (706)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999999888654 35899999999999999999999998 999999999999987665 999999999876
Q ss_pred CCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 540 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 540 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ............ ...+...
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~-~~~~~~~- 230 (284)
T 3kk8_A 159 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGA-YDYPSPE- 230 (284)
T ss_dssp CSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTC-CCCCTTT-
T ss_pred ccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc---hhHHHHHHHhcc-ccCCchh-
Confidence 4322 2233578999999999999999999999999999999999999975322 111111111110 0001000
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. ...+ ..+.+++..||+.||.+|||++|+++.
T Consensus 231 ---~-~~~~----~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 231 ---W-DTVT----PEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ---T-TTSC----HHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---h-cccC----HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 0111 245678999999999999999999873
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=348.78 Aligned_cols=249 Identities=23% Similarity=0.295 Sum_probs=200.8
Q ss_pred hccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 459 (706)
..++|++.+.||+|+||.||+|+... ++.||||++.+. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34789999999999999999999865 788999998653 223456788999999988 8999999999999999999
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999999653 34889999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 540 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 540 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......... .. ... +
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i~---~~-~~~-~- 240 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIM---EH-NVA-Y- 240 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH---HC-CCC-C-
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC---HHHHHHHHH---hC-CCC-C-
Confidence 3221 22334679999999999999999999999999999999999999985422 222221111 11 110 0
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCCh-----hHHHH
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCM-----PSVIL 658 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~-----~ev~~ 658 (706)
....+ ..+.+++..||+.||.+||+. ++|++
T Consensus 241 ----p~~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 241 ----PKSMS----KEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ----CTTSC----HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ----CCCCC----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 01111 245678999999999999964 66654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=346.39 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=197.9
Q ss_pred cCCCccceeccCCceeEEEEEeCC-Cc----EEEEEEcCc-cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQ----EIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
++|++.++||+|+||.||+|++.. ++ +|++|.+.. ......+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 689999999999999999999743 44 357787754 34455678999999999999999999999998654 889
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
|+||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 94 v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 999999999999996543 45889999999999999999999998 9999999999999999999999999998865
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ...... ........
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~~----~~~~~~~~ 241 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE----KGERLPQP 241 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHH----TTCCCCCC
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----cCCCCCCC
Confidence 4433333334567889999999999999999999999999999999 999986543322 111111 11111100
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
... ...+.+++..||+.||.+||+++||++.|+.+..
T Consensus 242 -----~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 242 -----PIC----TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -----TTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred -----ccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 011 1246678999999999999999999999987643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=349.23 Aligned_cols=251 Identities=26% Similarity=0.356 Sum_probs=196.6
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcC--CcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQ--HRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.++||+|+||.||++....++.||||++.. ......+.+.+|+.++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 46999999999999999999998899999999854 34556788999999999996 599999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
| +.+++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 67889999996543 5788899999999999999999988 99999999999995 589999999999876544
Q ss_pred CCcccccccccccCccCcccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASD-----------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWN 611 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 611 (706)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..........
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~~ 282 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIID 282 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHhC
Confidence 33333345679999999999865 4689999999999999999999999853221 1111122221
Q ss_pred cCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 612 EGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 612 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
......+. ... ...+.+++..||+.||.+|||+.||++.
T Consensus 283 ~~~~~~~~-----~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 283 PNHEIEFP-----DIP----EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TTSCCCCC-----CCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCCCC-----ccc----hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111110 011 1245678999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=368.04 Aligned_cols=258 Identities=27% Similarity=0.431 Sum_probs=207.6
Q ss_pred hccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
..++|++.++||+|+||.||+|++.++..||||++.... ...+.|.+|+.++++++||||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 346789999999999999999999888899999997543 335789999999999999999999999865 678999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++|+|.++|.... ...+++..++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+.....
T Consensus 343 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999996432 245889999999999999999999988 99999999999999999999999999987643211
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
.......++..|+|||++....++.++||||||++||||++ |+.||..... .+..... ..+......
T Consensus 419 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~i----~~~~~~~~~---- 486 (535)
T 2h8h_A 419 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQV----ERGYRMPCP---- 486 (535)
T ss_dssp -HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHHH----HTTCCCCCC----
T ss_pred -ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCCCCCCC----
Confidence 11222456789999999999999999999999999999999 8988754321 1222211 111111110
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
... ...+.+|+.+||+.||++|||+++|+++|+.+..
T Consensus 487 -~~~----~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 487 -PEC----PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp -TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred -CCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 011 1246678999999999999999999999998744
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=336.37 Aligned_cols=251 Identities=20% Similarity=0.300 Sum_probs=202.6
Q ss_pred hccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
..++|++.+.||+|+||.||+|+... +..+|+|++........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34679999999999999999999855 67899999877655667889999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE---cCCCCeEEeeeccccccC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFG 540 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfgla~~~~ 540 (706)
|+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++..+.
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999988653 34889999999999999999999998 9999999999999 888999999999998764
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
... ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||..... ....... ...... ...
T Consensus 161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~----~~~~~~-~~~ 228 (277)
T 3f3z_A 161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD---SEVMLKI----REGTFT-FPE 228 (277)
T ss_dssp TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH----HHCCCC-CCH
T ss_pred Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH---HHHHHHH----HhCCCC-CCc
Confidence 332 22335689999999998654 99999999999999999999999754321 1111111 111110 000
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
... ... ...+.+++..||+.||.+|||+.|+++
T Consensus 229 ~~~-~~~----~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KDW-LNV----SPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHH-TTS----CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhh-hcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 011 124567899999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=361.19 Aligned_cols=253 Identities=26% Similarity=0.338 Sum_probs=205.5
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999985 5899999998653 223456788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++|+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++.+..
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999996543 234899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.......... ..
T Consensus 339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~-~p----- 409 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE-YS----- 409 (576)
T ss_dssp TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC-CC-----
T ss_pred Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc-CC-----
Confidence 22 1223579999999999999999999999999999999999999987544333222222221111111 11
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCC-----ChhHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRP-----CMPSVIL 658 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~ 658 (706)
...+ ..+.+++..||+.||.+|| +++||++
T Consensus 410 ---~~~s----~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 410 ---ERFS----PQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ---TTSC----HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ---ccCC----HHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1111 2456789999999999999 6788764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=341.49 Aligned_cols=272 Identities=22% Similarity=0.301 Sum_probs=201.3
Q ss_pred HHHHhccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhh--cCCcceeeeEeEEEeC---
Q 005236 381 TIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSK--LQHRNLVKLLGCCIHG--- 455 (706)
Q Consensus 381 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~--- 455 (706)
......++|++.++||+|+||.||+|+.. ++.||||++.... ...+..|.+++.. ++||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 33445578999999999999999999985 8899999985432 2344455555554 4899999999999987
Q ss_pred -CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecccCCCcEEEcCCCCeE
Q 005236 456 -EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS-----RLRIIHRDLKASNVLLDQDMNPK 529 (706)
Q Consensus 456 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~Dikp~Nill~~~~~~k 529 (706)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.. +.+|+||||||+|||++.++.+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 6789999999999999999543 4889999999999999999999870 11399999999999999999999
Q ss_pred EeeeccccccCCCCCcc--cccccccccCccCccccccCCCCcc------hhhHHHHHHHHHHHhC----------CCCC
Q 005236 530 ISDFGLARAFGGDETEG--NTNRVVGTYGYMAPEYASDGQFSVK------SDVFSFGILLLEIVSG----------KKNR 591 (706)
Q Consensus 530 l~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~------sDv~SlGvil~elltG----------~~p~ 591 (706)
|+|||+++.+....... ......||+.|+|||++.+...+.+ +||||||+++|||++| +.|+
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999998764332221 1224579999999999988766665 9999999999999999 5555
Q ss_pred CCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 592 GFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
........... ..............+...+ ........+.+++.+||+.||.+|||+.||++.|+.+.+
T Consensus 263 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 263 HDLVPSDPSYE--DMREIVCIKKLRPSFPNRW---SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TTTSCSSCCHH--HHHHHHTTSCCCCCCCGGG---GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhcCCCCchh--hhHHHHhhhccCccccccc---hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 44332222111 1111111111111111111 111345567889999999999999999999999987643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=338.17 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=209.6
Q ss_pred hccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
..++|++.+.||+|+||.||+|++.. ++.||+|++... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45789999999999999999999865 788999998653 3346788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999996543 345899999999999999999999998 9999999999999999999999999998764332
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
. .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...... ...............
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~~~~~~~~~~------- 234 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLEKDYRMERP------- 234 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHHTTCCCCCC-------
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhccCCCCCC-------
Confidence 2 22233567889999999999999999999999999999999 88887543322 222111111111111
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
... ...+.+++..||+.||.+|||++||++.|+..
T Consensus 235 --~~~----~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 235 --EGC----PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp --TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCC----CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 011 12466789999999999999999999999764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=334.83 Aligned_cols=262 Identities=19% Similarity=0.271 Sum_probs=204.0
Q ss_pred hccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEE-EeCCeeEEEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCC-IHGEEKLLIY 462 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~ 462 (706)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++.++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999997 5688999998644322 24578899999999988877766655 6677889999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE---cCCCCeEEeeecccccc
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 539 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfgla~~~ 539 (706)
||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 999999996432 35899999999999999999999998 9999999999999 78999999999999876
Q ss_pred CCCCCc-----ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC
Q 005236 540 GGDETE-----GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM 614 (706)
Q Consensus 540 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 614 (706)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543321 122346789999999999999999999999999999999999999976555444444333322211111
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 615 PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 615 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
...+. ...+ ..+.+++..||+.+|++|||+++|++.|+.+
T Consensus 239 ~~~~~-----~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 239 IEVLC-----KGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHHT-----TTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hhhhh-----ccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 11110 1111 2466789999999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.73 Aligned_cols=266 Identities=24% Similarity=0.303 Sum_probs=197.8
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
.++|++.++||+|+||.||+|+... ++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 3689999999999999999999854 889999988553 3344567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 82 e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999988543 34889999999999999999999998 999999999999999999999999999876432
Q ss_pred CCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH--------HhhcC
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWK--------LWNEG 613 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~--------~~~~~ 613 (706)
.. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+..... .+...
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 156 SD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred cc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 21 2233578999999999976 6789999999999999999999999865433222221111100 00000
Q ss_pred C-CcccccccccCcCCH-----HHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 614 M-PSQLIDACFKDSFNL-----AEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 614 ~-~~~~~d~~~~~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. .....-+........ .....+.+++..||+.||.+|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 000000000000000 011246689999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=340.01 Aligned_cols=260 Identities=25% Similarity=0.408 Sum_probs=196.4
Q ss_pred hccCCCccceeccCCceeEEEEEeCC----CcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe-
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLAD----EQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEE- 457 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 457 (706)
..++|.+.+.||+|+||.||+|+... ++.||||++... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 45789999999999999999998742 457999998643 44556789999999999999999999999987653
Q ss_pred ----eEEEEecCCCCChhhhhhcc---cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEE
Q 005236 458 ----KLLIYEFMPNKSLDSFIFDQ---ERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 530 (706)
Q Consensus 458 ----~~lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 530 (706)
.++||||+++++|.+++... .....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 49999999999999998543 23356899999999999999999999988 999999999999999999999
Q ss_pred eeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHH
Q 005236 531 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKL 609 (706)
Q Consensus 531 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 609 (706)
+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .......
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~-- 263 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDYLL-- 263 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHH--
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHHHH--
Confidence 99999987654333233334567889999999999999999999999999999999 88887543322 2222211
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 610 WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 610 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
......... .. ...+.+++.+||+.+|.+|||+++|++.|+.+
T Consensus 264 --~~~~~~~~~-----~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 264 --HGHRLKQPE-----DC----LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp --TTCCCCCBT-----TC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --cCCCCCCCc-----cc----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111111 11 12466789999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=350.38 Aligned_cols=272 Identities=20% Similarity=0.269 Sum_probs=212.6
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC--eeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE--EKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV 461 (706)
.++|.+.++||+|+||.||+|++.. ++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 3679999999999999999999864 8899999987533 344677889999999999999999999998765 67999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE----cCCCCeEEeeecccc
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLAR 537 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~~kl~Dfgla~ 537 (706)
|||+++|+|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999977655555899999999999999999999998 9999999999999 788889999999998
Q ss_pred ccCCCCCcccccccccccCccCcccccc--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC-chhHHHHHHH
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYASD--------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN-KLNLIRHAWK 608 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~-~~~~~~~~~~ 608 (706)
...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||....... ..........
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 764322 2223568999999999865 567889999999999999999999986544322 2222222221
Q ss_pred HhhcCCCcccc---------ccc--ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 609 LWNEGMPSQLI---------DAC--FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 609 ~~~~~~~~~~~---------d~~--~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.........+. ... ............+.+++..||+.||++||++.|+++.|+.+
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 11111110000 000 01122344555677899999999999999999999888765
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=335.85 Aligned_cols=245 Identities=23% Similarity=0.310 Sum_probs=192.1
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.++||+|+||+||+|++. +++.||||++... .......+..|+..+.++ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999986 6899999998642 333444555666666555 8999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+ +++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 679998886543 45899999999999999999999988 999999999999999999999999999876432
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
. ......||+.|+|||++.+ .++.++||||||+++|||++|..++... . .+..+....... .
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~----~~~~~~~~~~~~----~ 272 (311)
T 3p1a_A 211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------E----GWQQLRQGYLPP----E 272 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------H----HHHHHTTTCCCH----H
T ss_pred C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------c----HHHHHhccCCCc----c
Confidence 2 2233568999999999876 7999999999999999999997764321 1 111111111111 1
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
+.... ...+.+++.+||+.||++|||++|+++.
T Consensus 273 ~~~~~----~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 273 FTAGL----SSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCC----CHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 11111 1346678999999999999999999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=357.18 Aligned_cols=251 Identities=26% Similarity=0.372 Sum_probs=202.4
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|.+.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 368999999999999999999985 58999999986532 23456788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 462 YEFMPNKSLDSFIFDQER-CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
|||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999975432 346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. ..... .. .+
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~--~i~~~-~~-~~-- 412 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ--RVLEQ-AV-TY-- 412 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH--HHHHC-CC-CC--
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH--HHhhc-cc-CC--
Confidence 3322 22335799999999999999999999999999999999999999865433222221111 11111 11 00
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChh
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMP 654 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ 654 (706)
....+ ..+.+++..||+.||.+||++.
T Consensus 413 ---p~~~s----~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 413 ---PDKFS----PASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp ---CTTSC----HHHHHHHHHHSCSSGGGSCCCB
T ss_pred ---CcccC----HHHHHHHHHhccCCHhHCCCCc
Confidence 01111 2456788999999999999763
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=337.49 Aligned_cols=262 Identities=22% Similarity=0.264 Sum_probs=198.4
Q ss_pred ccCCCcc-ceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEEE
Q 005236 386 TDNFSIN-KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 386 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 462 (706)
.+.|.+. +.||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3578874 78999999999999974 6889999999766555677899999999885 7999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC---eEEeeecccccc
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLARAF 539 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---~kl~Dfgla~~~ 539 (706)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999999654 35889999999999999999999998 999999999999998876 999999999865
Q ss_pred CCCCC-----cccccccccccCccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchh--------
Q 005236 540 GGDET-----EGNTNRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLN-------- 601 (706)
Q Consensus 540 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~-------- 601 (706)
..... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||......+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32211 111223469999999999975 568899999999999999999999986543322100
Q ss_pred HHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 602 LIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
........+...... +..... ... ...+.+++.+||+.||.+|||++|+++.
T Consensus 245 ~~~~~~~~i~~~~~~-~~~~~~-~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKYE-FPDKDW-AHI----SCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCCC-CCHHHH-TTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCcc-cCchhc-ccC----CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 001111111111110 000000 011 1246689999999999999999999984
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.68 Aligned_cols=264 Identities=22% Similarity=0.304 Sum_probs=197.5
Q ss_pred hccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccc-----hhhHHHHHHHHHHHhhc---CCcceeeeEeEEEeC
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKIS-----EQGLKELKNEIILFSKL---QHRNLVKLLGCCIHG 455 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~ 455 (706)
..++|++.++||+|+||.||+|+. .+++.||||++.... ......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357999999999999999999997 458899999986422 11134566777776666 499999999999876
Q ss_pred C-----eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEE
Q 005236 456 E-----EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 530 (706)
Q Consensus 456 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 530 (706)
. ..++||||++ ++|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4799999997 599999865432 34899999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 005236 531 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLW 610 (706)
Q Consensus 531 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 610 (706)
+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...........
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~ 235 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGKIFDLI 235 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH---HHHHHHHHHHH
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHh
Confidence 9999998754222 23346789999999999999999999999999999999999999854332 22222222222
Q ss_pred hcCCCcccc------ccccc--CcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 611 NEGMPSQLI------DACFK--DSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 611 ~~~~~~~~~------d~~~~--~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
......... ...+. ...... ....+.+++.+||+.||.+|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 111110000 00000 000011 11356789999999999999999999863
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=334.40 Aligned_cols=256 Identities=25% Similarity=0.335 Sum_probs=201.8
Q ss_pred CCCccceeccCCceeEEEEEeCC----CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCee-EEE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLAD----EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEK-LLI 461 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lV 461 (706)
.|.+.++||+|+||.||+|+..+ +..+|+|++... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667999999999999998633 236999998753 445567899999999999999999999999877665 999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+.+++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 9999999999999653 345789999999999999999999998 99999999999999999999999999987643
Q ss_pred CCC--cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 542 DET--EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 542 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
... ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+.. ................... ..
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~--~~~~~~~~~~~~~~~~~~~-~~-- 251 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR--HIDPFDLTHFLAQGRRLPQ-PE-- 251 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTT--TSCGGGHHHHHHTTCCCCC-CT--
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCc--cCCHHHHHHHhhcCCCCCC-Cc--
Confidence 321 1223345688999999999999999999999999999999996666422 1122222222111110000 00
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.. ...+.+++.+||+.+|.+|||++++++.|+.+
T Consensus 252 ------~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 252 ------YC----PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp ------TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------cc----hHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 12466789999999999999999999999876
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=341.78 Aligned_cols=263 Identities=22% Similarity=0.296 Sum_probs=204.6
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEe----CCeeEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIH----GEEKLL 460 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 460 (706)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46899999999999999999998 5688999999877667777889999999999999999999999873 347799
Q ss_pred EEecCCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 461 IYEFMPNKSLDSFIFDQE-RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999996532 2356899999999999999999999998 999999999999999999999999998764
Q ss_pred CCCCCcc-------cccccccccCccCccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH
Q 005236 540 GGDETEG-------NTNRVVGTYGYMAPEYASDGQ---FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKL 609 (706)
Q Consensus 540 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 609 (706)
....... ......||+.|+|||++.... ++.++||||||+++|||++|+.||......... .....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~--- 260 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAV--- 260 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHH---
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHh---
Confidence 3211110 112345799999999987654 789999999999999999999997532111111 11110
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 610 WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 610 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
........ .... ...+.+++.+||+.||.+|||+++|++.|+.+..
T Consensus 261 -~~~~~~~~-----~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 261 -QNQLSIPQ-----SPRH----SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -HCC--CCC-----CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred -hccCCCCc-----cccC----CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 11000000 0011 1246678999999999999999999999997643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=342.65 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=187.6
Q ss_pred hccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
..++|++.+.||+|+||.||+|+... ++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 34689999999999999999999864 7889999986533 34678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---CCCeEEeeeccccccC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLARAFG 540 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Dfgla~~~~ 540 (706)
|+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999999643 34889999999999999999999988 999999999999975 8999999999998753
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... .. ..... ...
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~---i~-~~~~~-~~~ 272 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMFRR---IL-NCEYY-FIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHHHH---HH-TTCCC-CCT
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHHHH---HH-hCCCc-cCC
Confidence 321 223457899999999999999999999999999999999999997532221 111111 11 11110 111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
+.. ...+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 273 ~~~-~~~~----~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 273 PWW-DEVS----LNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTT-TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred chh-hhCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 1111 245678999999999999999999873
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.49 Aligned_cols=247 Identities=25% Similarity=0.356 Sum_probs=198.5
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|++.+.||+|+||.||+|+... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4689999999999999999998854 6789999985432 22356789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999999654 34889999999999999999999987 99999999999999999999999999865432
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......... . .......
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~-~-~~~~~~~--- 229 (279)
T 3fdn_A 162 S----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYKRISR-V-EFTFPDF--- 229 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHH-T-CCCCCTT---
T ss_pred c----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH---HHHHHHHHh-C-CCCCCCc---
Confidence 2 22335789999999999999999999999999999999999999753221 111111111 0 1111111
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. ...+.+++..||+.+|.+|||++||++.
T Consensus 230 -----~----~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 230 -----V----TEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -----S----CHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -----C----CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1 1245678899999999999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=340.29 Aligned_cols=251 Identities=24% Similarity=0.264 Sum_probs=179.2
Q ss_pred cceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCeeEEEEecCCCCC
Q 005236 392 NKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKLLIYEFMPNKS 469 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gs 469 (706)
.+.||+|+||.||+++.. +++.||||++... ....+.+|+.++.++. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999985 5889999998543 3467788999999997 9999999999999999999999999999
Q ss_pred hhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC---CeEEeeeccccccCCCCCcc
Q 005236 470 LDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 470 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl~Dfgla~~~~~~~~~~ 546 (706)
|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 99999654 45899999999999999999999988 99999999999998766 899999999987543221
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCc
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDS 626 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 626 (706)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..................+..+... +....+. .
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~-~ 242 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS-FEGEAWK-N 242 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC-CCSHHHH-T
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC-CCccccc-C
Confidence 2234568999999999999999999999999999999999999986543322211122222222222211 0000000 0
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 627 FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 627 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. ...+.+++..||+.||.+|||++|+++.
T Consensus 243 ~----s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 243 V----SQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp S----CHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred C----CHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1 1246689999999999999999998743
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=332.03 Aligned_cols=261 Identities=19% Similarity=0.272 Sum_probs=206.4
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEE-EeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCC-IHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~e 463 (706)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++.++|++++..+..+ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 47899999999999999999997 5688999998754332 24688999999999998876666555 56778899999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE---cCCCCeEEeeeccccccC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFG 540 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfgla~~~~ 540 (706)
|+ +++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 999999996432 35899999999999999999999998 9999999999999 488999999999998765
Q ss_pred CCCCcc-----cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 541 GDETEG-----NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 541 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 433211 123467999999999999999999999999999999999999999765544433333332221111111
Q ss_pred cccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 616 SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 616 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
..+. ...+ ..+.+++.+||+.||.+|||+++|++.|+.+
T Consensus 240 ~~~~-----~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 240 EVLC-----KGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHT-----TTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred HHHH-----hhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 1110 1111 2466789999999999999999999999876
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=339.01 Aligned_cols=262 Identities=25% Similarity=0.380 Sum_probs=198.8
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCc---cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSK---ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|++.+.||+|+||.||+|.. .+++.||||++.. ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 46799999999999999999997 4688999999864 2345567889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 462 YEFMPNKSLDSFIFDQE-RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999996532 2355889999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.... ......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ....... ............
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~----~~~~~~~~~~~~ 260 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCK----KIEQCDYPPLPS 260 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHH----HHHTTCSCCCCT
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHH----HhhcccCCCCcc
Confidence 3221 22235689999999999999999999999999999999999999753221 1111111 111111111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
...+ ..+.+++.+||+.||.+|||+.+|++.|+.+.+
T Consensus 261 ----~~~~----~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 261 ----DHYS----EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp ----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----cccC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 1111 245678999999999999999999999988733
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=344.87 Aligned_cols=261 Identities=22% Similarity=0.337 Sum_probs=194.0
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhh-HHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQG-LKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
++|++.++||+|+||.||+|+.. +++.||||++....... ...+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999985 68899999986533221 22456799999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
++ ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 98 58988886532 45889999999999999999999998 9999999999999999999999999998653221
Q ss_pred cccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC---Cccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM---PSQLID 620 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d 620 (706)
.......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .............. ......
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHhchhhhc
Confidence 12233568999999999876 57899999999999999999999998653322 22222222221111 111110
Q ss_pred cc-c-----c--CcCCH-----HHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 621 AC-F-----K--DSFNL-----AEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 621 ~~-~-----~--~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.. . . ..... .....+.+++.+||+.||.+|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00 0 0 00000 01124568999999999999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=351.41 Aligned_cols=264 Identities=24% Similarity=0.373 Sum_probs=192.9
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCC--ee
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGE--EK 458 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 458 (706)
..++|++.++||+|+||.||+|.+. +++.||||++.. ......+.+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999974 588999999864 34455677889999999997 999999999998654 68
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999998 589988854 35889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCC-------------------cccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 005236 539 FGGDET-------------------EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 598 (706)
Q Consensus 539 ~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~ 598 (706)
+..... .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-- 236 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST-- 236 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH--
Confidence 632110 111233579999999999986 6799999999999999999999999864332
Q ss_pred chhHHHHHHHHhhcCCCccc-----------cc----------ccccCcCC------------HHHHHHHHHHHHHhcCC
Q 005236 599 KLNLIRHAWKLWNEGMPSQL-----------ID----------ACFKDSFN------------LAEVIRCIHIGLLCVQQ 645 (706)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~-----------~d----------~~~~~~~~------------~~~~~~~~~l~~~cl~~ 645 (706)
.............+....+ +. ......+. ......+.+++.+||+.
T Consensus 237 -~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 237 -MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp -HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred -HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 2222222221111110000 00 00000000 00112467899999999
Q ss_pred CCCCCCChhHHHHH
Q 005236 646 YPEDRPCMPSVILM 659 (706)
Q Consensus 646 ~p~~RPt~~ev~~~ 659 (706)
||.+|||++|+++.
T Consensus 316 dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 316 NPNKRISANDALKH 329 (388)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=345.78 Aligned_cols=254 Identities=23% Similarity=0.307 Sum_probs=201.3
Q ss_pred cCCCccceeccCCceeEEEEEe----CCCcEEEEEEcCccc----hhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL----ADEQEIAVKRLSKIS----EQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEE 457 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 457 (706)
++|++.++||+|+||.||+++. ..++.||||++.... ....+.+.+|+.++.++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 6899999999999999999997 368899999986532 23345677899999999 69999999999999999
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999654 34889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
.+..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+.. ........
T Consensus 208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~~~~~~ 284 (355)
T 1vzo_A 208 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--RILKSEPP 284 (355)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--HHHHCCCC
T ss_pred ecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH--HHhccCCC
Confidence 7533222 12234579999999999986 3578999999999999999999999875443333222222 11111110
Q ss_pred cccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCC-----ChhHHHHHh
Q 005236 616 SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP-----CMPSVILML 660 (706)
Q Consensus 616 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~~L 660 (706)
+ ..... ..+.+++.+||+.||.+|| +++|+++..
T Consensus 285 --~-----~~~~~----~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 285 --Y-----PQEMS----ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --C-----CTTSC----HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --C-----CcccC----HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0 01111 2456789999999999999 899998755
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=329.22 Aligned_cols=253 Identities=27% Similarity=0.402 Sum_probs=203.1
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 367999999999999999999985 5889999998643 33446788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++++|.+++... ..+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999998543 35889999999999999999999988 9999999999999999999999999998764332
Q ss_pred CcccccccccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
.........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ .... +...... ...
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~----~~~~~~~--~~~- 230 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSD----WKEKKTY--LNP- 230 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHH----HHTTCTT--STT-
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHH----hhhcccc--cCc-
Confidence 2223344678999999999988765 7899999999999999999999865433221 1111 1111110 000
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
. ...+ ..+.+++..||+.||.+|||++|+++
T Consensus 231 ~-~~~~----~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 W-KKID----SAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp G-GGSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred h-hhcC----HHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0 0111 24567899999999999999999976
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=335.38 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=199.6
Q ss_pred cCCCccceeccCCceeEEEEEeCC----CcEEEEEEcCc-cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEe-CCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD----EQEIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIH-GEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 460 (706)
.+|++.++||+|+||.||+|+..+ ...+|+|.+.. ......+.+.+|+.++++++||||+++++++.+ ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 568889999999999999998743 23589999875 344556789999999999999999999998654 557899
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 99999999999999643 345789999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCc--ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 541 GDETE--GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK-KNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 541 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++|. +|+...... ........ .....
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~~~~~----~~~~~ 252 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLLQ----GRRLL 252 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHHHHHT----TCCCC
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHHhc----CCCCC
Confidence 33221 1223356788999999999999999999999999999999954 454332222 22211111 11100
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
. . ...+ ..+.+++..||+.+|.+|||++|+++.|+.+
T Consensus 253 ~-~----~~~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 253 Q-P----EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp C-C----TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-C----ccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0 0111 2466789999999999999999999999876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=347.28 Aligned_cols=257 Identities=24% Similarity=0.288 Sum_probs=189.1
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-CcceeeeEeEEEe--------C
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIH--------G 455 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--------~ 455 (706)
..+|++.++||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 358999999999999999999974 68899999987766677788999999999996 9999999999953 3
Q ss_pred CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecc
Q 005236 456 EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 535 (706)
Q Consensus 456 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgl 535 (706)
...++||||++ |+|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+||||+.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 35789999996 799999876555566999999999999999999999864 3499999999999999999999999999
Q ss_pred ccccCCCCCcc----------cccccccccCccCcccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhH
Q 005236 536 ARAFGGDETEG----------NTNRVVGTYGYMAPEYA---SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNL 602 (706)
Q Consensus 536 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~ 602 (706)
++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||....... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~ 261 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---I 261 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---h
Confidence 98764332211 11134689999999998 56678999999999999999999999975322111 0
Q ss_pred HHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 603 IRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 603 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
. ....... ... .. ...+.+++..||+.||.+|||+.|+++.|+.+
T Consensus 262 ~---~~~~~~~-~~~--------~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 262 V---NGKYSIP-PHD--------TQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp -------CCCC-TTC--------CS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred h---cCcccCC-ccc--------cc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 0000000 000 00 01245688899999999999999999999876
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=341.26 Aligned_cols=248 Identities=26% Similarity=0.345 Sum_probs=203.1
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|.+.+.||+|+||.||+++..+ ++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4689999999999999999999854 778999998643 345567889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999988543 35889999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......... .......
T Consensus 194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~--~~~~~~~---- 262 (335)
T 2owb_A 194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---KETYLRIKK--NEYSIPK---- 262 (335)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHH--TCCCCCT----
T ss_pred Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH---HHHHHHHhc--CCCCCCc----
Confidence 221 22335789999999999999999999999999999999999999854321 111111110 0111111
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
..+ ..+.+++.+||+.||.+|||++|+++
T Consensus 263 ----~~~----~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 263 ----HIN----PVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ----TSC----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----cCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 23567889999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=329.99 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=202.9
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC--CeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG--EEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 462 (706)
++|++.+.||+|+||.||+|++. ++.||||++... .....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 67999999999999999999985 788999998653 445567899999999999999999999999877 7889999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ ..++||||||+||+++.++.++|.|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp ECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred cccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 9999999999996543 235899999999999999999999864 3499999999999999999999999998764321
Q ss_pred CCcccccccccccCccCccccccCCCCc---chhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSV---KSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
....||+.|+|||.+.+..++. ++||||||+++|||++|+.||..... ... ............+.
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~---~~~~~~~~~~~~~~ 233 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---MEI---GMKVALEGLRPTIP 233 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---HHH---HHHHHHSCCCCCCC
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---HHH---HHHHHhcCCCCCCC
Confidence 2246899999999998765544 89999999999999999999854321 111 11122222211111
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
. ..+ ..+.+++..||+.||.+|||++|+++.|+.+.
T Consensus 234 ~-----~~~----~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 234 P-----GIS----PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp T-----TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C-----CCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1 111 24667889999999999999999999998653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=331.72 Aligned_cols=249 Identities=26% Similarity=0.418 Sum_probs=203.0
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEe----------
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIH---------- 454 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 454 (706)
.++|++.+.||+|+||.||+|+.. +++.||||++.... +.+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 457999999999999999999985 68999999986543 356789999999999999999998864
Q ss_pred ------CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCe
Q 005236 455 ------GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 528 (706)
Q Consensus 455 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 528 (706)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 345799999999999999996543 346899999999999999999999988 9999999999999999999
Q ss_pred EEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH
Q 005236 529 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWK 608 (706)
Q Consensus 529 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 608 (706)
||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|..|+.. ......
T Consensus 162 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---------~~~~~~ 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---------TSKFFT 229 (284)
T ss_dssp EECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---------HHHHHH
T ss_pred EECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---------HHHHHH
Confidence 999999998764432 22235689999999999999999999999999999999999987421 111111
Q ss_pred HhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCCC
Q 005236 609 LWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVL 666 (706)
Q Consensus 609 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~~ 666 (706)
.......... .+ ..+.+++.+||+.||.+|||+.|+++.|......
T Consensus 230 ~~~~~~~~~~--------~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 230 DLRDGIISDI--------FD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHTTCCCTT--------SC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred Hhhccccccc--------CC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 2222222211 12 1355788999999999999999999999876443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=338.93 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=199.3
Q ss_pred cCCCccceeccCCceeEEEEEeCC-----CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-----EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
++|++.+.||+|+||.||+|+... +..||||++... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 578888999999999999998743 235999998753 44456688999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 99999999999999653 245899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCcc-cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 541 GDETEG-NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 541 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ...... ...+.....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~----~~~~~~~~~ 271 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKA----INDGFRLPT 271 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHH----HHTTCCCCC
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHH----HHCCCcCCC
Confidence 332211 2223456788999999999999999999999999999999 9999754321 111111 111111110
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
.. . ....+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus 272 ~~-----~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 272 PM-----D----CPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp CT-----T----CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cc-----c----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 1 1124667899999999999999999999998763
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=331.14 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=205.2
Q ss_pred cCCCccc-eeccCCceeEEEEEeC---CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINK-KLGEGGFGPVYKGTLA---DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
++|.+.+ .||+|+||.||+|+.. .++.||||++... .....+.+.+|+.++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4666666 9999999999999863 5778999999763 445677899999999999999999999999 56678999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 9999999999999543 345899999999999999999999998 99999999999999999999999999988754
Q ss_pred CCCc-ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 542 DETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 542 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
.... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ...... ........+.
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~----i~~~~~~~~~ 235 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAF----IEQGKRMECP 235 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHH----HHTTCCCCCC
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHH----HhcCCcCCCC
Confidence 3322 12233456889999999998899999999999999999999 9999854332 111111 1111111111
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
... ...+.+++..||+.+|.+||++.+|++.|+.+
T Consensus 236 -----~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 236 -----PEC----PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp -----TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCc----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 12466789999999999999999999999865
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.32 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=201.5
Q ss_pred ccCCCccceeccCCceeEEEEEeCC----CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD----EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
.++|++.+.||+|+||.||+|+..+ +..||||.+... .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4689999999999999999998643 346999998764 44556789999999999999999999999764 56789
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 90 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 999999999999996532 45889999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....... .......
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~~~----~~~~~~~ 236 (281)
T 3cc6_A 165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVLEK----GDRLPKP 236 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHHHH----TCCCCCC
T ss_pred ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHHhc----CCCCCCC
Confidence 33221 2223456889999999999999999999999999999998 999986433322 2211111 1110000
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
...+ ..+.+++.+||+.+|.+|||+.|+++.|+.+
T Consensus 237 -----~~~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 237 -----DLCP----PVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -----TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCC----HHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0111 2466789999999999999999999999865
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.40 Aligned_cols=253 Identities=19% Similarity=0.245 Sum_probs=190.2
Q ss_pred ccCCCcc-ceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHh-hcCCcceeeeEeEEEe----CCee
Q 005236 386 TDNFSIN-KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFS-KLQHRNLVKLLGCCIH----GEEK 458 (706)
Q Consensus 386 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~ 458 (706)
.++|.+. +.||+|+||.||+++.. +++.||||++... ..+.+|+.++. ..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567776 78999999999999985 5889999998532 35677888774 4589999999999876 5678
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---CCCeEEeeecc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGL 535 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Dfgl 535 (706)
++||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999996543 245899999999999999999999988 999999999999998 78999999999
Q ss_pred ccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||................. .+..
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~~~~ 284 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQY 284 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---HTCC
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---cCcc
Confidence 98754221 22346789999999999999999999999999999999999999865443322111111111 1110
Q ss_pred cccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 616 SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 616 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+..+.+ ...+ ..+.+++..||+.||.+|||+.||++.
T Consensus 285 -~~~~~~~-~~~s----~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 -EFPNPEW-SEVS----EEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -CCCTTTT-TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -cCCCccc-ccCC----HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000000 0111 246678999999999999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=356.45 Aligned_cols=247 Identities=25% Similarity=0.390 Sum_probs=202.7
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 368999999999999999999985 68999999986532 23356789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999999643 45899999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCcccccccccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ....... ..+... .
T Consensus 169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i----~~~~~~-~-- 235 (476)
T 2y94_A 169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLFKKI----CDGIFY-T-- 235 (476)
T ss_dssp TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHHHHH----HTTCCC-C--
T ss_pred cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHHHHH----hcCCcC-C--
Confidence 22 2234579999999999988776 6899999999999999999999854322 2222211 111110 0
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
....+ ..+.+++..||+.||.+|||++|+++
T Consensus 236 ---p~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 ---PQYLN----PSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---CTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---CccCC----HHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 00111 24567899999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=341.51 Aligned_cols=261 Identities=22% Similarity=0.317 Sum_probs=203.0
Q ss_pred HHHHHHhccCCCcc-ceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcC-CcceeeeEeEEE
Q 005236 379 LATIANATDNFSIN-KKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQ-HRNLVKLLGCCI 453 (706)
Q Consensus 379 ~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 453 (706)
+.......+.|.+. ++||+|+||.||+|+.. +++.||||++... .......+.+|+.++.++. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34445556778887 89999999999999985 5889999998653 2334678899999999995 699999999999
Q ss_pred eCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---CCCeEE
Q 005236 454 HGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKI 530 (706)
Q Consensus 454 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl 530 (706)
+....++||||+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999998543 2356899999999999999999999998 999999999999998 789999
Q ss_pred eeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 005236 531 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLW 610 (706)
Q Consensus 531 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 610 (706)
+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..........
T Consensus 176 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~- 248 (327)
T 3lm5_A 176 VDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---QETYLNISQV- 248 (327)
T ss_dssp CCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHT-
T ss_pred eeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHhc-
Confidence 9999998764322 22335789999999999999999999999999999999999999754222 1111111111
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 611 NEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 611 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.......... .. ...+.+++.+||+.||.+|||++|+++.
T Consensus 249 ~~~~~~~~~~-----~~----~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 NVDYSEETFS-----SV----SQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCCCCTTTTT-----TS----CHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ccccCchhhc-----cc----CHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1111111111 11 1245678999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=340.91 Aligned_cols=252 Identities=22% Similarity=0.287 Sum_probs=203.0
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccch------hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISE------QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 458 (706)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 367999999999999999999985 588999999865322 1367899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC----CeEEeeec
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFG 534 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~Dfg 534 (706)
++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 9999999999999999643 34789999999999999999999998 99999999999999888 79999999
Q ss_pred cccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC
Q 005236 535 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM 614 (706)
Q Consensus 535 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 614 (706)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ........ ....
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i----~~~~ 234 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANI----TSVS 234 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHH----HTTC
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC---HHHHHHHH----Hhcc
Confidence 998764322 2233568999999999999999999999999999999999999975322 11111111 1111
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 615 PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 615 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. . .++......+ ..+.+++.+||+.||.+|||++|+++.
T Consensus 235 ~-~-~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 Y-D-FDEEFFSHTS----ELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp C-C-CCHHHHTTCC----HHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred c-c-cChhhhcccC----HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 0 0100111111 245678999999999999999999873
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=361.10 Aligned_cols=248 Identities=21% Similarity=0.259 Sum_probs=192.3
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|++.++||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999974 5889999998653 334456778899999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999998653 358999999999999999999998 77 9999999999999999999999999998643
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... .....+.
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~--~~~~~p~--- 370 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILM--EEIRFPR--- 370 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH--CCCCCCT---
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHHHHh--CCCCCCc---
Confidence 222 223346799999999999999999999999999999999999999854221 111111111 1111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCC-----ChhHHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP-----CMPSVIL 658 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~ 658 (706)
..+ ..+.+++..||+.||.+|| +++|+++
T Consensus 371 -----~~~----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 371 -----TLG----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -----TSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----cCC----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 111 2456789999999999999 9999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=349.97 Aligned_cols=247 Identities=23% Similarity=0.274 Sum_probs=190.3
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccc---hhhHHHHHHHHHH-HhhcCCcceeeeEeEEEeCCeeEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKIS---EQGLKELKNEIIL-FSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
.++|++.+.||+|+||.||+++.+. ++.||||++.+.. ....+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 4689999999999999999999854 7889999986532 2334556677776 577899999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999999653 34788899999999999999999988 9999999999999999999999999998643
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........ ... .. .+
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i---~~~-~~-~~-- 258 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNI---LNK-PL-QL-- 258 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB---HHHHHHHH---HHS-CC-CC--
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHHHHH---Hhc-cc-CC--
Confidence 221 22344679999999999999999999999999999999999999985322 11221111 111 11 00
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI 657 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~ 657 (706)
....+ ..+.+++..||+.||.+||++.+.+
T Consensus 259 ---~~~~~----~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 259 ---KPNIT----NSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp ---CSSSC----HHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred ---CCCCC----HHHHHHHHHHcccCHHhCCCCCCCH
Confidence 01111 2456788999999999999986433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=339.28 Aligned_cols=259 Identities=29% Similarity=0.436 Sum_probs=202.9
Q ss_pred ccCCCccceeccCCceeEEEEEe------CCCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL------ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 458 (706)
.++|++.+.||+|+||.||+|+. .+++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 36899999999999999999984 34678999999653 455567889999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhcccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---CCCeEEe
Q 005236 459 LLIYEFMPNKSLDSFIFDQER----CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKIS 531 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~ 531 (706)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976432 245889999999999999999999998 999999999999994 4569999
Q ss_pred eeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHh
Q 005236 532 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLW 610 (706)
Q Consensus 532 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 610 (706)
|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ...... .
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~----~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEF----V 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHH----H
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHHH----H
Confidence 9999986543333333334567899999999999999999999999999999998 8888753221 111111 1
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 611 NEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 611 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
......... ...+ ..+.+++..||+.||.+||++.+|++.|+..
T Consensus 259 ~~~~~~~~~-----~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSGGRMDPP-----KNCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTTCCCCCC-----TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCCCCC-----CCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111111110 1111 2456789999999999999999999999865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=334.12 Aligned_cols=262 Identities=19% Similarity=0.261 Sum_probs=198.3
Q ss_pred HhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeE
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 459 (706)
...++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++...+..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34578999999999999999999985 5889999998653 2334578999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 111 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 999999999999999653 35889999999999999999999998 999999999999999999999999999875
Q ss_pred CCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC-ccc
Q 005236 540 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP-SQL 618 (706)
Q Consensus 540 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 618 (706)
..... .......|++.|+|||++.+..++.++||||||+++|||++|+.||..... .. .......... ...
T Consensus 185 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~---~~~~~~~~~~~~~~ 256 (309)
T 2h34_A 185 TDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL----SV---MGAHINQAIPRPST 256 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH----HH---HHHHHHSCCCCGGG
T ss_pred ccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH----HH---HHHHhccCCCCccc
Confidence 43221 122335689999999999999999999999999999999999999753221 11 1111111111 111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCC-ChhHHHHHhcCCCCCC
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP-CMPSVILMLGSEIVLP 667 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-t~~ev~~~L~~~~~~~ 667 (706)
.. ...+ ..+.+++.+||+.||.+|| +++++++.|+......
T Consensus 257 ~~----~~~~----~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 257 VR----PGIP----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp TS----TTCC----THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred cC----CCCC----HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 11 1111 1455788999999999999 9999999999774433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=339.78 Aligned_cols=264 Identities=27% Similarity=0.417 Sum_probs=207.1
Q ss_pred ccCCCccceeccCCceeEEEEEe-----CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC--ee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-----ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE--EK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 458 (706)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35789999999999999999984 458899999998776677788999999999999999999999987654 78
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 99999999999999996542 35889999999999999999999988 99999999999999999999999999988
Q ss_pred cCCCCCc-ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------CCCc-hhHHHHHHH
Q 005236 539 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH--------SDNK-LNLIRHAWK 608 (706)
Q Consensus 539 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~--------~~~~-~~~~~~~~~ 608 (706)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.... .... .........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 6543221 11223457788999999999899999999999999999999998864211 0000 011111111
Q ss_pred HhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 609 LWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 609 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
........... ... ...+.+++.+||+.||.+|||+.||++.|+.+
T Consensus 275 ~~~~~~~~~~~-----~~~----~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNGRLPRP-----DGC----PDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTCCCCCC-----TTC----CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCCCCCCC-----Ccc----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22111111111 111 13466799999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=349.32 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=192.1
Q ss_pred CCCccceeccCCceeEEEEEeCC----CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEe-CCeeEEE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLAD----EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIH-GEEKLLI 461 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV 461 (706)
.|.+.++||+|+||.||+|++.+ +..||||.+... .....+.+.+|+.++++++||||+++++++.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46778999999999999998732 236899998653 34556789999999999999999999998765 4578999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+||||++++.+||+|||+++.+..
T Consensus 170 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 9999999999999643 245788999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCcc--cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 542 DETEG--NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 542 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |.+||......+ ...... .+.....
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~~----~~~~~~~ 317 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLL----QGRRLLQ 317 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHHH----TTCCCCC
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHHH----cCCCCCC
Confidence 32211 2233457889999999999999999999999999999999 666665433322 211111 1111000
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
. ...+ ..+.+++.+||+.+|.+|||++||++.|+.+.
T Consensus 318 -p----~~~~----~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 318 -P----EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp -C----TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -C----CCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 0111 24667889999999999999999999998763
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=343.43 Aligned_cols=253 Identities=16% Similarity=0.145 Sum_probs=202.1
Q ss_pred HhccCCCccceeccCCceeEEEEE------eCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcC---CcceeeeEeEEEe
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGT------LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ---HRNLVKLLGCCIH 454 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 454 (706)
...++|.+.++||+|+||.||+|+ ...++.||||++.... ..++..|+.++.+++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 3558899999997643 346777888887776 9999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC--------
Q 005236 455 GEEKLLIYEFMPNKSLDSFIFDQE--RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-------- 524 (706)
Q Consensus 455 ~~~~~lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~-------- 524 (706)
.+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 999999999999999999997532 2356999999999999999999999988 999999999999998
Q ss_pred ---CCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchh
Q 005236 525 ---DMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLN 601 (706)
Q Consensus 525 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~ 601 (706)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 89999999999976543322333344679999999999999999999999999999999999999974322110
Q ss_pred HHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCC-CChhHHHHHhcCC
Q 005236 602 LIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDR-PCMPSVILMLGSE 663 (706)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R-Pt~~ev~~~L~~~ 663 (706)
..+...+......+ .+.+++..|++.+|.+| |+++++.+.|+..
T Consensus 293 ---------------~~~~~~~~~~~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 293 ---------------CKPEGLFRRLPHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ---------------EEECSCCTTCSSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ---------------eeechhccccCcHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 00111111112222 33467789999999988 6788888888764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=354.43 Aligned_cols=259 Identities=24% Similarity=0.285 Sum_probs=195.0
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC------C
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG------E 456 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 456 (706)
.++|++.++||+|+||.||+|+.. .++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999874 5889999998653 445567889999999999999999999999754 3
Q ss_pred eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 536 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla 536 (706)
..++||||++++ |.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 569999999865 555552 23889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC-
Q 005236 537 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP- 615 (706)
Q Consensus 537 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 615 (706)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ................
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~---~~~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPCPE 285 (464)
T ss_dssp -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSCCHH
T ss_pred eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCHH
Confidence 876432 223346799999999999999999999999999999999999999854332 2222222111111000
Q ss_pred ------------------------cccccccccCcCC---HHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 616 ------------------------SQLIDACFKDSFN---LAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 616 ------------------------~~~~d~~~~~~~~---~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
...+...+..... ......+.+|+.+||+.||.+|||++|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000 0113457889999999999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=331.35 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=196.7
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.++|.+.++||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 367999999999999999999984 58899999986532 3346789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE---cCCCCeEEeeecccccc
Q 005236 464 FMPNKSLDSFIFDQE-RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 539 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfgla~~~ 539 (706)
|+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999986532 3356899999999999999999999988 9999999999999 45688999999999875
Q ss_pred CCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 540 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 540 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
.... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||..... ...... .. ..........
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~~~~~~-~~-~~~~~~~~~~ 248 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---EEVQQK-AT-YKEPNYAVEC 248 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH-HH-HCCCCCCC--
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---HHHHhh-hc-cCCccccccc
Confidence 4322 223456899999999885 5789999999999999999999999754321 111111 11 1111111000
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
... ...+.+++.+||+.||.+|||++||++
T Consensus 249 -----~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 249 -----RPL----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -----CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -----CcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001 124567899999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=334.79 Aligned_cols=250 Identities=26% Similarity=0.458 Sum_probs=182.2
Q ss_pred hccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346899999999999999999998 468899999986432 2235778999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999999643 245899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .. .....
T Consensus 164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~----~~~~~-- 229 (278)
T 3cok_A 164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KV----VLADY-- 229 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------C----CSSCC--
T ss_pred CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------HH----hhccc--
Confidence 2221 2223568999999999999999999999999999999999999986533221110 00 00000
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
......+ ..+.+++.+||+.||.+|||+++|++
T Consensus 230 -~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 -EMPSFLS----IEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -CCCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -CCccccC----HHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0111111 24567899999999999999999886
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=335.78 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=199.9
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
.++|.+.+.||+|+||.||+++.. +++.||+|++........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467999999999999999999985 6889999999765554556789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE---cCCCCeEEeeeccccccCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfgla~~~~~ 541 (706)
+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||++ ++++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999998653 34889999999999999999999988 9999999999999 7889999999999976432
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....... ..+... ...+
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i----~~~~~~-~~~~ 229 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLFEKI----KEGYYE-FESP 229 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHH----HHCCCC-CCTT
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH----HcCCCC-CCcc
Confidence 1 22335689999999999999999999999999999999999999754221 1221111 111110 0000
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
. ....+ ..+.+++.+||+.||.+|||++|+++
T Consensus 230 ~-~~~~~----~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 230 F-WDDIS----ESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp T-TTTSC----HHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred c-cccCC----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 01111 24667899999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=340.42 Aligned_cols=266 Identities=27% Similarity=0.383 Sum_probs=194.8
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHH--HhhcCCcceeeeEeEEEe-----CCee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIIL--FSKLQHRNLVKLLGCCIH-----GEEK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~ 458 (706)
.++|++.++||+|+||.||+|+. +++.||||++..... ..+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 47899999999999999999987 678999999864332 334444444 556899999999986653 2256
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCceEecccCCCcEEEcCCCCeE
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD---------SRLRIIHRDLKASNVLLDQDMNPK 529 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------~~~~ivH~Dikp~Nill~~~~~~k 529 (706)
++||||+++|+|.+++.... .++..++.++.||++||+|||+. + |+||||||+||||+.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 89999999999999995433 48889999999999999999988 6 99999999999999999999
Q ss_pred EeeeccccccCCCCC------cccccccccccCccCcccccc-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 005236 530 ISDFGLARAFGGDET------EGNTNRVVGTYGYMAPEYASD-------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHS 596 (706)
Q Consensus 530 l~Dfgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDv~SlGvil~elltG~~p~~~~~~ 596 (706)
|+|||+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|..|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987643321 112223569999999999976 4567899999999999999999877533222
Q ss_pred CCch-hH----------HHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 597 DNKL-NL----------IRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 597 ~~~~-~~----------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
.... .. ...............-+...+.. .......+.+++.+||+.||++|||++||++.|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE--NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCC--CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccccc--ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 1111 00 00111111111111111111111 1123446778999999999999999999999998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=363.87 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=199.0
Q ss_pred CCCccc-eeccCCceeEEEEEeC---CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 388 NFSINK-KLGEGGFGPVYKGTLA---DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 388 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++.+.+ +||+|+||.||+|.+. ++..||||+++.. .....+.+.+|+.++++++|||||++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 444444 8999999999999874 4567999999764 33457889999999999999999999999976 5689999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.+...
T Consensus 415 E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp ECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 999999999999643 345899999999999999999999988 999999999999999999999999999876433
Q ss_pred CCcc-cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 543 ETEG-NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 543 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.... ......+|+.|+|||++....++.++|||||||+||||++ |+.||...... +.... +..+.......
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~----i~~~~~~~~p~ 562 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQGKRMECPP 562 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHH----HHTTCCCCCCT
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHH----HHcCCCCCCCC
Confidence 2211 1222346789999999999999999999999999999998 99998654322 22211 11221111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.. ...+.+++..||+.+|.+||++.+|++.|+..
T Consensus 563 -----~~----~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 563 -----EC----PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp -----TC----CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----cC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 13566789999999999999999999999865
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=341.97 Aligned_cols=258 Identities=21% Similarity=0.336 Sum_probs=204.3
Q ss_pred HHHHHHhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--------hhhHHHHHHHHHHHhhc-CCcceeee
Q 005236 379 LATIANATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--------EQGLKELKNEIILFSKL-QHRNLVKL 448 (706)
Q Consensus 379 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l 448 (706)
........++|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.++.++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444555678999999999999999999985 68999999885432 12245688999999999 79999999
Q ss_pred EeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCe
Q 005236 449 LGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 528 (706)
Q Consensus 449 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 528 (706)
++++......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 99999999999999999999999999643 35899999999999999999999988 9999999999999999999
Q ss_pred EEeeeccccccCCCCCcccccccccccCccCcccccc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhH
Q 005236 529 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNL 602 (706)
Q Consensus 529 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~ 602 (706)
||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... ....
T Consensus 240 kl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~ 313 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILM 313 (365)
T ss_dssp EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHH
T ss_pred EEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHH
Confidence 999999998764332 2234679999999999863 368899999999999999999999975322 1111
Q ss_pred HHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 603 IRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 603 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.... ...... ...+.+. .. ...+.+++.+||+.||.+|||+.|+++
T Consensus 314 ~~~i----~~~~~~-~~~~~~~-~~----~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 314 LRMI----MEGQYQ-FSSPEWD-DR----SSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHH----HHTCCC-CCHHHHS-SS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHH----HhCCCC-CCCcccc-cC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 111110 0000010 11 124667899999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=341.20 Aligned_cols=261 Identities=25% Similarity=0.355 Sum_probs=197.7
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
++|++.+.||+|+||.||+|+... ++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 689999999999999999999854 889999988543 33445678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 105 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 99999999887543 34899999999999999999999998 9999999999999999999999999998754322
Q ss_pred CcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhc----------
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNE---------- 612 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---------- 612 (706)
. ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+ ...........
T Consensus 179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID---QLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHHHH
T ss_pred c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhhhHhh
Confidence 1 22335689999999999875 78999999999999999999999975433221 11111111000
Q ss_pred -C-CCcccccccccCcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 613 -G-MPSQLIDACFKDSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 613 -~-~~~~~~d~~~~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
. .......+.+....... ....+.+++.+||+.||.+|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00000000111111111 1235678999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.73 Aligned_cols=269 Identities=22% Similarity=0.283 Sum_probs=207.4
Q ss_pred HHHHHHhccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhh--cCCcceeeeEeEEEeCC
Q 005236 379 LATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSK--LQHRNLVKLLGCCIHGE 456 (706)
Q Consensus 379 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~ 456 (706)
........++|++.+.||+|+||.||+|+. .++.||||++... ..+.+.+|++++.. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 333445567899999999999999999998 5889999998643 34567788888877 78999999999998876
Q ss_pred ----eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecccCCCcEEEcC
Q 005236 457 ----EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH--------QDSRLRIIHRDLKASNVLLDQ 524 (706)
Q Consensus 457 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~Dikp~Nill~~ 524 (706)
..++||||+++|+|.+++... .+++..++.++.||+.||+||| +.+ |+||||||+||||+.
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK 182 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred CccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence 789999999999999999543 4889999999999999999999 666 999999999999999
Q ss_pred CCCeEEeeeccccccCCCCCcc--cccccccccCccCccccccC------CCCcchhhHHHHHHHHHHHhC---------
Q 005236 525 DMNPKISDFGLARAFGGDETEG--NTNRVVGTYGYMAPEYASDG------QFSVKSDVFSFGILLLEIVSG--------- 587 (706)
Q Consensus 525 ~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDv~SlGvil~elltG--------- 587 (706)
++.+||+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 9999999999998764432211 22345799999999999775 334789999999999999999
Q ss_pred -CCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 588 -KKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 588 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
+.||......... ................+... .........+.+++.+||+.||.+|||++||++.|+.+
T Consensus 263 ~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 263 YQLPYYDLVPSDPS--VEEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCTTTTTSCSSCC--HHHHHHHHTTSCCCCCCCGG---GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCccccCcCccc--HHHHHHHHHHHHhCCCCccc---ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 6666543322211 11111222122111111111 12234556778899999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=330.37 Aligned_cols=254 Identities=28% Similarity=0.398 Sum_probs=201.0
Q ss_pred cCCCccc-eeccCCceeEEEEEe---CCCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINK-KLGEGGFGPVYKGTL---ADEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
++|.+.+ .||+|+||.||+|.+ ..++.||||++.... ....+.+.+|+.++++++||||+++++++ +.+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 5788887 999999999999965 236789999986532 33467899999999999999999999999 6678899
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 95 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 99999999999999653 34889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCcc-cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 541 GDETEG-NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 541 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .... ...........
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~----~~~~~~~~~~~ 241 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVT----AMLEKGERMGC 241 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHH----HHHHTTCCCCC
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHH----HHHHcCCCCCC
Confidence 433221 1222456789999999999899999999999999999999 9999754322 1111 11111111111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
. ... ...+.+++..||+.||.+||++.+|++.|+..
T Consensus 242 ~-----~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 242 P-----AGC----PREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp C-----TTC----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C-----CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 111 12466789999999999999999999999865
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=341.18 Aligned_cols=264 Identities=23% Similarity=0.302 Sum_probs=192.9
Q ss_pred HHhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeE
Q 005236 383 ANATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 383 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 459 (706)
....++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 445578999999999999999999874 68899999986533 233567789999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc-----CCCCeEEeeec
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-----QDMNPKISDFG 534 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~-----~~~~~kl~Dfg 534 (706)
+||||+++ +|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||
T Consensus 110 lv~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99999985 9999986543 4889999999999999999999998 99999999999994 55569999999
Q ss_pred cccccCCCCCcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC
Q 005236 535 LARAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG 613 (706)
Q Consensus 535 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 613 (706)
+++.+.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..............
T Consensus 183 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 183 LARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE---IDQLFKIFEVLGLP 257 (329)
T ss_dssp HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCC
T ss_pred CccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH---HHHHHHHHHHhCCC
Confidence 998764322 122335689999999999874 589999999999999999999999754322 22222222211111
Q ss_pred C---Cccccc-cccc------CcCCHH------HHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 614 M---PSQLID-ACFK------DSFNLA------EVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 614 ~---~~~~~d-~~~~------~~~~~~------~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
. ...... +.+. ...... ....+.+++.+||+.||.+|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 1 000000 0000 000111 1135678999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=331.90 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=199.1
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccch------hhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISE------QGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 459 (706)
++|++.+.||+|+||.||+++.. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57999999999999999999986 588999999864321 23678999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC----CeEEeeecc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFGL 535 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~Dfgl 535 (706)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ ++||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999999643 35899999999999999999999988 99999999999999887 899999999
Q ss_pred ccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
+....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ...... +.....
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~----~~~~~~ 228 (283)
T 3bhy_A 159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---QETLTN----ISAVNY 228 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHH----HHTTCC
T ss_pred ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---HHHHHH----hHhccc
Confidence 98764322 12335689999999999999999999999999999999999999754221 111111 111111
Q ss_pred cccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 616 SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 616 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
. . ........ ...+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~-~-~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 D-F-DEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C-C-CHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-C-cchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 0 00000111 124567899999999999999999987
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=332.96 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=203.3
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|.+.+.||+|+||.||+++... ++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 4689999999999999999999864 778999988543 344567889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++++|.+++... ..+++..++.++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999988543 35889999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .... . ...... .+
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~---~-~~~~~~-~~--- 234 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---ETYL---R-IKKNEY-SI--- 234 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH---H-HHTTCC-CC---
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HhhccC-CC---
Confidence 221 223356899999999999999999999999999999999999998543211 1111 1 111111 00
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
....+ ..+.+++.+||+.||.+|||++|+++.
T Consensus 235 --~~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 --PKHIN----PVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --CTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --ccccC----HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01111 245678899999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.77 Aligned_cols=246 Identities=28% Similarity=0.456 Sum_probs=198.1
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
+.|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588899999999999999997 56889999998643 3344567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||++ |+|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 9997 6788877543 245899999999999999999999998 99999999999999999999999999986532
Q ss_pred CCcccccccccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
.....||+.|+|||++. ...++.++||||||+++|||++|+.||..... .... ......... ...
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---~~~~---~~~~~~~~~-~~~ 274 (348)
T 1u5q_A 207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSAL---YHIAQNESP-ALQ 274 (348)
T ss_dssp -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH---HHHHHSCCC-CCC
T ss_pred -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHH---HHHHhcCCC-CCC
Confidence 22357899999999985 56789999999999999999999999753221 1111 112222111 111
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. ...+ ..+.+++..||+.+|.+|||++++++.
T Consensus 275 ~----~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 S----GHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp C----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C----CCCC----HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 1111 235678899999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=340.13 Aligned_cols=268 Identities=22% Similarity=0.296 Sum_probs=200.7
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC-------
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHG------- 455 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 455 (706)
.++|++.++||+|+||.||+|+. .+++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36899999999999999999998 568899999985532 23345778999999999999999999999873
Q ss_pred -CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeec
Q 005236 456 -EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 534 (706)
Q Consensus 456 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 534 (706)
+..++||||+++ +|.+.+.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999985 7777664432 34899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCC--cccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh
Q 005236 535 LARAFGGDET--EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWN 611 (706)
Q Consensus 535 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 611 (706)
+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9987643222 122334578999999999876 4689999999999999999999999864332222222222111111
Q ss_pred cCCCcccccccc--------cCcCCHHH-------HHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 612 EGMPSQLIDACF--------KDSFNLAE-------VIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 612 ~~~~~~~~d~~~--------~~~~~~~~-------~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
............ .......+ ...+.+++.+||+.||.+|||++|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 111111100000 00111111 1236789999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=338.84 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=198.2
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 462 (706)
..++|++.+.||+|+||.||+++.+ +++.||||++..... ...+|++++.++ +||||+++++++.++...++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3468999999999999999999985 588999999865432 235688888887 7999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC----CCeEEeeeccccc
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISDFGLARA 538 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~----~~~kl~Dfgla~~ 538 (706)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999999654 35899999999999999999999998 9999999999998543 3599999999987
Q ss_pred cCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............... ..+... +
T Consensus 170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i----~~~~~~-~ 242 (342)
T 2qr7_A 170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI----GSGKFS-L 242 (342)
T ss_dssp CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH----HHCCCC-C
T ss_pred CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH----ccCCcc-c
Confidence 643322 223457899999999998888999999999999999999999998654333322222221 111111 0
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
....+ ...+ ..+.+++..||+.||.+|||+.|+++
T Consensus 243 ~~~~~-~~~s----~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 243 SGGYW-NSVS----DTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CSTTT-TTSC----HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred Ccccc-ccCC----HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 1111 24567899999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.04 Aligned_cols=197 Identities=26% Similarity=0.378 Sum_probs=174.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 67999999999999999999985 5889999998653 445567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
+++++|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999999654 3488999999999999999999985 6 999999999999999999999999999764211
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 593 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~ 593 (706)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22335789999999999999999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=328.76 Aligned_cols=259 Identities=25% Similarity=0.332 Sum_probs=203.7
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEe--CCeeEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIH--GEEKLL 460 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 460 (706)
.++|++.+.||+|+||.||+++.. +++.||+|++.. ......+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999985 588999999864 244556789999999999999999999998865 567899
Q ss_pred EEecCCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 461 IYEFMPNKSLDSFIFDQE-RCKLLDWSKRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997543 2345899999999999999999999875 1349999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ...... +..+....
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~----i~~~~~~~ 235 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGK----IREGKFRR 235 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH----HHHTCCCC
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHH----Hhhccccc
Confidence 7643221 12235689999999999999999999999999999999999999764321 111111 11222211
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
+. ...+ ..+.+++.+||+.+|.+||+++||++.+..
T Consensus 236 ~~-----~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 236 IP-----YRYS----DELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CC-----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CC-----cccC----HHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11 1111 246678899999999999999999998764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=339.26 Aligned_cols=243 Identities=23% Similarity=0.308 Sum_probs=199.6
Q ss_pred hccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccc--------hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKIS--------EQGLKELKNEIILFSKLQHRNLVKLLGCCIHG 455 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 455 (706)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999997 458889999986532 11344677899999999999999999999999
Q ss_pred CeeEEEEecCCCC-ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeec
Q 005236 456 EEKLLIYEFMPNK-SLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 534 (706)
Q Consensus 456 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 534 (706)
+..++||||+.+| +|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 999998654 34899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC
Q 005236 535 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG 613 (706)
Q Consensus 535 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 613 (706)
+++.+.... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ...
T Consensus 176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----------~~~ 241 (335)
T 3dls_A 176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-----------AAI 241 (335)
T ss_dssp TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT-----------TCC
T ss_pred cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh-----------hcc
Confidence 998764332 2233578999999999988877 8899999999999999999999853211000 000
Q ss_pred CCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 614 MPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 614 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.... ..+ ..+.+++..||+.||.+|||++|+++.
T Consensus 242 ~~~~--------~~~----~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 242 HPPY--------LVS----KELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CCSS--------CCC----HHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred CCCc--------ccC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 111 245678999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=336.36 Aligned_cols=256 Identities=28% Similarity=0.449 Sum_probs=201.1
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcE--EEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQE--IAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 461 (706)
++|++.+.||+|+||.||+|+.. ++.. +|||++... .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 68999999999999999999975 4554 499988653 344556789999999999 899999999999999999999
Q ss_pred EecCCCCChhhhhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCe
Q 005236 462 YEFMPNKSLDSFIFDQE-------------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 528 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 528 (706)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996542 2346899999999999999999999988 9999999999999999999
Q ss_pred EEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHH
Q 005236 529 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAW 607 (706)
Q Consensus 529 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 607 (706)
||+|||+++.... ........+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ... .
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~----~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AEL----Y 251 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHH----H
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---HHH----H
Confidence 9999999975321 112223456889999999999899999999999999999998 9999754321 111 1
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 608 KLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 608 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
............ ... ...+.+++.+||+.+|.+|||++|+++.|+.+.
T Consensus 252 ~~~~~~~~~~~~-----~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 252 EKLPQGYRLEKP-----LNC----DDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp HHGGGTCCCCCC-----TTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhcCCCCCCC-----CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111111111100 011 124667899999999999999999999998763
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=327.50 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=198.6
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
++|.....||+|+||.||+|+. .+++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 4455567999999999999997 457899999997766666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-CCCeEEeeeccccccCCCCC
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfgla~~~~~~~~ 544 (706)
++++|.+++........+++..+..++.||+.||.|||+.+ ++|+||||+||+++. ++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 99999999976544455778889999999999999999988 999999999999987 8999999999998764322
Q ss_pred cccccccccccCccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQ--FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
.......|++.|+|||++.+.. ++.++||||||+++|||++|+.||...... ...... .... .....+
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~-~~~~--~~~~~~---- 247 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP--QAAMFK-VGMF--KVHPEI---- 247 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH--HHHHHH-HHHH--CCCCCC----
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch--hHHHHh-hccc--cccccc----
Confidence 1223356899999999997653 889999999999999999999997532211 111111 1111 111111
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
....+ ..+.+++.+||+.||++||++.|+++
T Consensus 248 -~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 -PESMS----AEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -CTTSC----HHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -cccCC----HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111 24567889999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=326.99 Aligned_cols=246 Identities=21% Similarity=0.308 Sum_probs=197.5
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999985 6899999998653 334456788999999999 999999999999999999999
Q ss_pred EecCCCCChhhhhhcccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC---------------
Q 005236 462 YEFMPNKSLDSFIFDQER-CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD--------------- 525 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~--------------- 525 (706)
|||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999975432 256899999999999999999999998 9999999999999844
Q ss_pred ----CCeEEeeeccccccCCCCCcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCch
Q 005236 526 ----MNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKL 600 (706)
Q Consensus 526 ----~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~ 600 (706)
..+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|.+++...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------ 234 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------ 234 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------
Confidence 479999999998764322 23589999999999776 6678999999999999999998774321
Q ss_pred hHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 601 NLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
... ..........+. ...+ ..+.+++..||+.||.+|||+.|+++.
T Consensus 235 ~~~----~~~~~~~~~~~~-----~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 235 DQW----HEIRQGRLPRIP-----QVLS----QEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHH----HHHHTTCCCCCS-----SCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred hHH----HHHHcCCCCCCC-----cccC----HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111 111122221111 1111 245678999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=349.19 Aligned_cols=261 Identities=19% Similarity=0.278 Sum_probs=207.7
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCC-cceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQH-RNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e 463 (706)
.++|++.++||+|+||.||+|+. .+++.||||++..... ...+..|+.+++.++| ++|..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999997 5688999998754322 2357889999999987 556666777778889999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE---cCCCCeEEeeeccccccC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFG 540 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfgla~~~~ 540 (706)
|+ +++|.+++.... ..+++..++.|+.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 999999996432 35899999999999999999999998 9999999999999 688999999999999865
Q ss_pred CCCCcc-----cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 541 GDETEG-----NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 541 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...........+............
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 433211 222467999999999999999999999999999999999999999766555444444333322222221
Q ss_pred cccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 616 SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 616 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
..+.. .. ...+.+++..||+.+|.+||++++|+++|+.+
T Consensus 238 ~~l~~-----~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 238 EALCR-----GY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHT-----TS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHhc-----CC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11111 11 12567889999999999999999999998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=342.01 Aligned_cols=261 Identities=16% Similarity=0.223 Sum_probs=204.3
Q ss_pred ccCCCccceeccCCceeEEEEEeCC---------CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceee---------
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD---------EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVK--------- 447 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 447 (706)
.++|++.+.||+|+||.||+|+... ++.||||.+... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999864 789999998643 46789999999999999988
Q ss_pred ------eEeEEEe-CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcE
Q 005236 448 ------LLGCCIH-GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 520 (706)
Q Consensus 448 ------l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Ni 520 (706)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 67889999999 999999997542 346899999999999999999999998 99999999999
Q ss_pred EEcCCC--CeEEeeeccccccCCCCCc-----ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005236 521 LLDQDM--NPKISDFGLARAFGGDETE-----GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 593 (706)
Q Consensus 521 ll~~~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~ 593 (706)
|++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999876432211 112335799999999999999999999999999999999999999865
Q ss_pred CCCCCchhHHHHHHHHhhcCCCccccccccc-CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 594 YHSDNKLNLIRHAWKLWNEGMPSQLIDACFK-DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
..... ..+......+... ...+.+.... ...+ ..+.+++..||+.||.+||++++|++.|+.+
T Consensus 271 ~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 271 CLPNT--EDIMKQKQKFVDK-PGPFVGPCGHWIRPS----ETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GTTCH--HHHHHHHHHHHHS-CCCEECTTSCEECCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CCcCH--HHHHHHHHhccCC-hhhhhhhccccCCCc----HHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 43221 2222222222111 1122221111 0111 2466788999999999999999999999876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=329.36 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=195.8
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC-CeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG-EEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~ 464 (706)
.++|++.+.||+|+||.||+++.. ++.||||++.... ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 368999999999999999999884 7899999986543 457889999999999999999999997655 478999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 99999999996542 234788999999999999999999988 999999999999999999999999999864322
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... ..........
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~----~~~~~~~~~~---- 236 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR----VEKGYKMDAP---- 236 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHH----HTTTCCCCCC----
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HhcCCCCCCc----
Confidence 122457889999999999999999999999999999998 99997643322 11111 1111111111
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
... ...+.+++..||+.||.+|||+.|+++.|+.+
T Consensus 237 -~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 237 -DGC----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp -TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -ccC----CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 111 12466788999999999999999999999865
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=326.95 Aligned_cols=249 Identities=26% Similarity=0.448 Sum_probs=204.1
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.+.|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 357999999999999999999874 5889999998643 23456789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999853 35899999999999999999999998 9999999999999999999999999998764332
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.|+..... ...... ........+
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~----~~~~~~~~~----- 239 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFL----IPKNNPPTL----- 239 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHH----HHHSCCCCC-----
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHH----hhcCCCCCC-----
Confidence 2 22345789999999999999999999999999999999999999754321 111111 111111111
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
....+ ..+.+++..||+.+|.+|||+.||++.
T Consensus 240 ~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNYS----KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSCC----HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccccC----HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11112 246678999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=329.07 Aligned_cols=252 Identities=22% Similarity=0.302 Sum_probs=197.5
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc----hhhHHHHHHHHHHHhhcCCcceeeeEeEEE--eCCee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS----EQGLKELKNEIILFSKLQHRNLVKLLGCCI--HGEEK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 458 (706)
.++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999984 57899999986532 234678999999999999999999999985 44578
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||++++ |.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999987 767665432 346899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCcccccccccccCccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASDGQ--FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (706)
..............||+.|+|||++.+.. ++.++||||||+++|||++|+.||.... ...... .+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~----~i~~~~~- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKLFE----NIGKGSY- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHH----HHHHCCC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHH----HHhcCCC-
Confidence 65433333334457899999999997654 4789999999999999999999975422 111111 1111111
Q ss_pred ccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 617 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+ ....+ ..+.+++.+||+.||.+|||++|+++.
T Consensus 231 ~~-----~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 AI-----PGDCG----PPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CC-----CSSSC----HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CC-----CCccC----HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 01111 245678899999999999999999964
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=330.11 Aligned_cols=246 Identities=24% Similarity=0.332 Sum_probs=201.0
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 368999999999999999999985 47789999986432 22356789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++++|.+++... ..+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999999654 34889999999999999999999988 99999999999999999999999999976532
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
. ......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ..... ... .... .
T Consensus 167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~---~~~-~~~~-~---- 230 (284)
T 2vgo_A 167 L----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---TETHR---RIV-NVDL-K---- 230 (284)
T ss_dssp S----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHH---HHH-TTCC-C----
T ss_pred c----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH---hHHHH---HHh-cccc-C----
Confidence 2 12335689999999999999999999999999999999999999754321 11111 111 1111 0
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+....+ ..+.+++.+||+.+|.+||+++|+++
T Consensus 231 -~~~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 -FPPFLS----DGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -CCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCCcCC----HHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 001111 24567899999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=345.00 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=190.8
Q ss_pred HhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--------hhhHHHHHHHHHHHhhcCCcceeeeEeEEEe
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--------EQGLKELKNEIILFSKLQHRNLVKLLGCCIH 454 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 454 (706)
...++|.+.++||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34578999999999999999999985 47899999986421 122335889999999999999999999975
Q ss_pred CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC---CeEEe
Q 005236 455 GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKIS 531 (706)
Q Consensus 455 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl~ 531 (706)
.+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 55689999999999999988543 45899999999999999999999988 99999999999997544 59999
Q ss_pred eeccccccCCCCCcccccccccccCccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH
Q 005236 532 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWK 608 (706)
Q Consensus 532 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 608 (706)
|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ .....
T Consensus 285 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i-- 357 (419)
T 3i6u_A 285 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI-- 357 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHH--
T ss_pred ecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHH--
Confidence 99999876432 12234679999999999863 6788999999999999999999999865333222 11111
Q ss_pred HhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 609 LWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 609 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
...... .....+ ... ...+.+++.+||+.||.+|||++|+++.
T Consensus 358 --~~~~~~-~~~~~~-~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 --TSGKYN-FIPEVW-AEV----SEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp --HTTCCC-CCHHHH-TTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --hcCCCC-CCchhh-ccc----CHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 111111 000000 011 1246688999999999999999999863
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.14 Aligned_cols=266 Identities=27% Similarity=0.317 Sum_probs=197.1
Q ss_pred HhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchh-----hHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQ-----GLKELKNEIILFSKLQHRNLVKLLGCCIHGEE 457 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 457 (706)
...++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999985 4889999998643221 12467899999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.++||||+++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 888888543 245788899999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (706)
.+.... .......||+.|+|||++.+. .++.++||||||+++|||++|.+||.... ..................
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~---~~~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS---DLDQLTRIFETLGTPTEE 235 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCTT
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHHHcCCCChh
Confidence 764322 122335789999999999764 58999999999999999999999875432 222222222222111111
Q ss_pred ccc------cccc---cCcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHHHh
Q 005236 617 QLI------DACF---KDSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVILML 660 (706)
Q Consensus 617 ~~~------d~~~---~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L 660 (706)
... +... ....... ....+.+++..||+.||.+|||++|+++.-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 000 0000 0001111 113567899999999999999999998753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=348.87 Aligned_cols=242 Identities=16% Similarity=0.165 Sum_probs=188.8
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCc---cchhhHHHHHHHH---HHHhhcCCcceeeeE-------eE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSK---ISEQGLKELKNEI---ILFSKLQHRNLVKLL-------GC 451 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 451 (706)
.++|++.+.||+|+||.||+|+. .+++.||||++.. ......+.+.+|+ .++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46899999999999999999997 4589999999863 3444567899999 555666899999998 66
Q ss_pred EEeCC-----------------eeEEEEecCCCCChhhhhhccccc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 005236 452 CIHGE-----------------EKLLIYEFMPNKSLDSFIFDQERC----KLLDWSKRFHIICGTARGLLYLHQDSRLRI 510 (706)
Q Consensus 452 ~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~~----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 510 (706)
+...+ ..++||||+ +|+|.+++...... ..+++..++.++.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 65543 278999999 68999999754321 12335888899999999999999998 9
Q ss_pred EecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccC-----------CCCcchhhHHHHH
Q 005236 511 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-----------QFSVKSDVFSFGI 579 (706)
Q Consensus 511 vH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDv~SlGv 579 (706)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986322 2233567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 580 LLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 580 il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
++|||++|+.||.......... .+.... ...+ ..+.+++.+||+.||.+|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~---------------~~~~~~--~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSE---------------WIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSG---------------GGGSSC--CCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchh---------------hhhhhc--cCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999985433222111 111100 1111 24567899999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=361.54 Aligned_cols=248 Identities=29% Similarity=0.407 Sum_probs=195.2
Q ss_pred ceeccCCceeEEEEEeC---CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLA---DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
++||+|+||.||+|.+. .++.||||+++.. .....+++.+|+.++++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 4678999999753 3344688999999999999999999999986 4568899999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc-c
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE-G 546 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~-~ 546 (706)
|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 9999999543 45889999999999999999999998 999999999999999999999999999987543322 2
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...... .... .+..+.......
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~----~i~~~~~~~~p~----- 595 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA----MLEKGERMGCPA----- 595 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTTCCCCCCT-----
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCCCCCC-----
Confidence 2233457889999999999999999999999999999998 99997543221 1111 111221111111
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.. ...+.+++..||+.||++||++++|++.|+..
T Consensus 596 ~~----~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 596 GC----PREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp TC----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 13466789999999999999999999999753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=341.98 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=194.0
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC------
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE------ 456 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 456 (706)
.++|++.+.||+|+||.||+|+. .+++.||||++.. ......+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999998 4589999999854 34445678899999999999999999999997653
Q ss_pred eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 536 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla 536 (706)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899999854 34889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 537 RAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 537 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
+..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ............. ..
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~-~~ 246 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTGT-PP 246 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCC-CC
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCC-CC
Confidence 875322 233578999999999987 6899999999999999999999999864332 1222211111100 00
Q ss_pred cccc-------------------cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 616 SQLI-------------------DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 616 ~~~~-------------------d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+++ ...+.... ......+.+++.+||+.||.+|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000 00000000 0011246688999999999999999999984
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=322.11 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=197.1
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEe----CCeeE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIH----GEEKL 459 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 459 (706)
+.|.+.+.||+|+||.||+|... ++..||+|++.. ......+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45788899999999999999985 477899999864 345567789999999999999999999999875 35689
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc-CCCCeEEeeeccccc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARA 538 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~Dfgla~~ 538 (706)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ +++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999999653 45889999999999999999999874 2499999999999998 889999999999976
Q ss_pred cCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
.... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||..... .... ............
T Consensus 182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~----~~~~~~~~~~~~ 250 (290)
T 1t4h_A 182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQI----YRRVTSGVKPAS 250 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHH----HHHHTTTCCCGG
T ss_pred cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHH----HHHHhccCCccc
Confidence 4322 223356899999999886 4599999999999999999999999754221 1111 111112211111
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.+. ... ..+.+++..||+.||.+|||++||++
T Consensus 251 ~~~----~~~----~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 FDK----VAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGG----CCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCC----CCC----HHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111 111 24667899999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=353.54 Aligned_cols=252 Identities=26% Similarity=0.360 Sum_probs=200.3
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
..++|++.++||+|+||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3468999999999999999999985 6889999998642 233467889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc---CCCCeEEeeeccccc
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARA 538 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~~kl~Dfgla~~ 538 (706)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999988654 35899999999999999999999998 99999999999995 556799999999987
Q ss_pred cCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ......... .+.....
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~----~~~~~~~ 242 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVE----TGKYAFD 242 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH----HTCCCSC
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHH----hCCCCCC
Confidence 64322 2233579999999999875 59999999999999999999999975422 122222211 1111100
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+.+. ..+ ..+.+++..||+.+|.+|||+.|+++.
T Consensus 243 -~~~~~-~~s----~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 -LPQWR-TIS----DDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -SGGGG-GSC----HHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -CcccC-CCC----HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00111 111 245688999999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.34 Aligned_cols=248 Identities=24% Similarity=0.376 Sum_probs=194.3
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999985 68899999986532 23456889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999999654 34889999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCcccccccccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.. ......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ...... ....... +
T Consensus 164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~----~~~~~~~-~-- 230 (276)
T 2h6d_A 164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---PTLFKK----IRGGVFY-I-- 230 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH----HHHCCCC-C--
T ss_pred Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHH----hhcCccc-C--
Confidence 22 1223568999999999988765 6899999999999999999999754221 111111 1111110 0
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
....+ ..+.+++.+||+.||.+|||++||++.
T Consensus 231 ---~~~~~----~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 ---PEYLN----RSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---chhcC----HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01111 245678999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=327.36 Aligned_cols=254 Identities=21% Similarity=0.314 Sum_probs=201.0
Q ss_pred HHhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---------hhhHHHHHHHHHHHhhcC-CcceeeeEeE
Q 005236 383 ANATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---------EQGLKELKNEIILFSKLQ-HRNLVKLLGC 451 (706)
Q Consensus 383 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~ 451 (706)
....++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 344578999999999999999999985 57899999985432 223467889999999996 9999999999
Q ss_pred EEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEe
Q 005236 452 CIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 531 (706)
Q Consensus 452 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 531 (706)
+......++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred eccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence 99999999999999999999999653 35899999999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccccCccCccccc------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHH
Q 005236 532 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS------DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRH 605 (706)
Q Consensus 532 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~ 605 (706)
|||++..+.... ......+++.|+|||++. ...++.++||||||+++|||++|+.||..... ......
T Consensus 167 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~ 240 (298)
T 1phk_A 167 DFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLRM 240 (298)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH
T ss_pred cccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---HHHHHH
Confidence 999998764322 223356899999999985 45789999999999999999999999753221 111111
Q ss_pred HHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 606 AWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 606 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.. ..... ...+... .. ...+.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~----~~~~~-~~~~~~~-~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IM----SGNYQ-FGSPEWD-DY----SDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HH----HTCCC-CCTTTGG-GS----CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Hh----cCCcc-cCccccc-cc----CHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11 11111 0000000 11 124667899999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=346.80 Aligned_cols=196 Identities=27% Similarity=0.432 Sum_probs=155.9
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC-----Ce
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG-----EE 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 457 (706)
.++|++.++||+|+||.||+|+.. +++.||||++.. ......+.+.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999875 588999999865 3445567899999999999999999999998543 46
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.++||||+ +++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 57899888543 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCc-------------------------ccccccccccCccCcccc-ccCCCCcchhhHHHHHHHHHHHhCC
Q 005236 538 AFGGDETE-------------------------GNTNRVVGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK 588 (706)
Q Consensus 538 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDv~SlGvil~elltG~ 588 (706)
........ ......+||+.|+|||++ ....++.++|||||||+||||++|.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 76432111 122345789999999986 5667999999999999999999943
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=327.71 Aligned_cols=252 Identities=26% Similarity=0.438 Sum_probs=197.3
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
.++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 468999999999999999999986 4889999999776666778899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++++|.+++.... ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 170 (302)
T 2j7t_A 98 CPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-- 170 (302)
T ss_dssp CTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--
T ss_pred CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc--
Confidence 99999999986532 45899999999999999999999988 999999999999999999999999997643111
Q ss_pred cccccccccccCccCcccc-----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 545 EGNTNRVVGTYGYMAPEYA-----SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~-----~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
........||+.|+|||++ ....++.++||||||+++|||++|+.|+..... .... .............
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~---~~~~~~~~~~~~~ 244 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVL---LKIAKSDPPTLLT 244 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH---HHHHHSCCCCCSS
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHH---HHHhccCCcccCC
Confidence 1112235689999999998 366789999999999999999999999754322 1111 1111111111111
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.. ..+ ..+.+++.+||+.||.+|||+.++++
T Consensus 245 ~~----~~~----~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 245 PS----KWS----VEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp GG----GSC----HHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cc----ccC----HHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11 111 24567899999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=353.04 Aligned_cols=250 Identities=26% Similarity=0.352 Sum_probs=195.8
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
.++|++.++||+|+||.||+|+.. .+..||||++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 357999999999999999999985 57899999986532 334577899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC---CCeEEeeecccccc
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLARAF 539 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~~kl~Dfgla~~~ 539 (706)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.. +.+||+|||+++.+
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999988654 34889999999999999999999998 9999999999999764 55999999999876
Q ss_pred CCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 540 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 540 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||..... ........ .+... ..
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~----~~~~~-~~ 257 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEILRKVE----KGKYT-FD 257 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----HTCCC-CC
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH----hCCCC-CC
Confidence 4332 223357999999999886 5799999999999999999999999854322 22222211 11110 00
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.+.+. ..+ ..+.+++..||+.+|.+|||++|+++
T Consensus 258 ~~~~~-~~s----~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 SPEWK-NVS----EGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp SGGGT-TSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhcc-cCC----HHHHHHHHHHCCCChhhCccHHHHhc
Confidence 11111 111 24567899999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=330.25 Aligned_cols=265 Identities=25% Similarity=0.403 Sum_probs=186.1
Q ss_pred HhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999874 58899999986532 34456788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcc-----cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccc
Q 005236 462 YEFMPNKSLDSFIFDQ-----ERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 536 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla 536 (706)
|||+++++|.+++... .....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998642 12345899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCC---cccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhc
Q 005236 537 RAFGGDET---EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNE 612 (706)
Q Consensus 537 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 612 (706)
..+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ...........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~ 245 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLMLTLQNDPP 245 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHHHHTSSCC
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHHHHhccCCC
Confidence 87643221 112233578999999999876 578999999999999999999999986543321 11111111000
Q ss_pred CCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 613 GMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 613 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.......+.......+ ..+.+++.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0001111111111112 24567889999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=338.96 Aligned_cols=261 Identities=21% Similarity=0.283 Sum_probs=201.7
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcC--------CcceeeeEeEEE---
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQ--------HRNLVKLLGCCI--- 453 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 453 (706)
.++|++.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999874 5788999999643 445678889999999985 788999999988
Q ss_pred -eCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEcCCC-----
Q 005236 454 -HGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDM----- 526 (706)
Q Consensus 454 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~----- 526 (706)
.....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 456789999999 556666654432 24589999999999999999999998 7 99999999999999775
Q ss_pred --------------------------------------------CeEEeeeccccccCCCCCcccccccccccCccCccc
Q 005236 527 --------------------------------------------NPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562 (706)
Q Consensus 527 --------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~ 562 (706)
.+||+|||+++..... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 8999999999875422 223578999999999
Q ss_pred cccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhH---HHHHHHHhhcCCCcc----------cccc--------
Q 005236 563 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNL---IRHAWKLWNEGMPSQ----------LIDA-------- 621 (706)
Q Consensus 563 ~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~----------~~d~-------- 621 (706)
+.+..++.++|||||||++|||++|+.||........... .......... .+.. .+..
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK-VPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCS-CCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCC-CChHHhhcccccccccCCcccccccc
Confidence 9999999999999999999999999999876544332211 1111111111 1100 0000
Q ss_pred ----------cc-cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 622 ----------CF-KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 622 ----------~~-~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.. ...........+.+|+.+||+.||.+|||++||++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 01123445567889999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=327.73 Aligned_cols=257 Identities=26% Similarity=0.374 Sum_probs=195.4
Q ss_pred cCCCccceeccCCceeEEEEEeC--CCc--EEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA--DEQ--EIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 459 (706)
++|++.+.||+|+||.||+|++. +++ .||||++... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 68999999999999999999863 233 6899988653 3345678999999999999999999999987654 88
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
+||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++..
T Consensus 97 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 9999999999999996542 45889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCc-ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 540 GGDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 540 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
...... .......+|..|+|||++.+..++.++||||||+++|||++ |+.||..... ...... .........
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~---~~~~~~~~~ 245 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHK---IDKEGERLP 245 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHH---HHTSCCCCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHHHH---HHccCCCCC
Confidence 443221 12233467889999999999899999999999999999999 9999754321 111111 111111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
.. ... ...+.+++.+||+.+|.+|||+.++++.|+...
T Consensus 246 ~~-----~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 246 RP-----EDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CC-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CC-----cCc----CHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 10 111 134667899999999999999999999998764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=365.73 Aligned_cols=249 Identities=24% Similarity=0.294 Sum_probs=201.8
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 459 (706)
..++|++.++||+|+||.||+|+.. +++.||||++.+. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999985 4778999998653 233456788899999987 7999999999999999999
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999654 34899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 540 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 540 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
.... .......||+.|+|||++.+..++.++|||||||+||||++|+.||.... ........ . .... .+
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---~~~~~~~i---~-~~~~-~~- 561 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSI---M-EHNV-AY- 561 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH---H-SSCC-CC-
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC---HHHHHHHH---H-hCCC-CC-
Confidence 3222 22344689999999999999999999999999999999999999985422 22222211 1 1111 00
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCCh-----hHHHH
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCM-----PSVIL 658 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~-----~ev~~ 658 (706)
....+ ..+.+|+..||+.||.+||++ +||++
T Consensus 562 ----p~~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 562 ----PKSMS----KEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ----CTTSC----HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ----CccCC----HHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 01111 246678999999999999998 66653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=342.63 Aligned_cols=261 Identities=20% Similarity=0.261 Sum_probs=195.0
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe------eE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEE------KL 459 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~ 459 (706)
..+|++.++||+|+||.||+|+...+..+|+|++..... ...+|+.+++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 357999999999999999999998877899998854322 22469999999999999999999976443 78
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc-CCCCeEEeeeccccc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARA 538 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~Dfgla~~ 538 (706)
+||||++++.+............+++..+..++.||++||+|||+.+ |+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999988655544433333456899999999999999999999998 99999999999999 799999999999987
Q ss_pred cCCCCCcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC----
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG---- 613 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---- 613 (706)
+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+ ............
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID---QLVEIIKVLGTPSREQ 265 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHH
Confidence 643222 2235689999999998765 58999999999999999999999986433222 222111111100
Q ss_pred -----------CCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 614 -----------MPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 614 -----------~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
....+....+...+.......+.+++.+||+.||.+|||+.|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000000000011112356789999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=352.24 Aligned_cols=252 Identities=26% Similarity=0.346 Sum_probs=199.1
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccch-------------hhHHHHHHHHHHHhhcCCcceeeeEe
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISE-------------QGLKELKNEIILFSKLQHRNLVKLLG 450 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 450 (706)
..++|.+.++||+|+||.||+|+.. .++.||||++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999985 478999999865321 33578899999999999999999999
Q ss_pred EEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC---C
Q 005236 451 CCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---N 527 (706)
Q Consensus 451 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~ 527 (706)
++.+....++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999998654 34899999999999999999999998 99999999999999776 6
Q ss_pred eEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 005236 528 PKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAW 607 (706)
Q Consensus 528 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 607 (706)
+||+|||+++.+.... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||..... ........
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~ 260 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND---QDIIKKVE 260 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH
Confidence 9999999998764332 223457999999999986 5699999999999999999999999864322 12221111
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 608 KLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 608 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+.... ..+.+ ...+ ..+.+++..||+.||.+|||++|+++.
T Consensus 261 ----~~~~~~-~~~~~-~~~s----~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 261 ----KGKYYF-DFNDW-KNIS----DEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ----HCCCCC-CHHHH-TTSC----HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----cCCCCC-Ccccc-CCCC----HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111100 00000 0111 246678999999999999999999853
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=354.73 Aligned_cols=251 Identities=27% Similarity=0.353 Sum_probs=202.0
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|++.++||+|+||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357999999999999999999985 6889999998542 234567899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE---cCCCCeEEeeeccccc
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARA 538 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfgla~~ 538 (706)
|||+.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999998654 34889999999999999999999998 9999999999999 5678999999999987
Q ss_pred cCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ......... .+....
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~----~~~~~~- 246 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDILKKVE----KGKYTF- 246 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH----HCCCCC-
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHH----cCCCCC-
Confidence 64332 2234579999999999876 69999999999999999999999985432 222222211 111110
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
..+.+. ..+ ..+.+++..||+.+|.+|||+.|+++.
T Consensus 247 ~~~~~~-~~s----~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 247 ELPQWK-KVS----ESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CSGGGG-GSC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCcccc-cCC----HHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 001111 111 245678999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=330.53 Aligned_cols=255 Identities=19% Similarity=0.290 Sum_probs=197.0
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-CcceeeeEeEEEe--CCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIH--GEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV~ 462 (706)
++|++.++||+|+||.||+|+. .+++.||||++.... .+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6899999999999999999987 568899999986433 467899999999997 9999999999988 56789999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-CeEEeeeccccccCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFGG 541 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfgla~~~~~ 541 (706)
||+++++|.+++. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999883 3788899999999999999999998 99999999999999777 899999999987643
Q ss_pred CCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh---------h
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLW---------N 611 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~---------~ 611 (706)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||..... ............ .
T Consensus 184 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 184 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCHHHHHHHHH
T ss_pred CC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc--hHHHHHHHHHhcCCchhhhHHH
Confidence 32 2233578999999999977 6799999999999999999999999743222 111111111100 0
Q ss_pred cCC--------------CcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 612 EGM--------------PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 612 ~~~--------------~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
... ....................+.+++..||+.||.+|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 00000000000000001235678999999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=343.42 Aligned_cols=199 Identities=27% Similarity=0.444 Sum_probs=167.6
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC-----Ce
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG-----EE 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 457 (706)
.++|++.+.||+|+||.||+|+.. +++.||||++.. ......+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999985 478899999965 3445567899999999999999999999999776 56
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.++||||++ ++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999987 5999998543 45899999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCc--------------------ccccccccccCccCcccc-ccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 005236 538 AFGGDETE--------------------GNTNRVVGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGKKNR 591 (706)
Q Consensus 538 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDv~SlGvil~elltG~~p~ 591 (706)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76433211 122456799999999986 5567999999999999999999866554
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=324.30 Aligned_cols=252 Identities=26% Similarity=0.384 Sum_probs=186.4
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46899999999999999999998 46889999998653 2223344555666688899999999999999999999999
Q ss_pred ecCCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 463 EFMPNKSLDSFIFDQ-ERCKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 463 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||++ |+|.+++... .....+++..++.++.||+.||+|||++ + |+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 4888877542 2335689999999999999999999997 7 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccCccCcccc----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYA----SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (706)
... ......||+.|+|||++ ....++.++||||||+++|||++|+.||..... ..... ..........
T Consensus 162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~---~~~~~~~~~~ 233 (290)
T 3fme_A 162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--PFQQL---KQVVEEPSPQ 233 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--HHHHH---HHHHHSCCCC
T ss_pred ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--hHHHH---HHHhccCCCC
Confidence 322 22234689999999996 556789999999999999999999999853221 11111 1122222111
Q ss_pred ccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 617 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
... ...+ ..+.+++.+||+.||.+|||++|+++
T Consensus 234 -~~~----~~~~----~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 -LPA----DKFS----AEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -CCT----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -ccc----ccCC----HHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111 1111 24567899999999999999999976
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.12 Aligned_cols=268 Identities=21% Similarity=0.276 Sum_probs=198.1
Q ss_pred HHHHHHhccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccc-----------hhhHHHHHHHHHHHhhcCCcceee
Q 005236 379 LATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKIS-----------EQGLKELKNEIILFSKLQHRNLVK 447 (706)
Q Consensus 379 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv~ 447 (706)
..++....++|++.+.||+|+||.||+|+..+++.||||++.... ....+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 456777889999999999999999999999889999999985421 223478999999999999999999
Q ss_pred eEeEEEeC-----CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE
Q 005236 448 LLGCCIHG-----EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 522 (706)
Q Consensus 448 l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill 522 (706)
+++++... ...++||||++ |+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 99998653 25799999998 6888888543 345899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchh
Q 005236 523 DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLN 601 (706)
Q Consensus 523 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~ 601 (706)
+.++.+||+|||+++..... .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~ 241 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF---YN 241 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HH
T ss_pred cCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH---HH
Confidence 99999999999999854322 22234578999999999877 6799999999999999999999999864332 12
Q ss_pred HHHHHHHHhhcCCCc-------------------ccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 602 LIRHAWKLWNEGMPS-------------------QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 602 ~~~~~~~~~~~~~~~-------------------~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
............... ......+. .........+.+++..||+.||.+|||++|+++.
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWT-AVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHH-HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHH-hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 222221111111100 00000000 0000011246689999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=338.24 Aligned_cols=257 Identities=24% Similarity=0.343 Sum_probs=183.6
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC------C
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG------E 456 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 456 (706)
.++|++.+.||+|+||.||+|+. .+++.||||++.. ......+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999987 4588999999865 3344567888999999999999999999998754 5
Q ss_pred eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 536 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla 536 (706)
..++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 7899998854 35899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 537 RAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 537 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .............. .
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~p-~ 250 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTP-G 250 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSC-C
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCC-C
Confidence 875322 233578999999999987 6899999999999999999999999864332 22222222211110 0
Q ss_pred ccccccc------------c-cCcCCHHH-----HHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 616 SQLIDAC------------F-KDSFNLAE-----VIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 616 ~~~~d~~------------~-~~~~~~~~-----~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+.+... . ........ ...+.+|+.+||+.||.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000 0 00011111 1246789999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=340.57 Aligned_cols=254 Identities=11% Similarity=0.057 Sum_probs=180.2
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhc--CCcceeeeE-------eEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELKNEIILFSKL--QHRNLVKLL-------GCC 452 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 452 (706)
..+|.+.++||+|+||.||+|++. +++.||||++.... ....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 346899999999999999999975 68899999987633 34456778886555555 699988755 444
Q ss_pred EeC-----------------CeeEEEEecCCCCChhhhhhcccccCCCCHHHH------HHHHHHHHHHHHHHHhCCCCc
Q 005236 453 IHG-----------------EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKR------FHIICGTARGLLYLHQDSRLR 509 (706)
Q Consensus 453 ~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~l~~LH~~~~~~ 509 (706)
... ...++||||++ |+|.+++..... .+.+..+ +.++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 433 33799999999 899999976432 3455555 778899999999999998
Q ss_pred eEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhC
Q 005236 510 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSG 587 (706)
Q Consensus 510 ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvil~elltG 587 (706)
|+||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999875321 113567799999999987 6899999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 588 KKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 588 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+.||.............. ............+.. ... ...+.+++.+||+.||++|||+.|+++
T Consensus 290 ~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~-~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWKRP---SLRVPGTDSLAFGSC-TPL----PDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTCCCBC---CTTSCCCCSCCCTTS-SCC----CHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccchhhh---hhhhccccccchhhc-cCC----CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999865433211100000 000000000000000 011 234667899999999999999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=340.44 Aligned_cols=261 Identities=20% Similarity=0.252 Sum_probs=193.8
Q ss_pred HhccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC-------
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG------- 455 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 455 (706)
...++|++.+.||+|+||.||+|+. .+++.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999997 5689999999854322 234799999999999999999998543
Q ss_pred -------------------------------CeeEEEEecCCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHH
Q 005236 456 -------------------------------EEKLLIYEFMPNKSLDSFIFDQ-ERCKLLDWSKRFHIICGTARGLLYLH 503 (706)
Q Consensus 456 -------------------------------~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH 503 (706)
...++||||++ ++|.+.+... .....+++..+..++.||++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34789999998 5888777542 23356899999999999999999999
Q ss_pred hCCCCceEecccCCCcEEEc-CCCCeEEeeeccccccCCCCCcccccccccccCccCccccccC-CCCcchhhHHHHHHH
Q 005236 504 QDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILL 581 (706)
Q Consensus 504 ~~~~~~ivH~Dikp~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil 581 (706)
+.+ |+||||||+|||++ .++.+||+|||+++.+.... ......+|+.|+|||++.+. .++.++||||+||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 988 99999999999998 68999999999998764332 22335689999999998775 589999999999999
Q ss_pred HHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC---------------CcccccccccCcCCHHHHHHHHHHHHHhcCCC
Q 005236 582 LEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM---------------PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQY 646 (706)
Q Consensus 582 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~ 646 (706)
|||++|+.||...... .............. ...+....+...........+.+++.+||+.|
T Consensus 233 ~ell~g~~pf~~~~~~---~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETSI---DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 9999999998643322 22222221111110 00000000100011111224678999999999
Q ss_pred CCCCCChhHHHH
Q 005236 647 PEDRPCMPSVIL 658 (706)
Q Consensus 647 p~~RPt~~ev~~ 658 (706)
|.+|||+.|+++
T Consensus 310 P~~R~t~~e~l~ 321 (383)
T 3eb0_A 310 PDLRINPYEAMA 321 (383)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999984
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=339.55 Aligned_cols=198 Identities=23% Similarity=0.305 Sum_probs=171.7
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhc------CCcceeeeEeEEEeCCee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKL------QHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 458 (706)
..+|++.++||+|+||.||+|+... ++.||||++... ....+.+.+|+.+++.+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 4679999999999999999998854 789999999653 34456778888888877 577999999999999999
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC--eEEeeeccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGLA 536 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfgla 536 (706)
++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 68999886543 244899999999999999999999998 999999999999999987 999999999
Q ss_pred cccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 005236 537 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 594 (706)
Q Consensus 537 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~ 594 (706)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 764322 22357899999999999999999999999999999999999997643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=323.44 Aligned_cols=251 Identities=27% Similarity=0.443 Sum_probs=197.6
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999985 48899999986532 34678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++++|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999998532 345899999999999999999999988 9999999999999999999999999998764322
Q ss_pred CcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .... ...... ....+..+
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~---~~~~~~-~~~~~~~~-- 248 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP---MRAI---FMIPTN-PPPTFRKP-- 248 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH---HHHHHS-CCCCCSSG--
T ss_pred c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---HHHH---HHHhcC-CCcccCCc--
Confidence 1 22335689999999999999999999999999999999999999754321 1111 111111 11111000
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
... ...+.+++..||+.||.+|||+.++++
T Consensus 249 -~~~----~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 -ELW----SDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -GGS----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011 124567899999999999999999976
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=335.69 Aligned_cols=259 Identities=23% Similarity=0.282 Sum_probs=191.6
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC------
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE------ 456 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 456 (706)
.++|++.+.||+|+||.||+|+.. +++.||||++.. ......+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999874 588999999864 23455678889999999999999999999997654
Q ss_pred eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 536 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla 536 (706)
..++||||+++ +|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999975 7877773 23788999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC---
Q 005236 537 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG--- 613 (706)
Q Consensus 537 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 613 (706)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..............
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTPCPE 248 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHC-CCCCCHH
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHH
Confidence 8753221 22335789999999999999999999999999999999999999854322 11111111110000
Q ss_pred ---------------CC-------cccccccccCcCC---HHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 614 ---------------MP-------SQLIDACFKDSFN---LAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 614 ---------------~~-------~~~~d~~~~~~~~---~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.. ..++......... ......+.+++.+||+.||.+|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00 0000000000000 1123467889999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=330.34 Aligned_cols=263 Identities=22% Similarity=0.321 Sum_probs=200.3
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC-----Cee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG-----EEK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 458 (706)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 368999999999999999999975 5788999998753 344457889999999999999999999999765 367
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999998 589998854 34899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCcc-cccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc
Q 005236 539 FGGDETEG-NTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616 (706)
Q Consensus 539 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (706)
........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+ ..........
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQE 254 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH---HHHHCSCCHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH---HHHhCCCCHH
Confidence 64332211 2234579999999998754 45899999999999999999999998654433322222 1111111000
Q ss_pred cc---cc--------ccc-cCcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 617 QL---ID--------ACF-KDSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 617 ~~---~d--------~~~-~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+ .+ ... ....... ....+.+++.+||+.||.+|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00 000 0000000 11246789999999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.24 Aligned_cols=255 Identities=26% Similarity=0.348 Sum_probs=196.5
Q ss_pred HHhccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcC--CcceeeeEeEEEeCCee
Q 005236 383 ANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQ--HRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 383 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~ 458 (706)
....++|++.+.||+|+||.||+++..+++.||||++.. ......+.+.+|+.++.+++ ||||+++++++.+.+..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 344578999999999999999999998899999999854 34556688999999999997 59999999999999999
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||| +.+++|.+++... ..+++..++.++.||++||.|||+.+ |+||||||+|||+++ +.+||+|||+++.
T Consensus 104 ~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccc
Confidence 99999 6788999999653 35889999999999999999999998 999999999999964 8999999999987
Q ss_pred cCCCCCcccccccccccCccCcccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASD-----------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAW 607 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 607 (706)
..............||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~ 250 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLH 250 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHH
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHH
Confidence 654433333344578999999999875 4788999999999999999999999853221 111111
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 608 KLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 608 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
..........+.+ .. ...+.+++.+||+.||.+||+++|+++.
T Consensus 251 ~~~~~~~~~~~~~-----~~----~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 251 AIIDPNHEIEFPD-----IP----EKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHCTTSCCCCCC-----CS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhcccccCCcc-----cc----hHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 2221111111111 11 1245678899999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.54 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=202.3
Q ss_pred ccCCCccceeccCCceeEEEEEe--CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcc------eeeeEeEEEeCCe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL--ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRN------LVKLLGCCIHGEE 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 457 (706)
.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.+++.++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 36899999999999999999987 35789999998653 344677889999999987665 9999999999999
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-------------
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ------------- 524 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~------------- 524 (706)
.++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 899999986543 245889999999999999999999998 999999999999987
Q ss_pred ------CCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 005236 525 ------DMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 598 (706)
Q Consensus 525 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~ 598 (706)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999874322 223578999999999999999999999999999999999999986543322
Q ss_pred chhHHHHHHHHhhcCCCccccc------------------------------ccc-cCcCCHHHHHHHHHHHHHhcCCCC
Q 005236 599 KLNLIRHAWKLWNEGMPSQLID------------------------------ACF-KDSFNLAEVIRCIHIGLLCVQQYP 647 (706)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~d------------------------------~~~-~~~~~~~~~~~~~~l~~~cl~~~p 647 (706)
....+.. .. ...+..... +.. ...........+.+++.+||+.||
T Consensus 242 ~~~~~~~---~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 242 HLAMMER---IL-GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp HHHHHHH---HH-CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred HHHHHHH---Hh-CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 1111111 11 111110000 000 001112334567889999999999
Q ss_pred CCCCChhHHHHH
Q 005236 648 EDRPCMPSVILM 659 (706)
Q Consensus 648 ~~RPt~~ev~~~ 659 (706)
.+|||++||++.
T Consensus 318 ~~Rpt~~ell~h 329 (339)
T 1z57_A 318 AKRITLREALKH 329 (339)
T ss_dssp TTSCCHHHHTTS
T ss_pred ccccCHHHHhcC
Confidence 999999999753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=330.44 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=196.2
Q ss_pred HHHHhccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEe----
Q 005236 381 TIANATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIH---- 454 (706)
Q Consensus 381 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 454 (706)
.+....++|++.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 3344568999999999999999999998 468899999986432 3346788999999999 79999999999987
Q ss_pred --CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEee
Q 005236 455 --GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 532 (706)
Q Consensus 455 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 532 (706)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEee
Confidence 467899999999999999996543 345889999999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 005236 533 FGLARAFGGDETEGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAW 607 (706)
Q Consensus 533 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 607 (706)
||++....... .......||+.|+|||++. ...++.++||||||+++|||++|+.||..... .... .
T Consensus 173 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~---~ 244 (326)
T 2x7f_A 173 FGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRAL---F 244 (326)
T ss_dssp CTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH---H
T ss_pred CcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHH---H
Confidence 99998753221 1223357899999999997 56789999999999999999999999753221 1111 1
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 608 KLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 608 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
....... ..... ...+ ..+.+++.+||+.||.+||++.++++
T Consensus 245 ~~~~~~~-~~~~~----~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 245 LIPRNPA-PRLKS----KKWS----KKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHSCC-CCCSC----SCSC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhhcCcc-ccCCc----cccC----HHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111111 11111 1111 24567889999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.88 Aligned_cols=262 Identities=22% Similarity=0.302 Sum_probs=193.4
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEE-----------
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCI----------- 453 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 453 (706)
.++|++.+.||+|+||.||+|+... ++.||||++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 3689999999999999999999865 8899999997777777888999999999999999999999873
Q ss_pred ---eCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc-CCCCeE
Q 005236 454 ---HGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPK 529 (706)
Q Consensus 454 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~k 529 (706)
+....++||||++ |+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 699999843 34889999999999999999999998 99999999999997 567999
Q ss_pred EeeeccccccCCCCC-cccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 005236 530 ISDFGLARAFGGDET-EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAW 607 (706)
Q Consensus 530 l~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 607 (706)
|+|||+++....... ........+|..|+|||.+.. ..++.++||||||+++|||++|+.||...... .......
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL---EQMQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH
Confidence 999999987643221 122334567999999998865 68899999999999999999999998643321 1111111
Q ss_pred HHhhcC----------CCcccccccc-cCcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 608 KLWNEG----------MPSQLIDACF-KDSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 608 ~~~~~~----------~~~~~~d~~~-~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
...... .....+.... ....... ....+.+++.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 110000 0000000000 0000000 1234678999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.73 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=193.9
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--------hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--------EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE 456 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 456 (706)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 468999999999999999999985 47899999986432 122345889999999999999999999987654
Q ss_pred eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC---eEEeee
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDF 533 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---~kl~Df 533 (706)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 89999999999999988543 45889999999999999999999988 999999999999987665 999999
Q ss_pred ccccccCCCCCcccccccccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 005236 534 GLARAFGGDETEGNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLW 610 (706)
Q Consensus 534 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 610 (706)
|+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||........ ......
T Consensus 162 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~--- 233 (322)
T 2ycf_A 162 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT--- 233 (322)
T ss_dssp TTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHH---
T ss_pred ccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHH---
Confidence 9998764221 123356899999999974 56789999999999999999999999865433222 111111
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 611 NEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 611 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
..... .... ..... ...+.+++.+||+.||.+||++.|+++
T Consensus 234 -~~~~~-~~~~-~~~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 -SGKYN-FIPE-VWAEV----SEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -HTCCC-CCHH-HHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -hCccc-cCch-hhhhc----CHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11110 0000 00111 124668899999999999999999974
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=335.03 Aligned_cols=258 Identities=22% Similarity=0.321 Sum_probs=202.1
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhh-----------------HHHHHHHHHHHhhcCCcceeee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQG-----------------LKELKNEIILFSKLQHRNLVKL 448 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l 448 (706)
.++|++.+.||+|+||.||+|+. +++.||||++....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999999 89999999986432211 2789999999999999999999
Q ss_pred EeEEEeCCeeEEEEecCCCCChhhh------hhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCcEE
Q 005236 449 LGCCIHGEEKLLIYEFMPNKSLDSF------IFDQERCKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVL 521 (706)
Q Consensus 449 ~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dikp~Nil 521 (706)
++++.+.+..++||||+++++|.++ +... ....+++..++.++.||+.||.|||+ .+ |+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 4321 24568999999999999999999998 77 999999999999
Q ss_pred EcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccC-CCCc-chhhHHHHHHHHHHHhCCCCCCCCCCCCc
Q 005236 522 LDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSV-KSDVFSFGILLLEIVSGKKNRGFYHSDNK 599 (706)
Q Consensus 522 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~sDv~SlGvil~elltG~~p~~~~~~~~~ 599 (706)
++.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 999999999999999876432 23345789999999999887 6766 999999999999999999998643321
Q ss_pred hhHHHHHHHHhhcCCCcc------cccccccC---cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 600 LNLIRHAWKLWNEGMPSQ------LIDACFKD---SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~------~~d~~~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
...... +....... ........ .........+.+++.+||+.||.+|||++|+++
T Consensus 259 ~~~~~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 VELFNN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111 11111100 00000000 000011235668999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=341.74 Aligned_cols=259 Identities=22% Similarity=0.269 Sum_probs=191.3
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC------eeE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE------EKL 459 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 459 (706)
.+|++.+.||+|+||.||+|++. +++.||||++.... ....+|+.++++++|||||++++++.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46899999999999999999985 58999999985432 22347999999999999999999986421 357
Q ss_pred EEEecCCCCChhhhhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-CCeEEeeecccc
Q 005236 460 LIYEFMPNKSLDSFIFDQ-ERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLAR 537 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfgla~ 537 (706)
+||||+++ +|.+.+... .....+++..+..++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999986 565555432 23356899999999999999999999988 9999999999999965 568999999998
Q ss_pred ccCCCCCcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC---
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG--- 613 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 613 (706)
.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+..........
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~---~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG---VDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSCCHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHH
Confidence 7643221 2235789999999999765 799999999999999999999999864322 22222222111110
Q ss_pred -------CCccccccc-----ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 614 -------MPSQLIDAC-----FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 614 -------~~~~~~d~~-----~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
...++.-+. +...+.......+.+|+.+||+.||.+|||+.|+++.
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 001110000 0000011112356789999999999999999999853
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=336.66 Aligned_cols=269 Identities=20% Similarity=0.238 Sum_probs=188.7
Q ss_pred HHHHHhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe-
Q 005236 380 ATIANATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEE- 457 (706)
Q Consensus 380 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 457 (706)
.......++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+|+..+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 344566789999999999999999999985 58899999885432 233456778888999999999999999976443
Q ss_pred ------eEEEEecCCCCChhhhhh-cccccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceEecccCCCcEEEcC-CCC
Q 005236 458 ------KLLIYEFMPNKSLDSFIF-DQERCKLLDWSKRFHIICGTARGLLYLH--QDSRLRIIHRDLKASNVLLDQ-DMN 527 (706)
Q Consensus 458 ------~~lV~e~~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~~ia~~l~~LH--~~~~~~ivH~Dikp~Nill~~-~~~ 527 (706)
.++||||++++ |...+. .......+++..+..++.|++.||.||| +.+ |+||||||+||||+. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 78999999874 444333 2234456889999999999999999999 777 999999999999997 899
Q ss_pred eEEeeeccccccCCCCCcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH
Q 005236 528 PKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHA 606 (706)
Q Consensus 528 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~ 606 (706)
+||+|||+++.+..... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...... ......
T Consensus 171 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~~ 244 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA---GQLHEI 244 (360)
T ss_dssp EEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH
T ss_pred EEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH---HHHHHH
Confidence 99999999987643322 2235689999999998665 4899999999999999999999998643322 222222
Q ss_pred HHHhhcCC-----------C-ccccc------ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 607 WKLWNEGM-----------P-SQLID------ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 607 ~~~~~~~~-----------~-~~~~d------~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
........ . ....+ ..............+.+++.+||+.||.+|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 21111100 0 00000 000001111123467789999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=329.49 Aligned_cols=258 Identities=28% Similarity=0.422 Sum_probs=198.3
Q ss_pred hccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
..++|++.+.||+|+||.||+|+..+ .+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35789999999999999999999854 4999998643 2333456788999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 109 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp BCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred ecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 999999999999653 245889999999999999999999998 99999999999998 689999999998765322
Q ss_pred CC---cccccccccccCccCcccccc---------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 005236 543 ET---EGNTNRVVGTYGYMAPEYASD---------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLW 610 (706)
Q Consensus 543 ~~---~~~~~~~~gt~~y~aPE~~~~---------~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 610 (706)
.. ........|++.|+|||++.. ..++.++||||||+++|||++|+.||..... ..... ..
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~---~~- 255 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIW---QM- 255 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHHHH---HH-
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---Hh-
Confidence 11 122233568999999999874 4578999999999999999999999754321 11111 11
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 611 NEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 611 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
........... ..+ ..+.+++..||+.+|.+|||+.+|+++|+.+..
T Consensus 256 ~~~~~~~~~~~----~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 256 GTGMKPNLSQI----GMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp HTTCCCCCCCS----SCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred ccCCCCCCCcC----CCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11111111110 011 135578889999999999999999999998743
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=328.47 Aligned_cols=266 Identities=22% Similarity=0.308 Sum_probs=201.1
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-----------CcceeeeEeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-----------HRNLVKLLGCCI 453 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 453 (706)
.++|++.+.||+|+||.||+|+. .+++.||||++.. .....+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36899999999999999999997 4688999999864 3344567889999998886 899999999998
Q ss_pred eCC----eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEc-----
Q 005236 454 HGE----EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLD----- 523 (706)
Q Consensus 454 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dikp~Nill~----- 523 (706)
... ..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++ + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 789999999 9999999965432 3488999999999999999999997 7 99999999999994
Q ss_pred -CCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc---
Q 005236 524 -QDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK--- 599 (706)
Q Consensus 524 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~--- 599 (706)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999875322 2235789999999999999999999999999999999999999875433221
Q ss_pred hhHHHHHHHHhhcCCCcccc----------------c-----------ccc--cCcCCHHHHHHHHHHHHHhcCCCCCCC
Q 005236 600 LNLIRHAWKLWNEGMPSQLI----------------D-----------ACF--KDSFNLAEVIRCIHIGLLCVQQYPEDR 650 (706)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~----------------d-----------~~~--~~~~~~~~~~~~~~l~~~cl~~~p~~R 650 (706)
...+......... .+..+. . ..+ ...........+.+++..||+.||.+|
T Consensus 247 ~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 247 DDHIAQIIELLGE-LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHCS-CCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHHHHhcCC-CCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 1112121111111 000000 0 000 012234455677899999999999999
Q ss_pred CChhHHHH--HhcCC
Q 005236 651 PCMPSVIL--MLGSE 663 (706)
Q Consensus 651 Pt~~ev~~--~L~~~ 663 (706)
||++||++ .+.+.
T Consensus 326 pt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDT 340 (373)
T ss_dssp BCHHHHHTCGGGTTC
T ss_pred CCHHHHhhChhhhcc
Confidence 99999987 34443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=354.59 Aligned_cols=257 Identities=23% Similarity=0.324 Sum_probs=202.0
Q ss_pred HhccCCCccceeccCCceeEEEEEeCC----CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCee
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTLAD----EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 458 (706)
...++|++.+.||+|+||.||+|++.. +..||||++... .....+.+.+|+.++++++||||+++++++. .+..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 345789999999999999999998743 457999998653 4445678999999999999999999999984 5678
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999999643 235889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
...... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||..... ........ ......
T Consensus 541 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~~~i~----~~~~~~ 612 (656)
T 2j0j_A 541 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIE----NGERLP 612 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHH----HTCCCC
T ss_pred cCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHH----cCCCCC
Confidence 643322 12223456789999999999999999999999999999997 8988754322 12222211 111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
+.. .. ...+.+++.+||+.||.+|||+.||++.|+.+
T Consensus 613 ~~~-----~~----~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 613 MPP-----NC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp CCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCc-----cc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 11 12466789999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=328.41 Aligned_cols=202 Identities=23% Similarity=0.352 Sum_probs=171.1
Q ss_pred HhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-Cc-----ceeeeEeEEEeCC
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-HR-----NLVKLLGCCIHGE 456 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~ 456 (706)
...++|++.++||+|+||.||+|+.. +++.||||++... ....+++..|+.++..++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 34579999999999999999999985 5788999999643 344567788998888885 44 4999999999999
Q ss_pred eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc--CCCCeEEeeec
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDFG 534 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~~~kl~Dfg 534 (706)
..++||||++ ++|.+++.... ...+++..+..++.||+.||.|||++ ..+|+||||||+||||+ .++.+||+|||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred ceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 9999999996 59999986543 24589999999999999999999953 12499999999999995 57889999999
Q ss_pred cccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 005236 535 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 594 (706)
Q Consensus 535 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~ 594 (706)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 207 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 207 SSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Cceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99876432 22357899999999999999999999999999999999999998643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.53 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=200.4
Q ss_pred HhccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 384 NATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 384 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
...++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999985 6889999998543 23456789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC---CCeEEeeecccc
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLAR 537 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~~kl~Dfgla~ 537 (706)
||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999999988654 34889999999999999999999988 9999999999999764 469999999998
Q ss_pred ccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
...... ......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||..... ...... +..+....
T Consensus 173 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~----~~~~~~~~ 241 (287)
T 2wei_A 173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKR----VETGKYAF 241 (287)
T ss_dssp TBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH----HHHCCCCC
T ss_pred eecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHH----HHcCCCCC
Confidence 764322 2223468999999999865 489999999999999999999999754321 111111 11111110
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
... .. ...+ ..+.+++.+||+.+|.+|||+.|+++
T Consensus 242 ~~~-~~-~~~~----~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 DLP-QW-RTIS----DDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CSG-GG-TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cch-hh-hhcC----HHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000 00 0111 24567899999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.41 Aligned_cols=262 Identities=22% Similarity=0.320 Sum_probs=197.3
Q ss_pred hccCCCccceeccCCceeEEEEEe--CCCcEEEEEEcCccc--hhhHHHHHHHHHHHhhc---CCcceeeeEeEEE----
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTL--ADEQEIAVKRLSKIS--EQGLKELKNEIILFSKL---QHRNLVKLLGCCI---- 453 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 453 (706)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999998 457889999986432 12223556777777666 8999999999987
Q ss_pred -eCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEee
Q 005236 454 -HGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 532 (706)
Q Consensus 454 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 532 (706)
.....++||||++ |+|.+++..... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 699999865432 34889999999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhc
Q 005236 533 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNE 612 (706)
Q Consensus 533 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 612 (706)
||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .............
T Consensus 164 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~ 237 (326)
T 1blx_A 164 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGL 237 (326)
T ss_dssp CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC
T ss_pred CcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHcCC
Confidence 9999865322 122345789999999999999999999999999999999999999764332 2222222221111
Q ss_pred CCCccc----------cc----ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 613 GMPSQL----------ID----ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 613 ~~~~~~----------~d----~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
...... .. ..+. .........+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGG-GTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhh-hccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 100000 00 0000 000011124567899999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=334.70 Aligned_cols=267 Identities=21% Similarity=0.328 Sum_probs=183.4
Q ss_pred cCCCc-cceeccCCceeEEEEEeC---CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEe--CCeeEE
Q 005236 387 DNFSI-NKKLGEGGFGPVYKGTLA---DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIH--GEEKLL 460 (706)
Q Consensus 387 ~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 460 (706)
+.|.+ .++||+|+||.||+|+.. +++.||||++..... .+.+.+|+.++++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34555 468999999999999975 478899999965322 2467899999999999999999999965 568899
Q ss_pred EEecCCCCChhhhhhccc------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE----cCCCCeEE
Q 005236 461 IYEFMPNKSLDSFIFDQE------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKI 530 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~~kl 530 (706)
||||+++ +|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999974 7877775322 1234899999999999999999999998 9999999999999 77899999
Q ss_pred eeeccccccCCCCC-cccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC------chhH
Q 005236 531 SDFGLARAFGGDET-EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN------KLNL 602 (706)
Q Consensus 531 ~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~------~~~~ 602 (706)
+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.....+. ....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987643221 1223346789999999999874 58999999999999999999999986433211 1122
Q ss_pred HHHHHHHhhcCCCc---ccc---------ccccc---CcCCHHH---------HHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 603 IRHAWKLWNEGMPS---QLI---------DACFK---DSFNLAE---------VIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 603 ~~~~~~~~~~~~~~---~~~---------d~~~~---~~~~~~~---------~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+............. .+. ..... ....... ...+.+|+..||+.||.+|||++|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 22222222111110 000 00000 0000000 124678999999999999999999987
Q ss_pred H
Q 005236 659 M 659 (706)
Q Consensus 659 ~ 659 (706)
.
T Consensus 334 h 334 (405)
T 3rgf_A 334 D 334 (405)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=329.66 Aligned_cols=262 Identities=23% Similarity=0.296 Sum_probs=197.6
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC-----Cee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG-----EEK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 458 (706)
.++|.+.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 478999999999999999999985 5889999998653 344566788999999999999999999998764 678
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 589988854 35899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCcc--------cccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH
Q 005236 539 FGGDETEG--------NTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKL 609 (706)
Q Consensus 539 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 609 (706)
+....... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||...... .........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~ 238 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR---HQLLLIFGI 238 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHH
Confidence 64322111 1223468999999998765 78999999999999999999999998643321 111111111
Q ss_pred hhcCCCcc----cccc--------ccc-CcCCH-----HHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 610 WNEGMPSQ----LIDA--------CFK-DSFNL-----AEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 610 ~~~~~~~~----~~d~--------~~~-~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
........ +... ... ..... .....+.+++.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11110000 0000 000 00000 01124668999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=319.68 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=190.6
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEe----------
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIH---------- 454 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 454 (706)
.++|++.+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467999999999999999999974 688999999854 34456789999999999999999999999865
Q ss_pred ---CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEe
Q 005236 455 ---GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 531 (706)
Q Consensus 455 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 531 (706)
....++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 356789999999999999996532 34678889999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCCC------------cccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 005236 532 DFGLARAFGGDET------------EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 598 (706)
Q Consensus 532 Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~ 598 (706)
|||+++....... ........||+.|+|||++.+. .++.++||||||+++|||++ |+.. .
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~--~-- 231 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST--G-- 231 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS--H--
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC--c--
Confidence 9999987643210 1122345689999999999865 78999999999999999998 3321 1
Q ss_pred chhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 599 KLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.... ........... .+ .+ .........+.+++.+||+.||.+|||+.++++.
T Consensus 232 -~~~~-~~~~~~~~~~~-~~-~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 -MERV-NILKKLRSVSI-EF-PP----DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -HHHH-HHHHHHHSTTC-CC-CT----TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -hhHH-HHHHhcccccc-cc-Cc----cccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111 11111111111 00 01 1111122345678999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=325.85 Aligned_cols=258 Identities=20% Similarity=0.255 Sum_probs=173.2
Q ss_pred hccCCCccc-eeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEe----CCee
Q 005236 385 ATDNFSINK-KLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIH----GEEK 458 (706)
Q Consensus 385 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 458 (706)
..++|.+.+ .||+|+||.||+|+.. +++.||||++.... . ...+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 346888855 6999999999999986 58899999985422 1 22223334667799999999999976 4458
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---CCCeEEeeecc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGL 535 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Dfgl 535 (706)
++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999997543 246899999999999999999999998 999999999999986 45599999999
Q ss_pred ccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
++..... ......+|+.|+|||++....++.++||||||+++|||++|+.||........................
T Consensus 178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (336)
T 3fhr_A 178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP 253 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence 9865322 223356899999999999889999999999999999999999998643332211110000000000000
Q ss_pred cccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH--HhcCC
Q 005236 616 SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL--MLGSE 663 (706)
Q Consensus 616 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~--~L~~~ 663 (706)
.+.. ... ...+.+++..||+.||.+|||++|+++ .+...
T Consensus 254 ----~~~~-~~~----~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 254 ----NPEW-SEV----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ----TTTS-TTC----CHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ----chhh-ccC----CHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 0000 011 124567899999999999999999997 44443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=335.37 Aligned_cols=256 Identities=22% Similarity=0.328 Sum_probs=195.2
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCee----
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEK---- 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 458 (706)
.++|.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999975 5889999998653 444567889999999999999999999999877655
Q ss_pred --EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccc
Q 005236 459 --LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 536 (706)
Q Consensus 459 --~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla 536 (706)
++||||++ ++|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 68887772 23889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 537 RAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 537 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .............. .
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~-~ 262 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVP-G 262 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCC-C
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCC-c
Confidence 865322 233568999999999987 7899999999999999999999999854322 12222211111100 0
Q ss_pred cccccc------------ccc-CcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 616 SQLIDA------------CFK-DSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 616 ~~~~d~------------~~~-~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+.... ... ...... ....+.+++..||+.||.+|||++|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000 000 000000 12356789999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=329.04 Aligned_cols=256 Identities=23% Similarity=0.316 Sum_probs=194.5
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe-----
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEE----- 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 457 (706)
.++|.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 368999999999999999999984 5889999998653 34446788999999999999999999999987654
Q ss_pred -eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccc
Q 005236 458 -KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 536 (706)
Q Consensus 458 -~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla 536 (706)
.++||||++ ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999998 58888773 23889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 537 RAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 537 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
+..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ................
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGT 245 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH---HHHHHHHHHHHCBCCH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCH
Confidence 865322 223578999999999877 6889999999999999999999999864332 1222211111100000
Q ss_pred ------------------cccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 616 ------------------SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 616 ------------------~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.......+.. ........+.+++.+||+.||.+|||++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000 000112356788999999999999999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=325.04 Aligned_cols=258 Identities=20% Similarity=0.293 Sum_probs=198.8
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-C-cEEEEEEcCccchhhHHHHHHHHHHHhhcCCcc------eeeeEeEEEeCCe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-E-QEIAVKRLSKISEQGLKELKNEIILFSKLQHRN------LVKLLGCCIHGEE 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 457 (706)
.++|++.+.||+|+||.||+|+... + +.||||++... ....+.+.+|+.++++++|++ ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 4789999999999999999999743 3 68999998643 344577889999999998766 9999999999999
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE---------------
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL--------------- 522 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill--------------- 522 (706)
.++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 667777665432 245899999999999999999999987 9999999999999
Q ss_pred ----cCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 005236 523 ----DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 598 (706)
Q Consensus 523 ----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~ 598 (706)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 67889999999999864322 223578999999999999999999999999999999999999986433222
Q ss_pred chhHHHHHHHHhhcCCCcccccc------------cc-------------------cCcCCHHHHHHHHHHHHHhcCCCC
Q 005236 599 KLNLIRHAWKLWNEGMPSQLIDA------------CF-------------------KDSFNLAEVIRCIHIGLLCVQQYP 647 (706)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~d~------------~~-------------------~~~~~~~~~~~~~~l~~~cl~~~p 647 (706)
......... ...+...... .+ ...........+.+++.+||+.||
T Consensus 247 ---~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 247 ---HLVMMEKIL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp ---HHHHHHHHH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred ---HHHHHHHHc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 111111111 1111100000 00 001112234467789999999999
Q ss_pred CCCCChhHHHH
Q 005236 648 EDRPCMPSVIL 658 (706)
Q Consensus 648 ~~RPt~~ev~~ 658 (706)
.+|||+.|+++
T Consensus 323 ~~Rpt~~e~l~ 333 (355)
T 2eu9_A 323 AQRITLAEALL 333 (355)
T ss_dssp TTSCCHHHHTT
T ss_pred hhCcCHHHHhc
Confidence 99999999974
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=323.94 Aligned_cols=255 Identities=27% Similarity=0.373 Sum_probs=177.0
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHH-HHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEII-LFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
.++|++.+.||+|+||.||+|+.. +++.||||++... .......+..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 378999999999999999999985 6889999998653 3334455566665 778889999999999999999999999
Q ss_pred ecCCCCChhhhhhcc--cccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 463 EFMPNKSLDSFIFDQ--ERCKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 463 e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
||+++ +|.+++... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 887777532 1235688999999999999999999998 7 999999999999999999999999999876
Q ss_pred CCCCCcccccccccccCccCcccc----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 540 GGDETEGNTNRVVGTYGYMAPEYA----SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 540 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
.... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||....... ..... ......
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~-~~~~~~ 247 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLTQ-VVKGDP 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-CCCSCC
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHHH-HhcCCC
Confidence 4322 12234689999999998 45678999999999999999999999986432110 00000 011111
Q ss_pred cccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 616 SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 616 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
..+... ..... ...+.+++.+||+.||.+|||+.||++
T Consensus 248 ~~~~~~-~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQLSNS-EEREF----SPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCC-SSCCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCc-ccccC----CHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111110 00111 124667899999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.14 Aligned_cols=253 Identities=24% Similarity=0.282 Sum_probs=185.5
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEEEecC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
+.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+....++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345567889999999998776678999999998543 245678899999886 8999999999999999999999999
Q ss_pred CCCChhhhhhcccccC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-------------CCe
Q 005236 466 PNKSLDSFIFDQERCK----LLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-------------MNP 528 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~-------------~~~ 528 (706)
+ |+|.+++....... ...+..++.++.||+.||+|||+.+ |+||||||+||||+.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999997543221 1233456789999999999999988 9999999999999754 489
Q ss_pred EEeeeccccccCCCCCcc--cccccccccCccCcccccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 005236 529 KISDFGLARAFGGDETEG--NTNRVVGTYGYMAPEYASD-------GQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDN 598 (706)
Q Consensus 529 kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~ 598 (706)
||+|||+++.+....... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~- 246 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR- 246 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-
Confidence 999999999875433221 2234579999999999976 678999999999999999999 89997532211
Q ss_pred chhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 599 KLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
......... ..... ...........+.+++.+||+.||.+|||+.||++
T Consensus 247 ---~~~i~~~~~---~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 ---ESNIIRGIF---SLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HHHHHHTCC---CCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHhcCCC---Ccccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111111110 11110 11112233456778999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.36 Aligned_cols=245 Identities=24% Similarity=0.389 Sum_probs=188.8
Q ss_pred HHHhccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccch------hhHHHHHHHHHHHhhc----CCcceeeeEe
Q 005236 382 IANATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISE------QGLKELKNEIILFSKL----QHRNLVKLLG 450 (706)
Q Consensus 382 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~ 450 (706)
.....++|++.+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999987 4588999999865322 1233466799999998 8999999999
Q ss_pred EEEeCCeeEEEEec-CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc-CCCCe
Q 005236 451 CCIHGEEKLLIYEF-MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNP 528 (706)
Q Consensus 451 ~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~ 528 (706)
++...+..++|||| +.+++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++ +++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 8999999999653 34899999999999999999999998 99999999999999 88999
Q ss_pred EEeeeccccccCCCCCcccccccccccCccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 005236 529 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAW 607 (706)
Q Consensus 529 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 607 (706)
||+|||+++...... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||... ..+
T Consensus 180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~---- 245 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEI---- 245 (312)
T ss_dssp EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHH----
T ss_pred EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHH----
Confidence 999999998764322 2335689999999999877764 5899999999999999999997531 000
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 608 KLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 608 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
... .. .+ ....+ ..+.+++.+||+.+|++|||++|+++.
T Consensus 246 --~~~-~~-~~-----~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 246 --LEA-EL-HF-----PAHVS----PDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --HHT-CC-CC-----CTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --hhh-cc-CC-----cccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00 00 01111 245678999999999999999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.04 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=177.4
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 368999999999999999999985 68899999986532 222344555556788889999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
||+ ++.+..++... ...+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++..+..
T Consensus 104 e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 44555544322 24588999999999999999999985 7 99999999999999999999999999976543
Q ss_pred CCCcccccccccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (706)
.. ......||+.|+|||++. ...++.++||||||+++|||++|+.||..... ....... ...... .
T Consensus 178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~---~~~~~~-~ 248 (318)
T 2dyl_A 178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTK---VLQEEP-P 248 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHH---HHHSCC-C
T ss_pred Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHH---HhccCC-C
Confidence 22 222356899999999994 55788999999999999999999999754221 1122211 111111 1
Q ss_pred ccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 617 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.+... ...+ ..+.+++.+||+.||.+||+++|+++
T Consensus 249 ~~~~~---~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 LLPGH---MGFS----GDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCSS---SCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCcc---CCCC----HHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11000 0111 24567889999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=322.23 Aligned_cols=244 Identities=24% Similarity=0.381 Sum_probs=196.8
Q ss_pred HHhccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccch------hhHHHHHHHHHHHhhcC--CcceeeeEeEEE
Q 005236 383 ANATDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISE------QGLKELKNEIILFSKLQ--HRNLVKLLGCCI 453 (706)
Q Consensus 383 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~ 453 (706)
....++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34557899999999999999999987 4588999999865321 12245678999999996 599999999999
Q ss_pred eCCeeEEEEecCCC-CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc-CCCCeEEe
Q 005236 454 HGEEKLLIYEFMPN-KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKIS 531 (706)
Q Consensus 454 ~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~ 531 (706)
+.+..++|||++.+ ++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999986 8999999653 35889999999999999999999988 99999999999999 78999999
Q ss_pred eeccccccCCCCCcccccccccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHh
Q 005236 532 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLW 610 (706)
Q Consensus 532 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 610 (706)
|||+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... . ..
T Consensus 193 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~------~~ 256 (320)
T 3a99_A 193 DFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E------II 256 (320)
T ss_dssp CCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H------HH
T ss_pred eCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------h------hh
Confidence 99999876432 1223568999999999987776 688999999999999999999975311 0 01
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 611 NEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 611 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
..... .....+ ..+.+++.+||+.||.+|||++||++.
T Consensus 257 ~~~~~-------~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 257 RGQVF-------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HCCCC-------CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccccc-------ccccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11100 001111 245678999999999999999999873
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=326.79 Aligned_cols=249 Identities=22% Similarity=0.306 Sum_probs=184.3
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEEEecC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
.+|.+.++||+|+||+||.....+++.||||++..... ..+.+|+.+++++ +|||||++++++.+....++||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 46889999999999997665566789999999865322 2356799999999 7999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-----CCCeEEeeeccccccC
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLARAFG 540 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~-----~~~~kl~Dfgla~~~~ 540 (706)
+ |+|.+++..... ......++.++.||+.||+|||+.+ |+||||||+||||+. ...+||+|||+++.+.
T Consensus 101 ~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 101 A-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp S-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred C-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 6 599999965432 2444556789999999999999998 999999999999953 2358899999998764
Q ss_pred CCCC-cccccccccccCccCccccc---cCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 541 GDET-EGNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 541 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
.... ........||+.|+|||++. ...++.++|||||||++|||++ |..||..... .... ........
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~----~~~~---~~~~~~~~ 247 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ----RQAN---ILLGACSL 247 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT----HHHH---HHTTCCCC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH----HHHH---HHhccCCc
Confidence 3321 12233467999999999997 4577889999999999999999 8888743211 1111 11111111
Q ss_pred cccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 616 SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 616 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.... ........+.+++.+||+.||.+|||++||++
T Consensus 248 -~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 -DCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -TTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -cccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111 01122334668999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=342.78 Aligned_cols=266 Identities=23% Similarity=0.299 Sum_probs=196.4
Q ss_pred hccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEe------CC
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIH------GE 456 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 456 (706)
..++|++.++||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.. .+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 3478999999999999999999984 5889999998653 45556789999999999999999999998765 66
Q ss_pred eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCC---eEEeee
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDF 533 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---~kl~Df 533 (706)
..++||||+++|+|.+++........+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. +||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 78999999999999999977655556889999999999999999999988 999999999999997765 999999
Q ss_pred ccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCch-h-H-HHHHHHHh
Q 005236 534 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKL-N-L-IRHAWKLW 610 (706)
Q Consensus 534 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~-~-~-~~~~~~~~ 610 (706)
|+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... . . ........
T Consensus 169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245 (676)
T ss_dssp CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred cccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence 9998764332 223457899999999999999999999999999999999999998532110000 0 0 00000000
Q ss_pred hcCCCcc--cccccc--cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHH
Q 005236 611 NEGMPSQ--LIDACF--KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSV 656 (706)
Q Consensus 611 ~~~~~~~--~~d~~~--~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev 656 (706)
....... .....+ ...........+.+++..||+.||++|||++|+
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0000000 000000 011122234467789999999999999999773
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=344.28 Aligned_cols=237 Identities=19% Similarity=0.294 Sum_probs=190.1
Q ss_pred cCCCccceeccCCceeEEEEEeC--CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCe-----e
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA--DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEE-----K 458 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~ 458 (706)
++|++.++||+|+||.||+|.+. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 68999999999999999999985 5889999998643 44556788999999999999999999999987665 6
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||+++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+||||+.+ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 999999999999987743 5899999999999999999999998 9999999999999986 999999999987
Q ss_pred cCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
.... ....||+.|+|||++.+.. +.++||||||+++|||++|..|+....... ...
T Consensus 231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------~~~-- 286 (681)
T 2pzi_A 231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------LPE-- 286 (681)
T ss_dssp TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------CCT--
T ss_pred cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------------ccc--
Confidence 6432 3357999999999987654 899999999999999999988764311110 000
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCC-hhHHHHHhcC
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPC-MPSVILMLGS 662 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-~~ev~~~L~~ 662 (706)
..........+.+++.+||+.||.+||+ ++++...|..
T Consensus 287 ------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 287 ------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0000111235667999999999999995 5556555543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.37 Aligned_cols=230 Identities=11% Similarity=0.063 Sum_probs=181.2
Q ss_pred cCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.+.||+|+||.||+|+... ++.||||++... .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 679999999999999999999854 889999999753 2445678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++++|.+++... ....++.+++.||+.||+|||+++ |+||||||+||||+.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999999432 355578889999999999999998 9999999999999999999997443
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
|++| ++.++||||||+++|||++|+.||............. ..... .... ...
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~-~~~~--~~~ 227 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDTAG-QPIE--PAD 227 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCTTS-CBCC--HHH
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHhcc-CCCC--hhh
Confidence 3333 6889999999999999999999986543322110000 00000 0000 000
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
.....+ ..+.+++.+||+.||.+| |+.|+++.|+...
T Consensus 228 ~~~~~~----~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 228 IDRDIP----FQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HCTTSC----HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred cccCCC----HHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 011111 246678999999999999 9999999998763
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.60 Aligned_cols=228 Identities=20% Similarity=0.270 Sum_probs=176.2
Q ss_pred ccCCCcc-ceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHH-hhcCCcceeeeEeEEEe----CCee
Q 005236 386 TDNFSIN-KKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILF-SKLQHRNLVKLLGCCIH----GEEK 458 (706)
Q Consensus 386 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 458 (706)
.++|.+. +.||+|+||.||+++. .+++.||||++.. ...+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3577777 7899999999999998 4588999999854 24567788887 56699999999999987 6678
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---CCCeEEeeecc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGL 535 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Dfgl 535 (706)
++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999997643 245899999999999999999999998 999999999999998 78999999999
Q ss_pred ccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
+.... +..++.++||||||+++|||++|+.||......... ....
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~ 211 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMK 211 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSC
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHH
Confidence 87532 234678999999999999999999998543221100 0000
Q ss_pred cccccccccCcCCH----HHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 616 SQLIDACFKDSFNL----AEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 616 ~~~~d~~~~~~~~~----~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
..+..... .... .....+.+++..||+.||.+|||++|+++.
T Consensus 212 ~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 212 TRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000000 0000 012246678999999999999999999973
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=317.16 Aligned_cols=241 Identities=16% Similarity=0.180 Sum_probs=176.6
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCC-cce----------e----
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQH-RNL----------V---- 446 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~ni----------v---- 446 (706)
...|.+.+.||+|+||.||+|++ .+++.||||++... .....+.+++|+.+++.++| +|. +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34678889999999999999996 46889999998742 22336789999999999987 221 1
Q ss_pred -e------eEeEEEe-----CCeeEEEEecCCCCChhhhhhcc----cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 005236 447 -K------LLGCCIH-----GEEKLLIYEFMPNKSLDSFIFDQ----ERCKLLDWSKRFHIICGTARGLLYLHQDSRLRI 510 (706)
Q Consensus 447 -~------l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 510 (706)
. +..++.. ....+++|+++ +++|.+++... .....+++..++.++.||++||+|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 1 1111111 12346667655 68999888421 22345778899999999999999999998 9
Q ss_pred EecccCCCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCcccc----------ccCCCCcchhhHHHHHH
Q 005236 511 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA----------SDGQFSVKSDVFSFGIL 580 (706)
Q Consensus 511 vH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~sDv~SlGvi 580 (706)
+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999875322 233567 999999999 55568899999999999
Q ss_pred HHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHH
Q 005236 581 LLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI 657 (706)
Q Consensus 581 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~ 657 (706)
+|||++|+.||.......... .++.... ..+ ..+.+++..||+.||.+||++.+++
T Consensus 307 l~elltg~~Pf~~~~~~~~~~---------------~~~~~~~--~~~----~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSE---------------WIFRSCK--NIP----QPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSG---------------GGGSSCC--CCC----HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhhhHH---------------HHHhhcc--cCC----HHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999986433221111 1111000 111 3466789999999999999976664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=307.27 Aligned_cols=242 Identities=17% Similarity=0.134 Sum_probs=181.5
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccc--------hhhHHHHHHHHHHHhhcC---------Ccceeee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKIS--------EQGLKELKNEIILFSKLQ---------HRNLVKL 448 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l 448 (706)
.++|++.++||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999998 67999999986532 233578899999998886 7777777
Q ss_pred EeEEE-----------------e-------------CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHH
Q 005236 449 LGCCI-----------------H-------------GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARG 498 (706)
Q Consensus 449 ~~~~~-----------------~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 498 (706)
.+++. + ....++||||+++|++.+.+.+ ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 76643 2 6789999999999977666633 457899999999999999
Q ss_pred HHHHH-hCCCCceEecccCCCcEEEcCCC--------------------CeEEeeeccccccCCCCCcccccccccccCc
Q 005236 499 LLYLH-QDSRLRIIHRDLKASNVLLDQDM--------------------NPKISDFGLARAFGGDETEGNTNRVVGTYGY 557 (706)
Q Consensus 499 l~~LH-~~~~~~ivH~Dikp~Nill~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y 557 (706)
|+||| +.+ |+||||||+||||+.++ .+||+|||+|+.... ....||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecc
Confidence 99999 888 99999999999999887 899999999987642 135799999
Q ss_pred cCccccccCCCCcchhhHHHHHH-HHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHH
Q 005236 558 MAPEYASDGQFSVKSDVFSFGIL-LLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCI 636 (706)
Q Consensus 558 ~aPE~~~~~~~s~~sDv~SlGvi-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 636 (706)
+|||++.+.. +.++||||++++ .+++++|..||... ..................... ..........+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~----~~~~~~~s~~~~ 313 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLKQMTFKTKCN----TPAMKQIKRKIQ 313 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHHTCCCSSCCC----SHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhhhhccCcccc----hhhhhhcCHHHH
Confidence 9999998766 899999998777 78888898885210 000001111111111110000 000112334678
Q ss_pred HHHHHhcCCCCCCCCChhHHH
Q 005236 637 HIGLLCVQQYPEDRPCMPSVI 657 (706)
Q Consensus 637 ~l~~~cl~~~p~~RPt~~ev~ 657 (706)
+|+.+||+.| |++|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 8999999976 889888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-29 Score=283.07 Aligned_cols=186 Identities=18% Similarity=0.159 Sum_probs=131.0
Q ss_pred ceeccCCceeEEEEEe-CCCcEEEEEEcCcc----------chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEE
Q 005236 393 KKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI----------SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 460 (706)
..++.|+.|.+..++. --|+.+++|.+.+. .+...++|.+|+++|+++ .|+||++++++++++...||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3456677776666543 23778999998542 234457899999999999 79999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||++|++|.++|.+.. .++.. +|+.||+.||+|||+++ ||||||||+||||+++|++||+|||+|+...
T Consensus 320 VMEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999996543 35543 58899999999999998 9999999999999999999999999998764
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN 590 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p 590 (706)
.+.. .....+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 391 ~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 3322 2334689999999999875 467789999999999988776543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.2e-26 Score=253.23 Aligned_cols=185 Identities=17% Similarity=0.199 Sum_probs=146.0
Q ss_pred CccceeccCCceeEEEEEeCCCcEEEEEEcCccc--------hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 390 SINKKLGEGGFGPVYKGTLADEQEIAVKRLSKIS--------EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 390 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
...++||+|+||.||+|+. .++.+++|+..... ....+.+.+|+.++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457999999999999954 56788888754311 11245689999999999999999777777788888999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++++|.+++.. +..++.||++||+|||+++ |+||||||+|||+++ .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999854 4579999999999999988 999999999999999 999999999998643
Q ss_pred CCCcc-----cccccccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCC
Q 005236 542 DETEG-----NTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNR 591 (706)
Q Consensus 542 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvil~elltG~~p~ 591 (706)
..... ......||+.|||||++.. ..|+..+|+|+..+-..+.+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 22111 1234679999999999987 67888899999999999988887764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.4e-23 Score=210.82 Aligned_cols=152 Identities=19% Similarity=0.142 Sum_probs=122.9
Q ss_pred HHHHHhccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccch------------------hhHHHHHHHHHHHhhcC
Q 005236 380 ATIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISE------------------QGLKELKNEIILFSKLQ 441 (706)
Q Consensus 380 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~ 441 (706)
..+......|.+.+.||+|+||.||+|+..+++.||||.++.... .....+.+|+.++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344455567778899999999999999997799999999864221 23567899999999999
Q ss_pred CcceeeeEeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEE
Q 005236 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 521 (706)
Q Consensus 442 h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nil 521 (706)
| +++.+++. .+..++||||+++++|.+ +.. .....++.||+.||.|||+.+ |+||||||+|||
T Consensus 163 --~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 163 --G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp --T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred --C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 4 66666543 356799999999999988 411 234569999999999999988 999999999999
Q ss_pred EcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccc
Q 005236 522 LDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS 564 (706)
Q Consensus 522 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 564 (706)
|+ ++.+||+|||+++. +..++|||++.
T Consensus 226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 99 99999999999864 34578999874
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2e-21 Score=196.20 Aligned_cols=143 Identities=16% Similarity=0.181 Sum_probs=104.4
Q ss_pred ceEEEEecCCcEEEEecCCCCCceEEEeecCCCcccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcc
Q 005236 4 LSFLFVCYSGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPE 83 (706)
Q Consensus 4 ~~~~~l~~sGNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~ 83 (706)
+++|+|+|+|||||++ + .+|||| |||||||||||||.+.++|.. | ++.+||++|.|++.|+++|.
T Consensus 111 ~~~a~L~d~GNlVl~~--~----~~lWqS--~ptdtlLpg~~~~~~l~~g~~--L---~S~~dps~G~fsl~l~~dGn-- 175 (276)
T 3m7h_A 111 RTHLVLQDDGNIVLVD--S----LALWNG--TPAIPLVPGAIDSLLLAPGSE--L---VQGVVYGAGASKLVFQGDGN-- 175 (276)
T ss_dssp HEEEEECTTSCEEEEE--E----EEEEES--CTTSCCCCSCTTCEEECSSEE--E---CTTCEEEETTEEEEECTTSC--
T ss_pred ceEEEEeCCCCEEecC--C----ceeeCc--ccccccccccccccccccCcc--c---ccCCCCCCceEEEeecCCce--
Confidence 5689999999999997 2 799999 999999999999999998865 6 67899999999999999995
Q ss_pred eEEee-CCceeeeeCCCCCCccccccccccCcceeEEeecCC-eeEEEEEccCCceEEEEEEecccceEEEEEEeccCcc
Q 005236 84 LIMWK-GSRKFYRSGPWNGLRFSAATLRQNPVFNFSFVSSED-ELYYTFDLIDKAVFSRIVMNQTLYLRQRFTWKKATQN 161 (706)
Q Consensus 84 ~~~~~-~~~~yw~sg~w~g~~~s~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~G~~~~~~~w~~~~~~ 161 (706)
+++++ ++.+||++|+|++.. ....+.... .+.+.++.. ....++. ......|++|+.|| +++.|.| ...
T Consensus 176 lvLy~~~~~~yW~Sgt~~~~~-~~l~l~~dG--nLvl~d~~~~~vWsS~t--~~~~~~rl~Ld~dG-nLvly~~---~~~ 246 (276)
T 3m7h_A 176 LVAYGPNGAATWNAGTQGKGA-VRAVFQGDG--NLVVYGAGNAVLWHSHT--GGHASAVLRLQANG-SIAILDE---KPV 246 (276)
T ss_dssp EEEECTTSSEEEECCCTTTTC-CEEEECTTS--CEEEECTTSCEEEECSC--TTCTTCEEEECTTS-CEEEEEE---EEE
T ss_pred EEEEeCCCeEEEECCCCCCcc-EEEEEcCCC--eEEEEeCCCcEEEEecC--CCCCCEEEEEcCCc-cEEEEcC---CCe
Confidence 45555 468999999997643 111122111 222333332 2222222 22334799999999 8899998 346
Q ss_pred eEEEEeccC
Q 005236 162 WELQLNVPR 170 (706)
Q Consensus 162 W~~~~~~p~ 170 (706)
|..++..|.
T Consensus 247 Wqsf~~~P~ 255 (276)
T 3m7h_A 247 WARFGFQPT 255 (276)
T ss_dssp EESSSCCTT
T ss_pred EEccCccCC
Confidence 777766665
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.79 E-value=4.1e-19 Score=176.42 Aligned_cols=131 Identities=8% Similarity=0.090 Sum_probs=96.2
Q ss_pred eEEEEecCCcEEEEecCCCCCceEEEeecCCCcccc-cCCCccccee-ecCC-----ceEEEecCCCCCCCCCceEEEEe
Q 005236 5 SFLFVCYSGNLVLRGERDGGSETYLWQSFDYPSDTL-LPGMKLGWDL-KTGL-----ERRITSWKSPDDPSPGNFTWAVE 77 (706)
Q Consensus 5 ~~~~l~~sGNlVl~~~~~~~~~~~~WqSFd~PtDtl-Lpgqklg~~~-~tg~-----~~~L~Sw~s~~dps~G~fsl~~~ 77 (706)
..|+|+|+|||||++ .++||||||||||+ ||+| |.|. .+|+ ++.|+| .+||++|.|++.++
T Consensus 90 ~~~~l~d~Gnlvl~~-------~~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~s---~~d~s~G~~~l~l~ 157 (236)
T 1dlp_A 90 YVLVLQPDRTVTIYG-------PGLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLHA---TQSLQLSPYRLSME 157 (236)
T ss_dssp CEEEECSSSCEEEEC-------SEEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEECS---SCCCBCSSCEEEEE
T ss_pred EEEEEeCCCCEEEec-------CCEEECCCCCCcccccCCc--cceEEecCCcCCCccceEEc---CcEeecCcEEEEEC
Confidence 479999999999994 28999999999888 6776 6665 6665 667875 78999999999999
Q ss_pred eCCCcceEEeeCCceeeeeCCCCCCcccccc-ccccCcceeEEeecCCeeEEEEEccCCceEEEEEEecccceEEEE
Q 005236 78 RQDNPELIMWKGSRKFYRSGPWNGLRFSAAT-LRQNPVFNFSFVSSEDELYYTFDLIDKAVFSRIVMNQTLYLRQRF 153 (706)
Q Consensus 78 ~~g~~~~~~~~~~~~yw~sg~w~g~~~s~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G~~~~~~ 153 (706)
++| +++++++..+||++++|++. +...+ +..... .+.+..+..+.+.+|..... ...|++|+.+| ++++|
T Consensus 158 ~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gn-l~ly~~~~~~vw~s~~~~~~-~~~rl~Ld~dG-~l~ly 228 (236)
T 1dlp_A 158 TDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGR-MDVLTNQNIAVWTSGNSRSA-GRYVFVLQPDR-NLAIY 228 (236)
T ss_dssp TTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTE-EEEEETTTEEEEECCCCCSS-SCCEEEECSSS-CEEEE
T ss_pred CCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCc-EEEEeCCCcEEEEeCCCCCC-CCEEEEEcCCC-cEEEe
Confidence 998 58888888999999999764 44444 332221 12223344445555554333 46899999999 88877
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1e-18 Score=176.70 Aligned_cols=137 Identities=15% Similarity=0.153 Sum_probs=106.9
Q ss_pred CCCccceeccCCceeEEEEEe-CCCcE--EEEEEcCccch------------------------hhHHHHHHHHHHHhhc
Q 005236 388 NFSINKKLGEGGFGPVYKGTL-ADEQE--IAVKRLSKISE------------------------QGLKELKNEIILFSKL 440 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l 440 (706)
-|.+.+.||+|+||.||+|.. .+|+. ||||+++.... .....+.+|+..+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999998 67888 99998643211 1123678999999999
Q ss_pred CCcce--eeeEeEEEeCCeeEEEEecCCC-C----ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEe
Q 005236 441 QHRNL--VKLLGCCIHGEEKLLIYEFMPN-K----SLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH-QDSRLRIIH 512 (706)
Q Consensus 441 ~h~ni--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH 512 (706)
+|+++ +.++.. ...++||||+.+ | +|.+++.. .++..+..++.||+.+|.||| +.+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 88864 334432 367899999942 4 56555422 224466789999999999999 887 999
Q ss_pred cccCCCcEEEcCCCCeEEeeecccccc
Q 005236 513 RDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 513 ~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
|||||.|||+++ .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=4.8e-17 Score=170.86 Aligned_cols=142 Identities=13% Similarity=0.154 Sum_probs=101.4
Q ss_pred HHhccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccc--------------hhhHHH--------HHHHHHHHhhc
Q 005236 383 ANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKIS--------------EQGLKE--------LKNEIILFSKL 440 (706)
Q Consensus 383 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~--------~~~E~~~l~~l 440 (706)
....--|++..+||+|+||.||+|...+|+.||||+++... ...... ...|...|.++
T Consensus 91 ~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL 170 (397)
T 4gyi_A 91 AARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL 170 (397)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 33334489999999999999999999999999999864310 000111 23455666666
Q ss_pred CCcceeeeEeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcE
Q 005236 441 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 520 (706)
Q Consensus 441 ~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Ni 520 (706)
.+.++.-...+.. ...+|||||+++++|..+.. ......++.||+.+|.+||..+ ||||||||.||
T Consensus 171 ~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NI 236 (397)
T 4gyi_A 171 YEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNI 236 (397)
T ss_dssp HHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred HhcCCCCCeeeec--cCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHE
Confidence 5444321111111 23379999999998876541 1233567899999999999988 99999999999
Q ss_pred EEcCCCC----------eEEeeeccccc
Q 005236 521 LLDQDMN----------PKISDFGLARA 538 (706)
Q Consensus 521 ll~~~~~----------~kl~Dfgla~~ 538 (706)
||++++. +.|+||+.+..
T Consensus 237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 237 LIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EEeCCCCcccccccccceEEEEeCCccc
Confidence 9998873 89999998765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=2.7e-12 Score=129.89 Aligned_cols=147 Identities=16% Similarity=0.071 Sum_probs=116.3
Q ss_pred HHhccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCeeEEE
Q 005236 383 ANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 383 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 461 (706)
....++|++...++.|+.+.||++... ++.+++|+...........+.+|+.+++.+. |..+.++++++...+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 445578988899999999999999864 6789999986532223346889999999885 67788999999988899999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD------------------------------------ 505 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------------------------------------ 505 (706)
|||++|.+|.+.+. +......++.+++++|..||+.
T Consensus 89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999987631 1122346888999999999981
Q ss_pred --------------------CCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 506 --------------------SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 506 --------------------~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
.+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 114599999999999998766677999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.17 E-value=3e-11 Score=121.71 Aligned_cols=139 Identities=17% Similarity=0.131 Sum_probs=103.3
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcc--eeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRN--LVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e 463 (706)
..++.+....+.|..+.||++...+|..+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3455554444466679999998877888999987543 2246788999999886544 5568888887778899999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS------------------------------------- 506 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------- 506 (706)
|++|.+|. ... .+ ...++.++++.|..||+..
T Consensus 96 ~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 96 EVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred ecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99999884 211 11 2256777888888888643
Q ss_pred ------------------CCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 507 ------------------RLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 507 ------------------~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
+..++|+|++|.|||+++++.+.|+||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876678999998754
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.10 E-value=2.4e-10 Score=98.78 Aligned_cols=60 Identities=20% Similarity=0.396 Sum_probs=47.8
Q ss_pred ceEEEEecCCcEEEEecCCCCCceEEEeecCCCcccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcc
Q 005236 4 LSFLFVCYSGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPE 83 (706)
Q Consensus 4 ~~~~~l~~sGNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~ 83 (706)
.+.|+|+++|||||++ ++ .++|||| ++|++|.|++.++++|+
T Consensus 51 ~~~l~l~~~GNLvl~d-~~----~~~W~S~-------------------------------~~~~~g~~~l~l~~dGn-- 92 (112)
T 1xd5_A 51 GCVLKMQNDGNLVIYS-GS----RAIWASN-------------------------------TNRQNGNYYLILQRDRN-- 92 (112)
T ss_dssp SEEEEECTTSCEEEEE-TT----EEEEECC-------------------------------CCCSCCCCEEEECTTSC--
T ss_pred CEEEEEeCCCCEEEEc-CC----EEEEECC-------------------------------ccCCCCCEEEEEeCCCc--
Confidence 3568888888888887 33 6888888 35578899999999998
Q ss_pred eEEee-CCceeeeeCCCCC
Q 005236 84 LIMWK-GSRKFYRSGPWNG 101 (706)
Q Consensus 84 ~~~~~-~~~~yw~sg~w~g 101 (706)
++++. ...+||+|++|+|
T Consensus 93 lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 93 VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp EEEECTTSCEEEECCCCCC
T ss_pred EEEECCCCceEEECCCccC
Confidence 56665 5689999999987
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.6e-09 Score=114.79 Aligned_cols=142 Identities=16% Similarity=0.209 Sum_probs=107.3
Q ss_pred ccceeccCCceeEEEEEeCCCcEEEEEEcC--ccc-hhhHHHHHHHHHHHhhcC--CcceeeeEeEEEeC---CeeEEEE
Q 005236 391 INKKLGEGGFGPVYKGTLADEQEIAVKRLS--KIS-EQGLKELKNEIILFSKLQ--HRNLVKLLGCCIHG---EEKLLIY 462 (706)
Q Consensus 391 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lV~ 462 (706)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35789999999999998754 678888775 321 123457788999999997 45578888888766 3479999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS------------------------------------ 506 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------ 506 (706)
||++|..+.+.. ...++...+..++.++++.|..||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998885422 123677788889999999999999731
Q ss_pred -------------------CCceEecccCCCcEEEcCCCC--eEEeeeccccc
Q 005236 507 -------------------RLRIIHRDLKASNVLLDQDMN--PKISDFGLARA 538 (706)
Q Consensus 507 -------------------~~~ivH~Dikp~Nill~~~~~--~kl~Dfgla~~ 538 (706)
+..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997753 68999999865
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=98.94 E-value=1.7e-09 Score=94.14 Aligned_cols=55 Identities=15% Similarity=0.317 Sum_probs=43.8
Q ss_pred eEEEEecCCcEEEEecCCCCCceEEEeecCCCcccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcce
Q 005236 5 SFLFVCYSGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPEL 84 (706)
Q Consensus 5 ~~~~l~~sGNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~~ 84 (706)
+.++|+++|||||++.++ .++|||| ++|++|.|++.++++|+ +
T Consensus 63 ~~l~l~~dGNLVl~d~~~----~~lW~S~-------------------------------~~~~~g~~~l~l~~~Gn--l 105 (119)
T 1b2p_A 63 CRAVLQPDGVLVVITNEN----VTVWQSP-------------------------------VAGKAGHYVLVLQPDRN--V 105 (119)
T ss_dssp CEEEECTTSCEEEECTTC----CEEEECS-------------------------------CCCCSSCEEEEECTTSC--E
T ss_pred eEEEEccCCEEEEEeCCC----cEEEcCC-------------------------------CCCCCCCEEEEEECCCc--E
Confidence 468888888888886533 6888888 46678999999999998 5
Q ss_pred EEeeCCceeeeeCC
Q 005236 85 IMWKGSRKFYRSGP 98 (706)
Q Consensus 85 ~~~~~~~~yw~sg~ 98 (706)
++++ .+||+||+
T Consensus 106 vl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 106 VIYG--DALWATQT 117 (119)
T ss_dssp EEEE--SEEEECCC
T ss_pred EEEC--ccEeCCCC
Confidence 6666 49999986
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=1.8e-09 Score=93.58 Aligned_cols=59 Identities=17% Similarity=0.390 Sum_probs=46.8
Q ss_pred eEEEEecCCcEEEEecCCCCCceEEEeecCCCcccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcce
Q 005236 5 SFLFVCYSGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPEL 84 (706)
Q Consensus 5 ~~~~l~~sGNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~~ 84 (706)
+.++|+++|||||++.++ .++||||++ |++|.|++.++++|+ +
T Consensus 53 ~~l~l~~~GnLvl~d~~~----~~vW~S~~~-------------------------------~~~g~~~l~l~~dGn--l 95 (115)
T 2dpf_A 53 CRLTLLSDGNLVIYDHNN----NDVWGSACW-------------------------------GDNGKYALVLQKDGR--F 95 (115)
T ss_dssp CEEEECTTSCEEEECTTC----CEEEECCCC-------------------------------CSSSCCEEEECTTSC--E
T ss_pred eEEEECCCCcEEEECCCc----eEEEEcCCC-------------------------------CCCCCEEEEEeCCCe--E
Confidence 468888888888887533 688888887 457889999999998 6
Q ss_pred EEeeCCceeeeeCCCCCC
Q 005236 85 IMWKGSRKFYRSGPWNGL 102 (706)
Q Consensus 85 ~~~~~~~~yw~sg~w~g~ 102 (706)
++++. +||+|++|...
T Consensus 96 vl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 96 VIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp EEECS--EEECSSTTCBC
T ss_pred EEECC--CEEECCCCCCc
Confidence 66654 89999999654
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=2.2e-09 Score=92.24 Aligned_cols=31 Identities=6% Similarity=0.330 Sum_probs=25.7
Q ss_pred CCCCCCceEEEEeeCCCcceEEeeCCceeeeeCCC
Q 005236 65 DDPSPGNFTWAVERQDNPELIMWKGSRKFYRSGPW 99 (706)
Q Consensus 65 ~dps~G~fsl~~~~~g~~~~~~~~~~~~yw~sg~w 99 (706)
+++++|.|++.++++|+ +++++. +||+|+++
T Consensus 78 t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 56788999999999998 566665 89999975
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.90 E-value=1.2e-09 Score=112.80 Aligned_cols=185 Identities=18% Similarity=0.213 Sum_probs=121.1
Q ss_pred ceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-Ccc--eeeeEeEEEeCC---eeEEEEecCC
Q 005236 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-HRN--LVKLLGCCIHGE---EKLLIYEFMP 466 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~e~~~ 466 (706)
+.++.|....||+.. ..+++|+.... .....+.+|..+++.+. +.. +.+.+......+ ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 569999999999864 56889986432 34567899999998884 333 344444433333 3488999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD----------------------------------------- 505 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~----------------------------------------- 505 (706)
|.+|..... ..++..++..++.++++.|..||..
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 999875432 2356677778888888888888861
Q ss_pred --------------CCCceEecccCCCcEEEcC--CCCeEEeeeccccccCCCCCccccc------------ccccccCc
Q 005236 506 --------------SRLRIIHRDLKASNVLLDQ--DMNPKISDFGLARAFGGDETEGNTN------------RVVGTYGY 557 (706)
Q Consensus 506 --------------~~~~ivH~Dikp~Nill~~--~~~~kl~Dfgla~~~~~~~~~~~~~------------~~~gt~~y 557 (706)
....++|+|++|.||++++ ...+.|+||+.+..-.......... ......+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1245899999999999998 5568899999987531110000000 00000011
Q ss_pred cC-ccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 005236 558 MA-PEYASDGQFSVKSDVFSFGILLLEIVSGKKN 590 (706)
Q Consensus 558 ~a-PE~~~~~~~s~~sDv~SlGvil~elltG~~p 590 (706)
.. |+.... .....+.|+++.++|.+.+|..+
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~ 286 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMD 286 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHH
Confidence 12 222211 12236899999999999999876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.8e-06 Score=88.97 Aligned_cols=136 Identities=22% Similarity=0.162 Sum_probs=93.9
Q ss_pred cceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCc---ceeeeEeEEE-eCCeeEEEEecCCC
Q 005236 392 NKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHR---NLVKLLGCCI-HGEEKLLIYEFMPN 467 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~e~~~~ 467 (706)
.+.++.|....||+. +..++||+.. .......+..|..+++.+.+. .+.+.+.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 367888999999987 5678888853 233456789999999999753 3566666664 34457899999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD------------------------------------------ 505 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------------------------------------------ 505 (706)
.+|..... ..++......++.++++.|..||..
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 98876321 1123334444444444444444432
Q ss_pred ---------------CCCceEecccCCCcEEEcC---CCC-eEEeeeccccc
Q 005236 506 ---------------SRLRIIHRDLKASNVLLDQ---DMN-PKISDFGLARA 538 (706)
Q Consensus 506 ---------------~~~~ivH~Dikp~Nill~~---~~~-~kl~Dfgla~~ 538 (706)
.+..++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335799999999999998 455 48999998865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=2.6e-06 Score=85.96 Aligned_cols=136 Identities=16% Similarity=0.138 Sum_probs=98.4
Q ss_pred ceeccCCce-eEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCeeEEEEecCCCCC
Q 005236 393 KKLGEGGFG-PVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKLLIYEFMPNKS 469 (706)
Q Consensus 393 ~~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gs 469 (706)
+.+..|..+ .||+.... ++..++||+-... ....+..|...++.+. +--+.++++++.+.+..++|||+++|.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 455556655 68988764 4567899976432 3456788999988884 3346788899999999999999999998
Q ss_pred hhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 005236 470 LDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD-------------------------------------------- 505 (706)
Q Consensus 470 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-------------------------------------------- 505 (706)
+.+..... ......+..++++.|..||..
T Consensus 107 ~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 87755321 122334566667777777642
Q ss_pred -----------CCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 506 -----------SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 506 -----------~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
....++|+|+++.|||+++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112489999999999999887778999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=1.3e-06 Score=92.18 Aligned_cols=81 Identities=6% Similarity=0.019 Sum_probs=56.5
Q ss_pred ccee-ccCCceeEEEEEeC-------CCcEEEEEEcCccc---hhhHHHHHHHHHHHhhcCC---cceeeeEeEEEeC--
Q 005236 392 NKKL-GEGGFGPVYKGTLA-------DEQEIAVKRLSKIS---EQGLKELKNEIILFSKLQH---RNLVKLLGCCIHG-- 455 (706)
Q Consensus 392 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~-- 455 (706)
.+.| +.|....+|+.... +++.+++|+..... ......+..|+.+++.+.. ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3677 88999999998764 26678898765422 1012456788888887742 3467788777654
Q ss_pred -CeeEEEEecCCCCChhh
Q 005236 456 -EEKLLIYEFMPNKSLDS 472 (706)
Q Consensus 456 -~~~~lV~e~~~~gsL~~ 472 (706)
...++||||++|.++.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 34689999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=2.2e-05 Score=83.91 Aligned_cols=75 Identities=9% Similarity=0.173 Sum_probs=50.3
Q ss_pred cceeccCCceeEEEEEeC-CCcEEEEEEcCccch-------hhHHHHHHHHHHHhhcCC--cc-eeeeEeEEEeCCeeEE
Q 005236 392 NKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISE-------QGLKELKNEIILFSKLQH--RN-LVKLLGCCIHGEEKLL 460 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 460 (706)
.+.||.|..+.||+++.. +++.++||....... ...+.+..|..+++.+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999764 467899997643211 123456778888887742 44 4455543 4556789
Q ss_pred EEecCCCC
Q 005236 461 IYEFMPNK 468 (706)
Q Consensus 461 V~e~~~~g 468 (706)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=3.5e-05 Score=80.36 Aligned_cols=141 Identities=18% Similarity=0.243 Sum_probs=80.8
Q ss_pred ceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-----CcceeeeE-e--EEEeCCeeEEEEec
Q 005236 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-----HRNLVKLL-G--CCIHGEEKLLIYEF 464 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lV~e~ 464 (706)
+.|+.|..+.||+....++ .+++|+.... . ..+..|+.++..|. .|.++... + +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987655 5899988652 2 33344555555443 24443310 1 22346678999999
Q ss_pred CCCCChh-----------h---hhhcccc-c----------CCCCHHHHH------------------------------
Q 005236 465 MPNKSLD-----------S---FIFDQER-C----------KLLDWSKRF------------------------------ 489 (706)
Q Consensus 465 ~~~gsL~-----------~---~l~~~~~-~----------~~l~~~~~~------------------------------ 489 (706)
++|..+. . .++.... . ....|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9987653 0 1111110 0 011232110
Q ss_pred -HHHHHHHHHHHHHHh----------CCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 490 -HIICGTARGLLYLHQ----------DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 490 -~i~~~ia~~l~~LH~----------~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
.+...+.+++.+|+. ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223445666663 1245699999999999998888999999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.77 E-value=9.6e-05 Score=75.07 Aligned_cols=79 Identities=16% Similarity=0.188 Sum_probs=58.2
Q ss_pred CCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCc---ceeeeEeEEEeCCeeEEEEec
Q 005236 388 NFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHR---NLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lV~e~ 464 (706)
...-.+.+|.|..+.||+.+..+|+.++||+...........+..|+..|+.|.-. -+++.++. +..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 34456889999999999999999999999987654444445678899998888422 24445543 234789999
Q ss_pred CCCCCh
Q 005236 465 MPNKSL 470 (706)
Q Consensus 465 ~~~gsL 470 (706)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00016 Score=77.73 Aligned_cols=79 Identities=13% Similarity=0.042 Sum_probs=49.8
Q ss_pred CCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccccccc-ccccCccCccccccC---CCCcchhhHHHHHHHH
Q 005236 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV-VGTYGYMAPEYASDG---QFSVKSDVFSFGILLL 582 (706)
Q Consensus 507 ~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~s~~sDv~SlGvil~ 582 (706)
...++|+|++|.|||++.++ ++|+||+.+..-.. ........ .-...|++|+..... .-....++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p--~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM--GFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECH--HHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCch--HHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 45699999999999999877 99999998875210 00000000 012356677655321 1123456678888888
Q ss_pred HHHhCC
Q 005236 583 EIVSGK 588 (706)
Q Consensus 583 elltG~ 588 (706)
+.++++
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00041 Score=71.05 Aligned_cols=138 Identities=16% Similarity=0.128 Sum_probs=92.8
Q ss_pred cceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcC---CcceeeeEeEEEeCCeeEEEEecCCCC
Q 005236 392 NKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ---HRNLVKLLGCCIHGEEKLLIYEFMPNK 468 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~~g 468 (706)
.+.|+.|....+|+... +++.++||+.... ....+..|...++.|. ...+++.+.++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 47899999999999886 4678889986532 3567888999888874 356888888888888899999999998
Q ss_pred Chhh-----------hhhcccc---cC----------------CCCHHHHH---HHHH----------------HHHHH-
Q 005236 469 SLDS-----------FIFDQER---CK----------------LLDWSKRF---HIIC----------------GTARG- 498 (706)
Q Consensus 469 sL~~-----------~l~~~~~---~~----------------~l~~~~~~---~i~~----------------~ia~~- 498 (706)
.+.. .|+.... .. .-+|.... ++.. .++..
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 7531 1222111 00 12454322 1111 11111
Q ss_pred HHHHHh-CCCCceEecccCCCcEEEcCCCCeEEeeec
Q 005236 499 LLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFG 534 (706)
Q Consensus 499 l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 534 (706)
...|.. ..++.++|+|+.+.|++++.++ +.|+||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223421 2356799999999999999888 8899974
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=97.60 E-value=7.9e-05 Score=63.60 Aligned_cols=27 Identities=7% Similarity=0.214 Sum_probs=21.0
Q ss_pred CCCceEEEEeeCCCcceEEeeCCceeeeeCC
Q 005236 68 SPGNFTWAVERQDNPELIMWKGSRKFYRSGP 98 (706)
Q Consensus 68 s~G~fsl~~~~~g~~~~~~~~~~~~yw~sg~ 98 (706)
..|.|.+.++.+|+..++ . .++|.+++
T Consensus 83 ~~~~~~l~Lq~dGNlvly--~--~~~W~s~t 109 (111)
T 3mez_A 83 VRGNYAATLGPDQHVTIY--G--PAIWSTPA 109 (111)
T ss_dssp CSSCCEEEECTTSCEEEE--C--SEEEECCC
T ss_pred CCcCEEEEECCCCeEEEe--c--cCEEccCC
Confidence 457899999999986554 3 78998875
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.0002 Score=61.35 Aligned_cols=83 Identities=12% Similarity=0.108 Sum_probs=51.0
Q ss_pred ceEEEEecCCcEEEEecCCCCCceEEEeecCCCcccccCCCcccce------eecCCceEEEecCCCCCCCCCceEEEEe
Q 005236 4 LSFLFVCYSGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWD------LKTGLERRITSWKSPDDPSPGNFTWAVE 77 (706)
Q Consensus 4 ~~~~~l~~sGNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgqklg~~------~~tg~~~~L~Sw~s~~dps~G~fsl~~~ 77 (706)
...+.|.++|||||++.. .+.++|.|=-+-.. ++.++... ...+.+. +-|.|.+.-..|.|.+.++
T Consensus 25 ~~~L~~q~dGNLvL~~~~---~~~~vWssnt~~~~---~~~~l~l~~dGNLVl~d~~~~--~iW~S~t~~~~~~~~~~L~ 96 (113)
T 3mez_B 25 DYSLVMRDDCNLVLTKGS---KTNIVWESGTSGRG---QHCFMRLGHSGELDITDDRLN--TVFVSNTVGQEGDYVLILQ 96 (113)
T ss_dssp TEEEEECTTSCEEEEETT---TTEEEEECCCTTSC---SSCEEEECTTSCEEEECTTSC--EEEECSCCCSSSCCEEEEC
T ss_pred CEEEEEcCCCEEEEEECC---CCEEEEECCcccCC---cCEEEEEeCCCcEEEECCCCC--EEEECCCcCCCCCEEEEEc
Confidence 346788999999999752 23799997432111 22222111 0011111 2477776555678999999
Q ss_pred eCCCcceEEeeCCceeeeeCC
Q 005236 78 RQDNPELIMWKGSRKFYRSGP 98 (706)
Q Consensus 78 ~~g~~~~~~~~~~~~yw~sg~ 98 (706)
.+|+..++ . .+.|.||+
T Consensus 97 ~dGnlvly--~--~~~W~s~~ 113 (113)
T 3mez_B 97 INGQAVVY--G--PAVWSTAA 113 (113)
T ss_dssp TTSCEEEE--C--SEEEESCC
T ss_pred CCceEEEe--c--CCEecCCC
Confidence 99986544 3 68898875
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00027 Score=60.08 Aligned_cols=82 Identities=17% Similarity=0.212 Sum_probs=46.8
Q ss_pred ceEEEEecCCcEEEEecCCCCCceEEEeecCCCcc-----cccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEee
Q 005236 4 LSFLFVCYSGNLVLRGERDGGSETYLWQSFDYPSD-----TLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVER 78 (706)
Q Consensus 4 ~~~~~l~~sGNlVl~~~~~~~~~~~~WqSFd~PtD-----tlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~ 78 (706)
-..+.|.++|||||++. + +++|.|=-...+ +|...-.|-.- .+.+ -+-|.|.+....+.|.+.+++
T Consensus 20 ~~~L~~q~dGnLvly~~-~----~~vW~snt~~~~~~~~l~l~~dGNLvl~--~~~~--~~~W~S~t~~~~~~~~~~L~d 90 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-D----KPIWATNTGGLDRRCHLSMQSDGNLVVY--SPRN--NPIWASNTGGENGNYVCVLQK 90 (109)
T ss_dssp TEEEEECTTSCEEEEET-T----EEEEECCCTTSSSSCEEEECTTSCEEEE--CTTS--CEEEECCCCCSSSCEEEEECT
T ss_pred CEEEEEcCCCcEEEEeC-C----EEEEECCcccCCCCEEEEEeCCCCEEEE--CCCC--CEEEECCCCCCCCCEEEEEeC
Confidence 34577888888888865 2 688887432111 11111112110 1111 135666665555778999999
Q ss_pred CCCcceEEeeCCceeeeeCC
Q 005236 79 QDNPELIMWKGSRKFYRSGP 98 (706)
Q Consensus 79 ~g~~~~~~~~~~~~yw~sg~ 98 (706)
+|+..++ +. +.|.||.
T Consensus 91 dGNlvly--~~--~~W~s~t 106 (109)
T 3dzw_A 91 DRNVVIY--GT--ARWATGT 106 (109)
T ss_dssp TSCEEEE--ES--CCCCCCC
T ss_pred CCEEEEE--CC--CEEeCCC
Confidence 9985444 43 7787774
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00023 Score=60.55 Aligned_cols=34 Identities=9% Similarity=0.336 Sum_probs=22.3
Q ss_pred cCCCCCCCCCceEEEEeeCCCcceEEeeCCceeeeeCC
Q 005236 61 WKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFYRSGP 98 (706)
Q Consensus 61 w~s~~dps~G~fsl~~~~~g~~~~~~~~~~~~yw~sg~ 98 (706)
|.|.+....|.|.+.++.+|+..++ + .+.|.+|+
T Consensus 77 W~S~t~~~~~~~~~~L~~dGNlvly--~--~~~W~t~~ 110 (110)
T 3r0e_B 77 WSSRSSSKQGEYVLILQDDGFGVIY--G--PAIFETSS 110 (110)
T ss_dssp EECCCCCSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred EEcCCcCCCCCEEEEEcCCccEEEe--c--CCEecCCC
Confidence 4444333356689999999985544 3 47888763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00039 Score=71.71 Aligned_cols=143 Identities=16% Similarity=0.113 Sum_probs=80.1
Q ss_pred ceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcc--eeeeEeE------EEeCCeeEEEEec
Q 005236 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRN--LVKLLGC------CIHGEEKLLIYEF 464 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~e~ 464 (706)
+.|+.|....+|+....++ .+++|..... ...+.+..|+.++..+...+ +.+++.. ....+..+++|+|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 5677788899999987655 6888987652 11234556777776664222 2333321 1234567899999
Q ss_pred CCCCChhh----h----------hhccc-c---c--CC---CCHHHHHH------------HHHHHHHHHHHHHhC----
Q 005236 465 MPNKSLDS----F----------IFDQE-R---C--KL---LDWSKRFH------------IICGTARGLLYLHQD---- 505 (706)
Q Consensus 465 ~~~gsL~~----~----------l~~~~-~---~--~~---l~~~~~~~------------i~~~ia~~l~~LH~~---- 505 (706)
++|..+.. . ++... . . .. ..|...+. +...+.+.++.++..
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99876421 0 11110 0 0 00 11221110 011234455555532
Q ss_pred CCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 506 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 506 ~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
.+..++|+|+++.|||++++..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 234699999999999999876668999998753
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00041 Score=58.86 Aligned_cols=95 Identities=16% Similarity=0.126 Sum_probs=52.8
Q ss_pred cccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcceEEeeCCceeeeeCCCCCCccccccccccCcce
Q 005236 37 SDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAATLRQNPVFN 116 (706)
Q Consensus 37 tDtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~~~~~~~~~~yw~sg~w~g~~~s~~~~~~~~~~~ 116 (706)
+|||+|||.|..+ ..| +.|.|.|.|+.+|+..+ ++ .||.++......-....+.....
T Consensus 3 ~dtL~~gq~L~~g------~~L---------~~g~~~L~~q~dGNLvl--~~---~~Wssnt~~~~~~~~l~l~~dGn-- 60 (109)
T 3r0e_A 3 TNYLLSGQTLDTE------GHL---------KNGDFDLVMQDDCNLVL--YN---GNWQSNTANNGRDCKLTLTDYGE-- 60 (109)
T ss_dssp CSEEETTCEECTT------CEE---------EETTEEEEECTTSCEEE--ET---TTEECCCTTSCSSCEEEECTTSC--
T ss_pred cCCcCCCCCcCCC------CEe---------ECCCEEEEEecCCeEEE--Ee---CeEEcCCCCCCCcEEEEEcCCCe--
Confidence 6999999999433 235 46999999999998544 33 38988764321100001111111
Q ss_pred eEEeecCCeeEEEEEccCCceEEEEEEecccceEEEEE
Q 005236 117 FSFVSSEDELYYTFDLIDKAVFSRIVMNQTLYLRQRFT 154 (706)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G~~~~~~~ 154 (706)
+.+.+..................+++|..|| +++.|.
T Consensus 61 Lvl~d~~~~~vWss~t~~~~~~~~~~L~~dG-Nlvly~ 97 (109)
T 3r0e_A 61 LVIKNGDGSTVWKSGAQSVKGNYAAVVHPDG-RLVVFG 97 (109)
T ss_dssp EEEECTTSCEEEECCCCCSSSCCEEEEETTT-EEEEEC
T ss_pred EEEEeCCCCEEEcCCCcCCCcCEEEEEcCCC-eEEEEe
Confidence 1111222223332222222345689999999 888773
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00029 Score=75.81 Aligned_cols=73 Identities=19% Similarity=0.318 Sum_probs=49.9
Q ss_pred ceeccCCceeEEEEEeCC--------CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcce-eeeEeEEEeCCeeEEEEe
Q 005236 393 KKLGEGGFGPVYKGTLAD--------EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL-VKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e 463 (706)
+.|+.|....||+....+ ++.+++|+..... ..+.+..|..+++.+...++ .++++.+. + .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 678889999999998753 4788898874321 11445578888888753334 56666543 2 38999
Q ss_pred cCCCCChh
Q 005236 464 FMPNKSLD 471 (706)
Q Consensus 464 ~~~~gsL~ 471 (706)
|++|.+|.
T Consensus 153 ~l~G~~l~ 160 (429)
T 1nw1_A 153 YIPSRPLS 160 (429)
T ss_dssp CCCEEECC
T ss_pred EeCCcccC
Confidence 99875553
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00058 Score=58.05 Aligned_cols=97 Identities=12% Similarity=0.128 Sum_probs=53.9
Q ss_pred cccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcceEEeeCCceeeeeCCCCCCccccccccccCcce
Q 005236 37 SDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAATLRQNPVFN 116 (706)
Q Consensus 37 tDtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~~~~~~~~~~yw~sg~w~g~~~s~~~~~~~~~~~ 116 (706)
+|||+|||.|..+ ..|+| |.|.|.|+.+|+. ++++. .+||.++..+...-....+.....+
T Consensus 6 ~dtL~~gq~L~~g------~~L~s---------g~~~L~~q~dGnL--vl~~~-~~vW~snt~~~~~~~~l~l~~dGNL- 66 (110)
T 3r0e_B 6 NNLLFSGQVLYGD------GRLTA---------KNHQLVMQGDCNL--VLYGG-KYGWQSNTHGNGEHCFLRLNHKGEL- 66 (110)
T ss_dssp TTEEETTCEEETT------EEEEC---------SSCEEEECTTSCE--EEECS-SSCEECCCTTSSSSCEEEECTTSCE-
T ss_pred cCEECCCCEecCC------CEEEe---------CCEEEEEcCCCeE--EEECC-eEEEECCCcCCCcCEEEEEeCCCcE-
Confidence 6999999999433 34753 7899999999974 44555 6899887643110000111111111
Q ss_pred eEEeecCCeeEEEEEccCCceEEEEEEecccceEEEEE
Q 005236 117 FSFVSSEDELYYTFDLIDKAVFSRIVMNQTLYLRQRFT 154 (706)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G~~~~~~~ 154 (706)
.+.+........-.......-.+++|..|| +++.|.
T Consensus 67 -vl~d~~~~~iW~S~t~~~~~~~~~~L~~dG-Nlvly~ 102 (110)
T 3r0e_B 67 -IIKDDDFKTIWSSRSSSKQGEYVLILQDDG-FGVIYG 102 (110)
T ss_dssp -EEECTTCCEEEECCCCCSSSCCEEEECTTS-CEEEEC
T ss_pred -EEEeCCCCEEEEcCCcCCCCCEEEEEcCCc-cEEEec
Confidence 112222223222222112223678999999 888774
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00054 Score=72.13 Aligned_cols=141 Identities=19% Similarity=0.269 Sum_probs=83.0
Q ss_pred ceeccCCceeEEEEEeCC--------CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcc-eeeeEeEEEeCCeeEEEEe
Q 005236 393 KKLGEGGFGPVYKGTLAD--------EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRN-LVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~e 463 (706)
+.|..|-...+|+....+ ++.+++|+.... ........+|..+++.+.-.+ ..++++.+.+ -+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 677778889999988742 468899886332 223456668999888874222 3566666533 29999
Q ss_pred cCCCCChhhh-h----------------hccc--ccCCCC--HHHHHHHHHHHHH-------------------HHHH--
Q 005236 464 FMPNKSLDSF-I----------------FDQE--RCKLLD--WSKRFHIICGTAR-------------------GLLY-- 501 (706)
Q Consensus 464 ~~~~gsL~~~-l----------------~~~~--~~~~l~--~~~~~~i~~~ia~-------------------~l~~-- 501 (706)
|++|.+|..- + +... -.+... +.++.++..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998776421 1 1100 011122 3444444433321 1222
Q ss_pred --HHhC-CCCceEecccCCCcEEEcCC----CCeEEeeeccccc
Q 005236 502 --LHQD-SRLRIIHRDLKASNVLLDQD----MNPKISDFGLARA 538 (706)
Q Consensus 502 --LH~~-~~~~ivH~Dikp~Nill~~~----~~~kl~Dfgla~~ 538 (706)
|... ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2221 23469999999999999877 7899999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00057 Score=69.79 Aligned_cols=138 Identities=12% Similarity=0.088 Sum_probs=76.5
Q ss_pred cceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcce-eeeEeEEEeCCeeEEEEecC-CCCC
Q 005236 392 NKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL-VKLLGCCIHGEEKLLIYEFM-PNKS 469 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~-~~gs 469 (706)
.+.|+.|....+|+. +.+++|+........ .....|+.+++.+...++ .++++. ..+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 588999999999998 568888875432211 122457777776643233 455543 344567899999 6666
Q ss_pred hhhhh------------------hcccc--cCCCC-HHHHHHHHH--------------HHHHHH----HHHHh-CCCCc
Q 005236 470 LDSFI------------------FDQER--CKLLD-WSKRFHIIC--------------GTARGL----LYLHQ-DSRLR 509 (706)
Q Consensus 470 L~~~l------------------~~~~~--~~~l~-~~~~~~i~~--------------~ia~~l----~~LH~-~~~~~ 509 (706)
|.... +.... ....+ +.....+.. .+.+.+ ..|.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 54210 11000 00001 111111100 011111 11111 22345
Q ss_pred eEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 510 IIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 510 ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667889999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0012 Score=71.30 Aligned_cols=74 Identities=15% Similarity=0.115 Sum_probs=48.5
Q ss_pred ceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcce-eeeEeEEEeCCeeEEEEecCCCCCh
Q 005236 393 KKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL-VKLLGCCIHGEEKLLIYEFMPNKSL 470 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~gsL 470 (706)
+.|+.|-...+|+....+ +..+++|+......... .-..|..++..|...++ .++++.+ .+ .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 678889999999998865 47788887643221111 12578888888865555 5677665 22 359999998665
Q ss_pred h
Q 005236 471 D 471 (706)
Q Consensus 471 ~ 471 (706)
.
T Consensus 189 ~ 189 (458)
T 2qg7_A 189 S 189 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0016 Score=67.36 Aligned_cols=141 Identities=13% Similarity=0.067 Sum_probs=73.5
Q ss_pred ceeccCCcee-EEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCC--cceeeeEeEEEeCCeeEEEEecCCCCC
Q 005236 393 KKLGEGGFGP-VYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQH--RNLVKLLGCCIHGEEKLLIYEFMPNKS 469 (706)
Q Consensus 393 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gs 469 (706)
+.|+.|.... +|+....+++.+++|....... +.+..|+.++..+.. -.+.+++.+.. ..-+++||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence 4565555444 6677654467777876543211 234556666666632 23455666532 22378999998877
Q ss_pred hhhhhhccc-----------------------ccCCCCHHHHH-------HH-------------HHHHHHHHHHHH---
Q 005236 470 LDSFIFDQE-----------------------RCKLLDWSKRF-------HI-------------ICGTARGLLYLH--- 503 (706)
Q Consensus 470 L~~~l~~~~-----------------------~~~~l~~~~~~-------~i-------------~~~ia~~l~~LH--- 503 (706)
+.+++.... ....++..... .+ ...+...+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 755442110 00111111100 00 001112222221
Q ss_pred hCCCCceEecccCCCcEEEcCC----CCeEEeeeccccc
Q 005236 504 QDSRLRIIHRDLKASNVLLDQD----MNPKISDFGLARA 538 (706)
Q Consensus 504 ~~~~~~ivH~Dikp~Nill~~~----~~~kl~Dfgla~~ 538 (706)
......++|+|+++.|||++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1224569999999999999875 6899999998865
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0013 Score=55.82 Aligned_cols=97 Identities=9% Similarity=0.121 Sum_probs=55.1
Q ss_pred ccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcceEEeeCCceeeeeCCCCCCccccccccccCccee
Q 005236 38 DTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAATLRQNPVFNF 117 (706)
Q Consensus 38 DtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~~~~~~~~~~yw~sg~w~g~~~s~~~~~~~~~~~~ 117 (706)
+||+|||.|.. | ..|+ .|.|.|.|+.+|+. ++++...++|.++......-....+..... +
T Consensus 2 ntL~~gq~L~~----g--~~L~---------~g~~~L~~q~dGnL--vly~~~~~vW~snt~~~~~~~~l~l~~dGN--L 62 (109)
T 3dzw_A 2 NILYSGETLSP----G--EFLN---------NGRYVFIMQEDCNL--VLYDVDKPIWATNTGGLDRRCHLSMQSDGN--L 62 (109)
T ss_dssp CEEETTEEECT----T--CEEE---------ETTEEEEECTTSCE--EEEETTEEEEECCCTTSSSSCEEEECTTSC--E
T ss_pred CCcCCCCEeCC----C--CEEE---------CCCEEEEEcCCCcE--EEEeCCEEEEECCcccCCCCEEEEEeCCCC--E
Confidence 69999999932 2 2352 69999999999974 455667899998764321000011111111 1
Q ss_pred EEeecCCeeEEEEEccCCceEEEEEEecccceEEEEE
Q 005236 118 SFVSSEDELYYTFDLIDKAVFSRIVMNQTLYLRQRFT 154 (706)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G~~~~~~~ 154 (706)
.+.+........-.........+++|..|| +++.|.
T Consensus 63 vl~~~~~~~~W~S~t~~~~~~~~~~L~ddG-Nlvly~ 98 (109)
T 3dzw_A 63 VVYSPRNNPIWASNTGGENGNYVCVLQKDR-NVVIYG 98 (109)
T ss_dssp EEECTTSCEEEECCCCCSSSCEEEEECTTS-CEEEEE
T ss_pred EEECCCCCEEEECCCCCCCCCEEEEEeCCC-EEEEEC
Confidence 112222223332222223334689999999 887764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0027 Score=65.42 Aligned_cols=142 Identities=15% Similarity=0.145 Sum_probs=82.2
Q ss_pred ceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcc--eeeeEeE-----EEeCCeeEEEEecC
Q 005236 393 KKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRN--LVKLLGC-----CIHGEEKLLIYEFM 465 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lV~e~~ 465 (706)
+.|+ |....||+....+|+.+++|...... ...+.+..|..++..+.... +++++.. ....+..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999887777789999985321 12356667888877774222 3444432 22345567899999
Q ss_pred CCCChhh----h----------hhccc------ccCCCCHHHH----HHH---------------HHHHHHHHHHHHh--
Q 005236 466 PNKSLDS----F----------IFDQE------RCKLLDWSKR----FHI---------------ICGTARGLLYLHQ-- 504 (706)
Q Consensus 466 ~~gsL~~----~----------l~~~~------~~~~l~~~~~----~~i---------------~~~ia~~l~~LH~-- 504 (706)
+|..+.. . ++... ....+++... ..+ ...+.+.++.+..
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 9865431 1 11100 0111222211 000 1111122223322
Q ss_pred --CCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 505 --DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 505 --~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
..+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1244589999999999999 4 899999998754
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0011 Score=56.66 Aligned_cols=97 Identities=7% Similarity=0.105 Sum_probs=54.0
Q ss_pred cccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcceEEeeC--CceeeeeCCCCCCccccccccccCc
Q 005236 37 SDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKG--SRKFYRSGPWNGLRFSAATLRQNPV 114 (706)
Q Consensus 37 tDtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~~~~~~~--~~~yw~sg~w~g~~~s~~~~~~~~~ 114 (706)
.|||+|||.|..+ ..|+ .|.|.|.|+.+|+. ++++. ..+||.++......-....+.....
T Consensus 6 ~~tL~~gq~L~~g------~~L~---------~g~~~L~~q~dGNL--vL~~~~~~~~vWssnt~~~~~~~~l~l~~dGN 68 (113)
T 3mez_B 6 RNVLFSSQVMYDN------AQLA---------TRDYSLVMRDDCNL--VLTKGSKTNIVWESGTSGRGQHCFMRLGHSGE 68 (113)
T ss_dssp SSEEETTCEEETT------CEEE---------ETTEEEEECTTSCE--EEEETTTTEEEEECCCTTSCSSCEEEECTTSC
T ss_pred CCEeCCCCEECCC------CEeE---------cCCEEEEEcCCCEE--EEEECCCCEEEEECCcccCCcCEEEEEeCCCc
Confidence 5899999999433 2353 48999999999974 44554 5799998764211100011111111
Q ss_pred ceeEEeecCCeeEEEEEccCCceEEEEEEecccceEEEE
Q 005236 115 FNFSFVSSEDELYYTFDLIDKAVFSRIVMNQTLYLRQRF 153 (706)
Q Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G~~~~~~ 153 (706)
+.+.+........-.......-.+++|..|| +++.|
T Consensus 69 --LVl~d~~~~~iW~S~t~~~~~~~~~~L~~dG-nlvly 104 (113)
T 3mez_B 69 --LDITDDRLNTVFVSNTVGQEGDYVLILQING-QAVVY 104 (113)
T ss_dssp --EEEECTTSCEEEECSCCCSSSCCEEEECTTS-CEEEE
T ss_pred --EEEECCCCCEEEECCCcCCCCCEEEEEcCCc-eEEEe
Confidence 1111222222222222112223689999999 88877
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0027 Score=53.35 Aligned_cols=96 Identities=13% Similarity=0.131 Sum_probs=56.6
Q ss_pred ccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcceEEeeCCceeeeeCCCCCCcc-ccccccccCcce
Q 005236 38 DTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFYRSGPWNGLRF-SAATLRQNPVFN 116 (706)
Q Consensus 38 DtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~~~~~~~~~~yw~sg~w~g~~~-s~~~~~~~~~~~ 116 (706)
|||+|||.|. .| .+|+| |.|+|.|+.+|+ ++++....++|.++..+.... ....+.....
T Consensus 2 n~L~~g~~L~----~g--~~L~s---------g~y~l~~q~DgN--Lvly~~~~~vW~ant~~~~~~~~~L~l~~dGn-- 62 (105)
T 4h3o_A 2 NILDNNEGLY----AG--QSLDV---------EPYHFIMQDDCN--LVLYDHSTSTWASNTEIGGKSGCSAVLQSDGN-- 62 (105)
T ss_dssp CEECTTEEEC----TT--CEEEE---------TTEEEEECTTSC--EEEEETTEEEEECCCCCTTCCSCEEEECTTSC--
T ss_pred CCcCCCCEEc----CC--CEEEE---------CCEEEEECCCCe--EEEEECCEEEEEecCCCCCCccEEEEEeCCcc--
Confidence 7899999993 23 35754 889999999998 566778889998876432211 1111111111
Q ss_pred eEEeecCCeeEEEEEccCCceEEEEEEecccceEEEE
Q 005236 117 FSFVSSEDELYYTFDLIDKAVFSRIVMNQTLYLRQRF 153 (706)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G~~~~~~ 153 (706)
+...+.......+........-.++.|..+| ++..|
T Consensus 63 LvL~d~~~~~vWss~t~~~~~~~~l~L~ddG-NlVly 98 (105)
T 4h3o_A 63 FVVYDSSGRSLWASHSTRGSGNYILILQDDG-NVIIY 98 (105)
T ss_dssp EEEECTTCCEEEECCCCCCSSCEEEEECTTS-CEEEE
T ss_pred EEEECCCcEEEEEecCCCCCCCEEEEEeCCC-eEEEE
Confidence 1122223333333333333334578899999 77766
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00079 Score=57.08 Aligned_cols=35 Identities=23% Similarity=0.562 Sum_probs=25.4
Q ss_pred cCCCCCCCCCceEEEEeeCCCcceEEeeCCceeeeeCCC
Q 005236 61 WKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFYRSGPW 99 (706)
Q Consensus 61 w~s~~dps~G~fsl~~~~~g~~~~~~~~~~~~yw~sg~w 99 (706)
|.+.+....+.|.+.++++|+..++ . .+.|.+++|
T Consensus 72 Wss~t~~~~~~~~~~L~~dGNlvly--~--~~~W~s~t~ 106 (109)
T 3r0e_A 72 WKSGAQSVKGNYAAVVHPDGRLVVF--G--PSVFKIDPW 106 (109)
T ss_dssp EECCCCCSSSCCEEEEETTTEEEEE--C--SEEEEECTT
T ss_pred EcCCCcCCCcCEEEEEcCCCeEEEE--e--cCEECCCCc
Confidence 5554444456789999999985544 3 689999987
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0011 Score=69.89 Aligned_cols=73 Identities=15% Similarity=0.208 Sum_probs=44.3
Q ss_pred ceeccCCceeEEEEEeCC---------CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcc-eeeeEeEEEeCCeeEEEE
Q 005236 393 KKLGEGGFGPVYKGTLAD---------EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRN-LVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~ 462 (706)
+.|+.|....+|+....+ ++.+++|+....... ......|..+++.+...+ ..++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 577888889999998754 267888876543221 112356788877775333 34566543 2 37899
Q ss_pred ecCCCCCh
Q 005236 463 EFMPNKSL 470 (706)
Q Consensus 463 e~~~~gsL 470 (706)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998654
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0009 Score=65.60 Aligned_cols=82 Identities=20% Similarity=0.267 Sum_probs=47.2
Q ss_pred ceEEEEecCCcEEEEecCCCCCceEEEeecCCCcccccCCCcccceeecC-------CceEEEecCCCCCCCCCceEEEE
Q 005236 4 LSFLFVCYSGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTG-------LERRITSWKSPDDPSPGNFTWAV 76 (706)
Q Consensus 4 ~~~~~l~~sGNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgqklg~~~~tg-------~~~~L~Sw~s~~dps~G~fsl~~ 76 (706)
...+.+...|||||++. .+++|.+=.... .+-+|... ..| .+. +-|.|.+..+.|.|.+.+
T Consensus 27 ~f~l~f~~~gnl~ly~~-----~~~vW~an~~~~----~~~~l~l~-~dGnLvl~d~~~~--~vW~s~~~~~~~~~~~~l 94 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDS-----DVRVWASNTAGA----TGCRAVLQ-SDGLLVILTAQNT--IRWSSGTKGSIGNYVLVL 94 (236)
T ss_dssp TEEEEECTTSCEEEEES-----SSEEECCCCCSC----SCCBCCBC-SSSCBCCBCTTTC--CSCCCCCCCCSSCCEEEE
T ss_pred CEEEEECCCCcEEEEEC-----CEEEEECCCCCC----CCeEEEEc-CCCcEEEEcCCCc--EEEeCCccccCCcEEEEE
Confidence 34455667777777764 257777643211 22222111 011 111 236666655678899999
Q ss_pred eeCCCcceEEeeCCceeeeeCCCCC
Q 005236 77 ERQDNPELIMWKGSRKFYRSGPWNG 101 (706)
Q Consensus 77 ~~~g~~~~~~~~~~~~yw~sg~w~g 101 (706)
+.+|+..++ . ..+|.|..+..
T Consensus 95 ~d~Gnlvl~--~--~~~W~S~~~p~ 115 (236)
T 1dlp_A 95 QPDRTVTIY--G--PGLWDSGTSNK 115 (236)
T ss_dssp CSSSCEEEE--C--SEEEECSCCCS
T ss_pred eCCCCEEEe--c--CCEEECCCCCC
Confidence 999985443 2 28999887753
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0021 Score=54.60 Aligned_cols=97 Identities=9% Similarity=0.069 Sum_probs=53.2
Q ss_pred cccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcceEEeeCCceeeeeCCCCCCccccccccccCcce
Q 005236 37 SDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAATLRQNPVFN 116 (706)
Q Consensus 37 tDtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~~~~~~~~~~yw~sg~w~g~~~s~~~~~~~~~~~ 116 (706)
+|||+|||.|..+ ..| +.|.|.|.|+.+|+. ++.+... +|.++......-....+.....+
T Consensus 2 ~~~l~~gq~L~~g------~~L---------~~g~~~L~~q~dGnL--vl~~~~~-vW~snt~~~~~~~~l~l~~dGNL- 62 (111)
T 3mez_A 2 NNVLLTGDVIHTD------NQL---------SYESAAFVMQGDCNL--VLYNEAG-GFQSNTHGRGVDCTLRLNNRGQL- 62 (111)
T ss_dssp TTEEETTCEECTT------CEE---------EETTEEEEECTTSCE--EEECSSC-CEECCCTTSCSSCEEEECTTSCE-
T ss_pred cCEeCCCCEeCCC------CEE---------ecCCEEEEEccCCeE--EEECCCC-EEECCcccCCcCEEEEEcCCCcE-
Confidence 5899999999432 235 469999999999975 4455555 99887532111000011111111
Q ss_pred eEEeecCC-eeEEEEEc--cCCceEEEEEEecccceEEEEE
Q 005236 117 FSFVSSED-ELYYTFDL--IDKAVFSRIVMNQTLYLRQRFT 154 (706)
Q Consensus 117 ~~~~~~~~-~~~~~~~~--~~~~~~~~~~l~~~G~~~~~~~ 154 (706)
.+.+... .....-.. .......+++|..|| +++.|.
T Consensus 63 -Vl~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dG-Nlvly~ 101 (111)
T 3mez_A 63 -EIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQ-HVTIYG 101 (111)
T ss_dssp -EEECSSCSSCSEEESSSCCCCSSCCEEEECTTS-CEEEEC
T ss_pred -EEEeCCCCEEEEEeccccCCCCcCEEEEECCCC-eEEEec
Confidence 1111111 11222221 122235689999999 888774
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0047 Score=64.06 Aligned_cols=32 Identities=25% Similarity=0.366 Sum_probs=28.3
Q ss_pred CCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 507 ~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
+..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35699999999999999888999999988764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0067 Score=51.58 Aligned_cols=46 Identities=24% Similarity=0.427 Sum_probs=34.9
Q ss_pred cccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcceEEeeCCceeeeeCCC
Q 005236 37 SDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFYRSGPW 99 (706)
Q Consensus 37 tDtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~~~~~~~~~~yw~sg~w 99 (706)
||||+|||.|.. |. .| ..|.|.|.++.+|+.. +++...++|.++..
T Consensus 1 tdtl~~gq~L~~----g~--~L---------~~~~~~L~~~~dgnlv--l~~~~~~vW~sn~~ 46 (112)
T 1xd5_A 1 SDRLNSGHQLDT----GG--SL---------AEGGYLFIIQNDCNLV--LYDNNRAVWASGTN 46 (112)
T ss_dssp CCEEETTEEECT----TC--EE---------EETTEEEEECTTSCEE--EEETTEEEEECCCT
T ss_pred CCCCCCCCEECC----CC--EE---------eCCCEEEEEcCCCcEE--EEECCEEEEeCCCc
Confidence 799999999943 22 35 2588999999999754 45557899998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.30 E-value=0.031 Score=52.93 Aligned_cols=103 Identities=13% Similarity=0.070 Sum_probs=66.9
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCccc
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 547 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 547 (706)
-+|.+.|... ..++++.++|.++.|.+++|.-+-... .+ ..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 3788888543 367999999999999999988762211 01 1233457899999999988764 1110
Q ss_pred ccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 005236 548 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN 590 (706)
Q Consensus 548 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p 590 (706)
.....+.|||... ...+.+.=|||||++||.-+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123456888763 4567889999999999999875444
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=96.25 E-value=0.014 Score=49.76 Aligned_cols=46 Identities=22% Similarity=0.393 Sum_probs=35.0
Q ss_pred cccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcceEEeeCCceeeeeCCC
Q 005236 37 SDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFYRSGPW 99 (706)
Q Consensus 37 tDtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~~~~~~~~~~yw~sg~w 99 (706)
.|||+|||.|..+ ..|+ .|.|.|.++.+|+.. +++...++|.++..
T Consensus 2 ~dtl~~gq~L~~g------~~L~---------~g~~~L~~~~dgnlv--ly~~~~~vW~sn~~ 47 (115)
T 2dpf_A 2 DNVLLSGQTLHAD------HSLQ---------AGAYTLTIQNKCNLV--KYQNGRQIWASNTD 47 (115)
T ss_dssp CCEEETTCEEETT------EEEE---------ETTEEEEECTTSCEE--EEETTEEEEECSCT
T ss_pred CCEeCCCCEECCC------CEEE---------CCCEEEEEcCCCcEE--EEeCCEEEEeCCCC
Confidence 4899999999432 2364 589999999998754 44567899998764
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=96.11 E-value=0.012 Score=49.32 Aligned_cols=71 Identities=20% Similarity=0.247 Sum_probs=44.8
Q ss_pred eEEEEecCCcEEEEecCCCCCceEEEeecCC-CcccccCCCccccee------ecCCceEEEecCCCCCCCCCceEEEEe
Q 005236 5 SFLFVCYSGNLVLRGERDGGSETYLWQSFDY-PSDTLLPGMKLGWDL------KTGLERRITSWKSPDDPSPGNFTWAVE 77 (706)
Q Consensus 5 ~~~~l~~sGNlVl~~~~~~~~~~~~WqSFd~-PtDtlLpgqklg~~~------~tg~~~~L~Sw~s~~dps~G~fsl~~~ 77 (706)
-.+.|.++|||||++.+ +++|.|--+ |-. .+-+|.... ..+.+. +-|.|.+....+.+.+.++
T Consensus 21 y~l~~q~DgNLvly~~~-----~~vW~ant~~~~~---~~~~L~l~~dGnLvL~d~~~~--~vWss~t~~~~~~~~l~L~ 90 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDHS-----TSTWASNTEIGGK---SGCSAVLQSDGNFVVYDSSGR--SLWASHSTRGSGNYILILQ 90 (105)
T ss_dssp EEEEECTTSCEEEEETT-----EEEEECCCCCTTC---CSCEEEECTTSCEEEECTTCC--EEEECCCCCCSSCEEEEEC
T ss_pred EEEEECCCCeEEEEECC-----EEEEEecCCCCCC---ccEEEEEeCCccEEEECCCcE--EEEEecCCCCCCCEEEEEe
Confidence 45889999999999742 799999643 311 112221110 011111 3477777777888999999
Q ss_pred eCCCcceE
Q 005236 78 RQDNPELI 85 (706)
Q Consensus 78 ~~g~~~~~ 85 (706)
++|+..++
T Consensus 91 ddGNlVly 98 (105)
T 4h3o_A 91 DDGNVIIY 98 (105)
T ss_dssp TTSCEEEE
T ss_pred CCCeEEEE
Confidence 99986443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.84 E-value=0.013 Score=62.40 Aligned_cols=141 Identities=16% Similarity=0.174 Sum_probs=83.5
Q ss_pred cceeccCCceeEEEEEeCC--------CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcc-eeeeEeEEEeCCeeEEEE
Q 005236 392 NKKLGEGGFGPVYKGTLAD--------EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRN-LVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~ 462 (706)
.+.|..|-...+|+....+ ++.+++++....... .-.-.+|..+++.+...+ ..++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3677788889999998753 578898886443221 112356777777774323 34555432 2 37899
Q ss_pred ecCCCCChhhh-h----------------hccc----------ccCCCCHHHHHHHHHHH-------------------H
Q 005236 463 EFMPNKSLDSF-I----------------FDQE----------RCKLLDWSKRFHIICGT-------------------A 496 (706)
Q Consensus 463 e~~~~gsL~~~-l----------------~~~~----------~~~~l~~~~~~~i~~~i-------------------a 496 (706)
||++|.+|..- + +... ...+.-+..+.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99999775321 0 1100 00111233333333222 1
Q ss_pred HHHHHHH---------------------hCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 497 RGLLYLH---------------------QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 497 ~~l~~LH---------------------~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
..+..|. ...+..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2223322 112346899999999999 8888999999998864
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=95.26 E-value=0.17 Score=43.20 Aligned_cols=48 Identities=4% Similarity=0.048 Sum_probs=36.6
Q ss_pred cccccCCCcccceeecCCceEEE--ecCCCCCCCCCceEEEEeeCCCcceEEeeCCceeeeeCCC
Q 005236 37 SDTLLPGMKLGWDLKTGLERRIT--SWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFYRSGPW 99 (706)
Q Consensus 37 tDtlLpgqklg~~~~tg~~~~L~--Sw~s~~dps~G~fsl~~~~~g~~~~~~~~~~~~yw~sg~w 99 (706)
+|||.||+.|. .|+ .|+ | ..|.|.|.+..+|+. ++++...+.|.++..
T Consensus 8 ~~~l~~g~~L~----~g~--~l~~~S-------~~g~~~L~~~~dgnl--vly~~~~~vW~sn~~ 57 (119)
T 1b2p_A 8 QPDDNHPQILH----ATE--SLEILF-------GTHVYRFIMQTDCNL--VLYDNNNPIWATNTG 57 (119)
T ss_dssp CSSSCCCCEEE----TTC--EEEEEE-------TTEEEEEEECTTSCE--EEEETTEEEEECCCT
T ss_pred CcccCCCCEEc----CCC--EEEEeC-------CCCCEEEEEecCCCE--EEEECCEEEEeCCCc
Confidence 58999999993 343 476 5 578999999999874 455667889988753
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=94.48 E-value=0.24 Score=41.59 Aligned_cols=47 Identities=11% Similarity=0.141 Sum_probs=34.7
Q ss_pred cccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcceEEeeCCceeeeeCCC
Q 005236 37 SDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFYRSGPW 99 (706)
Q Consensus 37 tDtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~~~~~~~~~~yw~sg~w 99 (706)
||||.+||.|.. |. .|++ .|.|.|.|+.+|+. ++++...+.|.++..
T Consensus 1 ~d~l~~g~~L~~----g~--~l~~--------~~~~~l~~~~dGnl--vl~~~~~~vW~sn~~ 47 (110)
T 3a0c_A 1 VNSLSSPNSLFT----GH--SLEV--------GPSYRLIMQGDCNF--VLYDSGKPVWASNTG 47 (110)
T ss_dssp CCEEETTCEECT----TC--EEEE--------TTTEEEEECTTSCE--EEEETTEEEEECCCT
T ss_pred CCEeCCCCEECC----CC--EEEE--------CCCEEEEEcCCCcE--EEEECCEEEEECCCC
Confidence 799999999932 32 3531 57899999999975 455667899988753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.75 E-value=0.21 Score=52.84 Aligned_cols=30 Identities=23% Similarity=0.375 Sum_probs=25.5
Q ss_pred ceEecccCCCcEEE------cCCCCeEEeeeccccc
Q 005236 509 RIIHRDLKASNVLL------DQDMNPKISDFGLARA 538 (706)
Q Consensus 509 ~ivH~Dikp~Nill------~~~~~~kl~Dfgla~~ 538 (706)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567899999998864
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=89.29 E-value=0.75 Score=45.62 Aligned_cols=80 Identities=13% Similarity=0.106 Sum_probs=47.0
Q ss_pred eEEEEecCCcEEEEecCCCCCceEEEeecCCCcccccCCCccccee------ecCCceEEEecCCCCCCCCCceEEEEee
Q 005236 5 SFLFVCYSGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDL------KTGLERRITSWKSPDDPSPGNFTWAVER 78 (706)
Q Consensus 5 ~~~~l~~sGNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgqklg~~~------~tg~~~~L~Sw~s~~dps~G~fsl~~~~ 78 (706)
-.+.|.++|||||++.. +.++|+|=..-.+. ..+..+. ..+.+. .-|.+.+... +.+.+.++.
T Consensus 166 fsl~l~~dGnlvLy~~~----~~~yW~Sgt~~~~~----~~l~l~~dGnLvl~d~~~~--~vWsS~t~~~-~~~rl~Ld~ 234 (276)
T 3m7h_A 166 SKLVFQGDGNLVAYGPN----GAATWNAGTQGKGA----VRAVFQGDGNLVVYGAGNA--VLWHSHTGGH-ASAVLRLQA 234 (276)
T ss_dssp EEEEECTTSCEEEECTT----SSEEEECCCTTTTC----CEEEECTTSCEEEECTTSC--EEEECSCTTC-TTCEEEECT
T ss_pred EEEeecCCceEEEEeCC----CeEEEECCCCCCcc----EEEEEcCCCeEEEEeCCCc--EEEEecCCCC-CCEEEEEcC
Confidence 35788899999998542 37899984332221 1221110 011111 2355554433 347899999
Q ss_pred CCCcceEEeeCCceeeeeCC
Q 005236 79 QDNPELIMWKGSRKFYRSGP 98 (706)
Q Consensus 79 ~g~~~~~~~~~~~~yw~sg~ 98 (706)
+|+..++.| ...|.+..
T Consensus 235 dGnLvly~~---~~~Wqsf~ 251 (276)
T 3m7h_A 235 NGSIAILDE---KPVWARFG 251 (276)
T ss_dssp TSCEEEEEE---EEEEESSS
T ss_pred CccEEEEcC---CCeEEccC
Confidence 999888877 47787753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.72 E-value=1.5 Score=41.43 Aligned_cols=116 Identities=12% Similarity=0.105 Sum_probs=79.6
Q ss_pred cCCcceeeeEeEEEeCCeeEEEEecCCCC-ChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCC
Q 005236 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNK-SLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 518 (706)
Q Consensus 440 l~h~niv~l~~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~ 518 (706)
..||+++.. .+-.+.+...+.|+.-+.+ ++.. + ...+...+++++.+|+....+++. -+|--|+|.
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 368888876 4555666666666654422 2222 2 347788999999999998866653 478899999
Q ss_pred cEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005236 519 NVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRG 592 (706)
Q Consensus 519 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~ 592 (706)
||+++.++.++|.=.|+-.. ++|. ..+...=.-.+=+++..+++++..|+
T Consensus 109 NL~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999986665332 2222 12233334567788999999988864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.95 E-value=2.7 Score=39.80 Aligned_cols=116 Identities=8% Similarity=0.047 Sum_probs=77.1
Q ss_pred cCCcceeeeEeEEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHH-HHHhCCCCceEecccCCC
Q 005236 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLL-YLHQDSRLRIIHRDLKAS 518 (706)
Q Consensus 440 l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~-~LH~~~~~~ivH~Dikp~ 518 (706)
..||++ -...-.+++...+.++--+++.=...+ ..++...+++++.+|+.... +++. -+|--|+|+
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 368888 333345677777777765443222233 23678889999988888766 5543 688899999
Q ss_pred cEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005236 519 NVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRG 592 (706)
Q Consensus 519 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~ 592 (706)
||+++.++.++|.=.|+-. -++|.- .+..-=.-.+=+++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~-------------------~lpP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKE-------------------SLPPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETT-------------------TBSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcc-------------------cCCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999998666532 233322 1222234467788888888887753
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.85 E-value=0.21 Score=53.85 Aligned_cols=62 Identities=16% Similarity=0.214 Sum_probs=19.0
Q ss_pred CccceeccCCceeEEEEEeCC-CcEEEE------EEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEe
Q 005236 390 SINKKLGEGGFGPVYKGTLAD-EQEIAV------KRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIH 454 (706)
Q Consensus 390 ~~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 454 (706)
.+.++|| ||.||+|.+.. ..+||| |.... ...+....+.+|..++..++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 4456777 99999999864 367888 66543 233344568889999999999999999887654
|
| >1b9w_A Protein (merozoite surface protein 1); MSP-1, candidate malaria vaccine, surface antigen; 1.80A {Plasmodium cynomolgi} SCOP: g.3.11.4 g.3.11.4 PDB: 2npr_A | Back alignment and structure |
|---|
Probab=81.13 E-value=0.84 Score=36.05 Aligned_cols=46 Identities=17% Similarity=0.330 Sum_probs=34.9
Q ss_pred cCCCCccCCCCCCCccccC--CCCCcccccCCcccCCCCCccccCceeeccCcccc
Q 005236 169 PRDLCDTYALCGDYGICII--SDLPVCQCLKGFKPKSRGYVDWSQGCVRDKSLNYS 222 (706)
Q Consensus 169 p~~~C~~~~~CG~~g~C~~--~~~~~C~C~~Gf~~~~~~~~~~s~gC~~~~~~~c~ 222 (706)
+.+.| ++..|+.|+.|-. +....|+|+.||... ...|+++...+|.
T Consensus 3 ~~h~C-~~tkcp~NA~Cyr~~dg~EecRCllnykk~-------~~kCV~~~~~~C~ 50 (95)
T 1b9w_A 3 SEHRC-IDTNVPENAACYRYLDGTEEWRCLLYFKED-------AGKCVPAPNMTCK 50 (95)
T ss_dssp GGGSC-SSCCCCTTEEEEECTTSCEEEEECTTEEEE-------TTEEEECTTCCTT
T ss_pred cCccc-ccCCCCCCcCeEEEcCCCEEEEEECCeEec-------CCEEEcCCCCCcc
Confidence 34678 6779999999943 456799999999963 4568877777665
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 706 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-73 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-23 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 6e-73
Identities = 70/277 (25%), Positives = 133/277 (48%), Gaps = 20/277 (7%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
++ +++G G FG VYKG + + + ++ + Q L+ KNE+ + K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+G + ++ ++ SL + E + K I TA+G+ YLH S
Sbjct: 68 LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA--- 563
IIHRDLK++N+ L +D+ KI DFGLA ++ G+ +MAPE
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 564 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623
+S +SDV++FGI+L E+++G+ + + +N+ +I + + S++ C
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
K + C+++ ++RP P ++ +
Sbjct: 240 KA---------MKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 1e-66
Identities = 78/274 (28%), Positives = 125/274 (45%), Gaps = 22/274 (8%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
+ + ++LG G FG V+ G ++AVK L + E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+L E +I E+M N SL F+ K L +K + A G+ ++ + +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN 129
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 566
IHRDL+A+N+L+ ++ KI+DFGLAR +E + APE + G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 567 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDS 626
F++KSDV+SFGILL EIV+ + Y +I++ + + P +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNLERGYRMVRPDNCPE------ 237
Query: 627 FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
+ LC ++ PEDRP + +L
Sbjct: 238 -------ELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 6e-66
Identities = 68/275 (24%), Positives = 121/275 (44%), Gaps = 24/275 (8%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
+ +++G G FG V+ G ++ ++A+K + + ++ E + KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+L G C+ L++EFM + L + + + L + G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 566
+IHRDL A N L+ ++ K+SDFG+ R D+ ++ + +PE S
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 567 QFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625
++S KSDV+SFG+L+ E+ S GK + + I ++L+ + S
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST-------- 229
Query: 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
I C ++ PEDRP ++ L
Sbjct: 230 --------HVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 4e-65
Identities = 75/288 (26%), Positives = 128/288 (44%), Gaps = 23/288 (7%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
++ + KLG+G FG V+ GT +A+K L + E + KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+L E ++ E+M SL F+ E K L + + A G+ Y+ +
Sbjct: 76 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVER-- 131
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 566
+ +HRDL+A+N+L+ +++ K++DFGLAR +E + APE A G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189
Query: 567 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDS 626
+F++KSDV+SFGILL E+ + + Y ++ + + P + +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQVERGYRMPCPPECPE------ 241
Query: 627 FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLPQPK-QPG 673
+ C ++ PE+RP + L +P+ QPG
Sbjct: 242 -------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 8e-63
Identities = 60/274 (21%), Positives = 108/274 (39%), Gaps = 22/274 (8%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
+ + K+LG G FG V G + ++A+K + + E E + L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+L G C +I E+M N L +++ + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 566
+ +HRDL A N L++ K+SDFGL+R DE + + PE
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYS 176
Query: 567 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDS 626
+FS KSD+++FG+L+ EI S + ++ + ++ I +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLG---------------KMPYERFTNSETAEHIAQGLRLY 221
Query: 627 FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
+ I C + ++RP ++ +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 9e-63
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 11/206 (5%)
Query: 385 ATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK-ISEQGLKELKNEIILFSKLQH 442
D+F +LG G G V+K + +A K + I ++ E+ + +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL 502
+V G E + E M SLD + R + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562
+ +I+HRD+K SN+L++ K+ DFG++ + N VGT YM+PE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 563 ASDGQFSVKSDVFSFGILLLEIVSGK 588
+SV+SD++S G+ L+E+ G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 3e-62
Identities = 63/296 (21%), Positives = 114/296 (38%), Gaps = 28/296 (9%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
+ + +G+G FG V++G +E+AVK S E+ + EI L+H N++
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENIL 60
Query: 447 KLLGCCIHGEEKL----LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL 502
+ L+ ++ + SL ++ + + TA GL +L
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 116
Query: 503 HQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTNRVVGTY 555
H + + I HRDLK+ N+L+ ++ I+D GLA D + N VGT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 556 GYMAPEYASD------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN----KLNLIRH 605
YMAPE D + ++D+++ G++ EI G + L
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 606 AWKLWNEGMPSQLIDACFKDSFNLAEVIRCIH-IGLLCVQQYPEDRPCMPSVILML 660
+ + + + Q + + + E +R + I C R + L
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (528), Expect = 4e-62
Identities = 71/311 (22%), Positives = 128/311 (41%), Gaps = 46/311 (14%)
Query: 378 ELATIANATDNFSINKKLGEGGFGPVYKGTL------ADEQEIAVKRLSK-ISEQGLKEL 430
+L ++ +N + +GEG FG V++ +AVK L + S +
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 431 KNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKL-------- 482
+ E L ++ + N+VKLLG C G+ L++E+M L+ F+ +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 483 -------------LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 529
L +++ I A G+ YL + + +HRDL N L+ ++M K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 530 ISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 589
I+DFGL+R + +M PE +++ +SDV+++G++L EI S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 590 NRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPED 649
Y+ +I + +G + C + ++ LC + P D
Sbjct: 241 Q--PYYGMAHEEVIYY----VRDGNILACPENC---------PLELYNLMRLCWSKLPAD 285
Query: 650 RPCMPSVILML 660
RP S+ +L
Sbjct: 286 RPSFCSIHRIL 296
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-61
Identities = 72/277 (25%), Positives = 120/277 (43%), Gaps = 28/277 (10%)
Query: 392 NKKLGEGGFGPVYKGTLAD----EQEIAVKRLSKISEQG-LKELKNEIILFSKLQHRNLV 446
N+ +G G FG VY GTL D + AVK L++I++ G + + E I+ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 447 KLLGCCIHGEEK-LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD 505
LLG C+ E L++ +M + L +FI ++ + F + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFL 146
Query: 506 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR--VVGTYGYMAPEYA 563
+ + +HRDL A N +LD+ K++DFGLAR E + N+ +MA E
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 564 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623
+F+ KSDV+SFG+LL E+++ Y N ++ + + P D
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPD--- 261
Query: 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
+ L C E RP ++ +
Sbjct: 262 ----------PLYEVMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 5e-61
Identities = 69/275 (25%), Positives = 110/275 (40%), Gaps = 28/275 (10%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV 446
+ + +G+G FG V G ++AVK + + + E + ++L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63
Query: 447 KLLGCCIHGEEKL-LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD 505
+LLG + + L ++ E+M SL ++ + R +L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 506 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD 565
+HRDL A NVL+ +D K+SDFGL + + G + APE +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALRE 174
Query: 566 GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625
+FS KSDV+SFGILL EI S + Y +++ +G D C
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVVPR----VEKGYKMDAPDGCPPA 228
Query: 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
+ C RP + L
Sbjct: 229 ---------VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 5e-61
Identities = 70/282 (24%), Positives = 122/282 (43%), Gaps = 27/282 (9%)
Query: 385 ATDNFSI-NKKLGEGGFGPVYKGTLA---DEQEIAVKRLSKISEQG-LKELKNEIILFSK 439
DN I + +LG G FG V +G + ++A+K L + +E+ +E+ E + +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGL 499
L + +V+L+G C E +L+ E L F+ + + S ++ + G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 122
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-TNRVVGTYGYM 558
YL + +HRDL A NVLL KISDFGL++A G D++ + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618
APE + +FS +SDV+S+G+ + E +S + Y ++ +G +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVMA----FIEQGKRMEC 233
Query: 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
C + + C EDRP +V +
Sbjct: 234 PPECPPE---------LYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 9e-61
Identities = 77/306 (25%), Positives = 118/306 (38%), Gaps = 45/306 (14%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL------ADEQEIAVKRLSKISEQG-LKELKNEIILFSK 439
+N K LG G FG V T ++AVK L + ++ + L +E+ + ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 440 L-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQ--------------------E 478
L H N+V LLG C LI+E+ L +++ + E
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 479 RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538
+L + A+G+ +L +HRDL A NVL+ KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 539 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 598
D +MAPE +G +++KSDV+S+GILL EI S +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYPGIPV 272
Query: 599 KLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658
N +KL G ++ I C RP P++
Sbjct: 273 DANF----YKLIQNGFKMDQPFYATEE---------IYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 659 MLGSEI 664
LG ++
Sbjct: 320 FLGCQL 325
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (518), Expect = 1e-60
Identities = 72/301 (23%), Positives = 126/301 (41%), Gaps = 37/301 (12%)
Query: 377 FELATIANATDNFS---------INKKLGEGGFGPVYKGTLA----DEQEIAVKRLSK-I 422
F A F+ I + +G G FG V G L E +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 423 SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKL 482
+E+ ++ +E + + H N++ L G ++I EFM N SLD F ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD--SFLRQNDGQ 124
Query: 483 LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542
+ ++ G A G+ YL + +HRDL A N+L++ ++ K+SDFGL+R D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 543 ETEGNTNRVVG---TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK 599
++ +G + APE +F+ SDV+S+GI++ E++S + Y
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--PYWDMTN 239
Query: 600 LNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659
++I I+ ++ + + L C Q+ RP ++
Sbjct: 240 QDVI-------------NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 660 L 660
L
Sbjct: 287 L 287
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (517), Expect = 1e-60
Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 22/275 (8%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL 445
+ ++ KLG G +G VY+G +AVK L + ++E E + +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 75
Query: 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD 505
V+LLG C +I EFM +L ++ + R + + ++ + + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE-- 132
Query: 506 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD 565
+ IHRDL A N L+ ++ K++DFGL+R GD + + APE +
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190
Query: 566 GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625
+FS+KSDV++FG+LL EI + + Y + + ++L + + + C +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS--PYPGID----LSQVYELLEKDYRMERPEGCPEK 244
Query: 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
+ C Q P DRP +
Sbjct: 245 ---------VYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-60
Identities = 69/273 (25%), Positives = 115/273 (42%), Gaps = 23/273 (8%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK-ISEQGLKELKNEIILFSKLQHRN 444
+++ + + LGEG +G V E+ +AVK + + + +K EI + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ 504
+VK G G + L E+ L I + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 505 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS 564
+ I HRD+K N+LLD+ N KISDFGLA F + E N++ GT Y+APE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 565 DGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623
+F + DV+S GI+L +++G+ + + + P + ID+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236
Query: 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSV 656
++ + + P R +P +
Sbjct: 237 LA------LLHK------ILVENPSARITIPDI 257
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 7e-60
Identities = 75/301 (24%), Positives = 113/301 (37%), Gaps = 40/301 (13%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSKISEQG-LKELKNEIILFSK 439
+ S K LG G FG V + T +AVK L + + L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 440 L-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKL---------------L 483
L H N+V LLG C G L+I E+ L +F+ + + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 484 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543
D A+G+ +L IHRDL A N+LL KI DFGLAR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLI 603
+MAPE + ++ +SDV+S+GI L E+ S + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---- 255
Query: 604 RHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663
+K+ EG + + I C P RP ++ ++ +
Sbjct: 256 -KFYKMIKEGFRMLSPEHAPAE---------MYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
Query: 664 I 664
I
Sbjct: 306 I 306
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-59
Identities = 73/292 (25%), Positives = 117/292 (40%), Gaps = 39/292 (13%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD---EQEIAVKRLSKI-SEQGLKELKNEIILFSKL-Q 441
++ +GEG FG V K + + A+KR+ + S+ ++ E+ + KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFI-------------FDQERCKLLDWSKR 488
H N++ LLG C H L E+ P+ +L F+ L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 489 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 548
H ARG+ YL Q + IHRDL A N+L+ ++ KI+DFGL+R E
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 549 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWK 608
+MA E + ++ SDV+S+G+LL EIVS Y L +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEKLPQ 241
Query: 609 LWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
+ P D + C ++ P +RP +++ L
Sbjct: 242 GYRLEKPLNCDD-------------EVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 1e-59
Identities = 67/279 (24%), Positives = 117/279 (41%), Gaps = 26/279 (9%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHR 443
+++ + +G G +G K +D + + K L ++E + L +E+ L +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 444 NLVKLLGCCIHGEEKLL--IYEFMPNKSLDSFIFDQERCK-LLDWSKRFHIICGTARGLL 500
N+V+ I L + E+ L S I + + LD ++ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 501 YLHQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
H+ D ++HRDLK +NV LD N K+ DFGLAR D + VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYM 181
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618
+PE + ++ KSD++S G LL E+ + + + ++ L + +P +
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELAGKIREGKFRRIPYRY 238
Query: 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI 657
S L E+I + RP + ++
Sbjct: 239 -------SDELNEIITR------MLNLKDYHRPSVEEIL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (510), Expect = 2e-59
Identities = 73/288 (25%), Positives = 126/288 (43%), Gaps = 34/288 (11%)
Query: 373 DLPLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK---ISEQGLK 428
D + EL + FS +++G G FG VY + + + +A+K++S S + +
Sbjct: 1 DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 60
Query: 429 ELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKR 488
++ E+ KL+H N ++ GC + L+ E+ + D ++ L +
Sbjct: 61 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEI 117
Query: 489 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 548
+ G +GL YLH +IHRD+KA N+LL + K+ DFG A
Sbjct: 118 AAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APA 168
Query: 549 NRVVGTYGYMAPEYA---SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRH 605
N VGT +MAPE +GQ+ K DV+S GI +E+ + + N ++ + H
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER---KPPLFNMNAMSALYH 225
Query: 606 AWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCM 653
+ + + S F++ C+Q+ P+DRP
Sbjct: 226 IAQNESPALQSGHWSEYFRN------------FVDSCLQKIPQDRPTS 261
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 3e-59
Identities = 74/276 (26%), Positives = 128/276 (46%), Gaps = 27/276 (9%)
Query: 384 NATDNFSINKKLGEGGFGPVYKGTLADEQEI-AVKRLSKISEQGLKELKNEIILFSKLQH 442
N D + I +LG+G FG VYK + + A K + SE+ L++ EI + + H
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL 502
N+VKLL + ++ EF ++D+ + + ER L S+ + T L YL
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYL 126
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562
H +IIHRDLKA N+L D + K++DFG++ ++ +GT +MAPE
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEV 181
Query: 563 A-----SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617
D + K+DV+S GI L+E+ + +H N + ++ K+ P+
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVLL---KIAKSEPPTL 235
Query: 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCM 653
+ + S N + ++ C+++ + R
Sbjct: 236 AQPSRW--SSNFKDFLKK------CLEKNVDARWTT 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-59
Identities = 72/278 (25%), Positives = 116/278 (41%), Gaps = 34/278 (12%)
Query: 392 NKKLGEGGFGPVYKGTLADE---QEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLV 446
+K+LG G FG V KG + + +AVK L EL E + +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
+++G C E +L+ E L+ ++ + ++ + G+ YL +
Sbjct: 72 RMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES- 126
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN-RVVGTYGYMAPEYASD 565
+HRDL A NVLL KISDFGL++A DE + APE +
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 566 GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK--LNLIRHAWKL-WNEGMPSQLIDAC 622
+FS KSDV+SFG+L+ E S + + + ++ ++ G P ++ D
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQ-KPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD-- 241
Query: 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
+ LC E+RP +V L L
Sbjct: 242 ---------------LMNLCWTYDVENRPGFAAVELRL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 7e-59
Identities = 72/288 (25%), Positives = 131/288 (45%), Gaps = 27/288 (9%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD-----EQEIAVKRLSK-ISEQGLKELKNEIILFSKL 440
+ K +G G FG VYKG L E +A+K L +E+ + E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 441 QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLL 500
H N+++L G + ++I E+M N +LD F+ +++ + ++ G A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMK 124
Query: 501 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-NRVVGTYGYMA 559
YL + +HRDL A N+L++ ++ K+SDFGL+R D T + + A
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 560 PEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619
PE S +F+ SDV+SFGI++ E+++ + + S++++ + I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---------------MKAI 226
Query: 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLP 667
+ F+ + + + C QQ RP ++ +L I P
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 6e-58
Identities = 73/319 (22%), Positives = 130/319 (40%), Gaps = 30/319 (9%)
Query: 382 IANATDNFSINKKLGEGGFGPVYKGTLADEQE-----IAVKRLSKI-SEQGLKELKNEII 435
I T+ F K LG G FG VYKG E E +A+K L + S + KE+ +E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 436 LFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGT 495
+ + + + ++ +LLG C+ LI + MP L ++ + + +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQI 120
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 555
A+G+ YL R++HRDL A NVL+ + KI+DFGLA+ G +E E +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 556 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615
+MA E ++ +SDV+S+G+ + E+++ +
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFG---------------SKPYDGIPASEI 222
Query: 616 SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLPQPKQPGYL 675
S +++ + I I + C + RP +I+ + P++ +
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF--SKMARDPQRYLVI 280
Query: 676 ADRKSTRLDSSLSMPESSS 694
+ L S +
Sbjct: 281 QGDERMHLPSPTDSNFYRA 299
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-57
Identities = 72/302 (23%), Positives = 129/302 (42%), Gaps = 33/302 (10%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL------ADEQEIAVKRLSKI-SEQGLKELKNEIILFSK 439
+ +++++LG+G FG VY+G E +A+K +++ S + E NE + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKL-------LDWSKRFHII 492
++V+LLG G+ L+I E M L S++ SK +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 493 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 552
A G+ YL+ + + +HRDL A N ++ +D KI DFG+ R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 553 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNE 612
+M+PE DG F+ SDV+SFG++L EI + + Y + ++R +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVLRFVMEGGLL 254
Query: 613 GMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIVLPQPKQP 672
P D + +C Q P+ RP +I + E + P ++
Sbjct: 255 DKPDNCPD-------------MLFELMRMCWQYNPKMRPSFLEIISSI-KEEMEPGFREV 300
Query: 673 GY 674
+
Sbjct: 301 SF 302
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-57
Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 28/282 (9%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL----ADEQEIAVKRLSK---ISEQGLKELKNEIILFSK 439
+ + +KLG+G FG V +G +AVK L + + + E+
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGL 499
L HRNL++L G + K+ + E P SL + + LL R+ + A G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGM 124
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG-NTNRVVGTYGYM 558
YL R IHRDL A N+LL KI DFGL RA ++ + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618
APE FS SD + FG+ L E+ + + + N ++ K+ EG
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQIL---HKIDKEGERLPR 236
Query: 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
+ C +D ++ + C PEDRP ++ L
Sbjct: 237 PEDCPQD---------IYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-57
Identities = 61/277 (22%), Positives = 113/277 (40%), Gaps = 31/277 (11%)
Query: 389 FSINKKLGEGGFGPVYKGTLADE-QEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNL 445
+ ++G G F VYKG + E+A L +++ + K E + LQH N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 446 VKLLGCCIHGEEK----LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLY 501
V+ + +L+ E M + +L +++ R K++ +GL +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQF 127
Query: 502 LHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 560
LH + IIHRDLK N+ + + KI D GLA V+GT +MAP
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182
Query: 561 EYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620
E + ++ DV++FG+ +LE+ + + + N + R ++
Sbjct: 183 EMY-EEKYDESVDVYAFGMCMLEMATSE--YPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI 657
K+ I C++Q ++R + ++
Sbjct: 240 PEVKE------------IIEGCIRQNKDERYSIKDLL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 6e-57
Identities = 65/277 (23%), Positives = 108/277 (38%), Gaps = 35/277 (12%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSK---ISEQGLKELKNEIILFSKLQH 442
++F I + LG+G FG VY + +A+K L K +L+ E+ + S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL 502
N+++L G LI E+ P ++ + ++ D + I A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 122
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562
H R+IHRD+K N+LL KI+DFG + + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 563 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK--LNLIRHAWKLWNEGMPSQLID 620
K D++S G+L E + GK F + + I + + + D
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRISRVEFTFPDFVTEGARD 233
Query: 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI 657
+ ++ P RP + V+
Sbjct: 234 LISR-----------------LLKHNPSQRPMLREVL 253
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-56
Identities = 61/277 (22%), Positives = 129/277 (46%), Gaps = 24/277 (8%)
Query: 378 ELATIANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIIL 436
+ ++ + ++ +K+G+G G VY +A QE+A+++++ + + + NEI++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 437 FSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA 496
+ ++ N+V L + G+E ++ E++ SL + + D + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECL 126
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
+ L +LH ++IHRD+K+ N+LL D + K++DFG +++ + +VGT
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPY 181
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616
+MAPE + + K D++S GI+ +E++ G+ Y ++N L + + + G P
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRAL---YLIATNGTPE 235
Query: 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCM 653
S + + C+ E R
Sbjct: 236 LQNPEKL--SAIFRDFLNR------CLDMDVEKRGSA 264
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 6e-55
Identities = 74/298 (24%), Positives = 110/298 (36%), Gaps = 39/298 (13%)
Query: 387 DNFSINKKLGEGGFGPVYKGT------LADEQEIAVKRLSKISEQGLKE--LKNEIILFS 438
D + K LG G FG V + A + +AVK L + + + IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 439 KLQHRNLVKLLGCCIHGEEKLLI-YEFMPNKSLDSFIFDQERC-------------KLLD 484
H N+V LLG C L++ EF +L +++ + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 485 WSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544
A+G+ +L + IHRDL A N+LL + KI DFGLAR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIR 604
+MAPE D ++++SDV+SFG+LL EI S + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDE 244
Query: 605 HAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662
+ EG + D + L C P RP ++ LG+
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 2e-53
Identities = 66/281 (23%), Positives = 112/281 (39%), Gaps = 31/281 (11%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQE----IAVKRLSKISEQGLKE-LKNEIILFSKLQ 441
+ + + +GEG FG V++G + +A+K + ++E E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLY 501
H ++VKL+G +I E L SF+ R LD + + L Y
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAY 123
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 561
L R +HRD+ A NVL+ + K+ DFGL+R + D T ++ +MAPE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPE 179
Query: 562 YASDGQFSVKSDVFSFGILLLEI-VSGKKNRGFYHSDNKLNLIRHAWKL-WNEGMPSQLI 619
+ +F+ SDV+ FG+ + EI + G K +++ + I + +L P L
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239
Query: 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
+ C P RP + L
Sbjct: 240 S-----------------LMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 6e-53
Identities = 78/297 (26%), Positives = 118/297 (39%), Gaps = 41/297 (13%)
Query: 387 DNFSINKKLGEGGFGPVYKGTL--------ADEQEIAVKRLSK-ISEQGLKELKNEIILF 437
D + K LGEG FG V ++AVK L +E+ L +L +E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 438 SKL-QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKL-------------L 483
+ +H+N++ LLG C +I E+ +L ++ + L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 484 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543
ARG+ YL + IHRDL A NVL+ +D KI+DFGLAR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 544 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLI 603
T +MAPE D ++ +SDV+SFG+LL EI + + Y +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVP----V 243
Query: 604 RHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
+KL EG C + + C P RP ++ L
Sbjct: 244 EELFKLLKEGHRMDKPSNCTNE---------LYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 183 bits (465), Expect = 1e-52
Identities = 67/324 (20%), Positives = 120/324 (37%), Gaps = 32/324 (9%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL 445
D++ I+++LG G FG V++ T A A K + E + ++ EI S L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD 505
V L E ++IYEFM L + D+ + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 506 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 563
+H DLK N++ + K+ DFGL ++ GT + APE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVA 197
Query: 564 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623
+D++S G+L ++SG G + D L ++ ++ S +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI----- 252
Query: 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSV--------ILMLGSEIVLPQPKQPGYL 675
S + + IR + P R + G + +P +
Sbjct: 253 --SEDGKDFIRK------LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIR 304
Query: 676 ADRKSTRLDSSLSMPESSSTNTIT 699
K+ +P + +
Sbjct: 305 DSIKTKYDAWPEPLPPLGRISNYS 328
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-52
Identities = 66/240 (27%), Positives = 103/240 (42%), Gaps = 14/240 (5%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK---ISEQGLKELKNEIILFSKLQH 442
++F K LGEG F V LA +E A+K L K I E + + E + S+L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL 502
VKL E+ + N L +I + D + L YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYL 124
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562
H IIHRDLK N+LL++DM+ +I+DFG A+ + + N VGT Y++PE
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 563 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK--LNLIRHAWKLWNEGMPSQLID 620
++ SD+++ G ++ ++V+G F + I + E + D
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL--PPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 239
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (449), Expect = 3e-50
Identities = 59/268 (22%), Positives = 103/268 (38%), Gaps = 24/268 (8%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL 445
D + I ++LG G FG V++ A + K ++ +KNEI + ++L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD 505
+ L E +LI EF+ L I + ++ + + GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 506 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 563
I+H D+K N++ + KI DFGLA DE T + APE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 564 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623
+D+++ G+L ++SG L ++ ++E S +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV----- 255
Query: 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
S + I+ +Q+ P R
Sbjct: 256 --SPEAKDFIKN------LLQKEPRKRL 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-46
Identities = 61/324 (18%), Positives = 117/324 (36%), Gaps = 33/324 (10%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL 445
+ + I + LG G FG V++ + ++ K + K+ +K EI + + +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNI 63
Query: 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD 505
+ L EE ++I+EF+ + I L+ + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 506 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 563
I H D++ N++ + KI +FG AR + N + Y APE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175
Query: 564 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623
S +D++S G L+ ++SG + + I +A ++E ++
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI----- 230
Query: 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI--------LMLGSEIVLPQPKQPGYL 675
S + + + + + R + + S V+ K Y
Sbjct: 231 --SIEAMDFVDR------LLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYY 282
Query: 676 ADRKSTRLDSSLSMPESSSTNTIT 699
L+ +S S I
Sbjct: 283 HTLIKKDLNMVVSAARISCGGAIR 306
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-46
Identities = 69/279 (24%), Positives = 116/279 (41%), Gaps = 34/279 (12%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK---ISEQGLKELKNEI-ILFSKLQ 441
++F ++K LG+G FG V+ Q A+K L K + + ++ E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLY 501
H L + E + E++ L I + C D S+ GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQF 118
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 561
LH I++RDLK N+LLD+D + KI+DFG+ + + + NT GT Y+APE
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 562 YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK--LNLIRHAWKLWNEGMPSQLI 619
+++ D +SFG+LL E++ G+ F+ D + + IR + + +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQDEEELFHSIRMDNPFYPRWLEKEAK 231
Query: 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658
D K + PE R + I
Sbjct: 232 DLLVK-----------------LFVREPEKRLGVRGDIR 253
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 166 bits (420), Expect = 1e-46
Identities = 60/240 (25%), Positives = 107/240 (44%), Gaps = 19/240 (7%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK---ISEQGLKELKNEIILFSKLQH 442
+F I + LG G FG V+ + + A+K L K + + ++ +E ++ S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL 502
++++ G ++ +I +++ L S + +R +C L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LAL 117
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562
II+RDLK N+LLD++ + KI+DFG A+ + GT Y+APE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEV 172
Query: 563 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK--LNLIRHAWKLWNEGMPSQLID 620
S ++ D +SFGIL+ E+++G FY S+ I +A + + D
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTP--FYDSNTMKTYEKILNAELRFPPFFNEDVKD 230
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 163 bits (414), Expect = 3e-46
Identities = 60/275 (21%), Positives = 114/275 (41%), Gaps = 28/275 (10%)
Query: 386 TDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK---ISEQGLKELKNEIILFSKLQ 441
+D + + + LG GG V+ L +++AVK L + E + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 442 HRNLVKLLGCCIH----GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTAR 497
H +V + G ++ E++ +L + + + +I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQ 122
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG-NTNRVVGTYG 556
L + H + IIHRD+K +N+++ K+ DFG+ARA T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616
Y++PE A +SDV+S G +L E+++G+ + D+ +++ + + PS
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVSVAYQHVR-EDPIPPS 235
Query: 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
+ S +L V+ + + PE+R
Sbjct: 236 ARHEGL---SADLDAVVLK------ALAKNPENRY 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 166 bits (420), Expect = 4e-46
Identities = 68/273 (24%), Positives = 113/273 (41%), Gaps = 32/273 (11%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSK---ISEQGLKELKNEII---LFSK 439
++FS+++ +G GGFG VY AD + A+K L K +QG NE I L S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGL 499
+V + ++ I + M L + + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGL 120
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 559
++H +++RDLK +N+LLD+ + +ISD GLA F + + VGT+GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 560 PEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618
PE G + +D FS G +L +++ G + + +K + R + E +P
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-LPDSF 232
Query: 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
S L ++ +Q+ R
Sbjct: 233 -------SPELRSLLEG------LLQRDVNRRL 252
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-45
Identities = 59/273 (21%), Positives = 115/273 (42%), Gaps = 12/273 (4%)
Query: 381 TIANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQG-LKELKNEIILFS 438
+ + ++ +GEG +G V ++ +A+K++S Q + EI +
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 439 KLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARG 498
+ +H N++ + + + ++ + + ++ + + L + + RG
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 499 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-NRVVGTYGY 557
L Y+H ++HRDLK SN+LL+ + KI DFGLAR D V T Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 558 MAPEYASDGQFSVKS-DVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616
APE + + KS D++S G +L E++S + + + L+ + H + G PS
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYLDQLNHILGI--LGSPS 233
Query: 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPED 649
Q C + ++ H + + +
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPN 266
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 9e-45
Identities = 59/270 (21%), Positives = 101/270 (37%), Gaps = 21/270 (7%)
Query: 384 NATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQG-LKELKNEIILFSKLQ 441
+ D + LG G F V ++ +A+K ++K + +G ++NEI + K++
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 442 HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLY 501
H N+V L G LI + + L I +I + Y
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKY 122
Query: 502 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 561
LH + + LD+D ISDFGL++ + GT GY+APE
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPE 179
Query: 562 YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621
+ +S D +S G++ ++ G ++ +N L K S D
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYP---PFYDENDAKLFEQILK-AEYEFDSPYWDD 235
Query: 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
S + + IR +++ PE R
Sbjct: 236 I---SDSAKDFIRH------LMEKDPEKRF 256
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 9e-44
Identities = 50/283 (17%), Positives = 96/283 (33%), Gaps = 25/283 (8%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL 445
+ + + +K+G G FG +Y GT +A +E+A+K ++ +L E ++ +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD 505
+ + C + ++ + SL+ R + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH-- 120
Query: 506 SRLRIIHRDLKASNVL---LDQDMNPKISDFGLARAFGGDETEGN-----TNRVVGTYGY 557
IHRD+K N L + I DFGLA+ + T + + GT Y
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617
+ + S + D+ S G +L+ G + K +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
L + A + C +D+P + +
Sbjct: 240 LCKGYPSE---FATYLNF------CRSLRFDDKPDYSYLRQLF 273
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 156 bits (396), Expect = 9e-44
Identities = 58/282 (20%), Positives = 111/282 (39%), Gaps = 39/282 (13%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK---------ISEQGLKELKNEIIL 436
+N+ + LG G V + +E AVK + ++ + E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 437 FSKLQ-HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGT 495
K+ H N+++L L+++ M L ++ ++ L + I+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRAL 119
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 555
+ LH +L I+HRDLK N+LLD DMN K++DFG + E V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173
Query: 556 GYMAPEYASDGQ------FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKL 609
Y+APE + + D++S G+++ +++G + ++ ++R
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMS- 229
Query: 610 WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
N S D S + +++ + P+ R
Sbjct: 230 GNYQFGSPEWDDY---SDTVKDLVSR------FLVVQPQKRY 262
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 8e-43
Identities = 72/281 (25%), Positives = 113/281 (40%), Gaps = 23/281 (8%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVK--RLSKISEQGLKELKNEIILFSKLQHR 443
+NF +K+GEG +G VYK + +A+K RL +E EI L +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 444 NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH 503
N+VKLL + L++EF+ D + + +GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 504 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-Y 562
R++HRDLK N+L++ + K++DFGLARAFG V T Y APE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174
Query: 563 ASDGQFSVKSDVFSFGILLLEIVSGKKN-RGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621
+S D++S G + E+V+ + G D + R P
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 622 CFKDSF------NLAEVIRCIHIGLL-----CVQQYPEDRP 651
+K SF + ++V+ + + P R
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI 275
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (388), Expect = 1e-42
Identities = 38/285 (13%), Positives = 101/285 (35%), Gaps = 27/285 (9%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL 445
++ + +++GEG FG +++GT L + Q++A+K + S+ +L++E + L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 446 VKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD 505
+ + ++ + SL+ + + + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 506 SRLRIIHRDLKASNVLLDQDMNP-----KISDFGLARAFGGDETEGN-----TNRVVGTY 555
+++RD+K N L+ + + + DFG+ + + T+ + + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 556 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615
YM+ + S + D+ + G + + + G + ++ +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY---ERIGEKKQS 234
Query: 616 SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILML 660
+ L + C + + + P + +
Sbjct: 235 TPLRELCAGFPEEFYKYMHY------ARNLAFDATPDYDYLQGLF 273
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 61/289 (21%), Positives = 106/289 (36%), Gaps = 30/289 (10%)
Query: 385 ATDNFSINKKLGEGGFGPVYKGT--LADEQEIAVKRLSK--ISEQGLKELKNEIILFSKL 440
A + ++GEG +G V+K + +A+KR+ E E+ + L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 441 ---QHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDS---FIFDQERCKLLDWSKRFHIICG 494
+H N+V+L C + + +D D+ + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 495 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 554
RGL +LH R++HRDLK N+L+ K++DFGLAR + + VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 555 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKL----- 609
Y APE ++ D++S G + E+ K F S + L + +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK--PLFRGSSDVDQLGKILDVIGLPGE 236
Query: 610 --WNEGMPSQLIDACFKDSFNLAEVIRCIHIGLL-----CVQQYPEDRP 651
W + K + + + + I C+ P R
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 285
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 4e-41
Identities = 60/279 (21%), Positives = 109/279 (39%), Gaps = 33/279 (11%)
Query: 384 NATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKIS------EQGLKELKNEIIL 436
N D + ++LG G F V K + + A K + K ++++ E+ +
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 437 FSKLQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA 496
++QH N++ L + + +LI E + L F+ ++E L + +
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQIL 123
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLARAFGGDETEGNTNRVV 552
G+ YLH L+I H DLK N++L P KI DFGLA +
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177
Query: 553 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNE 612
GT ++APE + +++D++S G++ ++SG L + + +
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237
Query: 613 GMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
S S + IR + + P+ R
Sbjct: 238 EYFSNT-------SALAKDFIRR------LLVKDPKKRM 263
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 149 bits (377), Expect = 4e-41
Identities = 66/282 (23%), Positives = 116/282 (41%), Gaps = 23/282 (8%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVK--RLSKISEQGLKELKNEIILFSKLQHRN 444
+ + +K+GEG +G VYK + A+K RL K E EI + +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 445 LVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ 504
+VKL + +L++E + + L+ + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 505 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-YA 563
R++HRDLK N+L++++ KI+DFGLARAF + T Y AP+
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLM 173
Query: 564 SDGQFSVKSDVFSFGILLLEIVSGKK-NRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622
++S D++S G + E+V+G G +D + + R ++ P+
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 623 FKDSFNLAEVIR-----------CIHIGLLCVQQYPEDRPCM 653
+ +F + E + I + ++ P R
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-40
Identities = 71/280 (25%), Positives = 113/280 (40%), Gaps = 32/280 (11%)
Query: 393 KKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKE-----LKNEIILFSKLQHRNLV 446
LGEG F VYK Q +A+K++ K+ EI L +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 447 KLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS 506
LL H L+++FM ++ +L S + T +GL YLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 507 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 566
I+HRDLK +N+LLD++ K++DFGLA++FG V T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGA 175
Query: 567 Q-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625
+ + V D+++ G +L E++ F D+ L+ + ++ Q D C
Sbjct: 176 RMYGVGVDMWAVGCILAELLLR---VPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 626 SFNLAEVIRCIHIGLL--------------CVQQYPEDRP 651
+ + I + + P R
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 272
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 6e-40
Identities = 61/282 (21%), Positives = 102/282 (36%), Gaps = 43/282 (15%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKN------EIILFSK 439
+ + LG GGFG VY G ++D +A+K + K EL N E++L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 440 LQ--HRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTAR 497
+ +++LL + +LI E + L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLE 121
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
+ + H ++HRD+K N+L+D + K+ DFG + GT
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 174
Query: 557 YMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615
Y PE+ ++ + V+S GILL ++V G F H + I + + +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHDEE----IIRGQVFFRQRVS 228
Query: 616 SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI 657
S+ +IR C+ P DRP +
Sbjct: 229 SECQH-----------LIRW------CLALRPSDRPTFEEIQ 253
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-39
Identities = 50/238 (21%), Positives = 91/238 (38%), Gaps = 12/238 (5%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK---ISEQGLKELKNEIILFSKLQH 442
++F K LG+G FG V A + A+K L K I++ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL 502
L L + + E+ L + R ++ + A + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG---AEIVSAL 118
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562
+++RD+K N++LD+D + KI+DFGL + D GT Y+APE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEV 176
Query: 563 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620
D + D + G+++ E++ G+ + LI + + +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 234
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-39
Identities = 62/287 (21%), Positives = 103/287 (35%), Gaps = 33/287 (11%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLADE-QEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL 445
+++ K +G G FG VY+ L D + +A+K++ + E+ + KL H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNI 75
Query: 446 VKLLGCCIHGEEK------LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGL 499
V+L EK L+ +++P + L + R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 558
Y+H I HRD+K N+LLD D K+ DFG A+ E N + + Y
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRA 190
Query: 559 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNL--------------IR 604
++ DV+S G +L E++ G+ F L IR
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ--PIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 605 HAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
+ E Q+ + F I + ++ P R
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 7e-39
Identities = 51/275 (18%), Positives = 107/275 (38%), Gaps = 31/275 (11%)
Query: 387 DNFSI-NKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEI-ILFSKLQHR 443
D++ + ++ LG G G V + +++ A+K L + + E+ + + Q
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCP 65
Query: 444 NLVKLLGCCIHGEEK----LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGL 499
++V+++ + L++ E + L S I D+ + + I+ +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAI 124
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNP---KISDFGLARAFGGDETEGNTNRVVGTYG 556
YLH + I HRD+K N+L K++DFG A+ + T
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPY 178
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616
Y+APE ++ D++S G+++ ++ G ++S++ L + G
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYE 235
Query: 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
+ S + +IR ++ P R
Sbjct: 236 FPNPEWSEVSEEVKMLIRN------LLKTEPTQRM 264
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 55/262 (20%), Positives = 106/262 (40%), Gaps = 23/262 (8%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHR 443
+ K+G+G FG V+K Q++A+K++ E EI + L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 444 NLVKLLGCCIHGEEK--------LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGT 495
N+V L+ C L+++F + + L + + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 496 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR--VVG 553
L L+ R +I+HRD+KA+NVL+ +D K++DFGLARAF + V
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 554 TYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNE 612
T Y PE + + D++ G ++ E+ + + + + + +L
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP---IMQGNTEQHQLALISQLCGS 240
Query: 613 GMPSQLIDACFKDSFNLAEVIR 634
P + + + E+++
Sbjct: 241 ITPEVWPNVDNYELYEKLELVK 262
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-37
Identities = 55/283 (19%), Positives = 109/283 (38%), Gaps = 27/283 (9%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHR 443
+ +K+GEG +G V+K + +A+KR+ E EI L +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 444 NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLH 503
N+V+L ++ L++EF F + + L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 504 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 563
++HRDLK N+L++++ K+++FGLARAFG + VV +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVLF 174
Query: 564 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC- 622
+S D++S G + E+ + R + ++ + ++ ++L Q
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAG--RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 623 ---------FKDSFNLAEVIRCIHIGLL-----CVQQYPEDRP 651
+ + +L V+ ++ ++ P R
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (347), Expect = 2e-36
Identities = 59/269 (21%), Positives = 100/269 (37%), Gaps = 32/269 (11%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK---ISEQGLKELKNEIILFSKLQH 442
D F K LG G FG V A+K L K + + ++ NE + +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 443 RNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL 502
LVKL ++ E++ + S + R YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 562
H L +I+RDLK N+L+DQ +++DFG A+ +G T + GT +APE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209
Query: 563 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622
++ D ++ G+L+ E+ +G + +D + + PS
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP---PFFADQPIQIYEKIVSGKVR-FPSHF---- 261
Query: 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
S +L +++R +Q R
Sbjct: 262 ---SSDLKDLLRN------LLQVDLTKRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 6e-35
Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHR 443
+ + +G G +G V ++A+K+L + SE K E+ L ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 444 NLVKLLGCCIHGEEKLLIYEF-MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYL 502
N++ LL E +F + + + + + + L + ++ +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 503 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE- 561
H IIHRDLK N+ +++D KI DFGLAR + + V T Y APE
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 189
Query: 562 YASDGQFSVKSDVFSFGILLLEIVSGK 588
+ +++ D++S G ++ E+++GK
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (325), Expect = 1e-33
Identities = 57/285 (20%), Positives = 116/285 (40%), Gaps = 35/285 (12%)
Query: 345 VVNIARYFRENRNNRGTEQKN-EDQNIDLDLPLFELATIANATDNFSINKKLGEGGFGPV 403
V + AR + + +R E + E ++ D++ + +KLG G + V
Sbjct: 3 VPSRARVYTDVNTHRPREYWDYESHVVEWGNQ-----------DDYQLVRKLGRGKYSEV 51
Query: 404 YKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKL-- 459
++ + + +++ VK L + + K++K EI + L+ N++ L +
Sbjct: 52 FEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108
Query: 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 519
L++E + N + L + + L Y H + I+HRD+K N
Sbjct: 109 LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHN 159
Query: 520 VLLD-QDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ-FSVKSDVFSF 577
V++D + ++ D+GLA + + N V + + PE D Q + D++S
Sbjct: 160 VMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSL 216
Query: 578 GILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622
G +L ++ K+ F+H + + + K+ ID
Sbjct: 217 GCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 4e-33
Identities = 63/276 (22%), Positives = 113/276 (40%), Gaps = 31/276 (11%)
Query: 387 DNFSINKKLGEGGFGPVYKGTLA----DEQEIAVKRLSKIS----EQGLKELKNEIILFS 438
+NF + K LG G +G V+ + A+K L K + + + + E +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 439 KLQHR-NLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTAR 497
++ LV L + LI +++ L + + +ER + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI----- 138
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 557
+L L +L II+RD+K N+LLD + + ++DFGL++ F DETE GT Y
Sbjct: 139 -VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 558 MAPEYASDGQ--FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615
MAP+ G D +S G+L+ E+++G + D + N + + P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS---PFTVDGEKNSQAEISRRILKSEP 253
Query: 616 SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP 651
+ S ++I+ + + P+ R
Sbjct: 254 PYPQEM----SALAKDLIQR------LLMKDPKKRL 279
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-31
Identities = 55/247 (22%), Positives = 96/247 (38%), Gaps = 24/247 (9%)
Query: 387 DNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHR 443
+ K +G G G V ++ +A+K+LS+ ++ K E++L + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 444 NLVKLLGCCIH------GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTAR 497
N++ LL ++ L+ E M + D + +++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 498 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 557
G+ +LH IIHRDLK SN+++ D KI DFGLAR G V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184
Query: 558 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617
APE + D++S G ++ E+V K + + ++ + P
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKI---LFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 618 LIDACFK 624
+
Sbjct: 242 MKKLQPT 248
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-30
Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 11/212 (5%)
Query: 381 TIANATDNFSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSK--ISEQGLKELKNEIILF 437
TI + + +G G +G V +AVK+LS+ S K E+ L
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 438 SKLQHRNLVKLLGCCIHGEE-KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTA 496
++H N++ LL + ++ + + + + +C+ L +I
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 497 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 556
RGL Y+H IIHRDLK SN+ +++D KI DFGLAR + T R +
Sbjct: 132 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WY 184
Query: 557 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
+ ++ D++S G ++ E+++G+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (289), Expect = 1e-28
Identities = 46/215 (21%), Positives = 87/215 (40%), Gaps = 18/215 (8%)
Query: 389 FSINKKLGEGGFGPVYKGT-LADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVK 447
+ + +KLG G F V+ + + +A+K + + + ++EI L ++ + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 448 LLGCCIHGEEKLLIY--EFMPNKSLDSFIFDQERCKLLDWSKRF-----------HIICG 494
+ KLL + PN +F+ LL K++ I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 495 TARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGDETEGNTNRVVG 553
GL Y+H+ R IIH D+K NVL++ D + +A + + +
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 554 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 588
T Y +PE + +D++S L+ E+++G
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 96.8 bits (240), Expect = 1e-23
Identities = 38/205 (18%), Positives = 69/205 (33%), Gaps = 27/205 (13%)
Query: 390 SINKKLGEGGFGPVYKGTLADEQEIAVK--RLSKIS--------EQGLKELKNEIILFSK 439
+I K +GEG V+ E VK ++ S + G I ++
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 440 LQHRNLVKLLGCCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGL 499
+ R L KL G + +Y + N ++ + D + + ++ +
Sbjct: 63 NEFRALQKLQGLAVPK-----VYAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEV 116
Query: 500 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR-VVGTYGYM 558
+ I+H DL NVL+ + I DF + G + R V Y
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 559 APEYASDGQFSVKSDVFSFGILLLE 583
+ Y + D+ S +L+
Sbjct: 173 SRTY------RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 706 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.62 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.61 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.32 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.26 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.05 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.05 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 97.9 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.61 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 97.57 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 97.51 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 97.49 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 97.2 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 97.13 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.87 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.82 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 96.6 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 96.56 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.0 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 91.87 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 89.54 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 88.17 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 85.8 | |
| d1dx5i2 | 35 | Thrombomodulin, different EGF-like domains {Human | 84.29 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 83.66 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 83.22 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 82.82 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 80.22 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=409.97 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=201.5
Q ss_pred ccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.++|++.++||+|+||+||+|+.++ .||||+++. ......+.|.+|+.++++++|||||++++++. .+..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 3689999999999999999998753 599999864 34556789999999999999999999999875 457899999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++|+|.++|.... ..+++..++.++.||++||+|||+++ |+||||||+||||+.++++||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 999999999996543 45899999999999999999999987 9999999999999999999999999998765444
Q ss_pred CcccccccccccCccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.........||+.|||||++.+ ..++.++|||||||+||||+||+.||...... .............+....+..
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~ 236 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYLSPDLSKVRS 236 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHHTSCCCCGGGSCT
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCcchhccc
Confidence 3334455689999999999964 35899999999999999999999998543221 111111111111111111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.. ...+.+++.+||+.||.+||||+||++.|+.+
T Consensus 237 -----~~----~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 237 -----NC----PKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp -----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----cc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 12466789999999999999999999999865
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=407.49 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=198.2
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
++|++.++||+|+||.||+|++.+++.||||+++... ...++|.+|+.++++++|||||++++++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5789999999999999999999888899999997533 345789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+|+|.+++... ...+++..++.++.|||+||+|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence 99999998653 345889999999999999999999988 999999999999999999999999999876433222
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCc
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDS 626 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 626 (706)
......||+.|+|||++.+..++.++|||||||++|||+|+..|+.. ................... +. .
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~--~~~~~~~~~~i~~~~~~~~-p~--------~ 226 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE--NRSNSEVVEDISTGFRLYK-PR--------L 226 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC--SCCHHHHHHHHHHTCCCCC-CT--------T
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC--CCCHHHHHHHHHhcCCCCC-cc--------c
Confidence 22335789999999999999999999999999999999996544321 1122222222222111111 11 1
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 627 FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 627 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
. ...+.+++.+||+.||++||||+||++.|+.+
T Consensus 227 ~----~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 227 A----STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp S----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c----CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1 12466899999999999999999999999865
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=405.41 Aligned_cols=253 Identities=26% Similarity=0.349 Sum_probs=202.3
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.++|++.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 367999999999999999999985 58899999986532 3345678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+++|+|.++|... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 84 y~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999999543 45899999999999999999999988 9999999999999999999999999999875443
Q ss_pred CcccccccccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
........+||+.|||||++.+..+ +.++|||||||++|||++|+.||........ ...... ..........
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~~~~~---~~~~~~~~~~-- 230 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWK---EKKTYLNPWK-- 230 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HHHHHH---TTCTTSTTGG--
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HHHHHh---cCCCCCCccc--
Confidence 3333445789999999999988876 5789999999999999999999864332221 111111 1111110000
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
..+ ..+.+++.+||+.||++|||++|+++
T Consensus 231 ---~~s----~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 231 ---KID----SAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---GSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---cCC----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 24557889999999999999999865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=404.79 Aligned_cols=254 Identities=31% Similarity=0.451 Sum_probs=204.9
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
++|++.++||+|+||.||+|++++++.||||+++... ...+.|.+|+.++++++|||||++++++. .+..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCC
Confidence 5788999999999999999999888899999996533 34578999999999999999999999875 456799999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+|+|.+++.... ...+++..+++++.||++||+|||+.+ |+||||||+||||++++.+||+|||+|+.+......
T Consensus 91 ~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~- 165 (272)
T d1qpca_ 91 NGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT- 165 (272)
T ss_dssp TCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-
T ss_pred CCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc-
Confidence 999999885543 235899999999999999999999988 999999999999999999999999999987543222
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCc
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDS 626 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 626 (706)
......||+.|||||++.+..++.++|||||||++|||+||..|+... .......... ..+......+ .
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~--~~~~~~~~~i----~~~~~~~~p~-----~ 234 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--MTNPEVIQNL----ERGYRMVRPD-----N 234 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHH----HTTCCCCCCT-----T
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC--CCHHHHHHHH----HhcCCCCCcc-----c
Confidence 223457899999999999999999999999999999999976664321 1122222221 1211111111 1
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 627 FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 627 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
.+ ..+.+|+.+||+.||++||||+||+++|+.
T Consensus 235 ~~----~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 235 CP----EELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Ch----HHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 11 246678999999999999999999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-50 Score=409.58 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=209.5
Q ss_pred ccCCCccceeccCCceeEEEEEeCC-CcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLAD-EQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
.++|++.++||+|+||+||+|++.. ++.||||+++... ...++|.+|+.++++++|||||++++++.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 4678999999999999999999854 7889999986533 3467899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+++|+|.+++.... ...+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+....+..
T Consensus 95 ~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999996543 356899999999999999999999988 99999999999999999999999999997654322
Q ss_pred cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 545 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
. ......|++.|+|||++.+..++.++|||||||++|||++|..|+... ...... ......+......+
T Consensus 171 ~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~--~~~~~~----~~~i~~~~~~~~~~---- 239 (287)
T d1opja_ 171 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG--IDLSQV----YELLEKDYRMERPE---- 239 (287)
T ss_dssp E-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT--CCHHHH----HHHHHTTCCCCCCT----
T ss_pred e-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc--chHHHH----HHHHhcCCCCCCCc----
Confidence 2 223356899999999999999999999999999999999987775321 111111 12222222111111
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
..+ ..+.+|+..||+.||.+||||+||++.|+.+
T Consensus 240 -~~~----~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 240 -GCP----EKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp -TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -cch----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 2466899999999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=399.53 Aligned_cols=249 Identities=23% Similarity=0.405 Sum_probs=205.7
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
++|++.++||+|+||+||+|+. .+|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999997 458999999987655556678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++|+|.+++.+ ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 99999998754 34899999999999999999999998 99999999999999999999999999998643322
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......||+.|||||++.+..++.++|||||||++|||++|+.||.... ....... .............
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~---~~~~~~~~~~~~~---- 240 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN---PLRALYL---IATNGTPELQNPE---- 240 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHH---HHHHCSCCCSSGG----
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC---HHHHHHH---HHhCCCCCCCCcc----
Confidence 2334679999999999999999999999999999999999999985322 1222211 1111111100000
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
..+ ..+.+++.+||+.||.+|||++|+++
T Consensus 241 ~~s----~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 KLS----AIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GSC----HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 24567899999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-49 Score=407.49 Aligned_cols=257 Identities=26% Similarity=0.400 Sum_probs=197.1
Q ss_pred cCCCccceeccCCceeEEEEEeCC-C---cEEEEEEcCc-cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-E---QEIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
++|++.++||+|+||+||+|++.. + ..||||++.. ......+.|.+|+.++++++|||||++++++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 567888999999999999999753 2 2589998865 3555667899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++|+|.+++.... ..+++.+++.++.||++||+|||+++ |+||||||+||||+.++++||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999886432 45899999999999999999999988 99999999999999999999999999998754
Q ss_pred CCCcc---cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 542 DETEG---NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 542 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
..... ......||+.|||||.+.+..++.++|||||||+||||+| |+.||..... .+...... .+....
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i~----~~~~~~ 253 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAIE----QDYRLP 253 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHH----TTCCCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHHH----cCCCCC
Confidence 33222 1222457899999999999999999999999999999998 8999754322 22222211 111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
.. ......+.+++.+||+.||.+||||.||++.|+.+.
T Consensus 254 ~~---------~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 254 PP---------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp CC---------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CC---------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 10 011234667999999999999999999999998753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=401.46 Aligned_cols=245 Identities=25% Similarity=0.365 Sum_probs=203.3
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.+.||+|+||+||+|+.+ +++.||||++.+. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999985 5889999998642 2334577899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|.+++... ..+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999999653 35899999999999999999999988 999999999999999999999999999875332
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
......||+.|||||++.+..++.++|||||||+||||++|+.||.... ........ ..... .+ .
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i----~~~~~-~~-p-- 224 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRI----SRVEF-TF-P-- 224 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHH----HTTCC-CC-C--
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC---HHHHHHHH----HcCCC-CC-C--
Confidence 2334679999999999999999999999999999999999999985422 22222211 11111 00 0
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
...+ ..+.+++.+||+.||.+|||++|+++
T Consensus 225 --~~~s----~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 225 --DFVT----EGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --ccCC----HHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1111 24567899999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=406.24 Aligned_cols=248 Identities=25% Similarity=0.330 Sum_probs=201.1
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999984 5889999998652 2334578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999988644 35899999999999999999999998 999999999999999999999999999987544
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
..........||+.|||||++.+..++.++|||||||++|||++|+.||.... ........ . .... .+ .
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i---~-~~~~-~~-p-- 230 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EYLIFQKI---I-KLEY-DF-P-- 230 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH---H-TTCC-CC-C--
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC---HHHHHHHH---H-cCCC-CC-C--
Confidence 44444445689999999999999999999999999999999999999985422 22222111 1 1111 11 0
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVI 657 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~ 657 (706)
...+ ..+.+++.+||+.||.+|||++|++
T Consensus 231 --~~~s----~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 231 --EKFF----PKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp --TTCC----HHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred --ccCC----HHHHHHHHHHccCCHhHCcCHHHHc
Confidence 1111 2456889999999999999999964
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=398.49 Aligned_cols=254 Identities=25% Similarity=0.345 Sum_probs=194.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEe--CCeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIH--GEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 461 (706)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.++++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999984 5889999998653 45556789999999999999999999999875 4567999
Q ss_pred EecCCCCChhhhhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCC--CceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 462 YEFMPNKSLDSFIFDQE-RCKLLDWSKRFHIICGTARGLLYLHQDSR--LRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~--~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
|||+++|+|.+++.+.. ....+++..++.++.||+.||+|||+.+. .+|+||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999996532 34568999999999999999999998642 3499999999999999999999999999998
Q ss_pred cCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL 618 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (706)
+..... ......||+.|||||++.+..++.++|||||||++|||++|+.||.... ..+.... +..+....+
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~~----i~~~~~~~~ 234 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGK----IREGKFRRI 234 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHH----HHHTCCCCC
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHHHH----HHcCCCCCC
Confidence 643322 2334679999999999999999999999999999999999999985432 2222222 122222211
Q ss_pred ccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 619 IDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 619 ~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.. ..+ ..+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~-----~~s----~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 PY-----RYS----DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CT-----TSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Cc-----ccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11 112 24667889999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=391.77 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=209.5
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
++|++.++||+|+||+||+|+.++++.||||+++... ...++|.+|+.++++++|||||++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6899999999999999999999888899999987533 345789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+|+|.+++.... ..+++..+.+++.||++||+|||+.+ |+||||||+||||++++.+||+|||+++.+......
T Consensus 83 ~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 999999985543 45889999999999999999999988 999999999999999999999999999876543322
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......||+.|+|||.+.+..++.++||||||+++|||+| |+.||...... +...... .+......+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~~i~----~~~~~~~p~----- 224 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHIA----QGLRLYRPH----- 224 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHHH----TTCCCCCCT-----
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHHHHHH----hCCCCCCcc-----
Confidence 2333578999999999999999999999999999999998 88887644322 2222211 211111100
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
..+ ..+.+++..||+.||++|||++||++.|..
T Consensus 225 ~~~----~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 LAS----EKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccc----HHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 111 246689999999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=398.32 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=202.7
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMP 466 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 466 (706)
++|++.+.||+|+||.||+|++++++.||||++... ....+.|.+|+.++++++|||||++++++. .+..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 679999999999999999999988889999999653 334578999999999999999999999985 456899999999
Q ss_pred CCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc
Q 005236 467 NKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 546 (706)
Q Consensus 467 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 546 (706)
+|+|..++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||||++++++||+|||+++.+......
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~- 169 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 169 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence 999999886543 245899999999999999999999988 999999999999999999999999999876433322
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccCc
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDS 626 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 626 (706)
......||+.|+|||++....++.++||||||+++|||++|..|+.... ...+...... .+...... ..
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~--~~~~~~~~i~----~~~~~~~~-----~~ 238 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVE----RGYRMPCP-----PE 238 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHH----TTCCCCCC-----TT
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC--CHHHHHHHHH----hcCCCCCC-----cc
Confidence 2233578999999999999999999999999999999999776643322 2222222221 11111111 11
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 627 FNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 627 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
.+ ..+.+++.+||+.||++||||++|+++|+....
T Consensus 239 ~~----~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 239 CP----ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp SC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred cC----HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 11 246689999999999999999999999987643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=399.07 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=200.4
Q ss_pred cCCCccceeccCCceeEEEEEeCCC-----cEEEEEEcCc-cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADE-----QEIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
+.|++.++||+|+||.||+|.++.. ..||||++.. ......++|.+|+.++++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4688889999999999999987542 3699999865 344556689999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
||||+.+++|.+++.... ..+++..+++++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999999885433 45899999999999999999999988 9999999999999999999999999999865
Q ss_pred CCCCcc-cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 541 GDETEG-NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 541 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
...... ......||+.|||||++.+..++.++|||||||++|||++|..|+.... ........ +..+......
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~--~~~~~~~~----i~~~~~~~~~ 235 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKA----INDGFRLPTP 235 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHH----HHTTCCCCCC
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC--CHHHHHHH----HhccCCCCCc
Confidence 432222 2333568999999999999999999999999999999999766643221 11222222 2222211111
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
. .....+.+|+.+||+.+|++||||.||+++|+.++.
T Consensus 236 ~---------~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 236 M---------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp T---------TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred h---------hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 1 111356789999999999999999999999987654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=406.54 Aligned_cols=257 Identities=30% Similarity=0.441 Sum_probs=205.2
Q ss_pred cCCCccceeccCCceeEEEEEeCC------CcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCee
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD------EQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 458 (706)
++|++.++||+|+||+||+|++.. ...||||++... .....+.+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 679999999999999999998743 236899998653 344456789999999998 899999999999999999
Q ss_pred EEEEecCCCCChhhhhhcccc--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCC
Q 005236 459 LLIYEFMPNKSLDSFIFDQER--------------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 518 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~ 518 (706)
++||||+++|+|.++|..... ...+++..++.++.||++||+|||+++ |+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999975432 235899999999999999999999988 999999999
Q ss_pred cEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCC
Q 005236 519 NVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSD 597 (706)
Q Consensus 519 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~ 597 (706)
|||++.++++||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654443333345678999999999999999999999999999999998 89998644332
Q ss_pred CchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhc
Q 005236 598 NKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLG 661 (706)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~ 661 (706)
.. +.. ....+...+... .. ...+.+|+.+||+.||++|||++||+++|.
T Consensus 274 ~~--~~~----~~~~~~~~~~p~-----~~----~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 AN--FYK----LIQNGFKMDQPF-----YA----TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HH--HHH----HHHTTCCCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH--HHH----HHhcCCCCCCCC-----cC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 111 111211111110 11 124668999999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-49 Score=400.90 Aligned_cols=251 Identities=27% Similarity=0.383 Sum_probs=204.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFM 465 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 465 (706)
+.|++.++||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 57899999999999999999985 58899999997766667788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++|+|.+++.+.. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+..... .
T Consensus 92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~ 164 (288)
T d2jfla1 92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I 164 (288)
T ss_dssp TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--H
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--c
Confidence 9999999986432 45899999999999999999999998 999999999999999999999999999764221 1
Q ss_pred ccccccccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 546 GNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.......||+.|||||++. ...++.++|||||||++|||++|+.||...... +..... ..... ..+..
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~~~~~i---~~~~~-~~~~~ 237 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLLKI---AKSEP-PTLAQ 237 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHHHH---HHSCC-CCCSS
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---HHHHHH---HcCCC-CCCCc
Confidence 1223467999999999984 456899999999999999999999998644322 222211 11111 11111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+ ...+ ..+.+++.+||+.||.+|||++|+++
T Consensus 238 ~---~~~s----~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 238 P---SRWS----SNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp G---GGSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c---ccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0111 24567899999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=395.72 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=205.5
Q ss_pred cCCCccc-eeccCCceeEEEEEeC---CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINK-KLGEGGFGPVYKGTLA---DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
++|.+.+ +||+|+||+||+|.++ ++..||||+++.. .....++|.+|+.++++++|||||++++++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 5667777 4999999999999864 3457999999753 45557889999999999999999999999864 568999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++|+|.+++... ...+++..+++++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 9999999999998543 245899999999999999999999988 99999999999999999999999999998754
Q ss_pred CCCc-ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 542 DETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 542 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
.... .......||+.|||||++....++.++|||||||++|||+| |+.||...... +.... +..+...++.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~----i~~~~~~~~p 234 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQGKRMECP 234 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH----HHTTCCCCCC
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCCCCCC
Confidence 4322 22334568999999999999999999999999999999998 89998643321 22221 2222221211
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
. ..+ ..+.+|+.+||+.+|++||||.+|++.|+..
T Consensus 235 ~-----~~~----~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 235 P-----ECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp T-----TCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-----cCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 111 2456799999999999999999999998753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=393.25 Aligned_cols=247 Identities=29% Similarity=0.404 Sum_probs=196.6
Q ss_pred ceeccCCceeEEEEEeCC---CcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEecCCC
Q 005236 393 KKLGEGGFGPVYKGTLAD---EQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEFMPN 467 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 467 (706)
++||+|+||+||+|.+.+ ++.||||+++.. .....++|.+|+.++++++|||||+++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 467999998652 33446789999999999999999999999864 567899999999
Q ss_pred CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCcc-
Q 005236 468 KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG- 546 (706)
Q Consensus 468 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~- 546 (706)
|+|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 9999999653 34899999999999999999999988 9999999999999999999999999999875443322
Q ss_pred cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccccC
Q 005236 547 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFKD 625 (706)
Q Consensus 547 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 625 (706)
......||+.|||||.+.+..++.++|||||||++|||+| |+.||..... .+... .+..+.......
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~----~i~~~~~~~~p~----- 233 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTA----MLEKGERMGCPA----- 233 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHH----HHHTTCCCCCCT-----
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHH----HHHcCCCCCCCc-----
Confidence 2334578999999999999999999999999999999998 8999764322 12221 122222111111
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 626 SFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 626 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
..+ ..+.+|+.+||+.||++|||+++|+++|+.
T Consensus 234 ~~~----~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 234 GCP----REMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp TCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ccC----HHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 111 246679999999999999999999998874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=404.52 Aligned_cols=199 Identities=26% Similarity=0.369 Sum_probs=176.7
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.++|++.++||+|+||+||+|+.. +++.||+|+++.. .....+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 478999999999999999999984 5889999998653 34446789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
|+++|+|.+++.+. ..+++..+..++.||+.||.|||+. + |+||||||+||||++++++||+|||+|+.+..
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 99999999999654 3489999999999999999999974 6 99999999999999999999999999987532
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 594 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~ 594 (706)
......+||+.|||||++.+..++.++||||+||++|||++|+.||...
T Consensus 158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred ---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 1223468999999999999999999999999999999999999998643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=385.15 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=196.0
Q ss_pred CCccceeccCCceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEe----CCeeEEE
Q 005236 389 FSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIH----GEEKLLI 461 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV 461 (706)
|++.++||+|+||+||+|++. +++.||+|++.. ......+.+.+|++++++++|||||++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366789999999999999985 578999999864 345556789999999999999999999999875 3457999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc-CCCCeEEeeeccccccC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFG 540 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~Dfgla~~~~ 540 (706)
|||+++|+|.+++.+. ..+++..+..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999999653 35899999999999999999999874 3599999999999996 57999999999998643
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
.. ......||+.|||||++.+ .++.++|||||||++|||++|+.||..... .... .+.+..+..+..++
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~----~~~i~~~~~~~~~~ 235 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQI----YRRVTSGVKPASFD 235 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHH----HHHHTTTCCCGGGG
T ss_pred CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHHH----HHHHHcCCCCcccC
Confidence 22 2234679999999999865 699999999999999999999999853221 1111 11222222211111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.... ..+.+++.+||+.||++|||++|+++
T Consensus 236 ----~~~~----~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 ----KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----ccCC----HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1111 13567899999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-48 Score=399.11 Aligned_cols=263 Identities=26% Similarity=0.403 Sum_probs=210.8
Q ss_pred HHhccCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC
Q 005236 383 ANATDNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG 455 (706)
Q Consensus 383 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 455 (706)
+...++|++.++||+|+||+||+|+.+ +++.||||++... ..+..++|.+|+.++++++||||+++++++...
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 334578999999999999999999864 3578999999753 344567899999999999999999999999999
Q ss_pred CeeEEEEecCCCCChhhhhhccc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecc
Q 005236 456 EEKLLIYEFMPNKSLDSFIFDQE---------------------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRD 514 (706)
Q Consensus 456 ~~~~lV~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~D 514 (706)
+..++||||+++|+|.++|+... ....+++..++.++.||+.||+|||+++ |+|||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrD 165 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 165 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeE
Confidence 99999999999999999996422 1234889999999999999999999988 99999
Q ss_pred cCCCcEEEcCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCC-CCCC
Q 005236 515 LKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK-NRGF 593 (706)
Q Consensus 515 ikp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~-p~~~ 593 (706)
|||+||||+.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|.. |+..
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 999999999999999999999987654443334445678999999999999999999999999999999999964 5433
Q ss_pred CCCCCchhHHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 594 YHSDNKLNLIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
. ...+.... ...+....+.+ ... ..+.+|+.+||+.+|.+||||.||+++|+++.
T Consensus 246 ~---~~~e~~~~----v~~~~~~~~p~-----~~~----~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 246 M---AHEEVIYY----VRDGNILACPE-----NCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp S---CHHHHHHH----HHTTCCCCCCT-----TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred C---CHHHHHHH----HHcCCCCCCCc-----cch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 2 22222222 22222222211 111 24678999999999999999999999998764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-47 Score=402.92 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=207.7
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
.++|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999984 5889999999877777778899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc--CCCCeEEeeeccccccCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~~~kl~Dfgla~~~~~~ 542 (706)
+++|+|.+++.+. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999998543 245899999999999999999999998 99999999999996 4688999999999876433
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||.... ..+........ ........
T Consensus 180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~--~~~~~~~~--- 248 (350)
T d1koaa2 180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNVKSC--DWNMDDSA--- 248 (350)
T ss_dssp S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHT--CCCSCCGG---
T ss_pred c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHhC--CCCCCccc---
Confidence 2 2334679999999999999999999999999999999999999985332 22222221111 11111100
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. ...+ ..+.+++.+||+.||.+|||++|+++.
T Consensus 249 ~-~~~s----~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 F-SGIS----EDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp G-GGCC----HHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred c-cCCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0111 245678999999999999999999984
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-48 Score=397.76 Aligned_cols=255 Identities=23% Similarity=0.320 Sum_probs=189.8
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc-hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS-EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
.+.|++.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999985 58899999986532 2334678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc---CCCCeEEeeeccccccC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFG 540 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~~kl~Dfgla~~~~ 540 (706)
|+++|+|.++|... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999653 45899999999999999999999988 99999999999994 57899999999998754
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
... .....+||+.|||||++.+..++.++|||||||++|||++|+.||.... ......... ..... ...
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~---~~~~~--~~~ 230 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN---DAKLFEQIL---KAEYE--FDS 230 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHH---TTCCC--CCT
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHh---ccCCC--CCC
Confidence 322 2234679999999999999999999999999999999999999985322 122221111 11111 000
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH--hcC
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM--LGS 662 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~--L~~ 662 (706)
+ .....+ ..+.+++.+||+.||.+|||++|+++. +.+
T Consensus 231 ~-~~~~~s----~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 231 P-YWDDIS----DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp T-TTTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred c-cccCCC----HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 0 001111 246678999999999999999999983 544
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.5e-47 Score=399.89 Aligned_cols=256 Identities=23% Similarity=0.295 Sum_probs=208.6
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
.++|++.++||+|+||.||+|+. .+|+.||||++........+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46899999999999999999998 46899999999776666677889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc--CCCCeEEeeeccccccCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~~~kl~Dfgla~~~~~~ 542 (706)
+++|+|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999999887543 235899999999999999999999988 99999999999998 6789999999999987543
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||..... .......... ..........
T Consensus 183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~-~~~~~~~~~~-- 253 (352)
T d1koba_ 183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKRC-DWEFDEDAFS-- 253 (352)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHC-CCCCCSSTTT--
T ss_pred C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhC-CCCCCccccc--
Confidence 2 23346789999999999999999999999999999999999999854322 2222221111 0001111111
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH--hcC
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM--LGS 662 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~--L~~ 662 (706)
..+ ..+.+|+.+||+.||.+|||++|+++. +++
T Consensus 254 ---~~s----~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 254 ---SVS----PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp ---TSC----HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred ---CCC----HHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 111 245678999999999999999999874 544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-47 Score=390.03 Aligned_cols=245 Identities=29% Similarity=0.455 Sum_probs=199.5
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
+.|++.++||+|+||+||+|+.. +++.||||++... .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35899999999999999999974 5888999998653 2344567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 999999998776433 45899999999999999999999998 99999999999999999999999999986532
Q ss_pred CCcccccccccccCccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
.....||+.|||||++.+ ..++.++|||||||++|||++|+.||.... ....+. .......+ .+.
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~---~~~~~~---~i~~~~~~-~~~ 235 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALY---HIAQNESP-ALQ 235 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHH---HHHHSCCC-CCS
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC---HHHHHH---HHHhCCCC-CCC
Confidence 223579999999999864 468999999999999999999999975322 122221 12222111 111
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.. ..+ ..+.+++.+||+.||.+|||++|+++
T Consensus 236 ~~----~~s----~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 SG----HWS----EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CT----TSC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC----CCC----HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11 111 24667899999999999999999976
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=389.32 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=203.2
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccc------hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKIS------EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 458 (706)
.++|++.++||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+.++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36799999999999999999998 468899999985421 22367899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC----CeEEeeec
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFG 534 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~Dfg 534 (706)
++||||+++|+|.++|... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999999654 35899999999999999999999998 99999999999999877 49999999
Q ss_pred cccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC
Q 005236 535 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM 614 (706)
Q Consensus 535 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 614 (706)
+|+.+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+...... ...
T Consensus 163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~----~~~ 232 (293)
T d1jksa_ 163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVS----AVN 232 (293)
T ss_dssp TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH----TTC
T ss_pred hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC---HHHHHHHHH----hcC
Confidence 998764322 2234578999999999999999999999999999999999999985422 222221111 111
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 615 PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 615 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.. ...... ...+ ..+.+++.+||+.||.+|||++|+++
T Consensus 233 ~~-~~~~~~-~~~s----~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 YE-FEDEYF-SNTS----ALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CC-CCHHHH-TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC-CCchhc-CCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 000000 1111 24567899999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=390.23 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=200.8
Q ss_pred cCCCccceeccCCceeEEEEEeCC-Cc----EEEEEEcCc-cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQ----EIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLL 460 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 460 (706)
++|++.++||+|+||+||+|++.. |+ +||+|++.. ...+..++|.+|+.++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999998743 43 589998865 3445678899999999999999999999999864 5678
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccC
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 540 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~ 540 (706)
++||+.+|+|.+++... ...+++..+++++.||++||+|||+++ |+||||||+||||+.++++||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 89999999999988654 356899999999999999999999988 9999999999999999999999999999876
Q ss_pred CCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc
Q 005236 541 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI 619 (706)
Q Consensus 541 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (706)
............||+.|||||++.+..++.++|||||||+||||+| |+.||......+ ....... +......
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i~~----~~~~~~p 235 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEK----GERLPQP 235 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHHHH----TCCCCCC
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHc----CCCCCCC
Confidence 5554444455678999999999999999999999999999999999 788875443322 2222111 1111110
Q ss_pred cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 620 DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 620 d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
. .. ...+.+++.+||+.||.+|||++||++.|...
T Consensus 236 ~-----~~----~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 236 P-----IC----TIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp T-----TB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c-----cc----CHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 0 11 12466799999999999999999999988754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=388.33 Aligned_cols=261 Identities=28% Similarity=0.403 Sum_probs=199.0
Q ss_pred hccCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCc-cchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCC
Q 005236 385 ATDNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSK-ISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGE 456 (706)
Q Consensus 385 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 456 (706)
..++|++.++||+|+||.||+|++. .++.||||+++. ......+.+..|...+.++ +|+|||++++++.+.+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 3478999999999999999999863 246899999865 3444566788888888777 6899999999987654
Q ss_pred -eeEEEEecCCCCChhhhhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE
Q 005236 457 -EKLLIYEFMPNKSLDSFIFDQER-------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 522 (706)
Q Consensus 457 -~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill 522 (706)
..++||||+++|+|.++|..... ...+++..++.++.||++||+|||+++ |+||||||+||||
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence 68999999999999999975432 235889999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCCCchh
Q 005236 523 DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK-KNRGFYHSDNKLN 601 (706)
Q Consensus 523 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~-~p~~~~~~~~~~~ 601 (706)
++++++||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+||. .||...... .
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~---~ 244 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---E 244 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS---H
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH---H
Confidence 999999999999999775554444455578999999999999999999999999999999999975 455432221 1
Q ss_pred HHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 602 LIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.+.. ....+......+. .+ ..+.+++.+||+.||.+|||++||+++|+++
T Consensus 245 ~~~~---~~~~~~~~~~~~~-----~~----~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 245 EFCR---RLKEGTRMRAPDY-----TT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHH---HHHHTCCCCCCTT-----CC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH---HHhcCCCCCCCcc-----CC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111 1122222111111 11 2466889999999999999999999999865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=390.50 Aligned_cols=248 Identities=21% Similarity=0.263 Sum_probs=203.9
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
.++|++.+.||+|+||.||+|+. .+++.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36799999999999999999998 46899999998653 233467889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++++|++||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999986543 4788999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
.. ......+||+.|||||++.+..++.++|||||||++|||++|+.||..... ..+..... .... .+.
T Consensus 158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~~i~----~~~~-~~p-- 225 (337)
T d1o6la_ 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELIL----MEEI-RFP-- 225 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----HCCC-CCC--
T ss_pred CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHHHHHHh----cCCC-CCC--
Confidence 22 223446899999999999999999999999999999999999999754322 22222111 1111 010
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCC-----hhHHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPC-----MPSVIL 658 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~ev~~ 658 (706)
...+ ..+.+|+..||+.||.+||+ ++|+++
T Consensus 226 ---~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 226 ---RTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---TTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---ccCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1122 24567999999999999995 777775
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-47 Score=380.78 Aligned_cols=249 Identities=26% Similarity=0.387 Sum_probs=196.0
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC-CeeEEEEecC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG-EEKLLIYEFM 465 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~~ 465 (706)
++|++.++||+|+||.||+|+++ |+.||||+++.. ...+.+.+|+.++++++|||||++++++.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 57888999999999999999985 678999999653 3457899999999999999999999999654 5689999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++|+|.++|.... ...+++..+++++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 9999999996542 235899999999999999999999987 999999999999999999999999999865322
Q ss_pred ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccccc
Q 005236 546 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACFK 624 (706)
Q Consensus 546 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 624 (706)
.....+|..|+|||++.+..++.++||||||+++|||+| |+.|+...... +..... ..+...++.+
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i----~~~~~~~~~~---- 223 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EKGYKMDAPD---- 223 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH----TTTCCCCCCT----
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HcCCCCCCCc----
Confidence 223567899999999999999999999999999999998 67776543222 222222 1222112211
Q ss_pred CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 625 DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 625 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
..+ .++.+++.+||+.||.+||||.||+++|+.+
T Consensus 224 -~~~----~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 224 -GCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp -TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cCC----HHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111 2466889999999999999999999999764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=382.29 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=195.0
Q ss_pred cCCCccceeccCCceeEEEEEeCC----CcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD----EQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 461 (706)
++|++.+.||+|+||.||+|++.. +..||||++... .....+.+.+|+.++++++|||||++++++. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 679999999999999999998743 346899998653 4445678999999999999999999999985 5678999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++|+|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+||++++++.+||+|||+|+.+..
T Consensus 86 ~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence 9999999999987543 245899999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLID 620 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 620 (706)
... .......||+.|+|||++.+..++.++|||||||++|||++ |++|+...... +...... .+....+..
T Consensus 161 ~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~i~----~~~~~~~~~ 232 (273)
T d1mp8a_ 161 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIE----NGERLPMPP 232 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHH----TTCCCCCCT
T ss_pred Ccc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHHHH----cCCCCCCCC
Confidence 322 22334678999999999999999999999999999999998 88887654332 2222222 111111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 621 ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
..+ ..+.+|+.+||+.||.+|||++||++.|+.+
T Consensus 233 -----~~~----~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 233 -----NCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp -----TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 2466899999999999999999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=388.10 Aligned_cols=257 Identities=27% Similarity=0.420 Sum_probs=202.2
Q ss_pred cCCCccceeccCCceeEEEEEeCC-Cc--EEEEEEcCc-cchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD-EQ--EIAVKRLSK-ISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 461 (706)
++|++.++||+|+||.||+|++++ +. .||||++.. ......+.+.+|+.+++++ +|||||++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 689999999999999999999854 33 578888754 3444567899999999999 799999999999999999999
Q ss_pred EecCCCCChhhhhhcc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCe
Q 005236 462 YEFMPNKSLDSFIFDQ-------------ERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 528 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 528 (706)
|||+++|+|.++|+.. .....+++..+++++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999754 23456899999999999999999999988 9999999999999999999
Q ss_pred EEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCC-CCCCCCCCCchhHHHHHH
Q 005236 529 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK-NRGFYHSDNKLNLIRHAW 607 (706)
Q Consensus 529 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~-p~~~~~~~~~~~~~~~~~ 607 (706)
||+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|.. |+... ........
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~---~~~~~~~~-- 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAELYEK-- 238 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHH--
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC---CHHHHHHH--
Confidence 99999999864321 22234568999999999999999999999999999999999765 44322 22222211
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 608 KLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 608 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
+..+....... .. ...+.+|+.+||+.||++||||+||++.|+.+..
T Consensus 239 --i~~~~~~~~~~-----~~----~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 239 --LPQGYRLEKPL-----NC----DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp --GGGTCCCCCCT-----TB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHhcCCCCCCc-----cC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 12211111111 11 1256789999999999999999999999987743
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=385.60 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=211.3
Q ss_pred cCCCccceeccCCceeEEEEEeC------CCcEEEEEEcCc-cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA------DEQEIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 459 (706)
++|++.++||+|+||.||+|.++ .++.||||+++. ........|.+|+.++++++|||||++++++...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 68899999999999999999874 257899999975 34455667999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhccc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEee
Q 005236 460 LIYEFMPNKSLDSFIFDQE-------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 532 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 532 (706)
+||||+++|+|.+++.... ....+++..+.+++.|+++||.|||+.+ |+||||||+||||++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 9999999999999986432 2245789999999999999999999987 99999999999999999999999
Q ss_pred eccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCCCchhHHHHHHHHhh
Q 005236 533 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK-KNRGFYHSDNKLNLIRHAWKLWN 611 (706)
Q Consensus 533 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~ 611 (706)
||+++.+.............||+.|+|||.+.+..++.++||||||+++|||+||. .|+... ........ +.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~---~~~~~~~~----i~ 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRF----VM 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHHHHHHH----HH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC---CHHHHHHH----HH
Confidence 99998775444444445567899999999999999999999999999999999986 554322 11122211 11
Q ss_pred cCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCCC
Q 005236 612 EGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEIV 665 (706)
Q Consensus 612 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~~ 665 (706)
.+......+ ..+ ..+.+++.+||+.+|.+||||++|+++|++..+
T Consensus 250 ~~~~~~~p~-----~~~----~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGGLLDKPD-----NCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTCCCCCCT-----TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCCCCCCcc-----cch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 222222111 111 257789999999999999999999999987643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-46 Score=387.53 Aligned_cols=244 Identities=25% Similarity=0.321 Sum_probs=201.8
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.++||+|+||+||+|+.+ +|+.||||++++. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999984 5899999998652 2334678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999999988654 34788888999999999999999988 999999999999999999999999999876432
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
.....||+.|||||++.+..++.++|||||||+||||++|+.||.... ........... ....+.
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~i~~~--~~~~p~----- 222 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKTYEKILNA--ELRFPP----- 222 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHC--CCCCCT-----
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC---HHHHHHHHHcC--CCCCCC-----
Confidence 234689999999999999999999999999999999999999985422 22222221111 111111
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCC-----ChhHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRP-----CMPSVIL 658 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~ev~~ 658 (706)
..+ ..+.+++.+||+.||.+|| |++|+++
T Consensus 223 ---~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 223 ---FFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ---TSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 111 2356788999999999996 8999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-45 Score=388.68 Aligned_cols=244 Identities=21% Similarity=0.239 Sum_probs=202.7
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 462 (706)
++|++.++||+|+||.||+|+.+ +|+.||||++.+. .....+.+.+|+.+++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 58999999999999999999984 5899999998642 2334577899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 542 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~ 542 (706)
||+.+|+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+||||+.++++||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999996543 4899999999999999999999998 999999999999999999999999999986432
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
.....||+.|||||++.+..++.++|||||||++|||++|+.||... .......... .. ... ..
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~---~~-~~~-~p--- 258 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIV---SG-KVR-FP--- 258 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHH---HC-CCC-CC---
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---CHHHHHHHHh---cC-CCC-CC---
Confidence 23467999999999999999999999999999999999999998532 2222222211 11 110 00
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCC-----CChhHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDR-----PCMPSVIL 658 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~R-----Pt~~ev~~ 658 (706)
...+ ..+.+++.+||+.||.+| ||++|+++
T Consensus 259 --~~~s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 --SHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --TTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --ccCC----HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1111 245678999999999999 48999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=379.65 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=195.4
Q ss_pred cCCCccceeccCCceeEEEEEeCC--C--cEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD--E--QEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 459 (706)
++|++.+.||+|+||.||+|+... + ..||||++.+. .....+.|.+|+.++++++|||||++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 569999999999999999998632 2 36899998653 34456789999999999999999999999965 5678
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
+||||+++|+|.+++.... ..+++..+++++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 9999999999999886543 45899999999999999999999988 999999999999999999999999999987
Q ss_pred CCCCCcc-cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 540 GGDETEG-NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 540 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
....... ......||..|+|||++.+..++.++||||||+++|||+| |+.||..... .+... .....+...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~---~~~~~---~i~~~~~~~~ 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILH---KIDKEGERLP 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH---HHHTSCCCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH---HHHHH---HHHhCCCCCC
Confidence 5443322 2334567889999999999999999999999999999998 8999753222 22222 2222222211
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcC
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGS 662 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~ 662 (706)
..+ ..+ ..+.+++.+||+.||.+||||+||+++|++
T Consensus 236 ~~~-----~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 236 RPE-----DCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCT-----TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Ccc-----ccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111 111 246679999999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=383.93 Aligned_cols=259 Identities=29% Similarity=0.417 Sum_probs=207.1
Q ss_pred cCCCccceeccCCceeEEEEEeCC--------CcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCC
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLAD--------EQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGE 456 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 456 (706)
++|++.++||+|+||.||+|+... +..||||+++.. ......++.+|...+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 689999999999999999998632 347999999763 345567889999999888 7999999999999999
Q ss_pred eeEEEEecCCCCChhhhhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQER-------------CKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 523 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~ 523 (706)
..++||||+++|+|.++|..... ...+++..+++++.||+.||+|||+.+ |+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 99999999999999999965431 245899999999999999999999998 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCchhH
Q 005236 524 QDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNKLNL 602 (706)
Q Consensus 524 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ellt-G~~p~~~~~~~~~~~~ 602 (706)
.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~~- 245 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EE- 245 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH-
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---HH-
Confidence 999999999999998765555445555779999999999999999999999999999999998 6777643222 11
Q ss_pred HHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCCC
Q 005236 603 IRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSEI 664 (706)
Q Consensus 603 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~~ 664 (706)
....+..+....... ... ..+.+|+.+||+.||++|||+.||++.|+++.
T Consensus 246 ---~~~~i~~~~~~~~p~-----~~~----~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 246 ---LFKLLKEGHRMDKPS-----NCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp ---HHHHHHTTCCCCCCS-----SCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHcCCCCCCCc-----cch----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 122222222222111 111 24678999999999999999999999998763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=383.60 Aligned_cols=260 Identities=28% Similarity=0.399 Sum_probs=209.8
Q ss_pred ccCCCccceeccCCceeEEEEEe------CCCcEEEEEEcCcc-chhhHHHHHHHHHHHhhc-CCcceeeeEeEEEeCCe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL------ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKL-QHRNLVKLLGCCIHGEE 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 457 (706)
.++|++.++||+|+||.||+|++ ..++.||||+++.. ......++.+|+.+++++ +|||||++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 36899999999999999999985 23568999999753 445566899999999999 69999999999999999
Q ss_pred eEEEEecCCCCChhhhhhccc---------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE
Q 005236 458 KLLIYEFMPNKSLDSFIFDQE---------------RCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 522 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill 522 (706)
.++||||+++|+|.++|+... ....+++..+++++.||++||+|||+++ ++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999997542 2235889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCC-CCCCCCCCchh
Q 005236 523 DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN-RGFYHSDNKLN 601 (706)
Q Consensus 523 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p-~~~~~~~~~~~ 601 (706)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+|+..| +......+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~--- 255 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--- 255 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH---
Confidence 99999999999999987654444444557899999999999999999999999999999999995544 43322221
Q ss_pred HHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 602 LIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.+.. ....+....... .. ...+.+|+.+||+.||.+||||+||+++|++.
T Consensus 256 ~~~~---~i~~~~~~~~~~-----~~----~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 256 KFYK---MIKEGFRMLSPE-----HA----PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHH---HHHHTCCCCCCT-----TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH---HHhcCCCCCCcc-----cc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1111 111111111110 11 12467899999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.1e-46 Score=379.32 Aligned_cols=257 Identities=22% Similarity=0.335 Sum_probs=199.4
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc---chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC----e
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI---SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE----E 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 457 (706)
.++|++.+.||+|+||.||+|+. .+++.||||+++.. .....+.+.+|+.++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46899999999999999999997 46889999999653 3444668999999999999999999999998654 3
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.++||||+++++|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+||||+.++..+|+|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999988554 35899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCC-cccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC-
Q 005236 538 AFGGDET-EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP- 615 (706)
Q Consensus 538 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 615 (706)
....... ........||+.|||||++.+..++.++|||||||++|||+||+.||.... .... ..........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~---~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS---PVSV---AYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHH---HHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC---HHHH---HHHHHhcCCCC
Confidence 6543222 223344679999999999999999999999999999999999999985322 1121 2222222221
Q ss_pred cccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCC-ChhHHHHHhcC
Q 005236 616 SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRP-CMPSVILMLGS 662 (706)
Q Consensus 616 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-t~~ev~~~L~~ 662 (706)
..... ...+ ..+.+++.+||+.||.+|| |+++++..|..
T Consensus 234 ~~~~~----~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 PSARH----EGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp GGGTS----SSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred Cchhc----cCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 11111 1111 2456789999999999999 89999888764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-45 Score=375.44 Aligned_cols=252 Identities=22% Similarity=0.330 Sum_probs=201.5
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccc---------hhhHHHHHHHHHHHhhcC-CcceeeeEeEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKIS---------EQGLKELKNEIILFSKLQ-HRNLVKLLGCCIH 454 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 454 (706)
.++|++.+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999998 468899999986422 122356889999999997 9999999999999
Q ss_pred CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeec
Q 005236 455 GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 534 (706)
Q Consensus 455 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 534 (706)
.+..++||||+++|+|.++|... ..+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999999653 35899999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccCccCcccccc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH
Q 005236 535 LARAFGGDETEGNTNRVVGTYGYMAPEYASD------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWK 608 (706)
Q Consensus 535 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 608 (706)
+++.+.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... .......
T Consensus 156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~~~~~--- 226 (277)
T d1phka_ 156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRM--- 226 (277)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH---
T ss_pred heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHHHHHH---
Confidence 999875432 2233679999999999853 357889999999999999999999986432 1121111
Q ss_pred HhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 609 LWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 609 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
... +... ...+.. ...+ ..+.+++.+||+.||.+|||++||++.
T Consensus 227 i~~-~~~~-~~~~~~-~~~s----~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 227 IMS-GNYQ-FGSPEW-DDYS----DTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHH-TCCC-CCTTTG-GGSC----HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHh-CCCC-CCCccc-ccCC----HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111 1111 000000 0111 246678999999999999999998753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=380.90 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=200.6
Q ss_pred cceeccCCceeEEEEEeCCC----cEEEEEEcCc-cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC-CeeEEEEecC
Q 005236 392 NKKLGEGGFGPVYKGTLADE----QEIAVKRLSK-ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG-EEKLLIYEFM 465 (706)
Q Consensus 392 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~~ 465 (706)
.++||+|+||+||+|++.++ ..||||+++. ......++|.+|+.++++++|||||++++++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999998542 2589999975 4566678899999999999999999999998764 5789999999
Q ss_pred CCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCCc
Q 005236 466 PNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 545 (706)
Q Consensus 466 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 545 (706)
++|+|.+++... ...+++..+++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999998643 345778889999999999999999988 999999999999999999999999999987543322
Q ss_pred c--cccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccccc
Q 005236 546 G--NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDACF 623 (706)
Q Consensus 546 ~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 623 (706)
. ......||+.|+|||.+....++.++||||||+++|||+||+.|+..... ......... .+......+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i~----~g~~~~~p~--- 257 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLL----QGRRLLQPE--- 257 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH----TTCCCCCCT---
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHHH----cCCCCCCcc---
Confidence 2 23335789999999999999999999999999999999998887643221 111111111 111111101
Q ss_pred cCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 624 KDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 624 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.. ...+.+++.+||+.||++||+|.||++.|+++
T Consensus 258 --~~----~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 258 --YC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp --TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --cC----cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 12466899999999999999999999999876
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=381.64 Aligned_cols=268 Identities=23% Similarity=0.276 Sum_probs=199.6
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC----eeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE----EKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 462 (706)
++|.+.++||+|+||.||+|++ +|+.||||++...... ....+.|+..+.+++|||||++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4678889999999999999997 5789999998643221 222344555667889999999999998754 578999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
||+++|+|.++|++. .++|..+++++.|+|.||+|||+. ...+|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999653 488999999999999999999974 12459999999999999999999999999999
Q ss_pred ccCCCCC--cccccccccccCccCccccccCC------CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc--------hh
Q 005236 538 AFGGDET--EGNTNRVVGTYGYMAPEYASDGQ------FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNK--------LN 601 (706)
Q Consensus 538 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~s~~sDv~SlGvil~elltG~~p~~~~~~~~~--------~~ 601 (706)
....... ........||+.|||||++.+.. ++.++|||||||+||||+||..|+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 8744322 22334567999999999987653 67799999999999999999887643221110 01
Q ss_pred HHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 602 LIRHAWKLWNEGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
..............+.-+.. .....+....+.+++.+||+.||++|||+.||++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCG---GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCc---ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11222222222222111111 111223455677899999999999999999999999765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-46 Score=385.73 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=199.9
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCcc---chhhHHHHHHHHHHHh-hcCCcceeeeEeEEEeCCeeEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKI---SEQGLKELKNEIILFS-KLQHRNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV 461 (706)
++|++.++||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999985 5889999999652 2334556667777665 68999999999999999999999
Q ss_pred EecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCC
Q 005236 462 YEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 541 (706)
Q Consensus 462 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~ 541 (706)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999996543 4788999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA 621 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 621 (706)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......... .....+.
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~--~~~~~p~---- 224 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRM--DNPFYPR---- 224 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH--CCCCCCT----
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHc--CCCCCCc----
Confidence 32 22334679999999999999999999999999999999999999985422 2222222111 1111111
Q ss_pred cccCcCCHHHHHHHHHHHHHhcCCCCCCCCChh-HHHH
Q 005236 622 CFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMP-SVIL 658 (706)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~-ev~~ 658 (706)
..+ ..+.+|+.+||+.||.+||++. |+++
T Consensus 225 ----~~s----~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 225 ----WLE----KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----TSC----HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----cCC----HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111 2466889999999999999996 6754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-44 Score=382.19 Aligned_cols=249 Identities=25% Similarity=0.310 Sum_probs=197.1
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccc---hhhHHHHH---HHHHHHhhcCCcceeeeEeEEEeCCee
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKIS---EQGLKELK---NEIILFSKLQHRNLVKLLGCCIHGEEK 458 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~ 458 (706)
.++|++.++||+|+||.||+|+.. +|+.||||++.+.. ......+. .|+.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999985 58999999985421 12223333 446677778899999999999999999
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
++||||+++|+|.++|... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999999654 34788999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 539 FGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 539 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
+... ......||+.|||||++.. ..++.++|||||||+||||++|+.||......+..... ....... ..
T Consensus 157 ~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~~~~-~~ 227 (364)
T d1omwa3 157 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTMA-VE 227 (364)
T ss_dssp CSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHSSSCC-CC
T ss_pred cCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhcccCC-CC
Confidence 6433 2334679999999999975 56899999999999999999999998654433322211 1111111 11
Q ss_pred cccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCC-----hhHHHH
Q 005236 618 LIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPC-----MPSVIL 658 (706)
Q Consensus 618 ~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~ev~~ 658 (706)
+. ...+ ..+.+++..||+.||.+||| ++|+++
T Consensus 228 ~~-----~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 228 LP-----DSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CC-----SSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CC-----CCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11 1112 24567899999999999999 577764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=380.85 Aligned_cols=251 Identities=21% Similarity=0.288 Sum_probs=202.9
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
.++|++.++||+|+||+||+|+.. +++.||||+++.... ....+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999985 578899999976443 345688999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC--CCeEEeeeccccccCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLARAFGGD 542 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~--~~~kl~Dfgla~~~~~~ 542 (706)
+++|+|.++|.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 99999999995432 35899999999999999999999988 9999999999999854 58999999999876432
Q ss_pred CCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccccccc
Q 005236 543 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDAC 622 (706)
Q Consensus 543 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 622 (706)
. ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||..... ....... ...... +....
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~~~~~~i---~~~~~~--~~~~~ 226 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENI---MNAEYT--FDEEA 226 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHH---HHTCCC--CCHHH
T ss_pred C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---HHHHHHH---HhCCCC--CChhh
Confidence 2 23346789999999999999999999999999999999999999854322 1222111 111110 00000
Q ss_pred ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 623 FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 623 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+ ...+ ..+.+++..||+.||.+|||++|+++
T Consensus 227 ~-~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 F-KEIS----IEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp H-TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c-cCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 1111 24568899999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=376.97 Aligned_cols=257 Identities=27% Similarity=0.306 Sum_probs=194.4
Q ss_pred ccceeccCCceeEEEEEeC-CCcEEEEEEcCccchh-----hHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 391 INKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQ-----GLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 391 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
.+++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3579999999999999985 5889999998653221 134688999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+.++++..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 999887766532 345888899999999999999999998 99999999999999999999999999987643322
Q ss_pred cccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccccc--
Q 005236 545 EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLIDA-- 621 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-- 621 (706)
.....+||+.|+|||++... .++.++|||||||++|||++|+.||..... .+......+...........+.
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---HHHHHHHHHhcCCCChhhccchhc
Confidence 22335799999999998754 679999999999999999999999754332 2222222222211111000000
Q ss_pred -----ccc--CcCCHHH-----HHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 622 -----CFK--DSFNLAE-----VIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 622 -----~~~--~~~~~~~-----~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
... ....... ...+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000 0011111 135678999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-45 Score=380.53 Aligned_cols=253 Identities=19% Similarity=0.226 Sum_probs=195.6
Q ss_pred ccCCCccc-eeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhc-CCcceeeeEeEEEe----CCee
Q 005236 386 TDNFSINK-KLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKL-QHRNLVKLLGCCIH----GEEK 458 (706)
Q Consensus 386 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 458 (706)
.++|.+.. .||+|+||+||+|+. .+++.||||+++. .+.+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36898875 599999999999998 5588999999854 24567899887655 89999999999876 4568
Q ss_pred EEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---CCCeEEeeecc
Q 005236 459 LLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGL 535 (706)
Q Consensus 459 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Dfgl 535 (706)
++|||||+||+|.++|.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 99999999999999996532 245899999999999999999999998 999999999999985 56799999999
Q ss_pred ccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
|+...... ......||+.|||||++.+..++.++|||||||+||||+||+.||...........+ .........
T Consensus 161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i~~~~~ 234 (335)
T d2ozaa1 161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQY 234 (335)
T ss_dssp CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS
T ss_pred eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHHhcCCC
Confidence 98764432 223467999999999999999999999999999999999999998643332221111 111100000
Q ss_pred cccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 616 SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 616 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.+..+.. ..-...+.+|+.+||+.||.+|||+.|+++.
T Consensus 235 -~~~~~~~-----~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 -EFPNPEW-----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -SCCTTHH-----HHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCCCccc-----ccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000000 0112356789999999999999999999883
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=373.49 Aligned_cols=266 Identities=23% Similarity=0.306 Sum_probs=200.4
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccc--hhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKIS--EQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
++|++.++||+|+||+||+|+. .+++.||||+++... ....+.+.+|+.++++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999998 568999999986532 2345788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
|+.++.+. ++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~-~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKK-FMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHH-HHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhh-hhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99765444 33222 2355899999999999999999999998 9999999999999999999999999998764332
Q ss_pred CcccccccccccCccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhc---CCCcccc
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNE---GMPSQLI 619 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 619 (706)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.||..... ............. .......
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGG
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH---HHHHHHHHHhcCCCchhhccccc
Confidence 2233457999999999987765 57899999999999999999999864322 2222222211111 0000000
Q ss_pred c------ccc-cCcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHHH--hcC
Q 005236 620 D------ACF-KDSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVILM--LGS 662 (706)
Q Consensus 620 d------~~~-~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~~--L~~ 662 (706)
. ... ....... ....+.+++.+||+.||.+|||++|+++. +++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 0 000 0000111 11356788999999999999999999985 554
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.6e-44 Score=368.09 Aligned_cols=261 Identities=23% Similarity=0.302 Sum_probs=199.7
Q ss_pred cCCCccceeccCCceeEEEEEeCCCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 464 (706)
++|++.++||+|+||+||+|++++++.||||++... .....+.+.+|+.++++++|||||++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 689999999999999999999999999999998653 333457899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 544 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~~ 544 (706)
+.++.+..+... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 998877777643 245899999999999999999999988 99999999999999999999999999988643322
Q ss_pred cccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcccc----
Q 005236 545 EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQLI---- 619 (706)
Q Consensus 545 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 619 (706)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||..... .+..................
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCCChhhccchhh
Confidence 22335689999999999765 568999999999999999999999854322 22222222211111000000
Q ss_pred -----------cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 620 -----------DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 620 -----------d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
...........-...+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000001124668999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=360.75 Aligned_cols=239 Identities=25% Similarity=0.392 Sum_probs=192.9
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccch------hhHHHHHHHHHHHhhcC--CcceeeeEeEEEeCCe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISE------QGLKELKNEIILFSKLQ--HRNLVKLLGCCIHGEE 457 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 457 (706)
++|++.++||+|+||+||+|+.. +++.||||++.+... .....+.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999984 689999999864211 12234678999999997 8999999999999999
Q ss_pred eEEEEecCCC-CChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-CCCeEEeeecc
Q 005236 458 KLLIYEFMPN-KSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGL 535 (706)
Q Consensus 458 ~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfgl 535 (706)
.++||||+.+ +++.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 5777777543 35899999999999999999999988 999999999999985 47999999999
Q ss_pred ccccCCCCCcccccccccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCC
Q 005236 536 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGM 614 (706)
Q Consensus 536 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 614 (706)
|+..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||... +.+ .....
T Consensus 158 a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i------~~~~~ 221 (273)
T d1xwsa_ 158 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEI------IRGQV 221 (273)
T ss_dssp CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHH------HHCCC
T ss_pred ceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHH------hhccc
Confidence 9875322 2234679999999999988776 56789999999999999999998531 111 11111
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 615 PSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 615 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
. +....+ ..+.+++.+||+.||++|||++|+++
T Consensus 222 ~-------~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 F-------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp C-------CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-------CCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 011112 24567899999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=366.07 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=194.5
Q ss_pred ccCCCccceeccCCceeEEEEEeC-C-CcEEEEEEcCcc--chhhHHHHHHHHHHHhhc---CCcceeeeEeEEEe----
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-D-EQEIAVKRLSKI--SEQGLKELKNEIILFSKL---QHRNLVKLLGCCIH---- 454 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 454 (706)
.++|++.++||+|+||+||+|++. + ++.||||++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999973 3 567999998642 222233456777776665 89999999999864
Q ss_pred -CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeee
Q 005236 455 -GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 533 (706)
Q Consensus 455 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 533 (706)
....+++|||++++++...... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 2467899999999877655432 3355889999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC
Q 005236 534 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG 613 (706)
Q Consensus 534 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 613 (706)
|+++.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+............
T Consensus 161 g~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 161 GLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLP 234 (305)
T ss_dssp CSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCC
T ss_pred hhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCC
Confidence 99986432 2233456799999999999999999999999999999999999999864332 22222222211110
Q ss_pred CCcc----------ccc-------ccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 614 MPSQ----------LID-------ACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 614 ~~~~----------~~d-------~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
.... ... ..+....+ ..+.+|+.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s----~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDID----ELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC----HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhcccccccchhhhhccccccchhhccccCC----HHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 000 00001111 245678999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=360.68 Aligned_cols=268 Identities=22% Similarity=0.284 Sum_probs=197.7
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEe--------
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIH-------- 454 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 454 (706)
.++|++.++||+|+||+||+|++ .+|+.||||++... .....+.+.+|+.++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 37899999999999999999998 46899999998543 33345678899999999999999999999865
Q ss_pred CCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeec
Q 005236 455 GEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 534 (706)
Q Consensus 455 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 534 (706)
....++||||++++.+..+.. ....++...+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 346789999999887765543 2345788899999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCCCc--ccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhh
Q 005236 535 LARAFGGDETE--GNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWN 611 (706)
Q Consensus 535 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 611 (706)
+++.+...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...........+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99876543222 222335799999999998765 689999999999999999999999854332222222222111111
Q ss_pred cCCCccc--------ccccccCcCCHHH-------HHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 612 EGMPSQL--------IDACFKDSFNLAE-------VIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 612 ~~~~~~~--------~d~~~~~~~~~~~-------~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
....... +...........+ ...+++|+.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 1110000 0000111111111 1245679999999999999999999865
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-42 Score=354.42 Aligned_cols=260 Identities=19% Similarity=0.265 Sum_probs=196.2
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceee-eEeEEEeCCeeEEEEec
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVK-LLGCCIHGEEKLLIYEF 464 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lV~e~ 464 (706)
++|++.++||+|+||.||+|++ .+++.||||++..... .+++..|++++++++|+|++. +..++.+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999998 4588999998765322 246788999999998776554 55666778889999999
Q ss_pred CCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc---CCCCeEEeeeccccccCC
Q 005236 465 MPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGG 541 (706)
Q Consensus 465 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~~kl~Dfgla~~~~~ 541 (706)
+. ++|...+... ...+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 94 5565555332 245899999999999999999999998 99999999999986 455799999999998754
Q ss_pred CCCc-----ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc
Q 005236 542 DETE-----GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616 (706)
Q Consensus 542 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (706)
.... .......||+.|||||.+.+..++.++|||||||++|||++|+.||...........+.............
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 3221 12334679999999999999999999999999999999999999987655544433332222211111111
Q ss_pred ccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 617 QLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 617 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
.+.+ ..+ ..+.+++..||+.+|++||+++++.+.|+..
T Consensus 239 ~~~~-----~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 239 VLCK-----GYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHTT-----TSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred Hhcc-----CCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1111 111 2456788899999999999999999888754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-41 Score=350.15 Aligned_cols=261 Identities=15% Similarity=0.216 Sum_probs=206.2
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCC-cceeeeEeEEEeCCeeEEEEe
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQH-RNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e 463 (706)
.++|++.++||+|+||+||+|++. +++.||||++..... ...+.+|++.++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 368999999999999999999975 588999998754322 2457788999999975 899999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-----CCCeEEeeeccccc
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLARA 538 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~-----~~~~kl~Dfgla~~ 538 (706)
|+ +++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 689999885433 45889999999999999999999988 999999999999974 57899999999998
Q ss_pred cCCCCCc-----ccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcC
Q 005236 539 FGGDETE-----GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEG 613 (706)
Q Consensus 539 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 613 (706)
+...... .......||+.|||||.+.+..++.++|||||||++|||++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 6533221 12334679999999999999999999999999999999999999997655544433333222221111
Q ss_pred CCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHHhcCC
Q 005236 614 MPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILMLGSE 663 (706)
Q Consensus 614 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~L~~~ 663 (706)
...++.. ..+ ..+.+++..|++.+|.+||+++.+.+.|+..
T Consensus 236 ~~~~l~~-----~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 236 PLRELCA-----GFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp CHHHHTT-----TSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ChHHhcC-----CCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 2222211 111 2356688899999999999999998888754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-42 Score=362.67 Aligned_cols=261 Identities=23% Similarity=0.260 Sum_probs=192.6
Q ss_pred CCCccceeccCCceeEEEEEeC-CCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC------CeeEE
Q 005236 388 NFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG------EEKLL 460 (706)
Q Consensus 388 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 460 (706)
+|+..++||+|+||+||+|++. +++.||||++..... .+.+|+.++++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999985 589999999865332 234799999999999999999998643 24689
Q ss_pred EEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-CeEEeeecccccc
Q 005236 461 IYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAF 539 (706)
Q Consensus 461 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfgla~~~ 539 (706)
||||++++.+..+.........+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755554443344456899999999999999999999988 99999999999999775 8999999999876
Q ss_pred CCCCCcccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH--------HHHh
Q 005236 540 GGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHA--------WKLW 610 (706)
Q Consensus 540 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~--------~~~~ 610 (706)
..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+... +...
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 43322 223579999999998875 57899999999999999999999998643322211111110 0000
Q ss_pred h----cCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 611 N----EGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 611 ~----~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
. ...........+...........+.+|+.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00011100000000001111224667899999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-42 Score=355.21 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=201.1
Q ss_pred cCCCccceeccCCceeEEEEEeC----CCcEEEEEEcCcc----chhhHHHHHHHHHHHhhcCC-cceeeeEeEEEeCCe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA----DEQEIAVKRLSKI----SEQGLKELKNEIILFSKLQH-RNLVKLLGCCIHGEE 457 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 457 (706)
++|++.++||+|+||+||+|+.. .|+.||||++.+. .....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999862 3789999998652 22345678899999999976 899999999999999
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.++||||+.+|+|.+++.... .+....+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999996543 3677888999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccCccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCC
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMP 615 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (706)
.+..... .......|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+....+...........+
T Consensus 178 ~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~ 256 (322)
T d1vzoa_ 178 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256 (322)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred hhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc
Confidence 7643322 223346799999999999765 4788999999999999999999998765555444443332221111111
Q ss_pred cccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCC-----hhHHHH
Q 005236 616 SQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPC-----MPSVIL 658 (706)
Q Consensus 616 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~ev~~ 658 (706)
.. . ...+.+++.+||+.||.+||| ++|+++
T Consensus 257 ~~---------~----s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 257 QE---------M----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp TT---------S----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cc---------C----CHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11 1 124667889999999999995 788875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=356.45 Aligned_cols=264 Identities=22% Similarity=0.310 Sum_probs=196.3
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc-chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC----eeE
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI-SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE----EKL 459 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 459 (706)
.++|++.++||+|+||+||+|+. .+++.||||++... .....+.+.+|+.++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999987 46899999999753 3445678899999999999999999999987653 345
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccccc
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 539 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~ 539 (706)
++++|+.+|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 666778899999999543 4899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCc-ccccccccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCcc
Q 005236 540 GGDETE-GNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQ 617 (706)
Q Consensus 540 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (706)
...... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||...... .................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL---DQLNHILGILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH---HHHHHHhhhccCCChhh
Confidence 433222 22345679999999999854 56789999999999999999999998543221 11111111111100000
Q ss_pred c-----------cccc-ccCcCCHHH-----HHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 618 L-----------IDAC-FKDSFNLAE-----VIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 618 ~-----------~d~~-~~~~~~~~~-----~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
. .... ......... ..++.+++.+||+.||.+|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000 000001110 1246789999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=357.45 Aligned_cols=260 Identities=23% Similarity=0.315 Sum_probs=193.7
Q ss_pred ccCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCC------
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGE------ 456 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 456 (706)
.++|++.++||+|+||+||+|++. +|+.||||+++. ......+.+.+|+.++++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 368999999999999999999984 589999999975 34455678899999999999999999999998654
Q ss_pred eeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccc
Q 005236 457 EKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 536 (706)
Q Consensus 457 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla 536 (706)
..++||||+ +.+|..++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 5677776643 34899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH-----h
Q 005236 537 RAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKL-----W 610 (706)
Q Consensus 537 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~-----~ 610 (706)
+..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.................. +
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 875332 2346789999999998764 5789999999999999999999998543221111111110000 0
Q ss_pred h--------------cCCCcccccccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH--hcCC
Q 005236 611 N--------------EGMPSQLIDACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM--LGSE 663 (706)
Q Consensus 611 ~--------------~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~--L~~~ 663 (706)
. ...........+ ...+ ..+.+|+.+||+.||.+|||++|+++. ++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s----~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASIL-TNAS----PLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTC-TTCC----HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhcchhhhhhhccCCcccccchHHhc-cCCC----HHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0 000000000000 1111 245678999999999999999999985 6554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-41 Score=345.75 Aligned_cols=262 Identities=23% Similarity=0.292 Sum_probs=202.5
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeCCeeEEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 463 (706)
++|++.++||+|+||+||+|++ .+++.||||+++. ......+.+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999998 4688899999854 334456889999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeeccccccCCCC
Q 005236 464 FMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 543 (706)
Q Consensus 464 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~~~~~~ 543 (706)
++.+++|..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 99999998887543 45788999999999999999999988 9999999999999999999999999998864332
Q ss_pred CcccccccccccCccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCccc----
Q 005236 544 TEGNTNRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPSQL---- 618 (706)
Q Consensus 544 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 618 (706)
. ......+++.|+|||.+.... ++.++||||+||++|||++|+.||.. ..+..+.................
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC--CCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 2 222345788999999987665 68999999999999999999999632 22223333332222211110000
Q ss_pred --cc--------cccc-CcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 619 --ID--------ACFK-DSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 619 --~d--------~~~~-~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.+ .... ..........+.+|+.+||+.||.+|||++||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000 0000011124567899999999999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.8e-41 Score=349.38 Aligned_cols=255 Identities=19% Similarity=0.306 Sum_probs=194.3
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeC--CeeEEEE
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHG--EEKLLIY 462 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~ 462 (706)
++|++.++||+|+||+||+|+. .+++.||||+++... .+.+.+|+.++++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6899999999999999999998 458899999986543 457889999999995 99999999999854 4689999
Q ss_pred ecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-CeEEeeeccccccCC
Q 005236 463 EFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFGG 541 (706)
Q Consensus 463 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfgla~~~~~ 541 (706)
||+++++|..+. +.+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+..
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999998764 34889999999999999999999998 99999999999998765 599999999987643
Q ss_pred CCCcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHH-----------
Q 005236 542 DETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKL----------- 609 (706)
Q Consensus 542 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~----------- 609 (706)
.. ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....... .........
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~--~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHH
T ss_pred CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH--HHHHHHHHHHCCchhhhhhh
Confidence 32 23345789999999998765 57999999999999999999999976433211 111111000
Q ss_pred -hhcCCCcccc-----------cccccCcCCHHHHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 610 -WNEGMPSQLI-----------DACFKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 610 -~~~~~~~~~~-----------d~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
.......... ...............+.+|+.+||+.||.+|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000 000000000001124678999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=352.66 Aligned_cols=261 Identities=23% Similarity=0.267 Sum_probs=189.1
Q ss_pred cCCCccceeccCCceeEEEEEeC-CCcEEEEEEcCc--cchhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC------Ce
Q 005236 387 DNFSINKKLGEGGFGPVYKGTLA-DEQEIAVKRLSK--ISEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG------EE 457 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 457 (706)
++|++.++||+|+||+||+|++. +|+.||||++.. ......+.+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999985 589999999864 3445566789999999999999999999999643 57
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.++||||+.++.+..+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999776555432 34789999999999999999999998 9999999999999999999999999988
Q ss_pred ccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH----------
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAW---------- 607 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~---------- 607 (706)
..... .......+|+.|+|||++.+..++.++||||+||++|||++|+.||...+.......+....
T Consensus 168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 75332 22334578999999999999999999999999999999999999985432211111111000
Q ss_pred ------HHhhcCC-C-----cccccccccCcC---CHHHHHHHHHHHHHhcCCCCCCCCChhHHHHH
Q 005236 608 ------KLWNEGM-P-----SQLIDACFKDSF---NLAEVIRCIHIGLLCVQQYPEDRPCMPSVILM 659 (706)
Q Consensus 608 ------~~~~~~~-~-----~~~~d~~~~~~~---~~~~~~~~~~l~~~cl~~~p~~RPt~~ev~~~ 659 (706)
....... . ............ .......+.+|+.+||+.||++|||++||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 0 001111111111 11223457789999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=352.07 Aligned_cols=257 Identities=24% Similarity=0.331 Sum_probs=193.6
Q ss_pred ccCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCcc--chhhHHHHHHHHHHHhhcCCcceeeeEeEEEeC-----Ce
Q 005236 386 TDNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKI--SEQGLKELKNEIILFSKLQHRNLVKLLGCCIHG-----EE 457 (706)
Q Consensus 386 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 457 (706)
.++|++.++||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999997 46899999999753 344567889999999999999999999998643 34
Q ss_pred eEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEEeeecccc
Q 005236 458 KLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 537 (706)
Q Consensus 458 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~ 537 (706)
.+++|+|+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5777888899999999853 34899999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCCCcccccccccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHHhhcCCCc
Q 005236 538 AFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNLIRHAWKLWNEGMPS 616 (706)
Q Consensus 538 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (706)
... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+.......+ ...... ...
T Consensus 170 ~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i---~~~~~~-~~~ 240 (348)
T d2gfsa1 170 HTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGT-PGA 240 (348)
T ss_dssp CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCC-CCH
T ss_pred ccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCC-CCh
Confidence 642 223346789999999987765 4689999999999999999999998543222111111 111100 000
Q ss_pred cccc------------ccc-cCcCCHH-----HHHHHHHHHHHhcCCCCCCCCChhHHHH
Q 005236 617 QLID------------ACF-KDSFNLA-----EVIRCIHIGLLCVQQYPEDRPCMPSVIL 658 (706)
Q Consensus 617 ~~~d------------~~~-~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~ev~~ 658 (706)
+... ... ....... ....+.+|+.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000 000 0000010 0124568999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.1e-36 Score=317.47 Aligned_cols=264 Identities=20% Similarity=0.213 Sum_probs=192.0
Q ss_pred cCCCccceeccCCceeEEEEEe-CCCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-----------CcceeeeEeEEEe
Q 005236 387 DNFSINKKLGEGGFGPVYKGTL-ADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-----------HRNLVKLLGCCIH 454 (706)
Q Consensus 387 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 454 (706)
++|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999998 468999999997543 33467788998888875 5789999988865
Q ss_pred C--CeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCcEEEcCCCC----
Q 005236 455 G--EEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMN---- 527 (706)
Q Consensus 455 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~---- 527 (706)
. ...+++|+++..+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4567777777666554444444455668889999999999999999998 65 999999999999987654
Q ss_pred --eEEeeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCchhH---
Q 005236 528 --PKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNKLNL--- 602 (706)
Q Consensus 528 --~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~elltG~~p~~~~~~~~~~~~--- 602 (706)
++|+|||.+..... ......||+.|+|||++....++.++||||+||+++||++|+.||...........
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 99999999986432 22346799999999999999999999999999999999999999865433221111
Q ss_pred HHHHHHHhhc------------------C-CCccccc-------cc--ccCcCCHHHHHHHHHHHHHhcCCCCCCCCChh
Q 005236 603 IRHAWKLWNE------------------G-MPSQLID-------AC--FKDSFNLAEVIRCIHIGLLCVQQYPEDRPCMP 654 (706)
Q Consensus 603 ~~~~~~~~~~------------------~-~~~~~~d-------~~--~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ 654 (706)
.......... . ....+.. .. ............+.+|+.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 1111111100 0 0000000 00 01122334556788999999999999999999
Q ss_pred HHHHH
Q 005236 655 SVILM 659 (706)
Q Consensus 655 ev~~~ 659 (706)
|+++.
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=5.9e-23 Score=195.75 Aligned_cols=171 Identities=20% Similarity=0.176 Sum_probs=122.1
Q ss_pred CCccceeccCCceeEEEEEeCCCcEEEEEEcCccc------------------hhhHHHHHHHHHHHhhcCCcceeeeEe
Q 005236 389 FSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKIS------------------EQGLKELKNEIILFSKLQHRNLVKLLG 450 (706)
Q Consensus 389 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~~ 450 (706)
+.+.++||+|+||.||+|++.+|+.||||+++... ......+..|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 35679999999999999999899999999864210 011234567888999999999998876
Q ss_pred EEEeCCeeEEEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCCeEE
Q 005236 451 CCIHGEEKLLIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 530 (706)
Q Consensus 451 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 530 (706)
+. ..+++|||+++..+.+ ++......++.|++++|+|||+.+ |+||||||+|||+++++ ++|
T Consensus 82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEE
T ss_pred ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEE
Confidence 52 2479999998866543 334445679999999999999988 99999999999999655 899
Q ss_pred eeeccccccCCCCCcccccccccccCccCccccccCCCCcchhhHHHHHHHH
Q 005236 531 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLL 582 (706)
Q Consensus 531 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvil~ 582 (706)
+|||+|.............. ....+ .|. ....|+.++|+||..--+.
T Consensus 144 iDFG~a~~~~~~~~~~~l~r---d~~~~-~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILER---DVRNI-ITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCCTTCEETTSTTHHHHHHH---HHHHH-HHH-HHHHHCCCCCHHHHHHHHH
T ss_pred EECCCcccCCCCCcHHHHHH---HHHHH-HHH-HcCCCCCcccHHHHHHHHh
Confidence 99999976532111100000 00000 111 1356788999999865443
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.62 E-value=3e-08 Score=84.04 Aligned_cols=110 Identities=15% Similarity=0.138 Sum_probs=67.1
Q ss_pred EEecCCcEEEEecCCCCCceEEEeecCCCcccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcceEEe
Q 005236 8 FVCYSGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMW 87 (706)
Q Consensus 8 ~l~~sGNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~~~~~ 87 (706)
.+.++||+||.+. +|+|.|++||.++|.| ..|.|+|.|+.+|+. .++
T Consensus 4 v~~~~~n~il~~~----------~~~~~~~~~l~~~q~l---------------------~~g~y~L~~q~DGNL--vL~ 50 (120)
T d1dlpa2 4 VVANNGNSILYST----------QGNDNHPQTLHATQSL---------------------QLSPYRLSMETDCNL--VLF 50 (120)
T ss_dssp CCSSCCCEECCCC------------CCCCCCEECSSCCC---------------------BCSSCEEEEETTTEE--EEE
T ss_pred EEEeCCCeEEEcC----------CCCCCcccEEcCCCee---------------------EcCCEEEEEcCCCcE--EEe
Confidence 4556666666532 6789999999999999 578899999999974 667
Q ss_pred eCCceeeeeCCCCCCccccccccccCcceeEEeecCCeeEEEEEccCCceEEEEEEecccceEEEE
Q 005236 88 KGSRKFYRSGPWNGLRFSAATLRQNPVFNFSFVSSEDELYYTFDLIDKAVFSRIVMNQTLYLRQRF 153 (706)
Q Consensus 88 ~~~~~yw~sg~w~g~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G~~~~~~ 153 (706)
....++|.++.-........-+..... +.+.+...+..+...........+++|+.|| +++.|
T Consensus 51 ~~~~~vW~s~t~~~~~~~~~~l~~~Gn--Lvl~d~~~~~lW~S~t~~~~~~~~l~Lq~DG-nlvlY 113 (120)
T d1dlpa2 51 DRDDRVWSTNTAGKGTGCRAVLQPNGR--MDVLTNQNIAVWTSGNSRSAGRYVFVLQPDR-NLAIY 113 (120)
T ss_dssp BTTBCCSCCCCCSSCSSCEEEEETTTE--EEEEETTTEEEEECCCCCSSSCCEEEECSSS-CEEEE
T ss_pred cCCcEEEEEccccCCCcEEEEEeCCee--EEEEcCCCCEEEEeCCCCCCCcEEEEECCCC-cEEEe
Confidence 778899987642211111111222221 2222344444444333333334579999999 88876
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.61 E-value=8.9e-08 Score=93.86 Aligned_cols=149 Identities=16% Similarity=0.096 Sum_probs=103.6
Q ss_pred HHHHhccCCCccceeccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcC-CcceeeeEeEEEeCCeeE
Q 005236 381 TIANATDNFSINKKLGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQ-HRNLVKLLGCCIHGEEKL 459 (706)
Q Consensus 381 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 459 (706)
++....+.|++.+..+.++-+.||+... +++.++||+...........+.+|...+..+. +--+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3444556777766655555578998865 56678889876654444556778888887774 434677888888888999
Q ss_pred EEEecCCCCChhhhhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 005236 460 LIYEFMPNKSLDSFIFDQERCKLLDWSKRFHIICGTARGLLYLHQDS--------------------------------- 506 (706)
Q Consensus 460 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------- 506 (706)
+||+++++.++.+..... .....++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999998886544211 112334555666666666321
Q ss_pred -----------------------CCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 507 -----------------------RLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 507 -----------------------~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12489999999999999877778999998764
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.32 E-value=1.8e-06 Score=72.12 Aligned_cols=111 Identities=11% Similarity=0.162 Sum_probs=68.1
Q ss_pred cccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcceEEeeCCceeeeeCCCCCCccccccccccCcce
Q 005236 37 SDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAATLRQNPVFN 116 (706)
Q Consensus 37 tDtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~~~~~~~~~~yw~sg~w~g~~~s~~~~~~~~~~~ 116 (706)
||||+|||.|..+ ..|+ .|+|+|.|+.+|+ ++++....++|.++..+...-....+.....+
T Consensus 1 tDtL~~gq~L~~g------~~l~---------~g~~~l~~q~DGN--Lvly~~~~~vW~s~~~~~~~~~~l~l~~dGnL- 62 (112)
T d1xd5a_ 1 SDRLNSGHQLDTG------GSLA---------EGGYLFIIQNDCN--LVLYDNNRAVWASGTNGKASGCVLKMQNDGNL- 62 (112)
T ss_dssp CCEEETTEEECTT------CEEE---------ETTEEEEECTTSC--EEEEETTEEEEECCCTTSCSSEEEEECTTSCE-
T ss_pred CCEecCCCEecCC------CEEE---------ECCEEEEEcCCCC--EEEEcCCcEEEEccCccCCCCcEEEEeccccE-
Confidence 7999999999433 3364 3999999999998 56677888999887643221111112222211
Q ss_pred eEEeecCCeeEEEEEccCCceEEEEEEecccceEEEEEEeccCcceEEEEeccCCCC
Q 005236 117 FSFVSSEDELYYTFDLIDKAVFSRIVMNQTLYLRQRFTWKKATQNWELQLNVPRDLC 173 (706)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G~~~~~~~w~~~~~~W~~~~~~p~~~C 173 (706)
.. .+.....+...........+++|..+| ++..|. ......|+...+.|
T Consensus 63 -vl-~~~~~~~w~s~t~~~~~~~~l~L~ddG-Nlvly~-----~~~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 63 -VI-YSGSRAIWASNTNRQNGNYYLILQRDR-NVVIYD-----NSNNAIWATHTNVG 111 (112)
T ss_dssp -EE-EETTEEEEECCCCCSCCCCEEEECTTS-CEEEEC-----TTSCEEEECCCCCC
T ss_pred -EE-EecCCeEEEEeeccCCCceEEEEcCCC-CEEEEC-----CCCcEEecCCCccC
Confidence 11 122333333333334445689999999 877662 23456788777655
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.26 E-value=6.9e-07 Score=75.39 Aligned_cols=53 Identities=11% Similarity=0.256 Sum_probs=35.4
Q ss_pred ceEEEEecCCcEEEEecCCCCCceEEEeecCCCcccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcc
Q 005236 4 LSFLFVCYSGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPE 83 (706)
Q Consensus 4 ~~~~~l~~sGNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~ 83 (706)
.+.|+|+++|||||++.++ +++|||| ++.++|.|.+.|+++|+..
T Consensus 67 ~~~~~l~~~GnLvl~d~~~----~~lW~S~-------------------------------t~~~~~~~~l~Lq~DGnlv 111 (120)
T d1dlpa2 67 GCRAVLQPNGRMDVLTNQN----IAVWTSG-------------------------------NSRSAGRYVFVLQPDRNLA 111 (120)
T ss_dssp SCEEEEETTTEEEEEETTT----EEEEECC-------------------------------CCCSSSCCEEEECSSSCEE
T ss_pred cEEEEEeCCeeEEEEcCCC----CEEEEeC-------------------------------CCCCCCcEEEEECCCCcEE
Confidence 3456666777777766543 5667765 3457889999999999865
Q ss_pred eEEeeCCceeee
Q 005236 84 LIMWKGSRKFYR 95 (706)
Q Consensus 84 ~~~~~~~~~yw~ 95 (706)
++ +.++|.
T Consensus 112 lY----~~~~W~ 119 (120)
T d1dlpa2 112 IY----GGALWT 119 (120)
T ss_dssp EE----CCCCCB
T ss_pred Ee----CCCccc
Confidence 44 335664
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.05 E-value=8.3e-06 Score=68.34 Aligned_cols=104 Identities=13% Similarity=0.104 Sum_probs=66.8
Q ss_pred EEEeecCCCcccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcceEEeeCCceeeeeCCCCCCccccc
Q 005236 28 YLWQSFDYPSDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAA 107 (706)
Q Consensus 28 ~~WqSFd~PtDtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~~~~~~~~~~yw~sg~w~g~~~s~~ 107 (706)
+-||++|.|.+||-++|.|..+ + +.|+|+|.|+.+|+ ++++++..++|.++......-...
T Consensus 5 ~s~~~~~~~~~~l~~~q~l~~~----------~-------~~~~y~l~mQ~DGN--LVLy~~~~~vWssnt~~~~~~~~l 65 (119)
T d1b2pa_ 5 FSKQPDDNHPQILHATESLEIL----------F-------GTHVYRFIMQTDCN--LVLYDNNNPIWATNTGGLGNGCRA 65 (119)
T ss_dssp ECSCSSSCCCCEEETTCEEEEE----------E-------TTEEEEEEECTTSC--EEEEETTEEEEECCCTTSCSSCEE
T ss_pred EeeecCCCCCCEEeCCCeEEEe----------c-------CCceEEEEECCCCc--EEEEECCeEEEEecCCCCCcceEE
Confidence 3489999999999999998422 1 58999999999998 456788889999876422111111
Q ss_pred cccccCcceeEEeecCCeeEEEEEccCCceEEEEEEecccceEEEE
Q 005236 108 TLRQNPVFNFSFVSSEDELYYTFDLIDKAVFSRIVMNQTLYLRQRF 153 (706)
Q Consensus 108 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G~~~~~~ 153 (706)
.+..... +.+.+..................+++|..|| ++..|
T Consensus 66 ~l~~dGn--LvL~d~~g~~vWsS~t~~~~~~~~l~Lq~DG-NlvlY 108 (119)
T d1b2pa_ 66 VLQPDGV--LVVITNENVTVWQSPVAGKAGHYVLVLQPDR-NVVIY 108 (119)
T ss_dssp EECTTSC--EEEECTTCCEEEECSCCCCSSCEEEEECTTS-CEEEE
T ss_pred EEEeCCC--EEEECCCCcEEEECCCcCCCCceEEEEcCCC-CEEEE
Confidence 1222221 2223333444444333333345579999999 87776
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.05 E-value=6.3e-06 Score=79.72 Aligned_cols=131 Identities=18% Similarity=0.136 Sum_probs=86.9
Q ss_pred eeccCCc-eeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCC--cceeeeEeEEEeCCeeEEEEecCCCCCh
Q 005236 394 KLGEGGF-GPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQH--RNLVKLLGCCIHGEEKLLIYEFMPNKSL 470 (706)
Q Consensus 394 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL 470 (706)
.+..|.. +.||+....++..+++|....... ..+..|...++.+.. -.+.+++.+..+.+..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455553 678999988888899998654332 346777777776643 3356778888888889999999998776
Q ss_pred hhhhhcccccCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 005236 471 DSFIFDQERCKLLDWSKRFHIICGTARGLLYLH----------------------------------------------- 503 (706)
Q Consensus 471 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH----------------------------------------------- 503 (706)
.+... .. ..++.++++.|.-||
T Consensus 94 ~~~~~--------~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSHL--------AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSCC--------CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred ccccc--------cH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 44210 00 011122222222222
Q ss_pred ----hC----CCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 504 ----QD----SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 504 ----~~----~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
.. .+..++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 21 123489999999999999887788999998754
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=97.90 E-value=1.6e-05 Score=66.05 Aligned_cols=81 Identities=19% Similarity=0.204 Sum_probs=54.9
Q ss_pred eEEEEecCCcEEEEecCCCCCceEEEeecCCCc-cccc---CCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCC
Q 005236 5 SFLFVCYSGNLVLRGERDGGSETYLWQSFDYPS-DTLL---PGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQD 80 (706)
Q Consensus 5 ~~~~l~~sGNlVl~~~~~~~~~~~~WqSFd~Pt-DtlL---pgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g 80 (706)
..+.|.++|||||++.. .++|+|..+-. .+-+ +.=.|-.- ...+ -+-|.+.++.++|.|.+.|+++|
T Consensus 28 ~~l~~q~DGNLvL~~~~-----~~vW~s~t~~~~~~~l~l~~dGNLvl~--d~~~--~~vWsS~t~~~~g~y~l~Lq~DG 98 (115)
T d1dlpa1 28 FRFTMQSDCNLVLFDSD-----VRVWASNTAGATGCRAVLQSDGLLVIL--TAQN--TIRWSSGTKGSIGNYVLVLQPDR 98 (115)
T ss_dssp EEEEECTTSCEEEEESS-----SEEECCCCCSCSCCBCCBCSSSCBCCB--CTTT--CCSCCCCCCCCSSCCEEEECSSS
T ss_pred EEEEECCCCeEEEEcCC-----eeEEEcccCCCCceEEEEeccCCEEEE--ccCC--CEEEEcCCCCCCCCEEEEECCCC
Confidence 36889999999999742 58999986621 2111 11111111 1111 24599999999999999999999
Q ss_pred CcceEEeeCCceeeeeCC
Q 005236 81 NPELIMWKGSRKFYRSGP 98 (706)
Q Consensus 81 ~~~~~~~~~~~~yw~sg~ 98 (706)
+..+ + +.++|.+|.
T Consensus 99 Nlvl--Y--~~~~Wssgt 112 (115)
T d1dlpa1 99 TVTI--Y--GPGLWDSGT 112 (115)
T ss_dssp CEEE--E--CSEEEECSC
T ss_pred cEEE--e--CCCeecCCC
Confidence 8644 4 458999885
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.61 E-value=0.00012 Score=75.35 Aligned_cols=76 Identities=11% Similarity=0.187 Sum_probs=49.5
Q ss_pred ceeccCCceeEEEEEeCC-CcEEEEEEcCcc-------chhhHHHHHHHHHHHhhcC-C--cceeeeEeEEEeCCeeEEE
Q 005236 393 KKLGEGGFGPVYKGTLAD-EQEIAVKRLSKI-------SEQGLKELKNEIILFSKLQ-H--RNLVKLLGCCIHGEEKLLI 461 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lV 461 (706)
+.||.|....||+.+..+ ++.++||.-... .+....+...|...++.+. + ..+++++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 678999999999998755 678999964321 1122344566777777662 2 345556544 56677899
Q ss_pred EecCCCCCh
Q 005236 462 YEFMPNKSL 470 (706)
Q Consensus 462 ~e~~~~gsL 470 (706)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999987543
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=97.57 E-value=8.9e-05 Score=60.84 Aligned_cols=80 Identities=16% Similarity=0.240 Sum_probs=53.5
Q ss_pred EEEEecCCcEEEEecCCCCCceEEEeecCCCccc--cc---CCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCC
Q 005236 6 FLFVCYSGNLVLRGERDGGSETYLWQSFDYPSDT--LL---PGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQD 80 (706)
Q Consensus 6 ~~~l~~sGNlVl~~~~~~~~~~~~WqSFd~PtDt--lL---pgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g 80 (706)
.+.|..+|||||++.. +.+|+|..++..+ -| +.-.|-. ..+.+. +=|.|.+..+.+.|.+.|+++|
T Consensus 22 ~l~~q~DGNLvly~~~-----~~vW~s~~~~~~~~~~l~l~~~Gnlvl--~~~~g~--~vWsS~t~~~~~~~~l~L~ddG 92 (108)
T d1jpca_ 22 VFIMQEDCNLVLYDVD-----KPIWATNTGGLSRSCFLSMQTDGNLVV--YNPSNK--PIWASNTGGQNGNYVCILQKDR 92 (108)
T ss_dssp EEEECTTSCEEEEETT-----EEEEECCCTTSCSSCEEEECTTSCEEE--ECTTCC--EEEECCCCCSCSCEEEEECTTS
T ss_pred EEEECCCCeEEEEeCC-----ceeeEeCCCCCCCccEEEEeccceEEE--ECCCcc--ceEEccccCCCCcEEEEEcCCC
Confidence 5789999999999743 7999999987432 11 1111111 122222 3388888778889999999999
Q ss_pred CcceEEeeCCceeeeeCC
Q 005236 81 NPELIMWKGSRKFYRSGP 98 (706)
Q Consensus 81 ~~~~~~~~~~~~yw~sg~ 98 (706)
+..++ +.+.|.|+.
T Consensus 93 NlVly----~~~~W~S~t 106 (108)
T d1jpca_ 93 NVVIY----GTDRWATGT 106 (108)
T ss_dssp CEEEE----ECCCCCCCC
T ss_pred CEEEe----CCCcccCCC
Confidence 86544 245787764
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=97.51 E-value=0.00026 Score=57.89 Aligned_cols=96 Identities=11% Similarity=0.184 Sum_probs=59.0
Q ss_pred ccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcceEEeeCCceeeeeCCCCCCccccccccccCccee
Q 005236 38 DTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAATLRQNPVFNF 117 (706)
Q Consensus 38 DtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~~~~~~~~~~yw~sg~w~g~~~s~~~~~~~~~~~~ 117 (706)
|||+|||.|. .|+ .| ..|+|++.|+.+|+ ++++++..++|.++...........+.... .+
T Consensus 2 ~~L~~g~~L~----~G~--~l---------~ng~~~l~~q~DGN--Lvly~~~~~vW~s~~~~~~~~~~l~l~~~G--nl 62 (108)
T d1jpca_ 2 NILYSGETLS----TGE--FL---------NYGSFVFIMQEDCN--LVLYDVDKPIWATNTGGLSRSCFLSMQTDG--NL 62 (108)
T ss_dssp CEEETTEEEC----TTC--EE---------EETTEEEEECTTSC--EEEEETTEEEEECCCTTSCSSCEEEECTTS--CE
T ss_pred CCccCCCEec----CCC--EE---------EcCCEEEEECCCCe--EEEEeCCceeeEeCCCCCCCccEEEEeccc--eE
Confidence 7999999993 333 35 35999999999998 567888899998875432211111122111 12
Q ss_pred EEeecCCeeEEEEEccCCceEEEEEEecccceEEEE
Q 005236 118 SFVSSEDELYYTFDLIDKAVFSRIVMNQTLYLRQRF 153 (706)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G~~~~~~ 153 (706)
.+.+.......+..........+++|..|| ++..|
T Consensus 63 vl~~~~g~~vWsS~t~~~~~~~~l~L~ddG-NlVly 97 (108)
T d1jpca_ 63 VVYNPSNKPIWASNTGGQNGNYVCILQKDR-NVVIY 97 (108)
T ss_dssp EEECTTCCEEEECCCCCSCSCEEEEECTTS-CEEEE
T ss_pred EEECCCccceEEccccCCCCcEEEEEcCCC-CEEEe
Confidence 223334444444433334445578899999 88777
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=97.49 E-value=0.00015 Score=60.38 Aligned_cols=82 Identities=16% Similarity=0.195 Sum_probs=52.9
Q ss_pred EEEEecCCcEEEEecCCCCCceEEEeecCCCc--ccccCCCccc-ceeecCCceEEEecCCCCCCCCCceEEEEeeCCCc
Q 005236 6 FLFVCYSGNLVLRGERDGGSETYLWQSFDYPS--DTLLPGMKLG-WDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNP 82 (706)
Q Consensus 6 ~~~l~~sGNlVl~~~~~~~~~~~~WqSFd~Pt--DtlLpgqklg-~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~ 82 (706)
.+.|+.+|||||++.. ..+|+|..+.. ++-|--|.=| .-...+... +=|.+.+.-+.|.|.+.|+++|+.
T Consensus 33 ~l~mQ~DGNLVLy~~~-----~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~--~vWsS~t~~~~~~~~l~Lq~DGNl 105 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDNN-----NPIWATNTGGLGNGCRAVLQPDGVLVVITNENV--TVWQSPVAGKAGHYVLVLQPDRNV 105 (119)
T ss_dssp EEEECTTSCEEEEETT-----EEEEECCCTTSCSSCEEEECTTSCEEEECTTCC--EEEECSCCCCSSCEEEEECTTSCE
T ss_pred EEEECCCCcEEEEECC-----eEEEEecCCCCCcceEEEEEeCCCEEEECCCCc--EEEECCCcCCCCceEEEEcCCCCE
Confidence 4789999999999643 68999998764 2222111111 001112222 237777776778999999999986
Q ss_pred ceEEeeCCceeeeeCC
Q 005236 83 ELIMWKGSRKFYRSGP 98 (706)
Q Consensus 83 ~~~~~~~~~~yw~sg~ 98 (706)
.++ +.+.|.|+.
T Consensus 106 vlY----g~~~W~S~T 117 (119)
T d1b2pa_ 106 VIY----GDALWATQT 117 (119)
T ss_dssp EEE----ESEEEECCC
T ss_pred EEE----CCCEeccCC
Confidence 554 357898875
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=97.20 E-value=0.00042 Score=56.69 Aligned_cols=82 Identities=18% Similarity=0.260 Sum_probs=51.1
Q ss_pred eEEEEecCCcEEEEecCCCCCceEEEeecCC-Ccc-----cccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEee
Q 005236 5 SFLFVCYSGNLVLRGERDGGSETYLWQSFDY-PSD-----TLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVER 78 (706)
Q Consensus 5 ~~~~l~~sGNlVl~~~~~~~~~~~~WqSFd~-PtD-----tlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~ 78 (706)
-.+.|..+|||||+... +.+|.|..+ |-. +|-+.-.|-.- .+.+.. =|.|.+..+.|.|.+.|++
T Consensus 21 ~~l~~q~dgnLvl~~~~-----~~vW~ant~~~~~~~~~l~l~~dGnLvl~--~~~g~~--vW~s~t~~~~~~~~l~L~d 91 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYDHS-----TSVWASNTGILGKKGCKAVLQSDGNFVVY--DAEGRS--LWASHSVRGNGNYVLVLQE 91 (109)
T ss_dssp EEEEECTTSCEEEEETT-----EEEEECCCCCTTCCCCEEEECTTSCEEEE--CSSSCE--EEECCCCCCSSCCEEEECT
T ss_pred EEEEecCCCeEEEEeCC-----EEEEEeCCCCCCceeEEEEEcCCceEEEE--eCCCcE--EEEEeeECCCCCEEEEEeC
Confidence 35788999999999632 789999765 211 11122223221 112222 3777777677889999999
Q ss_pred CCCcceEEeeCCceeeeeCCC
Q 005236 79 QDNPELIMWKGSRKFYRSGPW 99 (706)
Q Consensus 79 ~g~~~~~~~~~~~~yw~sg~w 99 (706)
+|+..++ +.+.|.|+.+
T Consensus 92 dGNlvly----~~~~W~S~t~ 108 (109)
T d1kj1a_ 92 DGNVVIY----GSDIWSTGTY 108 (109)
T ss_dssp TSCEEEE----CCEEEECCCC
T ss_pred CCcEEEE----CCCEecCCCc
Confidence 9986443 3468888753
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=97.13 E-value=0.0012 Score=53.84 Aligned_cols=96 Identities=14% Similarity=0.128 Sum_probs=55.2
Q ss_pred ccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcceEEeeCCceeeeeCCCCCC-ccccccccccCcce
Q 005236 38 DTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFYRSGPWNGL-RFSAATLRQNPVFN 116 (706)
Q Consensus 38 DtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~~~~~~~~~~yw~sg~w~g~-~~s~~~~~~~~~~~ 116 (706)
|||.|||.|. .|. .|+ .|.|++.|+.+|+ ++++....++|.++.-... ......+.....
T Consensus 2 ~~L~~g~~L~----~g~--~l~---------~g~~~l~~q~dgn--Lvl~~~~~~vW~ant~~~~~~~~~l~l~~dGn-- 62 (109)
T d1kj1a_ 2 NLLTNGEGLY----AGQ--SLD---------VEPYHFIMQEDCN--LVLYDHSTSVWASNTGILGKKGCKAVLQSDGN-- 62 (109)
T ss_dssp CEEETTCEEE----TTC--EEE---------ETTEEEEECTTSC--EEEEETTEEEEECCCCCTTCCCCEEEECTTSC--
T ss_pred CCccCCCEEe----CCC--EEE---------eCCEEEEecCCCe--EEEEeCCEEEEEeCCCCCCceeEEEEEcCCce--
Confidence 7899999883 333 354 4899999999998 4667788899987542111 001111222221
Q ss_pred eEEeecCCeeEEEEEccCCceEEEEEEecccceEEEE
Q 005236 117 FSFVSSEDELYYTFDLIDKAVFSRIVMNQTLYLRQRF 153 (706)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G~~~~~~ 153 (706)
+...+........-.......-.+++|..|| ++..|
T Consensus 63 Lvl~~~~g~~vW~s~t~~~~~~~~l~L~ddG-Nlvly 98 (109)
T d1kj1a_ 63 FVVYDAEGRSLWASHSVRGNGNYVLVLQEDG-NVVIY 98 (109)
T ss_dssp EEEECSSSCEEEECCCCCCSSCCEEEECTTS-CEEEE
T ss_pred EEEEeCCCcEEEEEeeECCCCCEEEEEeCCC-cEEEE
Confidence 1122233333333333333334578999999 77776
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.87 E-value=0.0019 Score=64.10 Aligned_cols=136 Identities=14% Similarity=0.118 Sum_probs=78.7
Q ss_pred ceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCccee--eeE-----eEEEeCCeeEEEEecCCCCChhh
Q 005236 400 FGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNLV--KLL-----GCCIHGEEKLLIYEFMPNKSLDS 472 (706)
Q Consensus 400 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~l~-----~~~~~~~~~~lV~e~~~~gsL~~ 472 (706)
--.||+++..+|+.+++|..+.. ....+++..|...+..|....|. ..+ .........+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 46899999999999999987543 22346678888888777532221 111 12344567789999998754321
Q ss_pred ----hh----------hc------ccccCCCCHH-------------------HHHHHHHHHHHHHHHHHh----CCCCc
Q 005236 473 ----FI----------FD------QERCKLLDWS-------------------KRFHIICGTARGLLYLHQ----DSRLR 509 (706)
Q Consensus 473 ----~l----------~~------~~~~~~l~~~-------------------~~~~i~~~ia~~l~~LH~----~~~~~ 509 (706)
.+ +. ......+++. ..-.+...+.+.++.+.. ..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 01 10 0001111111 111122222223333322 22456
Q ss_pred eEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 510 IIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 510 ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
+||+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.82 E-value=0.0014 Score=67.14 Aligned_cols=73 Identities=21% Similarity=0.326 Sum_probs=48.9
Q ss_pred ceeccCCceeEEEEEeCCC--------cEEEEEEcCccchhhHHHHHHHHHHHhhcCCcce-eeeEeEEEeCCeeEEEEe
Q 005236 393 KKLGEGGFGPVYKGTLADE--------QEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL-VKLLGCCIHGEEKLLIYE 463 (706)
Q Consensus 393 ~~lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e 463 (706)
+.|+.|-.-.+|++...++ +.|++++.... . ......+|..+++.+.-.++ .++++++. -.+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-TESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-CHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEE
Confidence 6788899999999987543 45666655422 2 23345678888888753344 46777663 268999
Q ss_pred cCCCCChh
Q 005236 464 FMPNKSLD 471 (706)
Q Consensus 464 ~~~~gsL~ 471 (706)
|+++.+|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99886654
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=96.60 E-value=0.0077 Score=49.11 Aligned_cols=82 Identities=21% Similarity=0.343 Sum_probs=52.6
Q ss_pred eEEEEecCCcEEEEecCCCCCceEEEeecCCCcccccCCCcccce----e--ecCCceEEEecCCCCCCCCCceEEEEee
Q 005236 5 SFLFVCYSGNLVLRGERDGGSETYLWQSFDYPSDTLLPGMKLGWD----L--KTGLERRITSWKSPDDPSPGNFTWAVER 78 (706)
Q Consensus 5 ~~~~l~~sGNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgqklg~~----~--~tg~~~~L~Sw~s~~dps~G~fsl~~~~ 78 (706)
-.+.|.++|||||+..+ .++|+|..++.. ++-+|... . ..+ .. .-|.+.+.-..|.+.+.|++
T Consensus 21 ~~l~~q~DGNLvly~~~-----~~vW~s~~~~~~---~~~~l~l~~dGnLvl~~~-~~--~~w~s~t~~~~~~~~l~L~d 89 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYDNN-----RAVWASGTNGKA---SGCVLKMQNDGNLVIYSG-SR--AIWASNTNRQNGNYYLILQR 89 (112)
T ss_dssp EEEEECTTSCEEEEETT-----EEEEECCCTTSC---SSEEEEECTTSCEEEEET-TE--EEEECCCCCSCCCCEEEECT
T ss_pred EEEEEcCCCCEEEEcCC-----cEEEEccCccCC---CCcEEEEeccccEEEEec-CC--eEEEEeeccCCCceEEEEcC
Confidence 46889999999999742 799999876531 22222111 0 011 11 24666666667889999999
Q ss_pred CCCcceEEeeCCceeeeeCC
Q 005236 79 QDNPELIMWKGSRKFYRSGP 98 (706)
Q Consensus 79 ~g~~~~~~~~~~~~yw~sg~ 98 (706)
+|+..++ -....+.|.|+.
T Consensus 90 dGNlvly-~~~~~~~W~S~t 108 (112)
T d1xd5a_ 90 DRNVVIY-DNSNNAIWATHT 108 (112)
T ss_dssp TSCEEEE-CTTSCEEEECCC
T ss_pred CCCEEEE-CCCCcEEecCCC
Confidence 9985443 223568898875
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=96.56 E-value=0.0028 Score=52.05 Aligned_cols=90 Identities=11% Similarity=0.194 Sum_probs=52.8
Q ss_pred cccccCCCcccceeecCCceEEEecCCCCCCCCCceEEEEeeCCCcceEEeeCCceeeeeCCCCCCccccccccccCcce
Q 005236 37 SDTLLPGMKLGWDLKTGLERRITSWKSPDDPSPGNFTWAVERQDNPELIMWKGSRKFYRSGPWNGLRFSAATLRQNPVFN 116 (706)
Q Consensus 37 tDtlLpgqklg~~~~tg~~~~L~Sw~s~~dps~G~fsl~~~~~g~~~~~~~~~~~~yw~sg~w~g~~~s~~~~~~~~~~~ 116 (706)
++||-++|.| ..|.|+|.|+.+|+. +++++..+||.++.- +.......+.....+.
T Consensus 14 ~~tl~~~~~l---------------------~~g~~~l~~q~DGNL--vL~~~~~~vW~s~t~-~~~~~~l~l~~dGNLv 69 (115)
T d1dlpa1 14 PQTLHAAQSL---------------------ELSSFRFTMQSDCNL--VLFDSDVRVWASNTA-GATGCRAVLQSDGLLV 69 (115)
T ss_dssp CSCCCTTCEE---------------------CSTTEEEEECTTSCE--EEEESSSEEECCCCC-SCSCCBCCBCSSSCBC
T ss_pred cceecCCCcE---------------------EcCCEEEEECCCCeE--EEEcCCeeEEEcccC-CCCceEEEEeccCCEE
Confidence 4888888888 578999999999984 567788899998642 1111111122222111
Q ss_pred eEEeecCCeeEEEEEccCCceEEEEEEecccceEEEE
Q 005236 117 FSFVSSEDELYYTFDLIDKAVFSRIVMNQTLYLRQRF 153 (706)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G~~~~~~ 153 (706)
+.+..................+++|..|| ++..|
T Consensus 70 --l~d~~~~~vWsS~t~~~~g~y~l~Lq~DG-NlvlY 103 (115)
T d1dlpa1 70 --ILTAQNTIRWSSGTKGSIGNYVLVLQPDR-TVTIY 103 (115)
T ss_dssp --CBCTTTCCSCCCCCCCCSSCCEEEECSSS-CEEEE
T ss_pred --EEccCCCEEEEcCCCCCCCCEEEEECCCC-cEEEe
Confidence 11222232222222223333468899999 77766
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.00 E-value=0.011 Score=57.86 Aligned_cols=157 Identities=15% Similarity=0.033 Sum_probs=82.7
Q ss_pred HHHHHHhccCCCccce-----eccCCceeEEEEEeCCCcEEEEEEcCccchhhHHHHHHHHHHHhhcCCcce-----eee
Q 005236 379 LATIANATDNFSINKK-----LGEGGFGPVYKGTLADEQEIAVKRLSKISEQGLKELKNEIILFSKLQHRNL-----VKL 448 (706)
Q Consensus 379 ~~~~~~~~~~~~~~~~-----lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~l 448 (706)
..++.....+|.+.+. |..|---+.|+.+..+| .+++|+..... ..+++..|+.++..|.+.++ +..
T Consensus 5 ~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 5 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccccee
Confidence 3455556667766433 44666688899988665 58999875432 22355566667766643222 211
Q ss_pred E---eEEEeCCeeEEEEecCCCCChhhhh--------------hcc------cccC------------------CCCHHH
Q 005236 449 L---GCCIHGEEKLLIYEFMPNKSLDSFI--------------FDQ------ERCK------------------LLDWSK 487 (706)
Q Consensus 449 ~---~~~~~~~~~~lV~e~~~~gsL~~~l--------------~~~------~~~~------------------~l~~~~ 487 (706)
. .+.........++.++.+......- +.. .... ......
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 0 1122344566777777664432110 000 0000 000111
Q ss_pred HHHHHHHHHHHHHHHHh-CCCCceEecccCCCcEEEcCCCCeEEeeeccccc
Q 005236 488 RFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 538 (706)
Q Consensus 488 ~~~i~~~ia~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~Dfgla~~ 538 (706)
....+..+...+...+. .-+..+||+|+.+.||+++.+...-|+||+.+..
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 11222222233333222 1234599999999999999988889999998864
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.87 E-value=0.028 Score=33.81 Aligned_cols=32 Identities=34% Similarity=0.716 Sum_probs=25.3
Q ss_pred CCCccCCCCCCCccccCC-CCCcccccCCcccCC
Q 005236 171 DLCDTYALCGDYGICIIS-DLPVCQCLKGFKPKS 203 (706)
Q Consensus 171 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~Gf~~~~ 203 (706)
|+|.+-..|| +|.|+.- ..-.|.|-.||+|..
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 6899999999 7889543 234799999999863
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.54 E-value=0.059 Score=34.82 Aligned_cols=32 Identities=34% Similarity=0.714 Sum_probs=24.9
Q ss_pred CCCcc-CCCCCCCccccCC-CCCcccccCCcccC
Q 005236 171 DLCDT-YALCGDYGICIIS-DLPVCQCLKGFKPK 202 (706)
Q Consensus 171 ~~C~~-~~~CG~~g~C~~~-~~~~C~C~~Gf~~~ 202 (706)
|+|.. ...|..+|.|... ..-.|.|++||+-.
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G~ 37 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYTGP 37 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEEST
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCcCC
Confidence 67775 5789999999655 34589999999743
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.17 E-value=0.14 Score=32.30 Aligned_cols=32 Identities=34% Similarity=0.785 Sum_probs=24.4
Q ss_pred CCCccCCCCCCCccccCC-CCCcccccCCcccCC
Q 005236 171 DLCDTYALCGDYGICIIS-DLPVCQCLKGFKPKS 203 (706)
Q Consensus 171 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~Gf~~~~ 203 (706)
|.|. ...|...|.|... ..-.|.|++||+-..
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G~~ 33 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEGKN 33 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEETTT
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCcCc
Confidence 4565 4789999999655 446899999998543
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.80 E-value=0.16 Score=33.00 Aligned_cols=32 Identities=28% Similarity=0.650 Sum_probs=23.2
Q ss_pred CCCcc-CCCCCCCccccCC-CCCcccccCCcccCC
Q 005236 171 DLCDT-YALCGDYGICIIS-DLPVCQCLKGFKPKS 203 (706)
Q Consensus 171 ~~C~~-~~~CG~~g~C~~~-~~~~C~C~~Gf~~~~ 203 (706)
|+|.. ...| .++.|... .+-.|.|++||+...
T Consensus 4 dEC~~~~~~C-~~~~C~Nt~Gsy~C~C~~Gy~~~~ 37 (44)
T d1lmja1 4 DECRISPDLC-GRGQCVNTPGDFECKCDEGYESGF 37 (44)
T ss_dssp CTTTTCSSTT-TTSCEEEETTEEEECCCSSEEECT
T ss_pred cccCCCCCCC-CCCEeEcCCCCeEEeCCCCCccCC
Confidence 67876 4455 47999655 445899999998643
|
| >d1dx5i2 g.3.11.1 (I:388-422) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Thrombomodulin, different EGF-like domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.29 E-value=0.16 Score=29.75 Aligned_cols=19 Identities=21% Similarity=0.550 Sum_probs=15.3
Q ss_pred cccCCCCCcccccCCcccC
Q 005236 184 ICIISDLPVCQCLKGFKPK 202 (706)
Q Consensus 184 ~C~~~~~~~C~C~~Gf~~~ 202 (706)
.|+.+....|+||.||..-
T Consensus 11 dCdP~~p~~C~CPeGyIld 29 (35)
T d1dx5i2 11 DCDPNTQASCECPEGYILD 29 (35)
T ss_dssp EECTTSTTCEECCTTEEEE
T ss_pred ccCCCCCCcccCCCceEec
Confidence 5777777889999999753
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.66 E-value=0.37 Score=30.98 Aligned_cols=31 Identities=26% Similarity=0.465 Sum_probs=23.6
Q ss_pred CCCCccCCCCCCCccccCC-CCCcccccCCccc
Q 005236 170 RDLCDTYALCGDYGICIIS-DLPVCQCLKGFKP 201 (706)
Q Consensus 170 ~~~C~~~~~CG~~g~C~~~-~~~~C~C~~Gf~~ 201 (706)
.|+|..+. |+.++.|... .+-.|.|++||..
T Consensus 5 idEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEPD-VCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCCcC-CCCCCEeECCCCCeEeECCCCccc
Confidence 37897654 5578999665 4558999999986
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.22 E-value=0.2 Score=31.50 Aligned_cols=31 Identities=19% Similarity=0.526 Sum_probs=23.5
Q ss_pred CCCccCCCCCCCccccCC-CCCcccccCCcccC
Q 005236 171 DLCDTYALCGDYGICIIS-DLPVCQCLKGFKPK 202 (706)
Q Consensus 171 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~Gf~~~ 202 (706)
|.|. ...|...|.|... ..-.|.|++||.-.
T Consensus 2 d~C~-~~PC~n~g~C~~~~~~y~C~C~~G~~G~ 33 (39)
T d2vj3a2 2 NECV-SNPCQNDATCLDQIGEFQCICMPGYEGV 33 (39)
T ss_dssp CTTT-TCCCCSSCEEEECSSCEEEECCTTEESS
T ss_pred cCCc-CCCCCCCCEEECCCCCEEEeCCCCCccC
Confidence 4564 4679999999654 44589999999854
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.82 E-value=0.36 Score=30.66 Aligned_cols=30 Identities=30% Similarity=0.656 Sum_probs=22.9
Q ss_pred CCCccCCCCCCCccccCC-CCCcccccCCcccC
Q 005236 171 DLCDTYALCGDYGICIIS-DLPVCQCLKGFKPK 202 (706)
Q Consensus 171 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~Gf~~~ 202 (706)
|+|...+.| ..+|... .+-.|.|++||...
T Consensus 2 dEC~~~~~C--~~~C~n~~Gsy~C~C~~Gy~L~ 32 (41)
T d1i0ua2 2 DECQDPDTC--SQLCVNLEGGYKCQCEEGFQLD 32 (41)
T ss_dssp CTTTTTTSC--SSCEECSSSCCEECCCTTEEEC
T ss_pred ccCCCCCCC--CCEeECCCCCEEeECCCCCeEC
Confidence 678877777 4689655 44589999999974
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.22 E-value=0.21 Score=31.49 Aligned_cols=32 Identities=31% Similarity=0.565 Sum_probs=24.7
Q ss_pred CCCCccCCCCCCCccccCC-CCCcccccCCcccC
Q 005236 170 RDLCDTYALCGDYGICIIS-DLPVCQCLKGFKPK 202 (706)
Q Consensus 170 ~~~C~~~~~CG~~g~C~~~-~~~~C~C~~Gf~~~ 202 (706)
.|+|. ...|-..|.|... ...+|.|++||+-.
T Consensus 3 ~d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G~ 35 (39)
T d1edmb_ 3 GDQCE-SNPCLNGGSCKDDINSYECWCPFGFEGK 35 (39)
T ss_dssp CCTTT-TCCCCTTCEEEEETTEEEEECCTTCCST
T ss_pred cccCC-CCCCCCCcEEEcCCCCEEEECCCCCCCC
Confidence 36786 5789999999654 34589999999754
|